<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020189444A1-20021219-C00001.CDX SYSTEM "US20020189444A1-20021219-C00001.CDX" NDATA CDX>
<!ENTITY US20020189444A1-20021219-C00001.MOL SYSTEM "US20020189444A1-20021219-C00001.MOL" NDATA MOL>
<!ENTITY US20020189444A1-20021219-C00001.TIF SYSTEM "US20020189444A1-20021219-C00001.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-C00002.CDX SYSTEM "US20020189444A1-20021219-C00002.CDX" NDATA CDX>
<!ENTITY US20020189444A1-20021219-C00002.MOL SYSTEM "US20020189444A1-20021219-C00002.MOL" NDATA MOL>
<!ENTITY US20020189444A1-20021219-C00002.TIF SYSTEM "US20020189444A1-20021219-C00002.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-C00003.CDX SYSTEM "US20020189444A1-20021219-C00003.CDX" NDATA CDX>
<!ENTITY US20020189444A1-20021219-C00003.MOL SYSTEM "US20020189444A1-20021219-C00003.MOL" NDATA MOL>
<!ENTITY US20020189444A1-20021219-C00003.TIF SYSTEM "US20020189444A1-20021219-C00003.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-C00004.CDX SYSTEM "US20020189444A1-20021219-C00004.CDX" NDATA CDX>
<!ENTITY US20020189444A1-20021219-C00004.MOL SYSTEM "US20020189444A1-20021219-C00004.MOL" NDATA MOL>
<!ENTITY US20020189444A1-20021219-C00004.TIF SYSTEM "US20020189444A1-20021219-C00004.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-C00005.CDX SYSTEM "US20020189444A1-20021219-C00005.CDX" NDATA CDX>
<!ENTITY US20020189444A1-20021219-C00005.MOL SYSTEM "US20020189444A1-20021219-C00005.MOL" NDATA MOL>
<!ENTITY US20020189444A1-20021219-C00005.TIF SYSTEM "US20020189444A1-20021219-C00005.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-C00006.CDX SYSTEM "US20020189444A1-20021219-C00006.CDX" NDATA CDX>
<!ENTITY US20020189444A1-20021219-C00006.MOL SYSTEM "US20020189444A1-20021219-C00006.MOL" NDATA MOL>
<!ENTITY US20020189444A1-20021219-C00006.TIF SYSTEM "US20020189444A1-20021219-C00006.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00000.TIF SYSTEM "US20020189444A1-20021219-D00000.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00001.TIF SYSTEM "US20020189444A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00002.TIF SYSTEM "US20020189444A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00003.TIF SYSTEM "US20020189444A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00004.TIF SYSTEM "US20020189444A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00005.TIF SYSTEM "US20020189444A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020189444A1-20021219-D00006.TIF SYSTEM "US20020189444A1-20021219-D00006.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020189444</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10113400</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020401</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>B01D053/22</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>095</class>
<subclass>045000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>Purification of gas with liquid ionic compounds</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60280032</doc-number>
<document-date>20010330</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Joan</given-name>
<middle-name>F.</middle-name>
<family-name>Brennecke</family-name>
</name>
<residence>
<residence-non-us>
<city>Granger</city>
<country-code>IN</country-code>
</residence-non-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Edward</given-name>
<middle-name>J.</middle-name>
<family-name>Maginn</family-name>
</name>
<residence>
<residence-non-us>
<city>Granger</city>
<country-code>IN</country-code>
</residence-non-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>BARNES &amp; THORNBURG</name-1>
<name-2></name-2>
<address>
<address-1>11 South Meridian Street</address-1>
<city>Indianapolis</city>
<state>IN</state>
<postalcode>46204</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The present invention provides a method for purifying a gas by contacting the gas with a liquid ionic compound. Natural gas may be purified, removing water and carbon dioxide, by contacting the natural gas with a liquid ionic compound. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS REFERENCE TO RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims priority to provisional patent application Serial No. 60/280032 filed Mar. 30, 2001, the disclosure of which is incorporated herein by reference.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with Government support under Grant CTS 99-87627 and Grant R 826734-01-0 awarded by the National Science Foundation and the Environmental Protection Agency, respectively. The Government has certain rights in the invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> This invention pertains to the purification or separation of gases using liquid ionic compounds. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND AND SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Purified gases are necessary for many industrial processes. For example, air must be purified by removing water vapor to produce dried air for use in machinery such as spray painting equipment, dental compressors, coordinate measuring machines, process controls, HVAC systems, pneumatic controls, electronics, and the like. Furthermore, dried air is required for the preparation of dry nitrogen. Purified nitrogen, free of both water and oxygen, is used in the storage and shipping of both flowers and food, as well as in delicate scientific operations, such as gas chromatography and mass spectroscopy. Other important industrial gases that are used in purified form include helium, argon, hydrogen, oxygen, and hydrocarbons. Typically, the gas purification processes involve the removal of water, carbon dioxide, or other component gases which may interfere with the end-use dependent application of the purified gas. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> The natural gas commonly used in nearly every household originates in underground sedimentary rock formations. Natural gas may contain a variety of impurities including carbon dioxide (CO<highlight><subscript>2</subscript></highlight>) and water. It is desirable to remove these two impurities for several reasons. Water may form hydrocarbon hydrates, possibly forming solids, that can plug pipelines and pumping equipment. These hydrates are an exceptional concern in cold climates or in high-pressure systems where solid formation may be more likely. In addition, the presence of CO<highlight><subscript>2 </subscript></highlight>tends to decrease the heating value of natural gas. Finally, the combination of CO<highlight><subscript>2 </subscript></highlight>and water impurities in natural gas may form carbonic acid which is corrosive to pumping equipment and the pipeline used for transporting the natural gas to storage facilities or end-users. Economic benefit is realized by removing these impurities, and by doing so as close to the well-head as possible. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Current methods of gas purification include the use of serial gas/liquid absorbers or gas/solid adsorbers. Gas/liquid absorbers may include pure liquids or liquid solutions that preferentially partition components of the gas. Gas/solid adsorbers may include substances, such as sodium bicarbonate, and the like, that preferentially remove certain compounds based upon affinity, or molecular sieves that differentiate the various gas components on the basis of molecular size or other physical property. The liquid or solid material employed in these separators is known as a mass separating agent (MSA) and advantageously exhibits a differential affinity for one or more of the gas components. MSAs may also be chosen, for example based on their stability to extreme environments, such as extremes in temperature or pressure, stability to certain organic solvents, and stability to pH extremes. Furthermore, MSAs may be added directly to a process stream to enable separation. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Other separation schemes may also be employed, such as the use of inorganic membranes, polymeric membranes, supported liquid membranes, and the like. Gases may also be separated in cryogenic processes. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Serial gas/liquid and gas/solid separators may be configured in linear arrays of absorption and adsorption units. These arrays are designed to remove a plurality of gaseous impurities by contacting a gas stream with several liquid or solid MSAs, each designed to remove preferentially at least a portion of these gaseous impurities, thereby producing an effluent gas stream enriched in the remaining gaseous components. In such processes, the liquid or solid MSA becomes loaded with the gaseous impurity. In an alternative arrangement, the liquid or solid MSA may preferentially take up the desired gas component for recovery later, thus producing an effluent gaseous stream of impurities. The desired component may be released from the MSA in another step of the process. It is appreciated that the process design selected for removal of impurities or the alternative collection of a desired component in a given gas purification procedure will depend upon several factors, including the selectivity exhibited by the MSA for particular gas components, the ease with which the desired component may be recovered from the MSA, and others. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> In systems where impurities are removed by selective absorption, it is often the case that multiple absorbers are used, one for each gas component impurity. For example, at present, two absorbers are required to remove CO<highlight><subscript>2 </subscript></highlight>and water from natural gas. Carbon dioxide can be selectively removed with a gas/liquid absorption unit charged with an aqueous amine solution, such as mono- or diethanolamine. These amines form carbamates upon reaction with CO<highlight><subscript>2</subscript></highlight>, and these carbamates preferentially partition into the aqueous liquid stream. Similarly, water may be removed by preferential absorption with a gas/liquid absorption unit charged with an ethylene glycol liquid stream. In addition, water may be preferentially removed with polymeric membrane modules. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> As many gas purification processes require the removal of more than one impurity, current conventional gas/liquid absorbers employ a separate absorption unit for removing each impurity. For example, one unit designed to remove carbon dioxide and an additional unit designed to remove water may be used as described above for natural gas. In addition, volatile components present in the absorbers, such as the amines used for CO<highlight><subscript>2 </subscript></highlight>absorption, often evaporate into the gas stream. Thus, the removed CO<highlight><subscript>2 </subscript></highlight>impurity may be replaced by the amine absorbing component. The resulting amine contamination is typically removed via condensation by means of a cold trap, and may be returned to the absorbing unit. However, such removal requires additional components added to the purification system. The requirement for multiple absorption units along with additional purification steps to remove subsequently released MSA can increase process time and operating costs. Furthermore, such complex systems may preclude near well-head implementation in deference to a centralized system for purification, and further increase the overall cost of goods resulting from the increased cost of transporting impure material. Finally, once exhausted, traditional absorbers must be replaced and few options are available for recovery or regeneration of spent MSAs, thereby adding replacement and disposal costs. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Liquid ionic compounds (LICs), often called &ldquo;ionic liquids are essentially non-volatile, having immeasurably low vapor pressures; they are not volatilized into the purified gas stream. Their low vapor pressure minimizes loss of absorbing material during use and provides a simple mechanism for regeneration, such as by distillation, evacuation, or by extraction with a supercritical fluid, such as supercritical carbon dioxide. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> As described herein, in one embodiment, the LIC selectively solubilizes impurities, leaving the desired gas in the gas stream. It is appreciated that in variations of the methods described herein, the LIC may selectively solubilize the desired gas component, leaving the impurities behind in the effluent stream. In such variations, recovery of the desired material may be accomplished by processes analogous to the regeneration mechanisms described above. Distillation, evacuation, or extraction with a supercritical fluid, and the like, will regenerate the LIC and simultaneously recover the desired purified gas; recovery rates greater than 90% are not unexpected. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> Moreover, LICs can be tailored for specific needs, allowing a single absorption unit to be used for the removal of more than one impurity, depending on the relative solubilities and/or diffusibilities in the LIC of the desired gas and the impurities. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> Furthermore, LICs may be prepared by simple and relatively inexpensive methods. Therefore, purification systems designed around LICs may be more amenable to near-wellhead processes in anticipation of their reduced operating costs. Finally, their exceedingly low vapor pressures make LICs environmentally friendly, during both use and regeneration, since both MSA loss and waste associated with MSAs may be minimized. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> Thus, in one embodiment a method is provided for purifying a gaseous mixture by contacting the gaseous mixture with a liquid ionic compound. In an illustrated embodiment, natural gas containing impurities such as water and carbon dioxide may be advantageously processed using LICs to provide purified natural gas for various industrial uses. In an illustrated example, the LICs preferentially absorb those impurities when contacted with the crude gas stream. Similarly, in another illustrated example, in the first step of producing purified nitrogen from air, impurities such as water and carbon dioxide are removed using an LIC. Subsequent separation of the oxygen and nitrogen may be performed by cryogenic distillation. In another example, commercial argon is also produced via the cryogenic distillation of air. In some processes, liquefaction and distillation are used to produce a low-purity crude argon product. Further purification to a higher-purity commercial product by removing oxygen with a LIC is contemplated by the present invention. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> It is appreciated that a gas may be contacted with the liquid ionic compound by conventional means known by those of ordinary skill in the art. Once the liquid ionic material contacts the gas, certain components such as carbon dioxide and water are extracted from the gas owing to the solubilities exhibited by various gas components in the LIC. LICs of the present invention include, but are not limited to, quaternary imidazolium salts, and quaternary aromatic 5- and 6-membered-ring heterocycles such as imidazolium salts, pyridinium salts, and the like. Specific examples include, but are not limited to, 1-butyl-3-methylimidazolium hexafluorophosphate, 1-octyl-3-methylimidazolium hexafluorophosphate, 1-butyl-3-methylimidazolium nitrate, 1-octyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium ethylsulfate, and N-butylpyridinium tetrafluoroborate.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows the absorption/desorption isotherms for water vapor in 1-(n-butyl)-3-methylimidazolium hexafluorophosphate. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> shows the temperature-dependent solubility of water vapor in 1-(n-butyl)-3-methylimidazolium hexafluorophosphate. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> shows the temperature-dependent solubility of water vapor in 1-n-octyl-3-methylimidazolium hexafluorophosphate. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> shows the temperature-dependent solubility of water vapor in 1-n-octyl-3-methylimidazolium tetrafluoroborate. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> shows breakthrough curves for CO<highlight><subscript>2</subscript></highlight>/N<highlight><subscript>2 </subscript></highlight>separation with 1-(n-butyl)-3-methylimidazolium hexafluorophosphate at 0.59 mL/min and 3.66 mL/min. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> shows the temperature-dependent solubility of CO<highlight><subscript>2 </subscript></highlight>in 1-(n-butyl)-3-methylimidazolium hexafluorophosphate. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> shows the temperature-dependent solubility of C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>4 </subscript></highlight>in 1-(n-butyl)-3-methylimidazolium hexafluorophosphate. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> shows temperature-dependent solubility of various gases in 1-(n-butyl)-3-methylimidazolium hexafluorophosphate. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 9</cross-reference> shows a batch absorber configuration. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 10</cross-reference> shows a supported liquid membrane configuration.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> The present invention pertains to the use of a liquid ionic compound (LIC) to separate certain gas components from a gaseous mixture. The gaseous mixture may be contacted with one or more liquid ionic compounds to separate at least a few of the gaseous components in the gaseous mixture due to the preferential solubility and/or diffusibility of the components in the LICs. Therefore, impurities, such as water, carbon dioxide, oxygen, and the like, may be removed from gases using methods described herein. An illustrative embodiment is a method to purify natural gas by removing impurities, such as carbon dioxide and water, by contacting the natural gas with a LIC. In another illustrative embodiment, low purity argon is purified by separating the oxygen impurity upon contact with a LIC. Other gases which may be purified using the present invention include nitrogen and air. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> For the purposes of this disclosure, it is understood that the gas and gaseous mixture may include vapors (volatilized liquids), gaseous compounds, and/or gaseous elements. Furthermore, while reference is made to &ldquo;purification, &rdquo; it is understood that purification may include purification to be essentially free of one or more impurities, or may include separation to provide enrichment of the desired gas. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> The use of LICs in accordance with this invention takes advantage of the differential solubility of various gas components present in source gases. Henry&apos;s law (eq. 1) illustratively forms the basis for assessing the capability of separating such components.</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>p</italic></highlight><highlight><subscript>l</subscript></highlight><highlight><italic>&equals;K</italic></highlight><highlight><subscript>i</subscript></highlight>(<highlight><italic>x</italic></highlight><highlight><subscript>l</subscript></highlight>).&emsp;&emsp;(eq.1)</in-line-formula></paragraph>
<paragraph id="P-0030" lvl="7"><number>&lsqb;0030&rsqb;</number> For a gas component (i), the mole fraction (x) of the gas dissolved in the LIC is a function of the partial pressure (p) of the gas, related by Henry&apos;s law constant (K). Gases exhibiting lower Ks are more soluble in the LIC than gases with higher Ks. Therefore, the selectivity of the LIC for two gases (i) and (j) may be represented by the ratio of their Henry&apos;s law constants (K<highlight><subscript>i</subscript></highlight>/K<highlight><subscript>j</subscript></highlight>). This ratio is predictive of the efficiency of separation of the gas (i) from the gas (j) using a LIC. Therefore, the greater the ratio, the more efficiently gas (j) can be separated from gas (i) by the LIC. At ratios approaching about 20, separations are typically satisfactory for general industrial scale separations. However, some separation processes may require higher exhibited ratios to yield satisfactory levels of purification. On the other hand, it is possible to obtain a satisfactory separation/purification level when the ratio is as low as about 2.0. Certain separation methods, such as batch separation methods, may be effective even with somewhat lower ratios, wherein the ratio of Henry&apos;s law constants for the gases to be separated may be as low as about 1.7. Preferably the K<highlight><subscript>i</subscript></highlight>/K<highlight><subscript>j </subscript></highlight>ratio for two gases being separated in accordance with this invention is at least about 1.7 to 2.0, more preferably at least 17, and most preferably about 20 or higher for commercially efficient separations. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> The term &ldquo;liquid ionic compound&rdquo; or &ldquo;LIC&rdquo; as used herein refers to a nonpolymeric salt comprising an organic cation and any of a variety of anions that is reasonably fluid under ambient conditions. The salt may comprise monovalent or polyvalent anions or cations. In addition, the LIC may be a single salt or a mixture of salts. The anions described herein are typically relatively non-nucleophilic anions. The term &ldquo;ambient conditions&rdquo; as used herein refers to temperatures from about 1&deg; C. to about 100&deg; C. and pressures of about 1 atmosphere. It is appreciated that some LICs useful in the present invention may have melting points above ambient temperatures. However, all LICs can be distinguished from conventional &ldquo;molten salts&rdquo;, such as sodium chloride, requiring excessive temperatures (&gt;250&deg; C.) to achieve a liquid phase. The LICs of the present invention have advantageously negligible vapor pressures under ambient conditions and often form stable liquids at temperatures up to about 300&deg; C. LICs also have a wide range of miscibilities with organic solvents and water; however, the LIC is not necessarily soluble in either one or the other of organic solvents or water. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> It is appreciated that the anion component of the LIC may impart acidic, basic, or neutral properties to the LIC. Such properties may be conveniently considered when choosing the LIC to enhance the capacity or selectivity of the separation. For example, LICs exhibiting more basic character may be better suited for CO<highlight><subscript>2 </subscript></highlight>absorption rather than for ammonia absorption. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> It is also appreciated that &ldquo;dried&rdquo; LICs, those that are substantially anhydrous, may exhibit greater overall capacity for removing some gaseous components, the presence of water in the LIC may reduce the capacity of the LIC for dissolving gas components. In addition, the presence of water may decrease the solubility of certain gas components, especially those gas components that are hydrophobic. It is further appreciated that dried LICs may exhibit differential selectivities between various gaseous components when compared to those LICs containing measurable amounts of dissolved water, such as LICs having been exposed to humid atmospheres. LICs may be dried by conventional methods, such as by heat treatment, exposure to a reduced pressure environment, or a combination of heat and reduced pressure. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> It is known that gas solubility in various liquids, including LICs, is dependent upon temperature. It is therefore appreciated that different gas components may each elicit a different sensitivity to temperature changes as pertains to the solubility of the gas component in the LIC. This differential temperature dependence may be advantageously exploited by conducting variations of the process of the present invention at different temperatures to optimize gas component separation. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> Contacting the LIC with the gaseous mixture may be accomplished in any of the variety of ways. The process is illustratively selected to promote intimate mixing of the liquid ionic compound with the source gas and is conducted for a time sufficient to allow significant removal of targeted components. Thus, systems maximizing surface area contact are desirable. Illustratively, contacting can occur by permeation through a supported liquid membrane or by use of conventional liquid absorbers, such as counter-current liquid absorbers and the like. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> Supported liquid membranes comprise a solvent such as a liquid ionic compound contained within the pores of a solid microporous support, such as a ceramic, metal, or polymeric support. Supported liquid membranes fabricated from supports such as ceramics, metals, and certain heat stable polymers may advantageously be used in higher than ambient temperature operations. Such higher temperature operations may be preferred to effect a more rapid separation, requiring less contact time. In addition, these higher temperature operations may also be a consequence of the process configuration, such as configurations requiring purification of high temperature exhaust gases or other gases exiting high temperature operations. Supported liquid membranes suitable for purifying high temperature gases obviate the need to pre-cool such gases before contact with the supported liquid membrane. Microporous supports suitable for use in the present invention and their methods of preparation are well known in the art (see, for example, U.S. Pat. Nos. 3,426,754; 3,801,404; 3,802,444; 3,839,516; 3,843,761; 3,843,762; 3,920,785; 4,055,696; 4,255,376; 4,257,997; 4,359,510; 4,405,688 and 4,438,185, the disclosures of which are hereby incorporated by reference). The supported liquid membranes may be fabricated as thin films or hollow fibers with continuous networks of interconnected pores leading from one surface to the other. Supported liquid membranes contact a feed gas mixture on one side of the membrane and may effect separation of a gas component from the mixture by allowing that component to escape via permeation or diffusion into the LIC and through the liquid membrane. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> The LIC may also be used in a conventional gas/liquid absorption unit-based system comprising a fixed bed. Such systems can be operated in batch mode or continuous flow mode. In a typical batch mode configuration, the LIC is introduced into a vessel followed by introduction of the gas mixture. After a prescribed residence time, the resulting gas is removed, leaving behind an impurity or group of impurities dissolved in the LIC. The batch purified gas can be generated by heating or reduced pressure treatment as described above. To maximize contact of the LIC and the gas mixture, the LIC can be coated on a solid support, such as glass beads, and the like, to increase the surface area of the LIC capable of contacting the gas mixture. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> In another embodiment, the LIC may be contacted with the gas mixture in a flow apparatus. The above batch processes may be adapted for flow where the flow rate through the vessel correlates to the residence time of contact and is suitably chosen to afford an effluent stream with the desired purification tolerance. As the LIC capacity for impurity retention is exhausted and the tolerance is no longer met, the purification unit can be regenerated as described. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> To promote the desired intimate mixing discussed above, such gas/liquid absorption units also may be operated in a dual flow mode. Such dual flow can be co-current or counter-current. In such an embodiment, the gas mixture and the LIC flow through a purification unit contemporaneously. In either the co-current or the counter-current aspects, the contacted LIC may be regenerated prior to reintroduction to the purification unit. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> LICs for use in the present invention include, but are not limited to, quaternary aromatic 5- and 6-membered-ring aromatic heterocycles, such as imidazolium salts, pyridinium salts, pyrimidinium salts, and the like. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> In one embodiment, LICs of Formula I are employed:  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="71.7822" wi="198.02475" file="US20020189444A1-20021219-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20020189444A1-20021219-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20020189444A1-20021219-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0042" lvl="7"><number>&lsqb;0042&rsqb;</number> where: </paragraph>
<paragraph id="P-0043" lvl="2"><number>&lsqb;0043&rsqb;</number> R<highlight><superscript>1 </superscript></highlight>is hydrogen or C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18 </subscript></highlight>alkyl; </paragraph>
<paragraph id="P-0044" lvl="2"><number>&lsqb;0044&rsqb;</number> A is &mdash;O&mdash;, &mdash;S&mdash;, or &mdash;N(R<highlight><superscript>4</superscript></highlight>)&mdash;; </paragraph>
<paragraph id="P-0045" lvl="2"><number>&lsqb;0045&rsqb;</number> B is &mdash;N&mdash; or &mdash;C(R<highlight><superscript>5</superscript></highlight>)&mdash;; </paragraph>
<paragraph id="P-0046" lvl="2"><number>&lsqb;0046&rsqb;</number> R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>are independently hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>cycloalkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl, aryl, substituted aryl, aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl), or substituted aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl); and </paragraph>
<paragraph id="P-0047" lvl="2"><number>&lsqb;0047&rsqb;</number> X is an anion selected from the group consisting of hydroxide, chloride, bromide, iodide, borate, tetrafluoroborate, cuprate, Cu(I)Cl<highlight><subscript>2 </subscript></highlight>anion, phosphate, hexafluorophosphate, hexafluoroantimonate, perchlorate, nitrite, nitrate, sulfate, a carboxylate, a sulfonate, a sulfonimide, and a phosphonate; and, </paragraph>
<paragraph id="P-0048" lvl="2"><number>&lsqb;0048&rsqb;</number> n is an integer from 1 to 4. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> In another embodiment LICs of Formula II are employed for gas purification:  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="57.6072" wi="198.02475" file="US20020189444A1-20021219-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20020189444A1-20021219-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20020189444A1-20021219-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0050" lvl="7"><number>&lsqb;0050&rsqb;</number> where: </paragraph>
<paragraph id="P-0051" lvl="2"><number>&lsqb;0051&rsqb;</number> R<highlight><superscript>1 </superscript></highlight>is as defined above; </paragraph>
<paragraph id="P-0052" lvl="2"><number>&lsqb;0052&rsqb;</number> A is as defined above; </paragraph>
<paragraph id="P-0053" lvl="2"><number>&lsqb;0053&rsqb;</number> B is as defined above; </paragraph>
<paragraph id="P-0054" lvl="2"><number>&lsqb;0054&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>is as defined above; </paragraph>
<paragraph id="P-0055" lvl="2"><number>&lsqb;0055&rsqb;</number> R<highlight><superscript>6 </superscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>cycloalkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl, aryl, substituted aryl, aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl), or substituted aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl); </paragraph>
<paragraph id="P-0056" lvl="2"><number>&lsqb;0056&rsqb;</number> X is as defined above; and, </paragraph>
<paragraph id="P-0057" lvl="2"><number>&lsqb;0057&rsqb;</number> n is as defined above. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> In another embodiment LICs of Formula III are employed for gas purification:  
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="69.1173" wi="198.02475" file="US20020189444A1-20021219-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20020189444A1-20021219-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20020189444A1-20021219-C00003.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0059" lvl="7"><number>&lsqb;0059&rsqb;</number> where: </paragraph>
<paragraph id="P-0060" lvl="2"><number>&lsqb;0060&rsqb;</number> R<highlight><superscript>1 </superscript></highlight>is as defined above; </paragraph>
<paragraph id="P-0061" lvl="2"><number>&lsqb;0061&rsqb;</number> U, V, and W are independently &mdash;N&mdash; or &mdash;C(R<highlight><superscript>9</superscript></highlight>)&mdash;, provided that U and V are not simultaneously &mdash;N&mdash;; </paragraph>
<paragraph id="P-0062" lvl="2"><number>&lsqb;0062&rsqb;</number> R<highlight><superscript>7</superscript></highlight>, R<highlight><superscript>8</superscript></highlight>, and R<highlight><superscript>9 </superscript></highlight>are independently hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>cycloalkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl, aryl, substituted aryl, aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl), or substituted aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl); </paragraph>
<paragraph id="P-0063" lvl="2"><number>&lsqb;0063&rsqb;</number> X is as defined above; and, </paragraph>
<paragraph id="P-0064" lvl="2"><number>&lsqb;0064&rsqb;</number> n is as defined above. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> The term &ldquo;C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl&rdquo; refers to a monovalent linear or branched chain of from one to six carbon atoms, such as methyl, butyl, 2,3-dimethylbutyl, and the like. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> Similarly, the term &ldquo;C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18 </subscript></highlight>alkyl&rdquo; refers to a monovalent linear or branched chain of from one to eighteen carbon atoms, such as butyl, octyl, 2-methyldodecyl, and the like. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> The term &ldquo;C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl&rdquo; refers to a monovalent linear or branched chain of from two to six carbon atoms containing one or more double bonds, such as ethenyl, 2-propenyl, 3-methyl-3-butenyl, and the like. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> The term &ldquo;C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkynyl&rdquo; refers to a monovalent linear or branched chain of from two to six carbon atoms containing one or more triple bonds, such as ethynyl, 2-propynyl, 3-methyl-3-butynyl, and the like. </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> The term &ldquo;C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkyl&rdquo; refers to a monovalent chain of from three to eight carbon atoms that from a cyclic structure, such as cyclopropyl, cyclohexylmethyl, &agr;-methyl-2-methylcyclopentylmethyl, and the like. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> The term &ldquo;C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl&rdquo; refers to a monovalent chain of from three to eight carbon atoms containing one or more double bonds that from a cyclic structure, such as 2-cyclopropylethenyl, cyclohex-2-enylmethyl, &agr;-methyl-5-methylcyclopent-2-enylmethyl, and the like. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> The term &ldquo;aryl&rdquo; refers to a cyclic aromatic radical, optionally containing one or more heteroatoms, such as oxygen, nitrogen, and sulfur, such as phenyl, naphthyl, pyridyl, and the like. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> The term &ldquo;substituted aryl&rdquo; refers to aryl as described herein, where from one to about three hydrogen atoms on the aryl are substituted with monovalent groups, such as halo, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, alkylamino, alkanoyl, cyano, nitro, and the like. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> The term &ldquo;halo&rdquo; refers to one or more halogens as a substituent selected from the group consisting of fluoro, chloro, bromo, and iodo. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> The term &ldquo;alkoxy&rdquo; refers to a monovalent linear or branched chain of carbon atoms, and oxygen, such as methoxy, butoxy, 2,4-dimethylbutoxy, and the like. </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> The term &ldquo;alkylthio&rdquo; refers to a monovalent linear or branched chain of carbon atoms, and sulfur, such as methylthio, butylthio, 2,4-dimethylbutylthio, and the like. </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> The term &ldquo;alkylamino&rdquo; refers to one or two independently chosen alkyl groups, said alkyl groups each being a monovalent linear or branched chain of carbon atoms, and nitrogen, such as methylamino, dibutylamino, N-(2,4-dimethylbutyl)-N-methylamino, and the like. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> The term &ldquo;alkanoyl&rdquo; refers to a monovalent linear or branched chain of carbon atoms, and a carbonyl group, such as acetyl, butanoyl, 2,4-dimethylbutanoyl, and the like. </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> It is appreciated that any combination of the above terms will refer to the corresponding chemical structures. Hence, &ldquo;haloalkyl&rdquo; refers to alkyl, as defined above, substituted with halo, as defined above, such as trifluoromethyl, 2,2-difluoro-1-bromoethyl, 3,3,3,2,1,1-heptafluoro-2-trifluoromethylpropyl, and the like. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> Carboxylates useful as anions include alkylcarboxylates, such as acetate, substituted alkylcarboxylates, such as lactate, and haloalkylcarboxylates, such as trifluoroacetate, and the like. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> Sulfonates useful as anions include alkylsulfonates, such as mesylate, haloalkylsulfonates, such as triflate and nonaflate, and arylsulfonates, such as tosylate and mesitylate, and the like. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> Sulfonimides useful as anions may be mono- or disubstituted sulfonimides, such as methanesulfonimide and bis ethanesulfonimide, optionally halogenated sulfonimides, such as bis trifluoromethanesulfonimide, arylsulfonimides, such as bis (4-methoxybenzene)sulfonamide, and the like. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> Phosphonates useful as anions include alkylphosphonates, such as tert-butylphosphonate, and arylphosphonates, such as 3,4-dichlorophenylphosphonate, and the like. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> In one embodiment, the liquid ionic compound used for gas purification is a compound selected from the group of imidazolium salts, pyrazolium salts, oxazolium salts, thiazolium salts, triazolium salts, pyridinium salts, pyridazinium salts, pyrimidinium salts, and pyrazinium salts. Illustrative of such compounds are 1-ethyl-3-methylimidazolium chloride, 1-butyl-3-ethylimidazolium chloride, 1-butyl-3-methylimidazolium chloride, 1-butyl-3-methylimidazolium bromide, 1-methyl-3-propylimidazolium chloride, 1-methyl-3-hexylimidazolium chloride, 1-methyl-3-octylimidazolium chloride, 1-methyl-3-decylimidazolium chloride, 1-methyl-3-dodecylimidazolium chloride, 1-methyl-3-hexadecylimidazolium chloride, 1-methyl-3-octadecylimidazolium chloride, 1-ethylpyridinium bromide, 1-ethylpyridinium chloride, 1-butylpyridinium chloride, and 1-benzylpyridinium bromide, 1-butyl-3-methylimidazolium tetrafluoroborate, 1-butyl-3-methylimidazolium iodide, 1-butyl-3-methylimidazolium nitrate, 1-ethyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium bromide, 1-ethyl-3-methylimidazolium iodide, 1-ethyl-3-methylimidazolium nitrate, 1-butylpyridinium tetrafluoroborate, 1-butylpyridinium bromide, 1-butylpyridinium iodide, 1-butylpyridinium nitrate, 1-butyl-3-methylimidazolium hexafluorophosphate, 1-octyl-3-methylimidazolium hexafluorophosphate, 1-octyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium ethylsulfate, 1-butyl-3-methylimidazolium triflate, 1-butyl-3-methylimidazolium acetate, 1-butyl-3-methylimidazolium trifluoroacetate, and 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonimide). </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> In another embodiment, the liquid ionic compound is used in a conventional gas/liquid absorption unit. The gas/liquid absorption unit may be operated as a batch process or as a flow process. The flow processes may be operated in such a manner that the LIC flows co-currently or counter-currently relative to the flow of the gas stream to be purified or separated. </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> In another embodiment, the liquid ionic compound is applied to a membrane. The membrane can be a supported liquid membrane for liquid/gas separations. A supported liquid membrane comprises a LIC which is contained within the pores of a solid, microporous structure. </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> As an illustrated embodiment, the present invention provides a method for purifying a gas by removing carbon dioxide from a gaseous mixture. Carbon dioxide can be removed by contacting a multi-component gas stream containing carbon dioxide with a liquid ionic compound. The present invention also provides a method for removing water from a gaseous mixture by contacting the gaseous mixture with a liquid ionic compound. The present disclosure also provides a method for purifying a gas from a gaseous mixture by contacting the gaseous mixture with a single liquid ionic compound or a mixture of liquid ionic compounds to contemporaneously remove carbon dioxide and water. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> The liquid ionic compounds of the present invention can be prepared by any of preparation methods known in the art, such as by halide salt metathesis and acid-base neutralization reactions. Preparations are illustratively described in U.S. Pat. No. 6,048,388, incorporated herein by reference. For example, a 1-alkyl-3-methyl imidazolium halide can be prepared by mixing 1-methylimidazole with an alkylhalide either neat or optionally in a suitable organic solvent, such as acetonitrile or ethyl acetate. Solvents may be advantageously chosen to generate a homogenous mixture of the resulting LIC or a heterogenous mixture consisting primarily of two layers. In the latter, the layers may be separated for easy isolation of the LIC layer from the reaction mixture. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> The following examples set forth particular exemplary embodiments of the invention as described above. The examples are not to be construed as limiting the invention to the materials, conditions, or process parameters contained therein. </paragraph>
</section>
<section>
<heading lvl="1">Experimental Examples </heading>
<paragraph id="P-0089" lvl="7"><number>&lsqb;0089&rsqb;</number> Materials </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> The 1-n-butyl-3-methylimidazolium hexafluorophosphate (&lsqb;bmim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb;), was obtained from Sachem and had a residual chloride of 3 ppm. 1-n-octyl-3-methylimidazolium hexafluorophosphate (&lsqb;C<highlight><subscript>8</subscript></highlight>mim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb;) and 1-n-octyl-3-methylimidazolium tetrafluoroborate (&lsqb;C<highlight><subscript>8</subscript></highlight>mim&rsqb;&lsqb;BF<highlight><subscript>4</subscript></highlight>&rsqb;) were prepared by conventional methods. Water was deionized using a Milli-Q water filtration system from Millipore. The carbon dioxide was obtained from Scott Specialty Gases, with a purity of 99.99%. The methane and ethane were both obtained from Matheson Gas Products, with purities of 99.97% and 99.99%, respectively. The remaining gases were all purchased from Mittler Supply Company with the following purity: the ethylene had a purity of 99.5%, the hydrogen had a purity of 99.999%, carbon monoxide had a purity of 99.97%, the oxygen had a purity of 99.99%, the nitrogen had a purity of 99.999%, and the argon had a purity of 99.999%. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1">Water Vapor Solubility in Various LICs </heading>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> The vapor-liquid equilibrium measurements were made using a gravimetric microbalance (IGA 003, Hiden Analytical). The microbalance includes a sample pan and counterweight symmetrically configured to minimize buoyancy effects. The balance has a 1 &mgr;g stable resolution. Approximately 75 mg of ionic liquid sample was added to the sample pan and the chamber was sealed. The sample was dried and degassed by first pulling a coarse vacuum on the sample with a diaphragm pump (MZ 2d, Vacuubrand) and then fully evacuating the chamber to ca. 10<highlight><superscript>&minus;9 </superscript></highlight>bar with a turbomolecular pump (TMU 064, Pfeiffer). The sample was heated to about 75&deg; C. during this process with an external furnace (SFL TF 1042, Fisher Scientific). After 4 and 8 h, sample mass slowly decreased as residual water and gases were driven off. Once the mass had stabilized for 30 min, the sample was considered pure, and the absorption measurements were initiated. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> The furnace was removed and replaced by a water jacket connected to a constant temperature bath (RTE-111, Neslab). The sample temperature was monitored with a type K platinum thermocouple placed inside the sample chamber and automatically maintained to within 0.1 &deg; C. of the setpoint via the IGA software. Once the desired temperature of the sample was reached, water vapor was introduced into the sample chamber through a leak valve until a predetermined pressure was reached. Pressures from 0-100 mbar were measured using a capacitance manometer (Baratron 626, MKS), and above 100 mbar a strain gauge (PDCR 910, Druck) was used. The IGA software maintains the pressure to within 0.06% of the setpoint through control of the leak valve and exhaust valve. As the vapor entered the chamber, the sample mass increased as water absorbed into the sample. The weight change was monitored until the mass did not change significantly for 15 min. The sample was deemed to have reached equilibrium, yielding a single point on the absorption isotherm. This process was repeated through a predetermined set of pressures until the maximum pressure was reached (some fraction of the vapor pressure at the prevailing temperature). Once the highest pressure was reached, the process was reversed. The water pressure above the sample was gradually reduced in a series of small desorption steps, during which the decrease in sample mass was recorded. Upon completion of this process, a complete absorption/desorption isotherm was obtained, as shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. The degree of hysteresis between the two isotherm branches gives an indication of the accuracy of each value. After the completion of an absorption/desorption loop, the sample was dried and degassed and the mass compared with the initial mass to confirm that the ionic liquid did not volatilize or decompose during the run. Even after performing multiple absorption/desorption experiments over several weeks, none of the samples exhibited a detectable loss in mass. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> The amount of water absorbed by the LIC, when exposed to various pressures of water vapor, was measured for all three ionic liquids at three different temperatures: 10&deg; C., 25&deg; C., and 35&deg; C. The low pressure vapor-liquid equilibrium data for &lsqb;bmim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb; was also collected at 50&deg; C. These results, plotted as the weight percent of water absorbed into the ionic liquids versus the ratio of the pressure of water to the vapor pressure of the water (P<highlight><superscript>sat</superscript></highlight>), are shown in FIGS. <highlight><bold>2</bold></highlight>-<highlight><bold>4</bold></highlight>. The corresponding values of P<highlight><superscript>sat </superscript></highlight>each temperature, which are all less than 0.123 bar, are listed in Table 1. The solid lines are meant to guide the eye and the dotted lines indicate the extrapolation of the data out to the vapor pressure of water (P/P<highlight><superscript>sat</superscript></highlight>&equals;1). </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> As shown in FIGS. <highlight><bold>2</bold></highlight>-<highlight><bold>4</bold></highlight>, the solubility of water vapor is greatest in &lsqb;C<highlight><subscript>8 </subscript></highlight>mim&rsqb;&lsqb;BF<highlight><subscript>4</subscript></highlight>&rsqb;. A direct comparison of &lsqb;C<highlight><subscript>8 </subscript></highlight>mim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb; with &lsqb;C<highlight><subscript>8</subscript></highlight>mim&rsqb;&lsqb;BF<highlight><subscript>4</subscript></highlight>&rsqb; (FIG <highlight><bold>3</bold></highlight>-<highlight><bold>4</bold></highlight>) demonstrates the effect the anion may have in determining the amount of water vapor absorbed.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE I</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Henry&apos;s Law constants for water in</entry>
</row>
<row>
<entry>various LICs as a function of temperature.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="28PT" align="center"/>
<colspec colname="2" colwidth="28PT" align="center"/>
<colspec colname="3" colwidth="56PT" align="center"/>
<colspec colname="4" colwidth="49PT" align="center"/>
<colspec colname="5" colwidth="56PT" align="center"/>
<tbody valign="top">
<row>
<entry>T</entry>
<entry>p<highlight><superscript>sat</superscript></highlight></entry>
<entry>&lsqb;C<highlight><subscript>8</subscript></highlight>mim&rsqb;&lsqb;BF<highlight><subscript>4</subscript></highlight>&rsqb;</entry>
<entry>&lsqb;bmim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb;</entry>
<entry>&lsqb;C<highlight><subscript>8</subscript></highlight>mim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb;</entry>
</row>
<row>
<entry>(&deg; C.)</entry>
<entry>(bar)</entry>
<entry>H<highlight><subscript>1 </subscript></highlight>(bar)</entry>
<entry>H<highlight><subscript>1 </subscript></highlight>(bar)</entry>
<entry>H<highlight><subscript>1 </subscript></highlight>(bar)</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry>10</entry>
<entry>0.012</entry>
<entry>0.032 &plusmn; 0.006</entry>
<entry>0.08 &plusmn; 0.01</entry>
<entry>0.10 &plusmn; 0.01</entry>
</row>
<row>
<entry>25</entry>
<entry>0.032</entry>
<entry>0.060 &plusmn; 0.002</entry>
<entry>0.16 &plusmn; 0.02</entry>
<entry>0.20 &plusmn; 0.02</entry>
</row>
<row>
<entry>35</entry>
<entry>0.056</entry>
<entry>0.12 &plusmn; 0.03</entry>
<entry>0.24 &plusmn; 0.05</entry>
<entry>0.33 &plusmn; 0.04</entry>
</row>
<row>
<entry>50</entry>
<entry>0.123</entry>
<entry>&mdash;</entry>
<entry>0.47 &plusmn; 0.05</entry>
<entry>&mdash;</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">Solubility of Various Gases in Various Liquid Ionic Compounds </heading>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> The gas solubility measurements were made using a gravimetric microbalance (IGA 003, Hiden Analytical), as described above in Example 1 A small sample of LIC was added to the sample pan and the chamber was sealed. The sample was dried and degassed by evacuating the chamber to about 10<highlight><superscript>&minus;9 </superscript></highlight>bar and heating to 75&deg; C. Once the mass remained constant for at least 30 min, the sample was considered to be free of volatile contaminants. The temperature-controlled chamber was pressurized with the gas of interest using the static gas mode on the apparatus. The sample mass subsequently increased as gas absorbed into the sample. The weight change was monitored until the mass did not change significantly for at least 15 min. The sample was deemed to have reached equilibrium, yielding a single point on the absorption isotherm shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. This process was repeated in steps up to a pressure of 13 bar. After 13 bar pressure was reached, the process was reversed. The gas pressure above the sample was gradually reduced in a series of small desorption steps, during which the decrease in sample mass was recorded. Upon completion of this process, a complete absorption/desorption isotherm was obtained (<cross-reference target="DRAWINGS">FIG. 1</cross-reference>). The degree of hysteresis between the two isotherm branches gives an indication of the accuracy of each value. After the completion of an absorption/desorption loop, the sample was dried and degassed and the mass compared with the initial mass to confirm that the ionic liquid did not volatilize or decompose during the run. Even after performing multiple absorption/desorption experiments over many months, the sample exhibited no detectable loss in mass. </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> The absorption of the different gases into different LICs was measured at various temperatures to a maximum gas pressure of 13 bar. The solubilities were obtained at 10&deg; C., 25&deg; C., 50&deg; C., and 60&deg; C. The CO<highlight><subscript>2 </subscript></highlight>solubility in &lsqb;bmim&rsqb;&lsqb;PF<highlight><subscript>6</subscript></highlight>&rsqb; at the three temperatures is shown in <cross-reference target="DRAWINGS">FIG. 6</cross-reference>. These three curves exhibit a nonlinear trend as the CO<highlight><subscript>2 </subscript></highlight>pressure is increased. The curves begin to flatten out, indicating that the LIC is beginning to approach its maximum, pressure-independent capacity for CO<highlight><subscript>2</subscript></highlight>. In contrast, as seen in <cross-reference target="DRAWINGS">FIG. 7</cross-reference>, the C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>4 </subscript></highlight>solubility in the LIC at the three temperatures is linear with pressure. Similar linear behavior was seen with C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>6</subscript></highlight>, CH<highlight><subscript>4</subscript></highlight>, O<highlight><subscript>2</subscript></highlight>, and Ar as shown in <cross-reference target="DRAWINGS">FIG. 8</cross-reference>. Carbon dioxide has the largest solubility, followed by ethylene, ethane, and then methane. Oxygen and argon both have very low solubilities. The low-molecular weight gases H<highlight><subscript>2</subscript></highlight>, CO, and N<highlight><subscript>2 </subscript></highlight>all had solubilities below the detection limit of the apparatus. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1">Calculation of Henry&apos;s Law Constants for Various Gases in Various LICs </heading>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> The solubility of a gas in a liquid is frequently described in terms of Henry&apos;s Law, which implies that, for gases that behave nearly ideally, the solubility is linearly related to the pressure. This relation holds for the experimental measurements of C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>4</subscript></highlight>, C<highlight><subscript>2</subscript></highlight>, H<highlight><subscript>6</subscript></highlight>, CH<highlight><subscript>4</subscript></highlight>, O<highlight><subscript>2</subscript></highlight>, and Ar. Therefore, those Henry&apos;s constants were found by calculating the linear slope of the data plot of solubility. However, as CO<highlight><subscript>2 </subscript></highlight>was not linear for the entire pressure range, the Henry&apos;s Law constants were found by fitting a second order polynomial to the data and calculating the limiting slope as the pressure (or solubility) approaches zero. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> As the microbalance measures the gas solubility on a mass basis, the detection limit depends on the molecular weight of the gas. The low-molecular weight gases H<highlight><subscript>2</subscript></highlight>, CO, and N<highlight><subscript>2 </subscript></highlight>all had solubilities below the detection limit of the apparatus. Using the lowest solubility measured (O<highlight><subscript>2 </subscript></highlight>at 10&deg; C.) as the minimum change in mass that can measured with this apparatus, the Henry&apos;s Law constants can be approximated for gases with molecular weights of 2 g/mol (H2) and 28 g/mol (CO and N2) to be at least 1500 bar and 20,000 bar, respectively. The Henry&apos;s Law constants (K) for these gases are shown in Tables II-IV.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE II</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Henry&apos;s Law constants (K) of various gases in 1-n-butyl-3-</entry>
</row>
<row>
<entry>methylimidazolium hexafluorophosphate as a function of temperature.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="center"/>
<colspec colname="2" colwidth="42PT" align="center"/>
<colspec colname="3" colwidth="70PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>10&deg; C.</entry>
<entry>25&deg; C.</entry>
<entry>50&deg; C.</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="21PT" align="left"/>
<colspec colname="2" colwidth="70PT" align="center"/>
<colspec colname="3" colwidth="42PT" align="center"/>
<colspec colname="4" colwidth="70PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>H<highlight><subscript>2</subscript></highlight>O</entry>
<entry>0.09 &plusmn; 0.02</entry>
<entry>0.17 &plusmn; 0.02</entry>
<entry>0.45 &plusmn; 0.05</entry>
</row>
<row>
<entry></entry>
<entry>CO<highlight><subscript>2</subscript></highlight></entry>
<entry>38.7 &plusmn; 0.4&ensp;</entry>
<entry>53.4 &plusmn; 0.3&ensp;</entry>
<entry>81.3 &plusmn; 0.5&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>4</subscript></highlight></entry>
<entry>142 &plusmn; 14&ensp;</entry>
<entry>173 &plusmn; 17&ensp;</entry>
<entry>221 &plusmn; 22&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>C<highlight><subscript>2</subscript></highlight>H<highlight><subscript>6</subscript></highlight></entry>
<entry>284 &plusmn; 47&ensp;</entry>
<entry>355 &plusmn; 36&ensp;</entry>
<entry>404 &plusmn; 41&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>CH<highlight><subscript>4</subscript></highlight></entry>
<entry>1480 &plusmn; 110&ensp;</entry>
<entry>1690 &plusmn; 180&ensp;</entry>
<entry>1310 &plusmn; 290&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>O<highlight><subscript>2</subscript></highlight></entry>
<entry>23000 &plusmn; 15000</entry>
<entry>8000 &plusmn; 5400</entry>
<entry>1550 &plusmn; 170&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>Ar</entry>
<entry>22000 &plusmn; 10000</entry>
<entry>8000 &plusmn; 3800</entry>
<entry>1340 &plusmn; 220&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>CO</entry>
<entry>ND</entry>
<entry>ND</entry>
<entry>ND</entry>
</row>
<row>
<entry></entry>
<entry>N<highlight><subscript>2</subscript></highlight></entry>
<entry>ND</entry>
<entry>ND</entry>
<entry>ND</entry>
</row>
<row>
<entry></entry>
<entry>H<highlight><subscript>2</subscript></highlight></entry>
<entry>ND</entry>
<entry>ND</entry>
<entry>ND</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="left"><footnote id="FOO-00001">ND: &gt;20,000 for CO and N<highlight><subscript>2</subscript></highlight>; &gt;1,500 for H<highlight><subscript>2</subscript></highlight>. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number>  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE III</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Henry&apos;s Law constants (K) of CO<highlight><subscript>2 </subscript></highlight>in 1-n-butyl-2,3-dimethyl-</entry>
</row>
<row>
<entry>imidazolium hexafluorophosphate as a function of temperature.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="77PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>10&deg; C.</entry>
<entry>25&deg; C.</entry>
<entry>50&deg; C.</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="21PT" align="left"/>
<colspec colname="2" colwidth="70PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="77PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>CO<highlight><subscript>2</subscript></highlight></entry>
<entry>49.2 &plusmn; 8.1</entry>
<entry>65.4 &plusmn; 2.4</entry>
<entry>96.7 &plusmn; 10.4</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number>  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE IV</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Henry&apos;s Law constants (K) of CO<highlight><subscript>2 </subscript></highlight>in 1-n-butyl-2,3-dimethyl-</entry>
</row>
<row>
<entry>imidazolium tetrafluoroborate as a function of temperature.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="77PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>10&deg; C.</entry>
<entry>25&deg; C.</entry>
<entry>50&deg; C.</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="21PT" align="left"/>
<colspec colname="2" colwidth="70PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="77PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>CO<highlight><subscript>2</subscript></highlight></entry>
<entry>49.2 &plusmn; 4.1</entry>
<entry>67.8 &plusmn; 6.2</entry>
<entry>108.9 &plusmn; 10.4</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">Separation of Nitrogen and Carbon Dioxide in a Batch Process </heading>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> A mixture of gases consisting of 9.4% CO<highlight><subscript>2 </subscript></highlight>and 90.6% N<highlight><subscript>2 </subscript></highlight>was fed into 1 inch diameter column 10 containing glass beads 15 coated with 1-(n-butyl)-3-methylimidazolium hexafluorophosphate to a depth of about 3 inches, as shown in <cross-reference target="DRAWINGS">FIG. 9</cross-reference>. The gas flow rate was 0.59 mL/min or 3.66 mL/min. Breakthrough curves for CO<highlight><subscript>2 </subscript></highlight>saturation of the LIC coating on the glass beads are shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference> for the two flow rates. While glass beads are used for the support, it is understood that other solid particulate substrates may be used. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">Separation of Nitrogen and Carbon Dioxide in a Supported Liquid Membrane Configuration </heading>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> A mixture of 9.4% CO<highlight><subscript>2 </subscript></highlight>and 90.6% N<highlight><subscript>2 </subscript></highlight>was contacted with a supported liquid membrane 20 constructed from a thin anopore (alumina) membrane coated with 1-(n-butyl)-3-methylimidazolium hexafluorophosphate, as shown in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>. The pressure differential across the membrane was 8 psig. After 17 hours of contact of the gas mixture with the membrane, the permeate gas was collected and analyzed as essentially pure CO<highlight><subscript>2</subscript></highlight>. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">Additional Measurements </heading>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> The stability of additional gases in tri-isobutyl(methyl)phosphonium tosylate has been measured, as follows:  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="left"/>
<colspec colname="2" colwidth="98PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>CO<highlight><subscript>2 </subscript></highlight>at 50&deg; C.</entry>
<entry>&ensp;103.5 &plus; 5.2 bar</entry>
</row>
<row>
<entry></entry>
<entry>O<highlight><subscript>2 </subscript></highlight>at 60&deg; C.</entry>
<entry>1122.5 &plus; 313.0 bar</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> Although the invention has been described in detail with reference to certain preferred embodiments, variations and modifications exist within the scope and spirit of the invention as described and defined in the following claims. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method for separating a gas from a gaseous mixture, comprising the step of contacting the gaseous mixture with a liquid ionic compound, said liquid ionic compound comprising a nitrogen-containing heterocyclic cation. </claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound comprises a compound selected from the group consisting of: 
<claim-text>(a) a compound of the formula </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="64.8081" wi="84.2562" file="US20020189444A1-20021219-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20020189444A1-20021219-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20020189444A1-20021219-C00004.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;where: 
<claim-text>R<highlight><superscript>1 </superscript></highlight>is hydrogen or C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18 </subscript></highlight>alkyl; </claim-text>
<claim-text>A is &mdash;O&mdash;, &mdash;S&mdash;, or &mdash;N(R<highlight><superscript>4</superscript></highlight>)&mdash;; </claim-text>
<claim-text>B is &mdash;N&mdash;or &mdash;C(R<highlight><superscript>5</superscript></highlight>)&mdash;; </claim-text>
<claim-text>R<highlight><superscript>2</superscript></highlight>, R<highlight><superscript>3</superscript></highlight>, R<highlight><superscript>4</superscript></highlight>, and R<highlight><superscript>5 </superscript></highlight>are independently hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>cycloalkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl, aryl, substituted aryl, aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl), or substituted aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl); and </claim-text>
<claim-text>X is an anion selected from the group consisting of hydroxide, chloride, bromide, iodide, borate, tetrafluoroborate, cuprate, Cu(I)Cl<highlight><subscript>2 </subscript></highlight>anion, phosphate, hexafluorophosphate, hexafluoroantimonate, perchlorate, nitrite, nitrate, sulfate, a carboxylate, a sulfonate, a sulfonimide, and a phosphonate; and, </claim-text>
<claim-text>n is an integer from 1 to 4; and </claim-text>
</claim-text>
<claim-text>(b) a compound of the formula </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="50.6331" wi="94.09365" file="US20020189444A1-20021219-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20020189444A1-20021219-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20020189444A1-20021219-C00005.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;where: 
<claim-text>R<highlight><superscript>1 </superscript></highlight>is as defined above; </claim-text>
<claim-text>A is as defined above; </claim-text>
<claim-text>B is as defined above; </claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>is as defined above; </claim-text>
<claim-text>R<highlight><superscript>6 </superscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>cycloalkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl, aryl, substituted aryl, aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl), or substituted aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl); </claim-text>
<claim-text>X is as defined above; and, </claim-text>
<claim-text>n is as defined above; and </claim-text>
</claim-text>
<claim-text>(c) a compound of the formula </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="62.39835" wi="84.00105" file="US20020189444A1-20021219-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20020189444A1-20021219-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20020189444A1-20021219-C00006.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;where: 
<claim-text>R<highlight><superscript>1 </superscript></highlight>is as defined above; </claim-text>
<claim-text>U, V, and W are independently &mdash;N&mdash;or &mdash;C(R<highlight><superscript>9</superscript></highlight>)&mdash;, provided that U and V are not simultaneously &mdash;N&mdash;; </claim-text>
<claim-text>R<highlight><superscript>7</superscript></highlight>, R<highlight><superscript>8</superscript></highlight>, and R<highlight><superscript>9 </superscript></highlight>are independently hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkyl, C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>alkenyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>6 </subscript></highlight>cycloalkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>8 </subscript></highlight>cycloalkenyl, aryl, substituted aryl, aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl), or substituted aryl(C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>4 </subscript></highlight>alkyl); </claim-text>
<claim-text>X is as defined above; and, </claim-text>
<claim-text>n is as defined above. </claim-text>
</claim-text>
</claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound is a compound selected from the group consisting of imidazolium salts, pyrazolium salts, oxazolium salts, thiazolium salts, triazolium salts, pyridinium salts, pyridazinium salts, pyrimidinium salts, and pyrazinium salts. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound is selected from the group consisting of 1-ethyl-3-methylimidazolium chloride, 1-butyl-3-ethylimidazolium chloride, 1-butyl-3-methylimidazolium chloride, 1-butyl-3-methylimidazolium bromide, 1-methyl-3-propylimidazolium chloride, 1-methyl-3-hexylimidazolium chloride, 1-methyl-3-octylimidazolium chloride, 1-methyl-3-decylimidazolium chloride, 1-methyl-3-dodecylimidazolium chloride, 1-methyl-3-hexadecylimidazolium chloride, 1-methyl-3-octadecylimidazolium chloride, 1-ethylpyridinium bromide, 1-ethylpyridinium chloride, 1-butylpyridinium chloride, and 1-benzylpyridinium bromide, 1-butyl-3-methylimidazolium tetrafluoroborate, 1-butyl-3-methylimidazolium iodide, 1-butyl-3-methylimidazolium nitrate, 1-ethyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium bromide, 1-ethyl-3-methylimidazolium iodide, 1-ethyl-3-methylimidazolium nitrate, 1-butylpyridinium tetrafluoroborate, 1-butylpyridinium bromide, 1-butylpyridinium iodide, 1-butylpyridinium nitrate, 1-butyl-3-methylimidazolium hexafluorophosphate, 1-octyl-3-methylimidazolium hexafluorophosphate, 1-octyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium ethylsulfate, 1-butyl-3-methylimidazolium triflate, 1-butyl-3-methylimidazolium acetate, 1-butyl-3-methylimidazolium trifluoroacetate, and 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonimide). </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound is selected from the group consisting of 1-butyl-3-methylimidazolium hexafluorophosphate, 1-octyl-3-methylimidazolium hexafluorophosphate, 1-butyl-3-methylimidazolium nitrate, 1-octyl-3-methylimidazolium tetrafluoroborate, 1-ethyl-3-methylimidazolium ethylsulfate, N-butylpyridinium tetrafluoroborate, 1-butyl-3-methylimidazolium triflate, 1-butyl-3-methylimidazolium acetate, 1-butyl-3-methylimidazolium trifluoroacetate, and 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonimide). </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound is provided as a supported liquid membrane. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the gaseous mixture comprises carbon dioxide and nitrogen, the gas is nitrogen, and wherein carbon dioxide selectively diffuses through the supported liquid membrane. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00007">claim 7</dependent-claim-reference> wherein the carbon dioxide that diffuses through the supported liquid membrane is substantially free of nitrogen. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the supported liquid membrane comprises a first side and a second side, the contacting step comprises contacting the first side of the membrane with the gaseous mixture, and wherein impurities diffuse to the second side of the membrane. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, wherein the supported liquid membrane comprises a first side and a second side, the contacting step comprises contacting the first side with the gaseous mixture such that the gas diffuses to the second side of the membrane, and further comprising the step of collecting the gas that diffuses to the second side of the membrane. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the gas and an impurity in the gaseous mixture have a ratio of Henry&apos;s law constants for the liquid ionic compound of at least 20. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference> further comprising the step of adjusting the temperature of the liquid ionic compound to increase the ratio and improve separation efficiency. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the gaseous mixture comprises an alkane and an olefin, and the alkane and olefin have a ratio of Henry&apos;s law constants for the liquid ionic compound of at least 2.0. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound is substantially free of water. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the gaseous mixture is selected from the group consisting of natural gas and air. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the gaseous mixture includes carbon dioxide as an impurity and carbon dioxide is removed from the gaseous mixture. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the gaseous mixture includes water and water is removed from the gaseous mixture. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the gaseous mixture includes both water and carbon dioxide and the method comprises decreasing the amount of carbon dioxide and water in the gaseous mixture. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the liquid ionic compound is provided in a fixed bed and the contacting step comprises flowing the gaseous mixture into the fixed bed. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein the liquid ionic compound is coated on the surface of a solid particulate substrate within the fixed bed. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein the gaseous mixture is flowed continuously through the fixed bed. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein the gaseous mixture is held in contact with the fixed bed for a prescribed residence time. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein the gas is retained within the fixed bed and impurities are allowed to flow out of the fixed bed. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein impurities are retained within the fixed bed and the gas is collected as the gas flows out of the fixed bed. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein the gas and an impurity within the gaseous mixture have a ratio of Henry&apos;s law constants for the liquid ionic compound of at least 17. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 25</dependent-claim-reference> further comprising the step of adjusting the temperature of the liquid ionic compound to increase the effective ratio. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein the gaseous mixture comprises an alkane and an olefin, and the alkane and olefin have a ratio of Henry&apos;s law constants for the ionic compound of at least 1.7. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> further comprising the step of contacting the gaseous mixture with a second liquid ionic compound, said second liquid ionic compound comprising a nitrogen-containing heterocyclic cation. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference> wherein the first and second liquid ionic compounds are intermixed, and the steps of contacting the gaseous mixture with the liquid ionic compound and contacting the gaseous mixture with the second liquid ionic compound are performed at the same time. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the gas is purified to be essentially free of one or more impurities present in the gaseous mixture.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>10</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020189444A1-20021219-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020189444A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020189444A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020189444A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020189444A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020189444A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020189444A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020190415A1-20021219-D00000.TIF SYSTEM "US20020190415A1-20021219-D00000.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00001.TIF SYSTEM "US20020190415A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00002.TIF SYSTEM "US20020190415A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00003.TIF SYSTEM "US20020190415A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00004.TIF SYSTEM "US20020190415A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00005.TIF SYSTEM "US20020190415A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00006.TIF SYSTEM "US20020190415A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00007.TIF SYSTEM "US20020190415A1-20021219-D00007.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00008.TIF SYSTEM "US20020190415A1-20021219-D00008.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00009.TIF SYSTEM "US20020190415A1-20021219-D00009.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00010.TIF SYSTEM "US20020190415A1-20021219-D00010.TIF" NDATA TIF>
<!ENTITY US20020190415A1-20021219-D00011.TIF SYSTEM "US20020190415A1-20021219-D00011.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020190415</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10145658</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020514</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C04B035/634</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>264</class>
<subclass>042000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>264</class>
<subclass>621000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>264</class>
<subclass>670000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Hierarchically ordered porous oxides</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-of>
<parent-child>
<child>
<document-id>
<doc-number>10145658</doc-number>
<kind-code>A1</kind-code>
<document-date>20020514</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09432920</doc-number>
<document-date>19991102</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>ABANDONED</parent-status>
</parent-child>
</continuation-of>
</continuations>
<non-provisional-of-provisional>
<document-id>
<doc-number>60106982</doc-number>
<document-date>19981104</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Peidong</given-name>
<family-name>Yang</family-name>
</name>
<residence>
<residence-us>
<city>Berkeley</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Tao</given-name>
<family-name>Deng</family-name>
</name>
<residence>
<residence-us>
<city>Somerville</city>
<state>MA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>George</given-name>
<middle-name>M.</middle-name>
<family-name>Whitesides</family-name>
</name>
<residence>
<residence-us>
<city>Newton</city>
<state>MA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Galen</given-name>
<family-name>Stucky</family-name>
</name>
<residence>
<residence-us>
<city>Goleta</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Dongyaun</given-name>
<family-name>Zhao</family-name>
</name>
<residence>
<residence-non-us>
<city>Shanghai</city>
<country-code>CN</country-code>
</residence-non-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Bradley</given-name>
<family-name>Chmelka</family-name>
</name>
<residence>
<residence-us>
<city>Goleta</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>David</given-name>
<family-name>Pine</family-name>
</name>
<residence>
<residence-us>
<city>Santa Barbara</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Pingyun</given-name>
<family-name>Feng</family-name>
</name>
<residence>
<residence-us>
<city>Goleta</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Miles Yamanaka</name-1>
<name-2>FULBRIGHT &amp; JAWORSKI L.L.P.</name-2>
<address>
<address-1>Twenty-Ninth Floor</address-1>
<address-2>865 South Figueroa</address-2>
<city>Los Angeles</city>
<state>CA</state>
<postalcode>90017-2571</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A low-cost, efficient method of preparing hierarchically ordered structures by combining, concurrently or sequentially, micromolding, latex templating, and cooperative self-assembly of hydrolyzed inorganic species and amphiphilic block copolymers. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE WITH RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims the benefit of U.S. Provisional Application No. 60/106,982, filed Nov. 4, 1998.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with Government support under Grants No. DMR-9520971 (GDS), DMR-9257064 (BFC), and DMR-9632716, awarded by the National Science Foundation and Grant No. DMH-04-96-1-0443 from the U.S. Army Research Office. The Government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> 1. Field of the Invention </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> The invention relates to a method for synthesis of hierarchically ordered materials at multiple length scales using polyalkylene oxide triblock copolymers. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> 2. Description of Related Art </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Nature abounds in hierarchical structures that are formed through highly coupled and often concurrent synthesis and assembly process over both molecular and long-range length scales. &lsqb;Aksay, et al., Science, Vol. 273, 892 (1996)&rsqb;. The existence of these hierarchical structures, such as abalones and diatoms, has both biological and evolutionary significance. The special architecture of the natural structures make them simultaneously hard, strong, and tough. It has thus been a long-sought goal to mimic the natural process responsible for these exquisite architectures using biomimetic strategies to control the structural organization and thereby produce useful materials with similar architecture. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Several approaches are currently available for the preparation of ordered structures at different length scales. For example, organic molecular templates can be used to form zeolitic structures with ordering lengths less than 3 nm &lsqb;Bu, P., et al., Science, Vol. 278, 2080 (1997)&rsqb;. Mesoporous materials with ordering lengths of 3-30 nm can be obtained using surfactants or amphiphilic block copolymers as the structure-directing agents &lsqb;C. T. Kresge, et al., Nature, Vol. 359, 710 (1992); D. Zhao, et al., Science, Vol. 279, 548 (1998); P. Yang, et al., Nature, Vol. 399, 48 (1998); A. Firouzi, et al., J. Am. Chem. Soc. Vol.119,9466 (1997); and S. H. Tolbert, et al., Science, Vol. 278, 264 (1997)&rsqb;. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Studies have shown the use of latex spheres affords macroporous materials with ordering lengths of 100 nm -1 &mgr;m &lsqb;O. D. Velev, et al., Nature, Vol. 389, 447 (1997); M. Antonietti, et al., Adv. Mater., Vol.10,154 (1998); B. T. Holland, et al., Science, Vol. 281, 538 (1998); and J. E. G. J. Wijnhoven, et al., Science, Vol. 281, 802 (1998)&rsqb;. Soft lithography has also been shown to make high-quality patterns and structures with lateral dimensions of about 30 nm to 500 &mgr;m. &lsqb;Y. Xia, et al., Angew. Chem. Int. Ed., Vol. 37, 550 (1998); E. Kim, et al., Adv. Mater. Vol. 8, 245 (1996); and C. Marzolin, et al., Adv. Mater. Vol.10, 571 (1998)&rsqb;. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Previous studies have shown use of micromolding to form patterned mesoporous materials &lsqb;H. Yang, et al., Adv. Mater., Vol. 9, 811 (1997); and M. Trau, et al., Nature, Vol. 390, 674(1997)&rsqb;. These studies, however, used acidic aqueous conditions to carry out the cooperative self-assembly, which is disadvantageous because of the poor processibility of the aqueous solutions. &lsqb;Q. Huo, et al., Nature, Vol. 368, 317 (1994)&rsqb;. The results of these studies were that either non-continuous films were formed or an electric field was needed to guide the mesophase growth, which required a non-conducting substrate &lsqb;H. Yang, et al., supra; and M. Trau, et al., (1997), supra&rsqb;. Studies have also shown the use of latex spheres to make disordered macro- and mesoporous silica &lsqb;M. Antonietti, et al., supra&rsqb;. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Although previous studies addressed the synthesis of disordered mesoporous silica and alumina, using nonionic surfactants as the structure-directing agents and alkoxides as the inorganic sources, under aqueous media, the studies did not address large-pore mesoporous materials with vastly different composition, and nanocrystalline frameworks &lsqb;Sayari, A., Chem. Mater. Vol. 8,1840 (1996)&rsqb;. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Despite all of earlier efforts in nanostructuring materials, the fabrication of hierarchically ordered structures at multiple length scales has remained an experimental challenge. Such materials are important both for systematic fundamental study of structure-property relationships and for their technological promise in applications such as catalysis, selective separations, sensor arrays, waveguides, miniaturized electronic and magnetic devices, and photonic crystals with tunable band gaps &lsqb;D. Zhao, et al., Adv. Mater. Vol.10, 1380 (1998) and M. E. Gimon-Kinsel, et al., Stud. Surf. Sci. Cata., Vol.117, 111(1998)&rsqb;. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> Many applications for macro- and mesoporous metal oxides require structural ordering at multiple length scales. Thus, there exists a need for hierarchically ordered materials and a method for forming the materials which overcome or minimize the above mentioned problems and which have enormous potential for a variety of immediate and future industrial applications. A need also exists for forming the hierarchically ordered materials using low-cost, non-toxic, and biodegradable polyalkylene oxide block copolymers. </paragraph>
</section>
<section>
<heading lvl="1">BRIEF SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> The present invention overcomes drawbacks of the foregoing methods to prepare mesoporous materials and mesoscopic structures having orders at multiple length scales, and provides heretofore unattainable materials having very desirable and widely useful properties. These materials are prepared by combining amphiphilic block copolymer with an inorganic metal compound, preferably by creating a sol-gel solution. The amphiphilic block copolymer species acts as a structure-directing agent for the inorganic metal compound in self-assembling systems. Pressure is applied to the combination, thus the block copolymer and inorganic metal compound are self-assembled and polymerized into a mesoscopically structured material. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> In another embodiment of this invention, the combination, preferably a sol, is placed on a substrate and a mold is placed on top of the sol and the substrate. An effective amount of pressure is applied to the mold and substrate, the amount of pressure is preferably between about 1&times;10<highlight><superscript>5 </superscript></highlight>to 2&times;10<highlight><superscript>5 </superscript></highlight>Pa, whereby the sol-gel solution is compressed between the substrate and the mold. The mold is left in place, undisturbed, for at least about 12 hours to allow increased cross-linking and consolidation of the inorganic oxide network, thus the block copolymer and inorganic metal compound are self-assembled and polymerized into a mesoscopically structured material. The mold is then removed and the resulting patterned material is calcined to yield the patterned mesoscopically ordered porous material having a multiple length scale. Calcination occurs at 300&deg; C. to 600&deg; C., preferably at about 400&deg; C.-450&deg; C. Unlike previous mesoscopically ordered materials, the materials described in this invention can be produced with multiple length scales on the order of approximately 10 nm and 100 nm. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> In accordance with a further embodiment of the invention mesoporous materials and mesoscopic structures having orders at multiple length scales are synthesized. Synthesis is carried out by contacting a mold, which ends have been cut, with a substrate. A mold is filled with a latex colloidal suspension, whereby an array is formed within the mold. An amphiphilic block copolymer is then combined with an inorganic metal compound, preferably by creating a sol, and the mold is filled with the sol whereby the block copolymer and inorganic metal compound are self-assembled and polymerized into a mesoscopically structured material exhibiting multiple structural ordering length scales on the order of approximately 10, 100, and 1000 nm. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> These and other features, aspects, and advantages of the present invention will become better understood with regard to the following detailed description, appended claims, and accompanying drawings.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 1</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>1</bold></highlight><highlight><italic>b </italic></highlight>are schematic diagrams of the molding methods used to fabricate hierarchically ordered structures on a substrate; <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>a </italic></highlight>is a schematic diagram for patterning of mesoporous solids, a droplet of sol-gel/block copolymer precursor solution was compressed between the silicone mold and the substrate by applying pressure; <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>b </italic></highlight>is a schematic diagram of a sequential process for producing hierarchical ordering over three discrete and independent length scales. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 2</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>2</bold></highlight><highlight><italic>d </italic></highlight>are scanning electron microscope (SEM) images of different patterns of mesoporous silica (<cross-reference target="DRAWINGS">FIGS. 2</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>2</bold></highlight><highlight><italic>c</italic></highlight>) and niobia (<cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>d</italic></highlight>) formed using the scheme of <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>a</italic></highlight>; materials shown in (<cross-reference target="DRAWINGS">FIGS. 2</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>2</bold></highlight><highlight><italic>c</italic></highlight>) are made of hexagonally ordered mesoporous silica prepared using the amphiphilic block copolymer E0<highlight><subscript>20</subscript></highlight>P0<highlight><subscript>70</subscript></highlight>E0<highlight><subscript>20 </subscript></highlight>(Pluronic P-123) as the structure directing agent; the material shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>b </italic></highlight>is made of cubic mesoporous silica prepared using the block copolymer E0<highlight><subscript>106</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>106 </subscript></highlight>(Pluronic F-127); <cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>d </italic></highlight>shows a hexagonally ordered mesoporous niobia prepared using Pluronic P-123 block copolymer. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> is a SEM image of a typical structure of hierarchically ordered titania. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>d </italic></highlight>are SEM images, at different magnifications, of hierarchically ordered mesoporous silica possessing organization over three discrete characteristic dimensions, prepared using the scheme of <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>b</italic></highlight>; <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>b </italic></highlight>and <highlight><bold>4</bold></highlight><highlight><italic>d </italic></highlight>show a diamond lattice of the macroporous framework skeleton; <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>e </italic></highlight>and <highlight><bold>4</bold></highlight><highlight><italic>f </italic></highlight>are transmission electron microscope (TEM) images of <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>d</italic></highlight>, showing that the framework of the macroporous skeleton is made up of ordered cubic mesoporous silica with an ordering length of approximately 11 nm; this sample was synthesized using Pluronic F-127 block copolymer as the structure-directing agent. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 5</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>5</bold></highlight><highlight><italic>b </italic></highlight>are SEM images of hierarchically ordered materials with three distinct order length scales, prepared using the scheme of <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>a</italic></highlight>, with isolated pattern features; <cross-reference target="DRAWINGS">FIG. 5</cross-reference><highlight><italic>c </italic></highlight>is a TEM image of <cross-reference target="DRAWINGS">FIGS. 5</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>5</bold></highlight><highlight><italic>b</italic></highlight>, confirming that the macroporous framework of the material is made up of cubic mesoporous silica similar to <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>d. </italic></highlight></paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> is a schematic diagram of the microtransfer molding methods used to fabricate hierarchically ordered structures on a substrate. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> is an optical microscope image of the microtransfer molding method used to prepare mesoporous silica; the inorganic/block copolymer solution was used as the liquid precursor solution. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 8</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>8</bold></highlight><highlight><italic>b </italic></highlight>are SEM images of hierarchically ordered materials with three distinct order length scales prepared using the scheme of <cross-reference target="DRAWINGS">FIG. 6</cross-reference>, with isolated pattern features; <cross-reference target="DRAWINGS">FIG. 8</cross-reference><highlight><italic>c </italic></highlight>is a TEM image of <cross-reference target="DRAWINGS">FIGS. 8</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>8</bold></highlight><highlight><italic>b</italic></highlight>, confirming that the macroporous framework of the material is made up of cubic mesoporous silica similar to <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>d.</italic></highlight></paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> The present application is directed to an efficient preparation of hierarchically ordered structures with three-dimensional structures ordered over multiple length scales. The ordered structures are prepared by combining concurrently or sequentially the techniques of micromolding, latex templating, and cooperative self-assembly of hydrolyzed inorganic species and amphiphilic block copolymers. The resulting materials show hierarchical ordering over several discrete and tunable length scales ranging from about 10 nm to several micrometers. The respective ordering structures can be independently modified by choosing different mold patterns, latex spheres and block copolymers. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> The inorganic species includes: metal alkoxides; metal chlorides; metal oxides; such as Nb<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, TiO<highlight><subscript>2</subscript></highlight>, ZrO<highlight><subscript>2</subscript></highlight>, WO<highlight><subscript>3</subscript></highlight>, AlSiO<highlight><subscript>3,5</subscript></highlight>, AlSiO<highlight><subscript>5.5</subscript></highlight>, SiTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3</subscript></highlight>, Ta<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, SiO<highlight><subscript>2</subscript></highlight>, SnO<highlight><subscript>2</subscript></highlight>, HfO<highlight><subscript>2</subscript></highlight>, ZrTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>TiO<highlight><subscript>5</subscript></highlight>, and sulfides. The metal alkoxides, metal halides, and metal oxides can be transition metal alkoxides, transition metal chlorides, and transition metal oxides. The &ldquo;transition metal&rdquo;, as used herein, is an element designated in the Periodic Table as belonging to Group IIIB (e.g., scandium and yttrium), Group IVB (e.g., titanium, zirconium and hafnium), Group VB (e.g. chromium, molybdenum and tungsten), Group VIIB (e.g., manganese, technitium and rhenium), Group VIIIB (iron, ruthenium, osmium, cobalt, rhodium, iridium, nickel, palladium and platinum), Group IB (e.g., copper, gold and silver) and Group IIB (zinc, cadmium and mercury). </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> Commercially available, low-cost, non-toxic, and biodegradable amphiphilic poly(alkylene oxide) block polymers can be used as the structure-directing agents in non-aqueous solutions for organizing the network forming metal compound species. Preferably the block copolymer is a triblock copolymer in which a hydrophilic poly(alkylene oxide) such as polyethylene oxide (EO<highlight><subscript>x</subscript></highlight>) is linearly covalent with the opposite ends of a hydrophobic poly(alkylene oxide) such as poly(propylene oxide) (PO<highlight><subscript>y</subscript></highlight>) or a diblock polymer in which, for example, poly(ethylene oxide) is linearly covalent with poly(butylene oxide) (BO<highlight><subscript>y</subscript></highlight>). This can variously be designated as follows: </paragraph>
<paragraph id="P-0028" lvl="2"><number>&lsqb;0028&rsqb;</number> poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) </paragraph>
<paragraph id="P-0029" lvl="2"><number>&lsqb;0029&rsqb;</number> HO(CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>O)<highlight><subscript>x</subscript></highlight>(CH<highlight><subscript>2</subscript></highlight>CH(CH<highlight><subscript>3</subscript></highlight>)O)<highlight><subscript>y</subscript></highlight>(CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>O)<highlight><subscript>x</subscript></highlight>H </paragraph>
<paragraph id="P-0030" lvl="2"><number>&lsqb;0030&rsqb;</number> EO<highlight><subscript>x</subscript></highlight>PO<highlight><subscript>y</subscript></highlight>EO<highlight><subscript>x </subscript></highlight>or </paragraph>
<paragraph id="P-0031" lvl="2"><number>&lsqb;0031&rsqb;</number> poly(ethylene oxide)-poly(butylene oxide)-poly(ethylene oxide) </paragraph>
<paragraph id="P-0032" lvl="2"><number>&lsqb;0032&rsqb;</number> HO(CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>O)<highlight><subscript>x</subscript></highlight>(CH<highlight><subscript>2</subscript></highlight>CH(CH<highlight><subscript>3</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>)O)<highlight><subscript>y</subscript></highlight>H </paragraph>
<paragraph id="P-0033" lvl="2"><number>&lsqb;0033&rsqb;</number> PEO-PBO-PEO </paragraph>
<paragraph id="P-0034" lvl="2"><number>&lsqb;0034&rsqb;</number> EO<highlight><subscript>x</subscript></highlight>BO<highlight><subscript>y</subscript></highlight>EO<highlight><subscript>x </subscript></highlight></paragraph>
<paragraph id="P-0035" lvl="7"><number>&lsqb;0035&rsqb;</number> where x is 5 or greater and y is 30 or greater, with no theoretical upper limit to either value subject to practical considerations. Amphiphilic block copolymers with different architectures, molecular weight or concentrations have been used to obtain the third ordering structure that can be either hexagonal or cubic with ordering length between about 5 nm to 20 nm. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> The synthesis of the precursor solution was outlined in D. Zhao, et al., Science, Vol. 279, 548 (1998) and Zhao, et al., Adv. Mater, Vol.10, 1380 (1998). Tetraethoxysilane (TEOS), tetramethoxysilane (TMOS), and tetrapropoxysilane (TPOS) were suitable sources of silica for the preparation of mesoporous silica structures. Hexagonal mesoporous silica structures were formed in acid media (pH&lt;1) with HCl, HBr, HI, HNO<highlight><subscript>3</subscript></highlight>, H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>, or H<highlight><subscript>3</subscript></highlight>PO<highlight><subscript>4 </subscript></highlight>acids. In Zhao, et al., Adv. Mater, Vol. 10, oligomeric silica sol-gel was obtained by pre-hydrolyzing of TEOS in ethanol by an acid catalyzed. The oligomeric silica sol-gel was then added into a mixture solution of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) PEO-PPO-PEO triblock copolymers or alkyl poly(ethylene oxide) and inorganic metal precursor compound in water and ethanol. The final composition of this mixture was (in molar ratio) 0.0068-0.034 EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20 </subscript></highlight>triblock copolymer: 0.51 to about 3.0 inorganic metal compound: 1 tetraethylorthoxysilicane (TEOS): 11-50 ethanol (EtOH): 0.002-0.04 HCl: 18-65H<highlight><subscript>2</subscript></highlight>O. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> In a typical synthesis, 2.08 g TEOS were added to 5 g ethanol, 0.4 g water and 0.4 g (0.1 M) of HCl solution with stirring at room temperature for 0.5 hours, then heated at 70&deg; C. without stirring for 1 hours. After cooling to room temperature, I g EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20 </subscript></highlight>(average molecular weight 5800), 1 g NaCl, 10 g ethanol and 10 g water were added to this solution with stirring at room temperature for 1 hour. The samples are then calcined at about 400&deg; C. to 450&deg; C. for about 5 hours to remove the block copolymer. For the Al and SiAl metal oxides, calcination is carried out at 600&deg; C. for 4 hours. For WO<highlight><subscript>3</subscript></highlight>, calcination at 300&deg; C. is sufficient to yield ordered mesoporous oxides. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> Table 1 summarizes the synthetic conditions, including the inorganic precursors and aging temperatures and times for the mesostructured inorganic/copolymer composites (before calcination) using EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20 </subscript></highlight>as the structure-directing agent. The ordering lengths shown in Table 1 correspond to the largest d value observed from low-angle XRD patterns; it ranged from about 70 to 160 &angst; for the different systems. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> In practicing this invention, one can use a commercially available latex colloidal suspension containing latex spheres to template the second level ordering structure. A latex suspension containing polymer, preferably polystyrene, microspheres with sizes ranging from about 50 nm to 1500 nm is preferred. The latex spheres are also preferably uniform in size. The latex suspension used in the following examples was obtained from Bangs Laboratory, Fishers, Ind. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> The substrate used in the following examples was a freshly cleaned silicon wafer, however, other substrates such as glass, quartz, and polymers may be substituted for the silicon wafer. Besides ethanol, other organic solvents, such as methanol, 1,4-dioxane, tetrahydrofuran (THF), CH<highlight><subscript>3</subscript></highlight>CN, and propanol, can be used as solvents. The mold used in the following examples was a poly(dimethylsiloxane) (PDMS) mold. The procedure for making the mold is outlined in Y. Xia, et al., Angew. Chem. Int. Ed. 37, 550 (1998). The patterned structures of the resulting materials can have a thickness of a submicron to several tens micrometers depending on the relief depth of the micromold used. One skilled in the art may practice the invention using any mold having micro features. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> Mesoscopic ordering in the synthesized materials was characterized by their low-angle X-ray diffraction patterns and transmission electron microscope (TEM) images. All TEM images were recorded on a JEOL 2010 transmission electron microscope operated at 200 KeV. The scanning electron microscope (SEM) images were taken on a JEOL F6300 scanning electron microscope operated at 3 KeV. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> During latex templating, it is believed that the organization of latex spheres in confined geometries involves nucleation due to capillary attractive forces between the microspheres and growth due to evaporation and influx of suspension to compensate for the loss of solvent. &lsqb;See, E. Kim, et al., Adv. Mater. Vol. 8, 245 (1996)&rsqb;. The different packing sequences observed in the larger triangular and the smaller bridge areas are presumably the consequence of the different edge effects during the colloidal organization. &lsqb;See, A. van Blaaderen, et al., Nature, Vol. 385, 321 (1997)&rsqb;. In addition, the inorganic oxide, e.g., silica, framework of the macroporous structure is itself made up of mesoscopically ordered cubic arrays of cages with characteristic dimension of approximately 11 nm as established by the Pluronic F-127 block copolymer. <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>e </italic></highlight>and <highlight><bold>4</bold></highlight><highlight><italic>f </italic></highlight>show typical TEM images recorded for the same hierarchically ordered silica. The ordered macroporous structure (approximately 100 nm) can be seen in <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>f</italic></highlight>, along with the silica framework consisting of ordered cubic arrays of mesopores (approximately 11 nm). </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> The formation of end-caps in self-assembled surfactant cylinders is not favored given their high free energy of formation. Thus, within the highly confined geometries of the PDMS micromold, the cylindrical block copolymer aggregates are expected to oriented preferentially parallel to the micromold walls in order to minimize the number of aggregate end-caps. These patterned lines of mesoporous silica can be potentially used as waveguides. In addition, combining these patterning capabilities and the high porosities achievable, greater than 70%, for such mesoporous silica is extremely promising for low-dielectric material applications related to the miniaturization of electronic circuits and devices. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> Many applications of macro- and mesoporous metal oxides require structural ordering at multiple length scales. Development of such strategies for hierarchically ordered materials using low-cost, non-toxic, and biodegradable polyalkylene oxide block copolymers has enormous potential for a variety of immediate and future industrial applications. A continuing challenge for materials chemists and engineers is the ability to create multifunctional composite structures with well-defined superimposed structural order from nanometer to micrometer length scales Many uses have been proposed for patterned Macro- and mesoporous metal oxide materials, particularly in the fields of catalysis, molecular separations, fuel cells, adsorbents, optoelectronic devices, and chemical and biological sensors. For example, the patterned lines that were demonstrated for mesoporous silica and other metal oxides can be potentially used as waveguides. In addition, the combination of the patterning capabilities and the high porosities achievable for such mesoporous materials is extremely promising for dielectric material applications related to the miniaturization of electronic circuits and devices. &lsqb;D. Zhao, et al., Adv. Mater., Vol. 10, 1380 (1998)&rsqb;. Macro- and mesoporous Nb<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5 </subscript></highlight>can be potentially used as an ultra-sensitive humidity sensor. &lsqb;M. E. Gimon-Kinsel, et al., Stud. Surf. Sci. Cata., Vol. 117, 111 (1998)&rsqb;. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> The resulting materials showed hierarchical ordering over several discrete and tunable length scales ranging from 10 nm to several micrometers. The respective ordering structures can be independently modified by choosing different mold patterns, latex spheres and block copolymers. The versatility of this invention is exemplified by the syntheses of patterned macro- and mesoporous materials of various compositions, such as silica, niobia, and titania, which have various physical properties including semiconducting, low dielectric-constant, and high dielectric constants. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> The hierarchical ordering process can be further extended to the preparation of other patterned mesoporous metal oxides, such as TiO<highlight><subscript>2 </subscript></highlight>using sol-gel mesophase self-assembly chemistry developed in our laboratory. Particularly interesting for hierarchically ordered TiO<highlight><subscript>2 </subscript></highlight>is the possibility of fabricating photonic crystals with tunable photonic band gap in the visible and infrared region. Other possible applications include optical filter and antenna. There is also tremendous interest in using mesoporous ZrO<highlight><subscript>2</subscript></highlight>, AlSiO<highlight><subscript>3,5</subscript></highlight>, AlSiO<highlight><subscript>5.5</subscript></highlight>, and SiTiO<highlight><subscript>4 </subscript></highlight>as acidic catalysts. Mesoporous materials with semiconducting frameworks, such as WO<highlight><subscript>3 </subscript></highlight>and SnO<highlight><subscript>2 </subscript></highlight>can also be used in the construction of fuel cells. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> Thus, such materials are important both for systematic fundamental study of structure-property relationships and for their technological promise in applications such as catalysis, selective separations, sensor arrays, waveguides, miniaturized electronic and magnetic devices, and photonic crystals with tunable band gaps. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>a </italic></highlight>illustrates the procedure that was used to fabricate materials with two scale ordering. Here, the gelation of a self-assembling sol-gel precursor solution was carried out in the confined space of a poly(dimethylsiloxane) (PDMS) mold, the procedure for which is outlined in Y. Xia, et al., Angew. Chem. Int. Ed., Vol. 37, 550 (1998), incorporated herein by reference. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> The precursor solution had the same composition as used in the preparation of mesoporous silica films outlined in D. Zhao, et al., Science, Vol. 279, 548(1998) and Zhao, et al., Adv. Mater, Vol.10, 1380 (1998). </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> The sol-gel precursor solution of the present invention consisted of 0.008-0.018 poly(ethyleneoxide)-b-poly(propyleneoxide)-b-poly(ethyleneoxide) (EO<highlight><subscript>n</subscript></highlight>PO<highlight><subscript>m</subscript></highlight>EO<highlight><subscript>n</subscript></highlight>) triblock copolymer: 1 tetraethylorthoxysilicane (TEOS): 20-60 ethanol (EtOH): 0.01-0.04 HCl: 5-10H<highlight><subscript>2</subscript></highlight>O. Pluronic P-123 (EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20</subscript></highlight>) was used as the triblock copolymer. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> To mold these materials, a drop of the precursor solution was put on a freshly cleaned substrate (e.g. silicon wafer) after which the mold was placed face down to cover the drop on the surface of the substrate. A pressure of roughly 1&times;10<highlight><superscript>5 </superscript></highlight>to 2&times;10<highlight><superscript>5 </superscript></highlight>Pa was applied to the PDMS mold. The area of the patterned surface was typically 1-5 cm<highlight><superscript>2 </superscript></highlight>with molded feature sizes in the micrometer size range. It is important that the liquid dewets the surface to permit contact between the PDMS elastomer and the substrate in regions where no mesostructured material is desired. This dewetting is driven by both the applied pressure and the difference between the interfacial tensions of the precursor and the PDMS mold. &lsqb;See, C. Marzolin, et al., Adv. Mater. Vol. 10, 571 (1998)&rsqb;. Gelation of the mesophase precursor solutions normally occurred within hours. The mold and the resulting mesostructure were left undisturbed for at least 12 h to allow increased cross-linking and consolidation of the inorganic oxide network. After removing the mold, the patterned material was calcined at 400&deg; C. in air for 5 h to remove the amphiphilic block copolymer species and thereby produce patterned mesoscopically ordered porous solids. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 1 </heading>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> Mesoscopic ordering in these materials is characterized by their low-angle X-ray diffraction patterns and transmission electron microscope (TEM) images. <cross-reference target="DRAWINGS">FIGS. 2</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>2</bold></highlight><highlight><italic>c </italic></highlight>show several representative scanning electron microscope (SEM) images of the dual-scale synthesized ordered materials. The structural ordering observed at the micrometer level was imparted by the micromolding operation using the PDMS mold, while the mesoscopic ordering results from the self-assembly of the sol-gel block copolymer solution. Both isolated (<cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>a</italic></highlight>) and continuous (<cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>b</italic></highlight>) features can be produced by this overall process. The materials shown in <cross-reference target="DRAWINGS">FIGS. 2</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>2</bold></highlight><highlight><italic>c </italic></highlight>are hexagonal mesoporous silica (cell parameter a&equals;approximately 10.5 nm). The smallest line feature obtained with the micromolding was about 100 nm (<cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>c</italic></highlight>). </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> The procedure of Example 1 was followed, substituting Pluronic F-127 (EO<highlight><subscript>106</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>106</subscript></highlight>) for Pluronic P-123 (EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20</subscript></highlight>) as the structure-directing triblock copolymer species. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 2 </heading>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> The results of using Pluronic F-127 (EO<highlight><subscript>106</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>106</subscript></highlight>) as the triblock copolymer was the material synthesized was cubic mesoporous silica (cell parameter a&equals;approximately 11 nm), as seen in <cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>b. </italic></highlight></paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> The procedure of Example 1 was followed by substituting NbCl<highlight><subscript>5 </subscript></highlight>as the inorganic metal precursor compound. 1 g of Pluronic P-123 (EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20</subscript></highlight>) was dissolved in 10 g of ethanol. To this solution, 0.01 mole of NbCl<highlight><subscript>5 </subscript></highlight>was added with vigorous stirring. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 3 </heading>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference><highlight><italic>d </italic></highlight>shows a representative SEM image of a dual-scale synthesized ordered Nb<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5 </subscript></highlight>material, which is a potential ultra-sensitive humidity sensor. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> The procedure of Example 1 was followed by substituting TiCl<highlight><subscript>4 </subscript></highlight>as the inorganic metal precursor compound. 1 g of Pluronic P-123 (EO<highlight><subscript>20</subscript></highlight>PO<highlight><subscript>70</subscript></highlight>EO<highlight><subscript>20</subscript></highlight>) was dissolved in 10 g of ethanol. To this solution, 0.01 mole of TiCl<highlight><subscript>4 </subscript></highlight>was added with vigorous stirring. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 4 </heading>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> shows a SEM image of a typical structure of hierarchically ordered titania. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> To obtain materials with ordering on three discrete length scales, latex templating was combined sequentially or concurrently with micromolding and cooperative self-assembly. The sequential process is illustrated in <cross-reference target="DRAWINGS">FIG. 1</cross-reference><highlight><italic>b</italic></highlight>. Both ends of the PDMS mold were cut open to allow fluid to enter and air/solvent to escape. The mold was then placed on a freshly cleaned Si substrate. The compliant nature of the PDMS elastomer allowed conformal contact between the mold and the substrate, and a network of channels formed. A drop of a latex colloidal suspension containing polystyrene microspheres (200 nm diameter, 10 weight % in water) was placed at one cut end of the PDMS mold, so that the fluid suspension filled the network of the micromold channels by capillary action. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> Upon evaporation of the solvent at room temperature, the latex spheres organized into a close-packed array within the confinement of the micromold channel network. A drop of sol-gel block copolymer precursor solution, containing the same composition as in Example 1, was subsequently placed at the same end of the mold and similarly imbibed into the latex-sphere filled micromold channels by capillary action. The PDMS mold and contents were then left undisturbed for at least 12 hours, during which time cross-linking and polymerization of the inorganic oxide precursor species occurred to yield a robust composite product. The mold was removed and the resulting materials were calcined at 450&deg; C. in air for 2 hours to remove the block copolymer species and the polystyrene spheres. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 5 </heading>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> The synthesized materials exhibited hierarchical ordering with discrete characteristic length scales of 10, 100, and 1000 nm in a single body. <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>a</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>d </italic></highlight>illustrate several typical SEM images for these ordered structures. The structural organization over the three independent length scales was achieved by combining block copolymer self-assembly, latex-sphere templating, and micromolding to produce ordered mesopores (10 nm), macropores (100 nm), and surface patterns (1000 nm). Micromolding resulted in high quality surface patterns with micron size dimensions (<cross-reference target="DRAWINGS">FIG. 4</cross-reference><highlight><italic>a</italic></highlight>); the patterned features themselves were made of the inorganic oxide solid organized to form highly ordered macropores that had been templated by close-packed arrays of the latex spheres (<cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>b</italic></highlight>-<highlight><bold>4</bold></highlight><highlight><italic>d</italic></highlight>). The high degree of macropore ordering (approximately 100 nm) was clearly observed both in the triangular features seen in <cross-reference target="DRAWINGS">FIG. 4</cross-reference><highlight><italic>b </italic></highlight>and within the bridges observed in <cross-reference target="DRAWINGS">FIG. 4</cross-reference><highlight><italic>c</italic></highlight>, although <cross-reference target="DRAWINGS">FIGS. 4</cross-reference><highlight><italic>b </italic></highlight>and <highlight><bold>4</bold></highlight><highlight><italic>c </italic></highlight>show different packing sequences. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> In order to fabricate materials with three hierarchically ordering length scales into isolated patterned structures, the procedure of Example 1 was followed, with the addition of combining a latex sphere suspension with the sol-gel/triblock copolymer in a volume ration of 1:1. In this example, a drop of sol-gel/block copolymer and latex sphere suspension (volume ratio 1:1) was placed on the substrate before application of the PDMS mold. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 6 </heading>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 5</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>5</bold></highlight><highlight><italic>b </italic></highlight>show SEM images of such isolated surface pattern features with ordering lengths of both approximately 1000 and 100 nm, which resulted from micromolding and latex-sphere templating, respectively. The TEM image (<cross-reference target="DRAWINGS">FIG. 5</cross-reference><highlight><italic>c</italic></highlight>) and low angle X-ray diffraction patterns of these materials further confirmed that the inorganic oxide (silica) frameworks of the macropore structures consisted of highly ordered mesopore arrays. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> The technique of microtransfer molding was used to prepare materials with two scale or three scale ordered porous material. In this microtransfer molding process a drop of liquid inorganic precursor solution was applied to the patterned surface of a PDMS mold and the excess liquid was removed by scraping with a flat PDMS block. The liquid precursor used was the inorganic/block copolymer solution. The filled mold was then placed in contact with a silicon wafer substrate. A pressure of about 1&times;10<highlight><superscript>5 </superscript></highlight>to 2&times;10<highlight><superscript>5 </superscript></highlight>Pa was then applied to the mold and the mold/substrate structure was left undisturbed for at least 12 hours, to ensure the proper cross-linking of the inorganic frameworks. The mold was peeled away carefully to leave a patterned structure on the surface of the substrate. This structure was then calcined at 450&deg; C. to remove the block copolymer and the latex spheres. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 7 </heading>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> shows an optical microscope image of the mesoporous silica fabricated by microtransfer molding. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The procedure of Example 7 was followed, by substituting a mixture of latex suspension and inorganic/copolymer solution (in a volume ratio of 1:1) for the inorganic/block copolymer liquid precursor solution. </paragraph>
</section>
<section>
<heading lvl="1">Results of Example 8 </heading>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 8</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>8</bold></highlight><highlight><italic>b </italic></highlight>show SEM images of typical structures of hierarchically ordered silica that were fabricated by microtransfer molding. <cross-reference target="DRAWINGS">FIG. 8</cross-reference><highlight><italic>c </italic></highlight>shows a TEM image of <cross-reference target="DRAWINGS">FIGS. 8</cross-reference><highlight><italic>a </italic></highlight>and <highlight><bold>8</bold></highlight><highlight><italic>b</italic></highlight>. The TEM image and low angle X-ray diffraction patterns of these materials further confirmed that the inorganic oxide frameworks of the macropore structures consisted of highly ordered mesopore arrays. This method was also capable of generating both isolated and interconnected microstructures. However, residual materials cannot usually be avoided between the patterned raised features. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> The procedure of EXAMPLE 7 was followed by substituting the step of removing the excess liquid precursor solution by blowing off with a stream of nitrogen or air for the removal by scraping with a flat PDMS block. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES 10 TO 21 </heading>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> The procedure of Example 1 can be followed, by preparing a sol-gel solution as disclosed in P. Yang, et al., Science, Vol. 282, 2244 (1998), incorporated by reference herein, with diverse thermally stable mesostructured metal oxides, including ZrO<highlight><subscript>2</subscript></highlight>, WO<highlight><subscript>3</subscript></highlight>, AlSiO<highlight><subscript>3,5</subscript></highlight>, AlSiO<highlight><subscript>5.5</subscript></highlight>, SiTiO<highlight><subscript>4 </subscript></highlight>Al<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3</subscript></highlight>, Ta<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, SiO<highlight><subscript>2</subscript></highlight>, SnO<highlight><subscript>2</subscript></highlight>, HfO<highlight><subscript>2</subscript></highlight>, ZrTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>TiO<highlight><subscript>5</subscript></highlight>, and sulfides. The metal oxides may be used in the sol-gel solution by slowing hydrolysis of inorganic chloride precursor species in alcohol solutions. Table I summarizes the synthetic conditions for the mesostructured inorganic/copolymer composites. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> The syntheses of these hierarchically ordered materials demonstrate the ability to control the overall structure of the inorganic materials at several discrete and independent ordering length scales. It is the self-assembly of sol-gel inorganic/block copolymer mesophase around organized arrays of latex spheres in a patterned mold that leads to structures with such high complexities. The respective ordering lengths and structures can be independently modified by choosing a different mold pattern, latex spheres with different diameters, and/or amphiphilic block copolymers with different architectures, molecular weight or concentrations. Furthermore, the composition of the inorganic framework can be altered by using appropriate sol-gel inorganic precursor species, e.g, Nb<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, TiO<highlight><subscript>2</subscript></highlight>, ZrO<highlight><subscript>2</subscript></highlight>, WO<highlight><subscript>3</subscript></highlight>, AlSiO<highlight><subscript>3,5</subscript></highlight>, AlSiO<highlight><subscript>5.5</subscript></highlight>, SiTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3</subscript></highlight>, Ta<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, SiO<highlight><subscript>2</subscript></highlight>, SnO<highlight><subscript>2</subscript></highlight>, HfO<highlight><subscript>2</subscript></highlight>, ZrTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>TiO<highlight><subscript>5 </subscript></highlight>and even sulfides. &lsqb;See, P. Yang, et al., Nature, Vol. 396,152 (1998)&rsqb;. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> These materials possess both biomimetic significance and technological importance. The ease, reproducibility, and versatility of this synthetic approach facilitates the development of new materials with a variety of compositions, and offers far-ranging possibilities for tuning electronic, optical, and magnetic properties over several length scales independently. For example, hierarchically ordered titania may exhibit tunable photonic band gaps. Foreseeable technological applications of these materials include quantum optics or optical communications, large molecular catalysis, separation, host-guest systems, porous electrodes, and sensors. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> The following references are incorporated herein by reference: A. Aksay, et al., Science, 273, 892 (1996); X. Bu, et al., Science, 278, 2080 (1997); C. T. Kresge, et al., Nature, 359, 710 (1992); D. Zhao, et al., Science, 279, 548 (1998); P. Yang, et al., Science, Vol. 282, 2244 (1998); P. Yang, et al., Nature, Vol. 396,152 (1998); A. Firouzi, et al., J. Am. Chem. Soc. 119, 9466 (1997); S. H. Tolbert, et al., Science, 278, 264 (1997); D. Velev, et al., Nature, 389, 447 (1997); M. Antonietti, et al., Adv. Mater. 10,154 (1998); B. T. Holland, et al., Science, 281, 538 (1998); J. E. G. J. Wijnhoven, et al., Science, 281, 802 (1998); Y. Xia, et al., Angew. Chem. Int. Ed. 37, 550 (1998); E. Kim, et al., Adv. Mater. 8, 245 (1996); C. Marzolin, et al., Adv. Mater. 10, 571 (1998); H. Yang, et al., Adv. Mater. 9, 811 (1997); M. Trau, et al., Nature, 390, 674 (1997); Q. Huo, et al., Nature, 368, 317 (1994); D. Zhao, et al., Adv. Mater., Vol.10, 1380 (1998); S. L. Keller, et al., Phys. Rev. Lett. 80, 2725 (1998); Q. Huo, et al., Adv. Mater. 9, 974 (1997); M. E. Gimon-Kinsel, et al., Stud. Surf. Sci. Cata. 117,111 (1998); and A. van Blaaderen, et al., Nature, 385, 321 (1997). </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be obvious that various modifications and changes which are within the knowledge of those skilled in the art are considered to fall within the scope of the appended claims.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="35PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="left"/>
<colspec colname="3" colwidth="63PT" align="center"/>
<colspec colname="4" colwidth="56PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="5" align="center">TABLE 1</entry>
</row>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Inorganic</entry>
<entry>Aging Temperature,</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>System</entry>
<entry>Precursor</entry>
<entry>&deg; C.</entry>
<entry>Aging time (day)</entry>
<entry>d (&angst;)</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="35PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="left"/>
<colspec colname="3" colwidth="63PT" align="center"/>
<colspec colname="4" colwidth="56PT" align="char" char="."/>
<colspec colname="5" colwidth="21PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry>Zr</entry>
<entry>ZrC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>1</entry>
<entry>125</entry>
</row>
<row>
<entry>Ti</entry>
<entry>TiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>7</entry>
<entry>123</entry>
</row>
<row>
<entry>Al</entry>
<entry>AlC1<highlight><subscript>3</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>130</entry>
</row>
<row>
<entry>Si</entry>
<entry>SiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>171</entry>
</row>
<row>
<entry>Sn</entry>
<entry>SnC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>124</entry>
</row>
<row>
<entry>Nb</entry>
<entry>NbC1<highlight><subscript>5</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>106</entry>
</row>
<row>
<entry>Ta</entry>
<entry>TaC1<highlight><subscript>5</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>110</entry>
</row>
<row>
<entry>W</entry>
<entry>WC1<highlight><subscript>6</subscript></highlight></entry>
<entry>60</entry>
<entry>15</entry>
<entry>126</entry>
</row>
<row>
<entry>Hf</entry>
<entry>HfC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>1</entry>
<entry>124</entry>
</row>
<row>
<entry>Ge</entry>
<entry>GeC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>15</entry>
<entry>146</entry>
</row>
<row>
<entry>V</entry>
<entry>VC1<highlight><subscript>4</subscript></highlight></entry>
<entry>60</entry>
<entry>7</entry>
<entry>111</entry>
</row>
<row>
<entry>Zn</entry>
<entry>ZnC1<highlight><subscript>2</subscript></highlight></entry>
<entry>60</entry>
<entry>30</entry>
<entry>120</entry>
</row>
<row>
<entry>Cd</entry>
<entry>CdC1<highlight><subscript>2</subscript></highlight></entry>
<entry>40</entry>
<entry>7</entry>
<entry>111</entry>
</row>
<row>
<entry>In</entry>
<entry>InC1<highlight><subscript>3</subscript></highlight></entry>
<entry>60</entry>
<entry>30</entry>
<entry>124</entry>
</row>
<row>
<entry>Sb</entry>
<entry>SbC1<highlight><subscript>5</subscript></highlight></entry>
<entry>60</entry>
<entry>30</entry>
<entry>93</entry>
</row>
<row>
<entry>Mo</entry>
<entry>MoC1<highlight><subscript>5</subscript></highlight></entry>
<entry>60</entry>
<entry>7</entry>
<entry>100</entry>
</row>
<row>
<entry>Re</entry>
<entry>ReC1<highlight><subscript>5</subscript></highlight></entry>
<entry>60</entry>
<entry>7</entry>
<entry>121</entry>
</row>
<row>
<entry>Ru</entry>
<entry>RuC1<highlight><subscript>3</subscript></highlight></entry>
<entry>40</entry>
<entry>3</entry>
<entry>95</entry>
</row>
<row>
<entry>Ni</entry>
<entry>NiC1<highlight><subscript>2</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>100</entry>
</row>
<row>
<entry>Fe</entry>
<entry>FeC1<highlight><subscript>3</subscript></highlight></entry>
<entry>40</entry>
<entry>7</entry>
<entry>116</entry>
</row>
<row>
<entry>Cr</entry>
<entry>CrC1<highlight><subscript>3</subscript></highlight></entry>
<entry>40</entry>
<entry>4</entry>
<entry>117</entry>
</row>
<row>
<entry>Mn</entry>
<entry>MnC1<highlight><subscript>2</subscript></highlight></entry>
<entry>40</entry>
<entry>7</entry>
<entry>124</entry>
</row>
<row>
<entry>Cu</entry>
<entry>CuC1<highlight><subscript>2</subscript></highlight></entry>
<entry>40</entry>
<entry>7</entry>
<entry>98</entry>
</row>
<row>
<entry>SiAl</entry>
<entry>AlC1<highlight><subscript>3</subscript></highlight>/SiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>120</entry>
</row>
<row>
<entry>Si<highlight><subscript>2</subscript></highlight>Al</entry>
<entry>AlC1<highlight><subscript>3</subscript></highlight>/SiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>120</entry>
</row>
<row>
<entry>ZrTi</entry>
<entry>ZrC1<highlight><subscript>4</subscript></highlight>/TiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>2</entry>
<entry>110</entry>
</row>
<row>
<entry>Al<highlight><subscript>2</subscript></highlight>Ti</entry>
<entry>AlC1<highlight><subscript>3</subscript></highlight>/TiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>7</entry>
<entry>112</entry>
</row>
<row>
<entry>SiTi</entry>
<entry>SiC1<highlight><subscript>4</subscript></highlight>/TiC1<highlight><subscript>4</subscript></highlight></entry>
<entry>40</entry>
<entry>3</entry>
<entry>103</entry>
</row>
<row>
<entry>ZrW<highlight><subscript>2</subscript></highlight></entry>
<entry>ZrC1<highlight><subscript>4</subscript></highlight>/WC1<highlight><subscript>6</subscript></highlight></entry>
<entry>40</entry>
<entry>3</entry>
<entry>140</entry>
</row>
<row>
<entry>SnIn</entry>
<entry>SnC1<highlight><subscript>4</subscript></highlight>/InCl<highlight><subscript>3</subscript></highlight></entry>
<entry>40</entry>
<entry>30</entry>
<entry>83</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method of forming a multi-scale mesoscopically structured material, comprising: 
<claim-text>combining an amphiphilic block copolymer with an inorganic metal compound; </claim-text>
<claim-text>applying pressure to said combination, whereby the block copolymer and inorganic metal compound are self-assembled and polymerized into a mesoscopically structured material; and </claim-text>
<claim-text>polymerizing said mesoscopically structured material. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said amphiphilic block copolymer and said inorganic metal compound combine to form a sol. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein pressure is applied to said combination by placing said combination on a substrate, placing a mold on said combination and applying said pressure to said mold. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00003">claim 3</dependent-claim-reference>, wherein said combination dewets said substrate whereby to permit contact between said mold and said substrate where no mesoscopically structured material is desired. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00003">claim 3</dependent-claim-reference>, further comprising after polymerizing the mesoscopically structured material, of removing said mold to form a mesoporous material. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, further comprising after polymerizing the mesoscopically structured material, calcining said material whereby to remove said amphiphilic block copolymer thereby to form a mesostructured material with a multiple length scale. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, wherein said multiple length scale is approximately 10 and 100 nm. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said inorganic metal compound is a transition metal compound. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said inorganic metal compound is a sulfide. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said block copolymer is a triblock copolymer. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said triblock copolymer is a poly(ethylene oxide)-poly(alkylene oxide)-poly (ethylene oxide) polymer where the alkylene oxide moiety has at least three carbon atoms. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said triblock copolymer is poly(ethyleneoxide)-poly(propyleneoxide)-poly(ethyleneoxide). </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said mesoscopically structured material has a cubic mesostructure. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said mesoscopically structured material has a hexagonal mesostructure. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said metal compound, upon calcination, forms an oxide selected from Nb<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, TiO<highlight><subscript>2</subscript></highlight>, ZrO<highlight><subscript>2</subscript></highlight>, WO<highlight><subscript>3</subscript></highlight>, AlSiO<highlight><subscript>3,5</subscript></highlight>, AlSiO<highlight><subscript>5.5</subscript></highlight>, SiTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3</subscript></highlight>, Ta<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, SiO<highlight><subscript>2</subscript></highlight>, SnO<highlight><subscript>2</subscript></highlight>, HfO<highlight><subscript>2</subscript></highlight>, ZrTiO<highlight><subscript>4</subscript></highlight>, and Al<highlight><subscript>2</subscript></highlight>TiO<highlight><subscript>5</subscript></highlight>. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the pressure applied was about 1&times;10<highlight><superscript>5 </superscript></highlight>to 2&times;10<highlight><superscript>5 </superscript></highlight>Pa. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, further comprising combining a latex colloidal suspension with said combination, prior to applying pressure to said combination, whereby to form a mesoscopically structured material exhibiting multiple structural ordering length scales of approximately 10, 100, and 1000 nm. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said combination and said latex colloidal suspension are combined at a volume ratio of 1:1. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The mesoscopically structured material of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> having a multiple structural ordering scale. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The mesoscopically structured material of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference> wherein the multiple structural ordering length scale is approximately 10 and 100 nm. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A method of forming a multi-scale mesoscopically structured material, comprising: 
<claim-text>contacting a mold, having a first open end and a second open end, with a substrate; </claim-text>
<claim-text>filling said mold with a latex colloidal suspension; combining an amphiphilic block copolymer with an inorganic metal compound; and </claim-text>
<claim-text>filling said mold with said combination whereby the block copolymer and inorganic metal compound are self-assembled and polymerized into a mesoscopically structured material exhibiting multiple structural ordering length scales. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said structural ordering length scales approximately 10, 100, and 1000 nm. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, further comprising removing said mold to form both a mesoporous and macroporous material. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said block copolymer is a triblock copolymer. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>, wherein said triblock copolymer is a poly(ethylene oxide)-poly(alkylene oxide)-poly (ethylene oxide) polymer where the alkylene oxide moiety has at least three carbon atoms. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>, wherein said triblock copolymer is poly(ethyleneoxide)-poly(propyleneoxide)-poly(ethyleneoxide). </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said mesoscopically structured material has a cubic mesostructure. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said mesoscopically structured material has a hexagonal mesostructure. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said inorganic metal compound is a transition metal compound. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said inorganic metal compound is a sulfide. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said metal compound, upon calcination, forms an oxide selected from Nb<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, TiO<highlight><subscript>2</subscript></highlight>, ZrO<highlight><subscript>2</subscript></highlight>, WO<highlight><subscript>3</subscript></highlight>, AlSiO<highlight><subscript>3,5</subscript></highlight>, AlSiO<highlight><subscript>5.5</subscript></highlight>, SiTiO<highlight><subscript>4</subscript></highlight>, Al<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3</subscript></highlight>, Ta<highlight><subscript>2</subscript></highlight>O<highlight><subscript>5</subscript></highlight>, SiO<highlight><subscript>2</subscript></highlight>, SnO<highlight><subscript>2</subscript></highlight>, HfO<highlight><subscript>2</subscript></highlight>, ZrTiO<highlight><subscript>4</subscript></highlight>, and Al<highlight><subscript>2</subscript></highlight>TiO<highlight><subscript>5</subscript></highlight>. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said amphiphilic block copolymer and said inorganic metal compound combine to form a sol. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, further comprising after filling said mold, of polymerizing said mesoscopically structured material. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, further comprising after polymerizing the mesoscopically structured material, of removing said mold to form a mesoporous material. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, further comprising after polymerizing the mesoscopically structured material, calcining said material whereby to remove said amphiphilic block copolymer thereby to form a mesostructured material with a multiple length scale. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. The mesoscopically structured material of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference> having a multiple structural ordering scale. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. The mesoscopically structured material of <dependent-claim-reference depends_on="CLM-00033">claim 36</dependent-claim-reference> wherein the multiple structural ordering length scale is approximately 10, 100, and 1000 nm. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. A method of forming a multi-scale mesoscopically structured material, comprising: 
<claim-text>creating a sol in which an amphiphilic block copolymer is combined with an inorganic precursor compound; </claim-text>
<claim-text>providing a substrate on which said sol is placed; </claim-text>
<claim-text>providing a mold on said sol and said substrate; </claim-text>
<claim-text>applying pressure to said mold, whereby to compress said sol between said substrate and said mold and whereby the block copolymer and inorganic transition metal compound are self-assembled and polymerized into a mesoscopically structured material; and </claim-text>
<claim-text>polymerizing said mesoscopically structured material. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. A method of forming a multi-scale mesoscopically structured material, comprising: 
<claim-text>placing a mold, having a first open end and a second open end, on a substrate; </claim-text>
<claim-text>filling said mold with a latex colloidal suspension, whereby to form an array within the mold; </claim-text>
<claim-text>creating a sol in which an amphiphilic block copolymer is combined with an inorganic precursor compound; and </claim-text>
<claim-text>filling said mold with said sol whereby the block copolymer and inorganic metal compound are self-assembled and polymerized into a mesoscopically structured material exhibiting multiple structural ordering length scales.</claim-text>
</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1A</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020190415A1-20021219-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020190415A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020190415A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020190415A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020190415A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020190415A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020190415A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020190415A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020190415A1-20021219-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020190415A1-20021219-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020190415A1-20021219-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020190415A1-20021219-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020190607A1-20021219-M00001.NB SYSTEM "US20020190607A1-20021219-M00001.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00001.TIF SYSTEM "US20020190607A1-20021219-M00001.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00002.NB SYSTEM "US20020190607A1-20021219-M00002.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00002.TIF SYSTEM "US20020190607A1-20021219-M00002.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00003.NB SYSTEM "US20020190607A1-20021219-M00003.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00003.TIF SYSTEM "US20020190607A1-20021219-M00003.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00004.NB SYSTEM "US20020190607A1-20021219-M00004.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00004.TIF SYSTEM "US20020190607A1-20021219-M00004.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00005.NB SYSTEM "US20020190607A1-20021219-M00005.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00005.TIF SYSTEM "US20020190607A1-20021219-M00005.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00006.NB SYSTEM "US20020190607A1-20021219-M00006.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00006.TIF SYSTEM "US20020190607A1-20021219-M00006.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00007.NB SYSTEM "US20020190607A1-20021219-M00007.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00007.TIF SYSTEM "US20020190607A1-20021219-M00007.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00008.NB SYSTEM "US20020190607A1-20021219-M00008.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00008.TIF SYSTEM "US20020190607A1-20021219-M00008.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00009.NB SYSTEM "US20020190607A1-20021219-M00009.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00009.TIF SYSTEM "US20020190607A1-20021219-M00009.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00010.NB SYSTEM "US20020190607A1-20021219-M00010.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00010.TIF SYSTEM "US20020190607A1-20021219-M00010.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00011.NB SYSTEM "US20020190607A1-20021219-M00011.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00011.TIF SYSTEM "US20020190607A1-20021219-M00011.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00012.NB SYSTEM "US20020190607A1-20021219-M00012.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00012.TIF SYSTEM "US20020190607A1-20021219-M00012.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00013.NB SYSTEM "US20020190607A1-20021219-M00013.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00013.TIF SYSTEM "US20020190607A1-20021219-M00013.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00014.NB SYSTEM "US20020190607A1-20021219-M00014.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00014.TIF SYSTEM "US20020190607A1-20021219-M00014.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00015.NB SYSTEM "US20020190607A1-20021219-M00015.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00015.TIF SYSTEM "US20020190607A1-20021219-M00015.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00016.NB SYSTEM "US20020190607A1-20021219-M00016.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00016.TIF SYSTEM "US20020190607A1-20021219-M00016.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00017.NB SYSTEM "US20020190607A1-20021219-M00017.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00017.TIF SYSTEM "US20020190607A1-20021219-M00017.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00018.NB SYSTEM "US20020190607A1-20021219-M00018.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00018.TIF SYSTEM "US20020190607A1-20021219-M00018.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00019.NB SYSTEM "US20020190607A1-20021219-M00019.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00019.TIF SYSTEM "US20020190607A1-20021219-M00019.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00020.NB SYSTEM "US20020190607A1-20021219-M00020.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00020.TIF SYSTEM "US20020190607A1-20021219-M00020.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00021.NB SYSTEM "US20020190607A1-20021219-M00021.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00021.TIF SYSTEM "US20020190607A1-20021219-M00021.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00022.NB SYSTEM "US20020190607A1-20021219-M00022.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00022.TIF SYSTEM "US20020190607A1-20021219-M00022.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00023.NB SYSTEM "US20020190607A1-20021219-M00023.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00023.TIF SYSTEM "US20020190607A1-20021219-M00023.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00024.NB SYSTEM "US20020190607A1-20021219-M00024.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00024.TIF SYSTEM "US20020190607A1-20021219-M00024.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00025.NB SYSTEM "US20020190607A1-20021219-M00025.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00025.TIF SYSTEM "US20020190607A1-20021219-M00025.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00026.NB SYSTEM "US20020190607A1-20021219-M00026.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00026.TIF SYSTEM "US20020190607A1-20021219-M00026.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00027.NB SYSTEM "US20020190607A1-20021219-M00027.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00027.TIF SYSTEM "US20020190607A1-20021219-M00027.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00028.NB SYSTEM "US20020190607A1-20021219-M00028.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00028.TIF SYSTEM "US20020190607A1-20021219-M00028.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00029.NB SYSTEM "US20020190607A1-20021219-M00029.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00029.TIF SYSTEM "US20020190607A1-20021219-M00029.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00030.NB SYSTEM "US20020190607A1-20021219-M00030.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00030.TIF SYSTEM "US20020190607A1-20021219-M00030.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00031.NB SYSTEM "US20020190607A1-20021219-M00031.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00031.TIF SYSTEM "US20020190607A1-20021219-M00031.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00032.NB SYSTEM "US20020190607A1-20021219-M00032.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00032.TIF SYSTEM "US20020190607A1-20021219-M00032.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00033.NB SYSTEM "US20020190607A1-20021219-M00033.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00033.TIF SYSTEM "US20020190607A1-20021219-M00033.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00034.NB SYSTEM "US20020190607A1-20021219-M00034.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00034.TIF SYSTEM "US20020190607A1-20021219-M00034.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00035.NB SYSTEM "US20020190607A1-20021219-M00035.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00035.TIF SYSTEM "US20020190607A1-20021219-M00035.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00036.NB SYSTEM "US20020190607A1-20021219-M00036.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00036.TIF SYSTEM "US20020190607A1-20021219-M00036.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00037.NB SYSTEM "US20020190607A1-20021219-M00037.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00037.TIF SYSTEM "US20020190607A1-20021219-M00037.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00038.NB SYSTEM "US20020190607A1-20021219-M00038.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00038.TIF SYSTEM "US20020190607A1-20021219-M00038.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00039.NB SYSTEM "US20020190607A1-20021219-M00039.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00039.TIF SYSTEM "US20020190607A1-20021219-M00039.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00040.NB SYSTEM "US20020190607A1-20021219-M00040.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00040.TIF SYSTEM "US20020190607A1-20021219-M00040.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00041.NB SYSTEM "US20020190607A1-20021219-M00041.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00041.TIF SYSTEM "US20020190607A1-20021219-M00041.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00042.NB SYSTEM "US20020190607A1-20021219-M00042.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00042.TIF SYSTEM "US20020190607A1-20021219-M00042.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00043.NB SYSTEM "US20020190607A1-20021219-M00043.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00043.TIF SYSTEM "US20020190607A1-20021219-M00043.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00044.NB SYSTEM "US20020190607A1-20021219-M00044.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00044.TIF SYSTEM "US20020190607A1-20021219-M00044.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00045.NB SYSTEM "US20020190607A1-20021219-M00045.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00045.TIF SYSTEM "US20020190607A1-20021219-M00045.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00046.NB SYSTEM "US20020190607A1-20021219-M00046.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00046.TIF SYSTEM "US20020190607A1-20021219-M00046.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00047.NB SYSTEM "US20020190607A1-20021219-M00047.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00047.TIF SYSTEM "US20020190607A1-20021219-M00047.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00048.NB SYSTEM "US20020190607A1-20021219-M00048.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00048.TIF SYSTEM "US20020190607A1-20021219-M00048.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00049.NB SYSTEM "US20020190607A1-20021219-M00049.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00049.TIF SYSTEM "US20020190607A1-20021219-M00049.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00050.NB SYSTEM "US20020190607A1-20021219-M00050.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00050.TIF SYSTEM "US20020190607A1-20021219-M00050.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00051.NB SYSTEM "US20020190607A1-20021219-M00051.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00051.TIF SYSTEM "US20020190607A1-20021219-M00051.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00052.NB SYSTEM "US20020190607A1-20021219-M00052.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00052.TIF SYSTEM "US20020190607A1-20021219-M00052.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00053.NB SYSTEM "US20020190607A1-20021219-M00053.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00053.TIF SYSTEM "US20020190607A1-20021219-M00053.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00054.NB SYSTEM "US20020190607A1-20021219-M00054.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00054.TIF SYSTEM "US20020190607A1-20021219-M00054.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00055.NB SYSTEM "US20020190607A1-20021219-M00055.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00055.TIF SYSTEM "US20020190607A1-20021219-M00055.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00056.NB SYSTEM "US20020190607A1-20021219-M00056.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00056.TIF SYSTEM "US20020190607A1-20021219-M00056.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00057.NB SYSTEM "US20020190607A1-20021219-M00057.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00057.TIF SYSTEM "US20020190607A1-20021219-M00057.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00058.NB SYSTEM "US20020190607A1-20021219-M00058.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00058.TIF SYSTEM "US20020190607A1-20021219-M00058.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00059.NB SYSTEM "US20020190607A1-20021219-M00059.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00059.TIF SYSTEM "US20020190607A1-20021219-M00059.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00060.NB SYSTEM "US20020190607A1-20021219-M00060.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00060.TIF SYSTEM "US20020190607A1-20021219-M00060.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00061.NB SYSTEM "US20020190607A1-20021219-M00061.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00061.TIF SYSTEM "US20020190607A1-20021219-M00061.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00062.NB SYSTEM "US20020190607A1-20021219-M00062.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00062.TIF SYSTEM "US20020190607A1-20021219-M00062.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00063.NB SYSTEM "US20020190607A1-20021219-M00063.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00063.TIF SYSTEM "US20020190607A1-20021219-M00063.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00064.NB SYSTEM "US20020190607A1-20021219-M00064.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00064.TIF SYSTEM "US20020190607A1-20021219-M00064.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-M00065.NB SYSTEM "US20020190607A1-20021219-M00065.NB" NDATA NB>
<!ENTITY US20020190607A1-20021219-M00065.TIF SYSTEM "US20020190607A1-20021219-M00065.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-D00000.TIF SYSTEM "US20020190607A1-20021219-D00000.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-D00001.TIF SYSTEM "US20020190607A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-D00002.TIF SYSTEM "US20020190607A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020190607A1-20021219-D00003.TIF SYSTEM "US20020190607A1-20021219-D00003.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020190607</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10116415</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020402</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>H01L041/08</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>310</class>
<subclass>328000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>Frequency sensitivity analysis and optimum design for MEMS resonator</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60281517</doc-number>
<document-date>20010403</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Brad</given-name>
<family-name>Paden</family-name>
</name>
<residence>
<residence-us>
<city>Santa Barbara</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Rong</given-name>
<family-name>Liu</family-name>
</name>
<residence>
<residence-us>
<city>Goleta</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Kimberly</given-name>
<middle-name>L.</middle-name>
<family-name>Turner</family-name>
</name>
<residence>
<residence-us>
<city>Santa Barbara</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<assignee>
<organization-name>The Regents of the University of California</organization-name>
<assignee-type>02</assignee-type>
</assignee>
<correspondence-address>
<name-1>GATES &amp; COOPER LLP</name-1>
<name-2>HOWARD HUGHES CENTER</name-2>
<address>
<address-1>6701 CENTER DRIVE WEST, SUITE 1050</address-1>
<city>LOS ANGELES</city>
<state>CA</state>
<postalcode>90045</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A frequency stability analysis and design method for frequency robust resonators, such as MEMS resonators, is presented. The frequency characteristics of a laterally vibrating resonator are analyzed. With the fabrication error on the sidewall of the structure being considered, the first and second order frequency sensitivities to the fabrication error are derived. A relationship between the proof mass area and perimeter, and the beam width, is developed for single material structures, which expresses that the proof mass perimeter times the beam width should equal six times the area of the proof mass. Design examples are given for the single material and multi-layer structures. The results and principles presented in the paper can be used to analyze and design other MEMS resonators. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE TO RELATED APPLICATION </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims the benefit under 35 U.S.C. &sect;119(e) of the following co-pending and commonly-assigned U.S. Provisional Patent Application Serial No. 60/281,517, entitled &ldquo;FREQUENCY SENSITIVITY ANALYSIS AND OPTIMUM DESIGN FOR MEMS RESONATOR,&rdquo; filed on Apr. 3, 2001, by Brad Paden, Rong Liu, and Kimberly L. Turner, Attorney Docket No. 30794.84USP1, which application is incorporated by reference herein.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with Government support under Grant No. CMS-9800294, awarded by the National Science Foundation. The Government has certain tights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> 1. Field of the Invention </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> The present invention relates generally to frequency sensitivity analysis and optimum design for frequency robust resonators and particularly to microelectromechanical systems (MEMS) resonators. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> 2. Description of the Related Art </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> (Note: This application references a number of different publications as indicated throughout the specification by reference numbers enclosed in brackets, e.g., &lsqb;x&rsqb;. A list of these different publications ordered according to these reference numbers can be found below in Section 5 of the specification. Each of these publications is incorporated by reference herein.) </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Resonators have been widely used as a key component in MEMS devices, such as in micro-gyroscopes &lsqb;<highlight><bold>1</bold></highlight>,<highlight><bold>2</bold></highlight>,<highlight><bold>3</bold></highlight>&rsqb;, microvibromotors &lsqb;<highlight><bold>4</bold></highlight>&rsqb;, micro-engines &lsqb;<highlight><bold>5</bold></highlight>&rsqb;, and microwave systems &lsqb;<highlight><bold>6</bold></highlight>&rsqb;. Resonators are actuated, usually electrostatically, to oscillate at their natural resonant frequency. In many cases the robustness of the design frequency to process variations is one of the most important functional properties for the resonator design. Frequency accuracy of a resonator can directly affect the quality of the system in which it serves as a component. For the lateral vibrating rate gyroscopes, the frequency matching for their two vibrating modes is important for the output sensitivity. If frequency of any one of the modes shifts, the output signal&apos;s accuracy will be decreased. Although symmetry in these gyroscopes helps the two modes to track to first order, it is useful to enhance the frequency matching by designing the resonant frequency to be insensitive to process variations. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> In microvibromotors, several resonators impact a bar to make it move in the plane of the chip. If the impacting frequencies of the resonators are not harmonic, the motion of the bar will be unpredictable. Similarly, two orthogonal resonators actuate the previously mentioned micro-engine. The rotational stability of the engine is affected by the synchrony of these two resonators. Finally, in microwave systems, the resonator is used as an IF or RF filter. Therefore, the frequency accuracy of the resonator in this application is particularly important as its frequency determines the system performance in a fundamental way. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Several factors affect the stability of the resonator frequency, which include mass-loading &lsqb;<highlight><bold>7</bold></highlight>&rsqb;, Brownian force &lsqb;<highlight><bold>8</bold></highlight>&rsqb; and fabrication variations &lsqb;<highlight><bold>9</bold></highlight>&rsqb;. The mass-loading that is the instantaneous differences in the rate of adsorption and desorption of contaminant molecules to and from the resonator surface causes mass fluctuation, which in turn leads to frequency fluctuation. Yong and Vig have given the mathematical expression to quantify the mass-loading effects on phase noise. A Brownian force is produced by the impingement of gas/air molecules on the structure, which Gabrielson has studied theoretically. Although it was known that the fabrication errors affect the frequency stability &lsqb;<highlight><bold>11</bold></highlight>&rsqb;, fewer researchers have focused on this study because of the structure complexity and differences in micromachining methods. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> With present micromachining techniques, the fabrication process variation in MEMS is inevitable and it will continue to be the case when devices are miniaturized to the point of process limitations. For example, the fabrication tolerance for the width of a typical suspension beam is reported to be about 10% in &lsqb;<highlight><bold>10</bold></highlight>&rsqb;. Even the same fabrication errors will cause different frequency variations for different resonator structures. There is a need in the art for design and fabrication processes that optimize the structure, tolerances and performance of MEMS resonators. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> The present invention meets these needs. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> The present invention comprises a frequency robust resonator including at least one beam having a first end, a second end, and a beam width and a proof mass having a proof mass area and a perimeter wherein the proof mass is affixed to the first end of the beam and the second end of the beam is affixed to a ground and the proof mass perimeter multiplied by the beam width is substantially equivalent to six times the proof mass area. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> This invention applies to any resonant structure whose resonant frequency depends on a number of design parameters, one of which, is relatively uncertain. Let &ohgr;(p<highlight><subscript>0</subscript></highlight>, p<highlight><subscript>1</subscript></highlight>, p<highlight><subscript>2</subscript></highlight>, . . . , p<highlight><subscript>n</subscript></highlight>) be a resonant frequency of a structure and p<highlight><subscript>0</subscript></highlight>, p<highlight><subscript>1</subscript></highlight>, p<highlight><subscript>2</subscript></highlight>, . . . , p be dimensional, material and other parameters. Without loss of generality, assume p<highlight><subscript>0 </subscript></highlight>is the parameter subject to manufacturing variations. The invention is to constrain the design parameters such that  
<math-cwu id="MATH-US-00001">
<number>1</number>
<math>
<mrow>
  <mrow>
    <mfrac>
      <mo>&PartialD;</mo>
      <mrow>
        <mo>&PartialD;</mo>
        <msub>
          <mi>p</mi>
          <mn>0</mn>
        </msub>
      </mrow>
    </mfrac>
    <mo>&it;</mo>
    <mrow>
      <mi>&omega;</mi>
      <mo>&af;</mo>
      <mrow>
        <mo>(</mo>
        <mrow>
          <msub>
            <mi>p</mi>
            <mn>0</mn>
          </msub>
          <mo>,</mo>
          <msub>
            <mi>p</mi>
            <mn>1</mn>
          </msub>
          <mo>,</mo>
          <msub>
            <mi>p</mi>
            <mn>2</mn>
          </msub>
          <mo>,</mo>
          <mi>&hellip;</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>,</mo>
          <msub>
            <mi>p</mi>
            <mi>n</mi>
          </msub>
        </mrow>
        <mo>)</mo>
      </mrow>
    </mrow>
  </mrow>
  <mo>=</mo>
  <mn>0</mn>
</mrow>
</math>
<mathematica-file id="MATHEMATICA-00001" file="US20020190607A1-20021219-M00001.NB"/>
<image id="EMI-M00001" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00001.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0014" lvl="7"><number>&lsqb;0014&rsqb;</number> &ohgr;(p<highlight><subscript>0</subscript></highlight>, p<highlight><subscript>1</subscript></highlight>, p<highlight><subscript>2</subscript></highlight>, . . . , p<highlight><subscript>n</subscript></highlight>)&equals;0 so that the resonant frequency is insensitive, to first order, to manufacturing variations. Designs meeting this constraint are &ldquo;frequency robust&rdquo; resonators. The invention applies to vibrating structures of all shapes and boundary conditions. For example, in addition to MEMS resonators, the invention applies to the design of bell, chimes, and other resonating structures. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> In this invention, the frequency robustness for a folded-beam lateral vibrating resonator is analyzed. Based on the analysis, an optimum design method is presented for the resonator to obtain minimum frequency sensitivity. A simple relationship between the area and the perimeter of proof mass, and the beam width is derived for single material structures.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> Referring now to the drawings in which like reference numbers represent corresponding parts throughout: </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> illustrates a folded-beam suspended resonator; </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> illustrates a folded-beam resonator coated with two material layers; </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> illustrates a typical folded-beam suspended comb driven resonator; </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> illustrates a cantilever beam and its cross sections; and </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> FIGS. <highlight><bold>5</bold></highlight>A-<highlight><bold>5</bold></highlight>E illustrate beam equations for torsional and lateral resonation. </paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS </heading>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> In the following description, reference is made to the accompanying drawings which form a part hereof, and which is shown, by way of illustration, an embodiment of the present invention. It is understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present invention. </paragraph>
<paragraph id="P-0023" lvl="7"><number>&lsqb;0023&rsqb;</number> 1. Analysis of a Folded-Beam Suspended Resonator with Single Structural Material </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows a typical folded-beam suspended resonator where the cross-section of the beams is assumed to be rectangular. The merits of this kind of resonator include a wide frequency separation between the desired mode of oscillation and higher-frequency parasitic modes, and a smaller size than cantilevered beam resonators. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> One objective of this invention is to derive a simple relationship between the design parameters to ensure low sensitivity to photo- and etch-induced variations in line-width. Foundationally, a development of beam equations for MEMS resonators is shown in Appendix B. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> The lateral spring constant of the eight combined folded beams is given by  
<math-cwu id="MATH-US-00002">
<number>2</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mn>2</mn>
            <mo>&it;</mo>
            <msup>
              <mi>a</mi>
              <mn>3</mn>
            </msup>
            <mo>&it;</mo>
            <mi>bE</mi>
          </mrow>
          <msup>
            <mi>L</mi>
            <mn>3</mn>
          </msup>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>1</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00002" file="US20020190607A1-20021219-M00002.NB"/>
<image id="EMI-M00002" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00002.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> where a and b are the width and thickness of the beams respectively, L is the length of the each beam and E is the modulus of elasticity of the beam material. The natural frequency of the resonator can be expressed as  
<math-cwu id="MATH-US-00003">
<number>3</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <msqrt>
            <mfrac>
              <mi>k</mi>
              <msub>
                <mi>M</mi>
                <mi>eff</mi>
              </msub>
            </mfrac>
          </msqrt>
          <mo>=</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>bE</mi>
              </mrow>
              <mrow>
                <msub>
                  <mi>M</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>2</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00003" file="US20020190607A1-20021219-M00003.NB"/>
<image id="EMI-M00003" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00003.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> where, M<highlight><subscript>eff </subscript></highlight>is the effective mass including the proof mass and an equivalent mass contributed by the folded-beam. Assuming that the thickness of the mass (in the dimension normal to the chip) is the same as that of the beams and that the structure consists of only one material,</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>M</italic></highlight><highlight><subscript>eff</subscript></highlight><highlight><italic>&equals;&rgr;bA</italic></highlight><highlight><subscript>eff</subscript></highlight><highlight><italic>&equals;&rgr;b</italic></highlight>(<highlight><italic>A&plus;</italic></highlight>8 <highlight><italic>&mgr;La</italic></highlight>)&emsp;&emsp;(3)</in-line-formula></paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> where A<highlight><subscript>eff </subscript></highlight>is the effective area; &rgr; is the density of the material, A is the area of the proof mass excluding cut-outs etc., &mgr; is the mass equivalence coefficient (0.38 for folded-beam &lsqb;<highlight><bold>6</bold></highlight>&rsqb;). Presently, most proof masses are rectangular plates with attached comb-drive fingers and are solid or trussed. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> Substituting (3) into (2) yields the natural frequency of the resonator  
<math-cwu id="MATH-US-00004">
<number>4</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <msqrt>
          <mfrac>
            <mrow>
              <mn>2</mn>
              <mo>&it;</mo>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>E</mi>
            </mrow>
            <mrow>
              <mi>&rho;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msub>
                <mi>A</mi>
                <mi>eff</mi>
              </msub>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
          </mfrac>
        </msqrt>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>4</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00004" file="US20020190607A1-20021219-M00004.NB"/>
<image id="EMI-M00004" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00004.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> In computing (4), b is cancelled because it appears both in the numerator and in the denominator. This shows that when the thickness of beam is the same as that of the moving mass the natural frequency of the system is independent of the thickness. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> Hence it is reasonable to assume that the fabrication error is only on the &ldquo;sidewalls&rdquo; of the structure, i.e. there is a small uniform width error &dgr; in the lateral dimensions of folded-beam and proof mass. (It is shown in Appendix A that our results hold for arbitrary &ldquo;sidewall&rdquo; errors.) Then the natural resonant frequency becomes  
<math-cwu id="MATH-US-00005">
<number>5</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msub>
            <mi>&omega;</mi>
            <mn>0</mn>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mi>&delta;</mi>
            <mo>)</mo>
          </mrow>
        </mrow>
        <mo>=</mo>
        <msqrt>
          <mfrac>
            <mrow>
              <mn>2</mn>
              <mo>&it;</mo>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>&delta;</mi>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>E</mi>
            </mrow>
            <mrow>
              <mi>&rho;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>A</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mi>&delta;</mi>
                  <mo>)</mo>
                </mrow>
              </mrow>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
          </mfrac>
        </msqrt>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>5</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00005" file="US20020190607A1-20021219-M00005.NB"/>
<image id="EMI-M00005" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00005.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> where A<highlight><subscript>eff </subscript></highlight>(&dgr;)&equals;A(&dgr;)&plus;8 &mgr;L(a&plus;2&dgr;), and the approximation &dgr;&lt;&lt;L is used to simplify the influence of &dgr; on the length of the beams. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> Therefore the first order sensitivity of &ohgr;<highlight><subscript>0 </subscript></highlight>with respect to &dgr; is given as  
<math-cwu id="MATH-US-00006">
<number>6</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>&delta;</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mn>3</mn>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <mn>2</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mrow>
                      <mi>a</mi>
                      <mo>+</mo>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mi>&delta;</mi>
                      </mrow>
                    </mrow>
                    <mo>)</mo>
                  </mrow>
                  <mo>&it;</mo>
                  <mi>E</mi>
                </mrow>
                <mrow>
                  <mi>&rho;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mrow>
                    <msub>
                      <mi>A</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mi>&delta;</mi>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                  <mo>&it;</mo>
                  <msup>
                    <mi>L</mi>
                    <mn>3</mn>
                  </msup>
                </mrow>
              </mfrac>
            </msqrt>
          </mrow>
          <mo>-</mo>
          <mrow>
            <mfrac>
              <mn>1</mn>
              <mn>2</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <mn>2</mn>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>a</mi>
                        <mo>+</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mi>&delta;</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mi>E</mi>
                </mrow>
                <mrow>
                  <mi>&rho;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <msub>
                        <mi>A</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <msup>
                    <mi>L</mi>
                    <mn>3</mn>
                  </msup>
                </mrow>
              </mfrac>
            </msqrt>
            <mo>&it;</mo>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <mrow>
                  <msub>
                    <mi>A</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&delta;</mi>
              </mrow>
            </mfrac>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>6</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00006" file="US20020190607A1-20021219-M00006.NB"/>
<image id="EMI-M00006" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00006.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> It is easily observed that the derivative of the any area A with respect to the sidewall fabrication error &dgr; is directly proportional to the perimeter of area in question including the perimeter of enclosed holes and voids. That is,  
<math-cwu id="MATH-US-00007">
<number>7</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <mrow>
              <msub>
                <mi>A</mi>
                <mi>eff</mi>
              </msub>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mi>&delta;</mi>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>&delta;</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <msub>
              <mi>P</mi>
              <mi>eff</mi>
            </msub>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mi>&delta;</mi>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mrow>
              <mi>P</mi>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mi>&delta;</mi>
                <mo>)</mo>
              </mrow>
            </mrow>
            <mo>+</mo>
            <mrow>
              <mn>16</mn>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>&mu;L</mi>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>7</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00007" file="US20020190607A1-20021219-M00007.NB"/>
<image id="EMI-M00007" wi="216.027" he="18.00225" file="US20020190607A1-20021219-M00007.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> where P((&dgr;) is the perimeter of the proof mass. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> Substituting (7) into (6) yields  
<math-cwu id="MATH-US-00008">
<number>8</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>&delta;</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mn>3</mn>
              <mo>-</mo>
              <mfrac>
                <mrow>
                  <mrow>
                    <mo>(</mo>
                    <mrow>
                      <mi>a</mi>
                      <mo>+</mo>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mi>&delta;</mi>
                      </mrow>
                    </mrow>
                    <mo>)</mo>
                  </mrow>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>[</mo>
                    <mrow>
                      <mrow>
                        <mi>P</mi>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mi>&delta;</mi>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <mn>16</mn>
                        <mo>&it;</mo>
                        <mstyle>
                          <mtext>&emsp;</mtext>
                        </mstyle>
                        <mo>&it;</mo>
                        <mi>&mu;L</mi>
                      </mrow>
                    </mrow>
                    <mo>]</mo>
                  </mrow>
                </mrow>
                <mrow>
                  <mn>2</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <msub>
                      <mi>A</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mi>&delta;</mi>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </mfrac>
            </mrow>
            <mo>)</mo>
          </mrow>
          <mo>&it;</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>&delta;</mi>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mi>&rho;</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <msub>
                    <mi>A</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>8</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00008" file="US20020190607A1-20021219-M00008.NB"/>
<image id="EMI-M00008" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00008.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> The second order sensitivity of with respect to can be derived as  
<math-cwu id="MATH-US-00009">
<number>9</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <msup>
              <mo>&PartialD;</mo>
              <mn>2</mn>
            </msup>
            <mo>&it;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <msup>
              <mi>&delta;</mi>
              <mn>2</mn>
            </msup>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mn>3</mn>
              <mo>-</mo>
              <mfrac>
                <mrow>
                  <mn>3</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <msub>
                      <mi>P</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mi>&delta;</mi>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mrow>
                      <mi>a</mi>
                      <mo>+</mo>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mi>&delta;</mi>
                      </mrow>
                    </mrow>
                    <mo>)</mo>
                  </mrow>
                </mrow>
                <mrow>
                  <msub>
                    <mi>A</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mfrac>
              <mo>-</mo>
              <mfrac>
                <mrow>
                  <mn>4</mn>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>a</mi>
                        <mo>+</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mi>&delta;</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mn>2</mn>
                  </msup>
                </mrow>
                <mrow>
                  <msub>
                    <mi>A</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mfrac>
              <mo>+</mo>
              <mfrac>
                <mrow>
                  <mn>3</mn>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>P</mi>
                          <mi>eff</mi>
                        </msub>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mi>&delta;</mi>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mn>2</mn>
                  </msup>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>a</mi>
                        <mo>+</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mi>&delta;</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mn>2</mn>
                  </msup>
                </mrow>
                <mrow>
                  <mn>4</mn>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>A</mi>
                          <mi>eff</mi>
                        </msub>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mi>&delta;</mi>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mn>2</mn>
                  </msup>
                </mrow>
              </mfrac>
            </mrow>
            <mo>)</mo>
          </mrow>
          <mo>&times;</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>&delta;</mi>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mo>&it;</mo>
                <mi>&rho;</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <msub>
                    <mi>A</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>9</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00009" file="US20020190607A1-20021219-M00009.NB"/>
<image id="EMI-M00009" wi="216.027" he="69.1173" file="US20020190607A1-20021219-M00009.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> To set &part;&ohgr;<highlight><subscript>0</subscript></highlight>/&part;&dgr; and &part;<highlight><superscript>2</superscript></highlight>&ohgr;<highlight><subscript>0</subscript></highlight>/&part;&dgr;<highlight><superscript>2 </superscript></highlight>equal zero, the following conditions must be satisfied  
<math-cwu id="MATH-US-00010">
<number>10</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mrow>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <msub>
                  <mi>&omega;</mi>
                  <mn>0</mn>
                </msub>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&delta;</mi>
              </mrow>
            </mfrac>
            <mo>&RightBracketingBar;</mo>
          </mrow>
          <mi>&delta;</mi>
        </msub>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mrow>
              <mn>3</mn>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>A</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mi>&delta;</mi>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
            <mo>-</mo>
            <mrow>
              <mfrac>
                <mn>1</mn>
                <mn>2</mn>
              </mfrac>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>P</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mi>&delta;</mi>
                  <mo>)</mo>
                </mrow>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>a</mi>
                  <mo>+</mo>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mi>&delta;</mi>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mn>0</mn>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>10</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00010" file="US20020190607A1-20021219-M00010.NB"/>
<image id="EMI-M00010" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00010.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
 
<math-cwu id="MATH-US-00011">
<number>11</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <msup>
                <mo>&PartialD;</mo>
                <mn>2</mn>
              </msup>
              <mo>&it;</mo>
              <msub>
                <mi>&omega;</mi>
                <mn>0</mn>
              </msub>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <msup>
                <mi>&delta;</mi>
                <mn>2</mn>
              </msup>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mi>&delta;</mi>
          </msub>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mrow>
            <msup>
              <mrow>
                <mn>3</mn>
                <mo>&af;</mo>
                <mrow>
                  <mo>[</mo>
                  <mrow>
                    <mrow>
                      <msub>
                        <mi>A</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>-</mo>
                    <mrow>
                      <mfrac>
                        <mn>1</mn>
                        <mn>2</mn>
                      </mfrac>
                      <mo>&it;</mo>
                      <mrow>
                        <msub>
                          <mi>P</mi>
                          <mi>eff</mi>
                        </msub>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mi>&delta;</mi>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                      <mo>&it;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <mi>a</mi>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <mi>&delta;</mi>
                          </mrow>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mo>]</mo>
                </mrow>
              </mrow>
              <mn>2</mn>
            </msup>
            <mo>-</mo>
            <mrow>
              <mn>4</mn>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>A</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mi>&delta;</mi>
                  <mo>)</mo>
                </mrow>
              </mrow>
              <mo>&it;</mo>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>&delta;</mi>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>2</mn>
              </msup>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mn>0</mn>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>11</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00011" file="US20020190607A1-20021219-M00011.NB"/>
<image id="EMI-M00011" wi="216.027" he="22.08465" file="US20020190607A1-20021219-M00011.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> Setting &dgr; equal zero, and substituting (6) and (7) into (10) and (11) yields  
<math-cwu id="MATH-US-00012">
<number>12</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>&omega;</mi>
                <mn>0</mn>
              </msub>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <msup>
                <mi>&delta;</mi>
                <mn>2</mn>
              </msup>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <mi>&delta;</mi>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mrow>
              <mn>3</mn>
              <mo>&it;</mo>
              <mi>A</mi>
            </mrow>
            <mo>-</mo>
            <mrow>
              <mfrac>
                <mn>1</mn>
                <mn>2</mn>
              </mfrac>
              <mo>&it;</mo>
              <mi>P</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>a</mi>
            </mrow>
            <mo>+</mo>
            <mrow>
              <mn>16</mn>
              <mo>&it;</mo>
              <mi>&mu;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>L</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>a</mi>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mn>0</mn>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>12</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <msup>
                <mo>&PartialD;</mo>
                <mn>2</mn>
              </msup>
              <mo>&it;</mo>
              <msub>
                <mi>&omega;</mi>
                <mn>0</mn>
              </msub>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <msup>
                <mi>&delta;</mi>
                <mn>2</mn>
              </msup>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <mi>&delta;</mi>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mrow>
            <msup>
              <mrow>
                <mn>3</mn>
                <mo>&af;</mo>
                <mrow>
                  <mo>[</mo>
                  <mrow>
                    <mi>A</mi>
                    <mo>-</mo>
                    <mrow>
                      <mfrac>
                        <mn>1</mn>
                        <mn>2</mn>
                      </mfrac>
                      <mo>&it;</mo>
                      <mi>P</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>a</mi>
                    </mrow>
                  </mrow>
                  <mo>]</mo>
                </mrow>
              </mrow>
              <mn>2</mn>
            </msup>
            <mo>-</mo>
            <mrow>
              <mn>4</mn>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>A</mi>
                  <mo>+</mo>
                  <mrow>
                    <mn>8</mn>
                    <mo>&it;</mo>
                    <mi>&mu;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>L</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>a</mi>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mo>&it;</mo>
              <msup>
                <mi>a</mi>
                <mn>2</mn>
              </msup>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mn>0</mn>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>13</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00012" file="US20020190607A1-20021219-M00012.NB"/>
<image id="EMI-M00012" wi="216.027" he="45.1332" file="US20020190607A1-20021219-M00012.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> If the parameters of the structure are designed to satisfy (12) or, better yet, both (12) and (13), the frequency variation due to process variations can be reduced significantly. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> However, it is not usually the case that both (12) and (13) can be satisfied, as substituting (12) into (13) yields</paragraph>
<paragraph lvl="0"><in-line-formula>3<highlight><italic>A&plus;</italic></highlight>24 <highlight><italic>&mgr;La&equals;a</italic></highlight><highlight><superscript>2</superscript></highlight>&emsp;&emsp;(14) </in-line-formula> 
<math-cwu id="MATH-US-00013">
<number>13</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mrow>
            <mfrac>
              <mn>1</mn>
              <mn>2</mn>
            </mfrac>
            <mo>&it;</mo>
            <mi>P</mi>
          </mrow>
          <mo>+</mo>
          <mrow>
            <mn>8</mn>
            <mo>&it;</mo>
            <mi>&mu;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>L</mi>
          </mrow>
        </mrow>
        <mo>=</mo>
        <mi>a</mi>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>15</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00013" file="US20020190607A1-20021219-M00013.NB"/>
<image id="EMI-M00013" wi="216.027" he="18.00225" file="US20020190607A1-20021219-M00013.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> Generally, the width of the beam is a small, and to satisfy both (14) and (15) the area and perimeter of the proof mass have to be less than a<highlight><superscript>2 </superscript></highlight>and 2 a respectively, which is unreasonable for most MEMS resonators. Therefore, only the first order sensitivity of &ohgr;<highlight><subscript>0 </subscript></highlight>with respect to &dgr; can be designed to be zero in most cases. When the area of the proof mass is much larger than the area of the beam, (12) reduces to a convenient rule of thumb: the perimeter of the proof mass times the beam width should be roughly six times the area of the proof mass, i.e. Pa&ap;6A. </paragraph>
<paragraph id="P-0044" lvl="7"><number>&lsqb;0044&rsqb;</number> 2. Analysis for Multi-Layer Structures </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> shows a typical MEMS resonator coated with two material layers. For the sake of electrical conductivity, beams and proof masses in MEMS resonators ate usually coated with two material layers&mdash;one oxide layer with thickness t<highlight><subscript>1 </subscript></highlight>and one metal layer with side-thickness t<highlight><subscript>2 </subscript></highlight>and top-thickness t<highlight><subscript>3</subscript></highlight>. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> The moment of the inertia of the oxide layer and metal layer are given respectively by  
<math-cwu id="MATH-US-00014">
<number>14</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>I</mi>
          <mi>c1</mi>
        </msub>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mrow>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <msub>
                        <mi>t</mi>
                        <mn>1</mn>
                      </msub>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>b</mi>
                  <mo>+</mo>
                  <msub>
                    <mi>t</mi>
                    <mn>1</mn>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
            <mo>-</mo>
            <mrow>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>b</mi>
            </mrow>
          </mrow>
          <mn>12</mn>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>16</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>I</mi>
          <mi>c2</mi>
        </msub>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mrow>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>1</mn>
                          </msub>
                          <mo>+</mo>
                          <msub>
                            <mi>t</mi>
                            <mn>2</mn>
                          </msub>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>b</mi>
                  <mo>+</mo>
                  <msub>
                    <mi>t</mi>
                    <mn>1</mn>
                  </msub>
                  <mo>+</mo>
                  <msub>
                    <mi>t</mi>
                    <mn>3</mn>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
            <mo>-</mo>
            <mrow>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <msub>
                        <mi>t</mi>
                        <mn>1</mn>
                      </msub>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>b</mi>
                  <mo>+</mo>
                  <msub>
                    <mi>t</mi>
                    <mn>1</mn>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mn>12</mn>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>17</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00014" file="US20020190607A1-20021219-M00014.NB"/>
<image id="EMI-M00014" wi="216.027" he="42.0147" file="US20020190607A1-20021219-M00014.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> Because the coat-layers and the innermost silicon beam have the same lateral deflection on the tip of the beam, the following expression can be given as  
<math-cwu id="MATH-US-00015">
<number>15</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mtable>
        <mtr>
          <mtd>
            <mrow>
              <mrow>
                <mi>&Delta;</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>X</mi>
              </mrow>
              <mo>=</mo>
              <mrow>
                <mfrac>
                  <mrow>
                    <msub>
                      <mi>P</mi>
                      <mn>1</mn>
                    </msub>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                  <mrow>
                    <mn>3</mn>
                    <mo>&it;</mo>
                    <msub>
                      <mi>E</mi>
                      <mi>c1</mi>
                    </msub>
                    <mo>&it;</mo>
                    <msub>
                      <mi>I</mi>
                      <mi>c1</mi>
                    </msub>
                  </mrow>
                </mfrac>
                <mo>=</mo>
                <mrow>
                  <mfrac>
                    <mrow>
                      <msub>
                        <mi>P</mi>
                        <mn>2</mn>
                      </msub>
                      <mo>&it;</mo>
                      <msup>
                        <mi>L</mi>
                        <mn>3</mn>
                      </msup>
                    </mrow>
                    <mrow>
                      <mn>3</mn>
                      <mo>&it;</mo>
                      <msub>
                        <mi>E</mi>
                        <mi>c2</mi>
                      </msub>
                      <mo>&it;</mo>
                      <msub>
                        <mi>I</mi>
                        <mi>c2</mi>
                      </msub>
                    </mrow>
                  </mfrac>
                  <mo>=</mo>
                  <mfrac>
                    <mrow>
                      <mn>4</mn>
                      <mo>&it;</mo>
                      <msub>
                        <mi>P</mi>
                        <mn>3</mn>
                      </msub>
                      <mo>&it;</mo>
                      <msup>
                        <mi>L</mi>
                        <mn>3</mn>
                      </msup>
                    </mrow>
                    <mrow>
                      <mi>E</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <msup>
                        <mi>a</mi>
                        <mn>3</mn>
                      </msup>
                      <mo>&it;</mo>
                      <mi>b</mi>
                    </mrow>
                  </mfrac>
                </mrow>
              </mrow>
            </mrow>
          </mtd>
        </mtr>
        <mtr>
          <mtd>
            <mrow>
              <mo>=</mo>
              <mrow>
                <mfrac>
                  <mrow>
                    <mn>4</mn>
                    <mo>&it;</mo>
                    <mi>P</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                  <mtable>
                    <mtr>
                      <mtd>
                        <mrow>
                          <mrow>
                            <msup>
                              <mrow>
                                <msub>
                                  <mi>E</mi>
                                  <mi>c2</mi>
                                </msub>
                                <mo>&af;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <mi>a</mi>
                                    <mo>+</mo>
                                    <mrow>
                                      <mn>2</mn>
                                      <mo>&it;</mo>
                                      <mrow>
                                        <mo>(</mo>
                                        <mrow>
                                          <msub>
                                            <mi>t</mi>
                                            <mn>1</mn>
                                          </msub>
                                          <mo>+</mo>
                                          <msub>
                                            <mi>t</mi>
                                            <mn>2</mn>
                                          </msub>
                                        </mrow>
                                        <mo>)</mo>
                                      </mrow>
                                    </mrow>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                              <mn>3</mn>
                            </msup>
                            <mo>&it;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>b</mi>
                                <mo>+</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                                <mo>+</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>3</mn>
                                </msub>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                          <mo>-</mo>
                        </mrow>
                      </mtd>
                    </mtr>
                    <mtr>
                      <mtd>
                        <mrow>
                          <mrow>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <msub>
                                  <mi>E</mi>
                                  <mi>c2</mi>
                                </msub>
                                <mo>-</mo>
                                <msub>
                                  <mi>E</mi>
                                  <mi>c1</mi>
                                </msub>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                            <mo>&it;</mo>
                            <msup>
                              <mrow>
                                <mo>(</mo>
                                <mrow>
                                  <mi>a</mi>
                                  <mo>+</mo>
                                  <mrow>
                                    <mn>2</mn>
                                    <mo>&it;</mo>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>1</mn>
                                    </msub>
                                  </mrow>
                                </mrow>
                                <mo>)</mo>
                              </mrow>
                              <mn>3</mn>
                            </msup>
                            <mo>&it;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>b</mi>
                                <mo>+</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                          <mo>-</mo>
                          <mrow>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <msub>
                                  <mi>E</mi>
                                  <mi>c1</mi>
                                </msub>
                                <mo>-</mo>
                                <mi>E</mi>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                            <mo>&it;</mo>
                            <msup>
                              <mi>a</mi>
                              <mn>3</mn>
                            </msup>
                            <mo>&it;</mo>
                            <mi>b</mi>
                          </mrow>
                        </mrow>
                      </mtd>
                    </mtr>
                  </mtable>
                </mfrac>
                <mo>&AutoLeftMatch;</mo>
              </mrow>
            </mrow>
          </mtd>
        </mtr>
      </mtable>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>18</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00015" file="US20020190607A1-20021219-M00015.NB"/>
<image id="EMI-M00015" wi="216.027" he="55.93455" file="US20020190607A1-20021219-M00015.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0048" lvl="7"><number>&lsqb;0048&rsqb;</number> where P is overall force on the tip of the beam; P<highlight><subscript>1</subscript></highlight>, P<highlight><subscript>2</subscript></highlight>, P<highlight><subscript>3 </subscript></highlight>are the forces of P on the oxide layer, metal layer and silicon beam respectively. E<highlight><subscript>c1</subscript></highlight>, E<highlight><subscript>c2 </subscript></highlight>and E are the Young&apos;s modulus&apos; for three materials. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> Defining the effective beam width, effective beam thickness and effective Young&apos;s modulus&apos; respectively as</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>a</italic></highlight><highlight><subscript>eff</subscript></highlight>&equals;(<highlight><italic>a&plus;</italic></highlight>2(<highlight><italic>t</italic></highlight><highlight><subscript>1</subscript></highlight><highlight><italic>&plus;t</italic></highlight><highlight><subscript>2</subscript></highlight>))</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>b</italic></highlight><highlight><subscript>eff</subscript></highlight>&equals;(<highlight><italic>b&plus;t</italic></highlight><highlight><subscript>1</subscript></highlight><highlight><italic>&plus;t</italic></highlight><highlight><subscript>3</subscript></highlight>)&emsp;&emsp;(19) </in-line-formula> 
<math-cwu id="MATH-US-00016">
<number>16</number>
<math>
<mrow>
  <msub>
    <mi>E</mi>
    <mi>eff</mi>
  </msub>
  <mo>=</mo>
  <mrow>
    <msub>
      <mi>E</mi>
      <mi>c2</mi>
    </msub>
    <mo>-</mo>
    <mfrac>
      <mrow>
        <mrow>
          <mo>(</mo>
          <mrow>
            <msub>
              <mi>E</mi>
              <mi>c2</mi>
            </msub>
            <mo>-</mo>
            <msub>
              <mi>E</mi>
              <mi>c1</mi>
            </msub>
          </mrow>
          <mo>)</mo>
        </mrow>
        <mo>&it;</mo>
        <msup>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mi>a</mi>
              <mo>+</mo>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <msub>
                  <mi>t</mi>
                  <mn>1</mn>
                </msub>
              </mrow>
            </mrow>
            <mo>)</mo>
          </mrow>
          <mn>3</mn>
        </msup>
        <mo>&it;</mo>
        <mrow>
          <mo>(</mo>
          <mrow>
            <mi>b</mi>
            <mo>+</mo>
            <msub>
              <mi>t</mi>
              <mn>1</mn>
            </msub>
          </mrow>
          <mo>)</mo>
        </mrow>
      </mrow>
      <mrow>
        <msup>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mi>a</mi>
              <mo>+</mo>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <msub>
                      <mi>t</mi>
                      <mn>1</mn>
                    </msub>
                    <mo>+</mo>
                    <msub>
                      <mi>t</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
            <mo>)</mo>
          </mrow>
          <mn>3</mn>
        </msup>
        <mo>&it;</mo>
        <mrow>
          <mo>(</mo>
          <mrow>
            <mi>b</mi>
            <mo>+</mo>
            <msub>
              <mi>t</mi>
              <mn>1</mn>
            </msub>
            <mo>+</mo>
            <msub>
              <mi>t</mi>
              <mn>3</mn>
            </msub>
          </mrow>
          <mo>)</mo>
        </mrow>
      </mrow>
    </mfrac>
    <mo>-</mo>
    <mfrac>
      <mrow>
        <mrow>
          <mo>(</mo>
          <mrow>
            <msub>
              <mi>E</mi>
              <mi>c1</mi>
            </msub>
            <mo>-</mo>
            <mi>E</mi>
          </mrow>
          <mo>)</mo>
        </mrow>
        <mo>&it;</mo>
        <msup>
          <mi>a</mi>
          <mn>3</mn>
        </msup>
        <mo>&it;</mo>
        <mi>b</mi>
      </mrow>
      <mrow>
        <msup>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mi>a</mi>
              <mo>+</mo>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <msub>
                      <mi>t</mi>
                      <mn>1</mn>
                    </msub>
                    <mo>+</mo>
                    <msub>
                      <mi>t</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
            <mo>)</mo>
          </mrow>
          <mn>3</mn>
        </msup>
        <mo>&it;</mo>
        <mrow>
          <mo>(</mo>
          <mrow>
            <mi>b</mi>
            <mo>+</mo>
            <msub>
              <mi>t</mi>
              <mn>1</mn>
            </msub>
            <mo>+</mo>
            <msub>
              <mi>t</mi>
              <mn>3</mn>
            </msub>
          </mrow>
          <mo>)</mo>
        </mrow>
      </mrow>
    </mfrac>
  </mrow>
</mrow>
</math>
<mathematica-file id="MATHEMATICA-00016" file="US20020190607A1-20021219-M00016.NB"/>
<image id="EMI-M00016" wi="216.027" he="21.12075" file="US20020190607A1-20021219-M00016.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0050" lvl="7"><number>&lsqb;0050&rsqb;</number> (18) becomes  
<math-cwu id="MATH-US-00017">
<number>17</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>&Delta;</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>X</mi>
        </mrow>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mn>4</mn>
            <mo>&it;</mo>
            <mi>P</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mrow>
          <mrow>
            <msub>
              <mi>E</mi>
              <mi>eff</mi>
            </msub>
            <mo>&it;</mo>
            <msubsup>
              <mi>a</mi>
              <mi>eff</mi>
              <mn>3</mn>
            </msubsup>
            <mo>&it;</mo>
            <msub>
              <mi>b</mi>
              <mi>eff</mi>
            </msub>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>20</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00017" file="US20020190607A1-20021219-M00017.NB"/>
<image id="EMI-M00017" wi="216.027" he="23.04855" file="US20020190607A1-20021219-M00017.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> If the fabrication errors occur only on innermost beam, e.g. a becomes a&plus;2&dgr;, then the sensitivity of effective elastic modulus can be simply expressed as  
<math-cwu id="MATH-US-00018">
<number>18</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>E</mi>
              <mi>eff</mi>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>&delta;</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mfrac>
          <mtable>
            <mtr>
              <mtd>
                <mrow>
                  <mrow>
                    <mrow>
                      <mo>-</mo>
                      <mn>12</mn>
                    </mrow>
                    <mo>&it;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>E</mi>
                          <mi>c2</mi>
                        </msub>
                        <mo>-</mo>
                        <msub>
                          <mi>E</mi>
                          <mi>c1</mi>
                        </msub>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <msup>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <mi>a</mi>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <mi>&delta;</mi>
                          </mrow>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <msub>
                              <mi>t</mi>
                              <mn>1</mn>
                            </msub>
                          </mrow>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                      <mn>2</mn>
                    </msup>
                    <mo>&it;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>b</mi>
                        <mo>+</mo>
                        <msub>
                          <mi>t</mi>
                          <mn>1</mn>
                        </msub>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <msub>
                      <mi>t</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                  <mo>-</mo>
                </mrow>
              </mtd>
            </mtr>
            <mtr>
              <mtd>
                <mrow>
                  <mn>12</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mrow>
                      <msub>
                        <mi>E</mi>
                        <mi>c1</mi>
                      </msub>
                      <mo>-</mo>
                      <mi>E</mi>
                    </mrow>
                    <mo>)</mo>
                  </mrow>
                  <mo>&it;</mo>
                  <msup>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>a</mi>
                        <mo>+</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mi>&delta;</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mn>2</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mrow>
                    <mi>b</mi>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>t</mi>
                          <mn>1</mn>
                        </msub>
                        <mo>+</mo>
                        <msub>
                          <mi>t</mi>
                          <mn>2</mn>
                        </msub>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </mtd>
            </mtr>
          </mtable>
          <mrow>
            <msup>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>a</mi>
                  <mo>+</mo>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mi>&delta;</mi>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>t</mi>
                          <mn>1</mn>
                        </msub>
                        <mo>+</mo>
                        <msub>
                          <mi>t</mi>
                          <mn>2</mn>
                        </msub>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mn>4</mn>
            </msup>
            <mo>&it;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <mi>b</mi>
                <mo>+</mo>
                <msub>
                  <mi>t</mi>
                  <mn>1</mn>
                </msub>
                <mo>+</mo>
                <msub>
                  <mi>t</mi>
                  <mn>3</mn>
                </msub>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>21</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00018" file="US20020190607A1-20021219-M00018.NB"/>
<image id="EMI-M00018" wi="216.027" he="35.0406" file="US20020190607A1-20021219-M00018.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> If the t<highlight><subscript>1 </subscript></highlight>and t<highlight><subscript>2 </subscript></highlight>ate much smaller than the width of the beam, it can be assumed that the effective Young&apos;s modulus remains constant in the frequency sensitivity analysis. In this case, the first and second sensitivities to the fabrication errors are similar to resonators that are not coated. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> When there are fabrication errors in the lateral dimension of the layered materials, the effective modulus of elasticity will change too. The computation of sensitivities is straight-forward for those skilled in the art using computational algebra software such as Mathematica or Matlab. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> Besides the above deformation equations, the mass of the proof mass will also have different expressions than that for a single material structure. The expression is dependent on construction, trussed or solid, of the proof mass, and will be given in the following section. </paragraph>
<paragraph id="P-0055" lvl="7"><number>&lsqb;0055&rsqb;</number> 3. Example of a Robust Design </paragraph>
<paragraph id="P-0056" lvl="7"><number>&lsqb;0056&rsqb;</number> 3.1 Single Material Structure </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> illustrates a typical folded-beam suspended comb driven resonator. L is the length of each beam, proof mass width m comprises M&plus;2 row walls and length n comprises N&plus;2 column walls The trussed comb-driven mass is suspended by two symmetric folded-beams. The trussed structure for the mass simplifies the under-releasing of the structure from the substrate in, say, the SCREAM process &lsqb;<highlight><bold>12</bold></highlight>&rsqb;. Also, in some designs, it is useful that the truss decreases the squeeze-film damping when there is a vertical vibration &lsqb;<highlight><bold>11</bold></highlight>&rsqb;. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> The proof mass is divided by row and column walls into smaller squares of dimension (k&times;k), except for the rightmost or leftmost sub-regions which are rectangles of dimension k/2&times;k. The width of all the walls in the trussed proof mass is t; the number of row and column walls on the proof mass not including the outside walls are M and N respectively; the width and length of the comb fingers is d and g respectively, and the number of comb fingers on each side is n<highlight><subscript>&fnof;</subscript></highlight>. The four connectors that connect the folded beams to the proof mass are solid rectangles with width p and length q. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> The design task is to specify the above parameters in addition to the folded-beam parameters L and a, and the structure thickness b, so that the natural resonant frequency of the structure equals &ohgr;<highlight><subscript>0 </subscript></highlight>and its first order sensitivity to sidewall fabrication error is zero. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> The dimension of the inner square satisfies  
<math-cwu id="MATH-US-00019">
<number>19</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mrow>
              <mi>n</mi>
              <mo>-</mo>
              <mrow>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>N</mi>
                    <mo>+</mo>
                    <mn>2</mn>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mo>&it;</mo>
                <mi>t</mi>
              </mrow>
            </mrow>
            <mrow>
              <mi>N</mi>
              <mo>+</mo>
              <mrow>
                <mn>1</mn>
                <mo>/</mo>
                <mn>2</mn>
              </mrow>
            </mrow>
          </mfrac>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mi>m</mi>
              <mo>-</mo>
              <mrow>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>M</mi>
                    <mo>+</mo>
                    <mn>2</mn>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mo>&it;</mo>
                <mi>t</mi>
              </mrow>
            </mrow>
            <mrow>
              <mi>M</mi>
              <mo>+</mo>
              <mn>1</mn>
            </mrow>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>22</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00019" file="US20020190607A1-20021219-M00019.NB"/>
<image id="EMI-M00019" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00019.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> The solid area on the proof mass can be expressed as</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>A&equals;</italic></highlight>2<highlight><italic>n</italic></highlight><highlight><subscript>&fnof;</subscript></highlight><highlight><italic>dg&plus;</italic></highlight>4<highlight><italic>pq&plus;nm&minus;&lsqb;n&minus;</italic></highlight>(<highlight><italic>N&plus;</italic></highlight>2)<highlight><italic>t&rsqb;&lsqb;m&minus;</italic></highlight>(<highlight><italic>M&plus;</italic></highlight>2)<highlight><italic>t&rsqb;</italic></highlight>&emsp;&emsp;(23)</in-line-formula></paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> where, 2n<highlight><subscript>&fnof;</subscript></highlight>dg is the area of the comb finger; </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> 4pq is the area of four connectors; </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> nm is the overall area of rectangular proof mass; </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> &lsqb;n&minus;(N&plus;2)t&rsqb;&lsqb;m&minus;(M&plus;2)t&rsqb; is the total area of all inner trussed squares. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The overall perimeter of the proof mass is given by</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>P&equals;</italic></highlight>4<highlight><italic>n</italic></highlight><highlight><subscript>&fnof;</subscript></highlight><highlight><italic>g&plus;</italic></highlight>4(2<highlight><italic>q&minus;a</italic></highlight>)&plus;2(<highlight><italic>n&plus;m</italic></highlight>)&plus;2(<highlight><italic>M&plus;</italic></highlight>1)&lsqb;<highlight><italic>n&minus;</italic></highlight>(<highlight><italic>N&plus;</italic></highlight>2)<highlight><italic>t&rsqb;&plus;</italic></highlight>2(<highlight><italic>N&plus;</italic></highlight>1)&lsqb;<highlight><italic>m</italic></highlight>&minus;(<highlight><italic>M&plus;</italic></highlight>2)t&rsqb;&emsp;&emsp;(24)</in-line-formula></paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> Substituting (23) and (24) into (4), (12) and (13) yields a set of equations (the algebra is omitted as it is straight-forward). These equations plus (22) can be regarded as constraint conditions for solving for the structural parameters. The number of parameters is much larger than the number of the equations, so that these equations are under-defined and there is some design freedom. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> Practically, the parameters L and m can be initially given based on overall dimensional requirement of the whole device. The width p and length q of the connectors can also be given as a function of folded beam width. According to the designed electrostatic force, the size of the comb finger can be determined, which include d, n<highlight><subscript>&fnof;</subscript></highlight>and g. Since the total width of the fingers and gaps can not exceed the width of the device, a constraint condition has to be added as</paragraph>
<paragraph lvl="0"><in-line-formula>2<highlight><italic>n</italic></highlight><highlight><subscript>&fnof;</subscript></highlight><highlight><italic>d&lt;m</italic></highlight>&emsp;&emsp;(25)</in-line-formula></paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> The dimension t can be initially given. After the above 8 parameters (L, m, t, d, n<highlight><subscript>&fnof;</subscript></highlight>, g, p, q) ate determined, there are still four parameters (a, n, M, N) to be resolved with equations (4), (12), (13) and (14). </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> Rather than going through a complete design process involving detailed electrostatic design etc., these eight parameters are set to typical values found in the literature:</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>L&equals;</italic></highlight>500 &mgr;m, <highlight><italic>m&equals;</italic></highlight>350 &mgr;m</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula>p&equals;8 &mgr;m, <highlight><italic>q&equals;</italic></highlight>10 &mgr;m <highlight><italic>t&equals;</italic></highlight>1 &mgr;m&emsp;&emsp;(26)</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula>n<highlight><subscript>&fnof;</subscript></highlight>&equals;30, <highlight><italic>d&equals;</italic></highlight>4 &mgr;m, <highlight><italic>g&equals;</italic></highlight>30 &mgr;m</in-line-formula></paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> The material constants are chosen as those for silicon</paragraph>
<paragraph lvl="0"><in-line-formula>&rgr;&equals;2330 kg/m<highlight><superscript>3</superscript></highlight><highlight><italic>, E&equals;</italic></highlight>190 GPa&emsp;&emsp;(27)</in-line-formula></paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> The natural frequency of the resonator is selected to be 55 kHz, which is in the range of typical MEMS resonator frequencies. So the angular frequency is</paragraph>
<paragraph lvl="0"><in-line-formula>&ohgr;<highlight><subscript>0</subscript></highlight>&equals;2&pgr;&times;5500&equals;34557.519(rad/sec)&emsp;&emsp;(28)</in-line-formula></paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> From (4), (14) and (15), the beam width for first and second order insensitivity can be initially calculated to be  
<math-cwu id="MATH-US-00020">
<number>20</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>a</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mrow>
              <msubsup>
                <mi>&omega;</mi>
                <mn>0</mn>
                <mn>2</mn>
              </msubsup>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>&rho;</mi>
            </mrow>
            <mrow>
              <mn>6</mn>
              <mo>&it;</mo>
              <mi>E</mi>
            </mrow>
          </mfrac>
          <mo>=</mo>
          <mrow>
            <mn>3.05</mn>
            <mo>&times;</mo>
            <msup>
              <mn>10</mn>
              <mrow>
                <mo>-</mo>
                <mn>4</mn>
              </mrow>
            </msup>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>&mu;m</mi>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>29</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00020" file="US20020190607A1-20021219-M00020.NB"/>
<image id="EMI-M00020" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00020.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0074" lvl="7"><number>&lsqb;0074&rsqb;</number> which is too small for current MEMS fabrication technologies. Even though the width can be increased by increasing the beam length and natural frequency, the increase is limited and not sufficient to make the width consistent with current fabrication methods. Therefore, as mentioned previously, satisfying both the first and second order sensitivity conditions is almost impossible. When only the first condition is considered, the width of the folded beam can be set to 4 &mgr;m . Hence the solid area and perimeter can be calculated by solving (4) and (12)  
<math-cwu id="MATH-US-00021">
<number>21</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>A</mi>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <msubsup>
                  <mi>&omega;</mi>
                  <mn>0</mn>
                  <mn>2</mn>
                </msubsup>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>&rho;</mi>
              </mrow>
            </mfrac>
            <mo>-</mo>
            <mrow>
              <mn>8</mn>
              <mo>&it;</mo>
              <mi>&mu;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>L</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>a</mi>
            </mrow>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mn>6.38418</mn>
            <mo>&times;</mo>
            <msup>
              <mn>10</mn>
              <mn>4</mn>
            </msup>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msup>
              <mi>&mu;m</mi>
              <mn>2</mn>
            </msup>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>30</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mi>P</mi>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mrow>
                <mn>12</mn>
                <mo>&it;</mo>
                <msup>
                  <mi>a</mi>
                  <mn>2</mn>
                </msup>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <msubsup>
                  <mi>&omega;</mi>
                  <mn>0</mn>
                  <mn>2</mn>
                </msubsup>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>&rho;</mi>
              </mrow>
            </mfrac>
            <mo>-</mo>
            <mrow>
              <mn>16</mn>
              <mo>&it;</mo>
              <mi>&mu;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>L</mi>
            </mrow>
          </mrow>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>=</mo>
          <mrow>
            <mn>1.01843</mn>
            <mo>&times;</mo>
            <msup>
              <mn>10</mn>
              <mn>5</mn>
            </msup>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>&mu;m</mi>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>31</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00021" file="US20020190607A1-20021219-M00021.NB"/>
<image id="EMI-M00021" wi="216.027" he="47.99655" file="US20020190607A1-20021219-M00021.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> Now that the required area and perimeter of the proof mass are determined, solving (16), (17) and (18) with respect to variables m , M and N yields</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>n&equals;</italic></highlight>391.739 &mgr;m</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>N&equals;</italic></highlight>79.5717</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>M&equals;</italic></highlight>88.7765&emsp;&emsp;(32)</in-line-formula></paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> Because both N and M must be integers, the N and M in (26) are rounded to 80 and 89 respectively. Then t, l and m should be adjusted to satisfy (16), (17) and (18),</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>t&equals;</italic></highlight>0.999112 &mgr;m</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>n&equals;</italic></highlight>390.296 &mgr;m</in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>m&equals;</italic></highlight>349.703 &mgr;m&emsp;&emsp;(33)</in-line-formula></paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> From (16), the width of the inner square can be calculated as  
<math-cwu id="MATH-US-00022">
<number>22</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mrow>
              <mi>n</mi>
              <mo>-</mo>
              <mrow>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>N</mi>
                    <mo>+</mo>
                    <mn>2</mn>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mo>&it;</mo>
                <mi>t</mi>
              </mrow>
            </mrow>
            <mrow>
              <mo>(</mo>
              <mrow>
                <mi>N</mi>
                <mo>+</mo>
                <mrow>
                  <mn>1</mn>
                  <mo>/</mo>
                  <mn>2</mn>
                </mrow>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mfrac>
          <mo>=</mo>
          <mrow>
            <mn>3.32641</mn>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>&mu;m</mi>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>34</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00022" file="US20020190607A1-20021219-M00022.NB"/>
<image id="EMI-M00022" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00022.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0078" lvl="7"><number>&lsqb;0078&rsqb;</number> 3.2 Multi-layer Structure </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> In this subsection, we outline the design of a multi-layer structure. The design steps are similar to the single material design except for different expressions of design conditions. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> The top-view of the multi-layer structure is the same as <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. From (20), the lateral spring constant of the folded beams is given by  
<math-cwu id="MATH-US-00023">
<number>23</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>k</mi>
          <mi>eff</mi>
        </msub>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mn>2</mn>
            <mo>&it;</mo>
            <msubsup>
              <mi>a</mi>
              <mi>eff</mi>
              <mn>3</mn>
            </msubsup>
            <mo>&it;</mo>
            <msub>
              <mi>b</mi>
              <mi>eff</mi>
            </msub>
            <mo>&it;</mo>
            <msub>
              <mi>E</mi>
              <mi>eff</mi>
            </msub>
          </mrow>
          <msup>
            <mi>L</mi>
            <mn>3</mn>
          </msup>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>35</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00023" file="US20020190607A1-20021219-M00023.NB"/>
<image id="EMI-M00023" wi="216.027" he="19.93005" file="US20020190607A1-20021219-M00023.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> The natural frequency of the resonator can be expressed as  
<math-cwu id="MATH-US-00024">
<number>24</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <msqrt>
            <mfrac>
              <msub>
                <mi>k</mi>
                <mi>eff</mi>
              </msub>
              <msub>
                <mi>M</mi>
                <mi>eff</mi>
              </msub>
            </mfrac>
          </msqrt>
          <mo>=</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <msubsup>
                  <mi>a</mi>
                  <mi>eff</mi>
                  <mn>3</mn>
                </msubsup>
                <mo>&it;</mo>
                <msub>
                  <mi>b</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&it;</mo>
                <msub>
                  <mi>E</mi>
                  <mi>eff</mi>
                </msub>
              </mrow>
              <mrow>
                <msub>
                  <mi>M</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>36</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00024" file="US20020190607A1-20021219-M00024.NB"/>
<image id="EMI-M00024" wi="216.027" he="30.9582" file="US20020190607A1-20021219-M00024.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0082" lvl="7"><number>&lsqb;0082&rsqb;</number> where M<highlight><subscript>eff </subscript></highlight>is the effective mass comprising the mass of the proof mass M<highlight><subscript>proof </subscript></highlight>plus an equivalent mass due to the folded-beam M<highlight><subscript>beam</subscript></highlight></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>M</italic></highlight><highlight><subscript>eff</subscript></highlight><highlight><italic>&equals;M</italic></highlight><highlight><subscript>proof</subscript></highlight><highlight><italic>&plus;&mgr;M</italic></highlight><highlight><subscript>beam</subscript></highlight>&emsp;&emsp;(37)</in-line-formula></paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> From the construction, the mass M<highlight><subscript>proof </subscript></highlight>and M<highlight><subscript>beam </subscript></highlight>can be expressed respectively as</paragraph>
<paragraph id="P-0084" lvl="7"><number>&lsqb;0084&rsqb;</number>  
<math-cwu id="MATH-US-00025">
<number>25</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mtable>
          <mtr>
            <mtd>
              <mrow>
                <msub>
                  <mi>M</mi>
                  <mi>proof</mi>
                </msub>
                <mo>=</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mn>4</mn>
                  <mo>&it;</mo>
                  <mi>q</mi>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>{</mo>
                    <mrow>
                      <mrow>
                        <mi>pb</mi>
                        <mo>&it;</mo>
                        <mstyle>
                          <mtext>&emsp;</mtext>
                        </mstyle>
                        <mo>&it;</mo>
                        <mi>&rho;</mi>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>1</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mi>b</mi>
                              </mrow>
                              <mo>+</mo>
                              <mi>p</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                        <mo>&it;</mo>
                        <msub>
                          <mi>&rho;</mi>
                          <mn>1</mn>
                        </msub>
                      </mrow>
                      <mo>+</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mrow>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mrow>
                    <mrow>
                      <mo>[</mo>
                      <mrow>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mrow>
                            <msub>
                              <mi>t</mi>
                              <mn>2</mn>
                            </msub>
                            <mo>&af;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>b</mi>
                                <mo>+</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                        </mrow>
                        <mo>+</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>3</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>p</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>1</mn>
                                    </msub>
                                    <mo>+</mo>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>2</mn>
                                    </msub>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>]</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <msub>
                      <mi>&rho;</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                  <mo>}</mo>
                </mrow>
                <mo>+</mo>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mn>2</mn>
                  <mo>&it;</mo>
                  <msub>
                    <mi>n</mi>
                    <mi>f</mi>
                  </msub>
                  <mo>&it;</mo>
                  <mi>g</mi>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>{</mo>
                    <mrow>
                      <mrow>
                        <mi>db</mi>
                        <mo>&it;</mo>
                        <mstyle>
                          <mtext>&emsp;</mtext>
                        </mstyle>
                        <mo>&it;</mo>
                        <mi>&rho;</mi>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>1</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mi>b</mi>
                              </mrow>
                              <mo>+</mo>
                              <mi>d</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                        <mo>&it;</mo>
                        <msub>
                          <mi>&rho;</mi>
                          <mn>1</mn>
                        </msub>
                      </mrow>
                      <mo>+</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mrow>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mrow>
                    <mrow>
                      <mo>[</mo>
                      <mrow>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mrow>
                            <msub>
                              <mi>t</mi>
                              <mn>2</mn>
                            </msub>
                            <mo>&af;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>b</mi>
                                <mo>+</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                        </mrow>
                        <mo>+</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>3</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>d</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>1</mn>
                                    </msub>
                                    <mo>+</mo>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>2</mn>
                                    </msub>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>]</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <msub>
                      <mi>&rho;</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                  <mo>}</mo>
                </mrow>
                <mo>+</mo>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mo>{</mo>
                  <mrow>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>m</mi>
                    </mrow>
                    <mo>+</mo>
                    <mrow>
                      <mi>N</mi>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>[</mo>
                        <mrow>
                          <mi>m</mi>
                          <mo>-</mo>
                          <mrow>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>M</mi>
                                <mo>+</mo>
                                <mn>2</mn>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                            <mo>&it;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>t</mi>
                                <mo>+</mo>
                                <mrow>
                                  <mn>2</mn>
                                  <mo>&it;</mo>
                                  <mrow>
                                    <mo>(</mo>
                                    <mrow>
                                      <msub>
                                        <mi>t</mi>
                                        <mn>1</mn>
                                      </msub>
                                      <mo>+</mo>
                                      <msub>
                                        <mi>t</mi>
                                        <mn>2</mn>
                                      </msub>
                                    </mrow>
                                    <mo>)</mo>
                                  </mrow>
                                </mrow>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                        </mrow>
                        <mo>]</mo>
                      </mrow>
                    </mrow>
                    <mo>+</mo>
                  </mrow>
                </mrow>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mrow>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mrow>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>M</mi>
                        <mo>+</mo>
                        <mn>2</mn>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>[</mo>
                      <mrow>
                        <mi>n</mi>
                        <mo>-</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>t</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>1</mn>
                                    </msub>
                                    <mo>+</mo>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>2</mn>
                                    </msub>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>]</mo>
                    </mrow>
                  </mrow>
                  <mo>}</mo>
                </mrow>
                <mo>&times;</mo>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mo>{</mo>
                  <mrow>
                    <mrow>
                      <mi>tb</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>&rho;</mi>
                    </mrow>
                    <mo>+</mo>
                    <mrow>
                      <mrow>
                        <msub>
                          <mi>t</mi>
                          <mn>1</mn>
                        </msub>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mrow>
                            <mrow>
                              <mn>2</mn>
                              <mo>&it;</mo>
                              <mi>b</mi>
                            </mrow>
                            <mo>+</mo>
                            <mi>t</mi>
                            <mo>+</mo>
                            <mrow>
                              <mn>2</mn>
                              <mo>&it;</mo>
                              <msub>
                                <mi>t</mi>
                                <mn>1</mn>
                              </msub>
                            </mrow>
                          </mrow>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                      <mo>&it;</mo>
                      <msub>
                        <mi>&rho;</mi>
                        <mn>1</mn>
                      </msub>
                    </mrow>
                    <mo>+</mo>
                  </mrow>
                </mrow>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mrow>
                    <mo>[</mo>
                    <mrow>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>2</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>b</mi>
                              <mo>+</mo>
                              <msub>
                                <mi>t</mi>
                                <mn>1</mn>
                              </msub>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <msub>
                          <mi>t</mi>
                          <mn>3</mn>
                        </msub>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mrow>
                            <mi>t</mi>
                            <mo>+</mo>
                            <mrow>
                              <mn>2</mn>
                              <mo>&it;</mo>
                              <mrow>
                                <mo>(</mo>
                                <mrow>
                                  <msub>
                                    <mi>t</mi>
                                    <mn>1</mn>
                                  </msub>
                                  <mo>+</mo>
                                  <msub>
                                    <mi>t</mi>
                                    <mn>2</mn>
                                  </msub>
                                </mrow>
                                <mo>)</mo>
                              </mrow>
                            </mrow>
                          </mrow>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                    </mrow>
                    <mo>]</mo>
                  </mrow>
                  <mo>&it;</mo>
                  <msub>
                    <mi>&rho;</mi>
                    <mn>2</mn>
                  </msub>
                </mrow>
                <mo>}</mo>
              </mrow>
            </mtd>
          </mtr>
        </mtable>
        <mo>&it;</mo>
        <mstyle>
          <mtext>&NewLine;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mtable>
          <mtr>
            <mtd>
              <mrow>
                <msub>
                  <mi>M</mi>
                  <mi>beam</mi>
                </msub>
                <mo>=</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mn>8</mn>
                  <mo>&it;</mo>
                  <mi>L</mi>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>{</mo>
                    <mrow>
                      <mrow>
                        <mi>ab</mi>
                        <mo>&it;</mo>
                        <mstyle>
                          <mtext>&emsp;</mtext>
                        </mstyle>
                        <mo>&it;</mo>
                        <mi>&rho;</mi>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>1</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mi>b</mi>
                              </mrow>
                              <mo>+</mo>
                              <mi>a</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                        <mo>&it;</mo>
                        <msub>
                          <mi>&rho;</mi>
                          <mn>1</mn>
                        </msub>
                      </mrow>
                      <mo>+</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mrow>
                  <mrow>
                    <mo>[</mo>
                    <mrow>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>2</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>b</mi>
                              <mo>+</mo>
                              <msub>
                                <mi>t</mi>
                                <mn>1</mn>
                              </msub>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <msub>
                          <mi>t</mi>
                          <mn>3</mn>
                        </msub>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <mrow>
                            <mi>a</mi>
                            <mo>+</mo>
                            <mrow>
                              <mn>2</mn>
                              <mo>&it;</mo>
                              <mrow>
                                <mo>(</mo>
                                <mrow>
                                  <msub>
                                    <mi>t</mi>
                                    <mn>1</mn>
                                  </msub>
                                  <mo>+</mo>
                                  <msub>
                                    <mi>t</mi>
                                    <mn>2</mn>
                                  </msub>
                                </mrow>
                                <mo>)</mo>
                              </mrow>
                            </mrow>
                          </mrow>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                    </mrow>
                    <mo>]</mo>
                  </mrow>
                  <mo>&it;</mo>
                  <msub>
                    <mi>&rho;</mi>
                    <mn>2</mn>
                  </msub>
                </mrow>
                <mo>}</mo>
              </mrow>
            </mtd>
          </mtr>
        </mtable>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>38</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00025" file="US20020190607A1-20021219-M00025.NB"/>
<image id="EMI-M00025" wi="216.027" he="124.08795" file="US20020190607A1-20021219-M00025.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> The fabrication error here is assumed to occur only on the sidewalls of the innermost structure, i.e. there is a small width error &dgr; in the lateral dimension of all innermost components of the folded-beam and proof mass. There are no errors in the thickness. Then the natural resonant frequency becomes  
<math-cwu id="MATH-US-00026">
<number>26</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msub>
            <mi>&omega;</mi>
            <mn>0</mn>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mi>&delta;</mi>
            <mo>)</mo>
          </mrow>
        </mrow>
        <mo>=</mo>
        <msqrt>
          <mfrac>
            <mrow>
              <mn>2</mn>
              <mo>&it;</mo>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <msub>
                      <mi>a</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>&delta;</mi>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <msub>
                <mi>b</mi>
                <mi>eff</mi>
              </msub>
              <mo>&it;</mo>
              <mrow>
                <msub>
                  <mi>E</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mi>&delta;</mi>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
            <mrow>
              <mrow>
                <msub>
                  <mi>M</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mi>&delta;</mi>
                  <mo>)</mo>
                </mrow>
              </mrow>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
          </mfrac>
        </msqrt>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>39</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00026" file="US20020190607A1-20021219-M00026.NB"/>
<image id="EMI-M00026" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00026.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> Therefore the first order sensitivity of &ohgr;<highlight><subscript>0 </subscript></highlight>with respect to &dgr; can be given as  
<math-cwu id="MATH-US-00027">
<number>27</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>&omega;</mi>
                <mn>0</mn>
              </msub>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <mi>&delta;</mi>
            </mrow>
          </mfrac>
          <mo>=</mo>
          <mrow>
            <mrow>
              <mn>3</mn>
              <mo>&it;</mo>
              <msqrt>
                <mfrac>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>a</mi>
                          <mi>eff</mi>
                        </msub>
                        <mo>+</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mi>&delta;</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <msub>
                      <mi>b</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&it;</mo>
                    <mrow>
                      <msub>
                        <mi>E</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mrow>
                    <mrow>
                      <msub>
                        <mi>M</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                </mfrac>
              </msqrt>
            </mrow>
            <mo>+</mo>
            <mrow>
              <mfrac>
                <mn>1</mn>
                <mn>2</mn>
              </mfrac>
              <mo>&it;</mo>
              <msqrt>
                <mfrac>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <msup>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <msub>
                            <mi>a</mi>
                            <mi>eff</mi>
                          </msub>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <mi>&delta;</mi>
                          </mrow>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                      <mn>3</mn>
                    </msup>
                    <mo>&it;</mo>
                    <msub>
                      <mi>b</mi>
                      <mi>eff</mi>
                    </msub>
                  </mrow>
                  <mrow>
                    <mrow>
                      <msub>
                        <mi>E</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>&it;</mo>
                    <mrow>
                      <msub>
                        <mi>M</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                </mfrac>
              </msqrt>
              <mo>&it;</mo>
              <mfrac>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mrow>
                    <msub>
                      <mi>E</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mi>&delta;</mi>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mi>&delta;</mi>
                </mrow>
              </mfrac>
            </mrow>
            <mo>-</mo>
            <mrow>
              <mfrac>
                <mn>1</mn>
                <mn>2</mn>
              </mfrac>
              <mo>&it;</mo>
              <msqrt>
                <mfrac>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <msup>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <msub>
                            <mi>a</mi>
                            <mi>eff</mi>
                          </msub>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <mi>&delta;</mi>
                          </mrow>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                      <mn>3</mn>
                    </msup>
                    <mo>&it;</mo>
                    <msub>
                      <mi>b</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&it;</mo>
                    <mrow>
                      <msub>
                        <mi>E</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mrow>
                    <mrow>
                      <msub>
                        <mi>M</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                </mfrac>
              </msqrt>
              <mo>&it;</mo>
              <mfrac>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mrow>
                    <msub>
                      <mi>M</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mi>&delta;</mi>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mi>&delta;</mi>
                </mrow>
              </mfrac>
            </mrow>
          </mrow>
        </mrow>
        <mo>&it;</mo>
        <mstyle>
          <mtext>&NewLine;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mrow>
          <mrow>
            <mi>where</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>the</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <mrow>
                  <msub>
                    <mi>M</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&delta;</mi>
              </mrow>
            </mfrac>
          </mrow>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <mi>&delta;</mi>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mrow>
            <mi>can</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>be</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>expressed</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>as</mi>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>40</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00027" file="US20020190607A1-20021219-M00027.NB"/>
<image id="EMI-M00027" wi="216.027" he="90.01125" file="US20020190607A1-20021219-M00027.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
 
<math-cwu id="MATH-US-00028">
<number>28</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mrow>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <mrow>
                  <msub>
                    <mi>M</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&delta;</mi>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <msub>
              <mo>|</mo>
              <mrow>
                <mi>&delta;</mi>
                <mo>=</mo>
                <mn>0</mn>
              </mrow>
            </msub>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mrow>
              <mrow>
                <mo>{</mo>
                <mrow>
                  <mrow>
                    <mn>8</mn>
                    <mo>&it;</mo>
                    <mi>q</mi>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <mn>4</mn>
                    <mo>&it;</mo>
                    <msub>
                      <mi>n</mi>
                      <mi>f</mi>
                    </msub>
                    <mo>&it;</mo>
                    <mi>g</mi>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <mn>2</mn>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>[</mo>
                      <mrow>
                        <mrow>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>N</mi>
                              <mo>+</mo>
                              <mn>2</mn>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                          <mo>&it;</mo>
                          <mi>m</mi>
                        </mrow>
                        <mo>+</mo>
                        <mrow>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>M</mi>
                              <mo>+</mo>
                              <mn>2</mn>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                          <mo>&it;</mo>
                          <mi>n</mi>
                        </mrow>
                        <mo>-</mo>
                        <mrow>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>N</mi>
                              <mo>+</mo>
                              <mn>2</mn>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                          <mo>&it;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>M</mi>
                              <mo>+</mo>
                              <mn>2</mn>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                          <mo>&it;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>t</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <msub>
                                      <mi>t</mi>
                                      <mi>t</mi>
                                    </msub>
                                    <mo>+</mo>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>2</mn>
                                    </msub>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>]</mo>
                    </mrow>
                  </mrow>
                  <mo>-</mo>
                  <mrow>
                    <mn>16</mn>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>&mu;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>L</mi>
                  </mrow>
                </mrow>
                <mo>}</mo>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mrow>
                    <mi>b</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>&rho;</mi>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <msub>
                      <mi>t</mi>
                      <mn>1</mn>
                    </msub>
                    <mo>&it;</mo>
                    <msub>
                      <mi>&rho;</mi>
                      <mn>1</mn>
                    </msub>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <msub>
                      <mi>t</mi>
                      <mn>3</mn>
                    </msub>
                    <mo>&it;</mo>
                    <msub>
                      <mi>&rho;</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
            <mo>+</mo>
            <mrow>
              <mrow>
                <mn>2</mn>
                <mo>&af;</mo>
                <mrow>
                  <mo>[</mo>
                  <mrow>
                    <mi>M</mi>
                    <mo>+</mo>
                    <mi>N</mi>
                    <mo>+</mo>
                    <mn>4</mn>
                    <mo>-</mo>
                    <mrow>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <mi>N</mi>
                          <mo>+</mo>
                          <mn>2</mn>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                      <mo>&it;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <mi>M</mi>
                          <mo>+</mo>
                          <mn>2</mn>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mo>]</mo>
                </mrow>
              </mrow>
              <mo>&times;</mo>
              <mrow>
                <mo>{</mo>
                <mrow>
                  <mrow>
                    <mi>t</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>b</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>&rho;</mi>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <mrow>
                      <msub>
                        <mi>t</mi>
                        <mn>1</mn>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <mi>b</mi>
                          </mrow>
                          <mo>+</mo>
                          <mi>t</mi>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <msub>
                              <mi>t</mi>
                              <mn>1</mn>
                            </msub>
                          </mrow>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>&it;</mo>
                    <msub>
                      <mi>&rho;</mi>
                      <mn>1</mn>
                    </msub>
                  </mrow>
                  <mo>+</mo>
                  <mrow>
                    <mrow>
                      <mo>[</mo>
                      <mrow>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <mrow>
                            <msub>
                              <mi>t</mi>
                              <mn>2</mn>
                            </msub>
                            <mo>&af;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>b</mi>
                                <mo>+</mo>
                                <msub>
                                  <mi>t</mi>
                                  <mn>1</mn>
                                </msub>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                        </mrow>
                        <mo>+</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>3</mn>
                          </msub>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mi>t</mi>
                              <mo>+</mo>
                              <mrow>
                                <mn>2</mn>
                                <mo>&it;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>1</mn>
                                    </msub>
                                    <mo>+</mo>
                                    <msub>
                                      <mi>t</mi>
                                      <mn>2</mn>
                                    </msub>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>]</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <msub>
                      <mi>&rho;</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                </mrow>
                <mo>}</mo>
              </mrow>
            </mrow>
          </mrow>
        </mrow>
        <mo>&it;</mo>
        <mstyle>
          <mtext>&NewLine;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mrow>
          <mrow>
            <mrow>
              <mi>So</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>setting</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mfrac>
                <mrow>
                  <mo>&PartialD;</mo>
                  <msub>
                    <mi>&omega;</mi>
                    <mn>0</mn>
                  </msub>
                </mrow>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mi>&delta;</mi>
                </mrow>
              </mfrac>
            </mrow>
            <mo>&it;</mo>
            <msub>
              <mo>|</mo>
              <mrow>
                <mi>&delta;</mi>
                <mo>=</mo>
                <mn>0</mn>
              </mrow>
            </msub>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mn>0</mn>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>yields</mi>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>41</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00028" file="US20020190607A1-20021219-M00028.NB"/>
<image id="EMI-M00028" wi="216.027" he="81.1377" file="US20020190607A1-20021219-M00028.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
 
<math-cwu id="MATH-US-00029">
<number>29</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mrow>
            <mrow>
              <mrow>
                <mn>3</mn>
                <mo>&it;</mo>
                <msub>
                  <mi>M</mi>
                  <mi>eff</mi>
                </msub>
                <mo>&it;</mo>
                <msub>
                  <mi>E</mi>
                  <mi>eff</mi>
                </msub>
              </mrow>
              <mo>+</mo>
              <mrow>
                <mfrac>
                  <mrow>
                    <msub>
                      <mi>M</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&it;</mo>
                    <msub>
                      <mi>a</mi>
                      <mi>eff</mi>
                    </msub>
                  </mrow>
                  <mn>2</mn>
                </mfrac>
                <mo>&it;</mo>
                <mfrac>
                  <mrow>
                    <mo>&PartialD;</mo>
                    <mrow>
                      <msub>
                        <mi>E</mi>
                        <mi>eff</mi>
                      </msub>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mi>&delta;</mi>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mrow>
                    <mo>&PartialD;</mo>
                    <mi>&delta;</mi>
                  </mrow>
                </mfrac>
              </mrow>
            </mrow>
            <mo>&it;</mo>
            <msub>
              <mo>|</mo>
              <mrow>
                <mi>&delta;</mi>
                <mo>=</mo>
                <mn>0</mn>
              </mrow>
            </msub>
            <mo>&it;</mo>
            <mrow>
              <mrow>
                <mo>-</mo>
                <mfrac>
                  <mrow>
                    <msub>
                      <mi>E</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&it;</mo>
                    <msub>
                      <mi>a</mi>
                      <mi>eff</mi>
                    </msub>
                  </mrow>
                  <mn>2</mn>
                </mfrac>
              </mrow>
              <mo>&it;</mo>
              <mfrac>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mrow>
                    <msub>
                      <mi>M</mi>
                      <mi>eff</mi>
                    </msub>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mi>&delta;</mi>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mi>&delta;</mi>
                </mrow>
              </mfrac>
            </mrow>
            <mo>&it;</mo>
            <msub>
              <mo>|</mo>
              <mrow>
                <mi>&delta;</mi>
                <mo>=</mo>
                <mn>0</mn>
              </mrow>
            </msub>
          </mrow>
          <mo>=</mo>
          <mn>0</mn>
        </mrow>
        <mo>&it;</mo>
        <mstyle>
          <mtext>&NewLine;</mtext>
        </mstyle>
        <mo>&it;</mo>
        <mrow>
          <mrow>
            <mi>From</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mrow>
              <mo>(</mo>
              <mn>21</mn>
              <mo>)</mo>
            </mrow>
          </mrow>
          <mo>,</mo>
          <mrow>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <mrow>
                  <msub>
                    <mi>E</mi>
                    <mi>eff</mi>
                  </msub>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mi>&delta;</mi>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&delta;</mi>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <msub>
              <mo>|</mo>
              <mrow>
                <mi>&delta;</mi>
                <mo>=</mo>
                <mn>0</mn>
              </mrow>
            </msub>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mrow>
              <mi>can</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>be</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>expressed</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>as</mi>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>42</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00029" file="US20020190607A1-20021219-M00029.NB"/>
<image id="EMI-M00029" wi="216.027" he="39.123" file="US20020190607A1-20021219-M00029.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
 
<math-cwu id="MATH-US-00030">
<number>30</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>E</mi>
                <mi>eff</mi>
              </msub>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <mi>&delta;</mi>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <mi>&delta;</mi>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
        </mrow>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mrow>
              <mrow>
                <mo>-</mo>
                <mn>12</mn>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <msub>
                    <mi>E</mi>
                    <mi>c2</mi>
                  </msub>
                  <mo>-</mo>
                  <msub>
                    <mi>E</mi>
                    <mi>c1</mi>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mo>&it;</mo>
              <msup>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <msub>
                        <mi>t</mi>
                        <mn>1</mn>
                      </msub>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mn>2</mn>
              </msup>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>b</mi>
                  <mo>+</mo>
                  <msub>
                    <mi>t</mi>
                    <mn>1</mn>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mo>&it;</mo>
              <msub>
                <mi>t</mi>
                <mn>2</mn>
              </msub>
            </mrow>
            <mo>-</mo>
            <mrow>
              <mn>12</mn>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <msub>
                    <mi>E</mi>
                    <mi>c1</mi>
                  </msub>
                  <mo>-</mo>
                  <mi>E</mi>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mo>&it;</mo>
              <msup>
                <mi>a</mi>
                <mn>2</mn>
              </msup>
              <mo>&it;</mo>
              <mrow>
                <mi>b</mi>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <msub>
                      <mi>t</mi>
                      <mn>1</mn>
                    </msub>
                    <mo>+</mo>
                    <msub>
                      <mi>t</mi>
                      <mn>2</mn>
                    </msub>
                  </mrow>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
          </mrow>
          <mrow>
            <msubsup>
              <mi>a</mi>
              <mi>eff</mi>
              <mn>4</mn>
            </msubsup>
            <mo>&it;</mo>
            <msub>
              <mi>b</mi>
              <mi>eff</mi>
            </msub>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>43</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00030" file="US20020190607A1-20021219-M00030.NB"/>
<image id="EMI-M00030" wi="216.027" he="43.91415" file="US20020190607A1-20021219-M00030.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> On the proof mass, the inner square condition becomes  
<math-cwu id="MATH-US-00031">
<number>31</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mi>n</mi>
            <mo>-</mo>
            <mrow>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>N</mi>
                  <mo>+</mo>
                  <mn>2</mn>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mo>&it;</mo>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <mi>t</mi>
                  <mo>+</mo>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <msub>
                          <mi>t</mi>
                          <mn>1</mn>
                        </msub>
                        <mo>+</mo>
                        <msub>
                          <mi>t</mi>
                          <mn>2</mn>
                        </msub>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mrow>
            <mi>N</mi>
            <mo>+</mo>
            <mrow>
              <mn>1</mn>
              <mo>/</mo>
              <mn>2</mn>
            </mrow>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mrow>
              <mi>m</mi>
              <mo>-</mo>
              <mrow>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>M</mi>
                    <mo>+</mo>
                    <mn>2</mn>
                  </mrow>
                  <mo>)</mo>
                </mrow>
                <mo>&it;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mi>t</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <msub>
                            <mi>t</mi>
                            <mn>1</mn>
                          </msub>
                          <mo>+</mo>
                          <msub>
                            <mi>t</mi>
                            <mn>2</mn>
                          </msub>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                  </mrow>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
            <mrow>
              <mi>M</mi>
              <mo>+</mo>
              <mn>1</mn>
            </mrow>
          </mfrac>
          <mo>=</mo>
          <mi>k</mi>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>44</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00031" file="US20020190607A1-20021219-M00031.NB"/>
<image id="EMI-M00031" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00031.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> From the above analysis, when the multi-layer structure resonator is designed, three constraint conditions, (36), (42) and (44), should be satisfied. The design processes are similar to those of the single material structure resonator. Most of the design parameters are determined empirically based on process induced design rules. Only three variables are left to solve with the above three equations (36), (42) and (44). </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> In the case of multi-layer structures, if other fabrication errors, such as thickness errors and coated-layer fabrication errors, are considered, the analysis and design methods ate similar to above analysis. With these fabrication errors being considered, the natural vibrating frequency of the designed resonator will be robust. </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> In this invention, the frequency sensitivity characteristics of micro-resonators are analyzed, and a method to make the frequency robust to fabrication error of line width variation is presented. A generalization to arbitrary sidewall shape variation is included in Appendix A. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> For a resonator fabricated with only one material, the first and second order sensitivities of frequency to the Sine-width fabrication error were derived. With the assumption of the beam and proof mass having the same thickness, the natural frequency is independent of the thickness, so that the thickness fabrication error can be ignored when considering the frequency sensitivity. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> When both the first and second order sensitivities are set to be satisfied at the same time, the results will make the design unreasonable (excessively wide beam and excessively small proof mass). Therefore only the first order sensitivity is considered in the design example. A rule of thumb for robust resonator design is that the proof mass perimeter times the beam width should be six times the area of the proof mass. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> For the multi-layer structure, the effective modulus of elasticity and mass are given, and the first order frequency sensitivity to the sidewall fabrication error of the innermost beam is derived. The results can be used to analyze the effect of other fabrication errors on the structure. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> The concepts presented here can be applied to more complex systems using numerical optimization or computer algebra software such as Mathematica or Matlab. </paragraph>
<paragraph id="P-0095" lvl="7"><number>&lsqb;0095&rsqb;</number> 4. Conclusion </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> This concludes the description of one or more embodiments of the invention. In summary, the present invention discloses a frequency robust resonator comprising at least one beam having a first end, a second end, and a beam width and a proof mass having a proof mass area and a perimeter, wherein the proof mass is affixed to the first end of the beam and the second end of the beam is affixed to a ground and the proof mass perimeter multiplied by the beam width is substantially equivalent to six times the proof mass area. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> The foregoing description of one or more embodiments of the invention has been presented for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed. Many modifications and variations are possible in light of the above teaching. For example, high-frequency resonators may not have distinct inertial and compliant structures as does the folded beam resonator. Such structures, rather, have distributed mass and compliances. Nonetheless, the principles of our invention apply. It is intended that the scope of the invention be limited not by this detailed description, but rather by the claims appended hereto. </paragraph>
<paragraph id="P-0098" lvl="7"><number>&lsqb;0098&rsqb;</number> 5. References </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> The following references are incorporated by reference herein: </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> &lsqb;1&rsqb; W. C. Tang, M. G. Lir and R. T. Howe, &ldquo;Electrostatic Comb Drive Levitation and Control Method&rdquo;, Journal of Microelectromechanical System, Vol.1, No.4, December 1992, pp170-178. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> &lsqb;2&rsqb; Y. Mochida, M. Tamura and K. Ohwada, &ldquo;A Micromachined Vibrating Rate Gyroscope with Independent Beams for the Drive and Detection Modes&rdquo;, IEEE International conference on MEMS&apos;99, in Technical Digest, 1999, pp618-623. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> &lsqb;3&rsqb; L. A. Yeh, Hjiang and N. C. Tien, &ldquo;Integrated Polysilicon and DRIE Bulk Silicon Micromachining for an Electrostatic Torsional Actuator&rdquo;, Journal of Microelectromechanical System, Vol.8, No.4, December 1999, pp456-465. </paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> &lsqb;4&rsqb; M J. Daneman, N. C. Tien, O. Solgaard, A. P. Pisano, K. Y. Lau and R. S. Muller, &ldquo;Linear Microvibromotor for Positioning Optical Components&rdquo;, Journal of Microelectromechanical System, Vol.5, No.3, September 1996, pp159-165. </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> &lsqb;5&rsqb; L. A. Romero, F. M. Dickey and S. C. Holswade, &ldquo;A Method for Achieving Constant rotation Rates in a Microorthoginal Linkage System&rdquo;, Journal of Microelectromechanical System, Vol.9, No.2, June 2000, pp236-244. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> &lsqb;6&rsqb; Hector J. De Los Santos, &lt;Introduction to Microelectromechanical (MEM) Microwave System&gt;, Artech House, 1999. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> &lsqb;7&rsqb; Y. K. Yong and J. R. Vig, &ldquo;Resonator Surface Contamination&mdash;A Cause of Frequency Fluctuation&quest;&rdquo;, IEEE Trans. On Ultrasonic, Ferroelectrics, and Frequency Control, Vol.36, No.4, July 1989, pp452-458. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> &lsqb;8&rsqb; T. B. Gabrielson, &ldquo;Mechanical&mdash;Thermal Noise in Micromachined Acoustic and Vibration Sensors&rdquo;, IEEE Trans. On Electron Device, Vol.40, No.5, May 1993, pp903-909. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> &lsqb;9&rsqb; F. E. H. Tay, J. Xu, Y. C. Liang, V. J. Logeeswaran and Y. F. Yao, &ldquo;The effects of non-parallel plates in a differential capacitive microaccelerometer&rdquo;, Journal of Micromech. and Microeng., 9(1999),pp283-293. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> &lsqb;10&rsqb; Y. S. Hong, J. H. Lee and S. H. Kim, &ldquo;A laterally driven symmetric micro-resonator for gyroscopic applications&rdquo;, Journal of Micromech. and Microeng., 10(2000),pp452-458. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> &lsqb;11&rsqb; J. B. Starr, &ldquo;Squeeze-film Damping in Solid-State Accelerometers&rdquo;, in Solid-state Sensor and Actuator Workshop, Tech. Dig., New York, 1990, pp44-47. </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> &lsqb;12&rsqb; K. A. Shaw, Z. L. Zhang,and N. C. MacDonald, &ldquo;SCREAM-I, a single-mask single-crystal silicon, reactive ion etching process for microelectromechanical structures&rdquo;, Sensors and Actuators A, 40:63, 1994. </paragraph>
</section>
<section>
<heading lvl="1">Appendix A </heading>
<paragraph id="P-0112" lvl="7"><number>&lsqb;0112&rsqb;</number> 6. Equations for MEMS Resonator with Arbitrary Profile of Sidewall Fabrication Error </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> illustrates the cross-section of the beam. A thin segment of thickness &Dgr;y is considered. If &Dgr;y is small enough, this segment can be regarded as a rectangle in the dimension of b&times;(a&plus;2&dgr;<highlight><subscript>i</subscript></highlight>). &dgr;<highlight><subscript>i </subscript></highlight>is the fabrication error on the segment, and is dependent on the position of the segment on the cross-section. This segment with length of L is a thin beam. The tip deflection of this thin beam can be expressed as  
<math-cwu id="MATH-US-00032">
<number>32</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>&Delta;</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <msub>
            <mi>X</mi>
            <mi>i</mi>
          </msub>
        </mrow>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mn>4</mn>
            <mo>&it;</mo>
            <msub>
              <mi>P</mi>
              <mi>i</mi>
            </msub>
            <mo>&it;</mo>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mrow>
          <mrow>
            <msup>
              <mrow>
                <mi>E</mi>
                <mo>&af;</mo>
                <mrow>
                  <mo>[</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>+</mo>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <msub>
                        <mi>&delta;</mi>
                        <mi>i</mi>
                      </msub>
                    </mrow>
                  </mrow>
                  <mo>]</mo>
                </mrow>
              </mrow>
              <mn>3</mn>
            </msup>
            <mo>&it;</mo>
            <mi>&Delta;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>y</mi>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mstyle>
          <mtext>A-1</mtext>
        </mstyle>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00032" file="US20020190607A1-20021219-M00032.NB"/>
<image id="EMI-M00032" wi="216.027" he="21.12075" file="US20020190607A1-20021219-M00032.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0114" lvl="7"><number>&lsqb;0114&rsqb;</number> where the P<highlight><subscript>i </subscript></highlight>is the force on the tip of this thin beam. </paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> The whole beam can be divided into many thin beams as above. Because the overall force on the tip of the beam  
<math-cwu id="MATH-US-00033">
<number>33</number>
<math>
<mrow>
  <mrow>
    <mi>P</mi>
    <mo>=</mo>
    <mrow>
      <munder>
        <mo>&Sum;</mo>
        <mi>i</mi>
      </munder>
      <mo>&it;</mo>
      <msub>
        <mi>P</mi>
        <mi>i</mi>
      </msub>
    </mrow>
  </mrow>
  <mo>,</mo>
</mrow>
</math>
<mathematica-file id="MATHEMATICA-00033" file="US20020190607A1-20021219-M00033.NB"/>
<image id="EMI-M00033" wi="216.027" he="19.93005" file="US20020190607A1-20021219-M00033.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0116" lvl="7"><number>&lsqb;0116&rsqb;</number> , and any tip deflection of those thin beams is equal to tip deflection of the whole beam, i.e. &Dgr;X&equals;&Dgr;X<highlight><subscript>i</subscript></highlight>, the deformation equation of the whole beam can be given as  
<math-cwu id="MATH-US-00034">
<number>34</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>&Delta;</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <mi>X</mi>
        </mrow>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mn>4</mn>
            <mo>&it;</mo>
            <mi>P</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mrow>
          <mrow>
            <mi>E</mi>
            <mo>&it;</mo>
            <mrow>
              <msubsup>
                <mo>&Integral;</mo>
                <mn>0</mn>
                <mi>b</mi>
              </msubsup>
              <mo>&it;</mo>
              <mrow>
                <msup>
                  <mrow>
                    <mo>[</mo>
                    <mrow>
                      <mi>a</mi>
                      <mo>+</mo>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mrow>
                          <mi>&delta;</mi>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mi>y</mi>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                    </mrow>
                    <mo>]</mo>
                  </mrow>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mrow>
                  <mo>&dd;</mo>
                  <mi>y</mi>
                </mrow>
              </mrow>
            </mrow>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(A-2)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00034" file="US20020190607A1-20021219-M00034.NB"/>
<image id="EMI-M00034" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00034.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> Then the elastic coefficient of the beam can be obtained as  
<math-cwu id="MATH-US-00035">
<number>35</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mi>E</mi>
            <mo>&it;</mo>
            <mrow>
              <msubsup>
                <mo>&Integral;</mo>
                <mn>0</mn>
                <mi>b</mi>
              </msubsup>
              <mo>&it;</mo>
              <mrow>
                <msup>
                  <mrow>
                    <mo>[</mo>
                    <mrow>
                      <mi>a</mi>
                      <mo>+</mo>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mrow>
                          <mi>&delta;</mi>
                          <mo>&af;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mi>y</mi>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                    </mrow>
                    <mo>]</mo>
                  </mrow>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mrow>
                  <mo>&dd;</mo>
                  <mi>y</mi>
                </mrow>
              </mrow>
            </mrow>
          </mrow>
          <mrow>
            <mn>4</mn>
            <mo>&it;</mo>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(A-3)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00035" file="US20020190607A1-20021219-M00035.NB"/>
<image id="EMI-M00035" wi="216.027" he="28.09485" file="US20020190607A1-20021219-M00035.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> The mass of a unit length of beam can be expressed as</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>M</italic></highlight><highlight><subscript>unit</subscript></highlight>&equals;&rgr;&int;&lsqb;a&plus;2&dgr;(<highlight><italic>y</italic></highlight>)&rsqb;<highlight><italic>dy&equals;&rgr;b</italic></highlight>(<highlight><italic>a&plus;</italic></highlight>2&dgr;<highlight><subscript>mean</subscript></highlight>)&emsp;&emsp;(A-4)</in-line-formula></paragraph>
<paragraph id="P-0119" lvl="7"><number>&lsqb;0119&rsqb;</number> where &dgr;<highlight><subscript>mean</subscript></highlight> 
<math-cwu id="MATH-US-00036">
<number>36</number>
<math>
<mrow>
  <msub>
    <mi>&delta;</mi>
    <mrow>
      <mi>m</mi>
      <mo>&it;</mo>
      <mstyle>
        <mtext>&emsp;</mtext>
      </mstyle>
      <mo>&it;</mo>
      <mi>e</mi>
      <mo>&it;</mo>
      <mstyle>
        <mtext>&emsp;</mtext>
      </mstyle>
      <mo>&it;</mo>
      <mi>a</mi>
      <mo>&it;</mo>
      <mstyle>
        <mtext>&emsp;</mtext>
      </mstyle>
      <mo>&it;</mo>
      <mi>n</mi>
    </mrow>
  </msub>
  <mo>=</mo>
  <mfrac>
    <mrow>
      <msubsup>
        <mo>&Integral;</mo>
        <mn>0</mn>
        <mi>b</mi>
      </msubsup>
      <mo>&it;</mo>
      <mrow>
        <mrow>
          <mi>&delta;</mi>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mi>y</mi>
            <mo>)</mo>
          </mrow>
        </mrow>
        <mo>&it;</mo>
        <mrow>
          <mo>&dd;</mo>
          <mi>y</mi>
        </mrow>
      </mrow>
    </mrow>
    <mi>b</mi>
  </mfrac>
</mrow>
</math>
<mathematica-file id="MATHEMATICA-00036" file="US20020190607A1-20021219-M00036.NB"/>
<image id="EMI-M00036" wi="216.027" he="27.13095" file="US20020190607A1-20021219-M00036.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0120" lvl="7"><number>&lsqb;0120&rsqb;</number> is the mean fabrication error on one side of the beam. Equation (A-4) has the same form as that for a beam with line-width fabrication error, except the constant &dgr; for with line-width fabrication error beam is replaced with &dgr;<highlight><subscript>mean</subscript></highlight>. So the mass of the proof mass can be obtained similarly as &dgr;<highlight><subscript>mean </subscript></highlight>is considered as the mean fabrication error on the width of all structures.</paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>M&equals;&rgr;bA</italic></highlight>(&dgr;<highlight><subscript>mean</subscript></highlight>)&emsp;&emsp;(A-5)</in-line-formula></paragraph>
<paragraph id="P-0121" lvl="7"><number>&lsqb;0121&rsqb;</number> where A(&dgr;<highlight><subscript>mean</subscript></highlight>) is the area of the proof mass with fabrication error. </paragraph>
<paragraph id="P-0122" lvl="0"><number>&lsqb;0122&rsqb;</number> The natural frequency of the folded beam suspended resonator can be given as  
<math-cwu id="MATH-US-00037">
<number>37</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mtable>
          <mtr>
            <mtd>
              <mrow>
                <msub>
                  <mi>&omega;</mi>
                  <mn>0</mn>
                </msub>
                <mo>=</mo>
                <msqrt>
                  <mfrac>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>E</mi>
                      <mo>&it;</mo>
                      <mrow>
                        <msubsup>
                          <mo>&Integral;</mo>
                          <mn>0</mn>
                          <mi>b</mi>
                        </msubsup>
                        <mo>&it;</mo>
                        <mrow>
                          <msup>
                            <mrow>
                              <mo>[</mo>
                              <mrow>
                                <mi>a</mi>
                                <mo>+</mo>
                                <mrow>
                                  <mn>2</mn>
                                  <mo>&it;</mo>
                                  <mrow>
                                    <mi>&delta;</mi>
                                    <mo>&af;</mo>
                                    <mrow>
                                      <mo>(</mo>
                                      <mi>y</mi>
                                      <mo>)</mo>
                                    </mrow>
                                  </mrow>
                                </mrow>
                              </mrow>
                              <mo>]</mo>
                            </mrow>
                            <mn>3</mn>
                          </msup>
                          <mo>&it;</mo>
                          <mrow>
                            <mo>&dd;</mo>
                            <mi>y</mi>
                          </mrow>
                        </mrow>
                      </mrow>
                    </mrow>
                    <mrow>
                      <mi>b</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>&rho;</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>A</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mrow>
                        <mo>(</mo>
                        <msub>
                          <mi>&delta;</mi>
                          <mrow>
                            <mi>m</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>e</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>a</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>n</mi>
                          </mrow>
                        </msub>
                        <mo>)</mo>
                      </mrow>
                      <mo>&it;</mo>
                      <msup>
                        <mi>L</mi>
                        <mn>3</mn>
                      </msup>
                    </mrow>
                  </mfrac>
                </msqrt>
              </mrow>
            </mtd>
          </mtr>
          <mtr>
            <mtd>
              <mrow>
                <mo>=</mo>
                <msqrt>
                  <mfrac>
                    <mrow>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mi>E</mi>
                        <mo>&it;</mo>
                        <mstyle>
                          <mtext>&emsp;</mtext>
                        </mstyle>
                        <mo>&it;</mo>
                        <msup>
                          <mrow>
                            <mi>b</mi>
                            <mo>&af;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mi>a</mi>
                                <mo>+</mo>
                                <mrow>
                                  <mn>2</mn>
                                  <mo>&it;</mo>
                                  <msub>
                                    <mi>&delta;</mi>
                                    <mrow>
                                      <mi>m</mi>
                                      <mo>&it;</mo>
                                      <mstyle>
                                        <mtext>&emsp;</mtext>
                                      </mstyle>
                                      <mo>&it;</mo>
                                      <mi>e</mi>
                                      <mo>&it;</mo>
                                      <mstyle>
                                        <mtext>&emsp;</mtext>
                                      </mstyle>
                                      <mo>&it;</mo>
                                      <mi>a</mi>
                                      <mo>&it;</mo>
                                      <mstyle>
                                        <mtext>&emsp;</mtext>
                                      </mstyle>
                                      <mo>&it;</mo>
                                      <mi>n</mi>
                                    </mrow>
                                  </msub>
                                </mrow>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                          <mn>3</mn>
                        </msup>
                      </mrow>
                      <mo>+</mo>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mrow>
                          <mi>E</mi>
                          <mo>[</mo>
                          <mrow>
                            <mrow>
                              <mn>12</mn>
                              <mo>&it;</mo>
                              <mrow>
                                <mi>a</mi>
                                <mo>&af;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mrow>
                                    <mrow>
                                      <msubsup>
                                        <mo>&Integral;</mo>
                                        <mn>0</mn>
                                        <mi>b</mi>
                                      </msubsup>
                                      <mo>&it;</mo>
                                      <mrow>
                                        <msup>
                                          <mrow>
                                            <mi>&delta;</mi>
                                            <mo>&af;</mo>
                                            <mrow>
                                              <mo>(</mo>
                                              <mi>y</mi>
                                              <mo>)</mo>
                                            </mrow>
                                          </mrow>
                                          <mn>2</mn>
                                        </msup>
                                        <mo>&it;</mo>
                                        <mrow>
                                          <mo>&dd;</mo>
                                          <mi>y</mi>
                                        </mrow>
                                      </mrow>
                                    </mrow>
                                    <mo>-</mo>
                                    <mrow>
                                      <msubsup>
                                        <mi>&delta;</mi>
                                        <mrow>
                                          <mi>m</mi>
                                          <mo>&it;</mo>
                                          <mstyle>
                                            <mtext>&emsp;</mtext>
                                          </mstyle>
                                          <mo>&it;</mo>
                                          <mi>a</mi>
                                          <mo>&it;</mo>
                                          <mstyle>
                                            <mtext>&emsp;</mtext>
                                          </mstyle>
                                          <mo>&it;</mo>
                                          <mi>n</mi>
                                        </mrow>
                                        <mn>2</mn>
                                      </msubsup>
                                      <mo>&it;</mo>
                                      <mi>b</mi>
                                    </mrow>
                                  </mrow>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                            </mrow>
                            <mo>+</mo>
                            <mrow>
                              <mn>8</mn>
                              <mo>&it;</mo>
                              <mrow>
                                <mo>(</mo>
                                <mrow>
                                  <mrow>
                                    <msubsup>
                                      <mo>&Integral;</mo>
                                      <mn>0</mn>
                                      <mi>b</mi>
                                    </msubsup>
                                    <mo>&it;</mo>
                                    <mrow>
                                      <msup>
                                        <mrow>
                                          <mi>&delta;</mi>
                                          <mo>&af;</mo>
                                          <mrow>
                                            <mo>(</mo>
                                            <mi>y</mi>
                                            <mo>)</mo>
                                          </mrow>
                                        </mrow>
                                        <mn>3</mn>
                                      </msup>
                                      <mo>&it;</mo>
                                      <mrow>
                                        <mo>&dd;</mo>
                                        <mi>y</mi>
                                      </mrow>
                                    </mrow>
                                  </mrow>
                                  <mo>-</mo>
                                  <mrow>
                                    <msubsup>
                                      <mi>&delta;</mi>
                                      <mrow>
                                        <mi>m</mi>
                                        <mo>&it;</mo>
                                        <mstyle>
                                          <mtext>&emsp;</mtext>
                                        </mstyle>
                                        <mo>&it;</mo>
                                        <mi>a</mi>
                                        <mo>&it;</mo>
                                        <mstyle>
                                          <mtext>&emsp;</mtext>
                                        </mstyle>
                                        <mo>&it;</mo>
                                        <mi>n</mi>
                                      </mrow>
                                      <mn>3</mn>
                                    </msubsup>
                                    <mo>&it;</mo>
                                    <mi>b</mi>
                                  </mrow>
                                </mrow>
                                <mo>)</mo>
                              </mrow>
                            </mrow>
                          </mrow>
                        </mrow>
                      </mrow>
                    </mrow>
                    <mrow>
                      <mi>b</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>&rho;</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>A</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mrow>
                        <mo>(</mo>
                        <msub>
                          <mi>&delta;</mi>
                          <mrow>
                            <mi>m</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>e</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>a</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>n</mi>
                          </mrow>
                        </msub>
                        <mo>)</mo>
                      </mrow>
                      <mo>&it;</mo>
                      <msup>
                        <mi>L</mi>
                        <mn>3</mn>
                      </msup>
                    </mrow>
                  </mfrac>
                </msqrt>
              </mrow>
            </mtd>
          </mtr>
        </mtable>
        <mo>&AutoLeftMatch;</mo>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(A-6)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00037" file="US20020190607A1-20021219-M00037.NB"/>
<image id="EMI-M00037" wi="274.11615" he="63.13545" file="US20020190607A1-20021219-M00037.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0123" lvl="0"><number>&lsqb;0123&rsqb;</number> Because the following equations are satisfied  
<math-cwu id="MATH-US-00038">
<number>38</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mn>2</mn>
        <mo>&it;</mo>
        <mrow>
          <mi>E</mi>
          <mo>[</mo>
          <mrow>
            <mrow>
              <mrow>
                <mrow>
                  <mn>12</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <mi>a</mi>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mrow>
                          <msubsup>
                            <mo>&Integral;</mo>
                            <mn>0</mn>
                            <mi>b</mi>
                          </msubsup>
                          <mo>&it;</mo>
                          <mrow>
                            <msup>
                              <mrow>
                                <mi>&delta;</mi>
                                <mo>&af;</mo>
                                <mrow>
                                  <mo>(</mo>
                                  <mi>y</mi>
                                  <mo>)</mo>
                                </mrow>
                              </mrow>
                              <mn>2</mn>
                            </msup>
                            <mo>&it;</mo>
                            <mrow>
                              <mo>&dd;</mo>
                              <mi>y</mi>
                            </mrow>
                          </mrow>
                        </mrow>
                        <mo>-</mo>
                        <mrow>
                          <msubsup>
                            <mi>&delta;</mi>
                            <mrow>
                              <mi>m</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>a</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>n</mi>
                            </mrow>
                            <mn>2</mn>
                          </msubsup>
                          <mo>&it;</mo>
                          <mi>b</mi>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mo>+</mo>
                <mrow>
                  <mn>8</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mrow>
                      <mrow>
                        <msubsup>
                          <mo>&Integral;</mo>
                          <mn>0</mn>
                          <mi>b</mi>
                        </msubsup>
                        <mo>&it;</mo>
                        <mrow>
                          <msup>
                            <mrow>
                              <mi>&delta;</mi>
                              <mo>&af;</mo>
                              <mrow>
                                <mo>(</mo>
                                <mi>y</mi>
                                <mo>)</mo>
                              </mrow>
                            </mrow>
                            <mn>3</mn>
                          </msup>
                          <mo>&it;</mo>
                          <mrow>
                            <mo>&dd;</mo>
                            <mi>y</mi>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>-</mo>
                      <mrow>
                        <msubsup>
                          <mi>&delta;</mi>
                          <mrow>
                            <mi>m</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>a</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>n</mi>
                          </mrow>
                          <mn>3</mn>
                        </msubsup>
                        <mo>&it;</mo>
                        <mi>b</mi>
                      </mrow>
                    </mrow>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mrow>
              <mo>&it;</mo>
              <msub>
                <mo>|</mo>
                <mrow>
                  <mi>&delta;</mi>
                  <mo>=</mo>
                  <mn>0</mn>
                </mrow>
              </msub>
            </mrow>
            <mo>=</mo>
            <mn>0</mn>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(A-7)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <mo>&PartialD;</mo>
              <mrow>
                <mo>[</mo>
                <mrow>
                  <mn>2</mn>
                  <mo>&it;</mo>
                  <mrow>
                    <mi>E</mi>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>[</mo>
                      <mrow>
                        <mrow>
                          <mn>12</mn>
                          <mo>&it;</mo>
                          <mrow>
                            <mi>a</mi>
                            <mo>&af;</mo>
                            <mrow>
                              <mo>(</mo>
                              <mrow>
                                <mrow>
                                  <msubsup>
                                    <mo>&Integral;</mo>
                                    <mn>0</mn>
                                    <mi>b</mi>
                                  </msubsup>
                                  <mo>&it;</mo>
                                  <mrow>
                                    <msup>
                                      <mrow>
                                        <mi>&delta;</mi>
                                        <mo>&af;</mo>
                                        <mrow>
                                          <mo>(</mo>
                                          <mi>y</mi>
                                          <mo>)</mo>
                                        </mrow>
                                      </mrow>
                                      <mn>2</mn>
                                    </msup>
                                    <mo>&it;</mo>
                                    <mrow>
                                      <mo>&dd;</mo>
                                      <mi>y</mi>
                                    </mrow>
                                  </mrow>
                                </mrow>
                                <mo>-</mo>
                                <mrow>
                                  <msubsup>
                                    <mi>&delta;</mi>
                                    <mrow>
                                      <mi>m</mi>
                                      <mo>&it;</mo>
                                      <mstyle>
                                        <mtext>&emsp;</mtext>
                                      </mstyle>
                                      <mo>&it;</mo>
                                      <mi>a</mi>
                                      <mo>&it;</mo>
                                      <mstyle>
                                        <mtext>&emsp;</mtext>
                                      </mstyle>
                                      <mo>&it;</mo>
                                      <mi>n</mi>
                                    </mrow>
                                    <mn>2</mn>
                                  </msubsup>
                                  <mo>&it;</mo>
                                  <mi>b</mi>
                                </mrow>
                              </mrow>
                              <mo>)</mo>
                            </mrow>
                          </mrow>
                        </mrow>
                        <mo>+</mo>
                        <mrow>
                          <mn>8</mn>
                          <mo>&it;</mo>
                          <mrow>
                            <mo>(</mo>
                            <mrow>
                              <mrow>
                                <msubsup>
                                  <mo>&Integral;</mo>
                                  <mn>0</mn>
                                  <mi>b</mi>
                                </msubsup>
                                <mo>&it;</mo>
                                <mrow>
                                  <msup>
                                    <mrow>
                                      <mi>&delta;</mi>
                                      <mo>&af;</mo>
                                      <mrow>
                                        <mo>(</mo>
                                        <mi>y</mi>
                                        <mo>)</mo>
                                      </mrow>
                                    </mrow>
                                    <mn>3</mn>
                                  </msup>
                                  <mo>&it;</mo>
                                  <mrow>
                                    <mo>&dd;</mo>
                                    <mi>y</mi>
                                  </mrow>
                                </mrow>
                              </mrow>
                              <mo>-</mo>
                              <mrow>
                                <msubsup>
                                  <mi>&delta;</mi>
                                  <mrow>
                                    <mi>m</mi>
                                    <mo>&it;</mo>
                                    <mstyle>
                                      <mtext>&emsp;</mtext>
                                    </mstyle>
                                    <mo>&it;</mo>
                                    <mi>a</mi>
                                    <mo>&it;</mo>
                                    <mstyle>
                                      <mtext>&emsp;</mtext>
                                    </mstyle>
                                    <mo>&it;</mo>
                                    <mi>n</mi>
                                  </mrow>
                                  <mn>3</mn>
                                </msubsup>
                                <mo>&it;</mo>
                                <mi>b</mi>
                              </mrow>
                            </mrow>
                            <mo>)</mo>
                          </mrow>
                        </mrow>
                      </mrow>
                      <mo>]</mo>
                    </mrow>
                  </mrow>
                </mrow>
              </mrow>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>&delta;</mi>
                <mrow>
                  <mi>m</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>e</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>a</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>n</mi>
                </mrow>
              </msub>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <mi>&delta;</mi>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
        </mrow>
        <mo>=</mo>
        <mn>0</mn>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(A-8)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00038" file="US20020190607A1-20021219-M00038.NB"/>
<image id="EMI-M00038" wi="274.11615" he="53.04285" file="US20020190607A1-20021219-M00038.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0124" lvl="7"><number>&lsqb;0124&rsqb;</number> the first sensitivity of the natural frequency to the mean fabrication error can be expressed as  
<math-cwu id="MATH-US-00039">
<number>39</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mfrac>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>&omega;</mi>
                <mn>0</mn>
              </msub>
            </mrow>
            <mrow>
              <mo>&PartialD;</mo>
              <msub>
                <mi>&delta;</mi>
                <mrow>
                  <mi>m</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>e</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>a</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>n</mi>
                </mrow>
              </msub>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <mi>&delta;</mi>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
        </mrow>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mrow>
              <mn>3</mn>
              <mo>&it;</mo>
              <msqrt>
                <mfrac>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mrow>
                      <mo>(</mo>
                      <mrow>
                        <mi>a</mi>
                        <mo>+</mo>
                        <mrow>
                          <mn>2</mn>
                          <mo>&it;</mo>
                          <msub>
                            <mi>&delta;</mi>
                            <mrow>
                              <mi>m</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>e</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>a</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>n</mi>
                            </mrow>
                          </msub>
                        </mrow>
                      </mrow>
                      <mo>)</mo>
                    </mrow>
                    <mo>&it;</mo>
                    <mi>E</mi>
                  </mrow>
                  <mrow>
                    <mi>&rho;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mrow>
                      <mi>A</mi>
                      <mo>&af;</mo>
                      <mrow>
                        <mo>(</mo>
                        <msub>
                          <mi>&delta;</mi>
                          <mrow>
                            <mi>m</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>e</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>a</mi>
                            <mo>&it;</mo>
                            <mstyle>
                              <mtext>&emsp;</mtext>
                            </mstyle>
                            <mo>&it;</mo>
                            <mi>n</mi>
                          </mrow>
                        </msub>
                        <mo>)</mo>
                      </mrow>
                    </mrow>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                </mfrac>
              </msqrt>
            </mrow>
            <mo>-</mo>
            <mrow>
              <mfrac>
                <mn>1</mn>
                <mn>2</mn>
              </mfrac>
              <mo>&it;</mo>
              <msqrt>
                <mfrac>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <msup>
                      <mrow>
                        <mo>(</mo>
                        <mrow>
                          <mi>a</mi>
                          <mo>+</mo>
                          <mrow>
                            <mn>2</mn>
                            <mo>&it;</mo>
                            <msub>
                              <mi>&delta;</mi>
                              <mrow>
                                <mi>m</mi>
                                <mo>&it;</mo>
                                <mstyle>
                                  <mtext>&emsp;</mtext>
                                </mstyle>
                                <mo>&it;</mo>
                                <mi>e</mi>
                                <mo>&it;</mo>
                                <mstyle>
                                  <mtext>&emsp;</mtext>
                                </mstyle>
                                <mo>&it;</mo>
                                <mi>a</mi>
                                <mo>&it;</mo>
                                <mstyle>
                                  <mtext>&emsp;</mtext>
                                </mstyle>
                                <mo>&it;</mo>
                                <mi>n</mi>
                              </mrow>
                            </msub>
                          </mrow>
                        </mrow>
                        <mo>)</mo>
                      </mrow>
                      <mn>3</mn>
                    </msup>
                    <mo>&it;</mo>
                    <mi>E</mi>
                  </mrow>
                  <mrow>
                    <mi>&rho;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <msup>
                      <mrow>
                        <mi>A</mi>
                        <mo>&af;</mo>
                        <mrow>
                          <mo>(</mo>
                          <msub>
                            <mi>&delta;</mi>
                            <mrow>
                              <mi>m</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>e</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>a</mi>
                              <mo>&it;</mo>
                              <mstyle>
                                <mtext>&emsp;</mtext>
                              </mstyle>
                              <mo>&it;</mo>
                              <mi>n</mi>
                            </mrow>
                          </msub>
                          <mo>)</mo>
                        </mrow>
                      </mrow>
                      <mn>3</mn>
                    </msup>
                    <mo>&it;</mo>
                    <msup>
                      <mi>L</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                </mfrac>
              </msqrt>
              <mo>&it;</mo>
              <mfrac>
                <mrow>
                  <mo>&PartialD;</mo>
                  <mrow>
                    <mi>A</mi>
                    <mo>&af;</mo>
                    <mrow>
                      <mo>(</mo>
                      <msub>
                        <mi>&delta;</mi>
                        <mrow>
                          <mi>m</mi>
                          <mo>&it;</mo>
                          <mstyle>
                            <mtext>&emsp;</mtext>
                          </mstyle>
                          <mo>&it;</mo>
                          <mi>e</mi>
                          <mo>&it;</mo>
                          <mstyle>
                            <mtext>&emsp;</mtext>
                          </mstyle>
                          <mo>&it;</mo>
                          <mi>a</mi>
                          <mo>&it;</mo>
                          <mstyle>
                            <mtext>&emsp;</mtext>
                          </mstyle>
                          <mo>&it;</mo>
                          <mi>n</mi>
                        </mrow>
                      </msub>
                      <mo>)</mo>
                    </mrow>
                  </mrow>
                </mrow>
                <mrow>
                  <mo>&PartialD;</mo>
                  <msub>
                    <mi>&delta;</mi>
                    <mrow>
                      <mi>m</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>e</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>a</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>n</mi>
                    </mrow>
                  </msub>
                </mrow>
              </mfrac>
            </mrow>
          </mrow>
          <mo>&it;</mo>
          <msub>
            <mo>|</mo>
            <mrow>
              <msub>
                <mi>&delta;</mi>
                <mi>mean</mi>
              </msub>
              <mo>=</mo>
              <mn>0</mn>
            </mrow>
          </msub>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mstyle>
          <mtext>A-9</mtext>
        </mstyle>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00039" file="US20020190607A1-20021219-M00039.NB"/>
<image id="EMI-M00039" wi="216.027" he="46.0971" file="US20020190607A1-20021219-M00039.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0125" lvl="0"><number>&lsqb;0125&rsqb;</number> From (A-9), same results can be obtained as in (12) with &dgr; in (12) replaced by &dgr;<highlight><subscript>mean</subscript></highlight>. </paragraph>
</section>
<section>
<heading lvl="1">Appendix B </heading>
<paragraph id="P-0126" lvl="7"><number>&lsqb;0126&rsqb;</number> 7. Beam Equation on MEMS Resonator </paragraph>
<paragraph id="P-0127" lvl="0"><number>&lsqb;0127&rsqb;</number> Beams on MEMS resonator are used as suspensions for the moving mass. When the mass is resonating, its suspension beams will transform elastically. There are generally two kinds of resonation: torsional and lateral. In the following, the static transformation equations for those two kinds of resonation will be derived; then some mechanical properties of the beams will be discussed. </paragraph>
<paragraph id="P-0128" lvl="0"><number>&lsqb;0128&rsqb;</number> The transverse section of the beam discussed below is assumed to be rectangle with width a and thickness b (b&gt;a). For other cross-sections, only the moments of inertia or polar moment of inertia need to be changed. </paragraph>
<paragraph id="P-0129" lvl="7"><number>&lsqb;0129&rsqb;</number> 7.1 Torsional Motion Beam </paragraph>
<paragraph id="P-0130" lvl="0"><number>&lsqb;0130&rsqb;</number> From Saint-Venant&apos;s theory, the angle of twist for a beam with rectangular section as in <cross-reference target="DRAWINGS">FIG. 5A</cross-reference> can be expressed as  
<math-cwu id="MATH-US-00040">
<number>40</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&theta;</mi>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mi>T</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>L</mi>
          </mrow>
          <mrow>
            <mi>&beta;</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msup>
              <mi>a</mi>
              <mn>3</mn>
            </msup>
            <mo>&it;</mo>
            <mi>b</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>G</mi>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-1)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00040" file="US20020190607A1-20021219-M00040.NB"/>
<image id="EMI-M00040" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00040.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0131" lvl="7"><number>&lsqb;0131&rsqb;</number> where, T is the torque loaded on the end of the beam; L is the length of the beam; a and b are the length of short and long sides of the rectangle; G is the shearing modulus of elasticity; &bgr; is the numerical factor which is dependent on the aspect ratio of the rectangle, ranging from 0.15 to 0.34 
<math-cwu id="MATH-US-00041">
<number>41</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&beta;</mi>
        <mo>&TildeFullEqual;</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mn>3</mn>
          </mfrac>
          <mo>&it;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mn>1</mn>
              <mo>-</mo>
              <mrow>
                <mfrac>
                  <mrow>
                    <mn>192</mn>
                    <mo>&it;</mo>
                    <mi>a</mi>
                  </mrow>
                  <mrow>
                    <msup>
                      <mi>&pi;</mi>
                      <mn>5</mn>
                    </msup>
                    <mo>&it;</mo>
                    <mi>b</mi>
                  </mrow>
                </mfrac>
                <mo>&it;</mo>
                <mrow>
                  <mi>tanh</mi>
                  <mo>&af;</mo>
                  <mrow>
                    <mo>(</mo>
                    <mfrac>
                      <mrow>
                        <mi>&pi;</mi>
                        <mo>&it;</mo>
                        <mstyle>
                          <mtext>&emsp;</mtext>
                        </mstyle>
                        <mo>&it;</mo>
                        <mi>b</mi>
                      </mrow>
                      <mrow>
                        <mn>2</mn>
                        <mo>&it;</mo>
                        <mi>a</mi>
                      </mrow>
                    </mfrac>
                    <mo>)</mo>
                  </mrow>
                </mrow>
              </mrow>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-1-1)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00041" file="US20020190607A1-20021219-M00041.NB"/>
<image id="EMI-M00041" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00041.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0132" lvl="0"><number>&lsqb;0132&rsqb;</number> From (B-1), the torsional elasticity of the beam can be obtained  
<math-cwu id="MATH-US-00042">
<number>42</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>k</mi>
          <mi>&tau;</mi>
        </msub>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mi>T</mi>
            <mi>&theta;</mi>
          </mfrac>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mi>&beta;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>b</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>G</mi>
            </mrow>
            <mi>L</mi>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-2)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00042" file="US20020190607A1-20021219-M00042.NB"/>
<image id="EMI-M00042" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00042.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0133" lvl="0"><number>&lsqb;0133&rsqb;</number> The natural frequency of the beam and moving mass system is  
<math-cwu id="MATH-US-00043">
<number>43</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <msqrt>
          <mfrac>
            <msub>
              <mi>k</mi>
              <mi>&tau;</mi>
            </msub>
            <mi>J</mi>
          </mfrac>
        </msqrt>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-3)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00043" file="US20020190607A1-20021219-M00043.NB"/>
<image id="EMI-M00043" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00043.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0134" lvl="0"><number>&lsqb;0134&rsqb;</number> where the J is the moment of inertia of the system on Z axis, which is consisted of two parts. One is the moment of inertia of the beam itself  
<math-cwu id="MATH-US-00044">
<number>44</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>J</mi>
          <mn>1</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mn>12</mn>
          </mfrac>
          <mo>&it;</mo>
          <mrow>
            <mi>M</mi>
            <mo>&af;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <msup>
                  <mi>a</mi>
                  <mn>2</mn>
                </msup>
                <mo>+</mo>
                <msup>
                  <mi>b</mi>
                  <mn>2</mn>
                </msup>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-4)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00044" file="US20020190607A1-20021219-M00044.NB"/>
<image id="EMI-M00044" wi="216.027" he="18.00225" file="US20020190607A1-20021219-M00044.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0135" lvl="0"><number>&lsqb;0135&rsqb;</number> where M is the mass of the beam. The other part J<highlight><subscript>2 </subscript></highlight>is the moment of inertia of those movable parts connected to the beam, such as comb fingers, trussed cantilevered beam, and is independent on the size of the beam. Generally, the J<highlight><subscript>2 </subscript></highlight>is much bigger than the J<highlight><subscript>1</subscript></highlight>, so that the J<highlight><subscript>1 </subscript></highlight>can be negligible on practical calculation. </paragraph>
<paragraph id="P-0136" lvl="0"><number>&lsqb;0136&rsqb;</number> Substituting the (2) into (3) yields  
<math-cwu id="MATH-US-00045">
<number>45</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <msqrt>
          <mfrac>
            <mrow>
              <mi>&beta;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>b</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>G</mi>
            </mrow>
            <mrow>
              <mrow>
                <mo>(</mo>
                <mrow>
                  <msub>
                    <mi>J</mi>
                    <mn>1</mn>
                  </msub>
                  <mo>+</mo>
                  <msub>
                    <mi>J</mi>
                    <mn>2</mn>
                  </msub>
                </mrow>
                <mo>)</mo>
              </mrow>
              <mo>&it;</mo>
              <mi>L</mi>
            </mrow>
          </mfrac>
        </msqrt>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-5)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00045" file="US20020190607A1-20021219-M00045.NB"/>
<image id="EMI-M00045" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00045.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0137" lvl="0"><number>&lsqb;0137&rsqb;</number> Partially differentiating the &ohgr;<highlight><subscript>0 </subscript></highlight>with respects to width a and thickness b respectively yields  
<math-cwu id="MATH-US-00046">
<number>46</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>a</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mn>3</mn>
              <mn>2</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <mi>&beta;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>a</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>b</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>G</mi>
                </mrow>
                <mi>JL</mi>
              </mfrac>
            </msqrt>
          </mrow>
          <mo>+</mo>
          <mrow>
            <mfrac>
              <mn>1</mn>
              <mn>2</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <msup>
                    <mi>a</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mi>b</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>G</mi>
                </mrow>
                <mrow>
                  <mi>JL</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>&beta;</mi>
                </mrow>
              </mfrac>
            </msqrt>
            <mo>&it;</mo>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&beta;</mi>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>a</mi>
              </mrow>
            </mfrac>
          </mrow>
          <mo>-</mo>
          <mrow>
            <mfrac>
              <mrow>
                <mi>pL</mi>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mrow>
                      <mn>3</mn>
                      <mo>&it;</mo>
                      <msup>
                        <mi>a</mi>
                        <mn>2</mn>
                      </msup>
                      <mo>&it;</mo>
                      <mi>b</mi>
                    </mrow>
                    <mo>+</mo>
                    <msup>
                      <mi>b</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                  <mo>)</mo>
                </mrow>
              </mrow>
              <mn>24</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <mi>&beta;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <msup>
                    <mi>a</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>b</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>G</mi>
                </mrow>
                <mrow>
                  <msup>
                    <mi>J</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mi>L</mi>
                </mrow>
              </mfrac>
            </msqrt>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-6)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>b</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mn>1</mn>
              <mn>2</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <mi>&beta;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <msup>
                    <mi>a</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>G</mi>
                </mrow>
                <mrow>
                  <mi>JL</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>b</mi>
                </mrow>
              </mfrac>
            </msqrt>
          </mrow>
          <mo>+</mo>
          <mrow>
            <mfrac>
              <mn>1</mn>
              <mn>2</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <msup>
                    <mi>a</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mi>b</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>G</mi>
                </mrow>
                <mrow>
                  <mi>JL</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>&beta;</mi>
                </mrow>
              </mfrac>
            </msqrt>
            <mo>&it;</mo>
            <mfrac>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>&beta;</mi>
              </mrow>
              <mrow>
                <mo>&PartialD;</mo>
                <mi>b</mi>
              </mrow>
            </mfrac>
          </mrow>
          <mo>-</mo>
          <mrow>
            <mfrac>
              <mrow>
                <mi>pL</mi>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mrow>
                    <mrow>
                      <mn>3</mn>
                      <mo>&it;</mo>
                      <msup>
                        <mi>b</mi>
                        <mn>2</mn>
                      </msup>
                      <mo>&it;</mo>
                      <mi>a</mi>
                    </mrow>
                    <mo>+</mo>
                    <msup>
                      <mi>a</mi>
                      <mn>3</mn>
                    </msup>
                  </mrow>
                  <mo>)</mo>
                </mrow>
              </mrow>
              <mn>24</mn>
            </mfrac>
            <mo>&it;</mo>
            <msqrt>
              <mfrac>
                <mrow>
                  <mi>&beta;</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <msup>
                    <mi>a</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>b</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <mi>G</mi>
                </mrow>
                <mrow>
                  <msup>
                    <mi>J</mi>
                    <mn>3</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mi>L</mi>
                </mrow>
              </mfrac>
            </msqrt>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-7)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00046" file="US20020190607A1-20021219-M00046.NB"/>
<image id="EMI-M00046" wi="216.027" he="54.00675" file="US20020190607A1-20021219-M00046.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0138" lvl="0"><number>&lsqb;0138&rsqb;</number> where  
<math-cwu id="MATH-US-00047">
<number>47</number>
<math>
<mrow>
  <mfrac>
    <mrow>
      <mo>&PartialD;</mo>
      <msub>
        <mi>&omega;</mi>
        <mn>0</mn>
      </msub>
    </mrow>
    <mrow>
      <mo>&PartialD;</mo>
      <mi>a</mi>
    </mrow>
  </mfrac>
  <mo>&it;</mo>
  <mstyle>
    <mtext>&emsp;</mtext>
  </mstyle>
  <mo>&it;</mo>
  <mi>and</mi>
  <mo>&it;</mo>
  <mstyle>
    <mtext>&emsp;</mtext>
  </mstyle>
  <mo>&it;</mo>
  <mfrac>
    <mrow>
      <mo>&PartialD;</mo>
      <msub>
        <mi>&omega;</mi>
        <mn>0</mn>
      </msub>
    </mrow>
    <mrow>
      <mo>&PartialD;</mo>
      <mi>b</mi>
    </mrow>
  </mfrac>
</mrow>
</math>
<mathematica-file id="MATHEMATICA-00047" file="US20020190607A1-20021219-M00047.NB"/>
<image id="EMI-M00047" wi="216.027" he="17.03835" file="US20020190607A1-20021219-M00047.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0139" lvl="7"><number>&lsqb;0139&rsqb;</number> represent the sensitivity of &ohgr;<highlight><subscript>0 </subscript></highlight>with respect to width a and thickness b respectively. And  
<math-cwu id="MATH-US-00048">
<number>48</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>B</mi>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>a</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>32</mn>
            <mrow>
              <msup>
                <mi>&pi;</mi>
                <mn>4</mn>
              </msup>
              <mo>&it;</mo>
              <mi>a</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>cos</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mrow>
                <msup>
                  <mi>h</mi>
                  <mn>2</mn>
                </msup>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mfrac>
                    <mrow>
                      <mi>&pi;</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>b</mi>
                    </mrow>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>a</mi>
                    </mrow>
                  </mfrac>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
          </mfrac>
          <mo>=</mo>
          <mrow>
            <mfrac>
              <mn>64</mn>
              <mrow>
                <msup>
                  <mi>&pi;</mi>
                  <mn>5</mn>
                </msup>
                <mo>&it;</mo>
                <mi>b</mi>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <mrow>
              <mi>tanh</mi>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mfrac>
                  <mrow>
                    <mi>&pi;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>b</mi>
                  </mrow>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mi>a</mi>
                  </mrow>
                </mfrac>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-7-1)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>B</mi>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>b</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mn>64</mn>
              <mrow>
                <msup>
                  <mi>&pi;</mi>
                  <mn>5</mn>
                </msup>
                <mo>&it;</mo>
                <msup>
                  <mi>b</mi>
                  <mn>2</mn>
                </msup>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <mrow>
              <mi>tanh</mi>
              <mo>&af;</mo>
              <mrow>
                <mo>(</mo>
                <mfrac>
                  <mrow>
                    <mi>&pi;</mi>
                    <mo>&it;</mo>
                    <mstyle>
                      <mtext>&emsp;</mtext>
                    </mstyle>
                    <mo>&it;</mo>
                    <mi>b</mi>
                  </mrow>
                  <mrow>
                    <mn>2</mn>
                    <mo>&it;</mo>
                    <mi>a</mi>
                  </mrow>
                </mfrac>
                <mo>)</mo>
              </mrow>
            </mrow>
          </mrow>
          <mo>-</mo>
          <mfrac>
            <mn>32</mn>
            <mrow>
              <msup>
                <mi>&pi;</mi>
                <mn>4</mn>
              </msup>
              <mo>&it;</mo>
              <mi>b</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>cos</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mrow>
                <msup>
                  <mi>h</mi>
                  <mn>2</mn>
                </msup>
                <mo>&af;</mo>
                <mrow>
                  <mo>(</mo>
                  <mfrac>
                    <mrow>
                      <mi>&pi;</mi>
                      <mo>&it;</mo>
                      <mstyle>
                        <mtext>&emsp;</mtext>
                      </mstyle>
                      <mo>&it;</mo>
                      <mi>b</mi>
                    </mrow>
                    <mrow>
                      <mn>2</mn>
                      <mo>&it;</mo>
                      <mi>a</mi>
                    </mrow>
                  </mfrac>
                  <mo>)</mo>
                </mrow>
              </mrow>
            </mrow>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-7-2)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00048" file="US20020190607A1-20021219-M00048.NB"/>
<image id="EMI-M00048" wi="216.027" he="61.9164" file="US20020190607A1-20021219-M00048.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0140" lvl="7"><number>&lsqb;0140&rsqb;</number> 7.2 Lateral Beam Motion </paragraph>
<paragraph id="P-0141" lvl="7"><number>&lsqb;0141&rsqb;</number> 7.2.1 Single Cantilever Beam </paragraph>
<paragraph id="P-0142" lvl="0"><number>&lsqb;0142&rsqb;</number> From Mechanics of Materials, the lateral displacement of a cantilever beam as shown in <cross-reference target="DRAWINGS">FIG. 5B</cross-reference> can be expressed as  
<math-cwu id="MATH-US-00049">
<number>49</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>x</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mrow>
              <mi>P</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>z</mi>
                <mn>2</mn>
              </msup>
            </mrow>
            <mrow>
              <mn>6</mn>
              <mo>&it;</mo>
              <mi>E</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>I</mi>
            </mrow>
          </mfrac>
          <mo>&it;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mrow>
                <mn>3</mn>
                <mo>&it;</mo>
                <mi>L</mi>
              </mrow>
              <mo>-</mo>
              <mi>z</mi>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-8)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00049" file="US20020190607A1-20021219-M00049.NB"/>
<image id="EMI-M00049" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00049.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0143" lvl="0"><number>&lsqb;0143&rsqb;</number> where the P is the load at the end of the beam; L is the length of the beam; E is the modulus of elasticity; I is the moment of inertia on OY axis  
<math-cwu id="MATH-US-00050">
<number>50</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>I</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mn>12</mn>
          </mfrac>
          <mo>&it;</mo>
          <mi>b</mi>
          <mo>&it;</mo>
          <mstyle>
            <mtext>&emsp;</mtext>
          </mstyle>
          <mo>&it;</mo>
          <msup>
            <mi>a</mi>
            <mn>3</mn>
          </msup>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-9)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00050" file="US20020190607A1-20021219-M00050.NB"/>
<image id="EMI-M00050" wi="216.027" he="18.00225" file="US20020190607A1-20021219-M00050.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0144" lvl="0"><number>&lsqb;0144&rsqb;</number> The deflection at the end of the beam can be obtained from (B-8)  
<math-cwu id="MATH-US-00051">
<number>51</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&delta;</mi>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mi>P</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mrow>
          <mrow>
            <mn>3</mn>
            <mo>&it;</mo>
            <mi>E</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>I</mi>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-10)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00051" file="US20020190607A1-20021219-M00051.NB"/>
<image id="EMI-M00051" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00051.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0145" lvl="0"><number>&lsqb;0145&rsqb;</number> Substituting (B-9) into (B-10), the elasticity of the beam is  
<math-cwu id="MATH-US-00052">
<number>52</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mi>P</mi>
            <mi>&delta;</mi>
          </mfrac>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>b</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>E</mi>
            </mrow>
            <mrow>
              <mn>4</mn>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-11)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00052" file="US20020190607A1-20021219-M00052.NB"/>
<image id="EMI-M00052" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00052.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0146" lvl="0"><number>&lsqb;0146&rsqb;</number> The natural frequency of the beam and moving mass system is  
<math-cwu id="MATH-US-00053">
<number>53</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <msqrt>
            <mfrac>
              <mi>k</mi>
              <mi>M</mi>
            </mfrac>
          </msqrt>
          <mo>=</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>b</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mn>4</mn>
                <mo>&it;</mo>
                <mi>M</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-12)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00053" file="US20020190607A1-20021219-M00053.NB"/>
<image id="EMI-M00053" wi="216.027" he="24.01245" file="US20020190607A1-20021219-M00053.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0147" lvl="0"><number>&lsqb;0147&rsqb;</number> where M is the mass of the system. </paragraph>
<paragraph id="P-0148" lvl="0"><number>&lsqb;0148&rsqb;</number> From (B-12), the sensitivity of natural frequency with respect to width a and thickness b can be obtained respectively as  
<math-cwu id="MATH-US-00054">
<number>54</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>a</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>3</mn>
            <mn>4</mn>
          </mfrac>
          <mo>&it;</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mi>a</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>b</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mi>M</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-13)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>b</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mn>4</mn>
          </mfrac>
          <mo>&it;</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mi>b</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>M</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-14)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00054" file="US20020190607A1-20021219-M00054.NB"/>
<image id="EMI-M00054" wi="216.027" he="52.07895" file="US20020190607A1-20021219-M00054.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0149" lvl="7"><number>&lsqb;0149&rsqb;</number> 7.2.2 Two Cantilever Beams </paragraph>
<paragraph id="P-0150" lvl="0"><number>&lsqb;0150&rsqb;</number> When two cantilevered beams suspend the laterally moving part as shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>C, each beam&apos;s transformation is different from that of only one cantilevered beam suspension. At the point the beam is connected to the moving part, there is no rotation but lateral displacement a shown in <cross-reference target="DRAWINGS">FIG. 5D</cross-reference>. </paragraph>
<paragraph id="P-0151" lvl="0"><number>&lsqb;0151&rsqb;</number> At the end of the beam, there is not only the lateral motion force F, but also the torque T. The rotation and deflection caused by the Force F is  
<math-cwu id="MATH-US-00055">
<number>55</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&theta;</mi>
          <mn>1</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mrow>
                <mi>F</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>2</mn>
                </msup>
              </mrow>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mi>E</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>I</mi>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>and</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msub>
              <mi>&delta;</mi>
              <mn>1</mn>
            </msub>
          </mrow>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mi>F</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
            <mrow>
              <mn>3</mn>
              <mo>&it;</mo>
              <mi>E</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>I</mi>
            </mrow>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-15)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00055" file="US20020190607A1-20021219-M00055.NB"/>
<image id="EMI-M00055" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00055.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0152" lvl="0"><number>&lsqb;0152&rsqb;</number> The rotation and displacement caused by the torque T is  
<math-cwu id="MATH-US-00056">
<number>56</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&theta;</mi>
          <mn>2</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mrow>
                <mi>T</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>L</mi>
              </mrow>
              <mrow>
                <mi>E</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>I</mi>
              </mrow>
            </mfrac>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>and</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msub>
              <mi>&delta;</mi>
              <mn>2</mn>
            </msub>
          </mrow>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mi>T</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>2</mn>
              </msup>
            </mrow>
            <mrow>
              <mn>2</mn>
              <mo>&it;</mo>
              <mi>E</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>I</mi>
            </mrow>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-16)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00056" file="US20020190607A1-20021219-M00056.NB"/>
<image id="EMI-M00056" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00056.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0153" lvl="0"><number>&lsqb;0153&rsqb;</number> The boundary condition for the rotation can be expressed as</paragraph>
<paragraph lvl="0"><in-line-formula>&thgr;&equals;&thgr;<highlight><subscript>1</subscript></highlight>&plus;&thgr;<highlight><subscript>2</subscript></highlight>&equals;0&emsp;&emsp;(B-17)</in-line-formula></paragraph>
<paragraph id="P-0154" lvl="0"><number>&lsqb;0154&rsqb;</number> Substituting (B-15) and (B-16) into (B-17) yields  
<math-cwu id="MATH-US-00057">
<number>57</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>T</mi>
        <mo>=</mo>
        <mrow>
          <mo>-</mo>
          <mfrac>
            <mrow>
              <mi>F</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>L</mi>
            </mrow>
            <mn>2</mn>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-18)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00057" file="US20020190607A1-20021219-M00057.NB"/>
<image id="EMI-M00057" wi="216.027" he="18.00225" file="US20020190607A1-20021219-M00057.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0155" lvl="0"><number>&lsqb;0155&rsqb;</number> The total lateral displacement is  
<math-cwu id="MATH-US-00058">
<number>58</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&delta;</mi>
        <mo>=</mo>
        <mrow>
          <mrow>
            <msub>
              <mi>&delta;</mi>
              <mn>1</mn>
            </msub>
            <mo>+</mo>
            <msub>
              <mi>&delta;</mi>
              <mn>2</mn>
            </msub>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mfrac>
              <mrow>
                <mi>F</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
              <mrow>
                <mn>3</mn>
                <mo>&it;</mo>
                <mi>E</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>I</mi>
              </mrow>
            </mfrac>
            <mo>+</mo>
            <mfrac>
              <mrow>
                <mi>T</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>2</mn>
                </msup>
              </mrow>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mi>E</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>I</mi>
              </mrow>
            </mfrac>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-19)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00058" file="US20020190607A1-20021219-M00058.NB"/>
<image id="EMI-M00058" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00058.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> Substituting (B-18) into (B-19) yields  
<math-cwu id="MATH-US-00059">
<number>59</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&delta;</mi>
        <mo>=</mo>
        <mrow>
          <mrow>
            <mfrac>
              <mrow>
                <mi>F</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
              <mrow>
                <mn>3</mn>
                <mo>&it;</mo>
                <mi>E</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>I</mi>
              </mrow>
            </mfrac>
            <mo>+</mo>
            <mfrac>
              <mrow>
                <mi>T</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>2</mn>
                </msup>
              </mrow>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mi>E</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>I</mi>
              </mrow>
            </mfrac>
          </mrow>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mi>F</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
            <mrow>
              <mn>12</mn>
              <mo>&it;</mo>
              <mi>E</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>I</mi>
            </mrow>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-20)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00059" file="US20020190607A1-20021219-M00059.NB"/>
<image id="EMI-M00059" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00059.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0157" lvl="0"><number>&lsqb;0157&rsqb;</number> For two beams, F&equals;P/2, so that the deflection in term of P is  
<math-cwu id="MATH-US-00060">
<number>60</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&delta;</mi>
        <mo>=</mo>
        <mfrac>
          <mrow>
            <mi>P</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mrow>
          <mrow>
            <mn>24</mn>
            <mo>&it;</mo>
            <mi>E</mi>
            <mo>&it;</mo>
            <mstyle>
              <mtext>&emsp;</mtext>
            </mstyle>
            <mo>&it;</mo>
            <mi>I</mi>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-21)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00060" file="US20020190607A1-20021219-M00060.NB"/>
<image id="EMI-M00060" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00060.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> Compared (B-21) with (B-10), the elasticity of beam, the natural frequency and its sensitivity to width a and thickness b can be obtained as  
<math-cwu id="MATH-US-00061">
<number>61</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mi>P</mi>
            <mi>&delta;</mi>
          </mfrac>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <mn>2</mn>
              <mo>&it;</mo>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>b</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>E</mi>
            </mrow>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-22)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00061" file="US20020190607A1-20021219-M00061.NB"/>
<image id="EMI-M00061" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00061.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
 
<math-cwu id="MATH-US-00062">
<number>62</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <msqrt>
            <mfrac>
              <mi>k</mi>
              <mi>M</mi>
            </mfrac>
          </msqrt>
          <mo>=</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>b</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mi>M</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-23)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>a</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mn>3</mn>
          <mo>&it;</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <mi>a</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>b</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <mrow>
                <mn>2</mn>
                <mo>&it;</mo>
                <mi>M</mi>
                <mo>&it;</mo>
                <mstyle>
                  <mtext>&emsp;</mtext>
                </mstyle>
                <mo>&it;</mo>
                <msup>
                  <mi>L</mi>
                  <mn>3</mn>
                </msup>
              </mrow>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-24)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>b</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <msqrt>
          <mfrac>
            <mrow>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>E</mi>
            </mrow>
            <mrow>
              <mn>2</mn>
              <mo>&it;</mo>
              <mi>b</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>M</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>L</mi>
                <mn>3</mn>
              </msup>
            </mrow>
          </mfrac>
        </msqrt>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-25)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00062" file="US20020190607A1-20021219-M00062.NB"/>
<image id="EMI-M00062" wi="216.027" he="79.91865" file="US20020190607A1-20021219-M00062.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0159" lvl="7"><number>&lsqb;0159&rsqb;</number> 7.2.3 Folded Beams </paragraph>
<paragraph id="P-0160" lvl="0"><number>&lsqb;0160&rsqb;</number> For the folded beam shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>E, because both the moving bar and moving mass can only move laterally the transformation of all four beams is just like that of beam shown in <cross-reference target="DRAWINGS">FIG. 5D</cross-reference>. The upper two beams and lower two beams share the load P on the mass. The deflection on point A is the sum of deflections of beam-1 and beam-2 
<math-cwu id="MATH-US-00063">
<number>63</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&delta;</mi>
        <mo>=</mo>
        <mrow>
          <mrow>
            <msup>
              <mi>&delta;</mi>
              <mn>1</mn>
            </msup>
            <mo>+</mo>
            <msup>
              <mi>&delta;</mi>
              <mn>2</mn>
            </msup>
          </mrow>
          <mo>=</mo>
          <mrow>
            <mrow>
              <mn>2</mn>
              <mo>&times;</mo>
              <mfrac>
                <msup>
                  <mi>FL</mi>
                  <mn>3</mn>
                </msup>
                <mrow>
                  <mn>12</mn>
                  <mo>&it;</mo>
                  <mi>EI</mi>
                </mrow>
              </mfrac>
            </mrow>
            <mo>=</mo>
            <mfrac>
              <msup>
                <mi>FL</mi>
                <mn>3</mn>
              </msup>
              <mrow>
                <mn>6</mn>
                <mo>&it;</mo>
                <mi>EI</mi>
              </mrow>
            </mfrac>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-26)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00063" file="US20020190607A1-20021219-M00063.NB"/>
<image id="EMI-M00063" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00063.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0161" lvl="0"><number>&lsqb;0161&rsqb;</number> where F is the load on the point A, and F&equals;P/2. Therefore, the total deflection in terms of P is  
<math-cwu id="MATH-US-00064">
<number>64</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>&delta;</mi>
        <mo>=</mo>
        <mfrac>
          <msup>
            <mi>PL</mi>
            <mn>3</mn>
          </msup>
          <mrow>
            <mn>12</mn>
            <mo>&it;</mo>
            <mi>EI</mi>
          </mrow>
        </mfrac>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-27)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00064" file="US20020190607A1-20021219-M00064.NB"/>
<image id="EMI-M00064" wi="216.027" he="18.96615" file="US20020190607A1-20021219-M00064.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0162" lvl="0"><number>&lsqb;0162&rsqb;</number> The elasticity of beams the natural frequency and its sensitivity to width a and thickness b can be obtained as  
<math-cwu id="MATH-US-00065">
<number>65</number>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>k</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mi>P</mi>
            <mi>&delta;</mi>
          </mfrac>
          <mo>=</mo>
          <mfrac>
            <mrow>
              <msup>
                <mi>a</mi>
                <mn>3</mn>
              </msup>
              <mo>&it;</mo>
              <mi>bE</mi>
            </mrow>
            <msup>
              <mi>L</mi>
              <mn>3</mn>
            </msup>
          </mfrac>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-28)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&omega;</mi>
          <mn>0</mn>
        </msub>
        <mo>=</mo>
        <mrow>
          <msqrt>
            <mfrac>
              <mi>k</mi>
              <mi>M</mi>
            </mfrac>
          </msqrt>
          <mo>=</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>bE</mi>
              </mrow>
              <msup>
                <mi>ML</mi>
                <mn>3</mn>
              </msup>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-29)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>a</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>3</mn>
            <mn>2</mn>
          </mfrac>
          <mo>&it;</mo>
          <msqrt>
            <mfrac>
              <mi>abE</mi>
              <msup>
                <mi>ML</mi>
                <mn>3</mn>
              </msup>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-30)</mtext>
      </mstyle>
    </mtd>
  </mtr>
  <mtr>
    <mtd>
      <mrow>
        <mfrac>
          <mrow>
            <mo>&PartialD;</mo>
            <msub>
              <mi>&omega;</mi>
              <mn>0</mn>
            </msub>
          </mrow>
          <mrow>
            <mo>&PartialD;</mo>
            <mi>b</mi>
          </mrow>
        </mfrac>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mn>2</mn>
          </mfrac>
          <mo>&it;</mo>
          <msqrt>
            <mfrac>
              <mrow>
                <msup>
                  <mi>a</mi>
                  <mn>3</mn>
                </msup>
                <mo>&it;</mo>
                <mi>E</mi>
              </mrow>
              <msup>
                <mi>bML</mi>
                <mn>3</mn>
              </msup>
            </mfrac>
          </msqrt>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(B-31)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
<mathematica-file id="MATHEMATICA-00065" file="US20020190607A1-20021219-M00065.NB"/>
<image id="EMI-M00065" wi="216.027" he="102.9672" file="US20020190607A1-20021219-M00065.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0163" lvl="0"><number>&lsqb;0163&rsqb;</number> Comparing (B-27) with (B-20) shows that the deflection of folded beam on one side of mass is just like that of beam on one side of mass. If on the other side of the mass is there also a folded beam, the deflection of the mass will be same as that of two cantilevered beams. The elasticity of beams, the natural frequency and its sensitivity to width a and thickness b will also be same. </paragraph>
<paragraph id="P-0164" lvl="7"><number>&lsqb;0164&rsqb;</number> 7.3 Appendix B References </paragraph>
<paragraph id="P-0165" lvl="0"><number>&lsqb;0165&rsqb;</number> The following references ate incorporated by reference herein: </paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> 1. J. L Synge and B. A. Griffith, &ldquo;Principles of Mechanics&rdquo;, McGraw-Hill Book Company, 1942. </paragraph>
<paragraph id="P-0167" lvl="0"><number>&lsqb;0167&rsqb;</number> 2. A. Higdog, et al, &ldquo;Mechanics of Materials&rdquo;, John Wiley &amp; Sons Inc., 1985. </paragraph>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> 3. F. E. Miller and H. A. Doerings, &ldquo;Mechanics of Materials&rdquo;, Feld International Textbook Company. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A frequency robust resonator comprising: 
<claim-text>at least one beam having a first end, a second end, and a beam width; and </claim-text>
<claim-text>a proof mass having a proof mass area and a perimeter; </claim-text>
<claim-text>wherein the proof mass is affixed to the first end of the beam and the second end of the beam is affixed to a ground and the proof mass perimeter multiplied by the beam width is substantially equivalent to six times the proof mass area. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, further comprising a second beam having a first and second end, wherein the first end of the second beam is affixed to the proof mass and the second end of the second beam is affixed to a ground. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, wherein the first and second beam are affixed to opposite sides of the proof mass. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the at least one beam is a folded beam including a moving bar. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the resonator is a single material. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the resonator is comb-driven. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein proof mass is trussed. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00007">claim 7</dependent-claim-reference>, wherein the proof mass further includes a width comprising M&plus;2 row walls, where M is at least one. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00007">claim 7</dependent-claim-reference>, wherein the proof mass further includes a length comprising N&plus;2 row walls, where M is at least one. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The resonator of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the resonator is multi-layered.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020190607A1-20021219-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020190607A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020190607A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020190607A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020190759A1-20021219-C00001.CDX SYSTEM "US20020190759A1-20021219-C00001.CDX" NDATA CDX>
<!ENTITY US20020190759A1-20021219-C00001.MOL SYSTEM "US20020190759A1-20021219-C00001.MOL" NDATA MOL>
<!ENTITY US20020190759A1-20021219-C00001.TIF SYSTEM "US20020190759A1-20021219-C00001.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-C00002.CDX SYSTEM "US20020190759A1-20021219-C00002.CDX" NDATA CDX>
<!ENTITY US20020190759A1-20021219-C00002.MOL SYSTEM "US20020190759A1-20021219-C00002.MOL" NDATA MOL>
<!ENTITY US20020190759A1-20021219-C00002.TIF SYSTEM "US20020190759A1-20021219-C00002.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-C00003.CDX SYSTEM "US20020190759A1-20021219-C00003.CDX" NDATA CDX>
<!ENTITY US20020190759A1-20021219-C00003.MOL SYSTEM "US20020190759A1-20021219-C00003.MOL" NDATA MOL>
<!ENTITY US20020190759A1-20021219-C00003.TIF SYSTEM "US20020190759A1-20021219-C00003.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00000.TIF SYSTEM "US20020190759A1-20021219-D00000.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00001.TIF SYSTEM "US20020190759A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00002.TIF SYSTEM "US20020190759A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00003.TIF SYSTEM "US20020190759A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00004.TIF SYSTEM "US20020190759A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00005.TIF SYSTEM "US20020190759A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00006.TIF SYSTEM "US20020190759A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00007.TIF SYSTEM "US20020190759A1-20021219-D00007.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00008.TIF SYSTEM "US20020190759A1-20021219-D00008.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00009.TIF SYSTEM "US20020190759A1-20021219-D00009.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00010.TIF SYSTEM "US20020190759A1-20021219-D00010.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00011.TIF SYSTEM "US20020190759A1-20021219-D00011.TIF" NDATA TIF>
<!ENTITY US20020190759A1-20021219-D00012.TIF SYSTEM "US20020190759A1-20021219-D00012.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020190759</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10090211</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020304</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>G01R001/00</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>H03D001/00</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>H03K005/00</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>H03K009/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>327</class>
<subclass>001000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>Electrochemically accelerated self-assembly of molecular devices</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60272895</doc-number>
<document-date>20010302</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>James</given-name>
<middle-name>M.</middle-name>
<family-name>Tour</family-name>
</name>
<residence>
<residence-us>
<city>Houston</city>
<state>TX</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Jiping</given-name>
<family-name>Yang</family-name>
</name>
<residence>
<residence-us>
<city>Houston</city>
<state>TX</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Philipp</given-name>
<family-name>Harder</family-name>
</name>
<residence>
<residence-us>
<city></city>
<state></state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>David</given-name>
<middle-name>L.</middle-name>
<family-name>Allara</family-name>
</name>
<residence>
<residence-us>
<city></city>
<state></state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Paul</given-name>
<family-name>Weiss</family-name>
</name>
<residence>
<residence-us>
<city>State College</city>
<state>PA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>CONLEY ROSE &amp; TAYON, P.C.</name-1>
<name-2></name-2>
<address>
<address-1>P. O. BOX 3267</address-1>
<city>HOUSTON</city>
<state>TX</state>
<postalcode>77253-3267</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A method for selectively assembling a molecular device on a substrate comprises contacting the first substrate with a solution containing molecular devices; impeding bonding of the molecular devices to the substrate such that application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 1.5 times the rate of assembly of the molecular device on a voltage-neutral substrate; and applying a voltage potential to the substrate so as to cause the molecular devices to assemble on the substrate. More specifically, selective assembly can be obtained by providing a mixture comprising protected molecular devices in solution; removing protective groups from some of the molecular devices; activating the de-protected molecular devices; contacting the substrate with the solution; and allowing the activated devices to bond to the substrate such that the they assemble on the first substrate. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE TO RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims benefit of priority from U.S. application Ser. No. 60/272,895, filed Mar. 2, 2001, and entitled &ldquo;Electromechanically Accelerated Self-Assembly Of Molecular Devices,&rdquo; which is incorporated herein by reference in its entirety.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This work was supported by the Defense Advanced Research Projects Agency (DARPA), the Office of Naval Research (ONR), and the National Science Foundation (NSF, NSR-DMR-0073046).</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">TECHNICAL FIELD OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The present invention relates generally to a method for assembling molecular devices. More particularly, the present invention relates to the use of voltage to enhance the selective assembly of a desired composition on a desired metal surface. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Molecular scale electronics is an emerging field that proposes the use of single molecules or small groups of molecules to function as the key components in computational devices. The concept is based on the use of molecules or groups of molecules that transmit current either linearly or non-linearly when subjected to a voltage potential. In particular, molecules or groups of molecules that have linear I/V curves can resemble wires and are termed &ldquo;molecular wires,&rdquo; or sometimes &ldquo;molewires.&rdquo; Molecules or groups of molecules that have non-linear I/V curves can resemble other types of electronic devices and are therefore termed &ldquo;molecular components,&rdquo; &ldquo;molecular switches,&rdquo; or sometimes &ldquo;moleswitches.&rdquo; The term &ldquo;molecular device&rdquo; will be used herein to denote all such molecular-scale conducting devices. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> It is becoming more widely accepted that, given a sufficient selection of operable molecular devices, molecular-scale computers could be constructed using principles similar to those used to construct conventional, semiconductor-based computers. In addition to the substantial size reductions that would result, the response times of molecular devices can be in the range of femto-seconds, while the fastest present devices operate in the nanosecond regime. Thus, a significant increase in speed may be attainable, particularly if other circuit elements do not limit operational performance. Different substitution groups can be used to provide molecular devices with a variety of electronic properties, such as negative differential resistance (NDR), molecular memory capability, and molecule-scale switching behavior. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> An ongoing challenge in implementing molecular scale electronics has been the search for techniques that will allow the controlled assembly of molecular devices. While self-assembled monolayers (SAMs) of conjugated thiols on Au have drawn considerable attention due to their potential use in molecular electronics and have been shown to serve as molecular device components, controlled, precise placement of such SAMs in a manner that would allow them to function as molecular devices has not heretofore been possible. The success of molecular computing depends in part on the precise placement of molecular device components on a patterned substrate. Thus, in some instances, it becomes crucially important to accurately direct the assembly of the components onto specific electrodes. Conventional chemical self-assembly techniques cannot furnish such selectivity. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Several groups have reported successful electrochemical oxidative adsorption of alkane thiols on various surfaces, such as Au, Ag, and Hg. Recently, Hsueh and co-workers reported the electrochemical oxidation of alkylthiosulfate (R&mdash;S<highlight><subscript>2</subscript></highlight>O<highlight><subscript>3</subscript></highlight>&mdash;) on Au electrodes at &plus;1200 mV (versus Ag/AgNO<highlight><subscript>3</subscript></highlight>). Monolayer formation took place preferentially on the biased Au electrodes, while the electrodes that were not biased experienced slower adsorption. However, the thiosulfate method produces alkylsulfide radicals and has been demonstrated so far only with simple n-alkane derivatives. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Potential-enhanced self-assembly of certain alkanethiols that are not molecular devices is also known, but, until now, no one has yet discovered how to effect controlled, selective assembly of molecular devices on designated substrates under mild electric potentials. It has been observed that thiol-based molecules assemble almost equally rapidly on non-charged surfaces as on charged surfaces. The similar behavior of charged and non-charged surfaces has heretofore made it impossible to use voltage-assisted assembly to apply molecular device layers in a controlled or targeted manner. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Hence, there is still a need for methods that allow small, i.e. molecular scale, devices to be assembled quickly and accurately and in a controlled or targeted manner. A preferred method would allow the application of desired layers without undue expense. </paragraph>
</section>
<section>
<heading lvl="1">BRIEF SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> The present invention solves the problems associated with the prior art inasmuch as it allows controlled, selective assembly of molecular devices on metal electrodes under mild electric potentials and thus provides a method for assembling molecular scale devices quickly and accurately and without undue expense. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> The present invention comprises using a small voltage potential to drive the free thiols or thiolates to assemble on a metal surface. By impeding the rate of formation of thiolates in combination with the use of a voltage potential, sufficient differentiation between adjacent surfaces can be achieved to allow selective assembly of molecular devices.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> For a detailed understanding of the present invention, reference is made to the accompanying Figures, wherein: </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> illustrates six exemplary molecules that can be selectively assembled according to the present invention; </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> is a schematic overview of the steps involved in a preferred embodiment of the present method; </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> is a plot of the growth rate of a layer of molecule (a) on an Au surface in the absence of potential; </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> is plot showing cyclic voltammograms of a gold electrode in a solution of KCl/K<highlight><subscript>3</subscript></highlight>&lsqb;Fe(CN)<highlight><subscript>6</subscript></highlight>&rsqb;(0.1 M/1 mM); </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> is a plot showing cyclic voltammograms of a gold electrode covered with molecular device (a) of <cross-reference target="DRAWINGS">FIG. 1</cross-reference>; </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> is a plot showing cyclic voltammograms of a platinum electrode covered with molecular device (a) of <cross-reference target="DRAWINGS">FIG. 1</cross-reference>; </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> is a comparison between a layer of molecular device (a) in a KBr matrix (top) and monolayers on a gold electrode that were grown electrochemically or adsorbed from solution without potential; </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> illustrates six exemplary molecules that can be selectively assembled according to an alternate embodiment of the present invention; and </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> FIGS. <highlight><bold>9</bold></highlight>-<highlight><bold>14</bold></highlight> are illustrations of various molecules that can be used in the methods of the present invention to form molecular devices.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> It has been discovered that molecular devices can be selectively assembled on desired substrates quickly and with a high degree of precision. According to a preferred embodiment of the present invention, the difference in the rates of assembly of a given molecular device on a given metal substrate can be used to control the placement of the molecular device. More particularly, applicants have discovered a technique for slowing the assembly of molecular devices on a non-charged surface. As a result, the use of a small voltage sufficiently accelerates the rate of assembly that the present methods can be used to selectively assemble molecular devices on substrates that are at least as close together as 0.3 &mgr;m. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> According to one aspect of the present invention, thiol-terminated molecular devices are de-protonated in a basic solution, thereby forming thiolates. Thiolates assemble on charged and non-charged surfaces, but the rate of assembly on selected surfaces is greatly enhanced by the application of a voltage potential to those surfaces. According to another embodiment, free thiols are formed from protected molecular device molecules in an acidic solution. If the rate of formation of the fee thiol is slowed sufficiently, a layer can be selectively formed by enhancing the rate of deposition on a selected surface. While the bulk of the discussion below is presented in terms of the basic technique, the concepts set out herein are intended to include not only acidic and basic schemes, but any other scheme by which the rate of assembly of molecular device molecules can be impeded and selectively enhanced so as to allow for selective application. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Referring initially to <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, several thioacetates that are suitable for use in the present invention are shown. While the molecules illustrated in <cross-reference target="DRAWINGS">FIG. 1</cross-reference> are known to be effective in the present process, the present invention is not limited to the molecules shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. Additional suitable molecular device molecules, along with schemes for making them, can be found in Tour, J. M.; Rawlett, A. M.; Kozaki, M.; Yao, Y.; Jagessar, R. C.; Dirk, S. M.; Price, D. W.; Reed, M. A.; Zhou, C.; Chen J.; Wand, W.; and Campbell, I. <highlight><italic>Chem. Eur. J. </italic></highlight>2001, 7, No. 23, 5118-5134, which is incorporated herein by reference in its entirety. In addition, any of the molecular devices taught in Chen, J.; Reed, M. A.; Rawlett, A. M.; Tour, J. M. <highlight><italic>Science </italic></highlight>1999, 286, 1550, Chen, J.; Wang, W.; Reed, M. A.; Rawlett, A. M.; Price, D. W.; Tour, J. M. <highlight><italic>Appl. Phys. Lett. </italic></highlight>2000, 77, 1224, or Bumm, L. A.; Arnold, J. J.; Cygan, M. T.; Dunbar, T. D.; Burgin, T. P.; Jones, L., II; Allara, D. L.; Tour, J. M.; Weiss, P. S. <highlight><italic>Science </italic></highlight>1996, 271, 1705, all of which are incorporated herein by reference, can be used in the present invention. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> Specifically, molecular devices that are suitable for use with the present invention include pi-conjugated aromatics and in particular, and in particular protected thiol-terminated oligo(phenylene ethynylene)s, are preferred for use as molecular devices. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> According to the present invention, the thiol-terminated molecular devices need to include on each thiol a protective group that can be removed by the application of a desired chemical or electrochemical stimulus. It has been discovered that the presence of the protective group sufficiently slows the rate of formation of thiolate in a basic solution, or thiol in an acidic solution, that the voltage applied to an electrode surface will cause the molecules to assemble on that surface significantly faster than on a non-charged surface in the same solution. Furthermore, a pH neutral solution could be used in a similar scheme, wherein the thiol protecting group is removed electrochemically. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> In one preferred embodiment, the stimulus is a voltage potential and the protective group is selected from the protective groups identified in Greene, T.; Wuts, P. <highlight><italic>Protective Groups in Organic Synthesis</italic></highlight>, 3d ed. (1999), which is incorporated herein by reference. Particularly preferred are the protective groups listed in chapter six of that reference, including thioethers, S-diphenylmethyl thioethers, substituted S-diphenylmethyl thioethers, and S-triphenylmethyl thioethers, substituted S-methyl derivatives, substituted S-ethyl derivatives, silyl thioethers, thioesters, thiocarbonate derivatives, and thiocarbamate derivatives. Also particularly preferred are thioacetates, sometimes called thioacetyl groups or thiolacetates, also known by the formula SCOCH<highlight><subscript>3</subscript></highlight>. A thiol-terminated molecular device protected in this manner will be referred to herein as a &ldquo;monolayer precursor.&rdquo; The exemplary molecules shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference> are S-acetyl-oligo(phenylene ethynylene)s. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> Referring now to <cross-reference target="DRAWINGS">FIG. 2</cross-reference>, the present method can be used to selectively assemble a first monolayer on at least one substrate <highlight><bold>10</bold></highlight>, which may be affixed to a base <highlight><bold>12</bold></highlight> adjacent to a second substrate <highlight><bold>14</bold></highlight>. One preferred embodiment of the present method includes electrically connecting a conducting lead <highlight><bold>13</bold></highlight> to the first substrate <highlight><bold>10</bold></highlight>, as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>(A). With lead <highlight><bold>13</bold></highlight> in place, base <highlight><bold>12</bold></highlight>, carrying substrates <highlight><bold>10</bold></highlight> and <highlight><bold>14</bold></highlight>, can be placed in a solution <highlight><bold>16</bold></highlight> containing the desired monolayer precursor molecules <highlight><bold>15</bold></highlight>, as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>(B). </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> A voltage potential is applied to the first substrate <highlight><bold>10</bold></highlight> via lead <highlight><bold>12</bold></highlight>. In <cross-reference target="DRAWINGS">FIG. 2</cross-reference>(B), lead <highlight><bold>13</bold></highlight> is identified as the working electrode (WE), and is used in a conventional manner in conjunction with a reference electrode (RE) and an auxiliary electrode (AE). It is not necessary to wait until the substrate <highlight><bold>10</bold></highlight> is submerged in the solution <highlight><bold>16</bold></highlight> to apply the voltage. Application of the voltage causes a layer of the desired precursor molecules <highlight><bold>15</bold></highlight> to assemble into a monolayer <highlight><bold>21</bold></highlight> on the surface of substrate <highlight><bold>10</bold></highlight>. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> According to the present invention and as described above, the monolayer precursor molecules <highlight><bold>15</bold></highlight> each include a protective group that prevents or impedes rapid assembly of the monolayer on the substrate in the absence of a potential to draw the low concentration of free thiol or thiolate to the surface. Depending on the precursor used, solution <highlight><bold>16</bold></highlight> can be either an acidic or basic solution. Without being bound by the following, it is speculated that the presence of a base causes the protective groups on certain monolayer precursor molecules to disassociate from the precursor molecules. The de-protected thiol groups on the precursor molecules are then deprotonated by the base, forming charged thiolate groups. These charged thiolate groups, in turn, are attracted to the positively charged electrode (substrate <highlight><bold>10</bold></highlight>) and assemble there. Similarly, we have discovered the methods of the present invention can be used advantageously in acidic solutions, albeit via a different mechanism. In acidic solutions, the terminal groups on the molecular device precursors do not form thiolates, and instead form free thiols, which, like thiolates, are advantageously drawn to the charged surface. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> It has been discovered that even though some monolayer precursors molecules may assemble on second substrate <highlight><bold>14</bold></highlight> while the layer is assembling on first substrate <highlight><bold>10</bold></highlight>, the disparity between the rates of assembly on the charged and non-charged substrates is great enough to allow selective assembly. More particularly, the use of a protective groups on the precursor prevents the thiol groups from assembling and impedes formation of thiolate groups, while the application of a voltage potential to first substrate <highlight><bold>10</bold></highlight> accelerates the rate of assembly on substrate <highlight><bold>10</bold></highlight>. The combination of these effects separates the rates of assembly on the two substrates to such a degree that the amount of monolayer that assembles on second substrate <highlight><bold>14</bold></highlight> during the time required to assemble a desired layer on first substrate <highlight><bold>10</bold></highlight> is relatively insignificant. For example, in some systems, the acetate-impeded, potential-assisted assembly is one to two orders of magnitude faster than acetate-impeded, non-potential-assisted assembly. The overall rate of assembly is partially dependent on molecular structure. According to the present invention, similar differentiation can be also achieved when the protective group is other than an acetate group. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> Referring still to <cross-reference target="DRAWINGS">FIG. 2</cross-reference>, following the selective placement of a monolayer on one or more of the substrates <highlight><bold>10</bold></highlight>, the base <highlight><bold>12</bold></highlight> can be placed in a second solution <highlight><bold>18</bold></highlight> containing second precursor molecules <highlight><bold>20</bold></highlight>. The second precursor is preferably but not necessarily a molecular device. Also, the second precursor may be protected or not protected, and the assembly of the second precursor into a monolayer can be voltage-assisted or not. Because the surface of the first substrate is already covered with the first monolayer <highlight><bold>15</bold></highlight>, molecules of the second precursor do not rapidly bond to substrate <highlight><bold>10</bold></highlight>. It is an advantage of the present invention that the de-protected, deprotonated thiolate of the present invention generally shows relatively slow tendency to displace an already-formed monolayer. Once a second monolayer <highlight><bold>25</bold></highlight> has formed on substrate <highlight><bold>14</bold></highlight>, base <highlight><bold>12</bold></highlight> can be removed from solution <highlight><bold>18</bold></highlight> and placed in a third solution <highlight><bold>28</bold></highlight>, which may contain precursors <highlight><bold>23</bold></highlight> for additional molecular devices and/or metal nanoparticles <highlight><bold>27</bold></highlight>, such as are known in the art. Hence, it is possible to apply different molecular device species sequentially without affecting previously applied layers. By applying different molecular devices sequentially using the present methods, it becomes possible to construct a complex device. In a particularly preferred embodiment, precursors <highlight><bold>23</bold></highlight> comprise conjugated molecules that have a thiol on each end, such as could be generated from <cross-reference target="DRAWINGS">FIG. 1</cross-reference>(<highlight><italic>a</italic></highlight>). </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> It has further been discovered that the application of a voltage potential to one substrate affects only those precursor molecules that are very close to that substrate. Thus, the present method has been used to selectively produce a monolayer on one of two substrates that are separated by gaps as small as 0.3 &mgr;m and it is expected that substrate differentiation could be achieved across even smaller distances, with the lower limited being defined only by the limits of lithography or other types of patterning, such as electron beam. Hence, the present method is suitable for use in the construction of micro- or nano-electronic devices. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> Another advantage of the present invention is that it allows the rapid assembly rate associated with thiolate or thiol assembly without requiring storage or handling of thiolate or thiol solutions. Specifically, thiolates and aromatic thiols are unstable against oxidation, while thioacetates can be stored for extended periods in air without degradation. According to the present invention, the convenience of having a thioacetate stock solution can be combined with a rapid adsorption. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> It has further been discovered that molecular device components containing electron-donating groups assemble faster than those with electron-withdrawing groups. For example, using the present invention, one can deposit molecules with electron donating groups, e.g. <cross-reference target="DRAWINGS">FIG. 1</cross-reference> (<highlight><italic>f</italic></highlight>), on one electrode, followed by the deposition of molecules with electron withdrawing groups, e.g. <cross-reference target="DRAWINGS">FIG. 1</cross-reference>(<highlight><italic>c</italic></highlight>), on another electrode. The formation of different layers on adjacent substrates is illustrated schematically in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. By bridging the two molecular wire-decorated electrodes with a conducting material, one may observe device behavior. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> One skilled in the art of molecular devices will recognize that the principles of the present invention are applicable to systems that include a variety of molecular device molecules. The molecular devices that can be applied or selectively applied using the present techniques include but are not limited to the various molecules shown in FIGS. <highlight><bold>9</bold></highlight>-<highlight><bold>14</bold></highlight>. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> The concepts of the present invention are useful with metal substrates generally, and more particularly with the coinage metals or late transition metals, including but not limited to gold, palladium, silver, copper and platinum. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> Similarly, the metal-bonding terminus of the present invention can be other than sulfur. For example, selenium and tellurium can be substituted for the sulphur. Hence, the present invention is not limited to thiol-terminated molecular devices, but also includes selenol and tellurolsm, as is known in the art. See, for example, Reinerth, W. A.; Tour, J. M. &ldquo;Protecting Groups for Organoselenium Compounds,&rdquo; <highlight><italic>J. Org. Chem. </italic></highlight>1998, 63, 2397-2400. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> Solvents that are useful in the present invention include but are not limited to alcohols, water, and any nonreactive organic solvent, or combination thereof. Similarly, the electrolyte can be any soluble ionic salt that is not corrosive to the electrode. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> The identity and orientation of the molecular device components on the metal surface is another important issue for the present electrochemical assembly technique. The average orientation of compound (a) on the surface can be derived from the relative intensities of a pair of IR absorption bands that correspond to molecular vibrations that are either parallel or perpendicular to the oligo(phenylene ethynylene) axis. A random orientation would give the same relative band intensities in both the external reflection IR spectrum of the monolayer and the transmission spectrum of the bulk sample. In contrast, an ordered orientation of the molecules will show an increased intensity of the parallel vibrations. If the molecules tilt towards the surface (angle &gt;54.7&deg;) the perpendicular bands will dominate the monolayer spectrum. IR spectra of substrates selectively coated according to the present invention confirm that monolayers are present. Layers deposited according the present technique have structures that are similar to the structures of layers deposited in a conventional, non-potential assisted manner. </paragraph>
<paragraph id="P-0041" lvl="7"><number>&lsqb;0041&rsqb;</number> Conclusions </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> The rate of assembly of thiolate-terminated oligo(phenylene ethylene) molecular device components under electric potential is greatly enhanced. A low thiolate concentration can be maintained by the in situ deprotection of some part of a thioacetate derivative stock solution. The accelerated adsorption on positively charged electrodes, combined with a low thiolate concentration in solution, makes it possible to selectively deposit molecules onto specific electrodes. The molecular orientation in the SAM made under electric potential is similar to the SAM made by conventional self-assembly technique. The in-situ cleavage of the thioacetate derivative reduces the problems with the instability of the thiolate or thiol solution. The thioacetate itself adsorbs only slowly on metal surfaces. Similar rate differentiation and selectivity can be obtained using a basic solution. The acid solution techniques is preferred for some molecular devices as it results in a more intact layer. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES </heading>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> The following Example are intended to illustrate the efficacy of certain embodiments of the invention and are not intended to be limiting in any way. </paragraph>
<paragraph id="P-0044" lvl="7"><number>&lsqb;0044&rsqb;</number> Self-Assembly of Thiolates on Gold Using Base Deprotection. </paragraph>
<paragraph id="P-0045" lvl="7"><number>&lsqb;0045&rsqb;</number> Materials. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> Ethanol (Pharmco Products Inc., 200 proof, USP Grade) was degassed with nitrogen prior to use. THF (Aldrich) was freshly distilled from Na/benzophenone under an atmosphere of nitrogen, and used immediately. Tetrabutylammonium tetrafluoroborate was purchased from Aldrich and used without further purification. The syntheses of the oligo(phenylene ethynylene)s are known, and are described in the references identified above. Au substrates were prepared by the sequential deposition of Cr (50 nm) and Au (120 nm) onto a clean single crystal Si wafer. Metal depositions were carried out using an Auto 306 Vacuum Coater (Edwards High Vacuum International) at an evaporation rate of &tilde;1 &angst;/s and a pressure of &tilde;4&times;10<highlight><superscript>&minus;6 </superscript></highlight>mm Hg. Pt substrates were prepared by sputtering a &tilde;50 nm layer of chromium (CrC-100 sputtering systems from Plasma Sciences, Inc.), followed by a 120 nm layer of Pt on clean surfaces of single crystal Si wafer. Au substrates were cleaned immediately prior to use by placing them in an aqueous solution of H<highlight><subscript>2</subscript></highlight>O<highlight><subscript>2</subscript></highlight>/NH<highlight><subscript>4</subscript></highlight>OH (H<highlight><subscript>2</subscript></highlight>O<highlight><subscript>2</subscript></highlight>:NH<highlight><subscript>4</subscript></highlight>OH:H<highlight><subscript>2</subscript></highlight>O&equals;1:1:5) for 15 min, followed by a thorough washing with deionized water and ethanol. Pt substrates were used without further cleaning. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> Self-assembly of thioacetates on Au was carried out in a vial which contained a piece of the Au substrate, the oligo(phenylene ethynylene) compound (1.0 mg), ethanol (20 mL), and NaOH (20 &mgr;L of a 0.27 M solution, final concentration 0.27 mM). The sample was removed and washed with acetone, THF and ethanol. </paragraph>
<paragraph id="P-0048" lvl="7"><number>&lsqb;0048&rsqb;</number> Electrochemical Assembly. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> Solutions for the potential-driven electrochemical assembly were prepared as follows: To a vial was added ethanol (20 mL), an oligo(phenylene ethynylene) (1.0 mg), tetrabutylammonium tetrafluoroborate (0.33 g, 1 mmol), and 20 &mgr;L of aqueous 0.27 M NaOH. A CV-50W Voltammetric Analyzer (BAS, Bioanalytical Systems, Inc) was used to control the electrical potential applied to the electrodes. The auxiliary electrode was Pt wire and a nonaqueous Ag/AgNO<highlight><subscript>3 </subscript></highlight>electrode was used as the reference. One of the following working electrodes was used: evaporated Au or Pt, an Au disk electrode, or a Pt disk electrode. The potential applied to the working electrode was &plus;400 mV (vs Ag/AgNO<highlight><subscript>3 </subscript></highlight>electrode). Assembled samples were washed with acetone, deionized water, and briefly sonicated in ethanol. </paragraph>
<paragraph id="P-0050" lvl="7"><number>&lsqb;0050&rsqb;</number> Measurements. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> The thicknesses of the self-assembled monolayers were measured using an ellipsometer (Rudolph Instruments, Model: 431A31WL633). The He-Ne laser (632.8 nm) was incident at 70&deg; to the sample surface. A refractive index (nf) of 1.55 was used for the film thickness calculation. Cyclic voltammograms were recorded by a CV-50W Voltammetric Analyzer (Bioanalytical Systems, Inc), employing a Pt counter electrode and a saturated calomel reference electrode (SCE). The working electrode was an Au electrode (MF-2014, Bioanalytical Systems, Inc.) or a Pt electrode (MF-2013, Bioanalytical Systems, Inc.) covered with a given oligo(phenylene ethynylene). The diameter of the Au and Pt electrodes was 1.6 mm. Cyclic voltammetry was performed in an aqueous solution of KCl/K<highlight><subscript>3</subscript></highlight>&lsqb;Fe(CN)<highlight><subscript>6</subscript></highlight>&rsqb; (0.1 M/1.0 mM) using a potential scan rate of 100 mV/s. </paragraph>
<paragraph id="P-0052" lvl="7"><number>&lsqb;0052&rsqb;</number> Infrared Spectroscopy. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> The orientation and thickness of assembled monolayer were checked using IR analyses. Details about the procedure and instrumentation used for the external reflection and transmission IR measurements are known in the art. </paragraph>
<paragraph id="P-0054" lvl="7"><number>&lsqb;0054&rsqb;</number> Discussion </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> There are three possible electrochemical methods for the deposition of molecular devices onto selected electrodes: 1) One can selectively deposit thiols on a biased Au electrode in the presence of an unbiased electrode. This method, to be useful, requires an appreciable different assembly rate between the biased and unbiased electrodes. 2) Conversely, one can permit assembly on an unbiased electrode while using a high potential to prevent assembly on the other electrode. 3) Lastly, one can uniformly form a SAM on both electrodes, then restore one electrode to its original bare state by the selective application of a high potential. For molecular electronic applications, the first approach is preferred. As described above, the present invention provided a technique for accomplishing the first method by allowing the molecules to assemble at a faster rate on the electrodes that are subjected to the potential than on the electrodes without potential. </paragraph>
<paragraph id="P-0056" lvl="7"><number>&lsqb;0056&rsqb;</number> Thiol Adsorption Kinetics on Au with and without Base or Electrostatic Potential  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="392PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 1</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Thiol adsorption under open circuit conditions and with applied potential.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="1" colwidth="245PT" align="center"/>
<colspec colname="2" colwidth="147PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Film thickness &lsqb;nm&rsqb;</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="245PT" align="center"/>
<colspec colname="2" colwidth="49PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="center"/>
<colspec colname="6" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Adsorption</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>Thiol Species</entry>
<entry>conditions<highlight><superscript>a</superscript></highlight></entry>
<entry>1 min</entry>
<entry>10 min</entry>
<entry>30 min</entry>
<entry>24 h</entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="245PT" align="center"/>
<colspec colname="2" colwidth="49PT" align="center"/>
<colspec colname="3" colwidth="21PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<colspec colname="6" colwidth="14PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="40.79565" wi="216.027" file="US20020190759A1-20021219-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20020190759A1-20021219-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20020190759A1-20021219-C00001.MOL"/>
</chemistry-cwu>
</entry>
<entry>Open circuit Open circuit &plus;base &plus;400 mV &plus;400 mV &plus;base</entry>
<entry>1.7 1.8 2.0 6.5</entry>
<entry>1.8 1.8 2.7</entry>
<entry>2.0</entry>
<entry>2.4</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="56.6433" wi="216.027" file="US20020190759A1-20021219-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20020190759A1-20021219-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20020190759A1-20021219-C00002.MOL"/>
</chemistry-cwu>
</entry>
<entry>Open circuit Open circuit &plus;base &plus;400 mV &plus;400 mV &plus;base</entry>
<entry>&thinsp;1.5 &thinsp;&thinsp;2.1</entry>
<entry>&thinsp;1.7 &thinsp;&thinsp;2.5</entry>
<entry></entry>
<entry>2.4</entry>
</row>
<row>
<entry> </entry>
</row>
<row>
<entry>
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="41.0508" wi="239.30235" file="US20020190759A1-20021219-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20020190759A1-20021219-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20020190759A1-20021219-C00003.MOL"/>
</chemistry-cwu>
</entry>
<entry>Open circuit &plus;400 mV</entry>
<entry>0.3 0.2</entry>
<entry></entry>
<entry>0.5 0.2</entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00001"><highlight><superscript>a</superscript></highlight>The relative potentials were determined against a AgCl coated Ag wire in contact with the adsorption solution. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> Alkanethiol adsorption isotherms typically show an initial rapid rise until the coverage reached 80-85% of a monolayer, followed by a second, slower step. Greater than 40% coverage was usually reached within the first 500 msec if the thiolate concentration was 1 mmol and within less than 60 sec. for a 1 &mgr;mol concentration. Overall, the aromatic thiol adsorption was found to be slower than the n-alkanethiol adsorption. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> Approximately 0.1 mM solutions of the preferred thiol-terminated oligo(phenylene ethynylene)s in ethanol reach a half monolayer coverage in less than 1 minute. Their low solubility in ethanol probably compensates for the slower diffusion rate (Table 1). The addition of 1 &mgr;L 0.27 M NaOH per mL solution was found to have no significant influence on the adsorption rate. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> A positive potential accelerates the thiol adsorption in the absence of a base and much more in combination with a base. The less soluble unsubstituted thiol shown at (i) in Table 1 forms a multilayer rapidly, and the more soluble nitro-substituted thiol (ii) reaches its theoretical monolayer thickness in 1 min instead of &tilde;1 h. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> Thioacetates adsorb much more slowly than thiols. A solution with 1 mg of thioacetate <highlight><bold>1</bold></highlight>(<highlight><italic>b</italic></highlight>) per 20 mL ethanol, or roughly 0.1 mM concentration, gives an 0.2 nm thick layer within 30 min, but the same was observed with a solution without thioacetate. Therefore, any layer formation can be attributed to advantageous adsorbate impurities, rather than to the thioacetate itself. </paragraph>
<paragraph id="P-0061" lvl="7"><number>&lsqb;0061&rsqb;</number> Assembly of Thioacetates with Base but without Potential </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> A 0.1 mM ethanolic solution of compound (a), which is shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference> and features two protected thiol termini, was assembled on Au after adding 1 &mgr;L 0.27 M NaOH per mL solution and the change in thickness over time was measured (<cross-reference target="DRAWINGS">FIG. 3</cross-reference>). The adsorption was slower than for the free thiol despite the thioacetate groups on both ends. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> Cyclic voltammetry (CV), as an indication of the surface coverage ratio, corroborated the ellipsometry measurements. <cross-reference target="DRAWINGS">FIG. 4</cross-reference> shows the cyclic voltammogram of an Au electrode before and after immersion in a solution of (a). In <cross-reference target="DRAWINGS">FIG. 4</cross-reference>, the solid line indicates the bare Au electrode; the dotted line corresponds to the Au electrode after immersion in 20 mL of 0.1 mM ethanolic solution of (a) with 20 &mgr;L aqueous solution of 0.27 M NaOH for 2 min.; and the dashed line corresponds to the Au electrode after immersion in the same solution for 10 min. After immersion for 2 min., the peak current intensity dropped &tilde;10 % and after immersion for 10 min., the peak current intensity dropped &tilde;55%, indicating that the surface coverage ratio of (a) on the Au electrode was &tilde;10% after 2 min and &tilde;55% after 10 min; in good agreement with the ellipsometry data. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> Compounds containing electron-withdrawing groups and only one thioacetate end assembled even more slowly. Compound (b), for example, with a nitro group on the central phenyl ring, took 15 min to reach a film thickness of 0.4 nm. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> The least polar methylmercapto-terminated biphenylthiols adsorbed 7 times faster than electron rich N,N-dimethylamino-terminated thiols and 20 times faster than electron poor nitro-terminated ones. Electron donor groups increase the gold sulfur binding energy but destabilize the monolayer because of their repulsive intermolecular dipole-dipole interactions. The slow adsorption of aromatic thiols with electron acceptor end groups is due to a weaker sulfur binding energy and stronger intermolecular electrostatic repulsion. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The majority of the deprotected thioacetate molecules in ethanol dissociate to thiolates with a high electron density on the sulfur, no matter what the substitutents are. The initial adsorption rates for a 0.1 mmol aromatic thioacetate/thiolate mixture without applied potential are however 1-2 orders of magnitude lower than for aromatic thiols: 2 min for 10% surface coverage versus less than 5 sec with aromatic thiols. The reaction between neutral ArS&mdash;H as a soft base and Au as a soft acid is fast, according to the hard-soft acid-base (HSAB) principle, while the thiolate adsorption on gold requires another molecule to become simultaneously reduced. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> The relatively faster adsorption of dithiolates and thiolates with electron donor groups correlates again with a higher gold sulfur binding energy but also with their lower dissociation constant. Electron acceptor groups shift the equilibrium to the dissociated and slowly-adsorbing thiolate, while donor groups reduce the acidity of the thiol proton. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> The positive potential on the gold adds an attractive force between the surface and the negatively charged thiolates without changing the thiol dissociation equilibrium. The attraction is strongest for the electron-rich thiolates where the negative charge is located at the sulfur atom. A positive potential therefore further increases the adsorption rate for the already preferred thiolates with electron donor groups. The foregoing observations are included for the purpose of illustration only and are not intended to define the chemical mechanisms involved in the present invention or to limit the scope of the claimed invention. </paragraph>
<paragraph id="P-0069" lvl="7"><number>&lsqb;0069&rsqb;</number> Assembly of Molecular Devices with an Applied Voltage </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> Table 2 summarizes the results of electrochemical assembly of a series of thioacetate derivatives on Au when a small amount of sodium hydroxide solution had been added. Under these conditions, the present compounds now quickly assemble under potential (compare <cross-reference target="DRAWINGS">FIG. 3</cross-reference> with entries 1-3 in Table 2) and the thickness of the layer increases with time (Table 2 entries 1-3,14-16). Electron-donating groups, such as ethyl and methoxy groups, can aid in the formation of SAMs (entries 1, 17, 19). Electron-withdrawing groups, such as a nitro group (entries 8,12) and a quinone unit (entry 14) tend to retard the growth rate. After 2 min, at &plus;400 mV, most of the layers from electron-donating group-containing molecules reached their full 5 length on the Au electrodes. (The molecular length of these compounds is 2.1 nm). Conversely, the compounds with strong electron-withdrawing groups were unable to assemble to their full length in 2 min. The right conditions for a complete monolayer coverage depend on the structure of the molecular device and have to be determined for each individual molecule. 2 min adsorption time on a Au surface at &plus;400 mV positive potential are just right for the compounds 1(a) and 1(b), too short for 1(c) and 1(d), and too long for 1(e) and 1(f). </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> For mono-thioacetate molecular device components, the thickness of the assembled layers roughly correlates with the molecular length. One exception is compound (e), for which the layer is thicker than the length of the molecule (entries 17,18). It is speculated that the excess adsorption in the case of the unfunctionalized phenylene-ethynylene-oligomers (e) and (h) is caused by their lower solubility in ethanol. A similar phenomenon has been observed in the self-assembly of long chain alkanethiols on Au from ethanol which gave a layer 20 % thicker than the length of the molecule. Dithioacetates also formed multilayers upon extended assembly times, presumably due to disulfide formation as promoted by trace oxygen or the applied electric potential. To obtain a monolayer of dithioacetate molecular devices, a short assembly time in an atmosphere excluding oxygen should be employed. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> We attempted to remove the layers assembled by the foregoing process, but once dried, the layer thicknesses remained virtually unchanged after sonication in THF, indicating that the excess molecules were either chemically bonded to the under layer or had been oxidized to the even less soluble disulfides.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 2</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Thickness measurement for the potential-driven</entry>
</row>
<row>
<entry>assembled film on Au and Pt surface</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="21PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="63PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="center"/>
<colspec colname="6" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Compound</entry>
<entry></entry>
<entry>Potential</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>Entry</entry>
<entry>(<cross-reference target="DRAWINGS">FIG. 1</cross-reference>)</entry>
<entry>Surface</entry>
<entry>(mV vs Ag/AgNO<highlight><subscript>3</subscript></highlight>)</entry>
<entry>Time</entry>
<entry>Thickness</entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry>&ensp;1</entry>
<entry>(a)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>2.9 nm</entry>
</row>
<row>
<entry>&ensp;2</entry>
<entry>(a)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;6 min</entry>
<entry>3.2 nm</entry>
</row>
<row>
<entry>&ensp;3</entry>
<entry>(a)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>4.3 nm</entry>
</row>
<row>
<entry>&ensp;4</entry>
<entry>(a)</entry>
<entry>Au</entry>
<entry>&minus;800</entry>
<entry>10 min</entry>
<entry>1.0 nm</entry>
</row>
<row>
<entry>&ensp;5</entry>
<entry>(a)</entry>
<entry>Au</entry>
<entry>&minus;1000&ensp;</entry>
<entry>10 min</entry>
<entry>0.5 nm</entry>
</row>
<row>
<entry>&ensp;6</entry>
<entry>(a)</entry>
<entry>Pt</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>2.0 nm</entry>
</row>
<row>
<entry>&ensp;7</entry>
<entry>(a)</entry>
<entry>Pt</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>3.6 nm</entry>
</row>
<row>
<entry>&ensp;8</entry>
<entry>(b)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>2.0 nm</entry>
</row>
<row>
<entry>&ensp;8b</entry>
<entry>(b)</entry>
<entry>Au</entry>
<entry>&emsp;&plus;0</entry>
<entry>15 min</entry>
<entry>0.4 nm</entry>
</row>
<row>
<entry>&ensp;9</entry>
<entry>(b)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>2.2 nm</entry>
</row>
<row>
<entry>10</entry>
<entry>(b)</entry>
<entry>Pt</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>0.7 nm</entry>
</row>
<row>
<entry>11</entry>
<entry>(b)</entry>
<entry>Pt</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>2.1 nm</entry>
</row>
<row>
<entry>12*</entry>
<entry>(c)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>0.4 nm</entry>
</row>
<row>
<entry>13*</entry>
<entry>(c)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>20 min</entry>
<entry>1.5 nm</entry>
</row>
<row>
<entry>14</entry>
<entry>(d)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>0.3 nm</entry>
</row>
<row>
<entry>15</entry>
<entry>(d)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>0.8 nm</entry>
</row>
<row>
<entry>16</entry>
<entry>(d)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>20 min</entry>
<entry>1.8 nm</entry>
</row>
<row>
<entry>17</entry>
<entry>(e)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>3.3 nm</entry>
</row>
<row>
<entry>18</entry>
<entry>(e)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>3.9 nm</entry>
</row>
<row>
<entry>19</entry>
<entry>(f)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>&ensp;2 min</entry>
<entry>2.2 nm</entry>
</row>
<row>
<entry>20</entry>
<entry>(f)</entry>
<entry>Au</entry>
<entry>&plus;400</entry>
<entry>10 min</entry>
<entry>6.1 nm</entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00002">*The base used here was concentrated ammonium hydroxide (20 &mgr;L). </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> shows the CV of an gold electrode covered with (a). It compares CV data from a bare gold electrode (solid line in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>), a covered gold electrode assembled without potential for 2 min (dotted line in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>), and a covered gold electrode assembled with potential for 2 min (dashed line in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>). In 2 min, nearly 100% of the gold surface was covered with a layer of (a). As shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>, assembly of the molecules with applied potential significantly faster than without applied potential. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> All of the CVs in <cross-reference target="DRAWINGS">FIG. 5</cross-reference> were recorded in an aqueous solution of KCl/K<highlight><subscript>3</subscript></highlight>&lsqb;Fe(CN)<highlight><subscript>6</subscript></highlight>&rsqb; (0.1 M/1 mM). The dotted line represents an electrode prepared without potential by immersing a rode for 2 min in a 20 mL ethanolic solution containing (a) (1.0 mg, <highlight><bold>2.1 &mgr;mol), Bu</bold></highlight><highlight><subscript>4</subscript></highlight>NBF<highlight><subscript>4</subscript></highlight>(0.33 g, 1 mmol), and aqueous solution of NaOH (20 &mgr;L, 5.4&times;10<highlight><superscript>&minus;3 </superscript></highlight>mmol). The dashed line represents an electrode obtained by applying &plus;400 mV (vs Ag/AgNO<highlight><subscript>3 </subscript></highlight>electrode) on a bare gold electrode for 2 min in a 20 mL ethanolic solution of (a) (0.1 mM), Bu<highlight><subscript>4</subscript></highlight>NBF<highlight><subscript>4 </subscript></highlight>(0.05 M), with aqueous solution of NaOH (20 &mgr;L, 5.4&times;10<highlight><superscript>&minus;3 </superscript></highlight>mmol). </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> The present technique of assembly under electric potential works on platinum also. Table 2 above includes data for the potential-assisted assembly of compounds (a) and (b) on platinum (entries <highlight><bold>6</bold></highlight>,<highlight><bold>7</bold></highlight>,<highlight><bold>10</bold></highlight>,<highlight><bold>11</bold></highlight>). Layers of molecular device components grow more slowly on platinum than on gold. <cross-reference target="DRAWINGS">FIG. 6</cross-reference> shows cyclic voltammograms of a platinum electrode covered with (a) made by the potential assembly technique. In 10 min, the surface coverage ratio was nearly 100%. In contrast, the conventional chemical self-assembly of 1 on platinum, under the same conditions of base concentration, was very slow. After immersion of a platinum electrode in a solution of 1 in ethanol for 10 min, the surface coverage ratio was only &tilde;5% (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>). </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> All of the three cyclic voltammograms in <cross-reference target="DRAWINGS">FIG. 6</cross-reference> were recorded in an aqueous solution of KCl/K3&lsqb;Fe(CN)6&rsqb; (0.1 M/1 mM). The solid line represents the bare platinum electrode; the dotted line represents the platinum electrode prepared without potential by immersing for 10 min in an ethanol solution (20 mL) of (a) (1.0 mg, 2.1 &mgr;mol), Bu<highlight><subscript>4</subscript></highlight>NBF<highlight><subscript>4 </subscript></highlight>(0.33 g, 1 mmol), NaOH (20 &mgr;L, 5.4&times;10<highlight><superscript>&minus;3 </superscript></highlight>mmol); and the dashed line represents the platinum electrode prepared by applying &plus;400 mV (vs Ag/AgNO<highlight><subscript>3 </subscript></highlight>electrode) on a bare platinum electrode for 10 min in the same solution. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> From this point of view, platinum electrodes are better than gold electrodes because thiols grow more slowly on platinum than on gold via conventional chemical self-assembly. Under electric potential, the growth rates are nearly the same, although slightly slower on platinum. This greater disparity results in a wider operation time window for the controlled deposition of molecular device components. Put another way, the unbiased platinum electrode will be even cleaner than the unbiased gold electrode under the same conditions. </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> The foregoing paragraphs discuss the formation of a SAM of molecular device components on the surface of a gold or platinum substrate under positive electric potential. Conversely, as discussed above, a negative potential can prevent the formation of this layer. Table 2 lists the results of the application of (a) to a gold electrode under negative potential (entries <highlight><bold>4</bold></highlight>,<highlight><bold>5</bold></highlight>). When the applied potential is sufficiently negative, the growth of the molecular devices on the gold electrodes can be slowed significantly. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> shows the IR spectrum of polycrystalline (a) dithioacetate in a KBr matrix (top) and the spectra of three monolayers on gold. One of the monolayers was deposited under electric potential and the other two were deposited without applied potential. The monolayer from the adsorption with applied potential still has about half of its thioacetate groups uncleaved. We assume that the uncleaved ends are mostly at the film-air interface because no thioacetate bands were observed in the IR spectra of monolayers from partially cleaved monothioacetate solutions on gold. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> The intrinsic band intensities can be determined from the transmission spectrum of a polycrystalline bulk sample, diluted with KBr and pressed into a transparent pellet. Differences between the intensities in the monolayer and bulk spectrum indicate an anisotropic film in which the molecules are aligned in a preferential direction. A semi-quantitative analysis is possible if the bulk and monolayer spectrum have at least two sufficiently intense bands with different orientations, i.e. parallel or perpendicular to the molecular main axis. Similar relative intensities for these two bands in the monolayer and bulk spectrum indicate that the molecules are either randomly oriented or that the molecules may be uniformly tilted by &tilde;54.7&deg; (magic angle) from the surface normal. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> Not all IR bands can be used for such a semi-quantitative analysis. Some of the bands are more sensitive to the changes in intermolecular distances and mobility. The best bands for a semi-quantitative analysis have the same position and width-at-half-height in the monolayer and polycrystalline bulk phase. The parallel mode at 1499 cm<highlight><superscript>&minus;1 </superscript></highlight>falls into this category. Among the perpendicular modes we can only take the doublet at 830/822 cm<highlight><superscript>&minus;1 </superscript></highlight>in the bulk spectrum that changes into a single band at 826 cm<highlight><superscript>1 </superscript></highlight>in the monolayer spectrum. The ratio of the integrated areas of these two bands are 0.61:1 and 0.62:1 for the chemically and potential-driven deposited monolayers respectively. This ratio also agrees with the result from the reference spectrum of the polycrystalline sample (0.58:1). The fast potential-driven deposition and the standard 24 h adsorption give monolayers with identical orientation. The molecules do not lie flat on the surface as they do at submonolayer coverages, but the higher coverage is not enough to reach an upright orientation. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> In <cross-reference target="DRAWINGS">FIG. 7</cross-reference>, transmission (T) and reflection (R) spectra are reported in absorbance units, defined as &minus;log (T/T<highlight><subscript>0</subscript></highlight>) and &minus;log(R/R<highlight><subscript>0</subscript></highlight>). The deposition under potential was done in 2 min in a solution of 20 mL ethanol with 2 &mgr;mol of 1 and 5 &mgr;mol of NaOH with a positive potential of 400 mV. The other two monolayers were prepared over 17 hours from THF with ammonium hydroxide as the base and from ethanol with NaOH as the base, respectively. </paragraph>
<paragraph id="P-0083" lvl="7"><number>&lsqb;0083&rsqb;</number> Self-Assembly of Thiolates on Gold Using Acid Deprotection. </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> The concepts of the present invention have applicability to systems other than base-activated systems. Specifically, some molecular devices, including those shown in <cross-reference target="DRAWINGS">FIG. 8</cross-reference>, can be selectively applied using acid deprotection, as described in detail below. </paragraph>
<paragraph id="P-0085" lvl="7"><number>&lsqb;0085&rsqb;</number> Gold Substrates </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> A single crystal silicon wafer was cut in 6&times;16 mm<highlight><superscript>2 </superscript></highlight>sheets, then cleaned for 30 min in a hot (40&deg; C.) fresh acidic peroxide (3:1 H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>/H<highlight><subscript>2</subscript></highlight>O<highlight><subscript>2</subscript></highlight>, v/v) solution, rinsed with a flowing distilled-water, ethanol and acetone, and the pieces of Si were dried in a flowing ultrahigh purity N<highlight><subscript>2 </subscript></highlight>gas. The gold films were deposited by thermal evaporation of 200 mn thick Au onto the Si sheets with a 25 nm Cr adhesion layer at a rate of 1 &angst;/s under the vacuum of 2&times;10<highlight><superscript>&minus;6 </superscript></highlight>Torr. The gold samples were finally stored in a N<highlight><subscript>2 </subscript></highlight>atmosphere. Before use, the gold substrates were cleaned by a UV/O<highlight><subscript>3 </subscript></highlight>cleaner (Boekel Industries, Inc., Model 135500) for 10 min in order to remove organic contamination, followed by ultrasonic cleaning in ethanol for 20 min to remove the resulting gold oxide layer, rinsing with ethanol and acetone, then dried in flowing N<highlight><subscript>2</subscript></highlight>. This procedure was confirmed to provide a clean, reproducible gold surface. </paragraph>
<paragraph id="P-0087" lvl="7"><number>&lsqb;0087&rsqb;</number> Chemicals </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> Methylene chloride (CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>) and acetonitrile were distilled from calcium hydride. Tetrahydrofuran was distilled from sodium/benzophenone ketyl. All other chemicals were used as received without further purification. The syntheses of compounds such as those in <cross-reference target="DRAWINGS">FIG. 8</cross-reference> are well known. See, for example, <highlight><italic>Chem. Eur. J. </italic></highlight>2001, 7, No. 23, 5118-5134, cited above. </paragraph>
<paragraph id="P-0089" lvl="7"><number>&lsqb;0089&rsqb;</number> Solution Preparation for Acid-Promoted Method </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> The compound (1 mg) was dissolved with a solvent mixture of CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH (2:1, v/v) in a 4 mL vial. 50-70 &mgr;L of concentrated H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4 </subscript></highlight>was then added and the solution was incubated for 1-4 h in order to give deprotection of thiol moiety. </paragraph>
<paragraph id="P-0091" lvl="7"><number>&lsqb;0091&rsqb;</number> Chemical Assembly </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> The cleaned gold substrates were immersed into the adsorbate solutions at room temperature for a period of 20-24 h. All the solutions were freshly prepared, previously purged with N<highlight><subscript>2 </subscript></highlight>for an oxygen-free environment and kept in the dark during immersion to avoid photo-oxidation. After the assembly, the samples were removed from the solutions, rinsed thoroughly with acetone, MeOH and CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>, and finally blown dry with N<highlight><subscript>2</subscript></highlight>. </paragraph>
<paragraph id="P-0093" lvl="7"><number>&lsqb;0093&rsqb;</number> Potential-Assisted Assembly </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> The same three-electrode cell described above was used with a gold substrate as the working electrode, a platinum wire as the counter electrode, and an Ag/AgNO<highlight><subscript>3 </subscript></highlight>(10 mM AgNO<highlight><subscript>3 </subscript></highlight>and 0.1 M Bu<highlight><subscript>4</subscript></highlight>NBF<highlight><subscript>4 </subscript></highlight>in acetonitrile) reference electrode. The monolayers were deposited by the constant potential of 400 mV for 5-60 min in the SAM solutions. After the modification, the samples were removed from the solutions, rinsed with acetone, MeOH and CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>, and blown dry with N<highlight><subscript>2</subscript></highlight>. </paragraph>
<paragraph id="P-0095" lvl="7"><number>&lsqb;0095&rsqb;</number> Electrochemical Measurement </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> Cyclic voltammetry (CV) for SAM formation was performed in an aqueous solution with 1 mM K<highlight><subscript>3</subscript></highlight>&lsqb;Fe(CN)<highlight><subscript>6</subscript></highlight>&rsqb; and 0.1 M KCl between &minus;0.2 and &plus;0.6 V (vs. SCE) at the rate of 100 mV/s. An Au disk electrode (MF-2014, BAS) with diameter 1.6 mm was used as the working electrode, a saturated calomel electrode (SCE) as a reference electrode and a Pt wire as a counter electrode. </paragraph>
<paragraph id="P-0097" lvl="7"><number>&lsqb;0097&rsqb;</number> Ellipsometry </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> Monolayer thickness was determined using a Rudolph series 43 1A ellipsometry. The He&mdash;Ne laser (632.8 nm) light was incident at 70&deg; on the sample. Measurements were carried out before and immediately after monolayer adsorption. All the thickness was calculated based on the refractive index of n<highlight><subscript>f</subscript></highlight>&equals;1.55. The length of the molecular wire was calculated from a sulfur atom to the furthest proton for the minimum energy extended forms by molecular mechanics. The theoretical thickness was then obtained with the assumed linear Au&mdash;S&mdash;C bond angles and 0.24 nm for the Au&mdash;S bond length. </paragraph>
<paragraph id="P-0099" lvl="7"><number>&lsqb;0099&rsqb;</number> UV-Vis Spectroscopy </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> The UV-Vis spectroscopes were recorded by UV-Vis-NIR scanning spectrophotometer (Shimadzu, UV-3101 PC). </paragraph>
<paragraph id="P-0101" lvl="7"><number>&lsqb;0101&rsqb;</number> Discussion </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> As described above, the thiolacetyl groups of molecular device compounds are easily deprotected to the free thiol or thiolate by deacylation with NH<highlight><subscript>4</subscript></highlight>OH, and then the SAM are formed on a gold surface by Au&mdash;S bonding. Table 3 illustrates the chemical assembly of molecular wires in a single solvent. The measured thickness of mononitro compounds (1 and 2) are near to the theoretical values. It indicates a compact monolayer has been formed. On the other hand, the thickness of multi-nitro compounds exhibit a large difference compared to the calculated values. A slower rate of adsorption is detected. The strong electron-withdrawing nitro group reduces the interaction of Au and S, finally results in the slower assembly rate and the poor adsorption on Au surface. Moreover, the multi-nitro groups of conjugated molecules are possibly attacked by hydroxide during the long assembly time, which decomposes the compounds and induces a precipitation in the unstable solution accompanied by color changes from yellow-green to brown.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 3</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Chemical assembly of thiolacetyl-terminated</entry>
</row>
<row>
<entry>molecular wires in a single solvent.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="42PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="42PT" align="center"/>
<colspec colname="6" colwidth="42PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Experimental</entry>
<entry>Calculated</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Time</entry>
<entry>Thickness</entry>
<entry>Thickness</entry>
</row>
<row>
<entry>Compound</entry>
<entry>Solvent</entry>
<entry>Base</entry>
<entry>(h)</entry>
<entry>(nm)<highlight><superscript>a</superscript></highlight></entry>
<entry>(nm)<highlight><superscript>b</superscript></highlight></entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry>(8a)</entry>
<entry>EtOH</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>2.4</entry>
<entry>2.14</entry>
</row>
<row>
<entry>(8b)</entry>
<entry>EtOH</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>2.0</entry>
<entry>2.14</entry>
</row>
<row>
<entry>(8c)</entry>
<entry>THF</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>1.0</entry>
<entry>2.14</entry>
</row>
<row>
<entry>(8d)</entry>
<entry>THF</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>0.8</entry>
<entry>2.62</entry>
</row>
<row>
<entry>(8e)</entry>
<entry>THF</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>0.7</entry>
<entry>2.62</entry>
</row>
<row>
<entry>(8f)</entry>
<entry>THF</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>1.6</entry>
<entry>2.86</entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00003"><highlight><superscript>a</superscript></highlight>The value measured by ellipsometry. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00004"><highlight><superscript>b</superscript></highlight>The theoretical thickness calculated by molecular mechanics without the consideration of the tilt angle of molecular wire in SAM. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> Thus, to get a well-ordered SAM of multi-nitro molecular wires, a mixed solvent is preferred and is selected based on the solubility and deprotection system. As shown in Table 4, the acetone/methanol solvent mixture performs best in the base-promoted method. All the SAM of dinitro compounds ((8c), (8d), (8e)) display thicknesses the same as the theoretical value after reaction of 24 h, thus complete assembly is achieved. Conversely, the tetra-nitro compound (8f) is not well assembled in the base-promoted system, as indicated by the relatively large difference between measured and theoretical thickness.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="273PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 4</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Chemical assembly of thiolacetyl-terminated molecular wires in a mixed solvent.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="49PT" align="center"/>
<colspec colname="2" colwidth="49PT" align="left"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="28PT" align="center"/>
<colspec colname="6" colwidth="42PT" align="center"/>
<colspec colname="7" colwidth="42PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Experimental</entry>
<entry>Calculated</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Time</entry>
<entry>Thickness</entry>
<entry>Thickness</entry>
</row>
<row>
<entry>Compound</entry>
<entry>Solvent<highlight><superscript>a</superscript></highlight></entry>
<entry>Acid</entry>
<entry>Base</entry>
<entry>(h)</entry>
<entry>(nm)</entry>
<entry>(nm)</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry>(8c)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>2.0</entry>
<entry>2.14</entry>
</row>
<row>
<entry>(8d)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>2.5</entry>
<entry>2.62</entry>
</row>
<row>
<entry>(8e)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>2.4</entry>
<entry>2.62</entry>
</row>
<row>
<entry>(8f)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>24</entry>
<entry>2.0</entry>
<entry>2.86</entry>
</row>
<row>
<entry>(8c)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>Cs<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight></entry>
<entry>24</entry>
<entry>2.4</entry>
<entry>2.14</entry>
</row>
<row>
<entry>(8c)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>24</entry>
<entry>2.2</entry>
<entry>2.14</entry>
</row>
<row>
<entry>(8d)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>24</entry>
<entry>2.4</entry>
<entry>2.62</entry>
</row>
<row>
<entry>(8e)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>24</entry>
<entry>2.5</entry>
<entry>2.62</entry>
</row>
<row>
<entry>(8f)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>24</entry>
<entry>2.9</entry>
<entry>2.86</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><footnote id="FOO-00005"><highlight><superscript>a</superscript></highlight>The ratio of mixed solvent is 2:1. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> An external electric field applied at the interface of liquid/gold can greatly change the assembly reaction rate and lead to a kinetically rather than thermodynamically controlled deposition process. UV-Vis spectra confirm that the acid-promoted method affords a more stable solution and it is reliable. Table 5 summarizes the results of potential-assisted assembly of various molecular wires on a gold electrode. The assembly rate is very fast and the SAM thickness increases with time. The rate of potential-assisted assembly is increased 10-100 times compared to the rate of the chemical assembly. In the base-promoted electrochemical assembly, the mononitro- and dinitro-compounds ((8a), (8c), (8e)) show a good assembly and near full-coverage on Au. The tetranitro compound (8f) slowly forms SAMs by base catalysis with either the potential-assisted procedure or the chemical method, as illustrated in Table 4. By using an acid-promoted electrochemical method, however, all the nitro-compounds ((8c), (8e), (8f)) can be completely assembled after a 60 min deposition time. The potential-assisted assembly is rapid and reproducible. UV-Vis spectra confirm that the acid-promoted method affords a more stable solution and it is reliable.  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="273PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 5</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Potential-assisted assembly of thiolacetyl-terminated molecular wires on gold electrode.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="42PT" align="center"/>
<colspec colname="2" colwidth="49PT" align="left"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<colspec colname="6" colwidth="21PT" align="center"/>
<colspec colname="7" colwidth="63PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Potential</entry>
<entry>Time</entry>
<entry>Reduced ratio of</entry>
</row>
<row>
<entry>Compound</entry>
<entry>Solvent<highlight><superscript>a</superscript></highlight></entry>
<entry>Acid</entry>
<entry>Base</entry>
<entry>(mV)</entry>
<entry>(min)</entry>
<entry>redox peak current<highlight><superscript>b</superscript></highlight></entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry>(8a)</entry>
<entry>EtOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>400</entry>
<entry>&ensp;5</entry>
<entry>99%</entry>
</row>
<row>
<entry>(8c)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>400</entry>
<entry>60</entry>
<entry>87%</entry>
</row>
<row>
<entry>(8e)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>400</entry>
<entry>30</entry>
<entry>59%</entry>
</row>
<row>
<entry>(8e)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>400</entry>
<entry>60</entry>
<entry>95%</entry>
</row>
<row>
<entry>(8f)</entry>
<entry>Acetone/MeOH</entry>
<entry>&mdash;</entry>
<entry>NH<highlight><subscript>4</subscript></highlight>OH</entry>
<entry>400</entry>
<entry>60</entry>
<entry>22%</entry>
</row>
<row>
<entry>Bare Au</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>&ensp;0%</entry>
</row>
<row>
<entry>(8c)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>400</entry>
<entry>60</entry>
<entry>90%</entry>
</row>
<row>
<entry>(8e)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>400</entry>
<entry>60</entry>
<entry>97%</entry>
</row>
<row>
<entry>(8f)</entry>
<entry>CH<highlight><subscript>2</subscript></highlight>Cl<highlight><subscript>2</subscript></highlight>/MeOH</entry>
<entry>H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>400</entry>
<entry>60</entry>
<entry>96%</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><footnote id="FOO-00006"><highlight><superscript>a</superscript></highlight>The ratio of mixed solvent is 2:1. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="7" align="left"><footnote id="FOO-00007"><highlight><superscript>b</superscript></highlight>The reduced ratio of redox peak current is deduced by (1-I<highlight><subscript>SAM</subscript></highlight>/I<highlight><subscript>AU</subscript></highlight>) % from CVs in an aqueous solution of K<highlight><subscript>3</subscript></highlight>&lsqb;Fe(CN)<highlight><subscript>6</subscript></highlight>&rsqb;/KCl. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> In the common chemical assembly, which is a passive incubation process, the open circuit potential (OCP) is about &minus;200 to &minus;300 mV. However, in an external positive electric field, the thiol and thiolate with negative charge can strongly adsorb on Au, therefore, a modest anodic potential (i.e., 400 mV) can greatly enhance the assembly rate. A lower negative potential will impede the assembly reaction and even peel away the existing SAM. Conversely, a higher positive potential will induce the MeOH and Au oxidation, which also deform the SAM. By the carefully selection of potential and solution, different molecular wires can be deposited on different parts of one electric device for the construction of a more complex logic circuit. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> The present invention includes the voltage-assisted assembly of molecular devices on a substrate, with and without the rate differentiation that is results from the use of a chemical inhibitor, such as an acetate group. Thus, it is within the contemplated scope of the invention to accelerate the rate of assembly of a layer of molecular devices on a substrate using a voltage potential. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> While preferred embodiments of the present invention have been discussed in detail herein, it will be understood that various modifications could be made thereto without departing from the scope of the invention. For example, the molecular devices, protective groups, solvents, electrolytes, electrodes, substrates, substrate surfaces, deprotection mechanisms, and activation mechanisms can all be varied. In addition, order in which the various steps of the present methods are performed can be varied. Unless order is explicitly recited in the claims, the mere recitation of claim steps in an order is not intended to require that the steps be performed in that order, or that one step must be completed before the next step can begin. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method for selectively assembling a molecular device on a first substrate, comprising: 
<claim-text>(a) contacting the first substrate with a solution containing molecular device molecules; </claim-text>
<claim-text>(b) impeding bonding of the molecular device molecules to the substrate sufficiently that application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 1.5 times the rate of assembly of the molecular device on a voltage-neutral substrate; and </claim-text>
<claim-text>(c) applying a voltage potential to the first substrate so as to cause the molecular device molecules to assemble on the first substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 2 times the rate of assembly of the molecular device on a voltage-neutral substrate. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 10 times the rate of assembly of the molecular device on a voltage-neutral substrate. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 100 times the rate of assembly of the molecular device on a voltage-neutral substrate. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, further including: 
<claim-text>(d) providing a second substrate adjacent to the first substrate; and </claim-text>
<claim-text>(e) contacting the first and second substrates with a solution containing second-type molecular device molecules that are different from the molecular device molecules of step (a) such that said second-type molecular device molecules assemble on said second substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, further including electrically connecting the molecular device molecules assembled on the first substrate with the second-type molecular device molecules assembled on the second substrate with a conducting material. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the bonding of the molecular device to the substrate is impeded by providing a protective group on the molecular device molecule. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the molecular device comprises an oligo(phenylene ethynylene). </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the molecular device comprises a thiol-terminated oligo(phenylene ethynylene) and the solution includes a base. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A method for assembling a molecular circuit on a first substrate, comprising: 
<claim-text>(a) providing a mixture comprising molecular device molecules in solution, each molecular device having a metal-bonding terminus protected by a protective group; </claim-text>
<claim-text>(b) removing the protective group from a portion of the molecular device molecules; </claim-text>
<claim-text>(c) activating the metal-bonding 1 terminii of the de-protected molecular device molecules; </claim-text>
<claim-text>(d) contacting the first substrate with the solution; and </claim-text>
<claim-text>(e) allowing the activated metal-bonding terminii to bond to the substrate such that the molecular devices assemble on the first substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein step (c) comprises providing a base in the solution. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein step (c) comprises providing a acid in the solution. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein step (c) comprises applying a voltage to the substrate. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein the molecular device is an oligo(phenylene ethynylene). </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein the protective group is selected from the group consisting of: thioethers, S-diphenylmethyl thioethers, substituted S-diphenylmethyl thioethers, and S-triphenylmethyl thio ethers, substituted S-methyl derivatives, substituted S-ethyl derivatives, silyl thioethers, thioesters, thiocarbonate derivatives, thiocarbamate derivatives, and thioacetates/thiolacetates/thioacetyls. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> wherein the protective group comprises acetate. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, further including (f) attracting the activated molecular devices to the first substrate by applying a voltage potential to the substrate. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, further including repeating steps (a)-(f) with a second substrate and with second-type molecular devices that are different from the molecular devices assembled on the first substrate. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A method for assembling a molecular circuit on a metal substrate, comprising: 
<claim-text>(a) providing a mixture comprising molecular device molecules in solution, each molecular device molecule having a metal-bonding group; </claim-text>
<claim-text>(b) contacting the metal substrate with the solution; and </claim-text>
<claim-text>(c) applying a voltage potential to the substrate so as to attract the metal-bonding groups to bond to the substrate such that the molecular devices assemble on the substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A molecular circuit prepared by: 
<claim-text>(a) contacting a first substrate with a solution containing molecular device molecules; </claim-text>
<claim-text>(b) impeding bonding of the molecular device molecules to the substrate sufficiently that application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 1.5 times the rate of assembly of the molecular device on a voltage-neutral substrate; and </claim-text>
<claim-text>(c) applying a voltage potential to the first substrate so as to cause the molecular device molecules to assemble on the first substrate. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A molecular circuit prepared by: 
<claim-text>(a) contacting a first substrate with a solution containing molecular device molecules; </claim-text>
<claim-text>(b) impeding bonding of the molecular device molecules to the substrate sufficiently that application of a voltage potential to the substrate results in assembly of the molecular device on the substrate at a rate that is at least 1.5 times the rate of assembly of the molecular device on a voltage-neutral substrate; </claim-text>
<claim-text>(c) applying a voltage potential to the first substrate so as to cause the molecular device molecules to assemble on the first substrate; </claim-text>
<claim-text>(d) providing a second substrate adjacent to the first substrate; </claim-text>
<claim-text>(e) contacting the first and second substrates with a solution containing second-type molecular device molecules that are different from the molecular device molecules of step (a) such that said second-type molecular device molecules assemble on said second substrate; and </claim-text>
<claim-text>(f) electrically connecting the molecular device molecules assembled on the first substrate to the second-type molecular device molecules assembled on the second substrate with a conducting material.</claim-text>
</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>2D</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020190759A1-20021219-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020190759A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020190759A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020190759A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020190759A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020190759A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020190759A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020190759A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020190759A1-20021219-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020190759A1-20021219-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020190759A1-20021219-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020190759A1-20021219-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00012">
<image id="EMI-D00012" file="US20020190759A1-20021219-D00012.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020191656A1-20021219-D00000.TIF SYSTEM "US20020191656A1-20021219-D00000.TIF" NDATA TIF>
<!ENTITY US20020191656A1-20021219-D00001.TIF SYSTEM "US20020191656A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020191656A1-20021219-D00002.TIF SYSTEM "US20020191656A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020191656A1-20021219-D00003.TIF SYSTEM "US20020191656A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020191656A1-20021219-D00004.TIF SYSTEM "US20020191656A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020191656A1-20021219-D00005.TIF SYSTEM "US20020191656A1-20021219-D00005.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020191656</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09880659</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010613</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>H01S005/00</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>372</class>
<subclass>043000</subclass>
</uspc>
</classification-us-primary>
</classification-us>
<title-of-invention>Vertical-cavity surface-emitting semiconductor laser arrays</title-of-invention>
</technical-information>
<inventors>
<first-named-inventor>
<name>
<given-name>Luke</given-name>
<middle-name>J.</middle-name>
<family-name>Mawst</family-name>
</name>
<residence>
<residence-us>
<city>Sun Prairie</city>
<state>WI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Delai</given-name>
<family-name>Zhou</family-name>
</name>
<residence>
<residence-us>
<city>Madison</city>
<state>WI</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Harry C. Engstrom</name-1>
<name-2>FOLEY &amp; LARDNER</name-2>
<address>
<address-1>150 East Gilman Street</address-1>
<address-2>P.O. Box 1497</address-2>
<city>Madison</city>
<state>WI</state>
<postalcode>53701-1497</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A vertical-cavity surface-emitting semiconductor laser array device includes a semiconductor substrate and a multilayer structure on the substrate that includes at least four core elements arranged in a two-dimensional rectangular array, with the core elements separated from one another and surrounded by a matrix region formed to have an effective higher index than the core elements for antiguiding of the radiation leakage from the core elements. The width of the matrix region separating adjacent core elements may be selected to provide either in-phase or out-of-phase resonant coupling between the adjacent core elements, and the matrix region and upper and lower reflectors are positioned to act upon the light generated in an active region layer to produce lasing action phase-locked between the core elements to produce emission of light from at least one of the upper or lower faces of the semiconductor laser array. </paragraph>
</subdoc-abstract>
<subdoc-description>
<federal-research-statement>
<heading lvl="1">STATEMENT OF GOVERNMENT RIGHTS </heading>
<paragraph-federal-research-statement id="P-0001"><number>&lsqb;0001&rsqb;</number> This invention was made with United States government support awarded by the following agency: NSF <highlight><bold>9734283</bold></highlight>. The United States government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> This invention pertains generally to the field of semiconductor diode lasers and particularly to vertical-cavity surface-emitting laser arrays. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Vertical-cavity surface-emitting lasers (VCSELs) have several significant advantages including low-threshold, high-fiber coupling efficiency, and a compact size that is well suited to integration. In addition, VCSELs also have a simplified fabrication process as compared to edge-emitting distributed feedback lasers and allow wafer level characterization, which provides significant advantages in the manufacturing of such devices. A shortcoming of current VCSELs is the relatively low power output for single mode operation. Coupled arrays of VCSELs offer the potential to increase the coherent output power available from single VCSELs. However, stable, high-power diffraction limited beam operation from two-dimensional (2D) VCSEL arrays has not been realized. See, e.g., J. P. Van der Ziel, et al., IEEE J. Quantum Electron., Vol. 26, 1990, pp. 1873, et seq.; M. Orenstein, et al., Appl. Phys. Lett., Vol. 58, 1991, pp. 804, et seq.; R. A. Morgan, et al., Appl. Phys. Lett., Vol. 61, 1992, pp. 1160, et seq. In addition, prior phaselocked 2D VCSEL arrays operate in either an out-of-phase mode or a mixture of various modes, characteristic of weakly index guided arrays, with poor intermodal discrimination. External phase shifters have been used on optically pumped VCSEL arrays to obtain &ldquo;in-phase mode-like&rdquo; emission, but with a relatively broad beam. M. E. Warren, et al., Appl. Phys. Lett., Vol. 61, 1992, pp. 1484, et seq. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> The limitations encountered in the development of 2D VCSEL arrays parallels that encountered in the development of edge-emitting phase-locked arrays. Weak coupling and poor intermodal discrimination found in evanescently coupled edge-emitting laser arrays has severely limited their single-mode output power. See, K. L. Chen, et al., Appl. Phys. Lett., Vol. 47, 1985, pp. 555, et seq. In contrast, antiguided array structures exhibit strong leaky-wave coupling, leading to high intermodal discrimination. As a result, edge-emitting antiguided arrays have demonstrated coherent output power in the watt range. See, D. Botez, et al., IEEE J. Quantum Electron., Vol. 26, 1990, pp. 482, et seq. The large built-in index step and strong lateral radiation leakage from an antiguide are well suited for array integration. Antiguided VCSELs have been demonstrated by the regrowth of high-index material and a buried heterostructure design (Y. A. Wu, et al., IEEE J. Sel. Top. Quantum Electron., Vol. 1, 1995, pp. 629, et seq.), by selective oxidation (T. H. Oh, et al., IEEE Photonics Technol. Lett., Vol. 10, 1998, pp. 12, et seq.), or by a cavity-induced resonant shifted structure (K. D. Choquette, et al., Electron. Lett., Vol. 34, 1998, pp. 1991, et seq.). Leaky-wave coupling between two antiguided VCSELs (coupled in-phase or out-of-phase) has been demonstrated using structures fabricated with a cavity-induced resonant shift. Serkland, et al., Appl. Phys. Lett., Vol. 75, 1999, pp. 3754, et seq. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> In accordance with the invention, stable, diffraction limited output at high power levels is obtained from an array of antiguided phase-locked vertical cavity surface-emitting laser arrays. The arrays may be fabricated by a selective etching process and regrowth by metalorganic chemical vapor deposition processes. Resonant coupling of the array of elements occurs with interelement spacings corresponding to an odd (or even) integral number of half waves of the antiguided radiation leakage. Interelement loss may be incorporated in the structure to effectively suppress nonresonant modes. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> The laser array device in accordance with the invention includes a semiconductor substrate and a multilayer structure on the substrate. The multilayer structure includes a layer with an active region at which light emission occurs, upper and lower layers surrounding the active region layer, upper and lower faces, and electrodes by which voltage can be applied across the multilayer structure and the substrate. At least four core elements are formed in the multilayer structure arranged in a two-dimensional array, the core elements being separated from one another and surrounded by a matrix region formed to have an effective higher index than the core elements for antiguiding of the radiation leakage from the core elements. The matrix region may also include material providing loss for the radiation in the interelement regions. The width of the matrix region separating adjacent core elements is selected to provide resonant coupling between the core elements. The spacing between core elements may be selected to be substantially equal to an odd integral number of half wavelengths of the antiguided radiation leakage for in-phase coupling, or an even integral number of half wavelengths for out-of-phase coupling. The device is preferably close to the resonance condition, but does not need to be exactly resonant. Operation close to resonance provides strong optical coupling throughout the array, resulting in a nearly uniform near-field intensity. The uniform near-field intensity reduces the influence of non-linear effects above laser threshold, helping to suppress the onset of lasing in other modules. Near the resonance condition, a combination of mode dependent edge losses and interelement losses acts to suppress unwanted modes (i.e., nonresonant modes). An upper reflector above the active region layer and a lower reflector below the active region layer provide vertical confinement of the emitted radiation. The matrix region and the upper and lower reflectors are positioned to act upon the light generated in the active region to produce lasing action phase-locked between the core elements to produce emission of light from at least one of the upper and lower faces of the semiconductor structure. Means for confining the current from the electrodes to the array of core elements may be incorporated in the multilayer structure. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> The core elements may be formed as a square, and the core elements may be arranged in rows and columns in the array with equal spacing between the core elements in the rows and columns. The core elements may also be arranged in various array geometries in addition to rectangular, e.g., triangular, etc. The laser array may be formed to either be top surface emitting or bottom surface emitting. For top surface emission, an upper electrode formed on the top face of the structure may include a plurality of openings therein each formed above a core element to define the output aperture for the light from each core element. For a bottom emitting laser, one of the electrodes may be formed over the upper face of the semiconductor laser, and another electrode is formed on the lower face over the substrate and has an opening therein under the array for passage of light therethrough to define the output aperture of the laser array. A heat sink may then be mounted in heat conductive contact with the electrode on the upper face of the semiconductor laser array to efficiently remove heat and allow the semiconductor array laser to operate at higher power levels. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> The semiconductor laser array may be formed with various semiconductor materials used in the fabrication of semiconductor lasers. Exemplary structures may include substrates of crystalline GaAs with an active region layer formed of a multiple quantum well structure of layers of, e.g., GaInNAs and GaAs or layers of GaAs and InGaAs. The upper and lower reflectors may be distributed Bragg reflectors formed of multiple pairs of layers, e.g., of AlGaAs and AlAs, AlAs and GaAs, etc. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> The material of the higher effective index matrix regions may be selected to locally increase the cavity resonance wavelength to provide an effective equivalent increase in the index of the matrix region. For example, the matrix region may include one or more thin spacer layers of material, e.g., GalnP and GaAs, between layers of an upper distributed Bragg reflector to provide the effective local increase in the cavity resonance wavelength in the matrix region. An additional layer of material, e.g., InGaAs or InGaAsN, may be incorporated in the spacer layers to provide loss in the interelement matrix regions. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Further objects, features and advantages of the invention will be apparent from the following detailed description when taken in conjunction with the accompanying drawings. </paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> In the drawings: </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is a simplified cross-sectional view of a vertical-cavity surface-emitting semiconductor laser array in accordance with the invention having an array of <highlight><bold>16</bold></highlight> core elements. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> is a simplified top view of the upper electrode for the semiconductor laser array of <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> are graphs of calculated modal edge radiation losses for the semiconductor laser array structure of <cross-reference target="DRAWINGS">FIGS. 2 and 3</cross-reference>, for core elements with d&equals;6 &mgr;m and an index step An &equals;0.05, and also including graphs calculated radiation losses for the in-phase (<highlight><bold>12</bold></highlight>,<highlight><bold>12</bold></highlight>) and out-of-phase (<highlight><bold>9</bold></highlight>,<highlight><bold>9</bold></highlight>) modes with an interelement loss of 100 cm<highlight><superscript>&minus;1</superscript></highlight>. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> is an illustrative view of the measured continuous wave (cw) far-field pattern for the device of <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> operating in the in-phase mode. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> is an illustrative view of the measured cw far-field pattern for the device of <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> operating in the out-of-phase mode. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> is a one-dimensional scan of the cw far-field intensity for the device of <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> functioning in the in-phase mode. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> is a one-dimensional scan of the cw far-field intensity for the device of <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> operating in the out-of-phase mode. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> is a simplified cross-sectional view of a semiconductor laser array structure utilizing a material system that provides top surface light emission at 1.3 &mgr;m. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 9</cross-reference> is a simplified cross-sectional view of a semiconductor laser array structure providing bottom surface emission.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> For purposes of exemplifying the invention, the leaky modes of a 4&times;4 antiguided VCSEL array structure as shown generally at <highlight><bold>20</bold></highlight> in <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> may be analyzed using a fiber-mode effective-index approximation. The VCSEL structure <highlight><bold>20</bold></highlight> of <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> supports leaky modes with the core elements <highlight><bold>21</bold></highlight> phase-locked in-phase or out-of-phase, as well as intermediate modes with varying phase relationships between core elements. Edge radiation losses and absorption losses selectively placed in the interelement matrix regions <highlight><bold>22</bold></highlight> of the array can discriminate against unwanted modes. The calculated modal edge radiation losses for the in-phase mode, (<highlight><bold>12</bold></highlight>,<highlight><bold>12</bold></highlight>) and the two out-of-phase modes, (<highlight><bold>9</bold></highlight>,<highlight><bold>9</bold></highlight>), and (<highlight><bold>15</bold></highlight>,<highlight><bold>15</bold></highlight>), for a 4&times;4 array structure with 6 &mgr;m wide (square) VCSEL core elements, with an index-step of &Dgr;n&equals;0.05 between the core elements and the higher index matrix region <highlight><bold>22</bold></highlight> that surrounds and separates the core elements, are shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. The mode number convention corresponds to the number of intensity nulls of the field profile in each direction. For this structure, the in-phase mode exhibits resonant leaky-wave coupling for an interelement matrix region spacing of s&equals;2.4 &mgr;m, since the interelement region contains an odd number of half-waves, &lgr;, of the radiation leakage (i.e., s&equals;3&lgr;<highlight><subscript>1</subscript></highlight>/2). Near the resonance condition for the in-phase mode, the in-phase mode has uniform intensity profile and highest edge loss (see <cross-reference target="DRAWINGS">FIG. 3</cross-reference>), similar to what is seen in 1D edge-emitting arrays. The out-of-phase mode &lsqb;mode (<highlight><bold>9</bold></highlight>,<highlight><bold>9</bold></highlight>), for s&lt;2.4 &mgr;ml is nonresonant and thus exhibits strong reflections in the interelement regions, resulting in high-interelement field intensity and a nonuniform (cosine-shaped) intensity profile. Some coupling and interference also occurs between diagonally adjacent elements in the array. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> In edge-emitting antiguided arrays, the 2D gain overlap suppresses nonresonant modes because they exhibit high field intensity in the (low gain) interelement regions. However, in the antiguided VCSEL array, the 2D gain overlap is not expected to be significantly mode dependent, because of the uniform gain profile. Therefore, the implementation of interelement loss into the 2D VCSEL array structure can be used to select the resonant mode by suppressing nonresonant modes that have high field intensity in the interelement regions. This effect is demonstrated in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, where the influence of interelement loss (for example, 100 cm<highlight><superscript>&minus;1</superscript></highlight>) on the total modal losses for the in-phase mode (<highlight><bold>12</bold></highlight>,<highlight><bold>12</bold></highlight>) and the lower out-of-phase mode (<highlight><bold>9</bold></highlight>,<highlight><bold>9</bold></highlight>) is also shown. As a result, for s&gt;2.3 &mgr;m, both of the out-of-phase modes (<highlight><bold>9</bold></highlight>,<highlight><bold>9</bold></highlight> and <highlight><bold>15</bold></highlight>,<highlight><bold>15</bold></highlight>) can be suppressed by either high-edge loss or interelement loss. Intermediate (adjacent) array modes are also found to have high edge losses, thereby suppressing their lasing, near the in-phase resonance condition. Thus, as shown in <cross-reference target="DRAWINGS">FIG. 3, a</cross-reference> 4&times;4 array structure designed with interelement loss and an interelement width in the range s&equals;2.3-2.8 &mgr;m can operate in a stable in-phase array mode. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> As an example, 4&times;4 VCSEL antiguided array structures as shown in <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference> were fabricated using a two-step MOCVD growth process. The structure includes a lower n-type distributed Bragg reflector (DBR) <highlight><bold>24</bold></highlight> grown on a GaAs substrate <highlight><bold>25</bold></highlight> formed of 27.5 pairs of AlAs/GaAs layers, an upper p-type DBR <highlight><bold>26</bold></highlight> formed of 23 pairs of Al<highlight><subscript>0.15</subscript></highlight>GaAs/AlAs layers, and a 1 &lgr; optical cavity <highlight><bold>27</bold></highlight> which includes three InGaAs quantum wells <highlight><bold>28</bold></highlight> with GaAs barrier layers <highlight><bold>29</bold></highlight>, and Al<highlight><subscript>0.3</subscript></highlight>GaAs confinement layers <highlight><bold>31</bold></highlight> and <highlight><bold>32</bold></highlight> for 980 nm emission. The first growth consists of the n-DBR <highlight><bold>24</bold></highlight>, cavity <highlight><bold>27</bold></highlight>, one or more pairs of p-DBR <highlight><bold>33</bold></highlight> (GaAs/AlAs) and two thin spacer layers of GainP <highlight><bold>35</bold></highlight> and GaAs <highlight><bold>36</bold></highlight>. These two thin layers were selectively etched away at the emitting core elements areas <highlight><bold>38</bold></highlight>, and then the remaining layers of the upper p-DBR <highlight><bold>26</bold></highlight> were regrown. This structure provides the required index step for antiguiding due to the shift of optical resonant mode in the regions containing the spacer layers <highlight><bold>35</bold></highlight> and <highlight><bold>36</bold></highlight>. In this example, each emitting core element is a 6 &mgr;m square, with an index step of &Dgr;n&equals;0.05. The interelement (high-index) matrix region width, s (the spacing between the core elements), was adjusted to select either the in-phase or out-of-phase resonance condition. These structures can also be formed to include absorbing layers for interelement loss to aid in the suppression of nonresonant modes. As shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>, the top face of the semiconductor structure has a metal electrode <highlight><bold>40</bold></highlight> formed thereon with a plurality of openings <highlight><bold>41</bold></highlight> formed therein, with each opening formed above a core element <highlight><bold>21</bold></highlight> to define the output aperture for the light from each core element. For example, for 6 &mgr;m by 6 &mgr;m square core elements, the openings <highlight><bold>41</bold></highlight> may be formed as 5 &mgr;m by 5 &mgr;m squares. A lower electrode <highlight><bold>43</bold></highlight> may be formed on the bottom face of the substrate <highlight><bold>25</bold></highlight> so that voltage can be applied across the semiconductor structure between the electrodes <highlight><bold>40</bold></highlight> and <highlight><bold>43</bold></highlight>. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> Arrays with interelement widths s&equals;2.5 &mgr;m are observed to operate in an in-phase mode. Arrays with interelement width s&equals;3.0 &mgr;m are observed to operate in an out-of-phase mode. This result is in general agreement with the calculations shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, provided that the modal loss curves are shifted towards higher s values by about 0.5 &mgr;m. This shift can occur due to a smaller index step (&Dgr;n&equals;0.036) than the design target of &Dgr;n&equals;0.05. Since the fabricated structure does not contain interelement loss, the lasing modes observed correspond to either the nonresonant in-phase mode (for s&equals;2.5 &mgr;m) or the nonresonant out-of-phase mode (for s&equals;3.0 &mgr;m). The measured cw far-field emission pattern for an array with s&equals;2.5 &mgr;m (in-phase) and s&equals;3.0 &mgr;m (out-of-phase), as captured by a CCD camera, are shown near laser threshold in <cross-reference target="DRAWINGS">FIGS. 4 and 5</cross-reference>, respectively. At higher driving currents, the minor side lobes become viewable. The angular lobe separation and widths are obtained from a 1D scan of the far-field intensity for the two arrays, as shown in <cross-reference target="DRAWINGS">FIGS. 6 and 7</cross-reference>, respectively. The full width half maximum (FWHM) for the in-phase mode is about 2&deg;, and the side lobes separation is 13.5&deg;. The emission patterns remain stable up to the maximum thermally limited cw output power ( &tilde;1-2 mW). Higher cw output powers are mainly limited due to the intensive heating for such closely packed arrays. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> The present invention may be implemented utilizing other material systems to obtain light emission at other wavelengths, as desired. An example of another vertical-cavity surface-emitting semiconductor laser array in accordance with the invention formed to emit light at 1.3 &mgr;m is shown generally at <highlight><bold>50</bold></highlight> in <cross-reference target="DRAWINGS">FIG. 8</cross-reference>. The laser array <highlight><bold>50</bold></highlight> includes a substrate <highlight><bold>51</bold></highlight> of GaAs, a lower n-type distributed Bragg reflector (n-DBR) <highlight><bold>52</bold></highlight> formed of multiple pairs of layers of AlAs and GaAs <highlight><bold>53</bold></highlight> and <highlight><bold>54</bold></highlight> (two pairs shown for illustration; typically 20 to 30 pairs may be utilized), a one wavelength cavity <highlight><bold>56</bold></highlight> including an active region layer <highlight><bold>57</bold></highlight> having GaInNAs quantum wells in layers of GaAs, and an upper confinement layer <highlight><bold>59</bold></highlight> and a lower confinement layer <highlight><bold>60</bold></highlight>. An upper p-type distributed Bragg reflector (p-DBR) <highlight><bold>62</bold></highlight> is formed of multiple pairs of layers of AlGaAs and AlAs <highlight><bold>63</bold></highlight> and <highlight><bold>64</bold></highlight> (typically 20 to 30 pairs of layers may be utilized). An upper metal electrode <highlight><bold>66</bold></highlight> is formed on the top face <highlight><bold>67</bold></highlight> of the semiconductor structure and a lower metal electrode <highlight><bold>69</bold></highlight> is formed on the lower face <highlight><bold>70</bold></highlight> (the face of the substrate) of the semiconductor structure. The upper electrode <highlight><bold>66</bold></highlight> has a plurality of openings <highlight><bold>71</bold></highlight> formed therein, each opening positioned above a core element <highlight><bold>73</bold></highlight> of a two-dimensional array of core elements arranged similarly to the array of <cross-reference target="DRAWINGS">FIGS. 1 and 2</cross-reference>. Two thin spacer layers <highlight><bold>74</bold></highlight> and <highlight><bold>75</bold></highlight> formed of GainP and GaAs, respectively, are formed in the upper DBR <highlight><bold>62</bold></highlight> and are etched, as discussed above, to form a two-dimensional array of areas <highlight><bold>77</bold></highlight> corresponding to the position of the core elements <highlight><bold>63</bold></highlight> in the array, separated by regions <highlight><bold>78</bold></highlight> of the layers <highlight><bold>74</bold></highlight> and <highlight><bold>75</bold></highlight> and bounded by the rest of the layers <highlight><bold>74</bold></highlight> and <highlight><bold>75</bold></highlight>. Proton implantation is applied to areas <highlight><bold>80</bold></highlight> of one or more pairs of DBR layers <highlight><bold>63</bold></highlight> and <highlight><bold>64</bold></highlight> outside of the array of core elements <highlight><bold>73</bold></highlight> as a means to confine current flowing between the upper electrode <highlight><bold>66</bold></highlight> and lower electrode <highlight><bold>69</bold></highlight> to the area of the array. Any other means for confining current to the area of the array may be used, one example of which is a blocking layer. The interelement sections <highlight><bold>78</bold></highlight> of the layers <highlight><bold>74</bold></highlight> and <highlight><bold>75</bold></highlight> define matrix regions in the semiconductor structure which have a higher effective index than the core element <highlight><bold>73</bold></highlight>, and the width of the separating regions <highlight><bold>78</bold></highlight> is selected so that the core elements are separated by a distance that is an even or odd integral number of half wavelengths of the antiguided radiation leakage from the core elements. Interelement loss may be provided in the matrix regions to suppress nonresonant modes. For example, the spacer layer may include a layer of InGaAs with the layers of GaAs and GalnP to increase the loss in the matrix regions between the core elements <highlight><bold>73</bold></highlight>. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> The invention may also be embodied in a semiconductor laser array that provides output emission through the substrate, as illustrated by the semiconductor structure <highlight><bold>90</bold></highlight> of <cross-reference target="DRAWINGS">FIG. 9</cross-reference>. The semiconductor laser array <highlight><bold>90</bold></highlight> includes a substrate <highlight><bold>91</bold></highlight> (e.g., GaAs), a lower n-type distributed Bragg reflector <highlight><bold>92</bold></highlight> which may be formed of multiple pairs of layers as discussed above, a one wavelength cavity <highlight><bold>93</bold></highlight> having an active region layer <highlight><bold>94</bold></highlight> which includes multiple quantum wells, and a lower confinement layer <highlight><bold>95</bold></highlight> and an upper confinement layer <highlight><bold>96</bold></highlight> below and above the active region layer <highlight><bold>94</bold></highlight>. These layers may be formed as discussed above or of any other desired appropriate material system. An upper p-type distributed Bragg reflector <highlight><bold>98</bold></highlight> is formed of multiple pairs of layers (e.g., as discussed above or of other appropriate material systems). A two-dimensional rectangular array of core elements <highlight><bold>100</bold></highlight> is defined by open areas <highlight><bold>101</bold></highlight> in spacer layers <highlight><bold>102</bold></highlight> and <highlight><bold>103</bold></highlight> of, e.g., GalnP and GaAs, formed in the upper DBR <highlight><bold>98</bold></highlight>, as discussed above, which includes regions <highlight><bold>104</bold></highlight> that separate the open areas <highlight><bold>101</bold></highlight> to provide an effective higher index in the matrix regions of the semiconductor structure, surrounding and separating the core elements <highlight><bold>100</bold></highlight>, than in the core elements. An absorption layer <highlight><bold>106</bold></highlight> of, e.g., InGaAs, may be included to introduce absorption loss to help suppress unwanted modes. A proton implantation into areas <highlight><bold>105</bold></highlight> of the DBR <highlight><bold>98</bold></highlight> around the array confines current flow between an upper electrode <highlight><bold>109</bold></highlight> and a lower electrode <highlight><bold>110</bold></highlight> to the area of the array. The upper p-metal electrode <highlight><bold>109</bold></highlight> covers the entire upper face <highlight><bold>111</bold></highlight> of the semiconductor structure including the area of the array of active core elements <highlight><bold>100</bold></highlight>. A metal heat sink <highlight><bold>114</bold></highlight> may be mounted in heat conducting contact to the upper electrode <highlight><bold>109</bold></highlight> to conduct heat away from the semiconductor structure. An opening <highlight><bold>115</bold></highlight> is formed in the lower electrode <highlight><bold>110</bold></highlight> to expose an area <highlight><bold>116</bold></highlight> of the bottom face of the substrate of the semiconductor structure to allow emission of light therethrough. The exposed bottom face <highlight><bold>116</bold></highlight> preferably has an antireflective coating <highlight><bold>117</bold></highlight> formed thereon to facilitate emission of light through the window defined by the open face <highlight><bold>116</bold></highlight> of the structure. The semiconductor structure of <cross-reference target="DRAWINGS">FIG. 9</cross-reference> has the advantage that heat generated in the multilayer semiconductor structure can be readily conducted away by the heat sink <highlight><bold>114</bold></highlight> to allow the semiconductor structure to operate at relatively high power levels. Such a structure is well suited to large arrays of core elements, e.g., 20&times;20 element arrays or even longer. Generally, the core elements are arranged in rows and columns in a rectangular array with equal spacing between the core elements in the rows and columns. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> The following is an exemplary process for producing the bottom emitting semiconductor laser array structure <highlight><bold>90</bold></highlight> of <cross-reference target="DRAWINGS">FIG. 9</cross-reference>. Assuming an n-type substrate <highlight><bold>91</bold></highlight>, a first MOCVD growth is utilized to grow the lower n-DBR <highlight><bold>92</bold></highlight>, the one wave cavity <highlight><bold>93</bold></highlight>, the spacer layers <highlight><bold>102</bold></highlight> and <highlight><bold>103</bold></highlight>, and the first few pairs of layers of the upper p-DBR <highlight><bold>98</bold></highlight> up to the spacer layers <highlight><bold>102</bold></highlight> and <highlight><bold>103</bold></highlight>. An array mask (e.g., 4&times;4 for a 4&times;4 array of openings) is utilized to selectively expose a photoresist and then etch away the spacer layers to form the openings <highlight><bold>101</bold></highlight> to define the antiguided array of core elements <highlight><bold>100</bold></highlight>. A second MOCVD growth is then carried out to grow the remainder of the top p-DBR <highlight><bold>98</bold></highlight>. A thick photoresist is then used to pattern the array to cover the area of the array to form an implantation mask for H&plus;ion implantation. The implantation mask is then again used to pattern the array, to do a p-metal deposit and then liftoff, with this (e.g., gold) pattern then being used later for backside alignment. The backside (bottom face) of the substrate <highlight><bold>91</bold></highlight> is then lapped down about 200 &mgr;m and polished to form a polished lower face <highlight><bold>116</bold></highlight>. A thick photoresist is then used to pattern the bottom face to define the window opening to be used for backside emission. Infrared illumination may be utilized for backside alignment. Thereafter n-metal is evaporated onto the backside face followed with a liftoff leaving the opening <highlight><bold>115</bold></highlight> exposing the bottom face <highlight><bold>116</bold></highlight>. The top surface <highlight><bold>111</bold></highlight> may have p-metal deposited thereon by evaporation. An antireflective coating <highlight><bold>117</bold></highlight> may then be coated onto the open window area <highlight><bold>116</bold></highlight>, and the backside window mask may then be used to etch away the coating on the lower electrode <highlight><bold>1</bold></highlight> <highlight><bold>10</bold></highlight> to allow electrical contact to the bottom electrode <highlight><bold>1</bold></highlight> <highlight><bold>10</bold></highlight>. The contact is then preferably alloyed at, e.g., 380&deg; C. for 30 seconds. The substrate wafer on which the multilayer structure is formed may then be scribed into individual devices for mounting. The individual devices are mounted with the p-metal side <highlight><bold>109</bold></highlight> down onto a heat sink (e.g., a copper block) <highlight><bold>114</bold></highlight>, preferably with a diamond heat spreader between them. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> Although the invention has been illustrated herein with core elements arranged in a rectangular two-dimensional array with equal spacing between the elements in the rows and columns, the invention may also be implemented with the core elements arranged in other types of two-dimensional array geometries, for example, triangular, etc. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> It is understood that the invention is not confined to the particular embodiments set forth herein as illustrative, but embraces all such forms thereof as come within the scope of the following claims. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A vertical-cavity surface-emitting semiconductor laser array device comprising: 
<claim-text>a semiconductor substrate and a multilayer structure on the substrate including a layer with an active region at which light emission occurs, upper and lower layers surrounding the active region layer, upper and lower faces, electrodes by which voltage can be applied across the multilayer structure and the substrate, at least four core elements arranged in a two-dimensional array, the core elements separated from one another and surrounded by a matrix region formed to have an effective higher index than the core elements for antiguiding of the radiation leakage from the core elements and arranged such that the device operates close to resonance to provide strong optical coupling throughout the array of elements, an upper reflector above the active region layer and a lower reflector below the active region layer, the matrix region and the upper and lower reflectors positioned to act upon the light generated in the active region to produce lasing action phase-locked between the core elements to produce emission of light from at least one of the upper and lower faces of the semiconductor laser array, and means for confining the current from the electrodes to the area of the array of core elements. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the width of the matrix region separating adjacent core elements is selected to be an even or odd integral number of half wavelengths of the antiguided radiation leakage from the core elements. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein each of the core elements is formed as a square, and the core elements are arranged in rows and columns in the array with equal spacing between the core elements in the rows and columns. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein there are at least 16 core elements in the array. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the means for confining the current to the array comprises proton implantation in regions of the multilayer structure surrounding the array. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the electrodes are formed on the upper and lower faces of the semiconductor laser and the upper electrode has a plurality of openings therein with each opening formed above a core element to define the output aperture for the light from each core element. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the material and thickness of the higher effective index matrix region is selected to locally increase the cavity resonance wavelength to provide an effective equivalent increase in the index in the matrix region. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the upper and lower reflectors are distributed Bragg reflectors. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference> wherein the lower distributed Bragg reflector is formed of multiple pairs of layers of n-type AlAs and GaAs and the upper distributed Bragg reflector is formed of multiple pairs of layers of p-type AlGaAs and AlAs. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> wherein the substrate is formed of GaAs, the active region layer is a multiple quantum well structure formed of layers of GaAs and InGaAs, and wherein the higher effective index matrix region includes a layer of GalnP and a layer of GaAs. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference> wherein a spacer layer is formed in the upper distributed Bragg reflector with an array of openings therein corresponding to the array of core elements, the spacer regions between the open areas of the spacer layer defining the higher effective index matrix regions surrounding and separating the core elements. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein the substrate is formed of GaAs, the upper reflector is a distributed Bragg reflector formed of multiple pairs of layers of p-type AlGaAs and AlAs, the lower reflector is a distributed Bragg reflector formed of multiple pairs of layers of n-type AlAs and GaAs, and the active region layer is a multiple quantum well structure formed of layers of GaInNAs and GaAs. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> wherein one of the electrodes is formed on the upper face of the semiconductor laser and covers the area of the array and wherein another electrode is formed on the lower face of the semiconductor laser over the substrate and has an opening therein under the array for passage of light therethrough to define the output aperture of the laser array. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> wherein the lower face of the semiconductor laser array through which light is emitted from the semiconductor laser array is coated with an antireflective coating. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 13</dependent-claim-reference> further including a heat sink in heat conductive contact with the electrode on the upper face of the semiconductor laser array. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A vertical-cavity surface-emitting semiconductor laser array device comprising: 
<claim-text>a semiconductor substrate and a multilayer structure on the substrate including a layer with an active region at which light emission occurs, upper and lower layers surrounding the active region layer, upper and lower faces, electrodes by which voltage can be applied across the multilayer structure and the substrate, at least four core elements arranged in a two-dimensional array, the core elements separated from one another and surrounded by a matrix region formed to have an effective higher index than the core elements for antiguiding of the radiation leakage from the core elements and including material providing loss for the radiation in the interelement regions, the width of the matrix region separating adjacent core elements selected to provide in-phase resonant coupling of the antiguided radiation leakage between the core elements, an upper reflector above the active region layer and a lower reflector below the active region layer, the matrix region and the upper and lower reflectors positioned to act upon the light generated in the active region to produce lasing action phase-locked between the core elements to produce emission of light from at least one of the upper and lower faces of the semiconductor laser array, and means for confining the current from the electrodes to the area of the array of core elements. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein each of the core elements is formed as a square, and the core elements are arranged in rows and columns in the array with equal spacing between the core elements in the rows and columns. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein there are at least <highlight><bold>16</bold></highlight> core elements in the array. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein the means for confining the current to the array comprises proton implantation in regions of the multilayer structure surrounding the array. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein the electrodes are formed on the upper and lower faces of the semiconductor laser and the upper electrode has a plurality of openings therein with each opening formed above a core element to define the output aperture for the light from each core element. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein the material of the higher effective index matrix region is selected to locally increase the cavity resonance wavelength to provide an effective equivalent increase in the index in the matrix region. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein the upper and lower reflectors are distributed Bragg reflectors. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference> wherein the lower distributed Bragg reflector is formed of multiple pairs of layers of n-type AlAs and GaAs and the upper distributed Bragg reflector is formed of multiple pairs of layers of p-type AlGaAs and GaAs. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein the substrate is formed of GaAs, the active region layer is a multiple quantum well structure formed of layers of GaAs and InGaAs, and wherein the higher effective index matrix region with loss includes a layer of GalnP, a layer of InGaAs and a layer of GaAs. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference> wherein a spacer layer is formed in the upper distributed Bragg reflector with an array of openings therein corresponding to the array of core elements, the spacer regions between the open areas of the spacer layer defining the higher effective index matrix regions surrounding and separating the core elements. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein the substrate is formed of GaAs, the upper reflector is a distributed Bragg reflector formed of multiple pairs of layers of p-type AlGaAs and AlAs, the lower reflector is a distributed Bragg reflector formed of multiple pairs of layers of n-type AlAs and GaAs, and the active region layer is a multiple quantum well structure formed of layers of GaInNAs and GaAs. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein one of the electrodes is formed on the upper face of the semiconductor laser array and covers the area of the array and wherein another electrode is formed on the lower face of the semiconductor laser over the substrate and has an opening therein under the array for passage of light therethrough to define the output aperture of the laser array. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference> wherein the lower face of the semiconductor laser array through which light is emitted from the semiconductor laser array is coated with an antireflective coating. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The semiconductor laser array device of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference> further including a heat sink in heat conductive contact with the electrode on the upper face of the semiconductor laser array.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020191656A1-20021219-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020191656A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020191656A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020191656A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020191656A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020191656A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020192479A1-20021219-D00000.TIF SYSTEM "US20020192479A1-20021219-D00000.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00001.TIF SYSTEM "US20020192479A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00002.TIF SYSTEM "US20020192479A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00003.TIF SYSTEM "US20020192479A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00004.TIF SYSTEM "US20020192479A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00005.TIF SYSTEM "US20020192479A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00006.TIF SYSTEM "US20020192479A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00007.TIF SYSTEM "US20020192479A1-20021219-D00007.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00008.TIF SYSTEM "US20020192479A1-20021219-D00008.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00009.TIF SYSTEM "US20020192479A1-20021219-D00009.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00010.TIF SYSTEM "US20020192479A1-20021219-D00010.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00011.TIF SYSTEM "US20020192479A1-20021219-D00011.TIF" NDATA TIF>
<!ENTITY US20020192479A1-20021219-D00012.TIF SYSTEM "US20020192479A1-20021219-D00012.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020192479</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10114383</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020401</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>B32B015/04</ipc>
</classification-ipc-primary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>428</class>
<subclass>469000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>427</class>
<subclass>446000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>428</class>
<subclass>408000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>428</class>
<subclass>450000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Method of producing nanocomposite coatings</title-of-invention>
</technical-information>
<continuity-data>
<division-of>
<parent-child>
<child>
<document-id>
<doc-number>10114383</doc-number>
<kind-code>A1</kind-code>
<document-date>20020401</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09449226</doc-number>
<document-date>19991124</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>ABANDONED</parent-status>
</parent-child>
</division-of>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>09449226</doc-number>
<document-date>19991124</document-date>
<country-code>US</country-code>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09276319</doc-number>
<document-date>19990326</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>GRANTED</parent-status>
<parent-patent>
<document-id>
<doc-number>6258417</doc-number>
<country-code>US</country-code>
</document-id>
</parent-patent>
</parent-child>
</continuation-in-part-of>
</continuations>
<non-provisional-of-provisional>
<document-id>
<doc-number>60109670</doc-number>
<document-date>19981124</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Ramasis</given-name>
<family-name>Goswami</family-name>
</name>
<residence>
<residence-us>
<city>Stony Brook</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Sanjay</given-name>
<family-name>Sampath</family-name>
</name>
<residence>
<residence-us>
<city>Setauket</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>John</given-name>
<family-name>Parise</family-name>
</name>
<residence>
<residence-us>
<city>East Setauket</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Herbert</given-name>
<family-name>Herman</family-name>
</name>
<residence>
<residence-us>
<city>Port Jefferson</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Pitney, Hardin, Kipp &amp; Szuch</name-1>
<name-2></name-2>
<address>
<address-1>685 Third Avenue,</address-1>
<address-2>19th Floor</address-2>
<city>New York</city>
<state>NY</state>
<postalcode>10017</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A method of producing a nanocomposite coating without gaseous precursor reactants. A non-nanocrystalline particulate containing a polymorphic material in an atmospheric phase is introduced into a high-velocity gas jet. The projected particulate is allowed to impact a substrate at a velocity effective to cause at a least a portion of the polymorphic material to transform to a nanocrystalline, high pressure phase. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> The present application claims priority under 35 U.S.C. &sect;119(e) from Provisional Application No. 60/109,670, filed Nov. 24, 1998, and under 35 U.S.C. &sect;120 from U.S. Ser. No. 09/276,319, filed Mar. 26, 1999.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> Development of the invention disclosed herein was made with support from the National Science Foundation under Grant No.: DMR 9632570. Accordingly, the U.S. Government may have rights in the disclosed invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The present invention relates to a method of producing shock-induced nanocomposite coatings, and more particularly to a method of producing shock-induced nanocomposite coatings with thermal or plasma spraying. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> A &ldquo;nanocomposite coating&rdquo; is a coating having more than one solid phase, in which at least one phase is in the nanometer range. Attention has been directed to nanoparticles and nanocomposites because of the unique properties exhibited by these materials. For example. Silicon (Si) is an indirect band gap semiconductor that can be potentially used for optoelectronic applications such as light emitting devices. Unfortunately, the development of such devices has been hindered since crystalline Si is not an efficient light emitter. However, this changed with the development of porous-Si (por-Si), an irregular network of nanocrystalline Si which exhibits a band gap energy twice the band gap energy of crystalline Si (L. T. Canham, Appl. Phys. Lett. 57(10): 1046-1048 (1990)). Thus, the potential applications of semiconductor materials, such as Si, have increased because of the development of nanomaterials. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> Typically, nanocrystalline or nanocomposite coatings are produced using chemical techniques such as Chemical Vapor Deposition (CVD), which require gaseous reactants and vacuum chambers to contain the gaseous reactants. However, the use of these gaseous reactants involves safety risks, in addition to time and cost considerations associated with containment of the gaseous reactants. Thus, for mass scale production of nanocrystalline or nanocomposite coatings CVD techniques are not without disadvantages. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> An common alternative to CVD is thermal or plasma spraying, which uses a particulate precursor material rather than a reactive gas. Thermal or plasma spray provides a flexible, cost-effective and safer method for producing coatings since gaseous reactants are avoided. Moreover, vacuum chambers are generally avoided since the coatings are typically sprayed at atmospheric pressure. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> However, nanocrystalline or nanocomposite coatings produced solely with plasma or thermal spraying have yet to be developed. While combinations of CVD and thermal spraying have been used to produce nanocrystalline coatings (Heberlein et al., Thermal Spray: A United Forum for Scientific and Technological Advances, 329-333 (1997)), reactive precursor gases are still required to form the nanocrystalline coating. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> In view of the current state of the art, there is a need for a method of producing nanocrystalline or nanocomposite coatings without reliance on gaseous precursor reactants. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Accordingly, it is an object of the present invention to provide a method of producing nanocomposite coatings without the use of reactive precursor gases. It is also an object of the present invention to provide a method of producing nanocomposite coatings having metastable, high pressure phases of nanocrystalline material. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> The present invention provides a method of producing a nanocomposite coating which avoids the disadvantages associated with gaseous precursor reactants. The method includes providing a thermal or plasma spray apparatus capable of generating a high-velocity gas jet, providing a substrate to be impinged by the gas jet, generating the high-velocity gas jet and introducing into the gas jet a particulate containing a polymorphic material in an atmospheric phase. The substrate is positioned at a distance from the spray apparatus where the particulate impinges the substrate at a velocity effective to induce transformation of at least a portion of the polymorphic materials to a nanocrystalline, high pressure phase. If desired, the velocity can be greater than said velocity effective to induce transformation of at least a portion of said particulate to said nanocrystalline, high pressure phase. Moreover, the particulate can be dispersed in a carrier gas prior to being introduced into the high-velocity gas jet. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> The particulate can have a particle size from 1 to 100 &mgr;m, with 5 to 50 &mgr;m being preferred. The particulate can be a semiconductor, a semiconductor precursor, a ceramic material, a ceramic/metal-based material, and combinations thereof. Semiconductors include, but are not limited to, silicon, germanium, doped derivatives thereof, and combinations thereof. Semiconductor precursors include, but are not limited to, graphite. Ceramics include, but are not limited to, silicon oxide, silicon nitride and silicon carbide. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> The substrate to have the nanocomposite coating deposited therein is preferably an inorganic material, such as a metal or non-metal. One particularly preferred non-metal substrate is silicon. One particularly preferred metal substrate is steel. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> The present also provides an article having a nanocomposite coating. The article is substrate having coated thereon the nancomposite coating which is a matrix of a polymorphic material in an atmospheric phase having dispersed therein nanocrystals of the polymorphic material in a high pressure phase. The coating can have a thickness from about 10 to about 500 micrometers. Preferably, the high pressure phase nanocrystals are at least 5 percent by volume of the nanocomposite coating, with at least 20 percent or at least 50 percent being more preferred. Preferably, the nanocrystals range in size from about 1 to about 100 nanometers, with about 5 to about 50 nanometers being more preferred. </paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is a composite of x-ray diffraction (XRD) patterns, patterns A-E, of silicon (Si) nanocomposite coatings produced in accordance with the present invention. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> is a de-convoluted peak analysis of the broad peak in the XRD pattern shown in pattern C of <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, Panels A &amp; B, are: (A) a transmission electron micrograph of a section of a Si nanocomposite coating deposited on a Si (100) wafer by Vacuum Plasma Spray; and (B) an electron diffraction pattern of the micrographed section shown in Panel A. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference>, Panels A &amp; B, are: (A) a transmission electron micrograph of another section of the Si nanocomposite coating shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>; and (B) an electron diffraction pattern of the micrographed section shown in Panel A. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> is a plot graph depicting the calculated Hugonoit pressure as a function of particle velocity for Si coatings deposited on Si wafers in (100), (110) and (111) orientations with four thermal spray processes (APS, VPS, IPSS and HVOF). </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> is an XRD pattern of a Si coating deposited on a Si (100) wafer with HVOF using a high velocity spray gun. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> is an XRD pattern of a germanium (Ge) coating deposited on a Si (100) wafer using HVOF. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> is a plot graph depicting the calculated Hugonoit pressure as a function of median particle velocity for diamond coatings deposited on steel substrate using HVOF. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 9</cross-reference> is a composite of XRD patterns, patterns A-C, for: (A) a Nickel-clad graphite particulate; (B) a diamond coating deposited on a steel substrate with HVOF using a conventional spray gun; and (C) a diamond coating deposited on a steel substrate with HVOF using a high velocity spray gun. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 10</cross-reference> is an electron diffraction pattern of the diamond coating deposited on the steel substrate with HVOF using a conventional spray gun. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 11</cross-reference> is a magnified section of a Raman spectrum of a diamond coating deposited on the steel substrate with HVOF using a high velocity spray gun. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 12</cross-reference> is a transmission electron micrograph of the diamond coating referred to in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> The present invention provides a method of producing a nanocomposite coating, while avoiding the disadvantages associated with the use of gaseous precursors. In accordance with the present invention, a nanocomposite coating is provided by thermal spraying a particulate containing a polymorphic material in an equilibrium phase at atmospheric pressure (i.e., atmospheric phase) onto a substrate at a velocity effective to induce transformation of the polymorphic material to a nanocrystalline, high pressure phase. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> &ldquo;Polymorphism&rdquo; is defined as the property of a chemical substance being able to crystallize into two or more forms having different structures. See Dictionary of Scientific and Technical Terms, McGraw-Hill, 5<highlight><superscript>th </superscript></highlight>Ed., 1994. Examples of polymorphic materials are abound in nature, with semiconductors such as silicon and germanium being representative examples. Semiconductor materials are in fact &ldquo;pressure polymorphs&rdquo;, which are chemical substances that undergo a transformation from one crystalline phase to another upon the application of pressure. Thus, in the context of the present invention, the term &ldquo;polymorph&rdquo; or &ldquo;polymorphic material&rdquo; is meant to refer to &ldquo;pressure polymorphs.&rdquo;</paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> In accordance with the present invention, the polymorphic material is a crystalline material that exhibits a crystalline phase at room or atmospheric pressure and exhibits at least one different crystalline phase at elevated pressures. In the context of the present invention, a crystalline phase exhibited at pressures greater than atmospheric is referred to as a &ldquo;high pressure phase.&rdquo; Preferably, the polymorphic material stably transforms from its atmospheric phase to a high pressure phase upon application of pressure (i.e., should not revert back to its atmospheric phase after quenching). </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> In one embodiment, the polymorphic material is a semiconductor. In another embodiment, the polymorphic material is a semiconductor other than diamond. Examples of semiconductors to be utilized in accordance with the present invention are Group IV and VI elements, semiconductors synthesized from these elements, and combinations thereof. Preferred examples of semiconductor are silicon, germanium, doped derivatives thereof, and combinations thereof. Silicon (Si) undergoes several transitions to high pressure phases at transition pressures ranging from about 10 Gigapascals (GPa) for Si-II, about 16 GPa for Si-V, about 37 GPa for Si-VI, about 42 GPa for hcp Si-VII, and about 78 GPa for fcc Si. In addition, other metastable forms of silicon (e.g., Si-IX, BC-8, R-8 and Si-IV) can be formed. Germanium (Ge) also undergoes a transition to high pressure phases at transition pressures ranging from about 10.6 GPa for Ge-II and about 75 for simple hexagonal Ge. Likewise, other metastable forms of germanium (e.g., ST-12, BC-8, hexagonal diamond) can be formed. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> Other examples of polymorphic materials include, but are limited to, semiconductor precursors, ceramic materials, and ceramic/metal-based materials. An example of a semiconductor precursor is carbon in an atmospheric crystalline phase (i.e., graphite), which when utilized in accordance with the invention, forms nanocrystalline diamond. Examples of ceramic materials include crystalline silicon oxide, silicon nitride and silicon carbide. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> In accordance with the invention, a particulate containing the polymorphic material in its atmospheric phase is introduced to a high velocity gas jet in which the gas jet is directed to a substrate causing the particulate to impinge the substrate at a velocity effective to induce a portion of the polymorphic material to transform to a nanocrystalline, high pressure phase. An &ldquo;effective&rdquo; velocity in this context is a velocity at which the particulate impinges or impacts the substrate with a shock pressure equivalent to the transition pressure of the desired high pressure phase. While not wishing to be bound by theory, it is believed that by causing the particulate to impinge the substrate at a shock pressure (i.e., a Hugonoit pressure) equal to, or greater than, the transition pressure of the polymorphic material a phase transformation is induced from a non-nanocrystalline, atmospheric phase to nanocrystalline, high pressure phase. propagates through the deposited coating and coating causing at least a portion of the deposited material to transform to a nanocrystalline, high pressure phase. A velocity effective to induce a phase transformation of a specific polymorphic material is calculated under shock loading from the modified Rankine-Hugonoit equation: </paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>U</italic></highlight><highlight><subscript>P</subscript></highlight><highlight><italic>&equals;P</italic></highlight><highlight><subscript>H</subscript></highlight>/&rgr;<highlight><subscript>o</subscript></highlight><highlight><italic>U</italic></highlight><highlight><subscript>S</subscript></highlight>&emsp;&emsp;(1) </in-line-formula></paragraph>
<paragraph id="P-0032" lvl="7"><number>&lsqb;0032&rsqb;</number> where P<highlight><subscript>H </subscript></highlight>is the shock pressure, &rgr;<highlight><subscript>o </subscript></highlight>is the density of the polymorphic material, and U<highlight><subscript>S </subscript></highlight>is the velocity of the shock wave. In order for the transformation to occur P<highlight><subscript>H </subscript></highlight>must be equal to or greater than the transition pressure for the polymorphic material. The shock velocity is calculated by the equations: </paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>U</italic></highlight><highlight><subscript>S</subscript></highlight><highlight><italic>&equals;a&plus;bU</italic></highlight><highlight><subscript>P</subscript></highlight>&emsp;&emsp;(2) </in-line-formula></paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>b&equals;</italic></highlight>0.5&plus;3<highlight><italic>&agr;K/</italic></highlight>2&rgr;<highlight><subscript>o</subscript></highlight><highlight><italic>C&ngr;</italic></highlight>&emsp;&emsp;(3) </in-line-formula></paragraph>
<paragraph id="P-0033" lvl="7"><number>&lsqb;0033&rsqb;</number> where b is related to Guneisen parameter and expressed by Equation 3, a is the longitudinal velocity of sound, &agr;is the linear thermal expansion coefficient of polymorphic material, K is the bulk modules of the polymorphic material and C&ngr; is the specific heat of polymorphic material at constant volume. Thus, one skilled in the art can calculate the required effective particle velocity (U<highlight><subscript>P</subscript></highlight>) upon ascertaining the other parameters of the modified Rankine-Hugonoit equation. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> The high velocity gas jet is generated using any known apparatus for thermal or plasma spray techniques. As will be apparent those skilled in the art, the thermal or plasma spray apparatus must be capable of generating a gas jet having a velocity sufficient to reach the effective particle velocity for phase transformation to occur. However, reaching an effective velocity to induce phase transformation is dependent on both the velocity of the gas jet and the distance between the thermal spray apparatus and the substrate. One can therefore adjust the distance between the spray apparatus and the substrate to provide the particulate with an effective velocity to induce transformation upon impact with the substrate. In addition, as will be apparent to those skilled in the art, other process parameters or conditions can be adjusted to alter particle velocity. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> The requisite velocity to induce formation of the nanocrystalline high pressure phase is also dependent on the polymorphic material to be deposited since different polymorphic materials have differing transition pressures. For example, to deposit a nanocomposite of Si, the thermal or plasma spray apparatus should provide the Si particulate with effective velocity before impact of at least 350 meters/seconds (m/s), with at least 400 meters/second being preferred. Examples of suitable thermal or plasma spray techniques that provide the above-described velocity requirements include, but are not limited to, vacuum plasma spraying, induction plasma with a supersonic nozzle, high velocity oxy-fuel (HVOF) spraying and non-combustive thermal spray processes such as solid state spray deposition. Low velocity spray techniques are not preferred since velocities of at least 300 m/s will be difficult to obtain. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> Preferably, velocities in excess of the required effective velocities are used to increase to nanocrystalline content of the nanocomposite coating. For example, between 350 and 400 m/s micrometer Si particulate forms a nanocomposite coating having between 20-30% by volume of nanocrystalline, high pressure Si. However, at 800 m/s or greater, the same Si particulate forms a nanocomposite coating having greater than 50% by volume of nanocrystalline, high pressure Si. Thus, particle velocities in excess of the effective velocity for transformation provide greater yields of the nanocrystalline material. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> The plasma or thermal spray apparatus should be capable of generating a gas jet having a temperature sufficient to at least partially melt the particulate to provide sufficient adhesion of the propelled particulate to the substrate. As will be apparent to those skilled in the art, the required temperature needed to melt the particulate will vary with the choice of the polymorphic material. Alternatively, the polymorphic material may be coated with a metal or other suitable adhesion promoting materials that will soften or melt upon introduction to the gas jet to provide sufficient adhesion to the substrate. Adhesion promoters are preferably used for particulates with high melting temperatures (e.g., greater than 3000&deg; C.) such as graphite, silicon oxide, and silicon nitride. Examples of metals to be used as adhesion promoters include, but are not limited to, nickel, iron and cobalt, aluminum, alloys thereof and combinations thereof. The adhesion promoters also provide the dual function of a pressure transfer medium for the polymorphic material which facilitates the propagation of the shock wave through the polymorphic material. Generally, the plasma or thermal spray apparatus should be capable of generating a gas jet having a temperature of at least 1000&deg; C., with at least 1500&deg; being preferred. While thermal and plasma spray techniques generating significantly higher temperatures can be used, such temperatures will also limit the choice of substrates. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> Alternatively, if the polymorphic material is malleable, cold spray techniques may be used, such as solid-state spray deposition. Particle adhesion to the substrate is facilitated by the malleable nature of the polymorphic material. Advantageously, this provides an opportunity to coat substrates that would otherwise be detrimentally affected by the high temperatures associated with conventional thermal spray techniques. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> The particulate of the invention contains the polymorphic material in an atmospheric phase and other optional components such as the adhesion promoters described above. Preferably, the particulate should have a particle size less than 100 microns, with a particle size less than 50 microns being preferred. Although larger particle size can be used, sufficient softening may not occur to allow the particulate to adhere to the substrate upon impact and particle velocity may be lessened. Morever, for ease of feeding into the spray apparatus, the particulate should have a particle size of at least 1 micron, with at least 5 microns being preferred. One particular advantage of the present invention, if desired, is that the use a high pressure phase seed material is avoided. Thus, to form the nanocomposite coating in accordance with the present invention only a particulate containing the atmospheric phase polymorphic material is required. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> Depending on the technique selected, the particulate may be dispersed in an inert carrier gas prior to being introduced to the gas jet. Examples of carrier gases to be used include, but are not limited to, argon, helium, hydrogen, nitrogen and combinations thereof. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> The substrates to be coated with the nanocomposite coating are materials that can withstand thermal or plasma spraying. The substrate can be an inorganic material such as a metal, semi-metal, non-metal, or can be an organic temperature resistant material. For example, the substrate can be a semiconductor in its atmospheric phase such as a silicon wafer (i.e., crystal) having deposited thereon a nanocomposite Si coating. Examples of metals to be coated include, but are not limited to, steel and aluminum. Likewise the substrate can be in any shape or form that is capable of being coated with the nanocomposite coating. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> The nanocomposite coating is a matrix of the polymorphic material in an atmospheric phase having dispersed therein nanocrystals of the polymorphic material is its high pressure phase. The nanocrystals range in size from about 1 to about 100 nanometers, with about 5 to about 50 nanometers being preferred. The size of the nanocrystals can be varied by adjusting the deposition pressure and the rate of pressure quenching. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> Preferably, the nanocomposite coating has a nanocrystalline content of at least 5 percent by volume. However, following the teachings of the present invention, nanocomposite coatings with nanocrystalline contents of 20%, 50% or greater can be produced. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> As will be apparent to those skilled in the art, the coating thickness is merely a function of coating time and other spray parameters. Generally, the coating can range in thickness from about 10 to about 500 micrometers (&mgr;m), with from about 20 to about 100 &mgr;m being more preferred. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> The present invention also provides a nanocomposite coated article, which is prepared by coating a substrate, as described above, with a nanocomposite coating produced in accordance with the present invention. For example, the nanocomposite article can be a silicon wafer having coated thereon a Si or Ge nanocomposite coating. Likewise, the nanocomposite article can be steel substrate (e.g., a steel drilling bit) having coated thereon a diamond nanocomposite coating. In another embodiment, the article can have successive layers of different nanocomposites (e.g., a Si wafer having a Si nanocomposite coating, with an additional Ge nanocomposite coating on top of the Si coating). Thus, following the teachings of the invention, a variety of nanocomposite coated articles can be made. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> Thus, the present invention provides a unique method of producing nanocomposite coatings that avoids the use of gaseous reactants, and nanocomposite articles of manufacture. The following non-limiting examples illustrate the use of the method of the present invention for the production of nanocomposite coatings. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> Nanocomposite Si coatings were prepared in the following manner. Using the four thermal spray techniques: air plasma spray (APS), vacuum plasma spray (VPS), induction plasma spray with a supersonic nozzle (IPSS) and high velocity oxy-fuel spray (HVOF), electronic-grade Si powder (5 to 20 micrometers particle size) was injected into the high-energy flame. The resulting stream of molten Si particles was directed towards Si wafers of two orientations, (100) and (111), where the particles impacted the substrate. The substrates were positioned approximately 6 to 9 inches from the nozzle of the thermal spray gun. Upon impact, the droplets spread and solidified rapidly. The deposited coatings were built up by successive deposition of the droplets until coatings approximately 15 to 30 micrometers thick were formed on the single-crystal Si wafers. The process parameters are listed in Table 1 set forth below.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 1</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Process Parameters for Thermal Spray Techniques</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="91PT" align="left"/>
<colspec colname="2" colwidth="70PT" align="left"/>
<colspec colname="3" colwidth="56PT" align="center"/>
<tbody valign="top">
<row>
<entry>Spray Processes/Spray Gun</entry>
<entry>Gas Composition</entry>
<entry>Velocity (m/s)</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry>APS (Sulzer Metco 3MB)</entry>
<entry>Air</entry>
<entry>50-200</entry>
</row>
<row>
<entry>IPSS (Tekna PL70)</entry>
<entry>Ar &plus; N<highlight><subscript>2</subscript></highlight></entry>
<entry>350-550&ensp;</entry>
</row>
<row>
<entry>VPS</entry>
<entry>Ar &plus; H<highlight><subscript>2 </subscript></highlight>(5:1)</entry>
<entry>400-600&ensp;</entry>
</row>
<row>
<entry>(Plasma Technik A.G.</entry>
</row>
<row>
<entry>F4V)</entry>
</row>
<row>
<entry>HVOF (Praxair HV-2000)</entry>
<entry>C<highlight><subscript>3</subscript></highlight>H<highlight><subscript>6 </subscript></highlight>&plus; O<highlight><subscript>2 </subscript></highlight>(1:4.5)</entry>
<entry>600-1000</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> The Si coatings were characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), and electron diffraction. <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows the XRD patterns of Si deposited on the Si (100) wafer using the four above described techniques (patterns A-D), and of the Si deposited on the Si (111) wafer using VPS (pattern E). A prominent broad peak was observed in the 2&thgr; range between 31.7 to 38.6 in addition to Si-I (Si in its atmospheric phase) for the IPSS, VPS and HVOF deposits. However, this broad peak was absent from pattern (a) which is the deposits coated on a Si (100) wafer with APS. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> The broad peak was de-convoluted in order to determine the contributing peaks. <cross-reference target="DRAWINGS">FIG. 2</cross-reference> shows the de-convoluted peaks of the two overlapping peaks that form the broad peak of VPS deposit shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, pattern C. The magnified view of the peak shows that shoulders at either side of the main peak occurred at &ap;34&deg;. A prominent shoulder also exists at higher angle &ap;36.7&deg;. The de-convolution, which was done assuming Gaussian peaks with variable peak width and peak position, produced peaks centered at d-spacings of 0.269, 0.264, 0.26, 0.256 and 0.245 nm. These values matched the d-values for Si-IX and R-8 phases (high pressure phase Si). </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> The percent by volume of nanocrystals in the VPS coating of <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, pattern C, was calculated from the relative intensity of the prominent XRD reflections. The VPS deposit was calculated to contain approximately 20% by volume of high pressure phase, nanocrystals. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> As will be apparent from <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, Pattern E, Si deposited on the Si (111) substrate did not exhibit a broad peak that would correspond to high pressure phase of Si. The broad hump was not observed because of the volume fraction the high pressure phase formed on the (111) substrate was below 2%. This behavior can be correlated with the anisotropic nature of the pressure-induced transformation of Si-I. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> The particle size of the VPS deposit of <cross-reference target="DRAWINGS">FIG. 1</cross-reference> pattern C was estimated using the major peak and the equation: </paragraph>
<paragraph lvl="0"><in-line-formula><highlight><italic>t&equals;</italic></highlight>0.9&lgr;/B cos (&thgr;) </in-line-formula></paragraph>
<paragraph id="P-0053" lvl="7"><number>&lsqb;0053&rsqb;</number> where B is the width at half maxima, &lgr; is the wave length and &thgr;<highlight><subscript>B </subscript></highlight>is half the Bragg angle. The particle size of Si-IX and R-8 were calculated to be approximately 4 to 5 nm and 5 to 6 nm, respectively. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> The particle size of the high pressure Si phase was confirmed with TEM. As can be seen from <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, Panel A, the VPS deposit of <cross-reference target="DRAWINGS">FIG. 1</cross-reference>, pattern C contains a very fine, homogenous dispersion of high pressure phase particles in the Si-I matrix. The particle size was ascertained to be approximately 2 to 5 nm in diameter. <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, Panel B is an electron diffraction pattern (DP) of a section of the VPS deposit which shows the presence of several broad rings in addition to (111) Si-I reflections. The four broad rings numbered <highlight><bold>1</bold></highlight>, <highlight><bold>2</bold></highlight>, <highlight><bold>3</bold></highlight>, and <highlight><bold>4</bold></highlight>, as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>, Panel B are in the d-spacing range of 0.33 to 0.29 nm, 0.285 to 0.243 nm, 0.21 to 0.19 nm and 0.185 to 0.165 nm, respectively. The broad ring <highlight><bold>1</bold></highlight> and part of ring <highlight><bold>4</bold></highlight> contain predominately major reflections of hexagonal diamond-Si and thus indicates the presence of this high pressure phase. Rings <highlight><bold>2</bold></highlight>, <highlight><bold>3</bold></highlight> and <highlight><bold>4</bold></highlight> indicate the presence of BC-8 and Si-IX. In fact, the broad peak in <cross-reference target="DRAWINGS">FIG. 1</cross-reference> has the same d-spacings range of ring <highlight><bold>2</bold></highlight>. Accordingly, the XRD and electron patterns confirm that the nanocrystals are high pressure phases of Si. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> Another section of the VPS deposit was examined by TEM and electron diffraction, in which hexagonal diamond Si was determined to be the majority high pressure phase present. <cross-reference target="DRAWINGS">FIG. 4</cross-reference>, Panel A is a bright-field micrograph of this region. The particle size was calculated to be approximately 2 to 5 nm, which is consistent with the other regions of the VPS deposit. The corresponding electron diffraction pattern, <cross-reference target="DRAWINGS">FIG. 4</cross-reference>, Panel B, shows two broad rings corresponding to the d-spacings of 0.33 to 0.285 nm and 0.18 to 0.165 nm. The d-spacing values correspond to hexagonal diamond-Si. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> The relationship between Hugonoit pressure and the velocities of impacting particles upon Si-I substrates in three different crystallographic orientations are graphically depicted in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>. The arrow indicates the pressure level sufficient to trigger the transformation from non-nanocrystalline, atmospheric phase Si to nanocrystalline, high pressure phase Si. The transformation pressure level was about 9 GPa which occurred at a velocity of approximately 350 m/s. Thus the plasma spray techniques VPS, IPSS and HVOF were able to trigger the formation of the nanocrystalline, high pressure phase deposits, but the lower velocity APS process was not. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> The effect of using velocities in excess of the required velocity for phase transformation was ascertained. Following the procedure of Example 1, a Si coatings between 15 to 30 micrometers was deposited on Si (100) and (111) wafers using the HVOF process described in Table 2.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 2</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Process Parameters for Thermal Spray Technique</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="left"/>
<colspec colname="3" colwidth="63PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Spray Process/Spray Gun</entry>
<entry>Gas Composition</entry>
<entry>Velocity (m/s)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>HVOF</entry>
<entry>C<highlight><subscript>3</subscript></highlight>H<highlight><subscript>6 </subscript></highlight>&plus; O<highlight><subscript>2 </subscript></highlight>&plus; air</entry>
<entry>800-1200</entry>
</row>
<row>
<entry></entry>
<entry>(Diamond Jet-METCO)</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> The coatings were examined by x-ray diffraction (XRD) as in Example 1. The XRD pattern for the Si deposit on a Si wafer in the (100) orientation is shown in <cross-reference target="DRAWINGS">FIG. 6</cross-reference>. Readily apparent from <cross-reference target="DRAWINGS">FIG. 6</cross-reference> is a broad peak in the 2&thgr; range between 31.7 to 38.6, which represents nanocrystalline, high pressure phase Si. From the XRD patterns, the nanocomposite coating was calculated to contain approximately 50% by volume nanocrystalline Si. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> A nanocomposite coating of Germanium (Ge) on a Si (100) wafer substrate was prepared following the procedure of Example 1 using a HV-2000 gun to spray Ge deposits of approximately 30 micrometer thick. The particulate ranged in size from 5 to 30 micrometers as in Example 1. <cross-reference target="DRAWINGS">FIG. 7</cross-reference> is an XRD pattern of the nanocomposite coating. Clearly evident from the pattern is a broad peak in the 20 range of 32 to 39 indicating the presence of nanocrystalline, high pressure phase Ge, in addition to atmospheric Ge. One of the high-pressure phase was determined to be ST-12. Particle size calculated from the peak broadening was determined to be about 5 nm. The nanocomposite coating was calculated to contain at least 5% by volume nanocrystalline Ge. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES 4 &amp; 5 </heading>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> Using the HVOF processes described in Examples 1 and 2, Nickel-clad (i.e., Ni-clad) graphite particles approximately 60 to 80 micrometers in diameter were sprayed onto steel substrates. Successive coatings were deposited onto the substrates to obtain a coating approximately 30 micrometers thick on each substrate. The particles were dispersed in an argon carrier gas before being injected into the flame. The flame exit to substrate distance was approximately 15 cm. Particle velocity and temperature were measured to be 1900-2000&deg; C., and 350-700 m/s, respectively, using a DPV-2000 optical sensor. Approximately 50 percent of the particle population had a velocity of 500-700 m/s depending on the HVOF process used. A plot graph illustrating the calculated Hugonoit pressure as a function of median particle velocity for the two HVOF processes is shown in <cross-reference target="DRAWINGS">FIG. 8</cross-reference>. The hugonoit pressures were calculated to be approximately 15 and 23 GPa for HVOF using the HV-2000 gun (first arrow) and for the HVOF using the Diamond Jet gun (second arrow), respectively. Both processes, therefore, provided a population of particles that had a velocity sufficient to reach the phase transformation pressure of 17 GPa. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> As in Example 1, the deposited coatings were examined by XRD. A composite XRD spectrum of the coatings, in addition to the Ni-clad graphite particulate, is shown in <cross-reference target="DRAWINGS">FIG. 9</cross-reference>. Referring to <cross-reference target="DRAWINGS">FIG. 9</cross-reference>, pattern A is the XRD spectra for the Ni-clad graphite particulate (i.e., starting material), pattern B is the XRD spectra for the diamond coating synthesized with the HV-2000 gun, and pattern C is the XRD spectra for the diamond coating synthesized with the Diamond Jet (DJ) gun. Readily apparent from pattern A is the sharp peak around the 2&thgr; value&ap;44 for Ni (111). Patterns B and C exhibit broadening of this peak, as indicated by the arrows pointing towards the new peak shoulders, which indicates the formation of diamond (111). Moreover, as will be apparent from patterns B and C the broadening of the peaks were greater for the DJ deposit than for the HV-2000 deposit. This increased peak broadening observed for pattern A was attributed to the increased diamond formation resulting from the increased particle velocities of the DJ gun. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> Formation of the diamond phase was confirmed with Electron Diffraction and Raman Spectroscopy. The electron diffraction pattern for the diamond coating sprayed with the HV-2000 gun is shown in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>. The diffraction pattern shows both reflections from the graphite and diamond phases present in the coating. The existence of the graphite phase was ascertained by the intense (0002) reflection in addition to the reflections at (0004) and (0006). The existence of the diamond phase was ascertained by the (111, 220, 113, 400 &amp; 133) reflections. Raman Spectra of the diamond nanocomposite sprayed with the DJ gun is shown in <cross-reference target="DRAWINGS">FIG. 11</cross-reference>. <cross-reference target="DRAWINGS">FIG. 11</cross-reference> shows a magnified view of the spectrum from wave numbers (cm<highlight><superscript>&minus;1</superscript></highlight>) 1100 to 1500. The peak between 1332 cm<highlight><superscript>&minus;1 </superscript></highlight>and 1338 cm<highlight><superscript>&minus;1</superscript></highlight>, as indicated by arrows, corresponds to the diamond phase in the coating. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> The diamond coating sprayed with the HV-2000 gun was also evaluated by TEM. A micrograph of the coating is shown in <cross-reference target="DRAWINGS">FIG. 12</cross-reference>. As can be seen from the micrograph, diamond particles approximately 5 to 10 nanometers in diameter are homogeneously dispersed throughout the graphite phase. Thus, a diamond nanocomposite coating was produced in accordance with the invention. </paragraph>
</section>
<section>
<heading lvl="1">COMPARATIVE EXAMPLE 6 </heading>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> Following the procedure of Examples 4 &amp; 5, an attempt was made to spray vitreous carbon (i.e., glassy carbon) onto a steel substrate to form a diamond coating as taught in U.S. Pat. No. 5,635,254. The glassy carbon was obtained from Alfa Aesar. The particulate had a spherical morphology and a particulate size from 0.4 to 12 microns. A steel substrate was sprayed with the particulate using the above described high velocity Diamond Jet gun. However, the sprayed particulate failed to adhere to the substrate and ricocheted off the substrate. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">We claim: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method of producing a nanocomposite coating, which comprises: 
<claim-text>providing a thermal or plasma spray apparatus capable of generating a high-velocity gas jet; </claim-text>
<claim-text>providing a substrate to be impinged by said high-velocity gas jet; </claim-text>
<claim-text>generating said high-velocity gas jet; and </claim-text>
<claim-text>introducing into said high-velocity gas jet a particulate comprising a polymorphic material in an atmospheric phase; wherein said substrate is positioned at a distance from said spray apparatus whereby said particulate impinges said substrate at a velocity effective to induce transformation of at least a portion of said polymorphic material to a nanocrystalline, high pressure phase. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said particulate is dispersed in a carrier gas prior to being introduced into said high-velocity gas jet. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said particulate has a particle size from 1 to 100 &mgr;m. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>, wherein said particle size is from 5 to 50 &mgr;m. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said substrate is an inorganic material. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, wherein said inorganic material is metal. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, wherein said metal substrate is steel. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference>, wherein said inorganic substrate is a non-metal. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said particulate is selected from the group consisting of a semiconductor, a semiconductor precursor, a ceramic material, a ceramic/metal-based material, and combinations thereof. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said semiconductor is selected from the group consisting of silicon, germanium, doped derivatives thereof, and combinations thereof. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said semiconductor precursor is graphite. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said ceramic material is silicon oxide. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said ceramic material is silicon nitride. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference>, wherein said ceramic material is silicon carbide. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said velocity is greater than said velocity effective to induce transformation of at least a portion of said polymorphic material to said nanocrystalline, high pressure phase. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. An article having a nanocomposite coating comprising a substrate having coated thereon said nancomposite coating being a matrix of a polymorphic material in an atmospheric phase having dispersed therein nanocrystals of said polymorphic material in a high pressure phase. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said nanocrystals in said high pressure phase are at least 5 percent by volume of said nanocomposite coating. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein said nanocrystals are at least 20 percent by volume. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference>, wherein said nanocrystals are at least 50 percent by volume. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said polymorphic material is selected from the group consisting of a semiconductor, a semiconductor precursor, a ceramic material, a ceramic/metal-based material, and combinations thereof. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said semiconductor is selected from the group consisting of silicon, germanium, doped derivatives thereof, and combinations thereof. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said nanocrystals have a particle size from about 1 to about 100 nanometers. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference>, wherein said particle size is from about 5 to about 50 nanometers. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said coating has a thickness from about 10 to about 500 micrometers. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The article of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said substrate is an inorganic material.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>1</representative-figure>
<figure id="figure-D00000">
<image id="EMI-D00000" file="US20020192479A1-20021219-D00000.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020192479A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020192479A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020192479A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020192479A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020192479A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020192479A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020192479A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020192479A1-20021219-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020192479A1-20021219-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020192479A1-20021219-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020192479A1-20021219-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00012">
<image id="EMI-D00012" file="US20020192479A1-20021219-D00012.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020192663A1-20021219-D00001.TIF SYSTEM "US20020192663A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020192663A1-20021219-D00002.TIF SYSTEM "US20020192663A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020192663A1-20021219-D00003.TIF SYSTEM "US20020192663A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020192663A1-20021219-D00004.TIF SYSTEM "US20020192663A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020192663A1-20021219-D00005.TIF SYSTEM "US20020192663A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020192663A1-20021219-D00006.TIF SYSTEM "US20020192663A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020192663A1-20021219-D00007.TIF SYSTEM "US20020192663A1-20021219-D00007.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020192663</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09972834</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20011004</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C12Q001/68</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C12P019/34</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N009/22</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>435</class>
<subclass>006000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>091200</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>199000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Thermostable polymerases having altered fidelity and methods of identifying and using same</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-of>
<parent-child>
<child>
<document-id>
<doc-number>09972834</doc-number>
<kind-code>A1</kind-code>
<document-date>20011004</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>08978806</doc-number>
<document-date>19971126</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>GRANTED</parent-status>
<parent-patent>
<document-id>
<doc-number>6395524</doc-number>
<country-code>US</country-code>
</document-id>
</parent-patent>
</parent-child>
</continuation-of>
</continuations>
<non-provisional-of-provisional>
<document-id>
<doc-number>60031496</doc-number>
<document-date>19961127</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Lawrence</given-name>
<middle-name>A.</middle-name>
<family-name>Loeb</family-name>
</name>
<residence>
<residence-us>
<city>Bellevue</city>
<state>WA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Leroy</given-name>
<family-name>Hood</family-name>
</name>
<residence>
<residence-us>
<city>Seattle</city>
<state>WA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Motoshi</given-name>
<family-name>Suzuki</family-name>
</name>
<residence>
<residence-non-us>
<city>Nogoya</city>
<country-code>JP</country-code>
</residence-non-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>CAMPBELL &amp; FLORES LLP</name-1>
<name-2></name-2>
<address>
<address-1>4370 LA JOLLA VILLAGE DRIVE</address-1>
<address-2>7TH FLOOR</address-2>
<city>SAN DIEGO</city>
<state>CA</state>
<postalcode>92122</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The present invention provides a method for identifying a thermostable polymerase having altered fidelity. The method consists of generating a random population of polymerase mutants by mutating at least one amino acid residue of a thermostable polymerase and screening the population for one or more active polymerase mutants by genetic selection. For example, the invention provides a method for identifying a thermostable polymerase having altered fidelity by mutating at least one amino acid residue in an active site O-helix of a thermostable polymerase. The invention also provides thermostable polymerases and nucleic acids encoding thermostable polymerases having altered fidelity, for example, high fidelity polymerases and low fidelity polymerases. The invention additionally provides a method for identifying one or more mutations in a gene by amplifying the gene with a high fidelity polymerase. The invention further provides a method for accurately copying repetitive nucleotide sequences using a high fidelity polymerase mutant. The invention also provides a method for diagnosing a genetic disease using a high fidelity polymerase mutant. The invention further provides a method for randomly mutagenizing a gene by amplifying the gene using a low fidelity polymerase mutant. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims the benefit of priority of U.S. Provisional Application serial No. 60/031,496, filed Nov. 27, 1996, the entire contents of which is incorporated herein by reference.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with government support under grant number OIG-R35-CA-39903 awarded by the National Institutes of Health and grant number BIR9214821 awarded by the National Science Foundation. The government has certain rights in the invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The present invention relates generally to thermostable polymerases and more specifically to methods for identifying polymerase mutants having desired fidelity. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Every living organism requires genetic material, deoxyribonucleic acid (DNA), to pass a unique collection of characteristics to its offspring. Genes are discreet segments of the DNA and provide the information required to generate a new organism. Even simple organisms, such as bacteria, contain thousands of genes, and the number is many fold greater in complex organisms such as humans. Understanding the complexities of the development and functioning of living organisms requires knowledge of these genes. However, the amount of DNA that can be isolated for study has often been limiting. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> A major breakthrough in the study of genes was the development of the polymerase chain reaction (PCR). PCR amplifies genes or portions of genes by making many identical copies, allowing isolation of genes from very tiny amounts of DNA. The motors for PCR are DNA polymerases that copy the DNA of each gene during each round of DNA synthesis. Using oligonucleotides that determine the start and termination of DNA synthesis, a single gene can be replicated into millions of copies. This process has created a revolution in biotechnology and has been used extensively for the identification of mutant genes that are responsible for or associated with inherited human diseases. It is now possible to identify a mutant gene in a single cell, amplify the gene a million times, and establish the nature of the mutation. One application of identifying a mutant gene is the determination of genetic susceptibility to disease, which can be mapped by gene amplification and DNA sequencing. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> DNA polymerases function in cells as the enzymes responsible for the synthesis of DNA. They polymerize deoxyribonucleoside triphosphates in the presence of a metal activator, such as Mg<highlight><superscript>2&plus;</superscript></highlight>, in an order dictated by the DNA template or polynucleotide template that is copied. Even though the template dictates the order of nucleotide subunits that are linked together in the newly synthesized DNA, these enzymes also function to maintain the accuracy of this process. The contribution of DNA polymerases to the fidelity of DNA synthesis is mediated by two mechanisms. First, the geometry of the substrate binding site in DNA polymerases contributes to the selection of the complementary deoxynucleoside triphosphates. Mutations within the substrate binding site on the polymerase can alter the fidelity of DNA synthesis. Second, many DNA polymerases contain a proof-reading 3&prime;-5&prime; exonuclease that preferentially and immediately excises non-complementary deoxynucleoside triphosphates if they are added during the course of synthesis. As a result, these enzymes copy DNA in vitro with a fidelity varying from 5&times;10<highlight><superscript>&minus;4 </superscript></highlight>(1 error per 2000 bases) to 10<highlight><superscript>&minus;7 </superscript></highlight>(1 error per 10<highlight><superscript>7 </superscript></highlight>bases) (Fry and Loeb, <highlight><italic>Animal Cell DNA Polymerases, </italic></highlight>pp. 221, CRC Press, Inc., Boca Raton, Fla. (1986); Kunkel, T. A., <highlight><italic>J. Biol. Chem. </italic></highlight>267:18251-18254(1992)). </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> In vivo, DNA polymerases participate in a spectrum of DNA synthetic processes including DNA replication, DNA repair, recombination, and gene amplification (Kornberg and Baker, <highlight><italic>DNA Replication, </italic></highlight>pp. 929, W.H. Freeman and Co., New York (1992)). During each DNA synthetic process, the DNA template is copied once or at most a few times to produce identical replicas. In vitro DNA replication, in contrast, can be repeated many times, for example, during PCR. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> In the initial studies with PCR, the DNA polymerase was added at the start of each round of DNA replication. Subsequently, it was determined that thermostable DNA polymerases could be obtained from bacteria that grow at elevated temperatures, and these enzymes need to be added only once. At the elevated temperatures used during-PCR, these enzymes would not denature. As a result, one can carry out repetitive cycles of polymerase chain reactions without adding fresh enzymes at the start of each synthetic addition process. The commercial market for the sale of DNA polymerases from thermostable organisms can be conservatively estimated at 200 million dollars per year. DNA polymerases, particularly thermostable polymerases, are the key to a large number of techniques in recombinant DNA studies and in medical diagnosis of disease. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Due to the importance of DNA polymerases in biotechnology and medicine, it would be highly advantageous to generate DNA polymerases having desired enzymatic properties such as altered fidelity. However, the ability to predict the effect of introducing an amino acid mutation into the sequence of a protein remains very limited. Even when structural information is available for the protein of interest, it is often very difficult to predict the effect of mutations of specific amino acid residues on the function of that protein. In particular, it is extremely difficult to predict amino acid substitutions that will alter the activity of an enzyme to achieve a desirable change. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Despite the limitations in predicting the effect of introducing amino acid substitutions into proteins, a number of mutant DNA polymerases have been discovered, or have been created by site-specific mutagenesis, and have been used in PCR amplification (Tabor and Richardson, <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>92:6339-6343 (1995)). Some of these mutant polymerases offer particular advantages with respect to thermostability, processivity, length of the newly synthesized DNA product, or fidelity of DNA synthesis. Those that are more accurate for the most part contain a 3&prime;-5&prime; exonuclease activity that removes misincorporated bases prior to adding the next nucleotide during DNA synthesis. However, the current spectrum of mutant DNA polymerases is quite limited. For the most part, these mutants have been obtained by introducing a single base substitution at a specified site, purifying the enzyme and studying the changes in catalytic activity (Joyce and Steitz, <highlight><italic>Annu. Rev. Biochem. </italic></highlight>63:777-822 (1994)). These laborious and step-wise procedures have been necessary due to the lack of adequate knowledge to predict the effects of most single amino acid substitutions and due to the lack of rules for predicting the effects of multiple simultaneous substitutions. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Thus, there exists a need for rapid and efficient methods to produce and screen for modified polymerases having desired fidelity in polynucleotide synthesis. The present invention satisfies this need and provides related advantages as well. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> The present invention provides a method for identifying a thermostable polymerase having altered fidelity. The method consists of generating a random population of polymerase mutants by mutating at least one amino acid residue of a thermostable polymerase and screening the population for one or more active polymerase mutants by genetic selection. For example, the invention provides a method for identifying a thermostable polymerase having altered fidelity by mutating at least one amino acid residue in an active site O-helix of a thermostable polymerase. The invention also provides thermostable polymerases and nucleic acids encoding thermostable polymerases having altered fidelity, for example, high fidelity polymerases and low fidelity polymerases. The invention additionally provides a method for identifying one or more mutations in a gene by amplifying the gene with a high fidelity polymerase. The invention further provides a method for accurately copying repetitive nucleotide sequences using a high fidelity polymerase mutant. The invention also provides a method for diagnosing a genetic disease using a high fidelity polymerase mutant. The invention further provides a method for randomly mutagenizing a gene by amplifying the gene using a low fidelity polymerase mutant.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows the nucleotide and amino acid sequence of Taq DNA polymerase I (SEQ ID NOS:1 and 2, respectively). </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> shows a compilation of amino acid substitutions identified in a screen of Taq DNA polymerase I mutants. Panel A shows single mutations, which were identified in the screen of a 9% library, listed under the wild type amino acids. Panel B shows the sequence of multiply substituted mutants identified in the screen of a 9% library. Panel C shows mutations selected from a totally random library of selected amino acids. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> shows the spectrum of single base changes generated in a forward mutation assay by Taq DNA polymerase I mutant Thr664Arg.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> The invention is directed to methods for screening and identifying thermostable polymerases that have altered fidelity of DNA synthesis as well as to the resultant polymerase compositions. As disclosed herein, the invention provides rapid and efficient methods to identify polymerase mutants having altered fidelity. These methods are applicable to the identification of polymerase mutants having a desired activity such as high fidelity or low fidelity. An advantage of the methods is that they use a population of polymerase mutants to rapidly identify active polymerase mutants having altered fidelity. The identification of low fidelity mutants is useful for introducing mutations into specific genes due to the increased frequency of misincorporation of nucleotides during error-prone PCR amplification. The identification of high fidelity mutants is useful for PCR amplification of genes and for mapping of genetic mutations. The methods of the invention can therefore be advantageously applied to the identification of polymerase mutants useful for the characterization of specific genes and for the identification and diagnosis of human genetic diseases. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> As used herein, the term &ldquo;polymerase&rdquo; is intended to refer to an enzyme that polymerizes nucleoside triphosphates. Polymerases use a template nucleic acid strand to synthesize a complementary nucleic acid strand. The template strand and synthesized nucleic acid strand can independently be either DNA or RNA. Polymerases can include, for example, DNA polymerases such as <highlight><italic>Escherichia coli </italic></highlight>DNA polymerase I and Thermus aquaticus (Taq) DNA polymerase I, DNA-dependent RNA polymerases and reverse transcriptases. The polymerase is a polypeptide or protein containing sufficient amino acids to carry out a desired enzymatic function of the polymerase. The polymerase need not contain all of the amino acids found in the native enzyme but only those which are sufficient to allow the polymerase to carry out a desired catalytic activity. Catalytic activities include, for example, 5&prime;-3&prime; polymerization, 5&prime;-3&prime; exonuclease and 3&prime;-5&prime; exonuclease activities. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> As used herein, the term &ldquo;polymerase mutant&rdquo; is intended to refer to a polymerase that contains one or more amino acids that differ from a selected polymerase. The selected polymerase is determined based on desired enzymatic properties and is used as a parent polymerase to generate a population of polymerase mutants. A selected polymerase can be, for example, a wild type polymerase as isolated from an organism or can be a mutant polymerase that differs from a wild type polymerase by one or more amino acids and has desirable enzymatic properties. As disclosed herein, a thermostable polymerase such as Taq DNA polymerase I can be selected, for example, as a polymerase to generate a population of polymerase mutants. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> As used herein, the term &ldquo;population&rdquo; is intended to refer to a group of two or more different molecular species. Molecular species differ by some detectable property such as a difference in at least one amino acid residue or at least one nucleotide residue or a difference introduced by the modification of an amino acid such as the addition of a chemical functional group. For example, a population of polymerase mutants would contain two or more different polymerase mutants. Typically, populations can be as small as two species and as large as 10<highlight><superscript>12 </superscript></highlight>species. In some embodiments, populations are between about five and 20 different species as well as up to hundreds or thousands of different species. In other embodiments, populations can be, for example, greater than 10<highlight><superscript>4</superscript></highlight>, 10<highlight><superscript>5 </superscript></highlight>and 10<highlight><superscript>6 </superscript></highlight>different species. In the specific example presented in Example I, the population described therein is 50,000 different species. In yet other embodiments, populations are between about 10<highlight><superscript>6</superscript></highlight>-10<highlight><superscript>8 </superscript></highlight>or more different species. Those skilled in the art will know a suitable size and diversity of a population sufficient for a particular application. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> A population of polymerase mutants consists of two or more mutant polymerases which differ by at least one amino acid from the parent polymerase. A population of polymerase mutants can consist, for example, of multiple substitutions of a single amino acid residue where the substitutions are changes to any or all of the non-parental, naturally occurring amino acids at that amino acid position. In this example, the population would comprise nineteen members, and all members of the polymerase mutant population would consist of nineteen different amino acid substitutions at a single amino acid position. A population of polymerase mutants can also consist, for example, of at least one substitution at two or more different amino acid positions. In this example, a minimal population containing two polymerase mutants would consist of a single amino acid substitution at two different positions. Such a population can be expanded with the addition of substitutions to any or all of the 19 non-parental amino acids at these two amino acid positions or additional amino acid positions. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> As used herein, the term &ldquo;random&rdquo; when used in reference to a population is intended to refer to a population of molecules generated without limiting the molecules to contain predetermined specific residues. Such a population excludes molecules in which a specific residue is substituted with a specific predetermined residue and individually assayed to determine its activity. The residues can be amino acid residues or nucleotide residues encoding a codon. The random molecules can be generated, for example, by introducing random nucleotides into an oligonucleotide sequence that encodes an amino acid sequence of a protein region of interest (see Example I). Thus, a random population is generated to contain random oligonucleotide sequences which can be expressed in appropriate cells to generate a random population of expressed proteins. A specific example of such a random population is the population of polymerase mutants described in Example I that were generated to screen for active polymerase mutants having altered fidelity. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> As used herein, the term &ldquo;catalytic activity&rdquo; or &ldquo;activity&rdquo; when used in reference to a polymerase is intended to refer to the enzymatic properties of the polymerase. The catalytic activity includes, for example: enzymatic properties such as the rate of synthesis of nucleic acid polymers; the K<highlight><subscript>m </subscript></highlight>for substrates such as nucleoside triphosphates and template strand; the fidelity of template-directed incorporation of nucleotides, where the frequency of incorporation of non-complementary nucleotides is compared to that of complementary nucleotides; processivity, the number of nucleotides synthesized by a polymerase prior to dissociation from the DNA template; discrimination of the ribose sugar; and stability, for example, at elevated temperatures. Polymerases can discriminate between templates, for example, DNA polymerases generally use DNA templates and RNA polymerases generally use RNA templates, whereas reverse transcriptases use both RNA and DNA templates. DNA polymerases also discriminate between deoxyribonucleoside triphosphates and dideoxyribonucleoside triphosphates. Any of these distinct enzymatic properties can be included in the meaning of the term catalytic activity, including any single property, any combination of properties or all of the properties. Although specific embodiments identifying polymerase mutants having altered fidelity are exemplified herein, the methods of the invention can similarly be applied to identify polymerases having altered catalytic activity distinct from altered fidelity. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> As used herein, the term &ldquo;fidelity&rdquo; when used in reference to a polymerase is intended to refer to the accuracy of template-directed incorporation of complementary bases in a synthesized DNA strand relative to the template strand. Fidelity is measured based on the frequency of incorporation of incorrect bases in the newly synthesized nucleic acid strand. The incorporation of incorrect bases can result in point mutations, insertions or deletions. Fidelity can be calculated according to the procedures described in Tindall and Kunkel (<highlight><italic>Biochemistry </italic></highlight>27:6008-6013 (1988)). Methods for determining fidelity are well known in the art and include, for example, those described in Example III. A polymerase or polymerase mutant can exhibit either high fidelity or low fidelity. As used herein, the term &ldquo;high fidelity&rdquo; is intended to mean a frequency of accurate base incorporation that exceeds a predetermined value. Similarly, the term &ldquo;low fidelity&rdquo; is intended to mean a frequency of accurate base incorporation that is lower than a predetermined value. The predetermined value can be, for example, a desired frequency of accurate base incorporation or the fidelity of a known polymerase. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> As used herein, the term &ldquo;altered fidelity&rdquo; refers to the fidelity of a polymerase mutant that differs from the fidelity of the selected parent polymerase from which the polymerase mutant is derived. The altered fidelity can either be higher or lower than the fidelity of the selected parent polymerase. Thus, polymerase mutants with altered fidelity can be classified as high fidelity polymerases or low fidelity polymerases. Altered fidelity can be determined by assaying the parent and mutant polymerase and comparing their activities using any assay that measures the accuracy of template directed incorporation of complementary bases. Such methods for measuring fidelity include, for example, those described in Example III as well as other methods known to those skilled in the art. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> As used herein, the term &ldquo;immutable&rdquo; when used in reference to an amino acid residue is intended to refer to an amino acid residue which cannot be substituted with another amino acid residue and still retain measurable function of the polypeptide. An immutable amino acid residue can be determined by introducing one or more substitutions of an amino acid residue and assaying the resulting mutant polypeptides for polypeptide function. An immutable residue can be identified, for example, using site-directed mutagenesis to substitute each of the 19 non-parental amino acids at a given position and determining if any of these mutants are active. Random mutagenesis can also be employed to introduce substitutions of each of the nineteen, naturally occurring non-parental amino acids at a given position. Random mutagenesis can provide a statistical representation of all 20 amino acids at a given position. Sequencing of polymerase-mutants allows determination of whether a given amino acid residue can tolerate any mutations. Assays for determining the function of mutant polypeptides include in vitro enzymatic assays as well as genetic complementation assays such as those described in Example I. If substitution of an amino acid residue with any other amino acid results in loss of polypeptide function, then that amino acid residue is considered to be immutable. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> As used herein, the term &ldquo;nearly immutable&rdquo; when used in reference to an amino acid residue is intended to refer to an amino acid residue which can only tolerate conservative substitutions and still retain polypeptide function. Conservative amino acids are known to those skilled in the art and include those amino acids which have similar structure and chemical properties. Conservative substitutions of amino acids include, for example, the identification of amino acid substitutions based on the frequencies of amino acid changes between corresponding proteins of homologous organisms (Schulz and Schirmer, <highlight><italic>Principles of Protein Structure, </italic></highlight>Springer Verlag, New York (1979)). </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> As used herein, the term &ldquo;substantially&rdquo; or &ldquo;substantially the same&rdquo; when used in reference to a nucleotide or amino acid sequence is intended to mean that the function of the polypeptide encoded by the nucleotide or amino acid sequence is essentially the same as the referenced parental nucleotide or amino acid sequence. For example, changes in a nucleotide or amino acid sequence that results in substitution of amino acids that differ from the parent molecule but that do not alter the desired activity of the encoded polypeptide would result in substantially the same sequence. A nucleotide or amino acid sequence is substantially the same if the difference in that sequence from the reference parental sequence does not result in any measurable difference in the desired activity of the encoded polypeptide. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> The invention provides a method for identifying a thermostable polymerase having altered fidelity. The method consists of generating a random population of polymerase mutants by mutating at least one amino acid residue of a thermostable polymerase and screening the population for one or more active polymerase mutants by genetic selection. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> The generation and identification of polymerases having altered fidelity or altered catalytic activity is accomplished by first creating a population of mutant polymerases through random sequence mutagenesis of regions within the polymerase that can influence the fidelity of polymerization (Loeb, L. A., <highlight><italic>Adv. Pharmacol. </italic></highlight>35:321-347 (1996)). The identification of active mutants is performed in vivo and is based on genetic complementation of conditional polymerase mutants under non-permissive conditions. Once identified, the active polymerases are then screened for fidelity of polynucleotide synthesis. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> The methods of the invention employ a population of polymerase mutants and the screening of the polymerase mutant population to identify an active polymerase mutant. Using a population of polymerase mutants is advantageous in that a number of amino acid substitutions including single amino acid and multiple amino acid substitutions can be examined for their effect on polymerase fidelity. The use of a population of polymerase mutants increases the probability of identifying a polymerase mutant having a desired fidelity. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> Screening a population of polymerase mutants has the additional advantage of alleviating the need to make predictions about the effect of specific amino acid substitutions on the activity of the polymerase. The substitution of single amino acids has limited predictability as to its effect on enzymatic activity and the effect of multiple amino acid substitutions is virtually unpredictable. The methods of the invention allow for screening a large number of polymerase mutants which can include single amino acid substitutions and multiple amino acid substitutions. In addition, using screening methods that select for active polymerase mutants has the additional advantage of eliminating inactive mutants that could complicate screening procedures that require purification of polymerase mutants to determine activity. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> Moreover, the methods of the invention allow for targeting of amino acid residues adjacent to immutable or nearly immutable amino acid residues. Immutable or nearly immutable amino acid residues are residues required for activity, and those immutable residues located in the active site provide critical residues for polymerase activity. Mutating amino acid residues adjacent to these required residues provides the greatest likelihood of modulating the activity of the polymerase. Introducing random mutations at these sites increases the probability of identifying a mutant polymerase having a desired alteration in activity such as altered fidelity. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> A polymerase is selected as a parent polymerase to introduce mutations for generating a library of mutants. Polymerases obtained from thermophlic organisms such as <highlight><italic>Thermus aquaticus </italic></highlight>have particularly desirable enzymatic characteristics due to their stability and activity at high temperatures. Thermostable polymerases are stable and retain activity at temperatures greater than about 37&deg; C., generally greater than about 50&deg; C., and particularly greater than about 90&deg; C. The use of the thermostable polymerase Taq DNA polymerase I as a parent polymerase to generate polymerase mutants is disclosed herein (see Example I). </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> Although a specific embodiment using Taq DNA polymerase I is disclosed in the examples, the methods of the invention can similarly be applied to other thermostable polymerases other than Thermus aquaticus DNA polymerases. Such other polymerases include, for example, RNA polymerases from Thermus aquaticus and RNA and DNA polymerases from other thermostable bacteria. Using the guidance provided herein in reference to DNA polymerases, those skilled in the art can apply the teachings of the invention to the generation and identification of these other polymerases having altered fidelity of polynucleotide synthesis. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> In addition to creating mutant DNA polymerases from organisms that grow at elevated temperatures, the methods of the invention can similarly be applied to non-thermostable polymerases provided that there is a selection or screen such as the genetic complementation of a conditional polymerase mutation as described herein (see Example I). Such a selection or screen of a non-thermostable polymerase can be, for example, the inducible or repressible-expression of an endogenous polymerase. Polymerases having altered fidelity can similarly be generated and selected from both prokaryotic and eukaryotic cells as well as viruses. Those skilled in the art will know how to apply the teachings described herein to the generation of polymerases having altered fidelity from such other organisms and such other cell types. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> Thus, the invention provides a general method for the production of a polymerase that has an altered fidelity in DNA or RNA synthesis. The method consists of producing a population of sufficient size and diversity so as to contain at least one polymerase molecule having an altered fidelity and then screening that population to identify the polymerase having altered fidelity. The altered polymerase fidelity can be either an increase or decrease in the accuracy of DNA synthesis. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> In one embodiment, the invention involves the production of a relatively large population of randomly mutagenized nucleic acids encoding a polymerase and introduction of the population into host cells to produce a library. The mutagenized polymerase encoding nucleic acids are expressed, and the library is screened for active polymerase mutants by complementation of a temperature sensitive mutation of an endogenous polymerase. Colonies which are viable at the non-permissive temperature are those which have polymerase encoding nucleic acids which code for active mutants. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> To generate a random population of polymerase mutants, a random sequence of nucleotides is substituted for a defined target sequence of a plasmid-encoded gene that specifies a biologically active molecule. In one application of this procedure, a double-stranded oligodeoxyribonucleotide is provided by hybridizing two partially complementary oligonucleotides, one or both of which contain random sequences at specified positions. The partially double-stranded oligonucleotide is filled in by DNA polymerase, cut at restriction sites and ligated into a DNA vector. The plasmid encodes the gene for a thermostable DNA polymerase, and the oligonucleotide is inserted in place of a portion of the gene that modulates the fidelity of DNA synthesis. After ligation, the reconstructed plasmids constitute a library of different nucleic acid sequences encoding the thermostable DNA polymerase and polymerase mutants. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> As disclosed herein, a genetic screen can be used to identify active polymerase mutants having altered fidelity. The library of nucleic acid sequences encoding polymerase and polymerase mutants are transfected into a bacterial strain such as <highlight><italic>E. coli </italic></highlight>strain recA718 polA12, which contains a temperature sensitive mutation in DNA polymerase. Exogenous DNA polymerases have been shown to functionally substitute for <highlight><italic>E. coli </italic></highlight>DNA polymerase I using <highlight><italic>E. coli </italic></highlight>strain recA718 polA12 and to complement the observed growth defect at elevated temperature, presumably caused by the instability of the endogenous DNA polymerase I at elevated temperatures (Sweasy and Loeb, <highlight><italic>J. Biol. Chem. </italic></highlight>267:1407-1410 (1992); Kim and Loeb, <highlight><italic>Proc. Natl. Acad. Sci USA </italic></highlight>92:684-688 (1995)). It was unknown, however, whether a thermostable polymerase could substitute for <highlight><italic>E. coli </italic></highlight>DNA polymerase given the distinct and harsh environment experienced by thermophilic organisms in which enzymes must function at extremely high temperatures. As disclosed herein, wild type Taq DNA polymerase I was found to complement the growth defect of <highlight><italic>E. coli </italic></highlight>strain-recA718 polA12 (see Example I). Using such a complementation system, various mutant Taq DNA polymerase I mutants were identified in host bacteria that harbor plasmids encoding active thermoresistant DNA polymerases that allowed bacterial growth and colony formation at elevated (restrictive) temperatures (see Examples I and II). </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> The invention also provides a method for identifying a thermostable polymerase having altered fidelity. The method consists of generating a random population of polymerase mutants by mutating at least one amino acid residue in an active site O-helix of a thermostable polymerase and screening the population for one or more active polymerase mutants. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> The invention additionally provides a method for identifying a thermostable polymerase having altered catalytic activity. The method consists of generating a random population of polymerase mutants by mutating at least one amino acid residue of a thermostable polymerase and screening the population for one or more active polymerase mutants. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> A random population of polymerase mutants is generated by mutating one or more amino acid residues in an active site O-helix target sequence of a thermostable polymerase. The O-helix has been postulated to interact with the substrate template complex (Joyce and Steitz, supra, (1994)). The O-helix has been observed in the crystal structure of <highlight><italic>E. coli </italic></highlight>DNA polymerase I Klenow fragment and Taq DNA polymerase (Beese et al., <highlight><italic>Science </italic></highlight>260:352-355 (1993); Kim et al., <highlight><italic>Nature </italic></highlight>376:612-616 (1995)). As disclosed in Example II, random sequences were substituted for nucleotides encoding amino acids Arg659 through Tyr671 of the O-helix of Taq DNA polymerase I to generate a random population of polymerase mutants. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> Using a genetic complementation screen, a variety of active Taq DNA polymerase I mutants were identified (see Example II). Several amino acid residues were found to be immutable or nearly immutable based on the complementation assay. These immutable or nearly immutable amino acid residues in the O-helix are Arg659, Lys663, Phe667 and Tyr671. As used herein, a wild type amino acid is designated as a residue preceding the number of the amino acid position. A mutated amino acid is designated as a residue following the number of the amino acid position. These immutable or nearly immutable sites are unable to be altered and still maintain the function of the DNA polymerase. Due to their position in the active site O-helix of Taq DNA polymerase I, these immutable or nearly immutable residues provide critical residues that are required for the activity of the polymerase. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> In addition to the O-helix of a polymerase, other regions of the polymerase can be targeted for random mutagenesis to generate a library of polymerase mutants to identify polymerase mutants having altered fidelity. Those skilled in the art can determine other regions to target for mutagenesis. Such other regions can be identified, for example, by sequence homology to other polymerases, which suggests conservation of function. Conserved sequences can also be used to identify target regions for mutagenesis based on activity studies of other polymerases. Protein structural models revealing the convergence of amino acid residues at the active site of a polymerase can similarly be used to identify target regions for mutagenesis. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> Alternatively, mutagenesis throughout the polymerase can be used to identify amino acid residues critical for polymerase function. Sequences containing these critical amino acid residues are target sequences for introducing random mutations to identify mutants having altered fidelity. Methods for identifying critical amino acid residues by introducing a small number of random mutations throughout a gene segment are well known to those skilled in the art and include, for example, copying by mutagenic polymerases, exposure of templates to DNA damaging agents prior to inserting into cells and replacement of regions of the DNA template with oligonucleotides containing sparsely populated random inserts. For example, a population of oligonucleotides with 91% correct substitutions and 3% of the non-complementary nucleotides at each position can be generated. Screening for polymerase mutants can be performed, for example, with the genetic complementation assay disclosed herein. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> The invention also provides a method for identifying a thermostable polymerase having altered fidelity. The method consists of generating a random population of polymerase mutants by mutating one or more amino acid residues adjacent to an immutable or nearly immutable residue in an active site O-helix of a thermostable polymerase and screening the population for one or more active polymerase mutants. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> In one embodiment, substitutions at amino acids adjacent to immutable or nearly immutable residues are used to identify polymerase mutants having altered fidelity. The adjacent amino acid residues can be immediately adjacent in the linear sequence or can be nearby. Adjacent residues that are nearby can be as many as two amino acids away from the immutable or nearly immutable residue in the linear sequence. A nearby residue can also be nearby in the three-dimensional structure of the polymerase and can be determined from a crystallographic molecular model of a polymerase. Nearby residues are in close enough proximity to an immutable or nearly immutable residue to modulate the activity of the polymerase. Generally, nearby residues are within two amino acid residues in the linear sequence from an immutable or nearly immutable residue or are within about 5 &angst; of the immutable or nearly immutable residues, in particular within about 3 &angst;. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> Substitutions involving amino acid residues adjacent to immutable or nearly immutable sites have been found to alter the fidelity of DNA synthesis (see Examples IV and V). The identified immutable or nearly immutable amino acid residues correspond to amino acid residues Arg659, Lys663, Phe667 and Tyr671 of Taq DNA polymerase I. Thus, the invention is directed to altering one or more amino acid residues adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase. Amino acid residues adjacent to these immutable residues include, for example, amino acids corresponding to Arg660, Ala661, Ala662, Thr664, Ile665, Asn666, Gly668, Val669 and Leu670 in Taq DNA polymerase I. Corresponding residues in other polymerases are also included and can be identified based on sequence homology or based on corresponding amino acids in structurally similar domains as defined by a crystallographic molecular model. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> The methods of the invention are also directed to altering residues immediately adjacent to the immutable or nearly immutable residues. Thus, the methods of the invention are directed to altering residues adjacent to required residues on DNA polymerases and identifying those mutations which have an effect on the fidelity of DNA synthesis. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> The invention further provides methods for determining a fidelity of the active polymerase mutant. The fidelity of active polymerase mutants can be determined by several methods. The active polymerases can be, for example, screened for altered fidelity from crude extracts of bacterial cells grown from the viable colonies. Methods for determining fidelity of synthesis are disclosed herein (see Example III). In one method, a primer extension assay is used with a biased ratio of nucleoside triphosphates consisting of only three of the nucleoside triphosphates. Elongation of the primer past template positions that are complementary to the deleted nucleoside triphosphate substrate in the reaction mixture results from errors in DNA synthesis. Processivity of high fidelity polymerases will terminate when they encounter a template nucleotide complementary to the missing nucleoside triphosphate whereas the low fidelity polymerases will be more likely to misincorporate a non-complementary nucleotide. The accuracy of incorporation for the primer extension assay can be measured by physical criteria such as by determining the size or the sequence of the extension product. This method is particularly suitable for screening for low fidelity mutants since increases in chain elongation are easily and rapidly quantitated. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> A second method for determining the fidelity of polymerase mutants employs a forward mutation assay. A template containing a single stranded gap in a reporter gene such as lacZ is used for the forward mutation assay. Filling in of the gapped segment is carried out by crude heat denatured bacterial extracts harboring plasmids expressing a thermostable DNA polymerase mutant. For determining low fidelity polymerase mutants, reactions are carried out in the presence of equimolar concentrations of each nucleoside triphosphate. For determining high fidelity polymerase mutants, the reaction is carried out with a biased pool of nucleoside triphosphates. Using a biased pool of nucleoside triphosphates results in incorporation of errors in the synthesized strand that are proportional to the ratio of non-complementary to complementary nucleoside triphosphates in the reaction. Therefore, the bias exaggerates the errors produced by the polymerases and facilitates the identification of high fidelity mutants. The fidelity of DNA synthesis is determined from the number of mutations produced in the reporter gene. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> Procedures other than those described above for identifying and characterizing the fidelity of a polymerase are known in the art and can be substituted for identifying high or low fidelity mutants. Those skilled in the art can determine which procedures are appropriate depending on the needs of a particular application. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> Also provided herein is an isolated thermostable polymerase mutant having altered fidelity. The polymerase mutant has one or more mutated amino acid residues in the active site O-helix of a thermostable polymerase. Additionally provided is an isolated thermostable polymerase mutant having altered fidelity. The polymerase mutant has one or more mutated amino acid residues adjacent to an immutable or nearly immutable amino acid residue in the active site O-helix of a thermostable polymerase. The mutated amino acid residue is adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> The invention also provides an isolated thermostable polymerase mutant having altered fidelity, where the polymerase has one or more mutated amino acid residues adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase and the mutant is a high fidelity mutant. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> Using the methods of the invention, a number of mutants have been identified as having high fidelity of DNA synthesis. For example, polymerases having one or more single-base substitutions adjacent to Arg659, Lys663, Phe667, and Tyr671 in the nucleotide sequence of Taq DNA polymerase I have been identified. Specific examples of these high fidelity mutants include, for example, polymerases having the single substitutions Asn666Asp, Asn666Ile, Ile665Leu, Leu670Val, Arg660Tyr Arg660Ser, Gly668Arg, Arg660Lys, Gly668Ser and Gly668Gln; polymerases having the double substitutions consisting of Thr664Ile together with Asn666Asp, and Ala661Ser together with Val669Leu; as well as polymerases having the triple substitutions consisting of Thr664Pro, Ile665Val together with Asn666Tyr, and Ala661Glu, Ile665Thr together with Phe667Leu. Additional high fidelity mutants include, for example, Phe667Leu and Phe667Tyr. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> The invention provides a high fidelity polymerase mutant having one or more amino acid substitutions selected from the group consisting of Phe667Leu; Asn666Asp; Asn666Ile; Ile665Leu; Leu670Val; Arg660Tyr; Arg660Ser; Gly668Arg; Arg660Lys; Gly668Ser; Gly668Gln; Thr664Ile and Asn666Asp; Ala661Ser and Val669Leu; Ala661Glu, Ile665Thr, and Phe667Leu; and Thr664Pro, Ile665Val and Asn666Tyr. The polymerase mutant Phe667Tyr has been previously described and is excluded from the compositions of the invention. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> The invention also provides an isolated thermostable polymerase mutant having altered fidelity, where the polymerase has one or more mutated amino acid residues adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase and the mutant is a low fidelity mutant. The invention additionally provides a low fidelity polymerase mutant having one or more amino acid substitutions selected from the group consisting of Ala661Glu; Ala661Pro; Thr664Pro; Thr664Asn; Thr664Arg; Asn666Val; Thr664Pro and Val669Ile; Arg660Pro and Leu670Thr; Arg660Trp and Thr664Lys; Ala662Gly and Thr664Asn; Ala661Gly and Asn666Ile; Ala661Pro and Asn666Ile; and Ala661Ser, Ala662Gly, Thr664Ser and Asn666Ile. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> Low fidelity mutant DNA polymerases include mutations involving substitutions at Ala661, Thr664, Asn666, and Leu670. Specific examples of low fidelity mutants include, for example, polymerases having the single substitutions Ala661Glu, Ala661Pro, Thr664Pro, Thr664Asn, Thr664Arg and Asn666Val; polymerases having the double substitutions consisting of Thr664Pro together with Val669Ile, Arg660Pro together with Leu670Thr, Arg660Trp together with Thr664Lys, Ala664Gly together with Thr664Asn, Ala661Gly together with Asn666Ile, and Ala661Pro together with Asn666Ile; as well as polymerases having four substitutions consisting of Ala661Ser, Ala662Gly, Thr664Ser together with Asn666Ile. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> For both the high fidelity and the low fidelity mutations described above, the invention provides polymerases other than Taq DNA polymerase having mutations at corresponding positions. In particular, the invention provides thermostable polymerases other than Taq DNA polymerase that have mutations at corresponding positions and that have altered fidelity. Those skilled in the art can determine corresponding positions based on sequence homology between the polymerases. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> The invention also provides an isolated nucleic acid molecule encoding a polymerase mutant having high fidelity. The nucleic acid molecule contains a nucleotide sequence encoding substantially an amino acid sequence of Taq DNA polymerase I having one or more amino acid substitutions selected from the group consisting of Phe667Leu; Asn666Asp; Asn666Ile; Ile665Leu; Leu670Val; Arg660Tyr; Phe667Tyr; Arg660Ser; Gly668Arg; Arg660Lys; Gly668Ser; Gly668Gln; Thr664Ile and Asn666Asp; Ala661Ser and Val669Leu; Ala661Glu, Ile665Thr, and Phe667Leu; and Thr664Pro, Ile665Val and Asn666Tyr. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> Additionally provided is an isolated nucleic acid molecule encoding a polymerase mutant having low fidelity. The nucleic acid molecule contains a nucleotide sequence encoding substantially an amino acid sequence of Taq DNA polymerase I having a substitution of one or more amino acids selected from the group consisting of Ala661, Thr664, Asn666 and Leu670. The invention also provides a polymerase mutant having one or more amino acid substitutions selected from the group consisting of Ala661Glu; Ala661Pro; Thr664Pro; Thr664Asn; Thr664Arg; Asn666Val; Thr664Pro and Val669Ile; Arg660Pro and Leu670Thr; Arg660Trp and Thr664Lys; Ala664Gly and Thr664Asn; Ala661Gly and Asn666Ile; Ala661Pro and Asn666Ile; and Ala661Ser, Ala662Gly, Thr664Ser and Asn666Ile. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> The invention also provides methods for the identification of one or more mutations in a gene using the high fidelity mutant DNA polymerases of the invention. For example, the use of a high fidelity mutant to amplify a gene of interest gives greater confidence that the amplified sequence will more accurately reflect the actual sequence in the sample and minimizes the introduction of artifactual mutations during amplification of the gene. The higher accuracy of gene amplification provided by a high fidelity mutant also improves the identification of genetic mutations due to the increased confidence that observed mutations are more likely to reflect genetic mutations in the sample rather than artifactual mutations introduced during amplification. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> Additionally, the invention provides methods for identifying one or more mutations in a gene by amplifying the gene using a high fidelity polymerase mutant under conditions which allow polymerase chain reaction amplification. The gene is amplified by exposing the strands of the gene to repeated cycles of denaturing, annealing and elongation to produce an amplified gene product. Methods for amplifying genes using PCR are well known to those skilled in the art and include those described previously in <highlight><italic>PCR Primer. A Laboratory Manual, </italic></highlight>Dieffenbach and Dveksler, eds., Cold Spring Harbor Press, Plainview, N.Y. (1995). The presence or absence of one or more mutations in the gene can be determined by sequencing the amplified product using methods well known to those skilled in the art. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> The invention provides methods for accurately copying repetitive nucleotide sequences by amplifying the repetitive nucleotide sequence using a high fidelity polymerase mutant. The repetitive nucleotide sequence can be in a gene or in a microsatellite between genes. The methods of amplifying the repetitive nucleotide sequences are carried out under conditions which allow PCR amplification with repeated cycles of denaturing, annealing and elongation as described above. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> The high fidelity mutants of the invention are advantageous for copying repetitive nucleotide sequences such as repetitive DNA because polymerases found in nature undergo slippage when copying DNA containing repetitive sequences. Therefore when polymerases found in nature are used, the amplification products of a nucleotide sequence containing a repetitive sequence do not accurately reflect the size or sequence of a DNA sequence in a sample. However, the use of a high fidelity polymerase mutant greatly increases the accuracy of an amplification product to reflect the actual size and sequence of the repetitive DNA sequence in the sample. Repetitive DNA can be found in microsatellites, which contain multiple repetitive nucleotide sequences and are dispersed throughout the genome. These repetitive di-, tri- and tetranucleotides are frequently, but not invariably, located between genes. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The invention also provides a method for determining an inherited mutation by amplifying a gene using a high fidelity polymerase mutant. Such an inherited mutation can be correlated with a genetic disease, thereby allowing diagnosis of the genetic disease. The invention additionally provides methods for diagnosing a genetic disease by amplifying a gene using a high fidelity polymerase mutant. A genetic disease is one in which a disease is caused by a genetic mutation in a coding or non-coding region of DNA. Such a genetic mutation can be a somatic mutation or a germline mutation. The methods of the invention can be used to diagnose any genetic disease using high fidelity polymerase mutants. Such genetic diseases can involve point mutations, insertions and deletions. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> The methods of the invention employ high fidelity polymerase mutants and can similarly be used to diagnose genetic diseases involving repetitive DNA. In one embodiment, the genetic disease involves mutations in a microsatellite or repetitive DNA. Microsatellites are relatively stable in normal cells but are found to be unstable and to vary in length in some forms of hereditary and non-hereditary cancer, including hereditary nonpolyposis colorectal cancer (HNPCC), other cancers that arise in HNPCC families, Muir-Torre syndrome and small-cell lung cancer (Loeb, <highlight><italic>Cancer Res. </italic></highlight>54:5059-5063 (1994); Brentnall, <highlight><italic>Am. J. Pathol. </italic></highlight>147:561-563 (1995); Honchel et al., <highlight><italic>Semin. Cell Biol. </italic></highlight>6:45-52 (1995); Eshleman and Markowitz, <highlight><italic>Curr. Opin. Oncol. </italic></highlight>7:83-89 (1995)). Microsatellite instability appears to be confined to tumors and is not present in normal tissues of affected individuals. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> The accuracy of amplification products of repetitive DNA sequences provided by the high fidelity mutants of the invention can be used to diagnose diseases involving mutations in repetitive DNA sequences. For example, with tumor samples, the accurate amplification of repetitive DNA sequences can be used to diagnose those cancers involving variable length in microsatellite DNA. Since microsatellite instability appears to be confined to tumors, amplification of repetitive DNA using the high fidelity mutants of the invention can additionally be applied to determining the prognosis or extent of disease of a cancer patient, evaluating outcomes of therapy, staging tumors and determining tumor status. High fidelity mutants of the invention can also be applied to amplify DNA in blood samples to identify circulating cells containing microsatellite instability as an indicator of a cancerous state. </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> Other genetic diseases also involve repetitive DNA sequences, in particular, unstable triplet repeats. These unstable triplet repeat diseases involve increasing lengths of triplet repeat regions, ranging from &tilde;50 repeats in normal individuals, &tilde;200 repeats in carriers to &tilde;2000 repeats in affected individuals. Such unstable triplet repeat diseases include, for example, fragile X syndrome, spinal and bulbar muscular atrophy, myotonic dystrophy, Huntington&apos;s disease, spinocereballar ataxia type 1, fragile X E mild mental retardation and dentatorubral pallidoluysian atrophy (Monckton and Caskey, <highlight><italic>Circulation </italic></highlight>91:513-520 (1995)). The diagnosis of unstable triplet repeat diseases is particularly valuable since the onset of symptoms can occur later in some diseases and the severity of the symptoms of some diseases can be correlated with the size of the extended triplet repeat region. Thus, amplification of these triplet repeat regions to more accurately reflect the actual size of the triplet repeat in the individual provides more accurate diagnosis and prognosis of the disease. Amplification of the large expanded regions associated with triplet repeat diseases can be carried out using low fidelity polymerase mutants of the invention since low fidelity polymerase mutants would be more likely to copy through very long stretches of repetitive nucleotide sequences. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> One method for identifying a genetic disease involves utilization of primers that hybridize to specific genes. The primers contain 3&prime;-terminal nucleotides complementary to the corresponding nucleotide in the mutant but not to the wild type gene. The mismatched primer is used to extend the primer template in the presence of a high fidelity mutant polymerase. The presence of an extension product is indicative of a mutant gene. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> The mismatch PCR method is based on the fact that a PCR primer that is not complementary to the template at the 3&prime; end is an inefficient substrate for polymerases such as Taq DNA polymerase I. Wild type Taq DNA polymerase will occasionally misextend a mismatched primer, resulting in a false positive in an assay for a gene mutation. For example, a mutant gene with a rare TT mutation would be difficult to specifically amplify out of a pool of DNA molecules containing a wild type CC at the position of the TT mutant because wild type Taq DNA polymerase would occasionally misextend the wild type gene using the mismatched primer. In contrast, a high fidelity polymerase would not extend the mismatched primer. The products of a high fidelity polymerase in the mismatch PCR assay would therefore correspond to the mutant gene and would have fewer false positives than that observed with wild type Taq DNA polymerase. Thus, the more discriminating assay based on the use of high fidelity polymerases results in a better assay for detecting somatic mutations. The use of high fidelity mutants in such a mismatch-PCR based assay is disclosed herein (see Example V). </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> The invention also provides a method for randomly mutagenizing a gene by amplifying the gene using the low fidelity polymerase mutants of the invention. The low fidelity polymerase mutants exhibit an efficiency of accurate base incorporation that is less than that of wild type polymerases. The efficiency of the low fidelity polymerase mutant is about 50% or more, generally 10% or more, and particularly 1% or more than that of a wild type polymerase. These low fidelity polymerase mutants would therefore exhibit between 2-fold to 100-fold lower fidelity than wild type polymerase. The introduction of mutations into specific genes using low fidelity polymerase mutants of the invention is useful for determining the effects of mutations on the function of those gene products. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> It is understood that modifications which do not substantially affect the activity of the various embodiments of this invention are also included within the definition of the invention provided herein. Accordingly, the following examples are intended to illustrate but not limit the present invention. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE I </heading>
</section>
<section>
<heading lvl="1">Random Sequence Mutagenesis and Identification of Active Taq DNA Polymerase Mutants </heading>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> This example demonstrates random nucleotide sequence mutagenesis of a polymerase target sequence and identification of active polymerase mutants. </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> Random sequence mutagenesis was used to introduce mutations into the O-helix of Taq DNA polymerase. Briefly, the Taq DNA polymerase I gene was obtained from the bacterial chromosome by cloning in pKK223-3 (Pharmacia Biotech, Piscataway, N.J.). A 3.2-kb fragment containing the Taq DNA polymerase I gene, including the 5&prime;-3&prime; exonuclease domain and the tac promoter region, was further transferred into the SalI site of pHSG576 (pTacTaq). The Taq DNA polymerase I gene was sequenced to confirm wild type sequence except for the lack of the N-terminal three amino acids. </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> A vector containing a nonfunctional insert within the Taq DNA polymerase I gene was constructed and subsequently replaced with an oligonucleotide containing the random sequence to avoid contamination with incompletely cut vectors. To generate the nonfunctional vector, a SacII site was produced using site-directed mutagenesis by changing 2070C to G using a synthetic oligomer, 5&prime;-GGG TCC ACG GCC TCC CGC GGG ACG CCG AAC ATC CAG CTG (SEQ ID NO:3) (SacII-2) and the single-stranded plasmid pFC85 (Kunkel, <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>82:488-492 (1985)). The BstX1-NheI fragment that carries the SacII site was substituted for the corresponding fragment in pTacTaq (pTacTaqSac). A SacII-NheI fragment in pTacTaqSac was further replaced with the synthetic oligomer 5&prime;-GGA CTG CAT ATG ACT G (SEQ ID NO:4) (DUM-U) hybridized with 5&prime;-CTA GCA GTC ATA TGC AGT CCG C (SEQ ID NO:5) (DUM-D) to create the nonfunctional vector (Dube et al., <highlight><italic>Biochemistry </italic></highlight>30:11760-11767 (1991)). </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> Oligonucleotides containing 9% random sequence, in which each nucleotide indicated in parentheses was 91% wild type nucleotide and 3% each of the other three nucleotides, were synthesized by Keystone Laboratories (Menlo Park, Calif.): O&plus;9 RANDOM is 5&prime;-CGG GAG GCC GTG GAC CCC CTG ATG (CGC CGG GCG GCC AAG ACC ATC AAC TTC GGG GTC CTC TAC) GGC ATG TCG GCC CAC CG (SEQ ID NO:6); O-0 RANDOM is 5&prime;-TGG CTA GCT CCT GGG AGA GGC GGT GGG CCG ACA TGC C (SEQ ID NO:7). The 17 nucleotide sequences at the 3&prime; ends of the two oligonucleotides are complementary. Equimolar amounts of these oligonucleotides (20 pmol) were mixed, hybridized, and extended by five cycles of PCR reaction (94&deg; C. for 30 sec, 57&deg; C. for 30 sec, and 72&deg; C. for 30 sec) in a 100 &mgr;l reaction mixture containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl<highlight><subscript>2</subscript></highlight>, 0.001% gelatin, 50 &mgr;M dNTPs, and 2.5 units of Taq DNA polymerase I. This PCR product (10 &mgr;l) was further amplified 25 cycles with 20 pmol of O(&plus;)PRIMER (5&prime;-TTC GGC GTC CCG CGG GAG GCC GTG GAC CCC CT)(SEQ ID NO:8) and 20 pmol of O(&minus;)PRIMER (5&prime;-GTA AGG GAT GGC TAG CTC CTG GGA)(SEQ ID NO:9) under the same conditions. The amplified product was purified by phenol/chloroform extraction followed by ethanol precipitation and digestion with the restriction enzymes, SacII and NheI, at 37&deg; C. for 30 min in 50 mM Tris-HCl (pH 7.9), 50 mM NaCl, 10 mM MgCl<highlight><subscript>2 </subscript></highlight>and 1 mM dithiothreitol. The restriction fragment containing the random sequence was purified by phenol/chloroform extraction, ethanol precipitation, and filtration using a Microcon 30 filter (Amicon, Beverly, Mass.). For the totally random library, five oligonucleotides (80-mers), each having totally random sequence at one of the codons 659, 660, 663, 667 or 668, were combined in equal amounts and hybridized to O-0 RANDOM. After extension and digestion with endonucleases, the combined products were purified and processed as above. </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> A random library of Taq DNA polymerase genes containing randomized nucleotide sequence corresponding to the O-helix was generated by digesting the vector containing the nonfunctional insert with NheI and SacII restriction endonucleases. The large DNA fragment was isolated by electrophoresis in a 0.8% agarose gel and purified by using GenCleanII (Bio101, Vista, Calif.). This large fragment, lacking the nonfunctional insert, was ligated with an oligonucleotide containing randomized sequence by incubating overnight at 16&deg; C. with T4 DNA ligase. The ligation mixture was then used to transform DH5&agr; by electroporation according to Bio-Rad (Hercules, Calif.). After electroporation, 1 ml of SOC (2% bactotryptone/0.5% yeast extract/10 mM NaCl/2.5 mM KCl/10 MM MgCl<highlight><subscript>2</subscript></highlight>/10 mM MgSO<highlight><subscript>4</subscript></highlight>/20 mM glucose) was added and incubation continued for 1 h at 37&deg; C. An aliquot was plated on 2&times;YT (16 g/liter tryptone, 10 g/liter yeast extract, 5 g/liter NaCl, pH 7.3) containing 30 &mgr;g/ml chloramphenicol to determine the total number of transformants, and the remainder was inoculated into 500 ml of 2&times;YT containing 30 &mgr;g/ml chloramphenicol and cultured at 37&deg; C. overnight. Plasmids (random library vector) were purified and used for transformation of recA718 polA12 strain. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> For genetic complementation to determine active polymerase mutants, <highlight><italic>E. coli </italic></highlight>recA719 polA12 cells (SC18-12 <highlight><italic>E. coli </italic></highlight>B/r strain, which has the genotype recA718 polA12 uvrA155 trpE65 lon-11 sulA1) were transformed with plasmids pHSG576 or pTacTaq by electroporation (Bio-Rad Genepulser, 2kV, 25 &mgr;FD, 400 &OHgr;) (Sweasy and Loeb, supra, (1992); Sweasy and Loeb, <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>90:4626-4630 (1993); Witkin and Roegner-Maniscalo, <highlight><italic>J. Bacteriol. </italic></highlight>174:4166-4168 (1992)). Thereafter, 1 ml of nutrient broth (NB) (8 g/liter) containing NaCl (4 g/liter) and 1 mM isopropyl &bgr;-D-thiogalactoside (IPTG) was added and the mixture was incubated for 1 h at 37&deg; C. The transformed cells were plated on nutrient agar plates (containing 23 g/liter Difco nutrient agar, 5 g/liter NaCl, 30 &mgr;g/ml chloramphenicol, 12.5 &mgr;g/ml tetracycline and 1 mM IPTG) and grown at 30&deg; C. overnight. Single colonies were transferred to NB for growth to logarithmic phase at 30&deg; C. Thereafter, &tilde;10 &mgr;l (10<highlight><superscript>4 </superscript></highlight>cells) was introduced at the center of an agar plate, and the inoculation loop was gradually moved from the center to the periphery as the plate was rotated. Duplicate plates were incubated at 30&deg; C. or 37&deg; C. for 30 h. To determine complementation efficiency by Taq DNA polymerase I and to isolate mutants, cultures of the recA718 polA12 strain harboring either pHSG576 or Taq DNA polymerase I were diluted with NB medium and plated (&tilde;500 colonies per plate). Duplicate plates were incubated at 30&deg; C. or 37&deg; C., and visible colonies were counted after a 30 h incubation. Complementation was verified by a second round of electroporation and colony formation at the nonpermissive temperature. Cell-free extracts were prepared from selected colonies obtained at the restrictive temperature and assayed to confirm that they contained a temperature-resistant DNA polymerase activity (Lawyer et al., <highlight><italic>J. Biol. Chem. </italic></highlight>264:6427-6437 (1989)). </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> Wild type Taq DNA polymerase I was tested for its ability to complement a temperature sensitive polymerase contained in the <highlight><italic>E. coli </italic></highlight>strain recA718 polA12, which is unable to grow at 37&deg; C. in rich media at low cell density (Witkin and Roegner-Maniscalo, 1992, supra). The temperature sensitive phenotype of <highlight><italic>E. coli </italic></highlight>strain recA718 polA12 was complemented by transformation with the pTacTaq plasmid encoding wild type Taq DNA polymerase I as indicated by growth at 37&deg; C. Therefore, this <highlight><italic>E. coli </italic></highlight>strain containing a temperature sensitive polymerase provides a good model system for testing Taq DNA polymerase I mutants. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> To evaluate the involvement of different amino acid residues in catalysis by Taq DNA polymerase I, random sequences were substituted for nucleotides encoding a portion of the substrate binding site of Taq DNA polymerase I (O-helix, amino acids Arg659 through Tyr671). The substituted stretch was 39 nucleotides long with 9% randomization. At each position the proportion of the wild type residue was 91% and the other 3 nucleotides were present in equal amounts (3% each). </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> A library of 50,000 independent mutants was obtained. The number of colonies obtained at 37&deg; C. was 11.8% of that obtained at 30&deg; C. Therefore, screening a randomized library using <highlight><italic>E. coli </italic></highlight>strain recA718 polA12 provided approximately 5900 colonies containing active Taq DNA polymerase and potential polymerase mutants. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> These results show that a randomized library can be used to generate a population of polymerase mutants. These results also show the identification of active Taq DNA polymerase I mutants by screening for active polymerase mutants using genetic selection. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE II </heading>
</section>
<section>
<heading lvl="1">Identification of Taq DNA Polymerase I Mutants and Immutable or Nearly Immutable Amino Acid Residues </heading>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> This example describes the identification Taq DNA polymerase I mutants generated by a randomized library and the identification of immutable or nearly immutable amino acid residues. </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> The active Taq DNA polymerase I mutants identified by the screen described in Example I were further characterized. The entire random nucleotide-containing insert was sequenced from a total of 234 plasmids obtained at 37&deg; C. (positively selected), 16 plasmids obtained at 30&deg; C. (nonselected) and 29 plasmids obtained at 30&deg; C., which failed to grow at 37&deg; C. (negatively selected). All substitutions were in the randomized nucleotides except for 12 clones. </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> Among the 230 positive plasmids, 168 contained silent mutations in one or more codons. At the amino acid level, 106 encoded the wild type residue and 124 encoded substitutions, in accord with the expected distribution in the plasmid population. Of the 124 plasmids with amino acid changes, 40 were unique mutants obtained just once. The remaining 84 plasmids represented 21 different mutants. At least 79% of those encoding the same amino acid substitutions were independently derived since they contained different silent mutations in other codons. In total, 61 different amino acid sequences were obtained that complemented the temperature-sensitive phenotype of the recA718 polA12 host. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> A compilation of the amino acid substitutions found in Taq DNA polymerase I is shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. Solid boxes indicate the amino acid residues for which no substitutions were detected. Dashed boxes mark the amino acid positions where only conservative substitutions were found. The amino acid positions of Taq DNA polymerase I and corresponding positions of <highlight><italic>E. coli </italic></highlight>DNA polymerase I are indicated at the top. WT represents the wild type sequence and randomized amino acids are written in boldface type. The amino acids that have not been found in the DNA polymerase I family are outlined (Braithwaite and Ito, <highlight><italic>Nucleic Acids Res. </italic></highlight>21:787-802 (1993)). Panel A shows single mutations selected from the 9% library listed under the wild type amino acids. Panel B shows the sequence of each multiply substituted mutant selected from the 9% library. Panel C shows mutations selected from the totally random library. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> The distribution of single amino acid substitutions among the active mutants was not random (see <cross-reference target="DRAWINGS">FIG. 2A</cross-reference>). For example, numerous diverse substitutions were observed at Ala661 and Thr664. In contrast, no substitutions were detected at five positions (Arg659, Arg660, Lys663, Phe667 and Gly668). This uneven distribution of replacements is unlikely to be the result of a bias in the nucleotide composition of the random insert since sequencing of both the nonselected and negatively selected plasmids revealed multiple nucleotide substitutions at each of the targeted positions and because silent mutations were detected at each of these positions in the selected clones. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> A nonrandom distribution of substitutions was also observed among active mutants containing multiple substitutions (see <cross-reference target="DRAWINGS">FIG. 2B</cross-reference>). Again, Ala661 and Thr664 were replaced with a variety of residues. However, no amino acid substitutions were observed in place of Arg659, Lys663 and Gly668, even though different silent nucleotide substitutions were found at each of these positions. A comparison of <cross-reference target="DRAWINGS">FIGS. 2A and B</cross-reference> shows that substitutions at Arg660 and Phe667 occur only in the presence of substitutions at other positions. In addition to the mutants containing multiple substitutions shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>B, two additional triple mutants were also found: mutant 44, with Ala661Pro, Thr664Arg, and Val669Leu; and mutant 54, with Ala661Thr, Thr664Pro and Ile665Val. </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> The partially substituted library (9%) does not provide a vigorous test of the immutability of specific codons. Only 0.07% of sequences at each codon would be expected to contain nucleotide substitutions at all three positions. To further probe the mutability of specific amino acid residues, a second library was constructed that contained totally random substitutions at a limited number of designated codons. In this library, nucleotides encoding each of the five amino acids Arg659, Arg660, Lys663, Phe667 and Gly668 were randomized. These were amino acid positions that did not yield single substitutions in the 9% random library (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>). Approximately 1300 transformants, which is 4 times more than the number required for each possible substitution at each of the target codons, were screened. At the nonpermissive temperature, 113 colonies were obtained, 84 of which contained codons that encoded the wild type amino acid sequence. Most of the amino acid substitutions occurred in place of Arg660 or Gly668. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> Again, Arg659 and Lys663 were completely conserved, with 16 and 5 silent mutations scored at these codons, respectively. The expected number of silent mutations were 21 and 4.2, respectively, assuming that the 5 randomized oligomers that comprised the library were mixed in equimolar proportions. These numbers show that the oligomers were roughly equally represented in the library and that sufficient mutants were sampled to conclude that Arg659 and Lys663 are immutable in these genetic complementation experiments (P&lt;0.05 for Met and Trp, P&lt;0.01 for all other substitutions). Only Tyr substituted for Phe at position 667 (<cross-reference target="DRAWINGS">FIG. 2C</cross-reference>), and six silent mutations were scored for this codon. An additional mutant obtained with the totally randomized library but not shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference> is mutant 601, with double substitutions Ile665Asn and Val669Ile. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> These results show that generating a random library and screening by genetic complementation provided a number of active Taq DNA polymerase I mutants. These results also show that amino acid residues Arg659 and Lys663 were found to be immutable and Phe667 and Tyr671 were found to tolerate only conservative substitutions. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE III </heading>
</section>
<section>
<heading lvl="1">Determination of the Fidelity of Active Taq DNA Polymerase I Mutants </heading>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> This example describes methods of determining the fidelity of active Taq DNA polymerase I mutants. Two types of assays are useful for determining the fidelity of active polymerase mutants, a primer extension assay and a forward mutation assay. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> Crude extracts were used to determine the fidelity of polymerase mutants. A single colony of <highlight><italic>E. coli </italic></highlight>DH5&agr; (F<highlight><superscript>&minus;</superscript></highlight>, &phgr;80dlacZ&Dgr;M15, &Dgr;(lacZYA-argF)U169, deoR, recA1, endA1, phoA, hsdR17(r<highlight><subscript>k</subscript></highlight><highlight><superscript>&minus;</superscript></highlight>m<highlight><subscript>k</subscript></highlight><highlight><superscript>&plus;</superscript></highlight>), supE44, &lgr;<highlight><superscript>&minus;</superscript></highlight>, thi-1, gyrA96, relA1) carrying wild type or mutant Taq DNA polymerase I was inoculated into 40 ml of 2&times;YT (16 g/liter tryptone, 10 g/liter yeast extract, 5 g/liter NaCl, pH 7.3) containing 30 mg/liter chloramphenicol. After incubation at 37&deg; C. overnight with vigorous shaking, an equal amount of fresh medium with 0.5 mM IPTG was added, and incubation was continued for 4 h. Cells were harvested, washed once with TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) and suspended in 100 &mgr;l of buffer A (50 mM Tris-HCl, pH 8.0, 2.4 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 0.5 mg/liter leupeptin, 1 mM EDTA, 250 mM KCl). Bacteria were lysed by incubating with lysozyme (0.2 mg/ml) at 0&deg; C. for 2 h. The lysate was centrifuged at 15,000 rpm (Sorvall, SA-600 rotor) (DuPont, Newtown, Conn.) for 15 min, and the supernatant solution was incubated at 72&deg; C. for 20 min. Insoluble material was removed by centrifugation. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> Polymerases were purified as described previously with some modifications (Lawyer et al., <highlight><italic>PCR Methods Application </italic></highlight>2:275-287 (1993). Briefly, a single colony of <highlight><italic>E. coli </italic></highlight>DH5&agr; carrying wild type or mutant Taq DNA polymerase I was inoculated into 10 ml of 2&times;YT. Two ml of the inoculum was immediately added to each of 5 bottles containing 1 liter of 2&times;YT with 30 mg/liter chloramphenicol. After overnight incubation at 37&deg; C. with vigorous shaking, 1 liter of 2&times;YT containing 30 mg/liter chloramphenicol and 0.5 mM IPTG was added, and incubation was continued for 4 h. Cells were harvested, washed once with TE buffer and suspended in 100 ml buffer A. Bacteria were lysed by incubating with lysozyme (0.2 mg/ml) at 0&deg; C. for 2 h and then sonicating on ice for 45 sec by using a micro-tip probe (Sonifier, Branson Sonic Power, Danbury, Conn.). </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> The lysate was centrifuged at 15,000 rpm (Sorvall, SA-600 rotor) for 15 min, and the supernatant solution was incubated at 72&deg; C. for 20 min. Insoluble material was removed by centrifugation. Ammonium sulfate (0.2 M) and Polymin P (0.6%) were added and the suspension was held on ice for 1 h. After removal of the precipitate by centrifugation and filtration through a Costar 8310 filter, the filtrate was applied to a 3&times;8-cm phenyl-SEPHAROSE HP (Pharmacia Biotech) column equilibrated with buffer A containing 0.2 M ammonium sulfate and 0.01% Triton-X-100. The column was washed with the same buffer (300 ml) and activity was eluted with buffer B (TE buffer containing 0.01% Triton X-100 and 50 mM KCl). The eluate (100 ml) was dialyzed overnight against 4 liters of buffer B and loaded onto a 0.8&times;8-cm heparin-SEPHAROSE CL6B (Pharmacia Biotech) column equilibrated with buffer B. After washing with buffer B (50 ml), activity was eluted in a 30 ml linear gradient of 50-500 mM KCl in TE buffer containing 0.01% Triton X-100. Active fractions were collected, dialyzed against 50 mM Tris-HCl (pH 8.0) containing 50 mM KCl and 50% glycerol, and stored at &minus;80&deg; C. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> To confirm and quantitate the presence of polymerase activity, crude extracts or purified enzyme was incubated at 72&deg; C. for 5 min in 50 mM Tris-HCl (pH 8.0), 2 mM MgCl<highlight><subscript>2</subscript></highlight>, 100 &mgr;M each dATP, dGTP, dCTP and dTTP, 0.2 &mgr;Ci of (<highlight><superscript>3</superscript></highlight>H)dATP and 200 &mgr;g/ml activated calf thymus DNA. Incorporation of radioactivity into an acid-insoluble product was measured according to Battula and Loeb (<highlight><italic>J. Biol. Chem. </italic></highlight>249:4086-4093 (1974). One unit represents incorporation of 10 nmol of dNMP in 1 h, corresponding to 0.1 unit as defined by Perkin-Elmer. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> For the primer extension assay, the 14-mer primer 5&prime;-CGCGCCGAATTCCC (SEQ ID NO:10) was <highlight><superscript>32</superscript></highlight>P-labeled at the 5&prime; end by incubation with (&ggr;<highlight><superscript>&minus;32</superscript></highlight>P)ATP and T4 polynucleotide kinase and annealed to an equimolar amount of the template 46-mer 5&prime;-GCGCGGAAGCTTGGCTGCAGAATATTGCTAGCGGGAATTCGGCGCG (SEQ ID NO:11). Heat-inactivated <highlight><italic>E. coli </italic></highlight>extracts containing 0.3-1 unit of wild type or mutant Taq DNA polymerases were incubated at 45&deg; C. for 60 min in 50 mM Tris-HCl (pH 8.0), 2 mM MgCl<highlight><subscript>2</subscript></highlight>, 50 mM KCl, 20 &mgr;M each dATP, dGTP, dCTP and dTTP and 1.4 ng of the annealed template primer. A set of four additional reactions, each lacking a different dNTP, was carried out for each polymerase. Purified enzyme (1 unit) was incubated for the times indicated under the same conditions as for crude extracts. After electrophoresis in a 14% polyacrylamide gel containing 8M urea, reaction products were analyzed by autoradiography. Extension was quantified by using an NIH imaging program (see http//www.nih.gov/). </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> For the forward mutation assay, the non-coding strand of the lacZ&agr; gene contained in 200 ng of gapped M13mp2 DNA was copied by using 5 units of wild type or mutant Taq DNA polymerase I in a reaction mixture containing 50 mM Tris-HCl (pH 8.0), 2 mM MgCl<highlight><subscript>2 </subscript></highlight>and 50 mM KCl (Feig et al. <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>91:6609-6613 (1994)). For determining low fidelity polymerase mutants, the reaction included 20 &mgr;M each dNTP. For determining high fidelity polymerase mutants, the reaction was carried out with biased dNTP pools containing 0.5 mM of one dNTP and 20 mM of each of the other three dNTPs. For example, the reaction could contain 0.5 mM dATP and 20 mM each of dGTP, dCTP and dTTP. After incubation at 72&deg; C. for 5 min, the DNA was transfected into host <highlight><italic>E. coli </italic></highlight>and the plaques were scored for white and pale blue mutant plaques (Tindall et al., <highlight><italic>Genetics </italic></highlight>118:551-560 (1988)). </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> These results show that the fidelity of active Taq DNA polymerase mutants can be determined using a primer extension assay and a forward mutation assay. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE IV </heading>
</section>
<section>
<heading lvl="1">Identification of Low Fidelity Taq DNA Polymerase I Mutants </heading>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> This example shows the identification of low fidelity Taq DNA polymerase I mutants. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> The active Taq DNA polymerase I mutants identified in Example II were assayed by the methods described in Example III to identify low fidelity mutants. Screening for activity was carried out on 67 of 75 sequenced mutants, including all 38 with single amino acid substitutions described in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. Plasmids encoding the mutant polymerases were cloned, purified and grown in <highlight><italic>E. coli</italic></highlight>, and host cells were analyzed for expression of Taq DNA polymerase I by measuring the activity of crude extracts. <highlight><italic>E. coli </italic></highlight>DNA polymerases and nucleases were inactivated by heating at 72&deg; C. for 20 min. The ability of heat-treated extracts to elongate primers in the absence of a complete complement of four dNTPs was then determined using a set of five reactions. One reaction contained all four complementary nucleoside triphosphates while each of the others lacked a different dNTP (&ldquo;minus conditions&rdquo;). Elongation in the minus reactions is limited by the rate of misincorporation at template positions complementary to the missing dNTP. </paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> A primer extension assay was performed on wild type Taq DNA polymerase I and several mutants, revealing that several mutants had elongation patterns that differed from wild type Taq DNA polymerase. In the presence of all four dNTPs, every extract examined extended more than 90% of the hybridized primer to a product of length similar to that of the template. In the minus reactions, wild type Taq DNA polymerase I extended 48-60% of the primer up to, but not opposite, the first template position complementary to the missing dNTP. The remaining primer was terminated opposite the missing dNTP, presumably by incorporation of a single non-complementary nucleotide, or was terminated further downstream, presumably by extension of the mispaired primer terminus. A variety of elongation patterns was observed for the 67 mutants. Thirteen mutants extended more of the primer and/or synthesized a greater proportion of longer products than the wild type enzyme in three or four of the minus reactions. For example, mutant 2 formed full-length products in reactions lacking dGTP or dTTP. This increased extension presumably reflects increased incorporation and/or extension of non-complementary nucleotides. Other mutants extended less of the primer or synthesized shorter products than the wild type enzyme, for example, mutant 5. In several cases, different amino acid substitutions at the same position either increased or decreased extension in comparable minus reactions. </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> A compilation of amino acid replacements in the 13 mutants that displayed increased extension in at least three of the minus reactions is shown in Table I.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE I</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Low Fidelity Mutants of Taq DNA Polymerase</entry>
</row>
<row>
<entry>I Identified in the Primer Extension Screen</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="14">
<colspec colname="1" colwidth="21PT" align="right"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="14PT" align="center"/>
<colspec colname="4" colwidth="14PT" align="center"/>
<colspec colname="5" colwidth="14PT" align="center"/>
<colspec colname="6" colwidth="21PT" align="center"/>
<colspec colname="7" colwidth="14PT" align="center"/>
<colspec colname="8" colwidth="7PT" align="center"/>
<colspec colname="9" colwidth="14PT" align="center"/>
<colspec colname="10" colwidth="21PT" align="center"/>
<colspec colname="11" colwidth="14PT" align="center"/>
<colspec colname="12" colwidth="21PT" align="center"/>
<colspec colname="13" colwidth="14PT" align="center"/>
<colspec colname="14" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>659</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>663</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>667</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>671</entry>
</row>
<row>
<entry>WT:</entry>
<entry>R</entry>
<entry>R</entry>
<entry>A</entry>
<entry>A</entry>
<entry>K</entry>
<entry>T</entry>
<entry>I</entry>
<entry>N</entry>
<entry>F</entry>
<entry>G</entry>
<entry>V</entry>
<entry>L</entry>
<entry>Y</entry>
</row>
<row><entry namest="1" nameend="14" align="center" rowsep="1"></entry>
</row>
<row>
<entry>29:</entry>
<entry></entry>
<entry></entry>
<entry>E</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>36:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>P</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>I</entry>
</row>
<row>
<entry>40:</entry>
<entry></entry>
<entry></entry>
<entry>P</entry>
</row>
<row>
<entry>45:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>P</entry>
</row>
<row>
<entry>53:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>N</entry>
</row>
<row>
<entry>130:</entry>
<entry></entry>
<entry>P</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>T</entry>
</row>
<row>
<entry>156:</entry>
<entry></entry>
<entry></entry>
<entry>S</entry>
<entry>G</entry>
<entry></entry>
<entry>S</entry>
<entry></entry>
<entry>I</entry>
</row>
<row>
<entry>175:</entry>
<entry></entry>
<entry>W</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>K</entry>
</row>
<row>
<entry>206:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>R</entry>
</row>
<row>
<entry>240:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>G</entry>
<entry></entry>
<entry>N</entry>
</row>
<row>
<entry>247:</entry>
<entry></entry>
<entry></entry>
<entry>G</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>I</entry>
</row>
<row>
<entry>248:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>V</entry>
</row>
<row>
<entry>306:</entry>
<entry></entry>
<entry></entry>
<entry>P</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>I</entry>
</row>
<row><entry namest="1" nameend="14" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0105" lvl="7"><number>&lsqb;0105&rsqb;</number> With the exception of Gly668, one or more substitutions that putatively reduce the accuracy of DNA synthesis were observed for each of the 9 non-conserved amino acids. Eleven mutants harbored substitutions at either Ala661 or Thr664, including several single mutants. This initial screen with crude extracts suggested that a large number of changes are permitted in the O-helix that do not reduce the ability of Taq DNA polymerase I to complement the growth defect of recA718 polA12. Many of the substitutions in the O-helix that do not reduce the ability of Taq DNA polymerase I to carry out functional complementation reduce the fidelity of DNA synthesis in vitro. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> To demonstrate that the reduction in fidelity exhibited by crude extracts is due to mutant Taq DNA polymerase I, wild type enzyme was purified as well as the three single mutants Ala661Glu, Ala661Pro and Thr664Arg. The mutant Ile665Thr, a mutant predicted to have no alteration in fidelity based on complementation assays, was also purified as a control. The mutated enzymes retained at least 29% of wild type activity in vitro, which is in accord with their ability to complement the growth defect caused in <highlight><italic>E. coli </italic></highlight>by temperature-sensitive host DNA polymerase I and ensures that analysis of fidelity will not be complicated by major impairments of catalytic efficiency. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> Primer extension assays were carried out with the homogenous mutant polymerases. Wild type Taq DNA polymerase I extended most of the primer to one nucleotide before the template position opposite the missing complementary dNTP in a 5 min reaction. Only about 30% of the primers were elongated further. In reactions containing equivalent activity, the mutant polymerases Ala661Glu, Thr664Arg and Ala661Pro extended a larger proportion of the primers past the sites where the wild type polymerase ceased synthesis. The control enzyme Ile665Thr yielded an elongation pattern similar to that of the wild type enzyme. Elongation reactions with the three polymerases were also carried out for 60 min. Again, Ala661Glu and Thr664Arg synthesized a greater proportion of longer products than obtained with the wild type and Ile665Thr polymerases. Notably, Ala661Glu, Thr664Arg and Ala661Pro synthesized longer products in 5 min than the wild type did in 60 min. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> To further analyze the reduced fidelity exhibited by the low fidelity polymerase mutants, a time course of primer elongation was carried out. Wild type Taq DNA polymerase I extended 9% of the primers past the first deoxyguanosine template residue within the 60 min incubation period, but elongation past the second deoxyguanosine was not detected. In the same interval, Thr664Arg extended 93% of the primer past the first template deoxyguanosine, and elongation proceeded past as many as five template deoxyguanosines. Importantly, a comparable proportion of primers was extended at all time points, despite the striking difference in the length of the products. These time course data indicate that greater elongation reflects increased ability to utilize non-complementary substrates and primer termini, rather than a putative difference in the amount of activity present. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> In a forward mutation assay, the fidelity of DNA synthesis by the purified polymerases was quantitated by measuring the frequency of mutations produced by copying a biologically active template in vitro (Kunkel and Loeb, <highlight><italic>J. Biol. Chem </italic></highlight>254:5718-5725 (1979)). The target sequence was the lacZ&agr; gene located within a single-stranded region in gapped circular double-stranded M13mp2 DNA (Feig and Loeb, <highlight><italic>Biochemistry </italic></highlight>32:4466-4473 (1993)). The gapped segment was filled by synthesis with the wild type or mutant enzymes. The double-stranded circular product was transfected into <highlight><italic>E. coli</italic></highlight>, and the mutation frequency was determined by scoring white and pale blue mutant plaques. A comparison of the specific activities and mutation frequencies of the purified enzymes is presented in Table II. After synthesis by wild type Taq DNA polymerase I, the mutation frequency was not greater than that of the uncopied control. Synthesis by Ala661Glu and Thr664Arg gave rise to mutation frequencies more than 7- and 25-fold greater, respectively, than that of the wild type polymerase.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE II</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Mutation Frequency in the lacZ&agr; Forward</entry>
</row>
<row>
<entry>Mutation Assay</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="56PT" align="left"/>
<colspec colname="1" colwidth="35PT" align="center"/>
<colspec colname="2" colwidth="70PT" align="center"/>
<colspec colname="3" colwidth="56PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Specific</entry>
<entry></entry>
<entry>Mutation</entry>
</row>
<row>
<entry></entry>
<entry>Activity</entry>
<entry>Plaques Scored</entry>
<entry>Frequency</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="42PT" align="left"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="42PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="56PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Taq Pol I</entry>
<entry>units/mg</entry>
<entry>Total</entry>
<entry>Mutant</entry>
<entry>x10<highlight><superscript>&minus;3</superscript></highlight></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="42PT" align="left"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="42PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="char" char="."/>
<colspec colname="5" colwidth="56PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>WT</entry>
<entry>66,000</entry>
<entry>8,637</entry>
<entry>22</entry>
<entry>2.5</entry>
</row>
<row>
<entry></entry>
<entry>A661E</entry>
<entry>45,000</entry>
<entry>6,782</entry>
<entry>116</entry>
<entry>17.1</entry>
</row>
<row>
<entry></entry>
<entry>T664R</entry>
<entry>23,000</entry>
<entry>5,148</entry>
<entry>324</entry>
<entry>62.9</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> A sample of independent, randomly chosen mutants produced by Thr664Arg was characterized by DNA sequence analysis using a THERMO SEQUENASE cycle sequencing kit (Amersham Life Science, Cleveland, Ohio). Both base substitutions and frameshifts were found throughout the targeted lacZ&agr; gene and its regulatory sequence. Of the 64 independent plaques, 57 had mutations in the target. Other mutations presumably occurred outside the target region. Some had more than one base substitution and a total of 66 mutations were observed (see <cross-reference target="DRAWINGS">FIG. 3</cross-reference>). Among them, 61 were base substitutions. Transitions (38/61) were more frequent than transversions (23/61). T&rarr;C transitions accounted for 31 of 61 base substitutions, while T&rarr;A (9/61), A&rarr;T (8/61) and G&rarr;A (5/61) substitutions were less frequent. This base substitution spectrum is essentially the same as that reported for wild type Taq DNA polymerase I (Tindall and Kunkel, supra, 1988). From these data, the base substitution fidelity of Thr664Arg can be calculated as 8.6&times;10<highlight><superscript>&minus;4 </superscript></highlight>or 1 error per 1200 nucleotides. On the basis of the five frameshift mutants detected, the frameshift error can be calculated as 4.9&times;10<highlight><superscript>&minus;5 </superscript></highlight>or 1 error per 20,000 nucleotides. </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> These results show that low fidelity Taq DNA polymerase I mutants were identified from a randomized library using a genetic complementation screen. The fidelity of Taq DNA polymerase I mutants was determined by primer extension assays and forward mutation assays. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE V </heading>
</section>
<section>
<heading lvl="1">Identification of High Fidelity Taq DNA Polymerase I Mutants </heading>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> This example shows the identification of high fidelity Taq DNA polymerase I mutants. </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> The active Taq DNA polymerase I mutants identified in Example II were assayed by the methods described in Example III to identify high fidelity mutants. A panel of 75 active polymerases was screened. Candidate high fidelity polymerase mutants are shown in Table III.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="259PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE III</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Candidate High Fidelity Mutants of Taq DNA Polymerase I</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="14">
<colspec colname="1" colwidth="21PT" align="right"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="14PT" align="center"/>
<colspec colname="4" colwidth="14PT" align="center"/>
<colspec colname="5" colwidth="14PT" align="center"/>
<colspec colname="6" colwidth="21PT" align="center"/>
<colspec colname="7" colwidth="14PT" align="center"/>
<colspec colname="8" colwidth="14PT" align="center"/>
<colspec colname="9" colwidth="14PT" align="center"/>
<colspec colname="10" colwidth="21PT" align="center"/>
<colspec colname="11" colwidth="14PT" align="center"/>
<colspec colname="12" colwidth="14PT" align="center"/>
<colspec colname="13" colwidth="14PT" align="center"/>
<colspec colname="14" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>659</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>663</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>667</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>671</entry>
</row>
<row>
<entry>WT:</entry>
<entry>R</entry>
<entry>R</entry>
<entry>A</entry>
<entry>A</entry>
<entry>K</entry>
<entry>T</entry>
<entry>I</entry>
<entry>N</entry>
<entry>F</entry>
<entry>G</entry>
<entry>V</entry>
<entry>L</entry>
<entry>Y</entry>
</row>
<row><entry namest="1" nameend="14" align="center" rowsep="1"></entry>
</row>
<row>
<entry>FL:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>L</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry>74:</entry>
<entry></entry>
<entry></entry>
<entry>E</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>T</entry>
<entry></entry>
<entry>L</entry>
</row>
<row>
<entry>146:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>D</entry>
</row>
<row>
<entry>147:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>I</entry>
</row>
<row>
<entry>149:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>I</entry>
<entry></entry>
<entry>D</entry>
</row>
<row>
<entry>169:</entry>
<entry></entry>
<entry></entry>
<entry>S</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>L</entry>
</row>
<row>
<entry>186:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>L</entry>
</row>
<row>
<entry>219:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>P</entry>
<entry>V</entry>
<entry>Y</entry>
</row>
<row>
<entry>254:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>V</entry>
</row>
<row>
<entry>407:</entry>
<entry></entry>
<entry>Y</entry>
</row>
<row>
<entry>424:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Y</entry>
</row>
<row>
<entry>426:</entry>
<entry></entry>
<entry>S</entry>
</row>
<row>
<entry>487:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>R</entry>
</row>
<row>
<entry>488:</entry>
<entry></entry>
<entry>K</entry>
</row>
<row>
<entry>530:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>S</entry>
</row>
<row>
<entry>614:</entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Q</entry>
</row>
<row><entry namest="1" nameend="14" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0114" lvl="7"><number>&lsqb;0114&rsqb;</number> Thirteen of the active polymerases exhibited greater accuracy in DNA synthesis. Table IV summarizes the results of a forward mutation assay of some of these high fidelity mutants. Several polymerase mutants displayed higher fidelity than the wild type Taq DNA polymerase. Polymerase mutants exhibiting particularly high fidelity are mutant 424, with Phe667Tyr, mutant 426, with Arg660Ser and mutant 488, with Arg660Lys.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE IV</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Fidelity of Taq DNA Polymerase Mutants in a</entry>
</row>
<row>
<entry>lacZ Forward Mutation Assay</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="35PT" align="left"/>
<colspec colname="2" colwidth="63PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="77PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>Mutation</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Total</entry>
<entry>Mutant</entry>
<entry>Frequency</entry>
</row>
<row>
<entry></entry>
<entry>Enzyme</entry>
<entry>Plaques</entry>
<entry>Plaques</entry>
<entry>x10<highlight><superscript>&minus;3</superscript></highlight></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="35PT" align="left"/>
<colspec colname="2" colwidth="63PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="char" char="."/>
<colspec colname="4" colwidth="77PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Wild Type</entry>
<entry>5680</entry>
<entry>49</entry>
<entry>8.6</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="203PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>High Fidelity Mutants</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="35PT" align="left"/>
<colspec colname="2" colwidth="63PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="char" char="."/>
<colspec colname="4" colwidth="77PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>MS147</entry>
<entry>7249</entry>
<entry>47</entry>
<entry>6.5</entry>
</row>
<row>
<entry></entry>
<entry>MS169</entry>
<entry>7275</entry>
<entry>34</entry>
<entry>5.1</entry>
</row>
<row>
<entry></entry>
<entry>MS254</entry>
<entry>6898</entry>
<entry>40</entry>
<entry>5.8</entry>
</row>
<row>
<entry></entry>
<entry>MS424</entry>
<entry>4810</entry>
<entry>14</entry>
<entry>2.7</entry>
</row>
<row>
<entry></entry>
<entry>MS426</entry>
<entry>5727</entry>
<entry>23</entry>
<entry>4.1</entry>
</row>
<row>
<entry></entry>
<entry>MS488</entry>
<entry>3442</entry>
<entry>13</entry>
<entry>1.5</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="203PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Low Fidelity Mutant</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="35PT" align="left"/>
<colspec colname="2" colwidth="63PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="char" char="."/>
<colspec colname="4" colwidth="77PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>MS206</entry>
<entry>3333</entry>
<entry>133</entry>
<entry>40</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> These results show that Taq DNA polymerase mutants were identified and found to exhibit higher fidelity than wild type Taq DNA polymerase. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE VI </heading>
</section>
<section>
<heading lvl="1">High Fidelity Taq DNA Polymerase Mutants Enhance the Sensitivity of Mismatch PCR-based Assays for Somatic Mutations </heading>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> This example shows the use of high fidelity mutants obtained by mutating the active site O-helix of Taq DNA polymerase I to enhance the sensitivity of mismatch PCR-based assays for somatic mutations. </paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> Mismatch PCR is the basis of allele-specific identification of inherited mutations within genes and somatic mutations that occur in tumors. In these studies, one compares the extension of a correctly matched primer with the lack of extension using a primer with a 3&prime;-terminal mismatch. The rate of extension by DNA polymerase using a primer with a single mismatch compared to a primer with a 3&prime;-complementary base pair (matched) terminus is approximately 10<highlight><superscript>&minus;5 </superscript></highlight>(Perinno and Loeb, <highlight><italic>J. Biol. Chem. </italic></highlight>262:2898-2905 (1989)). Elongation from a double mismatch is even less frequent, and thus offers an even more stringent test of the inability of mutant Taq DNA polymerases to elongate a mismatched primer terminus. </paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> A template containing the wild type sequence of human DNA polymerase-&bgr; at nucleotide positions 886-889 (CC<highlight><uline>CC</uline></highlight>TGGG) was utilized. PCR reactions were carried out with two complementary primers that flank the sequence (matched) or with one matched template and a second mismatched template containing a terminally mismatched primer with AA at the 3&prime; terminal position. The AA would be across from the CC (underlined) in the template strand. In these studies, the ratio of templates containing the complementary and non-complementary sequences were varied. The PCR amplified product was separated by polyacrylamide gel electrophoresis and quantitated by phosphoimage analysis. Wild type Taq DNA polymerase detected one molecule of template containing a TT substitution in place of the two template CC when present in a population of 10<highlight><superscript>5 </superscript></highlight>molecules containing the non-mutant templates with the CC substitution. In contrast, both of the high fidelity Taq DNA polymerase mutants, with substitutions Phe667Tyr and Arg659Ser, detected one molecule of the TT template amongst 10<highlight><superscript>8 </superscript></highlight>molecules of the CC template when the primer contained two terminal 3&prime;-AA nucleotide residues. </paragraph>
<paragraph id="P-0119" lvl="0"><number>&lsqb;0119&rsqb;</number> These results show that high fidelity Taq DNA polymerase mutants have two to three orders of magnitude enhanced sensitivity for detecting mutant DNA using a mismatch PCR-based assay. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE VII </heading>
</section>
<section>
<heading lvl="1">High Fidelity Taq DNA Polymerase Mutants Enhance Sensitivity of Detection of Repetitive DNA Sequences </heading>
<paragraph id="P-0120" lvl="0"><number>&lsqb;0120&rsqb;</number> This example demonstrates the use of high fidelity polymerase mutants to enhance the sensitivity and accuracy of amplifying repetitive DNA sequences. </paragraph>
<paragraph id="P-0121" lvl="0"><number>&lsqb;0121&rsqb;</number> Detection of the length of unstable microsatellite DNA in certain human tumors has depended on PCR amplification of specific sequences and determination of changes in electrophoretic mobility in gels. Due to the slippage of DNA polymerase while copying repetitive DNA, the interpretation of the results of this method have remained unsatisfactory. </paragraph>
<paragraph id="P-0122" lvl="0"><number>&lsqb;0122&rsqb;</number> High fidelity Taq DNA polymerases are identified using the methods described in Examples I and III. DNA templates containing runs of CA repeats with the number of repeats varying from 5 to 50 are used to test high fidelity Taq DNA polymerase mutants. After 20 to 70 rounds of PCR amplification, the product of the reaction is displayed on polyacrylamide gels. High fidelity polymerase mutants which display less slippage errors copying the repetitive sequences are identified. These high fidelity polymerase mutants are used to amplify repetitive DNA sequences in samples, for example tissue or tumor samples. </paragraph>
<paragraph id="P-0123" lvl="0"><number>&lsqb;0123&rsqb;</number> These results show that high fidelity mutants having enhanced sensitivity and accuracy in amplifying repetitive DNA sequences can be identified and used to amplify repetitive DNA in tissue or tumor samples. </paragraph>
<paragraph id="P-0124" lvl="0"><number>&lsqb;0124&rsqb;</number> Throughout this application various publications have been referenced. The disclosures of these publications in their entireties are hereby incorporated by reference in this application in order to more fully describe the state of the art to which this invention pertains. </paragraph>
<paragraph id="P-0125" lvl="0"><number>&lsqb;0125&rsqb;</number> Although the invention has been described with reference to the disclosed embodiments, those skilled in the art will readily appreciate that the specific experiments detailed are only illustrative of the invention. It should be understood that various modifications can be made without departing from the spirit of the invention.  </paragraph>
</section>
</detailed-description>
</subdoc-description>
<sequence-cwu id="SEQLST-1">
<number>1</number>
<sequence-list-old-rules>
<s-1>
<s-1-iii>
11 
</s-1-iii>
</s-1>
<s-2 seq-no="1 ">
<s-2-i>
<s-2-i-a>2626 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>both </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-ix>
<s-2-ix-a>CDS </s-2-ix-a>
<s-2-ix-b> 121..2616 
</s-2-ix-b>
</s-2-ix>
<s-2-xi> 1 
AAGCTCAGAT CTACCTGCCT GAGGGCGTCC GGTTCCAGCT GGCCCTTCCC GAGGGGGAGA     60 
GGGAGGCGTT TCTAAAAGCC CTTCAGGACG CTACCCGGGG GCGGGTGGTG GAAGGGTAAC    120 
ATG AGG GGG ATG CTG CCC CTC TTT GAG CCC AAG GGC CGG GTC CTC CTG      168 
Met Arg Gly Met Leu Pro Leu Phe Glu Pro Lys Gly Arg Val Leu Leu 
  1               5                  10                  15 
GTG GAC GGC CAC CAC CTG GCC TAC CGC ACC TTC CAC GCC CTG AAG GGC      216 
Val Asp Gly His His Leu Ala Tyr Arg Thr Phe His Ala Leu Lys Gly 
             20                  25                  30 
CTC ACC ACC AGC CGG GGG GAG CCG GTG CAG GCG GTC TAC GGC TTC GCC      264 
Leu Thr Thr Ser Arg Gly Glu Pro Val Gln Ala Val Tyr Gly Phe Ala 
         35                  40                  45 
AAG AGC CTC CTC AAG GCC CTC AAG GAG GAC GGG GAC GCG GTG ATC GTG      312 
Lys Ser Leu Leu Lys Ala Leu Lys Glu Asp Gly Asp Ala Val Ile Val 
     50                  55                  60 
GTC TTT GAC GCC AAG GCC CCC TCC TTC CGC CAC GAG GCC TAC GGG GGG      360 
Val Phe Asp Ala Lys Ala Pro Ser Phe Arg His Glu Ala Tyr Gly Gly 
 65                  70                  75                  80 
TAC AAG GCG GGC CGG GCC CCC ACG CCG GAG GAC TTT CCC CGG CAA CTC      408 
Tyr Lys Ala Gly Arg Ala Pro Thr Pro Glu Asp Phe Pro Arg Gln Leu 
                 85                  90                  95 
GCC CTC ATC AAG GAG CTG GTG GAC CTC CTG GGG CTG GCG CGC CTC GAG      456 
Ala Leu Ile Lys Glu Leu Val Asp Leu Leu Gly Leu Ala Arg Leu Glu 
            100                 105                 110 
GTC CCG GGC TAC GAG GCG GAC GAC GTC CTG GCC AGC CTG GCC AAG AAG      504 
Val Pro Gly Tyr Glu Ala Asp Asp Val Leu Ala Ser Leu Ala Lys Lys 
        115                 120                 125 
GCG GAA AAG GAG GGC TAC GAG GTC CGC ATC CTC ACC GCC GAC AAA GAC      552 
Ala Glu Lys Glu Gly Tyr Glu Val Arg Ile Leu Thr Ala Asp Lys Asp 
    130                 135                 140 
CTT TAC CAG CTC CTT TCC GAC CGC ATC CAC GTC CTC CAC CCC GAG GGG      600 
Leu Tyr Gln Leu Leu Ser Asp Arg Ile His Val Leu His Pro Glu Gly 
145                 150                 155                 160 
TAC CTC ATC ACC CCG GCC TGG CTT TGG GAA AAG TAC GGC CTG AGG CCC      648 
Tyr Leu Ile Thr Pro Ala Trp Leu Trp Glu Lys Tyr Gly Leu Arg Pro 
                165                 170                 175 
GAC CAG TGG GCC GAC TAC CGG GCC CTG ACC GGG GAC GAG TCC GAC AAC      696 
Asp Gln Trp Ala Asp Tyr Arg Ala Leu Thr Gly Asp Glu Ser Asp Asn 
            180                 185                 190 
CTT CCC GGG GTC AAG GGC ATC GGG GAG AAG ACG GCG AGG AAG CTT CTG      744 
Leu Pro Gly Val Lys Gly Ile Gly Glu Lys Thr Ala Arg Lys Leu Leu 
        195                 200                 205 
GAG GAG TGG GGG AGC CTG GAA GCC CTC CTC AAG AAC CTG GAC CGG CTG      792 
Glu Glu Trp Gly Ser Leu Glu Ala Leu Leu Lys Asn Leu Asp Arg Leu 
    210                 215                 220 
AAG CCC GCC ATC CGG GAG AAG ATC CTG GCC CAC ATG GAC GAT CTG AAG      840 
Lys Pro Ala Ile Arg Glu Lys Ile Leu Ala His Met Asp Asp Leu Lys 
225                 230                 235                 240 
CTC TCC TGG GAC CTG GCC AAG GTG CGC ACC GAC CTG CCC CTG GAG GTG      888 
Leu Ser Trp Asp Leu Ala Lys Val Arg Thr Asp Leu Pro Leu Glu Val 
                245                 250                 255 
GAC TTC GCC AAA AGG CGG GAG CCC GAC CGG GAG AGG CTT AGG GCC TTT      936 
Asp Phe Ala Lys Arg Arg Glu Pro Asp Arg Glu Arg Leu Arg Ala Phe 
            260                 265                 270 
CTG GAG AGG CTT GAG TTT GGC AGC CTC CTC CAC GAG TTC GGC CTT CTG      984 
Leu Glu Arg Leu Glu Phe Gly Ser Leu Leu His Glu Phe Gly Leu Leu 
        275                 280                 285 
GAA AGC CCC AAG GCC CTG GAG GAG GCC CCC TGG CCC CCG CCG GAA GGG     1032 
Glu Ser Pro Lys Ala Leu Glu Glu Ala Pro Trp Pro Pro Pro Glu Gly 
    290                 295                 300 
GCC TTC GTG GGC TTT GTG CTT TCC CGC AAG GAG CCC ATG TGG GCC GAT     1080 
Ala Phe Val Gly Phe Val Leu Ser Arg Lys Glu Pro Met Trp Ala Asp 
305                 310                 315                 320 
CTT CTG GCC CTG GCC GCC GCC AGG GGG GGC CGG GTC CAC CGG GCC CCC     1128 
Leu Leu Ala Leu Ala Ala Ala Arg Gly Gly Arg Val His Arg Ala Pro 
                325                 330                 335 
GAG CCT TAT AAA GCC CTC AGG GAC CTG AAG GAG GCG CGG GGG CTT CTC     1176 
Glu Pro Tyr Lys Ala Leu Arg Asp Leu Lys Glu Ala Arg Gly Leu Leu 
            340                 345                 350 
GCC AAA GAC CTG AGC GTT CTG GCC CTG AGG GAA GGC CTT GGC CTC CCG     1224 
Ala Lys Asp Leu Ser Val Leu Ala Leu Arg Glu Gly Leu Gly Leu Pro 
        355                 360                 365 
CCC GGC GAC GAC CCC ATG CTC CTC GCC TAC CTC CTG GAC CCT TCC AAC     1272 
Pro Gly Asp Asp Pro Met Leu Leu Ala Tyr Leu Leu Asp Pro Ser Asn 
    370                 375                 380 
ACC ACC CCC GAG GGG GTG GCC CGG CGC TAC GGC GGG GAG TGG ACG GAG     1320 
Thr Thr Pro Glu Gly Val Ala Arg Arg Tyr Gly Gly Glu Trp Thr Glu 
385                 390                 395                 400 
GAG GCG GGG GAG CGG GCC GCC CTT TCC GAG AGG CTC TTC GCC AAC CTG     1368 
Glu Ala Gly Glu Arg Ala Ala Leu Ser Glu Arg Leu Phe Ala Asn Leu 
                405                 410                 415 
TGG GGG AGG CTT GAG GGG GAG GAG AGG CTC CTT TGG CTT TAC CGG GAG     1416 
Trp Gly Arg Leu Glu Gly Glu Glu Arg Leu Leu Trp Leu Tyr Arg Glu 
            420                 425                 430 
GTG GAG AGG CCC CTT TCC GCT GTC CTG GCC CAC ATG GAG GCC ACG GGG     1464 
Val Glu Arg Pro Leu Ser Ala Val Leu Ala His Met Glu Ala Thr Gly 
        435                 440                 445 
GTG CGC CTG GAC GTG GCC TAT CTC AGG GCC TTG TCC CTG GAG GTG GCC     1512 
Val Arg Leu Asp Val Ala Tyr Leu Arg Ala Leu Ser Leu Glu Val Ala 
    450                 455                 460 
GAG GAG ATC GCC CGC CTC GAG GCC GAG GTC TTC CGC CTG GCC GGC CAC     1560 
Glu Glu Ile Ala Arg Leu Glu Ala Glu Val Phe Arg Leu Ala Gly His 
465                 470                 475                 480 
CCC TTC AAC CTC AAC TCC CGG GAC CAG CTG GAA AGG GTC CTC TTT GAC     1608 
Pro Phe Asn Leu Asn Ser Arg Asp Gln Leu Glu Arg Val Leu Phe Asp 
                485                 490                 495 
GAG CTA GGG CTT CCC GCC ATC GGC AAG ACG GAG AAG ACC GGC AAG CGC     1656 
Glu Leu Gly Leu Pro Ala Ile Gly Lys Thr Glu Lys Thr Gly Lys Arg 
            500                 505                 510 
TCC ACC AGC GCC GCC GTC CTG GAG GCC CTC CGC GAG GCC CAC CCC ATC     1704 
Ser Thr Ser Ala Ala Val Leu Glu Ala Leu Arg Glu Ala His Pro Ile 
        515                 520                 525 
GTG GAG AAG ATC CTG CAG TAC CGG GAG CTC ACC AAG CTG AAG AGC ACC     1752 
Val Glu Lys Ile Leu Gln Tyr Arg Glu Leu Thr Lys Leu Lys Ser Thr 
    530                 535                 540 
TAC ATT GAC CCC TTG CCG GAC CTC ATC CAC CCC AGG ACG GGC CGC CTC     1800 
Tyr Ile Asp Pro Leu Pro Asp Leu Ile His Pro Arg Thr Gly Arg Leu 
545                 550                 555                 560 
CAC ACC CGC TTC AAC CAG ACG GCC ACG GCC ACG GGC AGG CTA AGT AGC     1848 
His Thr Arg Phe Asn Gln Thr Ala Thr Ala Thr Gly Arg Leu Ser Ser 
                565                 570                 575 
TCC GAT CCC AAC CTC CAG AAC ATC CCC GTC CGC ACC CCG CTT GGG CAG     1896 
Ser Asp Pro Asn Leu Gln Asn Ile Pro Val Arg Thr Pro Leu Gly Gln 
            580                 585                 590 
AGG ATC CGC CGG GCC TTC ATC GCC GAG GAG GGG TGG CTA TTG GTG GCC     1944 
Arg Ile Arg Arg Ala Phe Ile Ala Glu Glu Gly Trp Leu Leu Val Ala 
        595                 600                 605 
CTG GAC TAT AGC CAG ATA GAG CTC AGG GTG CTG GCC CAC CTC TCC GGC     1992 
Leu Asp Tyr Ser Gln Ile Glu Leu Arg Val Leu Ala His Leu Ser Gly 
    610                 615                 620 
GAC GAG AAC CTG ATC CGG GTC TTC CAG GAG GGG CGG GAC ATC CAC ACG     2040 
Asp Glu Asn Leu Ile Arg Val Phe Gln Glu Gly Arg Asp Ile His Thr 
625                 630                 635                 640 
GAG ACC GCC AGC TGG ATG TTC GGC GTC CCC CGG GAG GCC GTG GAC CCC     2088 
Glu Thr Ala Ser Trp Met Phe Gly Val Pro Arg Glu Ala Val Asp Pro 
                645                 650                 655 
CTG ATG CGC CGG GCG GCC AAG ACC ATC AAC TTC GGG GTC CTC TAC GGC     2136 
Leu Met Arg Arg Ala Ala Lys Thr Ile Asn Phe Gly Val Leu Tyr Gly 
            660                 665                 670 
ATG TCG GCC CAC CGC CTC TCC CAG GAG CTA GCC ATC CCT TAC GAG GAG     2184 
Met Ser Ala His Arg Leu Ser Gln Glu Leu Ala Ile Pro Tyr Glu Glu 
        675                 680                 685 
GCC CAG GCC TTC ATT GAG CGC TAC TTT CAG AGC TTC CCC AAG GTG CGG     2232 
Ala Gln Ala Phe Ile Glu Arg Tyr Phe Gln Ser Phe Pro Lys Val Arg 
    690                 695                 700 
GCC TGG ATT GAG AAG ACC CTG GAG GAG GGC AGG AGG CGG GGG TAC GTG     2280 
Ala Trp Ile Glu Lys Thr Leu Glu Glu Gly Arg Arg Arg Gly Tyr Val 
705                 710                 715                 720 
GAG ACC CTC TTC GGC CGC CGC CGC TAC GTG CCA GAC CTA GAG GCC CGG     2328 
Glu Thr Leu Phe Gly Arg Arg Arg Tyr Val Pro Asp Leu Glu Ala Arg 
                725                 730                 735 
GTG AAG AGC GTG CGG GAG GCG GCC GAG CGC ATG GCC TTC AAC ATG CCC     2376 
Val Lys Ser Val Arg Glu Ala Ala Glu Arg Met Ala Phe Asn Met Pro 
            740                 745                 750 
GTC CAG GGC ACC GCC GCC GAC CTC ATG AAG CTG GCT ATG GTG AAG CTC     2424 
Val Gln Gly Thr Ala Ala Asp Leu Met Lys Leu Ala Met Val Lys Leu 
        755                 760                 765 
TTC CCC AGG CTG GAG GAA ATG GGG GCC AGG ATG CTC CTT CAG GTC CAC     2472 
Phe Pro Arg Leu Glu Glu Met Gly Ala Arg Met Leu Leu Gln Val His 
    770                 775                 780 
GAC GAG CTG GTC CTC GAG GCC CCA AAA GAG AGG GCG GAG GCC GTG GCC     2520 
Asp Glu Leu Val Leu Glu Ala Pro Lys Glu Arg Ala Glu Ala Val Ala 
785                 790                 795                 800 
CGG CTG GCC AAG GAG GTC ATG GAG GGG GTG TAT CCC CTG GCC GTG CCC     2568 
Arg Leu Ala Lys Glu Val Met Glu Gly Val Tyr Pro Leu Ala Val Pro 
                805                 810                 815 
CTG GAG GTG GAG GTG GGG ATA GGG GAG GAC TGG CTC TCC GCC AAG GAG     2616 
Leu Glu Val Glu Val Gly Ile Gly Glu Asp Trp Leu Ser Ala Lys Glu 
            820                 825                 830 
TGATACCACC                                                          2626 
</s-2-xi>
</s-2>
<s-2 seq-no="2 ">
<s-2-i>
<s-2-i-a>832 amino acids </s-2-i-a>
<s-2-i-b>amino acid </s-2-i-b>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-ii>
<s-2-ii-mt>protein </s-2-ii-mt>
</s-2-ii>
<s-2-xi> 2 
Met Arg Gly Met Leu Pro Leu Phe Glu Pro Lys Gly Arg Val Leu Leu 
  1               5                  10                  15 
Val Asp Gly His His Leu Ala Tyr Arg Thr Phe His Ala Leu Lys Gly 
             20                  25                  30 
Leu Thr Thr Ser Arg Gly Glu Pro Val Gln Ala Val Tyr Gly Phe Ala 
         35                  40                  45 
Lys Ser Leu Leu Lys Ala Leu Lys Glu Asp Gly Asp Ala Val Ile Val 
     50                  55                  60 
Val Phe Asp Ala Lys Ala Pro Ser Phe Arg His Glu Ala Tyr Gly Gly 
 65                  70                  75                  80 
Tyr Lys Ala Gly Arg Ala Pro Thr Pro Glu Asp Phe Pro Arg Gln Leu 
                 85                  90                  95 
Ala Leu Ile Lys Glu Leu Val Asp Leu Leu Gly Leu Ala Arg Leu Glu 
            100                 105                 110 
Val Pro Gly Tyr Glu Ala Asp Asp Val Leu Ala Ser Leu Ala Lys Lys 
        115                 120                 125 
Ala Glu Lys Glu Gly Tyr Glu Val Arg Ile Leu Thr Ala Asp Lys Asp 
    130                 135                 140 
Leu Tyr Gln Leu Leu Ser Asp Arg Ile His Val Leu His Pro Glu Gly 
145                 150                 155                 160 
Tyr Leu Ile Thr Pro Ala Trp Leu Trp Glu Lys Tyr Gly Leu Arg Pro 
                165                 170                 175 
Asp Gln Trp Ala Asp Tyr Arg Ala Leu Thr Gly Asp Glu Ser Asp Asn 
            180                 185                 190 
Leu Pro Gly Val Lys Gly Ile Gly Glu Lys Thr Ala Arg Lys Leu Leu 
        195                 200                 205 
Glu Glu Trp Gly Ser Leu Glu Ala Leu Leu Lys Asn Leu Asp Arg Leu 
    210                 215                 220 
Lys Pro Ala Ile Arg Glu Lys Ile Leu Ala His Met Asp Asp Leu Lys 
225                 230                 235                 240 
Leu Ser Trp Asp Leu Ala Lys Val Arg Thr Asp Leu Pro Leu Glu Val 
                245                 250                 255 
Asp Phe Ala Lys Arg Arg Glu Pro Asp Arg Glu Arg Leu Arg Ala Phe 
            260                 265                 270 
Leu Glu Arg Leu Glu Phe Gly Ser Leu Leu His Glu Phe Gly Leu Leu 
        275                 280                 285 
Glu Ser Pro Lys Ala Leu Glu Glu Ala Pro Trp Pro Pro Pro Glu Gly 
    290                 295                 300 
Ala Phe Val Gly Phe Val Leu Ser Arg Lys Glu Pro Met Trp Ala Asp 
305                 310                 315                 320 
Leu Leu Ala Leu Ala Ala Ala Arg Gly Gly Arg Val His Arg Ala Pro 
                325                 330                 335 
Glu Pro Tyr Lys Ala Leu Arg Asp Leu Lys Glu Ala Arg Gly Leu Leu 
            340                 345                 350 
Ala Lys Asp Leu Ser Val Leu Ala Leu Arg Glu Gly Leu Gly Leu Pro 
        355                 360                 365 
Pro Gly Asp Asp Pro Met Leu Leu Ala Tyr Leu Leu Asp Pro Ser Asn 
    370                 375                 380 
Thr Thr Pro Glu Gly Val Ala Arg Arg Tyr Gly Gly Glu Trp Thr Glu 
385                 390                 395                 400 
Glu Ala Gly Glu Arg Ala Ala Leu Ser Glu Arg Leu Phe Ala Asn Leu 
                405                 410                 415 
Trp Gly Arg Leu Glu Gly Glu Glu Arg Leu Leu Trp Leu Tyr Arg Glu 
            420                 425                 430 
Val Glu Arg Pro Leu Ser Ala Val Leu Ala His Met Glu Ala Thr Gly 
        435                 440                 445 
Val Arg Leu Asp Val Ala Tyr Leu Arg Ala Leu Ser Leu Glu Val Ala 
    450                 455                 460 
Glu Glu Ile Ala Arg Leu Glu Ala Glu Val Phe Arg Leu Ala Gly His 
465                 470                 475                 480 
Pro Phe Asn Leu Asn Ser Arg Asp Gln Leu Glu Arg Val Leu Phe Asp 
                485                 490                 495 
Glu Leu Gly Leu Pro Ala Ile Gly Lys Thr Glu Lys Thr Gly Lys Arg 
            500                 505                 510 
Ser Thr Ser Ala Ala Val Leu Glu Ala Leu Arg Glu Ala His Pro Ile 
        515                 520                 525 
Val Glu Lys Ile Leu Gln Tyr Arg Glu Leu Thr Lys Leu Lys Ser Thr 
    530                 535                 540 
Tyr Ile Asp Pro Leu Pro Asp Leu Ile His Pro Arg Thr Gly Arg Leu 
545                 550                 555                 560 
His Thr Arg Phe Asn Gln Thr Ala Thr Ala Thr Gly Arg Leu Ser Ser 
                565                 570                 575 
Ser Asp Pro Asn Leu Gln Asn Ile Pro Val Arg Thr Pro Leu Gly Gln 
            580                 585                 590 
Arg Ile Arg Arg Ala Phe Ile Ala Glu Glu Gly Trp Leu Leu Val Ala 
        595                 600                 605 
Leu Asp Tyr Ser Gln Ile Glu Leu Arg Val Leu Ala His Leu Ser Gly 
    610                 615                 620 
Asp Glu Asn Leu Ile Arg Val Phe Gln Glu Gly Arg Asp Ile His Thr 
625                 630                 635                 640 
Glu Thr Ala Ser Trp Met Phe Gly Val Pro Arg Glu Ala Val Asp Pro 
                645                 650                 655 
Leu Met Arg Arg Ala Ala Lys Thr Ile Asn Phe Gly Val Leu Tyr Gly 
            660                 665                 670 
Met Ser Ala His Arg Leu Ser Gln Glu Leu Ala Ile Pro Tyr Glu Glu 
        675                 680                 685 
Ala Gln Ala Phe Ile Glu Arg Tyr Phe Gln Ser Phe Pro Lys Val Arg 
    690                 695                 700 
Ala Trp Ile Glu Lys Thr Leu Glu Glu Gly Arg Arg Arg Gly Tyr Val 
705                 710                 715                 720 
Glu Thr Leu Phe Gly Arg Arg Arg Tyr Val Pro Asp Leu Glu Ala Arg 
                725                 730                 735 
Val Lys Ser Val Arg Glu Ala Ala Glu Arg Met Ala Phe Asn Met Pro 
            740                 745                 750 
Val Gln Gly Thr Ala Ala Asp Leu Met Lys Leu Ala Met Val Lys Leu 
        755                 760                 765 
Phe Pro Arg Leu Glu Glu Met Gly Ala Arg Met Leu Leu Gln Val His 
    770                 775                 780 
Asp Glu Leu Val Leu Glu Ala Pro Lys Glu Arg Ala Glu Ala Val Ala 
785                 790                 795                 800 
Arg Leu Ala Lys Glu Val Met Glu Gly Val Tyr Pro Leu Ala Val Pro 
                805                 810                 815 
Leu Glu Val Glu Val Gly Ile Gly Glu Asp Trp Leu Ser Ala Lys Glu 
            820                 825                 830 
</s-2-xi>
</s-2>
<s-2 seq-no="3 ">
<s-2-i>
<s-2-i-a>39 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 3 
GGGTCCACGG CCTCCCGCGG GACGCCGAAC ATCCAGCTG                            39 
</s-2-xi>
</s-2>
<s-2 seq-no="4 ">
<s-2-i>
<s-2-i-a>16 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 4 
GGACTGCATA TGACTG                                                     16 
</s-2-xi>
</s-2>
<s-2 seq-no="5 ">
<s-2-i>
<s-2-i-a>22 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 5 
CTAGCAGTCA TATGCAGTCC GC                                              22 
</s-2-xi>
</s-2>
<s-2 seq-no="6 ">
<s-2-i>
<s-2-i-a>80 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 6 
CGGGAGGCCG TGGACCCCCT GATGCGCCGG GCGGCCAAGA CCATCAACTT CGGGGTCCTC     60 
TACGGCATGT CGGCCCACCG                                                 80 
</s-2-xi>
</s-2>
<s-2 seq-no="7 ">
<s-2-i>
<s-2-i-a>37 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 7 
TGGCTAGCTC CTGGGAGAGG CGGTGGGCCG ACATGCC                              37 
</s-2-xi>
</s-2>
<s-2 seq-no="8 ">
<s-2-i>
<s-2-i-a>32 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 8 
TTCGGCGTCC CGCGGGAGGC CGTGGACCCC CT                                   32 
</s-2-xi>
</s-2>
<s-2 seq-no="9 ">
<s-2-i>
<s-2-i-a>24 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 9 
GTAAGGGATG GCTAGCTCCT GGGA                                            24 
</s-2-xi>
</s-2>
<s-2 seq-no="10 ">
<s-2-i>
<s-2-i-a>14 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 10 
CGCGCCGAAT TCCC                                                       14 
</s-2-xi>
</s-2>
<s-2 seq-no="11 ">
<s-2-i>
<s-2-i-a>46 base pairs </s-2-i-a>
<s-2-i-b>nucleic acid </s-2-i-b>
<s-2-i-c>single </s-2-i-c>
<s-2-i-d>linear </s-2-i-d>
</s-2-i>
<s-2-xi> 11 
GCGCGGAAGC TTGGCTGCAG AATATTGCTA GCGGGAATTC GGCGCG                    46
</s-2-xi>
</s-2>
</sequence-list-old-rules>
</sequence-cwu>
<subdoc-claims>
<heading lvl="1">We claim: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method for identifying a thermostable polymerase having altered fidelity, comprising generating a random population of polymerase mutants by mutating at least one amino acid residue of a thermostable polymerase and screening said population for one or more active polymerase mutants by genetic selection. </claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein two or more amino acid residues of said thermostable polymerase are mutated. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, further comprising determining a fidelity of said active polymerase mutant. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said mutated amino acid residue is adjacent to an immutable or nearly immutable residue. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>, wherein said mutated amino acid residue is immediately adjacent to an immutable or nearly immutable residue. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said mutated amino acid residue is in an O-helix of a thermostable polymerase. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>, wherein said mutated amino acid residue is adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00007">claim 7</dependent-claim-reference>, wherein said thermostable polymerase is Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A method for identifying a thermostable polymerase having altered fidelity, comprising generating a random population of polymerase mutants by mutating at least one amino acid residue in an active site O-helix of a thermostable polymerase and screening said population for one or more active polymerase mutants. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein two or more amino acid residues of said thermostable polymerase is mutated. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, further comprising determining a fidelity of said active polymerase mutant. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein said mutated amino acid residue is adjacent to an immutable or nearly immutable residue. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 12</dependent-claim-reference>, wherein said mutated amino acid residue is immediately adjacent to an immutable or nearly immutable residue. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 12</dependent-claim-reference>, wherein said one or more amino acid residues is adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference>, wherein said thermostable polymerase is Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. An isolated thermostable polymerase mutant having altered fidelity, wherein said mutant comprises one or more mutated amino acid residues in the active site O-helix of a thermostable polymerase. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference>, wherein said polymerase is Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference>, wherein said mutated amino acid residue is adjacent to an immutable or nearly immutable residue. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein said mutated amino acid residue is immediately adjacent to an immutable or nearly immutable residue. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein said mutated amino acid residue is adjacent to an amino acid residue corresponding to Arg659, Lys663, Phe667 or Tyr671 in Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein said polymerase is Taq DNA polymerase. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said polymerase mutant is a high fidelity mutant. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>, wherein said polymerase mutant comprises one or more amino acid substitutions selected from the group consisting of Phe667Leu; Asn666Asp; Asn666Ile; Ile665Leu; Leu670Val; Arg660Tyr; Arg660Ser; Gly668Arg; Arg660Lys; Gly668Ser; Gly668Gln; Thr664Ile and Asn666Asp; Ala661Ser and Val669Leu; Ala661Glu, Ile665Thr, and Phe667Leu; and Thr664Pro, Ile665Val and Asn666Tyr. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein said polymerase mutant is a low fidelity mutant. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>, wherein said polymerase mutant comprises substitution of one or more amino acids selected from the group consisting of Ala661, Thr664, Asn666 and Leu670. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 25</dependent-claim-reference>, wherein said polymerase mutant comprises one or more amino acid substitutions selected from the group consisting of Ala661Glu; Ala661Pro; Thr664Pro; Thr664Asn; Thr664Arg; Asn666Val; Thr664Pro and Val669Ile; Arg660Pro and Leu670Thr; Arg660Trp and Thr664Lys; Ala662Gly and Thr664Asn; Ala661Gly and Asn666Ile; Ala661Pro and Asn666Ile; and Ala661Ser, Ala662Gly, Thr664Ser and Asn666Ile. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. An isolated nucleic acid molecule encoding a polymerase mutant having high fidelity, comprising a nucleotide sequence encoding substantially an amino acid sequence of Taq DNA polymerase I comprising one or more amino acid substitutions selected from the group consisting of Phe667Leu; Asn666Asp; Asn666Ile; Ile665Leu; Leu670Val; Arg660Tyr; Arg660Ser; Gly668Arg; Arg660Lys; Gly668Ser; Gly668Gln; Thr664Ile and Asn666Asp; Ala661Ser and Val669Leu; Ala661Glu, Ile665Thr, and Phe667Leu; and Thr664Pro, Ile665Val and Asn666Tyr. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. An isolated nucleic acid molecule encoding a polymerase mutant having low fidelity, comprising a nucleotide sequence encoding substantially an amino acid sequence of Taq DNA polymerase I comprising substitution of one or more amino acids selected from the group consisting of Ala661, Thr664, Asn666 and Leu670. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The nucleic acid molecule of <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said polymerase mutant comprises one or more amino acid substitutions selected from the group consisting of Ala661Glu; Ala661Pro; Thr664Pro; Thr664Asn; Thr664Arg; Asn666Val; Thr664Pro and Val669Ile; Arg660Pro and Leu670Thr; Arg660Trp and Thr664Lys; Ala662Gly and Thr664Asn; Ala661Gly and Asn666Ile; Ala661Pro and Asn666Ile; and Ala661Ser, Ala662Gly, Thr664Ser and Asn666Ile. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A method for identifying one or more mutations in a gene, comprising amplifying said gene using a high fidelity polymerase mutant under conditions which allow polymerase chain reaction amplification. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. A method for identifying one or more mutations in a gene, comprising amplifying said gene using the high fidelity polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference> under conditions which allow polymerase chain reaction amplification. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>, wherein said gene is amplified by exposing the strands of said gene to repeated cycles of denaturing, annealing and elongation to produce an amplified product. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference>, further comprising determining the presence or absence of one or more mutations in the sequence of said gene. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>, wherein said polymerase mutant comprises one or more amino acid substitutions selected from the group consisting of Phe667Leu; Asn666Asp; Asn666Ile; Ile665Leu; Leu670Val; Arg660Tyr; Arg660Ser; Gly668Arg; Arg660Lys; Gly668Ser; Gly668Gln; Thr664Ile and Asn666Asp; Ala661Ser and Val669Leu; Ala661Glu, Ile665Thr, and Phe667Leu; and Thr664Pro, Ile665Val and Asn666Tyr. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. A method for accurately copying repetitive nucleotide sequences, comprising amplifying said repetitive nucleotide sequence using a high fidelity polymerase mutant. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said repetitive nucleotide sequence is in a gene. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said repetitive nucleotide sequence is in a microsatellite between genes. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. A method for accurately copying repetitive nucleotide sequences, comprising amplifying said repetitive nucleotide sequence using said high fidelity polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. A method for determining an inherited mutation, comprising amplifying a gene using a high fidelity polymerase mutant. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. A method for diagnosing a genetic disease, comprising correlating the inherited mutation determined in <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference> with said genetic disease. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. A method for diagnosing a genetic disease, comprising amplifying a gene using a high fidelity polymerase mutant. </claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. A method for diagnosing a genetic disease, comprising amplifying a gene using said high fidelity polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference>, wherein said genetic disease comprises mutations in microsatellite or repetitive DNA. </claim-text>
</claim>
<claim id="CLM-00044">
<claim-text><highlight><bold>44</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 43</dependent-claim-reference>, wherein said genetic disease is cancer. </claim-text>
</claim>
<claim id="CLM-00045">
<claim-text><highlight><bold>45</bold></highlight>. A method for determining the prognosis of a genetic disease, comprising amplifying said gene in <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00046">
<claim-text><highlight><bold>46</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference>, wherein said polymerase mutant comprises one or more amino acid substitutions selected from the group consisting of Phe667Leu; Asn666Asp; Asn666Ile; Ile665Leu; Leu670Val; Arg660Tyr; Arg660Ser; Gly668Arg; Arg660Lys; Gly668Ser; Gly668Gln; Thr664Ile and Asn666Asp; Ala661Ser and Val669Leu; Ala661Glu, Ile665Thr, and Phe667Leu; and Thr664Pro, Ile665Val and Asn666Tyr. </claim-text>
</claim>
<claim id="CLM-00047">
<claim-text><highlight><bold>47</bold></highlight>. A method for randomly mutagenizing a gene, comprising amplifying said gene using a low fidelity polymerase mutant. </claim-text>
</claim>
<claim id="CLM-00048">
<claim-text><highlight><bold>48</bold></highlight>. A method for randomly mutagenizing a gene, comprising amplifying said gene using said low fidelity polymerase mutant of <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00049">
<claim-text><highlight><bold>49</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 48</dependent-claim-reference>, wherein said polymerase mutant comprises substitution of one or more amino acid residues selected from the group consisting of Ala661, Thr664, Asn666 and Leu670. </claim-text>
</claim>
<claim id="CLM-00050">
<claim-text><highlight><bold>50</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 49</dependent-claim-reference>, wherein said polymerase mutant comprises one or more amino acid substitutions selected from the group consisting of Ala661Glu; Ala661Pro; Thr664Pro; Thr664Asn; Thr664Arg; Asn666Val; Thr664Pro and Val669Ile; Arg660Pro and Leu670Thr; Arg660Trp and Thr664Lys; Ala662Gly and Thr664Asn; Ala661Gly and Asn666Ile; Ala661Pro and Asn666Ile; and Ala661Ser, Ala662Gly, Thr664Ser and Asn666Ile.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020192663A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020192663A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020192663A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020192663A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020192663A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020192663A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020192663A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020192767A1-20021219-C00001.CDX SYSTEM "US20020192767A1-20021219-C00001.CDX" NDATA CDX>
<!ENTITY US20020192767A1-20021219-C00001.MOL SYSTEM "US20020192767A1-20021219-C00001.MOL" NDATA MOL>
<!ENTITY US20020192767A1-20021219-C00001.TIF SYSTEM "US20020192767A1-20021219-C00001.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00001.TIF SYSTEM "US20020192767A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00002.TIF SYSTEM "US20020192767A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00003.TIF SYSTEM "US20020192767A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00004.TIF SYSTEM "US20020192767A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00005.TIF SYSTEM "US20020192767A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00006.TIF SYSTEM "US20020192767A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00007.TIF SYSTEM "US20020192767A1-20021219-D00007.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00008.TIF SYSTEM "US20020192767A1-20021219-D00008.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00009.TIF SYSTEM "US20020192767A1-20021219-D00009.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00010.TIF SYSTEM "US20020192767A1-20021219-D00010.TIF" NDATA TIF>
<!ENTITY US20020192767A1-20021219-D00011.TIF SYSTEM "US20020192767A1-20021219-D00011.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020192767</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10087451</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020228</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C12P019/62</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C12P017/18</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N001/21</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>435</class>
<subclass>076000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>252300</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>252330</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>119000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Biosynthesis of polyketide synthase substrates</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>10087451</doc-number>
<kind-code>A1</kind-code>
<document-date>20020228</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09798033</doc-number>
<document-date>20010228</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</continuation-in-part-of>
</continuations>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>09798033</doc-number>
<document-date>20010228</document-date>
<country-code>US</country-code>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09687855</doc-number>
<document-date>20001013</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</continuation-in-part-of>
</continuations>
<non-provisional-of-provisional>
<document-id>
<doc-number>60159090</doc-number>
<document-date>19991013</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
<non-provisional-of-provisional>
<document-id>
<doc-number>60206082</doc-number>
<document-date>20000518</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
<non-provisional-of-provisional>
<document-id>
<doc-number>60232379</doc-number>
<document-date>20000914</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Chaitan</given-name>
<family-name>Khosla</family-name>
</name>
<residence>
<residence-us>
<city>Palo Alto</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Blaine</given-name>
<family-name>Pfeifer</family-name>
</name>
<residence>
<residence-us>
<city>Palo Alto</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Kate H. Murashige</name-1>
<name-2>Morrison &amp; Foerster LLP</name-2>
<address>
<address-1>Suite 500</address-1>
<address-2>3811 Valley Centre Drive</address-2>
<city>San Diego</city>
<state>CA</state>
<postalcode>92130-2332</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The use of enzymes which catalyze the production of starter and extender units for polyketides is described. In addition, modified loading modules are described, which can accept a variety of starting units such as substituted benzoates, and which can be used to generate substituted derivatives of natural products. These enzymes may be used to enhance the yield of polyketides that are natively produced or polyketides that are rationally designed. By using these techniques, the synthesis of a complete polyketide has been achieved in <highlight><italic>E. coli</italic></highlight>. Production can be enhanced in microbial organisms of polyketides and other secondary metabolites by delaying production until after exponential phase and by maintaining relatively constant nutrient levels in the medium. In addition, polyketide production can be enhanced by providing an expression system for a thioesterase II. Thus, by modifying the host organism and changing the culture conditions, synthesis of a secondary metabolite can be enhanced. The present invention also results in a host organism with desirable characteristics to be used in the production of such polyketides and to assess the results of gene shuffling. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE TO RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application is a continuation-in-part of U.S. Ser. No. 09/798,033 filed Feb. 28, 2001, which is a continuation-in-part of Ser. No. 09/687,855 filed Oct. 13, 2000, which application claimed priority under 35 U.S.C. &sect;119(e) from U.S. Ser. No. 60/159,090 filed Oct. 13, 1999, Ser. No. 60/206,082 filed May 18, 2000 and Ser. No. 60/232,379 filed Sep. 14, 2000. Also, this application claims priority under 35 U.S.C. &sect;119(e) from the provisional application filed Feb. 8, 2002 (attorney docket No. 286003022600). The foregoing applications are incorporated herein by reference.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">Statement of Rights to Inventions Made Under Federally Sponsored Research </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with U.S. government support from the National Institutes of Health and the National Science Foundation. The U.S. government may have certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">TECHNICAL FIELD </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The invention relates to methods to adapt microbial hosts for efficient production of polyketides. In one aspect, the hosts are modified to synthesize the starter and/or extender units used by polyketide synthases in the synthesis of polyketides. In another aspect, hosts are modified to synthesize synthases which accept substituted benzoates as starter units. Other host modifications may also be made. Thus, the invention includes methods for production of complex polyketides in such diverse organisms as <highlight><italic>Escherichia coli, </italic></highlight>Bacillus, Myxococcus, and Streptomyces. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND ART </heading>
</section>
<section>
<heading lvl="1">Rifamycin B </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> The rifamycin synthetase is primed with a 3-amino-5-hydroxybenzoate (AHB) starter unit by a loading module that contains domains homologous to the adenylation (A) and thiolation (T) domains of nonribosomal peptide synthetases. The rifamycin synthetase of <highlight><italic>Amycolatopsis mediterranei </italic></highlight>is responsible for the biosynthesis of prosansamycin X, a precursor to the antibiotic rifamycin B (<cross-reference target="DRAWINGS">FIG. 1</cross-reference>). (The protein complex responsible for biosynthesis of prosansamycin X, a rifamycin B precursor, is referred to herein as rifamycin synthetase because the results described herein establish that ATP is required for covalent attachment of the aryl starter unit to the loading module of the complex.) The rifamycin synthetase consists of a core of five multifunctional proteins, RifA, RifB, RifC, RifD, and RifE, in addition to RifF, a protein that is believed to cyclize the linear product of the other proteins via intramolecular amide formation (Schupp, T., et al., <highlight><italic>FEMS Microbiol. Lett. </italic></highlight>(1998) 159:201-207; August, P. R., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1998) 5:69-79; Tang, L., et al., <highlight><italic>Gene </italic></highlight>(1998) 216:255-265; Floss, H. G., et al., <highlight><italic>Curr. Opin. Chem. Biol. </italic></highlight>(1999) 3:592-597). The five multifunctional proteins can be further subdivided into one nonribosomal peptide synthetase (NRPS)-like loading module and ten polyketide synthase (PKS) modules, based on sequence homology to other systems. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> RifA, the N-terminal protein component of rifamycin synthetase, contains an NRPS-like module, the adenylation-thiolation (A-T) loading didomain, upstream of the first condensing module (<cross-reference target="DRAWINGS">FIG. 1</cross-reference>). The first such A-T type loading module was identified in the gene cluster for the natural product rapamycin (Schwecke, T., et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>(1995) 92:7839-7843). Complete gene clusters for other synthetases that contain hybrid modular interfaces have since been reported (Gehring, A. M., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1998) 5:573-586; Quadri, L. E. N., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1998) 5:631-645; Silakowski, B., et al., <highlight><italic>J. Biol. Chem. </italic></highlight>(1999) 274:37391-37399; Julien, B., et al., <highlight><italic>Gene </italic></highlight>(2000) 249:153-160.; Tillett, D., et al., <highlight><italic>Chem. Biol. </italic></highlight>(2000) 7:753-764; Wu, K., et al., <highlight><italic>Gene </italic></highlight>(2000) 251:81-90; Du, L., et al., <highlight><italic>Chem. Biol. </italic></highlight>(2000) 7:623-640), and these synthetases produce hybrid natural products that are composed of both ketide and peptide units. The proven track record of polyketide and peptide natural products as therapeutics suggests that the increased combinatorial diversity embodied in hybrid products will advance drug discovery. It would be advantageous to use a biochemical understanding of hybrid synthetases coupled with the ability to manipulate hybrid interfaces through protein engineering to enable the potential of such hybrid molecules to be realized. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> The NRPS-like A-T didomain of RifA presumably primes the synthetase with 3-amino-5-hydroxybenzoate (AHB), which has been shown to be the precursor of the mC<highlight><subscript>7</subscript></highlight>N structural element of rifamycin B (<cross-reference target="DRAWINGS">FIG. 1</cross-reference>) (Ghisalba, O., et al. <highlight><italic>J. Antibiot. </italic></highlight>(1981) 34:64-71; Anderson, M. G., et al., <highlight><italic>J. Chem. Soc. Chem. Commun. </italic></highlight>(1989) 311-313). However, the mechanism of this priming has not been established. Two alternative models can be envisioned. In the coenzyme A (CoA) ligase model prevalent in the literature (Schupp, T., et al., <highlight><italic>FEMS Microbiol. Lett. </italic></highlight>(1998) 159:201-207; August, P. R., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1998) 5:69-79; Ghisalba, O., et al., <highlight><italic>J. Antibiot. </italic></highlight>(1981) 34:64-71), the activated AHB-adenylate product of the A domain is attacked by CoA to generate an AHB-CoA intermediate, and the aryl thioester enzyme intermediate results from transthiolation onto the T domain (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>). In an alternative mechanism, which has been confirmed as detailed below, that is analogous to the mechanism used to prime NRPS modules, AHB is activated as the aryl-adenylate by the A domain, and the thiol of the phosphopantetheine cofactor of the T domain attacks AHB-adenylate directly to form a covalent aryl thioester enzyme intermediate (<cross-reference target="DRAWINGS">FIG. 2B</cross-reference>). </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Although AHB is the natural substrate of the A-T didomain, previous in vivo studies have revealed that RifA can be primed by the alternative substrates 3-hydroxybenzoate (3-HB) and 3,5-dihydroxybenzoate (Hunziker, D., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1998) 120:1092-1093). It would be advantageous to harness this innate substrate tolerance for its implications for the production of unnatural natural products. In one aspect, it would be advantageous to reconstitute the activity of the A-T didomain of rifamycin synthetase in vitro in order to establish the mechanism of this priming module and to systematically investigate its substrate tolerance. Thus, the invention provides homologous substituted substrates for the production of unnatural natural products. </paragraph>
</section>
<section>
<heading lvl="1">6-Deoxyerythronolide B </heading>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Erythromycin, a broad spectrum antibiotic synthesized by the bacterium <highlight><italic>Saccharopolyspora erythraea, </italic></highlight>is a prototype of a class of complex natural products called polyketides (O&apos;Hagan, D., <highlight><italic>The Polyketide Metabolites </italic></highlight>(Ellis Horwood, Chichester, U.K., 1991). Complex polyketides such as 6-deoxyerythronolide B (6-dEB), the macrocyclic core of the antibiotic erythromycin, constitute an important class of natural products. These biomolecules are synthesized from simple building blocks such as acetyl-CoA, propionyl-CoA, malonyl-CoA and methylmalonyl-CoA through the action of large modular megasynthases called polyketide synthases (Cane, D. E., et al., <highlight><italic>Science </italic></highlight>(1998) 282:63), generally found in actinomycetes. For example, the polyketide synthase (PKS) which results in the synthesis of 6-dEB is produced in <highlight><italic>Sacromyces erythraea. </italic></highlight>The polyketides produced in these native hosts are generally subsequently tailored to obtain the finished antibiotic by glycosylation, oxidation, hydroxylation and other modifying reactions. Polyketide structural complexity often precludes the development of practical laboratory synthetic routes, leaving fermentation as the only viable source for the commercial production of these pharmaceutically and agriculturally useful agents. At the same time, the challenges associated with developing scalable and economically feasible fermentation processes for polyketide production from natural biological sources (principally the Actinomyces family of bacteria) are enormous, and represent the most serious bottleneck during polyketide pre-clinical and clinical development. Recent work from this laboratory has demonstrated that it is possible to express polyketide synthase modules in a functional form in <highlight><italic>Escherichia coli </italic></highlight>(Gokhale, R. S., et al., <highlight><italic>Science </italic></highlight>(1999) 284:482-485). However, in order to harness these modular enzymes for polyketide biosynthesis in <highlight><italic>E. coli</italic></highlight>, or in other hosts that do not normally produce them it is also necessary to produce their appropriate substrates in vivo in a controlled manner. For example, metabolites such as acetyl-CoA, propionyl-CoA, malonyl-CoA and methylmalonyl-CoA are the most common substrates of these enzymes. <highlight><italic>E. coli </italic></highlight>has the capability to produce acetyl-CoA, propionyl-CoA, and malonyl-CoA; however, the latter two substrates are only present in small quantities in the cell, and their biosynthesis is tightly controlled. The ability of <highlight><italic>E. coli </italic></highlight>to synthesize methylmalonyl-CoA has not been documented thus far. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Similar conditions prevail in other microbial cells, especially those that do not natively produce polyketides, such as various species of Escherichia, Bacillus, Rhizobium, Pseudomonas, and Flavobacterium. Thus, generally, the required starter and/or extender units may not be produced in adequate amounts in any particular host. Further, by appropriate selection of the acyl transferase (AT) domains of the PKS in question, substrates more complex than those just mentioned may be employed. As an example, the PKS for synthesis of FK506 comprises an acyl transferase domain that incorporates substrates such as propyl malonyl-CoA in preference to malonyl-CoA or methylmalonyl-CoA. It would be helpful to have available a method which provides this range of substrates in appropriate levels in any arbitrarily chosen host organism. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Additional problems that may need to be surmounted in effecting the production of polyketides in procaryotic hosts, especially those which do not natively produce polyketides, include the presence of enzymes which catabolize the required starter and/or extender units, such as the enzymes encoded by the prp operon of <highlight><italic>E. coli</italic></highlight>, which are responsible for catabolism of exogenous propionate as a carbon and energy source in this organism. In order to optimize production of a polyketide which utilizes propionyl CoA as a starter unit and/or utilizes its carboxylation product, methylmalonyl CoA as an extender unit, this operon should be disabled, except for that portion (the E locus) which encodes a propionyl CoA synthetase. Any additional loci which encode catabolizing enzymes for starter or extender units are also advantageously disabled. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> In addition, a particular procaryotic host, such as <highlight><italic>E. coli</italic></highlight>, may lack the phosphopantetheinyl transferase required for activation of the polyketide synthase. It may be required to modify the host to contain such a transferase as well. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> Recent studies in several Streptomyces spp. have demonstrated the beneficial impact of a thioesterase-like enzyme on polyketide productivity (Butler, A. R., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1999) 6(5);287-292; and Tang, L, et al., <highlight><italic>Chem. Biol. </italic></highlight>(1999) 6(8):553-558). Homologs of these enzymes (termed thioesterase II or TEII) are encoded within the biosynthetic gene clusters of many macrolides. The mechanism of the <highlight><italic>Saccharopolyspora erythraea </italic></highlight>TEII is unclear, and it has been proposed that these enzymes play an editing role in polyketide biosynthesis (Butler, supra; and Heathcote, M. L., et al., <highlight><italic>Chemistry </italic></highlight>&amp; <highlight><italic>Biology </italic></highlight>(2001) 8:207-220. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> In summary, it would be advantageous to effect the production of polyketides in microbial, especially procaryotic, hosts in general, including hosts which do not natively produce polyketides. These latter hosts often have advantages over native polyketide producers such as Streptomyces in terms of ease of transformation, ability to grow rapidly in culture, and the like. These advantages are particularly useful in assessing the results of random mutagenesis or gene shuffling of polyketide synthases. Thus, the invention provides a multiplicity of approaches to adapt microbial hosts for the production of polyketides. </paragraph>
</section>
<section>
<heading lvl="1">DISCLOSURE OF THE IVNENTION </heading>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> In one aspect, the invention has achieved, for the first time, the production of a complete complex polyketide product, 6-dEB, in the ubiquitously useful host organism, <highlight><italic>E. coli</italic></highlight>. The methods used to achieve this result are adaptable to microbial hosts in general, especially procaryotes. They can be used to adapt microbial hosts which do not natively produce polyketides to such production and to enhance the production of polyketides in hosts that normally produce them. Depending on the host chosen, the modifications required may include incorporation into the organism of expression systems for the polyketide synthase genes themselves; disabling of endogenous genes which encode catabolic enzymes for the starter and/or extender units; incorporation of expression systems for enzymes required for post translational modification of the synthases, such as phosphopantetheinyl transferase; and incorporation of enzymes which enhance the levels of starter and/or extender units. The particular combination of modifications required to adapt the host will vary with the nature of the polyketide desired and with the nature of the host itself. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> Thus, in one aspect, the invention is directed to microbial host cells which are genetically modified for enhanced synthesis of at least one polyketide wherein said modification comprises incorporation of at least one expression system for producing a protein that catalyzes the production of starter and/or extender units and/or disabling at least one endogenous pathway for catabolism of starter and/or extender units. In a particularly preferred embodiment, these modifications are made in the genome of the host organism, as this is advantageous for large-scale production of polyketides. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> In another aspect, the invention is directed to the production of a polyketide product comprising substituted benzoates used as starter unit substrates for an A-T loading didomain of a rifamycin synthetase to make modified polyketides in organisms such as <highlight><italic>E. coli</italic></highlight>. In still another aspect, the invention includes a screening method to determine which substituted benzoate derivatives are viable substrates for an A-T didomain. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> Additional modifications may also be made, such as incorporating at least one expression system for a polyketide synthase protein and, if necessary, incorporating at least one expression system for a phosphopantetheinyl transferase. Additional expression systems can also be employed, if necessary, for further modification of synthesized polyketides such as hydroxylation, glycosylation, and the like. Also, an expression system for TEII may be employed. Again, it is often advantageous, although not necessary, to incorporate these expression systems into the genome of the host. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> In other aspects, the invention is directed to methods of preparing polyketides, including complete polyketides, in the modified cells of the invention. A preferred embodiment is a method to synthesize 6-dEB, 6-dEB analogs or other complete polyketides in <highlight><italic>E. coli. </italic></highlight></paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> In still another aspect, the invention is directed to a method to assess the results of gene shuffling or random mutagenesis of polyketide synthase genes by taking advantage of the high transformation efficiency of <highlight><italic>E. coli</italic></highlight>. An assay for polyketide production is also contemplated.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is a proposed biosynthetic scheme for prosansamycin X, a precursor to rifamycin B. The rifamycin synthetase consists of a core of five large multifunctional proteins, RifA, RifB, RifC, RifD, and RifE, each containing one or more PKS modules. Each PKS module catalyzes one cycle of chain extension and associated &bgr;-ketoreduction for the biosynthesis of prosansamycin X. The N-terminal A-T loading didomain of RifA primes the synthetase with AHB and is reminiscent of a minimal NRPS module. The location of the mC<highlight><subscript>7</subscript></highlight>N unit derived from AHB is shown in bold in the prosansamycin X structure. The active sites denote adenylation (A), thiolation (T), acyltransferase (AT), ketosynthase (KS), &bgr;-ketoreductase (KR), or dehydratase (DH) domains. As indicated, RifF is believed to catalyze cyclization via intramolecular amide formation. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> illustrates possible mechanisms for the A-T loading didomain. (A) In the CoA ligase model, the activated AHB-adenylate product of the A domain is attacked by CoA to generate an AHB-CoA intermediate, and the aryl thioester enzyme intermediate results from transthiolation onto the T domain. (B) In the NRPS-like mechanism, AHB is activated as the AHB-adenylate by the A domain, and the thiol of the phosphopantetheine cofactor of the T domain attacks AHB-adenylate directly to form a covalent aryl thioester enzyme intermediate. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> is a chart showing the presence or absence of apo or holo A-T didomain, ATP, and &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;-B or &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;-3-HB based on the results of the ATP-dependent covalent loading of the holo A-T didomain with B and 3-HB is shown based on Coomassie-stained gel (4-15% gradient) of the reaction mixtures and an autoradiograph of this gel (not shown). </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> graphs the high performance liquid chromatography (HPLC) traces of time courses of reactions containing the apo A-T didomain. No net formation of benzoyl-CoA is observed. Labeled peaks were identified by co-injection with authentic standards of CoA, B, and benzoyl-CoA. The HPLC traces were shifted progressively by 0.15 min. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> graphs the saturation curves for covalent loading of the holo A-T didomain by 3-HB (&square;) or B (O). <cross-reference target="DRAWINGS">FIG. 5A</cross-reference> is a linear representation of the data. <cross-reference target="DRAWINGS">FIG. 5B</cross-reference> is a logarithmic representation of the data to facilitate evaluation of both data sets simultaneously. The lines are best fits of the data to a simple saturation model and give k<highlight><subscript>cat</subscript></highlight>&equals;1.9 min<highlight><superscript>&minus;1 </superscript></highlight>and K<highlight><subscript>M</subscript></highlight>&equals;180 &mgr;M for 3-HB, and k<highlight><subscript>cat</subscript></highlight>&equals;0.14 min<highlight><superscript>&minus;1 </superscript></highlight>and K<highlight><subscript>M</subscript></highlight>&equals;170 &mgr;M for B. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> shows the two plasmids used a synthetic operon approach to facilitate the expression of the DEBS and pcc genes. The restriction sites are abbreviated as follows: X, XbaI; N, NdeI; E, EcoRI; H, HindIII; B, Bpu1102I; Ns, NsiI; Ps, PstI; P, PacI; D, DraIII. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7A</cross-reference> is a schematic of the 6-deoxyerythronolide B synthase (DEBS). The catalytic domains are: KS, ketosynthase; AT, acyl transferase; ACP, acyl carrier protein; KR, ketoreductase; ER, enoyl reductase; DH, dehydratase, TE, thioesterase. DEBS utilizes 1 mole of propionyl-CoA and 6 moles of (2S)-methylmalonyl-CoA to synthesize 1 mole of 6-deoxyerythronolide B (6dEB, compound 1). <cross-reference target="DRAWINGS">FIG. 7B</cross-reference> illustrates that truncated DEBS1&plus;TE produces the triketide lactone (compound 2). <cross-reference target="DRAWINGS">FIG. 7C</cross-reference> illustrates that the rifamycin synthetase is a polyketide synthase that is naturally primed by a nonribosomal peptide synthetase loading module, comprised of two domains- an ATP dependent adenylation domain (A) and a thiolation domain (T). Substitution of this A-T didomain in place of the loading didomain of DEBS yields an engineered &ldquo;hybrid&rdquo; synthase that utilizes exogenous acids such as benzoic acid to synthesize substituted macrocycles such as compound 3 in an engineered strain of <highlight><italic>E. coli. </italic></highlight></paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> is a schematic of the genetic design of <highlight><italic>E. coli </italic></highlight>BAP1. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 9</cross-reference> shows the production of 6dEB in <highlight><italic>E. coli</italic></highlight>. Cellular protein content and 6dEB concentration are plotted versus time. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 10A and 10B</cross-reference> show <highlight><italic>E. coli </italic></highlight>Fed Batch Fermentation Experiments. <cross-reference target="DRAWINGS">FIG. 10A</cross-reference> shows: No additional propionate added over time. <cross-reference target="DRAWINGS">FIG. 10B</cross-reference> shows: With additional propionate feeding as specified in the Materials and Methods section. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 11</cross-reference> shows <highlight><italic>E. coli </italic></highlight>6dEB Fed-Batch Fermentation including TEII gene expression.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">MODES OF CARRYING OUT THE INVENTION </heading>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> With regard to one illustrative aspect of the invention, in the illustrative example below, <highlight><italic>E. coli </italic></highlight>is modified to effect the production of 6-dEB, the polyketide precursor of erythromycin. The three proteins required for this synthesis, DEBS 1, DEBS2 and DEBS3 are known and the genes encoding them have been cloned and sequenced. A multiplicity of additional PKS genes have been cloned and sequenced as well, including those encoding enzymes which produce the polyketide precursors of avermectin, oleandomycin, epothilone, megalomycin, picromycin, FK506, FK520, rapamycin, tylosin, spinosad, and many others. In addition, methods to modify native PKS genes so as to alter the nature of the polyketide produced have been described. Production of hybrid modular PKS proteins and synthesis systems is described and claimed in U.S. Pat. No. 5,962,290. Methods to modify PKS enzymes so as to permit efficient incorporation of diketides is described in U.S. Pat. No. 6,080,555. Methods to modify PKS enzymes by mixing and matching individual domains or groups of domains is described in U.S. Ser. No. 09/073,538. Methods to alter the specificity of modules of modular PKS&apos;s to incorporate particular starter or extender units are described in U.S. Ser. No. 09/346,860, now allowed. Improved methods to prepare diketides for incorporation into polyketides is described in U.S. Ser. No. 09/492,733. Methods to mediate the synthesis of the polyketide chain between modules are described in U.S. Ser. No. 09/500,747. The contents of the foregoing patents and patent applications are incorporated herein by reference. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> Thus, a selected host may be modified to include any one of many possible polyketide synthases by incorporating therein appropriate expression systems for the proteins included in such synthases. Either complete synthases or partial synthases may be supplied depending on the product desired. If the host produces polyketide synthase natively, and a different polyketide from that ordinarily produced is desired, it may be desirable to delete the genes encoding the native PKS. Methods for such deletion are described in U.S. Pat. No. 5,830,750, which is incorporated herein by reference. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> For hosts which do not natively produce polyketides, the enzymes that tailor polyketide synthases may be lacking or deficient, so that in addition to supplying the expression systems for the polyketide synthases themselves, it may be necessary, depending on the host chosen, to supply an expression system for these enzymes. One enzyme which is essential for the activity of PKS is a phosphopantetheinyl transferase. The genes encoding these transferases have been cloned and are available. These are described in U.S. patent application 08/728,742, which is now published, for example, in Canadian application 2,232,230. The contents of these documents are incorporated herein by reference. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> A particular selected host may natively include genes which produce proteins that catabolize desired starter and/or extender units. If such a host is selected, it may be advantageous to disable the production of proteins which catalyze such catabolism, as an important aspect of the invention is to modify the host so that the levels of required starter and/or extender units are enhanced. One non-limiting example of a catabolic system includes the prp operon wherein the proteins encoded by subunits A-D catabolize exogenous propionate. The enzyme encoded by prp E is desirable however as it is a propionyl CoA synthetase. The portions of the operon encoding catabolizing enzymes are advantageously disabled in modifying <highlight><italic>E. coli</italic></highlight>. Similar operons in other hosts may be disabled as needed. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> An assay can be used to determine polyketide production in a cell that is unable to carry out propionate catabolism or anabolism by adding labeled propionate and separating it from polyketide that has been produced. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> In one aspect of the invention, enzymes that enhance or enable the production of starter and/or extender units, and any enzymes required for activation of these production enzymes are incorporated into the cells by modifying them to contain expression systems for these proteins. As stated above, these expression systems may be supplied as extrachromosomal replicating vectors, but are preferably integrated into the host genome. When integrated into the genome, the necessity for selection pressure is mitigated and a stable production organism is obtained. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> In one illustrative embodiment of this aspect, advantage is taken of the matABC operon, which was recently cloned from <highlight><italic>Rhizobium trifoli </italic></highlight>(An, J. H., et al., <highlight><italic>Eur. J. Biochem. </italic></highlight>(1988) 15:395-402). This operon provides enzymes which permit the production of both extender and starter units commonly used in the synthesis of polyketides. Although it results normally in the production of malonyl-CoA and acetyl-CoA, the specificity of the enzymes encoded is not strict and thus, for example, propionyl-CoA and methylmalonyl-CoA can also be produced. This particular operon is used only for illustration, and genes encoding comparable enzymes can be found in a multiplicity of other organisms. Those of skill in the art are able to access such enzymes through homology searches in publicly available databases. Thus, this aspect of the invention is not to be regarded as limited to the matABC operon from <highlight><italic>Rhizobium trifoli </italic></highlight>only, but to extend to comparable systems available from other organisms. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> There are three proteins encoded by this operon. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> MatA encodes a malonyl-CoA decarboxylase, which normally catalyzes the reaction: malonyl-CoA&rarr;acetyl-CoA&plus;CO<highlight><subscript>2</subscript></highlight>. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> MatB encodes a malonyl-CoA synthetase which catalyzes the reaction: malonic acid&plus;CoASH&rarr;malonyl-CoA (in an ATP dependent reaction). </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> MatC encodes a malonate transporter which is believed to be responsible for transport of malonic acid across the cell membrane. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> These enzymes are demonstrated herein to be somewhat promiscuous with respect to substrate in their ability to catalyze the reactions shown. Thus, in addition to malonyl-CoA and malonic acids (for MatA and MatB respectively) as substrates, these enzymes can also utilize methylmalonyl-CoA and methylmalonic acid; ethylmalonyl-CoA and ethylmalonic acid; propylmalonyl-CoA and propylmalonic acid and the like. Thus, these enzymes can be used to provide a variety of starter and extender units for synthesis of desired polyketides. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> As stated above, homologs of this operon are also contemplated. For example, homologs of matB and matC derived from <highlight><italic>S. coelicolor </italic></highlight>(GenBank accession No. AL163003) can be used. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> Also useful in supplying an extender unit is the gene encoding propionyl CoA carboxylase. In one example of this activity, the carboxylase enzyme is a dimer encoded by the pccB and accA2 genes which have been characterized from Streptomyces coelicolor A3 by Rodriguez, E., et al., <highlight><italic>Microbiology </italic></highlight>(1999) 145:3109-3119. Methods of making 2S-methylmalonyl CoA using homologs of accA2 and pccB genes is also contemplated. A biotin ligase encoded natively in this case by the accA1 gene is needed for activation of these proteins. Alternative biotin ligases could also be used. The typical substrate for this enzyme is propionyl-CoA which is converted to methylmalonyl-CoA; a reaction which is summarized as propionyl-CoA&plus;CO<highlight><subscript>2</subscript></highlight>&rarr;methylmalonyl-CoA (an ATP dependent reaction). </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> Other acyl-CoA substrates may also be converted to the corresponding malonyl-CoA products by this enzyme and its homologs. Again, homologs of these genes can readily be found by those of skill in the art using standard searching techniques on publicly available databases. The biotin ligase, in particular, need not necessarily be derived from the same genetic complement as the carboxylase itself. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> In addition to providing modified host cells that are efficient in producing polyketides, the polyketide synthases, their activation enzymes, and enzymes which provide starter and/or extender units can be used in in vitro systems to produce the desired polyketides. For example, the enzymes malonyl-CoA decarboxylase and/or malonyl-CoA synthetase such as those encoded by the matABC operon and/or propionyl-CoA carboxylase such as that encoded by the pccB and accA2 genes can be used in in vitro cultures to convert precursors to suitable extender and starter units for a desired PKS to effect synthesis of a polyketide in a cell-free or in in vitro cell culture system. Purified MatB is particularly advantageously used for the preparative cell free production of polyketides, since CoA thioesters are the most expensive components in such cell-free synthesis systems. Alternatively, as set forth above, these genes are used (in any suitable combination) in a general strategy for production by cells in culture of these substrates. MatB and MatC can be used to effect production of any alpha-carboxylated CoA thioester where the corresponding free acid can be recognized as a substrate by MatB. The MatA protein may also be used to supplement in vitro or in vivo levels of starter units such as acetyl-CoA and propionyl-CoA. The genes encoding propionyl-CoA carboxylase can also be used to provide the enzyme to synthesize suitable extender units in vivo. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> The host may have a repertoire of other enzymes, such as the biotin ligase birA, which provides additional support. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> In general, the invention contemplates providing microbes that contain extender and/or starter units useful in polyketide synthases where the host either makes insufficient quantities of these materials for efficient synthesis or does not make detectable quantities of them at all. For example, <highlight><italic>E. coli </italic></highlight>does not produce detectable amounts of S-methylmalonyl CoA, a required intermediate in 6dEB biosynthesis. Thus, the invention is directed specifically in one aspect to <highlight><italic>E. coli </italic></highlight>which are modified to contain S-methylmalonyl CoA. Similarly, other organisms are modified to contain additional polyketide intermediates such as ethylmalonyl CoA, methoxymalonyl CoA or hydroxymalonyl CoA of the appropriate stereochemistry for incorporation into polyketides. These hosts are distinguished from their unmodified forms by either the presence of, or by increased levels of, these polyketide synthase substrates and can be verified to contain these modifications by acquiring the ability to synthesize the relevant polyketides or to synthesize them at an enhanced level. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> In one general aspect, the invention is directed to modified host organisms which contain enhanced levels of PKS substrates or which contain them per se in the instance wherein the unmodified host does not contain detectable levels. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> The invention also includes a method to enhance or enable the production of a polyketide, including a complete complex polyketide in a microbial host, which method comprises culturing a modified host which has been provided with at least one expression system for an enzyme which enhances or enables the production of starter and/or extender units used in constructing the polyketide. A &ldquo;complete&rdquo; polyketide is a polyketide which forms the basis for an antibiotic, such as the polyketides which are precursors to erythromycin, megalomycin, and the like. The enzymes which are provided include but are not limited to those encoded by the matABC operon and their homologs in other organisms as well as the pccB and accA2 genes (and accA1) encoding propionyl carboxylase and their homologs in other organisms. In another aspect, the invention is directed to a method of enhancing or enabling production of polyketides in cell-free systems by providing one or more of these enzymes to the cell-free system. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> The invention is also directed to cells modified to produce the enzymes and to methods of producing polyketides using these cells, as well as to methods of producing polyketides using cell-free systems. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> The invention also includes a method to enhance or enable polyketide production in a microbial system by supplementing the medium with a substrate for an endogenous enzyme which converts this substrate to a starter or extender unit. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> The invention also includes a method to produce polyketides in microbial hosts containing modifications to assist polyketide production, such as disarming of the endogenous genes which encode proteins for catabolism of required substrates, by supplying these cells with synthetic precursors, such as diketide precursors. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> The polyketide produced may be one normally produced by the PKS and may exist in nature; in this case the presence of the gene encoding the starter/extender production-enhancing enzyme in vivo or of the enzyme itself in cell free systems may simply enhance the level of production. In addition, the PKS may be a modified PKS designed to produce a novel polyketide, whose production may be enhanced in similar fashion. Because of the ability of the enzymes described herein to accept a wide range of substrates, extender units and starter units can be provided based on a wide range of readily available reagents. As stated above, diketide starting materials may also be supplied. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> The invention thus also includes the various other modifications of microbial hosts described above to permit or enhance their production of polyketides and to methods of producing polyketides using such hosts. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> The ability to modify hosts such as <highlight><italic>E. coli </italic></highlight>and other procaryotes such as Bacillus to permit production of polyketides in such hosts has numerous advantages, many of which reside in the inherent nature of <highlight><italic>E. coli</italic></highlight>. One important advantage resides in the ease with which <highlight><italic>E. coli </italic></highlight>can be transformed as compared to other microorganisms which natively produce polyketides. One important application of this transformation ease is in assessing the results of gene shuffling of polyketide synthases. Thus, an additional aspect of the invention is directed to a method to assess the results of polyketide synthase gene shuffling which method comprises transfecting a culture of the <highlight><italic>E. coli </italic></highlight>modified according to the invention with a mixture of shuffled polyketide synthases and culturing individual colonies. Those colonies which produce polyketides contain successfully shuffled genes. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> In addition to modifying microbial hosts, especially procaryotic hosts, to produce polyketides, these hosts may further be modified to produce the enzymes which &ldquo;tailor&rdquo; the polyketides and effect their conversion to antibiotics. Such tailoring reactions include glycosylation, oxidation, hydroxylation and the like. Organisms, preferably <highlight><italic>E. coli</italic></highlight>, which are modified to contain one or more polyketide modification enzymes, such as those relating to p450, sugar biosynthesis and transfer, and methyl transferase are also contemplated. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> With regard to the nature of the hosts, <highlight><italic>E. coli </italic></highlight>is used as an important illustration. However, a variety of procaryotic hosts may also be useful. For example, in addition to <highlight><italic>E. coli</italic></highlight>, Bacillus, Salmonella, Rhizobium, Pseudomonas, and generally gram negative bacteria are useful. Other procaryotes may be used, and even eucaryotic microbes such as yeast. The advantages of the use of <highlight><italic>Saccharomyces cerevisiae, </italic></highlight>for example, as a production organism are well known. In addition, organisms such as Streptomyces which natively produce polyketides may be used as hosts since the production of polyketides in these organisms may be enhanced by the methods of the invention. This is particularly the case where the host, which natively produces a polyketide, has been modified so that alternative extender units or alternative starter units are incorporated. In this case, even though the host natively makes polyketides, it may not have detectable levels of the starter and/or extender units now required for the modified PKS. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> As will be apparent to the skilled artisan, the precise nature of the manner of enhancing the levels of, or providing useable amounts of starter and/or extender units not natively produced will depend on the nature of the starter and/or extender units required. Typically, most complex polyketides require at least malonyl CoA or methylmalonyl CoA of the appropriate stereochemistry. Additional types of substituted malonyl CoA derivatives may be required in particular instances. The appropriate choice of expression system to provide the enzymes for production of such substrates or the inactivation of endogenous enzymes which may catabolize desired substrates is dependent on the nature of the polyketide to be synthesized and the nature of the host. Indeed, although typically the requisite expression systems for synthesis enzymes are provided from heterologous sources, in some instances, the native host may itself contain genes encoding the appropriate enzymes wherein these genes are not expressed. One example of this is the &ldquo;sleeping beauty&rdquo; operon in <highlight><italic>E. coli. </italic></highlight></paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> To effect production of the polyketides in a microbial host, it is preferable to permit substantial growth of the culture prior to inducing the enzymes which effect the synthesis of the polyketides. Thus, in hosts which do not natively produce polyketides, the required expression systems for the PKS genes are placed under control of an inducible promoter, such as the T7 promoter which is induced by isopropyl-&bgr;-D-thiogalactopyranoside (IPTG). There is a plethora of suitable promoters which are inducible in a variety of such microbial hosts. The skilled artisan will be aware of promoters which are inducible under conditions that are compatible with polyketide production and which are appropriate for a particular host suggested. Other advantageous features of the modified host, such as the ability to synthesize starters or extenders, may also be under inducible control. Finally, precursors to the starting materials for polyketide synthase may be withheld until synthesis is desired. Thus, for example, if the starting materials are derived from propionate, propionate can be supplied at any desired point during the culturing of the cells. If a diketide or triketide starting material is used, this too can be withheld until the appropriate time. Prior to addition of the precursor, a minimal medium may be used and alternate carbon sources employed to supply energy and materials for growth. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> The advantages of controlling the timing of production of substances such as polyketides are well known. Typically, the growth of the energy and metabolite requirements for the synthesis of such secondary metabolites impairs the ability of the organism to proliferate rapidly. Accordingly, it is advantageous to allow the organism to undergo exponential growth prior to inducing the production of a secondary metabolite. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> The success of applying the methods of the invention to provide useable or enhanced levels of substrate for polyketide synthase can conveniently be measured by the levels or rate of polyketide produced. Thus, the methods of the invention will enhance the level of production of polyketides by at least 5%, more preferably 10%, more preferably 25% and more preferably at least 50% as compared to production when the host is not modified under the same conditions. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> As described above, the invention provides methods for both in vitro and in vivo synthesis of any arbitrarily chosen polyketide where the in vivo synthesis may be conducted in any microbial, especially procaryotic host. The procaryotic host is typically of the genus Bacillus, Pseudomonas, Flavobacterium, or more typically Escherichia, in particular <highlight><italic>E. coli</italic></highlight>. Whether in vitro or in vivo synthesis is employed, it may be necessary to supply one or more of a suitable polyketide synthase (which may be native or modified), one or more enzymes to produce starter and/or extender units, typically including converting the free acid to the CoA derivative, and, if the foregoing enzymes are produced in a host, tailoring enzymes to activate them. In addition, for in vivo synthesis, it may be necessary to disarm catabolic enzymes which would otherwise destroy the appropriate starting materials. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> With respect to production of starting materials, the genes of the matABC operon and the genes encoding propionyl carboxylase can be employed to produce their encoded proteins for use in cell free polyketide synthesis and also to modify recombinant hosts for production of polyketides in cell culture. These genes and their corresponding encoded products are useful to provide optimum levels of substrates for polyketide synthase in any host in which such synthesis is to be effected. The host may be one which natively produces a polyketide and its corresponding antibiotic or may be a recombinantly modified host which either does not natively produce any polyketide or which has been modified to produce a polyketide which it normally does not make. Thus, microorganism hosts which are useable for the synthesis of polyketides include various strains of Streptomyces, in particular <highlight><italic>S. coelicolor </italic></highlight>and <highlight><italic>S. lividans, </italic></highlight>various strains of Myxococcus, industrially favorable hosts such as <highlight><italic>E. coli</italic></highlight>, Bacillus, Pseudomonas or Flavobacterium, and other microorganisms such as yeast. These genes and their corresponding proteins are useful in adjusting substrate levels for polyketide synthesis generally. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> The methods of the invention can be used to enhance the production of a specific polyketide by a microbe. If the microbe does not natively produce the polyketide, but contains the relevant PKS genes only by virtue of recombinant manipulation, without the methods of the invention to provide starter and/or extender units, the production of polyketide may not proceed at all. Thus, the enhancement is essentially infinite (only because the base is 0). However, where detectable levels of polyketides are produced, either by virtue of prior modifications or because the microbe is natively able to produce them, the methods of the invention will enhance the levels of production by at least 5%, preferably 25%, more preferably 50%, and more preferably 100%, 200%, 5 fold, 10 fold, 100 fold or 200 fold. An extremely wide variation in the levels of polyketides produced is available depending on the starting point and the modifications made. </paragraph>
</section>
<section>
<heading lvl="1">Substrate Specificity and Polyketide Design </heading>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> These genes and their products are particularly useful because of the ability of the enzymes to utilize a range of starting materials. Thus, in general, propionyl carboxylase converts a thioester of the formula R<highlight><subscript>2</subscript></highlight>&mdash;CH&mdash;CO&mdash;SCoA, where each R is H or an optionally substituted alkyl or other optionally substituted hydrocarbyl group to the corresponding malonic acid thioester of the formula R<highlight><subscript>2</subscript></highlight>C(COOH)COSCoA. Other thioesters besides the natural co-enzyme A thioester may also be used such as the N-acyl cysteamine thioesters. Similarly, the product of the matB gene can convert malonic acid derivatives of the formula R<highlight><subscript>2</subscript></highlight>C(COOH)<highlight><subscript>2 </subscript></highlight>to the corresponding acyl thioester, where each R is independently H or optionally substituted hydrocarbyl. A preferred starting material is that wherein R is alkyl (1-4C), preferably RCH(COOH)<highlight><subscript>2</subscript></highlight>. For in vivo systems, it may be advantageous to include the matC gene to ensure membrane transport of the starting malonic acid related material. The matA gene encodes a protein which converts malonyl-CoA substrates of the formula R<highlight><subscript>2</subscript></highlight>C(COOH)COSCoA to the corresponding acyl-CoA of the formula R<highlight><subscript>2</subscript></highlight>CHCOSCoA, where R is defined as above, for use as a starter unit. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> Typically, the hydrocarbyl groups referred to above are alkyl groups of 1-8C, preferably 1-6C, and more preferably 1-4C. The alkyl groups may be straight chain or branch chain, but are preferably straight chain. The hydrocarbyl groups may also include unsaturation and may further contain substituents such as halo, hydroxyl, methoxyl or amino or methyl or dimethyl amino. Thus, the hydrocarbyl groups may be of the formula CH<highlight><subscript>3</subscript></highlight>CHCHCH<highlight><subscript>2</subscript></highlight>; CH<highlight><subscript>2</subscript></highlight>CHCH<highlight><subscript>2</subscript></highlight>; CH<highlight><subscript>3</subscript></highlight>OCH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>; CH<highlight><subscript>3</subscript></highlight>CCCH<highlight><subscript>2</subscript></highlight>; CH<highlight><subscript>3</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>; and the like. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> Also prepared by the invention methods and materials are extender units of the formula</paragraph>
<paragraph lvl="0"><in-line-formula>ROCH(COOH)COSCoA</in-line-formula></paragraph>
<paragraph id="P-0069" lvl="7"><number>&lsqb;0069&rsqb;</number> wherein R is defined as set forth above. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> The substituted alkyl groups are also 1-8C in the backbone chain, preferably 1-6C and more preferably 1-4C. The alkenyl and alkynyl hydrocarbyl groups contain 2-8C, preferably 2-6C, and more preferably 2-4C and may also be branched or straight chain, preferably straight chain. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> Further variability can be obtained by supplying as a starting material a suitable diketide. The diketide generally of the formulas such as those set forth in U.S. Ser. No. 09/311,756 filed May 14, 1999 and incorporated herein by reference. A variety of substituents can then be introduced. Thus, the diketide will be of the general formula R&prime; CH<highlight><subscript>2</subscript></highlight>CHOHCR<highlight><subscript>2</subscript></highlight>COSNAc wherein R is defined as above, and R&prime; can be alkyl, 1-8C, aryl, aryl alkyl, and the like. SNAc represents a thioester of N-acetyl cysteamine, but alternative thioesters could also be used. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> For either in vivo or in vitro production of the polyketides, acyl transferase domains with desired specificities can be incorporated into the relevant PKS. Methods for assuring appropriate specificity of the AT domains is described in detail in U.S. patent application Ser. No. 09/346,860 filed Jul. 2, 1999, the contents of which are incorporated herein by reference, to describe how such domains of desired specificity can be created and employed. Also relevant to the use of these enzymes in vitro or the genes in vivo are methods to mediate polyketide synthase module effectiveness by assuring appropriate transfer of the growing polyketide chain from one module to the next. Such methods are described in detail in U.S. Ser. No. 09/500,747 filed Feb. 9, 2000, the contents of which are incorporated herein by reference for this description. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> As a preliminary matter in determining which substituted benzoates can serve as starter units, adenylation and thiolation activities of the loading module were reconstituted in vitro and shown to be independent of coenzyme A, countering literature proposals that the loading module is a coenzyme A ligase as shown in Example 7. Kinetic parameters for covalent arylation of the loading module were measured directly for the unnatural substrates benzoate (B) and 3-hydroxybenzoate (3-HB) as described in Example 8. This analysis was extended through competition experiments to determine the relative rates of incorporation of a series of substituted benzoates as described in Examples 9 and 10. The results in the examples show that the loading module can accept a variety of substituted benzoates, although it exhibits a preference for the 3-, 5-, and 3,5-disubstituted benzoates that most closely resemble its biological substrate. The remarkable substrate tolerance of the loading module of rifamycin synthetase suggests that the module is useful as a tool for generating substituted derivatives of natural products. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> Substituted benzoates are defined as benzoate molecules that include any substituent or substituents. Benzoate substrates is a subset of substituted benzoates that primes an A-T didomain of a rifamycin synthase or otherwise can be incorporated as a starter unit into a loading module or as an extender unit into a module of a synthase or a synthetase. Preferably the benzoate substrates include 3-, 5-, and 3,5-disubstituted benzoates. More preferably, the benzoates are selected from the group consisting of 2-aminobenzoate, 3-aminobenzoate, 4-aminobenzoate, 3-amino-5-hydroxybenzoate, 3-amino-4-hydroxybenzoate, 4-amino-2-hydroxybenzoate, 3-bromobenzoate, 3-chlorobenzoate, 3,5-diaminobenzoate, 3,5-dibromobenzoate, 3,5-dichlorobenzoate, 3,5-difluorobenzoate, 2,3-dihydroxybenzoate, 3,5-dihydroxybenzoate, 3,5-dinitrobenzoate, 3-fluorobenzoate, 2-hydroxybenzoate, 3-hydroxybenzoate, 4-hydroxybenzoate, 3-methoxybenzoate, 3-nitrobenzoate, and 3-sulfobenzoate. </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> The observation that CoA is not required for arylation of the T domain and that benzoyl-CoA is not a competent intermediate in this process establishes the loading module of rifamycin synthetase as an NRPS-like A-T didomain (<cross-reference target="DRAWINGS">FIG. 2B</cross-reference>). </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> The conclusion that the loading module of rifamycin synthetase functions as an NRPS-like A-T didomain has implications for other systems. Biosynthetic gene clusters for rapamycin (Lowden, P. A. S., et al., <highlight><italic>Anges. Chem. Int. Ed. Engl. </italic></highlight>(1996) 35:2249-2251), FK506 (Motamedi, H., et al., <highlight><italic>Eur. J. Biochem. </italic></highlight>(1998) 256:528-534), ansatrienin (Chen, S., et al., <highlight><italic>Eur. J. Biochem. </italic></highlight>(1999) 261:98-107, FK520 (Wu, K., et al., <highlight><italic>Gene </italic></highlight>(2000) 251:81-90), microcystin (Tillett, D., et al., <highlight><italic>Chem. Biol. </italic></highlight>(2000) 7:753-764), and pimaricin (Aparicio, J. F., et al., <highlight><italic>Chem. Biol. </italic></highlight>(2000) 7:895-905) all encode loading modules with homology to the A-T didomain of rifamycin synthetase. However, several of these systems have been proposed to be primed by an activated CoA substrate, presumably generated via a CoA ligase mechanism analogous to that shown in <cross-reference target="DRAWINGS">FIG. 2A</cross-reference>. (Schwecke, T., et al. <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>(1995) 92:7839-7843; Motamedi, H., et al., <highlight><italic>Eur. J Biochem. </italic></highlight>(1998) 256:528-534; Moore, R. E., et al., <highlight><italic>J. Am. Chem. Soc., </italic></highlight>(1991) 113:5083-5084.) A more likely mechanism for priming of these systems is the adenylation-thiolation mechanism operative for rifamycin synthetase. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> Although the mechanisms shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference> are distinct, the chemistries involved are essentially the same. In both cases activation of AHB occurs via the aryl-adenylate, and the only difference is whether or not there is intermediate transfer of AHB to CoA prior to arylation of the T domain. Because the phosphopantetheine cofactor of the T domain is derived from CoA, the thiol nucleophiles of the T domain and CoA are chemically equivalent. Therefore, it is not difficult to envision how an enzyme could evolve from a CoA ligase into an A-T didomain, simply by covalent incorporation of the nucleophilic end of CoA as a phosphopantetheine cofactor. There is presumably an advantage to covalently tethering the aryl substrate moiety to the synthetase via the T domain instead of noncovalently binding it as the aryl-CoA. Nevertheless, aryl-CoA ligases are known to be involved in polyketide synthesis in the plant kingdom (see, for example, Beerhues, L., <highlight><italic>FEBS Lett. </italic></highlight>(1996) 383:264-266; Barillas, W., et al., <highlight><italic>Biol. Chem. </italic></highlight>(2000) 381:155-160), and benzoyl-CoA appears to be a substrate of the iterative type II PKS that produces enterocin (Hertweck, C., et al., <highlight><italic>Tetrahedron </italic></highlight>(2000) 56:9115-9120). </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> Prior to this investigation, AHB, 3-HB, and 3,5-dihydroxybenzoate were known to be substrates of the A-T didomain (Hunziker, D., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1998) 120:1092-1093). Eleven additional substrates, including benzoate (B), have been identified herein (Table 1). Previous work suggests that the substrate tolerance of the A-T didomain of rifamycin synthetase for alternative substituted benzoates is shared to a degree by related bacterial benzoyl-CoA ligases (Geissler, J. F., et al., <highlight><italic>J. Bact. </italic></highlight>(1988) 170:1709-1714; Altenschmidt, U., <highlight><italic>J. Bact. </italic></highlight>(1991) 173:5494-5501); and EntE (Rusnak, R., et al., <highlight><italic>Biochemistry </italic></highlight>(1989) 28:6827-6835), a stand-alone A domain that is a component of the enterobactin synthetase. These proteins are able to accept several alternative substituted benzoates, in addition to their biological substrates. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> Although analysis of the substrate specificity results for the A-T didomain at a detailed molecular level awaits a crystal structure of this loading module, some preliminary observations can be made based on the substrate screening results and the relative reactivity data in Table 1. With the exception of 2-aminobenzoate and B, only benzoates with 3-, 5-, or both 3-and 5-substituents are substrates for the A-T didomain. Binding sites that accommodate the 3-amino- and 5-hydroxy- substituents of the biological substrate AHB can apparently also accommodate alternative substituents at these positions. 3-Sulfobenzoate, 3-nitrobenzoate, and 3,5-dinitrobenzoate were likely rejected as substrates for steric reasons (<cross-reference target="DRAWINGS">FIG. 7</cross-reference>), since both sulfo- and nitro-substituents are significantly larger than the amino- and hydroxy-substituents of AHB. In this regard, it is surprising that 3-methoxybenzoate is accepted as a substrate, albeit a poor one, since the methoxy- substituent is also significantly larger than either substituent of AHB. The 3-fluoro- and 3,5-difluorobenzoates are discriminated against by factors of 5 and 30 with respect to their chlorinated and brominated counterparts (Table 1). Changes in the electronic properties of the aromatic ring upon fluorination may account for these differences. Phenylacetate and 3-hydroxyphenylacetate do not appear to be utilized as substrates by the A-T didomain, despite the reactivity of the corresponding benzoates, B and 3-HB (Table 1). This result suggests that the register of the carboxylate is a determinant of its reactivity, as the carboxylate of the phenylacetates is displaced by one methylene group relative to the benzoates. It should be noted that substituted benzoates were targeted as putative substrates in this study; the possibility that the tolerance of the A-T didomain for substituted benzoates extends to other types of aromatic substrates (e.g., heterocycles) remains to be tested. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> The remarkable substrate tolerance of the loading module of rifamycin synthetase for substituted benzoates has implications for the production of unnatural natural products through protein engineering. The endogenous loading module of 6-deoxyerythronolide B PKS was recently replaced by the loading module of the avermectin PKS, and the resulting hybrid synthase produced erythromycin derivatives that had incorporated branched starter units characteristic of the avermectin family (Marsden, A. F., et al., <highlight><italic>Science </italic></highlight>(1998) 279;199-202). Similarly, exploiting the priming promiscuity of the A-T didomain of rifamycin synthetase by appending it to other synthases or synthetases, with the goal of generating substituted derivatives of the original products is contemplated according to the invention. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> Finally, this initial characterization of the loading module of rifamycin synthetase as an NRPS-like A-T didomain sets the stage for investigation of the hybrid NRPS/PKS interface in this system. Biochemical studies that combine the NRPS-like loading module and PKS module 1 of rifamycin synthetase (in cis or in trans) should allow functional and structural questions regarding NRPS/PKS biosynthetic interfaces to be addressed. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> The nucleotide sequences encoding a multiplicity of PKS permits their use in recombinant procedures for producing a desired PKS and for production of the proteins useful in postmacrolide conversions, as well as modified forms thereof. For example, the nucleotide sequences for genes related to the production of erythromycin is disclosed in U.S. Pat. No. 6,004,787 and U.S. Pat. No. 5,998,194; for avermectin in U.S. Pat. No. 5,252,474; for FK506 in U.S. Pat. No. 5,622,866; for rifamycin in WO98/7868; for spiramycin in U.S. Pat. No. 5,098,837. These are merely examples. Portions of, or all of, the desired coding sequences can be synthesized using standard solid phase synthesis methods such as those described by Jaye, et al., <highlight><italic>J. Biol. Chem. </italic></highlight>(1984) 259:6331 and which are available commercially from, for example, Applied Biosystems, Inc. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> A portion of the PKS which encodes a particular activity can be isolated and manipulated, for example, by using it to replace the corresponding region in a different modular PKS. In addition, individual modules of the PKS may be ligated into suitable expression systems and used to produce the portion of the protein encoded by the open reading frame and the protein may then be isolated and purified, or which may be employed in situ to effect polyketide synthesis. Depending on the host for the recombinant production of the module or an entire open reading frame, or combination of open reading frames, suitable control sequences such as promoters, termination sequences, enhancers, and the like are ligated to the nucleotide sequence encoding the desired protein. Suitable control sequences for a variety of hosts are well known in the art. </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> The availability of these nucleotide sequences expands the possibility for the production of novel polyketides and their corresponding antibiotics using host cells modified to contain suitable expression systems for the appropriate enzymes. By manipulating the various activity-encoding regions of a donor PKS by replacing them into a scaffold of a different PKS or by forming hybrids instead of or in addition to such replacements or other mutagenizing alterations, a wide variety of polyketides and corresponding antibiotics may be obtained. These techniques are described, for example, in U.S. Ser. No. 09/073,538 filed May 6, 1998 and incorporated herein by reference. </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> A polyketide synthase may be obtained that produces a novel polyketide by, for example, using the scaffolding encoded by all or the portion employed of a natural synthase gene. The synthase will contain at least one module that is functional, preferably two or three modules, and more preferably four or more modules and contains mutations, deletions, or replacements of one or more of the activities of these functional modules so that the nature of the resulting polyketide is altered. This description applies both at the protein and genetic levels. Particularly preferred embodiments include those wherein a KS, AT, KR, DH or ER has been deleted or replaced by a version of the activity from a different PKS or from another location within the same PKS. Also preferred are derivatives where at least one noncondensation cycle enzymatic activity (KR, DH or ER) has been deleted or wherein any of these activities has been mutated so as to change the ultimate polyketide synthesized. </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> Thus, in order to obtain nucleotide sequences encoding a variety of derivatives of the naturally occurring PKS, and a variety of polyketides, a desired number of constructs can be obtained by &ldquo;mixing and matching&rdquo; enzymatic activity-encoding portions, and mutations can be introduced into the native host PKS gene cluster or portions thereof. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> Mutations can be made to the native sequences using conventional techniques. The substrates for mutation can be an entire cluster of genes or only one or two of them; the substrate for mutation may also be portions of one or more of these genes. Techniques for mutation include preparing synthetic oligonucleotides including the mutations and inserting the mutated sequence into the gene encoding a PKS subunit using restriction endonuclease digestion (See, e.g., Kunkel, T. A., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>(1985) 82:448; Geisselsoder, et al., <highlight><italic>BioTechniques </italic></highlight>(1987) 5:786) or by a variety of other art-known methods. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> Random mutagenesis of selected portions of the nucleotide sequences encoding enzymatic activities can also be accomplished by several different techniques known in the art, e.g., by inserting an oligonucleotide linker randomly into a plasmid, by irradiation with X-rays or ultraviolet light, by incorporating incorrect nucleotides during in vitro DNA synthesis, by error-prone PCR mutagenesis, by preparing synthetic mutants or by damaging plasmid DNA in vitro with chemicals. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> In addition to providing mutated forms of regions encoding enzymatic activity, regions encoding corresponding activities from different PKS synthases or from different locations in the same PKS synthase can be recovered, for example, using PCR techniques with appropriate primers. By &ldquo;corresponding&rdquo; activity encoding regions is meant those regions encoding the same general type of activity&mdash;e.g., a ketoreductase activity in one location of a gene cluster would &ldquo;correspond&rdquo; to a ketoreductase-encoding activity in another location in the gene cluster or in a different gene cluster; similarly, a complete reductase cycle could be considered corresponding&mdash;e.g., KR/DH/ER would correspond to KR alone. </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> If replacement of a particular target region in a host polyketide synthase is to be made, this replacement can be conducted in vitro using suitable restriction enzymes or can be effected in vivo using recombinant techniques involving homologous sequences framing the replacement gene in a donor plasmid and a receptor region in a recipient plasmid. Such systems, advantageously involving plasmids of differing temperature sensitivities are described, for example, in PCT application WO 96/40968. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> Finally, polyketide synthase genes, like DNA sequences in general, in addition to the methods for systematic alteration and random mutagenesis outlined above, can be modified by the technique of &ldquo;gene shuffling&rdquo; as described in U.S. Pat. No. 5,834,458, assigned to Maxygen, and U.S. Pat. Nos. 5,830,721, 5,811,238 and 5.605,793, assigned to Affymax. In this technique, DNA sequences encoding bPKS are cut with restriction enzymes, amplified, and then re-ligated. This results in a mixture of rearranged genes which can be assessed for their ability to produce polyketides. The ability to produce polyketides in easily transformed hosts, such as <highlight><italic>E. coli</italic></highlight>, makes this a practical approach. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> There are five degrees of freedom for constructing a polyketide synthase in terms of the polyketide that will be produced. First, the polyketide chain length will be determined by the number of modules in the PKS. Second, the nature of the carbon skeleton of the PKS will be determined by the specificities of the acyl transferases which determine the nature of the extender units at each position&mdash;e.g., malonyl, methyl malonyl, or ethyl malonyl, etc. Third, the loading domain specificity will also have an effect on the resulting carbon skeleton of the polyketide. Thus, the loading domain may use a different starter unit, such as acetyl, propionyl, butyryl and the like. Fourth, the oxidation state at various positions of the polyketide will be determined by the dehydratase and reductase portions of the modules. This will determine the presence and location of ketone, alcohol, double bonds or single bonds in the polyketide. Finally, the stereochemistry of the resulting polyketide is a function of three aspects of the synthase. The first aspect is related to the AT/KS specificity associated with substituted malonyls as extender units, which affects stereochemistry only when the reductive cycle is missing or when it contains only a ketoreductase since the dehydratase would abolish chirality. Second, the specificity of the ketoreductase will determine the chirality of any &bgr;-OH. Finally, the enoyl reductase specificity for substituted malonyls as extender units will influence the result when there is a complete KR/DH/ER available. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> One useful approach is to modify the KS activity in module I which results in the ability to incorporate alternative starter units as well as module 1 extended units. This approach was illustrated in PCT application U.S. Ser. No. 96/11317, incorporated herein by reference, wherein the KS-I activity was inactivated through mutation. Polyketide synthesis is then initiated by feeding chemically synthesized analogs of module 1 diketide products. The methods of the invention can then be used to provide enhanced amount of extender units. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> Modular PKSs have relaxed specificity for their starter units (Kao, et al., Science (1994), supra). Modular PKSs also exhibit considerable variety with regard to the choice of extender units in each condensation cycle. The degree of &bgr;-ketoreduction following a condensation reaction has also been shown to be altered by genetic manipulation (Donadio, et al., <highlight><italic>Science </italic></highlight>(1991), supra; Donadio, S. et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>(1993) 90:7119-7123). Likewise, the size of the polyketide product can be varied by designing mutants with the appropriate number of modules (Kao, C. M., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1994) 116:11612-11613). Lastly, these enzymes are particularly well-known for generating an impressive range of asymmetric centers in their products in a highly controlled manner. The polyketides and antibiotics produced by the methods of the present invention are typically single stereoisomeric forms. Although the compounds of the invention can occur as mixtures of stereoisomers, it is more practical to generate individual stereoisomers using the PKS systems. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> The polyketide products of the PKS may be further modified, typically by hydroxylation, oxidation and/or glycosylation, in order to exhibit antibiotic activity. </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> Methods for glycosylating the polyketides are generally known in the art; the glycosylation may be effected intracellularly by providing the appropriate glycosylation enzymes or may be effected in vitro using chemical synthetic means as described in U.S. Ser. No. 09/073,538 incorporated herein by reference. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> The antibiotic modular polyketides may contain any of a number of different sugars, although D-desosamine, or a close analog thereof, is most common. For example, erythromycin, picromycin, narbomycin and methymycin contain desosamine. Erythromycin also contains L-cladinose (3-O-methyl mycarose). Tylosin contains mycaminose (4-hydroxy desosamine), mycarose and 6-deoxy-D-allose. 2-acetyl-1-bromodesosamine has been used as a donor to glycosylate polyketides by Masamune, et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1975) 97:3512, 3513. Other, apparently more stable, donors include glycosyl fluorides, thioglycosides, and trichloroacetimidates; Woodward, R. B., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1981) 103:3215; Martin, S. F., et al., <highlight><italic>Am. Chem. Soc. </italic></highlight>(1997) 119:3193; Toshima, K., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1995) 117:3717; Matsumoto, T., et al., <highlight><italic>Tetrahedron Lett </italic></highlight>(1988) 29:3575. Glycosylation can also be effected using the macrolides as starting materials and using mutants of <highlight><italic>S. erythraea </italic></highlight>that are unable to synthesize the macrolides to make the conversion. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> In general, the approaches to effecting glycosylation mirror those described above with respect to hydroxylation. The purified enzymes, isolated from native sources or recombinantly produced may be used in vitro. Alternatively, glycosylation may be effected intracellularly using endogenous or recombinantly produced intracellular glycosylases. In addition, synthetic chemical methods may be employed. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> If the hosts ordinarily produce polyketides, it may be desirable to modify them so as to prevent the production of endogenous polyketides by these hosts. Such hosts have been described, for example, in U.S. Pat. No. 5,672,491, incorporated herein by reference, which describes <highlight><italic>S. coelicolor </italic></highlight>CH999 used in the examples below. In such hosts, it may not be necessary to provide enzymatic activity for posttranslational modification of the enzymes that make up the recombinantly produced polyketide synthase; these hosts generally contain suitable enzymes, designated holo-ACP synthases, for providing a pantetheinyl residue needed for functionality of the synthase. However, in hosts such as yeasts, plants, or mammalian cells which ordinarily do not produce polyketides, it may be necessary to provide, also typically by recombinant means, suitable holo-ACP synthases to convert the recombinantly produced PKS to functionality. Provision of such enzymes is described, for example, in PCT application WO 98/27203, incorporated herein by reference. </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> Again, depending on the host, and on the nature of the product desired, it may be necessary to provide &ldquo;tailoring enzymes&rdquo; or genes encoding them, wherein these tailoring enzymes modify the macrolides produced by oxidation, hydroxylation, glycosylation, and the like. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> The encoding nucleotide sequences are operably linked to promoters, enhancers, and/or termination sequences which operate to effect expression of the encoding nucleotide sequence in host cells compatible with these sequences; host cells modified to contain these sequences either as extrachromosomal elements or vectors or integrated into the chromosome, and methods to produce PKS and post-PKS enzymes as well as polyketides and antibiotics using these modified host cells. Multiple vector systems for use in organisms such as <highlight><italic>E. coli </italic></highlight>are contemplated. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> The vectors used to perform the various operations to replace the enzymatic activity in the host PKS genes or to support mutations in these regions of the host PKS genes may be chosen to contain control sequences operably linked to the resulting coding sequences in a manner that expression of the coding sequences may be effected in a appropriate host. However, simple cloning vectors may be used as well. </paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> Particularly useful control sequences are those which themselves, or using suitable regulatory systems, activate expression during transition from growth to stationary phase in the vegetative mycelium. The system contained in the illustrative plasmid pRM5, i.e., the actI/actIII promoter pair and the actII-ORF4, an activator gene, is particularly preferred. Particularly preferred hosts are those which lack their own means for producing polyketides so that a cleaner result is obtained. Illustrative host cells of this type include the modified <highlight><italic>S. coelicolor </italic></highlight>CH999 culture described in PCT application WO 96/40968 and similar strains of <highlight><italic>S. lividans. </italic></highlight></paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> Methods for introducing the recombinant vectors of the present invention into suitable hosts are known to those of skill in the art and typically include the use of CaCl<highlight><subscript>2 </subscript></highlight>or other agents, such as divalent cations, lipofection, DMSO, protoplast transformation and electroporation. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> As disclosed in Ser. No. 08/989,332 filed Dec.11, 1997, incorporated herein by reference, a wide variety of hosts can be used, even though some hosts natively do not contain the appropriate post-translational mechanisms to activate the acyl carrier proteins of the synthases. These hosts can be modified with the appropriate recombinant enzymes to effect these modifications. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> To demonstrate the power of engineering modular polyketide synthases in a new heterologous system, we attempted to construct a derivative of DEBS in which a PKS module was fused to a nonribosomal peptide synthetase (NRPS)-like module (Mootz, H. D., et al., <highlight><italic>Curr. Opin. Chem. Biol. </italic></highlight>(1997) 1:543). The first module of the rifamycin synthetase has recently been shown to be an NRPS-like module comprised of two domains: an adenylation (A) domain and a thiolation (T) domain (Admiraal, S. J., et al., <highlight><italic>Biochemistry </italic></highlight>Submitted). The A domain activates 3-amino-5-hydroxybenzoate (as well as benzoate and several benzoate derivatives, (Admiraal, supra)) in an ATP-dependent reaction, and transfers the aryl adenylate onto the phosphopantetheine arm of the T domain (<cross-reference target="DRAWINGS">FIG. 7</cross-reference>). This NRPS-like module was fused upstream of the first condensation module of DEBS in lieu of the loading didomain of DEBS (The construction of plasmid pBP165, carrying the rifamycin loading didomain fused to DEBS1 as well as the pccAB genes, is described in Example 11.) In the presence of exogenous propionate and benzoate, the resulting strain of <highlight><italic>E. coli </italic></highlight>produced the expected 6dEB analog (compound 3), as confirmed by NMR and mass spectrometry (<cross-reference target="DRAWINGS">FIG. 7</cross-reference>) (<highlight><superscript>13</superscript></highlight>C-NMR (CDCl<highlight><subscript>3</subscript></highlight>, 500 MHz) &dgr;213.76, 177.43, 79.70, 76.60, 71.24, 37.72 (enriched carbon atoms only). Mass Spectrometry (AP-CI) for expected <highlight><superscript>12</superscript></highlight>C<highlight><subscript>19</subscript></highlight><highlight><superscript>13</superscript></highlight>C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>38</subscript></highlight>O<highlight><subscript>6</subscript></highlight>Na: 463.2757; observed: 463.2847). </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> In summary, we have demonstrated the feasibility of engineering <highlight><italic>E. coli </italic></highlight>to produce complex polyketide natural products. Multiple changes were made to the <highlight><italic>E. coli </italic></highlight>genome for relevant 6dEB production, including introduction of the three DEBS genes from <highlight><italic>Saccharopolyspora erythraea, </italic></highlight>introduction of the sfp phosphopantetheinyl transferase gene from <highlight><italic>Bacillus subtilis, </italic></highlight>introduction of genes encoding a heterodimeric propionyl-CoA carboxylase from <highlight><italic>Streptomyces coelicolor, </italic></highlight>deletion of the endogenous prpRBCD genes, and overexpression of the endogenous prpE and birA genes. When gene expression was coordinately induced at low temperature, propionate could be converted into 6dEB by this metabolically engineered cellular catalyst with excellent kinetic parameters. Given the availability of well-established scalable protocols for fermenting <highlight><italic>E. coli </italic></highlight>to overproduce bioproducts, the ability to synthesize complex polyketides in this heterologous host bodes well for the practical production of these bioactive natural products. Equally important, as indicated by the hybrid PKS-NRPS described here, it opens the door for harnessing the enormous power of molecular biology in <highlight><italic>E. coli </italic></highlight>to engineer modular polyketide synthases using directed and random approaches. As such, organisms such as <highlight><italic>E. coli </italic></highlight>that make a hybrid modular polyketide synthases such as one that comprises NRPS and incorporate a variety of benzoate substrates are also contemplated. </paragraph>
</section>
<section>
<heading lvl="1">Starting Material Enhancement and Variation </heading>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> Thus, proteins (and their encoding sequences) wherein the proteins catalyze the production of starter and/or extender units can be used to enhance the production of polyketides by providing a considerable variety of these starter and extender units at higher levels than would ordinarily be produced. As set forth above, the required enzymes used to modify the microbial hosts, including those which are effective in providing for the production of, or enhancing the production of, starter and/or extender units may be supplied as extrachromosomal replicating elements, but are preferably introduced into the host genome, for example, by techniques of homologous recombination. By integrating the desired expression systems into the genome, the need for selection pressure is avoided and suitable production strains are obtained which are stable and can be used under ideal production conditions without additional antibiotics. In addition, the host may contain silent genes which are useful in the production of substrates that are activated by recombinant techniques. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> Because the proteins catalyze reactions to obtain starter and/or extender units using a variety of substrates, they are versatile tools in enhancing the availability of starter and extender units for a wide variety of PKS, whether modified or unmodified. As stated above, particularly useful are the products of the matABC operon (or analogous operons in other species) and the propionic carboxylase encoded by the pccB and accA2 along with accA1 genes (or their analogs in other species). These enzymes and their encoding sequences are useful in view of the discovery that the matABC operon and the propionic carboxylase-encoding genes provide enzymes which not only carry out the required reactions on a variety of substances, but also do so with the production of products with the stereochemistry required for use in polyketide synthesis. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> The ability of the genes described herein to provide appropriate starter and extender units was established as described below. </paragraph>
</section>
<section>
<heading lvl="1">Improved Culture Conditions </heading>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> In addition to the modification of the hosts described above, the culture conditions of the microbe may be modified to improve the yields of polyketide synthesized. The success of these conditions can be measured by the levels of, or rates of, polyketides produced by at least 5%, preferably 10%, more preferably 25%, and most preferably at least by 50%. Enhanced production levels of 200% may also be achieved. These enhancements are perhaps relatively modest, and it has been possible by modifying the genomic complement of the host organism or by manipulating the culture conditions or both to enhance the levels 5 fold, 10 fold, 20 fold, 100 fold, 200 fold or 500 fold. The production levels or rate of production are measured under the set of conditions where everything else is held constant other than the parameter being varied. </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> As shown below, the yield of polyketide is markedly increased by (1) maintaining relatively steady nutrient levels throughout the fermentation; (2) providing an auxiliary thioesterase; (3) batch feeding additional precursor for starter and/or extender units; and (4) permitting growth to high cell densities. Using one or more of these strategies, the yield of polyketide will be enhanced by at least 1.25 fold, preferably 1.5 fold, more preferably 2 fold, and in many instances 5 fold, 10 fold, 25 fold, 50 fold, 100 fold, 200 fold or 500 fold. </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> As shown in Example 12, addition of precursor after the initial concentration is depleted is beneficial, as is providing an expression system for thioesterase II (TEII). Especially beneficial is maintaining nutrient levels at a relatively constant value during the course of polyketide synthesis and permitting cell growth to high cell densities. </paragraph>
<paragraph id="P-0114" lvl="0"><number>&lsqb;0114&rsqb;</number> By &ldquo;relatively constant value&rdquo; of nutrients is meant maintaining nutrients at low concentration, typically below 2 g/L in the case of <highlight><italic>E. coli</italic></highlight>. By &ldquo;high cell densities&rdquo; is meant OD<highlight><subscript>600 </subscript></highlight>values of about 40-80, preferably 50-70 for <highlight><italic>E. coli. </italic></highlight></paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1">Production of Malonyl CoA and 2S-Methylmalonyl CoA Using the CoA Synthetase </heading>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> <highlight><italic>E. coli </italic></highlight>strain L8 has a temperature-sensitive mutation in the acetyl-CoA carboxylase gene such that malonyl-CoA cannot be produced from acetyl-CoA at 37&deg; C. However, the gene product is able to effect this conversion at 30&deg; C. See Harder, M. E., et al., <highlight><italic>Proc. Natl. Acad. Sci. </italic></highlight>(1972) 69:3105-3109. Since acetyl-CoA carboxylase conversion of acetyl-CoA into malonyl-CoA is the only known route for malonyl-CoA production in <highlight><italic>E. coli</italic></highlight>, and since malonyl-CoA is essential for fatty acid biosynthesis, this mutant strain of <highlight><italic>E. coli </italic></highlight>can grow at 30&deg; C., but not at 37&deg; C. A transformant of L8 carrying the matABC operon is produced by transforming with the plasmid pMATOP2 which contains the matA, matB and matC genes under control of their native promoter and is described in An, J. H., et al., <highlight><italic>Eur. J Biochem. </italic></highlight>(1998) 257:395-402. This transformant is still unable to grow at 37&deg; C. in the absence of malonic acid; however, addition of 1-5 mM malonic acid to the medium permits it to grow at this temperature. (In the absence of the plasmid, malonic acid is unable to support growth at 37&deg; C.) The concentration of the extracellular malonic acid is important, however, as increasing the concentration to 40 mM results in an absence of growth, possibly due to a metabolic imbalance caused by overproduction of malonyl CoA in comparison to the amount of coenzyme A available. Lethality was also induced in XL1-Blue (a wild-type strain of <highlight><italic>E. coli</italic></highlight>) in the presence of the plasmid carrying the matABC operon and high concentrations of methylmalonic acid. </paragraph>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> Nevertheless, the results set forth above demonstrate that the protein encoded by matB produces malonyl-CoA in vivo under physiological conditions as long as free malonic acid is available; and transported into the cells by the protein encoded by matC. Thus, the matBC genes can be used to supplement malonyl-CoA availability in an <highlight><italic>E. coli </italic></highlight>cell in which complex polyketides are to be produced by feeding malonic acid. </paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> In addition to converting malonic acid into malonyl-CoA, MatB has also been shown to convert methylmalonic acid into methylmalonyl-CoA. However the stereochemistry of the resulting product has not been reported. This is important, because modular polyketide synthases are known to only accept one isomer of methylmalonyl-CoA, namely 2S-methylmalonyl-CoA (Marsden, A. F., et al., <highlight><italic>Science </italic></highlight>(1994) 263:378-380). To investigate whether MatB can make the correct isomer of methylmalonyl-CoA, construct encoding a glutathione-S-transferase fusion (GST-MatB) was used to produce this protein. See An, J. H., et al., <highlight><italic>Biochem. J. </italic></highlight>(1999) 344:159-166. The GST-MatB protein was purified according to standard protocols as described and mixed with (module 6&plus;TE) of the erythromycin polyketide synthase, also expressed in <highlight><italic>E. coli </italic></highlight>as described by Gokhale, R. S., et al., <highlight><italic>Science </italic></highlight>(1999) 284:482-485. </paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> In earlier studies, Applicants have established the activity of (module 6&plus;TE) by demonstrating its ability to catalyze the following reaction in vitro. </paragraph>
<paragraph id="P-0119" lvl="0"><number>&lsqb;0119&rsqb;</number> N-acetylcysteamine thioester of (2S, 3R)-2-methyl-3-hydroxy-pentanoic acid&plus;2 (RS)-methylmalonyl-CoA&plus;NADPH&rarr;(2R,3S,4S,5R)-2,4-dimethyl-3,5-dihydroxy-n-heptanoic acid &dgr;-lactone&plus;NADP<highlight><superscript>&plus;</superscript></highlight>. </paragraph>
<paragraph id="P-0120" lvl="0"><number>&lsqb;0120&rsqb;</number> The methylmalonic thioester product obtained using methylmalonic acid as the substrate for GST-MatB provides the correct stereochemistry to serve as the source of the extender unit in this reaction. More specifically, to generate the substrate for the above polyketide synthesis in situ, the following reaction mixture (containing 6&plus;TE and GST-MatB) was prepared in a reaction buffer of 100 mM Na Phosphate (pH7) buffer, 1 mM ethylenediaminetetraacetic acid (EDTA), 2.5 mM dithiothreitol (DTT) and 20% glycerol: </paragraph>
<paragraph id="P-0121" lvl="2"><number>&lsqb;0121&rsqb;</number> 40 mM methylmalonic acid (pH 6) </paragraph>
<paragraph id="P-0122" lvl="2"><number>&lsqb;0122&rsqb;</number> 16.6 mM MgCl<highlight><subscript>2 </subscript></highlight></paragraph>
<paragraph id="P-0123" lvl="2"><number>&lsqb;0123&rsqb;</number> 5 mM ATP </paragraph>
<paragraph id="P-0124" lvl="2"><number>&lsqb;0124&rsqb;</number> 5 mM CoASH </paragraph>
<paragraph id="P-0125" lvl="2"><number>&lsqb;0125&rsqb;</number> 13.3 mM NADPH </paragraph>
<paragraph id="P-0126" lvl="2"><number>&lsqb;0126&rsqb;</number> 1 mM N-acetylcysteamine thioester of (2S, 3R)-2-methyl-3-hydroxypentanoic acid (prepared in radioactive form). </paragraph>
<paragraph id="P-0127" lvl="0"><number>&lsqb;0127&rsqb;</number> After 4 hrs, the reaction was quenched and extracted with ethyl acetate (extracted twice with three times the reaction volume). The samples were dried in vacuo and subjected to thin layer chromatography analysis. </paragraph>
<paragraph id="P-0128" lvl="0"><number>&lsqb;0128&rsqb;</number> A positive control was performed under identical conditions to those described earlier&mdash;i.e., conditions wherein (RS)-methylmalonyl-CoA was substituted for the combination of methylmalonic acid, MgCl<highlight><subscript>2</subscript></highlight>, ATP, CoA SH, and GST-MatB. A negative control included all of the components listed above except for the GST-MatB fusion protein. The results demonstrated that the two-enzyme system described above is able to produce the expected product in quantities comparable to the positive control reaction. This confirms that MatB synthesizes the correct isomer of methylmalonyl-CoA. </paragraph>
<paragraph id="P-0129" lvl="0"><number>&lsqb;0129&rsqb;</number> Thus, MatB/MatC is useful to synthesize both malonyl-CoA and 2S-methylmalonyl-CoA in vivo for polyketide biosynthesis. This is the first instance of engineering <highlight><italic>E. coli </italic></highlight>with the ability to produce 2S-methylmalonyl-CoA in vivo under physiological conditions. Moreover, co-expression of matA in vivo should allow conversion of methylmalonyl-CoA into propionyl-CoA, thereby supplementing available sources of this starter unit. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">Ability of Propionyl CoA Carboxylase to Generate 2S-Methylmalonyl CoA </heading>
<paragraph id="P-0130" lvl="0"><number>&lsqb;0130&rsqb;</number> To utilize the propionyl carboxylase gene from <highlight><italic>S. coelicolor </italic></highlight>described above, an <highlight><italic>E. coli </italic></highlight>expression host (BL-21 (DE3)) was prepared using the method developed by Hamilton, C. M., et al., <highlight><italic>J. Bacteriol. </italic></highlight>(1989) 171:4617-4622. The new strain (BAPS) contains a phosphopantethiene-transferase gene (the sfp gene) from <highlight><italic>Bacillus subtilis </italic></highlight>integrated into the prp operon of <highlight><italic>E. coli</italic></highlight>. The T7 promoter drives sfp expression. In the recombination procedure, the prpE gene was also placed under control of the T7 promoter, but the rest of the operon was removed. This genetic alteration would ideally provide three features: 1) the expression of the sfp protein needed for post-translational modification of the DEBS and potentially other polyketide synthases (PKSs); 2) the expression of the prpE protein, a putative propionyl-CoA synthetase theoretically capable of ligating CoASH to propionate; and 3) a cellular environment that is no longer able to metabolize propionyl-CoA as a carbon/energy source. </paragraph>
<paragraph id="P-0131" lvl="0"><number>&lsqb;0131&rsqb;</number> First, it was verified that the BAP1 strain, by virtue of its production of the product of the sfp gene was able to effect phosphopantetheinylation of a PKS produced in these cells. BAP1 was transfected with a plasmid comprising an expression system for module 6&plus;TE and the activity of the module produced was compared to the activity of the module produced recombinantly in BL-21 (DE3) cells where the sfp gene was plasmid borne. These levels were comparable. In contrast, when expressed alone in BL-21 (DE3), module 6&plus;TE showed no activity. Additionally, BAP1 was confirmed for its inability to grow on propionate as a sole carbon source (a property exhibited by <highlight><italic>E. coli </italic></highlight>strains such as BL21 (DE3)). BAP1 is a preferred host for the heterologous expression of polyketide synthases in conjunction with enzymes such as MatBC and propionyl-CoA carboxylase. </paragraph>
<paragraph id="P-0132" lvl="0"><number>&lsqb;0132&rsqb;</number> The propionyl-CoA carboxylase enzyme was expressed in <highlight><italic>E. coli </italic></highlight>under the T7 promoter. The product enzyme was able to supply substrate for module 6&plus;TE in vitro. This was demonstrated using the coupling of the methylmalonyl-CoA thioester product of the propionyl CoA carboxylase enzyme to the N-acetyl cysteamine thioester of (2S,2R)2-methyl-3-hydroxypentanoic acid. The pccB and accA2 genes described above which encode the components of the propionyl-CoA carboxylase, were expressed and the products individually purified according to standard procedures. Initially, the pccB and accA2 subunits were allowed to complex on ice in 150 mM phosphate (pH7) and 300 &mgr;g BSA. After 1 hour, the following substrates were added to a volume of 100 &mgr;l and incubated for an additional 30 minutes at 30&deg; C.: </paragraph>
<paragraph id="P-0133" lvl="2"><number>&lsqb;0133&rsqb;</number> 1 mM propionyl-CoA </paragraph>
<paragraph id="P-0134" lvl="2"><number>&lsqb;0134&rsqb;</number> 50 mM sodium bicarbonate </paragraph>
<paragraph id="P-0135" lvl="2"><number>&lsqb;0135&rsqb;</number> 3 mM ATP </paragraph>
<paragraph id="P-0136" lvl="2"><number>&lsqb;0136&rsqb;</number> 5 mM MgCl<highlight><subscript>2 </subscript></highlight></paragraph>
<paragraph id="P-0137" lvl="0"><number>&lsqb;0137&rsqb;</number> Module 6&plus;TE was then added with the following final set of reagents to give 200 &mgr;l total and allowed to react for an additional hour at 30&deg; C.: </paragraph>
<paragraph id="P-0138" lvl="2"><number>&lsqb;0138&rsqb;</number> 10 % glycerol </paragraph>
<paragraph id="P-0139" lvl="2"><number>&lsqb;0139&rsqb;</number> 1.25 mM DTT </paragraph>
<paragraph id="P-0140" lvl="2"><number>&lsqb;0140&rsqb;</number> 0.5 mM EDTA </paragraph>
<paragraph id="P-0141" lvl="2"><number>&lsqb;0141&rsqb;</number> 4 mM NADPH </paragraph>
<paragraph id="P-0142" lvl="2"><number>&lsqb;0142&rsqb;</number> 2 mM N-acetylcysteamine thioester of (2S, 3R)-2-methyl-3-hydroxypentanoic acid (prepared in radioactive form). </paragraph>
<paragraph id="P-0143" lvl="0"><number>&lsqb;0143&rsqb;</number> The reaction was quenched and extracted as described above, and showed formation of expected product. A positive control included racemic malonyl-CoA. When either ATP or sodium bicarbonate was removed from the reaction, no product was formed. The propionyl-CoA carboxylase thus produces a substrate suitable for polyketide synthase activity. This is particularly useful for polyketide production, especially in conjunction with the new expression host mentioned above, BAP1. </paragraph>
<paragraph id="P-0144" lvl="0"><number>&lsqb;0144&rsqb;</number> The DEBS protein DEBS1&plus;TE is produced by pRSG32. DEBS1 shows the weakest expression of the three DEBS proteins and, until recently, the enzyme showed no in vitro activity. However, by growing <highlight><italic>E. coli </italic></highlight>containing pRSG32 in M9 minimal medium, and inducing protein expression at 22&deg; C., DEBS1&plus;TE activity is now reproducibly observed. </paragraph>
<paragraph id="P-0145" lvl="0"><number>&lsqb;0145&rsqb;</number> Plasmids pRSG32 (DEBS1&plus;TE) and p132 (a plasmid containing the a and &bgr; components of propionyl-CoA carboxylase) were cotransfected into BAP1. Cultures of 10 ml M9 minimal media were grown to mid-log phase levels and concentrated to 1 ml for induction with IPTG and the addition of 0.267 mM <highlight><superscript>14</superscript></highlight>C-propionate. The samples were then incubated at 22&deg; C. for 12-15 hours. The culture supernatant was then extracted with ethyl acetate for analytical TLC. A product ran with the expected positive control and this same product was undetectable when using either wild type BL-21 (DE3) or removing p132. thus, the carboxylase forms the correct stereoisomer. </paragraph>
<paragraph id="P-0146" lvl="0"><number>&lsqb;0146&rsqb;</number> In addition, 100 ml cultures of M9 minimal media containing BAP1 transformed with pRSG32, p132, and pCY214 (a biotin ligase included to aid biotin&apos;s attachment to the &agr; subunit of the propionyl-CoA carboxylase) were grown to mid-log phase for induction with IPTG and the addition of 100 mg/L <highlight><superscript>13</superscript></highlight>C-propionate. The activity of the biotinylated subunit (pccA) could be significantly enhanced upon co-expression of the <highlight><italic>E. coli </italic></highlight>birA biotin ligase gene. Upon extraction of the culture supernatant and concentration of the sample, <highlight><superscript>13</superscript></highlight>C-NMR confirmed the location of the expected enriched product peaks. A subsequent negative control using BL-21 (DE3) failed to yield the same spectrum. In addition to demonstrating the ability of <highlight><italic>E. coli </italic></highlight>to make complex polyketides in vivo, these results also suggest that the prpE protein programmed to express in BAP1 is active. </paragraph>
<paragraph id="P-0147" lvl="0"><number>&lsqb;0147&rsqb;</number> Alternatively, M9 minimal media cultures of transformed cells were grown at 37&deg; C. to mid-log phase, followed by induction at 22&deg; C. with 0.5-1 mM IPTG, 2.5 g/L arabinose, and 26 mg/L or 250 mg/L &lsqb;1-<highlight><superscript>14</superscript></highlight>C&rsqb;-or &lsqb;1-<highlight><superscript>13</superscript></highlight>&rsqb;-propionate, respectively. Regarding the <highlight><superscript>14</superscript></highlight>C-1-propionate feeding, individual transformants were inoculated into M9 minimal media cultures with glucose (Maniatis, T., et al., Molecular Cloning: A Laboratory Manual. 1982) in the presence of 50 &mgr;g/ml carbenicillin, 25 &mgr;g/ml kanamycin, and 17 &mgr;g/ml chloramphenicol at 37&deg; C. and 250 rpm. Cultures were grown to mid-log phase (OD<highlight><subscript>600</subscript></highlight>&equals;0.6-0.8), cooled at 22&deg; C. for 5 min, and then centrifuged. The cell pellets were resuspended in 1 ml of the remaining supernatant and induced with 1 mM IPTG and 0.25% arabinose (for pCY216). In addition, regarding the <highlight><superscript>14</superscript></highlight>C-1-propionate (at 56 mCi/mmol) was added at final concentration of 0.27 mM. The culture was then stirred for an additional 12-15 hrs at 22&deg; C. At this point the culture was centrifuged and 100 &mgr;l of the supernatant was extracted (2&times;) with ethyl acetate (300 &mgr;L each time). The extract was dried in vacuo and subjected to TLC analysis. Negative controls included cultures of BAP1/pRSG32/pCY216 and BL21(DE3)/pRSG32/pTR132/pCY216. </paragraph>
<paragraph id="P-0148" lvl="0"><number>&lsqb;0148&rsqb;</number> Regarding the <highlight><superscript>13</superscript></highlight>C-1-propionate feeding, a single transformant of BAP1/pRSG32/pTR132/pCY216 was used to start a 3 mL LB culture with 100 &mgr;g/ml carbenicillin, 50 &mgr;g/ml kanamycin, and 34 &mgr;g/ml chloramphenicol at 37&deg; C. and 250 rpm. The starter culture was used to inoculate 100 mL M9 minimal media with glucose at the same antibiotic concentrations as above. These cultures were grown at 250 rpm and 37&deg; C. to mid-log phase (OD<highlight><subscript>600</subscript></highlight>&equals;0.5-0.7), cooled for 15 minutes in a 22&deg; C. bath, and induced with 500 &mgr;M IPTG and 0.25% arabinose. <highlight><superscript>13</superscript></highlight>C-1-propionate was added at 100 mg/L and the cultures were incubated at 22&deg; C. for 12-15 hrs. The sample was then centrifuged and the supernatant extracted twice with 300 ml ethyl acetate. The sample was dried in vacuo, resuspended in CDCl<highlight><subscript>3</subscript></highlight>, and analyzed via <highlight><superscript>13</superscript></highlight>C-NMR. A negative control was performed with BL21(DE3)/pRSG32/pTR132/pCY216. After 12-48 hours the culture supernatant was extracted and analyzed for formation of the expected triketide lactone (<cross-reference target="DRAWINGS">FIG. 7</cross-reference>, compound 2) product of DEBS1&plus;TE. Formation of triketide lactone under both feeding conditions confirmed the ability of BAP1 to produce polyketides. </paragraph>
<paragraph id="P-0149" lvl="0"><number>&lsqb;0149&rsqb;</number> Construction of plasmids pRSG32, pBP49, pRSG50: Genes encoding DEBS1&plus;TE (pRSG32), DEBS2 (pBP49) and DEBS3 (pRSG50) were cloned into pET21c (Novagen). The DEBS1&plus;TE gene was cloned as the NdeI-EcoRI fragment from pCK12 (6). The DEBS3 gene was cloned as the NdeI-EcoRI fragment from pJRJ10 (Jacobsen, J. R., et al., <highlight><italic>Biochemistry </italic></highlight>(1998) 37:4928). To express the DEBS2 gene, the BsmI-EcoRI fragment from pRSG34 (Gokhale, R. S., et al., <highlight><italic>Science </italic></highlight>(1999) 284:482), which has been used previously to express module 3&plus;TE, was replaced with a BsmI-EcoRI fragment encoding module 4. The EcoRI site (in bold) was engineered immediately upstream of the stop codon of the DEBS2 gene by modifying the natural sequence to the following: CGGGGGAGAGGACCTGAATTC. </paragraph>
<paragraph id="P-0150" lvl="0"><number>&lsqb;0150&rsqb;</number> It should be noted that a first attempt was made to express the genes encoding each of the three DEBS proteins, followed by in vitro assays of protein activity. DEBS3, DEBS2 and a variant of DEBS1, DEBS1&plus;TE were cloned individually into the pET21c expression vector and introduced via transformation into <highlight><italic>E. coli </italic></highlight>BL21(DE3) harboring the sfp phosphopantetheinyl transferase gene on pRSG56 (Kao, C. M., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1995) 117:9105-9106, Cortes, J., et al., <highlight><italic>Science </italic></highlight>(1995) 268:1487-1489; Lambalot, R. H., et al., <highlight><italic>Chemistry </italic></highlight>&amp; <highlight><italic>Biology </italic></highlight>(1996) 3:923-936; Gokhale, R. S., et al., <highlight><italic>Science </italic></highlight>(1999) 284:482-485). The expression levels of the three DEBS genes were found to be comparable to those reported earlier from <highlight><italic>S. erythraea </italic></highlight>(Caffrey, P., et al., <highlight><italic>FEBS Letters </italic></highlight>(1992) 304:225-228) or <highlight><italic>S. coelicolor </italic></highlight>(Pieper, R., et al., <highlight><italic>Nature </italic></highlight>(1995) 378:263-266). Individual transformants were used to start 25 ml LB seed cultures containing 100 &mgr;g/ml carbenicillin and 50 &mgr;g/ml kanamycin at 250 rpm and 37&deg; C. These cultures were used to inoculate 1 L of LB medium, and the culture was grown under the same conditions. At mid-log phase (OD<highlight><subscript>600</subscript></highlight>&equals;0.4-0.8) cells were induced with 1 mM IPTG and transferred to a 30&deg; C. incubator. Cells were harvested after 4-6 hours and their protein content was analyzed via 7.5% SDS-PAGE. The three DEBS proteins were expressed at ca. 1% total cellular protein. However, although DEBS3 was found to be active in these lysates, DEBS1&plus;TE and DEBS2 lacked any detectable activity (DEBS 1&plus;TE (Pieper, R., supra) and DEBS3 were assayed as described earlier (Jacobsen, J. R., et al., <highlight><italic>Biochemistry </italic></highlight>(1998) 37:4928). Although an assay for the entire DEBS2 has not yet been developed, the activity of module 3 on this protein can be assayed as described earlier (Gokhale, R. S., supra). Consistent with these results, recombinant DEBS3 could be purified from these lysates using procedures described earlier, (Pohl, N. L., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1998) 120:11206-11207), but neither DEBS1&plus;TE nor DEBS2 could be purified in detectable quantities. The key parameter that facilitated detection of in vitro activity and subsequent purification of DEBS 1&plus;TE and DEBS2 was the incubation temperature following IPTG (isopropylthio-&bgr;-D-galactoside) induction. Upon lowering the expression temperature from 30&deg; C. to 22&deg; C., active DEBS1&plus;TE, DEBS2, and DEBS3 proteins could be detected in recombinant <highlight><italic>E. coli </italic></highlight>lysates. Hereafter, low temperature induction conditions were maintained throughout the course of this study. </paragraph>
<paragraph id="P-0151" lvl="0"><number>&lsqb;0151&rsqb;</number> The use of low temperatures in the favorable expression of large genes and proteins in <highlight><italic>E. coli </italic></highlight>suggests that other large genes and proteins can be expressed in <highlight><italic>E. coli </italic></highlight>as well as other organisms by beneficially using low temperatures as shown herein. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1">Enhanced Production of 6-dEB in <highlight><italic>S. coelicolor </italic></highlight></heading>
<paragraph id="P-0152" lvl="0"><number>&lsqb;0152&rsqb;</number> The presence of the matB and matC genes was also able to enhance the recombinant production of 6-dEB in <highlight><italic>S. coelicolor </italic></highlight>which had been recombinantly modified to produce this polyketide by insertion of the DEBS gene complex on the vector pCK7. The matB and matC genes were expressed in a recombinant strain of <highlight><italic>Streptomyces coelicolor </italic></highlight>that produces 50 mg/L 6-deoxyerythronolide B by virtue of plasmid borne DEBS genes. The matB and matC genes were inserted immediately downstream of DEBS genes on pCK7. </paragraph>
<paragraph id="P-0153" lvl="0"><number>&lsqb;0153&rsqb;</number> In more detail, the source of the matBC genes is pFL482, a derivative of PCR-Blunt (Invitrogen) containing a 5 kb BglII/HindIII fragment from pMATOP2 which carries the matBC genes. The NsiI fragment of pFL482 containing the matBC genes was cloned into the unique NsiI site of pCK7 in the same direction as the DEBS genes to yield pFL494. Upon transformation of plasmid pFL494 into <highlight><italic>S. coelicolor </italic></highlight>CH999, macrolide titer increases of 100-300% were obtained in the presence of exogenous methylmalonate (0.1-1 g/L). </paragraph>
<paragraph id="P-0154" lvl="0"><number>&lsqb;0154&rsqb;</number> Cultures of <highlight><italic>S. coelicolor </italic></highlight>CH999 with or without plasmid pCK7 or pFL494 were grown in flasks using R6 medium (sucrose, 103 g/L; K<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>, 0.25 g/L; MgCl<highlight><subscript>2</subscript></highlight>.6H<highlight><subscript>2</subscript></highlight>O, 10.12 g/L; sodium propionate, 0.96 g/L; casamino acids (Difco), 0.1 g/L; trace elements solution, 2 mL/L; yeast extract (Fisher), 5 g/L; pH 7) supplemented with bis-tris propane buffer (28.2 g/L). Trace elements solution contained ZnCl<highlight><subscript>2</subscript></highlight>, 40 mg/L; FeCl<highlight><subscript>3</subscript></highlight>.6H<highlight><subscript>2</subscript></highlight>O, 200 mg/L; CuCl<highlight><subscript>2</subscript></highlight>.2H<highlight><subscript>2</subscript></highlight>O, 10 mg/L; MnCl<highlight><subscript>2</subscript></highlight>.4H<highlight><subscript>2</subscript></highlight>O, 10 mg/L; Na<highlight><subscript>2</subscript></highlight>B<highlight><subscript>4</subscript></highlight>O<highlight><subscript>7</subscript></highlight>.1OH<highlight><subscript>2</subscript></highlight>O, 10 mg/L; (NH<highlight><subscript>4</subscript></highlight>)<highlight><subscript>6</subscript></highlight>Mo<highlight><subscript>7</subscript></highlight>O<highlight><subscript>24</subscript></highlight>.4H<highlight><subscript>2</subscript></highlight>O. All media were supplemented with 50 mg/L thiostrepton (Calbiochem) to select for plasmid-containing cells, and with 5 mL/L Antifoam B (JT Baker) for control of foam. Thiostrepton was dissolved in DMSO prior to addition to cultures, giving a final DMSO concentration of approximately 1 mL/L of medium. </paragraph>
<paragraph id="P-0155" lvl="0"><number>&lsqb;0155&rsqb;</number> Seed cultures for the fermentation were prepared by inoculation of 50 mL medium, followed by growth for two days at 240 rpm and 30&deg; C. in 250 mL baffled flasks (Bellco). These seed cultures were then used to inoculate 50 mL medium in the presence or absence of 1 g/L methylmalonate in 250-mL baffled flasks at 5% of final volume. All flask cultures were run in duplicate and sampled daily. The entire experiment was repeated once to ensure batch-to-batch reproducibility of the results. </paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> Quantitation of 6-dEB and 8,8a-deoxyoleandolide was carried out using a Hewlett-Packard 1090 HPLC equipped with an Alltec 500 evaporative light scattering detector. HPLC samples were first centrifuged 5 min at 12,000&times;g to remove insolubles. The supernatant (20 &mgr;L) was applied onto a 4.6&times;10 mm column (Inertsil, C18 ODS3, 5 &mgr;m), washed with water (1 ml/min for 2 min), and finally eluted onto the main column (4.6&times;50 mm, same stationary phase and flow rate) with a 6-min gradient starting with 100% water and ending with 100% acetonitrile. 100% acetonitrile was then maintained for one min. Under these conditions, 6-dEB eluted at 6.2 minutes and 8.8a-deoxyoleandolide at 5.8 min. Standards were prepared from 6-dEB purified from fermentation broth. Quantitation error was estimated to be &plusmn;10%. </paragraph>
<paragraph id="P-0157" lvl="0"><number>&lsqb;0157&rsqb;</number> As described above, <highlight><italic>S. coelicolor </italic></highlight>CH999 either containing pCK7 or containing pFL494 were compared for their productivity of 6-dEB and 8,8a-deoxyoleandolide. </paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> The results show the following: </paragraph>
<paragraph id="P-0159" lvl="2"><number>&lsqb;0159&rsqb;</number> 1. Cell density was substantially the same for both strains. </paragraph>
<paragraph id="P-0160" lvl="2"><number>&lsqb;0160&rsqb;</number> The production of both 6-dEB and 8,8a-deoxyoleandolide is dramatically enhanced in CH999/pFL494 as compared to CH999/pCK7, whether measured in terms of mg/liters/hour or in mg/liter as a final titer after six days. (8,8a-deoxyoleandolide is the same as 6-dEB except that it contains methyl instead of ethyl as position 12, since acetyl CoA rather than propionyl CoA is used as a starter unit.) More specifically, after six days CH999/pFL494 plus methylmalonic acid produced 180 mg/l 6-dEB and about 90 mg/l of 8,8a-deoxyoleandolide. If methylmalonic acid was not added to the medium, 6-dEB was produced at a level of 130 mg/l while 8,8a-deoxyoleandolide was produced at bout 40 mg/l. For CH999 modified to contain pCK7, in the presence of methylmalonic acid in the medium, only 60 mg/l 6-dEB were formed along with about 20 mg/l of 8,8a-deoxyoleandolide. Without methylmalonic acid, these cells produced slightly less of each of these macrolides. </paragraph>
<paragraph id="P-0161" lvl="2"><number>&lsqb;0161&rsqb;</number> 3. CH999/pFL494 completely consumed methylmalonate supplied at 1 g/L by day 6. </paragraph>
<paragraph id="P-0162" lvl="2"><number>&lsqb;0162&rsqb;</number> 4. Consumption of 1 g/L methylmalonate results in a cumulative increase in macrolide of 200 m/L, representing a 35% conversion efficiency of methylmalonate into products. </paragraph>
<paragraph id="P-0163" lvl="2"><number>&lsqb;0163&rsqb;</number> CH999/pFL494 shows improved production of both macrolides even in the absence of exogenous methylmalonate (see 2 above). </paragraph>
<paragraph id="P-0164" lvl="2"><number>&lsqb;0164&rsqb;</number> Even CH999/pCK7 showed a 20% improvement in 6-dEB production when exogenous methylmalonate was added (see 2 above). </paragraph>
<paragraph id="P-0165" lvl="0"><number>&lsqb;0165&rsqb;</number> In addition to enhancing the productivity of known polyketides in natural and heterologous hosts, MatB is also used to produce novel polyketides. In contrast to other enzymes that produce the alpha-carboxylated CoA thioester building blocks for polyketide biosynthesis, such as methylmalonyl-CoA mutase (which has a high degree of specificity for succinyl-CoA) and acetyl/propionyl-CoA carboxylase (which prefers acetyl-CoA and/or propionyl-CoA), MatB is active with respect to a wide range of substrates. In addition to malonate and methylmalonate, MatB is able to activate substrates such as ethylmalonate, dimethylmalonate, isopropylmalonate, propylmalonate, allylmalonate, cyclopropylmalonate, and cyclobutylmalonate into their corresponding CoA thioesters. </paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> Incorporation of these substrates into polyketide synthases requires a suitable acyltransferase (AT) which may be engineered into the appropriate module of a polyketide synthase, so that it can accept the unnatural substrate. Though none of these dicarboxylic acids yield detectable quantities of novel compounds when fed to CH999/pFL494, certain PKS enzymes naturally possess AT domains with orthogonal substrate specificity. For example, the FK506 PKS contains an acyltransferase domain that ordinarily incorporates bulky substrates such as propylmalonyl-CoA in preference to substrates such as malonyl-CoA or methylmalonyl-CoA, and can thus accept MatB-generated unnatural building blocks without any PKS engineering. </paragraph>
<paragraph id="P-0167" lvl="0"><number>&lsqb;0167&rsqb;</number> Using a protein engineering strategy described by Lau, J., et al., <highlight><italic>Biochemistry </italic></highlight>(1999) 38:1643-1651, the AT domain of module 6 of DEBS in pFL494 was modified to include the specificity determining segment from the niddamycin AT4 domain which incorporates ethylmalonyl-CoA. See: Kakavas, S. J., et al., <highlight><italic>J. Bacteriol </italic></highlight>(1997) 179:7515-7522. The resulting plasmid pFL508 was transformed into CH999. Upon feeding this strain with ethylmalonate, mass spectroscopy was able to detect a product corresponding to 2-ethyl-6dEB in levels comparable to that of 6dEB. The new compound was undetectable in the absence of ethylmalonate or in a control strain lacking the matBC genes. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">Production of 6-dEB in <highlight><italic>E. coli </italic></highlight></heading>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> We have demonstrated the ability of <highlight><italic>E. coli </italic></highlight>to produce complex, complete, polyketides, when programmed with the ability to express a functional PKS, a pantetheinyltransferase, and one or more pathways for producing starter and extender units. <highlight><italic>E. coli </italic></highlight>strain BL-21 (DE) obtained from Novagen was modified genetically by inserting the phosph6pantetheinyl transferase gene (the sfp gene) from <highlight><italic>Bacillus subtilis </italic></highlight>into the chromosome under the control of the phage T7 promoter by deleting the prpA-D portion of the prp operon, thus also placing the prpE locus, which encodes a propionyl CoA synthetase, under control of the T7 promoter. This genetically modified strain was then modified to include expression systems for the three genes encoding the DEBS1, DEBS2, and DEBS3 proteins, also under control of the T7 promoter as well as genes encoding propionyl CoA carboxylase and a gene encoding biotin ligase which is necessary for activation of the propionyl CoA carboxylase enzyme. The resulting <highlight><italic>E. coli </italic></highlight>contains a complete synthase for 6-dEB, a phosphopantetheinyl transferase necessary for the activation of this PKS, the propionyl CoA carboxylase enzymes that supply methylmalonyl CoA from propionyl CoA, and an inducible means to produce the endogenous propionyl CoA synthase capable of converting exogenous propionate to propionyl CoA. In addition, the endogenous system for catabolism of propionate was disarmed. </paragraph>
<paragraph id="P-0169" lvl="0"><number>&lsqb;0169&rsqb;</number> Thus, the <highlight><italic>E. coli </italic></highlight>are provided enzymes for synthesis of both starter and extender units under control of an inducible promoter, the endogenous mechanism for destruction of the propionate precursor of the starter and extender units has been disarmed; and expression systems (also under inducible promoters) have been provided for the necessary PKS proteins along with an expression system for the enzyme for activation of the PKS proteins. </paragraph>
<paragraph id="P-0170" lvl="0"><number>&lsqb;0170&rsqb;</number> In more detail, the genetically modified BL-21(DE3) strain was prepared according to the procedure described in Hamilton, et al., <highlight><italic>J. Bacteriol </italic></highlight>(1989) 171:4617-4622, which is incorporated herein by reference. A derivative of pMAK705 described in this publication, was prepared. In the derived vector, a T7 promoter coupled to the sfp gene was flanked by a 1,000 base pair sequence identical to that upstream of the A locus of the pip operon and a 1,000 base pair sequence identical to the sequence downstream of the E locus of this operon. The sfp gene was obtained from pUC8-sfp, a plasmid described by Nakano, et al., <highlight><italic>Mol. Gen. Genet. </italic></highlight>(1992) 232:313-321. The resulting integrated sequence deletes the prp loci A-D and inserts the T7 promoter controlling the sfp gene in their place and further results in placing the prpE locus under the control of the T7 promoter. As suggested herein, this site was chosen for sfp gene insertion for two reasons. First, the prp operon is putatively responsible for propionate catabolism in <highlight><italic>E. coli </italic></highlight>(Horswill, A. R., and Escalante-Semerena, J. C., <highlight><italic>J. Bacteriol. </italic></highlight>(1999) 181:5615-5623). Since propionate was intended to be the sole source of carbon building blocks for 6dEB biosynthesis (see below), concurrent propionate catabolism and anabolism were deemed undesirable. By deleting prpRBCD in the process of sfp integration, the ability of BAP1 to utilize propionate as a carbon and energy source was eliminated. Second, together with the sfp gene, the prpE gene in BAP1 was also placed under control of an IPTG-inducible promoter such as a T7 promoter. PrpE is thought to convert propionate into propionyl-CoA (Horswill, A. R., and Escalante-Semerena, J. C., <highlight><italic>Microbiology </italic></highlight>(1999) 145:1381-1388); therefore, in the presence of exogenous propionate, propionyl-CoA can be expected to accumulate inside the cell at the same time as DEBS is expressed in an active form. It is noted, however, that it may not be desirable to delete prpRBCD is a production strain. It may be desirable in some strains, alternatively, to inactivate only some of the prpRBCD genes. The T7 promoter is inducible by IPTG. </paragraph>
<paragraph id="P-0171" lvl="0"><number>&lsqb;0171&rsqb;</number> The resulting genetically altered host, designated BAP 1, was than transfected with three plasmids each selectable for a different antibiotic resistance. These plasmids are as follows: </paragraph>
<paragraph id="P-0172" lvl="2"><number>&lsqb;0172&rsqb;</number> pBP130 is derived from pET21 (carb<highlight><superscript>R</superscript></highlight>) obtained from Novagen and modified to contain the DEBS2 and DEBS3 genes under control of the T7 promoter. </paragraph>
<paragraph id="P-0173" lvl="2"><number>&lsqb;0173&rsqb;</number> pBP144 is a modified form of pET28 (kan<highlight><superscript>R</superscript></highlight>) also available from Novagen containing the pcc and DEBS1 genes, also under control of the T7 promoter. </paragraph>
<paragraph id="P-0174" lvl="2"><number>&lsqb;0174&rsqb;</number> pCY214 (cm<highlight><superscript>R</superscript></highlight>) contains the <highlight><italic>E. coli </italic></highlight>birA (biotin ligase) gene under the ara promoter and is described in Chapman-Smith, et al., <highlight><italic>Biochem. J. </italic></highlight>(1994) 302:881-887. This plasmid was obtained as a gift from Dr. Hugo Gramajo. The PCC protein and pcc gene are described in Rodriguez, et al., <highlight><italic>Microbiol. </italic></highlight>(1999) 145:3109-3119. </paragraph>
<paragraph id="P-0175" lvl="0"><number>&lsqb;0175&rsqb;</number> Construction of plamids pBP130, pBP144: The expression vectors pET21c and pET28a were first re-engineered by replacing the Bpu11021-DraIII fragments in these vectors with a polylinker possessing the Bpu11021, NsiI, PstI, PacI and DraIII sites. The DEBS2 gene from pBP49 and the DEBS3 gene from pRSG50 were cloned into the pET21c derivative between the NdeI-EcoRI and NsiI-PacI sites, respectively, yielding pBP130 (25.5 kb). Thus, pBP130 is capable of expressing the DEBS2 and DEBS3 genes under the control of the same pT7 promoter. Similarly, pBP144 (20 kb) was constructed from the pET28a derivative described above by inserting the pccAB genes from pTR132 (Rodriguez, E., and Gramajo, H., <highlight><italic>Microbiology </italic></highlight>(1999) 145:3109-3119) and the DEBS1 gene into the NdeI-EcoRI and PstI-PacI sites, respectively. This DEBS1 gene was derived from pRSG32 by replacing the SpeI-EcoRI fragment with a fragment amplified from the 3&prime; end of the natural DEBS1 gene using the following oligonucleotides: 5&prime; oligonucleotide: </paragraph>
<paragraph id="P-0176" lvl="7"><number>&lsqb;0176&rsqb;</number> TTACTAGTGAGCTCGGCACCGAGGTCCGGGG; 3&prime; oligonucleotide: TTGAATTCGGATCGCCGTCGAGCTCCCGGCCGA. Thus, pBP144 expresses the pccAB genes and the DEBS1 gene, each under the control of its own pT7 promoter. </paragraph>
<paragraph id="P-0177" lvl="0"><number>&lsqb;0177&rsqb;</number> For the production of 6-dEB, BAP1 cells transformed with pBP130, pBP144, and pCY214 were grown in M9 minimal media with the appropriate antibiotics. The culture was grown to mid-log phase, followed by induction with IPTG and arabinose and the concomitant addition of 250 mg/L <highlight><superscript>13</superscript></highlight>C-1-propionate. Induced cultures were grown for 12-24 hrs at 22&deg; C. (Both the minimal medium and lower temperatures were found to be beneficial for DEBS gene expression. This protocol permitted growth-related production of 6-dEB, since glucose provided the carbon and energy source for general metabolism, while propionate was converted into 6-dEB.) </paragraph>
<paragraph id="P-0178" lvl="0"><number>&lsqb;0178&rsqb;</number> After 12-24 h the culture supernatant was extracted with ethyl acetate. The organic phase was dried in vacuo, and re-dissolved in CDCl<highlight><subscript>3 </subscript></highlight>for <highlight><superscript>13</superscript></highlight>C-NMR analysis. The accompanying spectrum showed that 6-dEB was the major <highlight><superscript>13</superscript></highlight>C-labeled product. Other major <highlight><superscript>13</superscript></highlight>C-labeled compound(s) with peaks in the range of 120-140 ppm are not derived from propionate incorporation, as confirmed by a separate experiment in which <highlight><superscript>13</superscript></highlight>C-3-propionate was used in lieu of <highlight><superscript>13</superscript></highlight>C-1-propionate. From the intensities of peaks corresponding to 6-dEB, it is estimated that at least 75% of the exogenous propionate was converted into 6-dEB. This was consistent with the disappearance of the propionate signal from the <highlight><superscript>13</superscript></highlight>C NMR spectrum of the culture medium at the end of the fermentation. Negative control strains, which lacked either pBP130 or pBP144, failed to yield detectable quantities of 6-dEB. </paragraph>
<paragraph id="P-0179" lvl="0"><number>&lsqb;0179&rsqb;</number> The foregoing experiments were performed at low cell densities (OD<highlight><subscript>600 </subscript></highlight>in the range of 0.5-2.5); a major advantage of synthesizing recombinant products in <highlight><italic>E. coli </italic></highlight>is that this bacterium can be grown to extremely high cell densities (OD<highlight><subscript>600 </subscript></highlight>of 100-200) without significant loss in its specific catalytic activity. </paragraph>
<paragraph id="P-0180" lvl="0"><number>&lsqb;0180&rsqb;</number> The use of the matB and C genes or any of their homologs from other organisms in a non-native expression system is useful as a general strategy for the in vivo production of any alpha-carboxylated CoA thioester in any microbial host. The in vivo production of such CoA thioesters could be intended to enhance natural polyketide productivity or to produce novel polyketides. The matA gene is also useful to supplement in vivo levels of substrates such as acetyl-CoA and propionyl-CoA. Purified MatB is also used for the preparative in vitro production of polyketides, since CoA thioesters are the most expensive components in such cell-free synthesis systems. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">Incorporation of Diketides </heading>
<paragraph id="P-0181" lvl="0"><number>&lsqb;0181&rsqb;</number> The BAP1 <highlight><italic>E. coli </italic></highlight>host organism described in Example 4 was transfected with p132 which contains an expression system for the PCCA and B subunits and with pRSG36 which contains an expression system for module 6&plus;TE of DEBS3. The transfected cultures were grown on minimal selection media for both plasmids and then fed <highlight><superscript>14</superscript></highlight>C labeled diketide. When induced and provided with propionate, <highlight><superscript>14</superscript></highlight>C labeled triketide was obtained. </paragraph>
<paragraph id="P-0182" lvl="0"><number>&lsqb;0182&rsqb;</number> Alternatively, to co-express all three DEBS genes and the pcc genes, vectors pET21c and pET28a (Novagen) were modified to express two and three genes, respectively (The construction of plasmids pBP130 and pBP144 is described in Example 4.) When tested individually, protein production was observed from each gene located on both plasmids. BAP1 was transformed with these plasmids together with the birA plasmid. Individual transformants were cultured, induced and analyzed similar to the experiment for DEBS1&plus;TE (above) using &lsqb;1-<highlight><superscript>13</superscript></highlight>C&rsqb;-propionate. NMR analysis of the crude organic extract revealed 6-dEB as the major propionate-derived metabolite of these recombinant cells. The product was later purified by HPLC and subjected to mass spectrometry yielding a major peak of the expected mass. Plasmids pBP130, pBP144, and pCY216 were transformed into BAP1 as previously described. Culture conditions were identical to those described for <highlight><superscript>13</superscript></highlight>C-1-propionate fed at 250 mg/L described above in Example 2. Cultures were sampled regularly over 3 days. Samples were centrifuged and the supernatant (either 2 or 20 &mgr;L) loaded onto a Hewlett-Packard 1090 HPLC using an initial 4.6&times;10 mm column (Inertsil, C18 ODS3, 5 &mgr;m), washed with water (1 ml/min for 2 min), and then loaded onto a main 4.6&times;50 mm column with the same stationary phase and flow rate. A 6-minute gradient was then applied starting with 100% water and finishing with 100% acetonitrile maintained for an additional 1 minute. The samples were analyzed with an Alltech evaporative light scattering detection system (ELSD500), and a peak at 6.4 min retention time was confirmed as hepta-<highlight><superscript>13</superscript></highlight>C-labeled 6dEB by mass spectrometry (MW<highlight><subscript>obs</subscript></highlight>&equals;393). Product concentrations were measured in comparison to standard 6-dEB samples using the same detection scheme. At the end of the incubation period, the entire culture supernatant was extracted as before with ethyl acetate, dried, and analyzed by <highlight><superscript>13</superscript></highlight>C-NMR. Additionally, the final cell pellet was analyzed via SDS-PAGE to confirm the presence of the three DEBS proteins and the PCC. No differences were observed between the expression levels of the proteins at 12 h and 48 h post-induction. The stability of each plasmid in BAP1/pBP130/pBP144/pCY216 was also tested at 12 h and 36 h post-induction. No loss of pBP144 was observed at either time-point, whereas pBP130 and pCY216 were maintained in 50% and 35% of the colonies at 12 h and 36 h, respectively. No rearrangement of any plasmid was detected at either time-point, based on restriction analysis of multiple re-transformed colonies. Negative controls for the <highlight><superscript>13</superscript></highlight>C-NMR experiments included BAP1/pBP130/pCY216, BAP1/pBP144/pCY216, and BAP1/pBP130/pBP160/pCY216. (Plasmid pBP160 carries a C -&gt;A null mutation at the active site of the KS domain in module 1 (Kao, C., et al., <highlight><italic>Biochemistry </italic></highlight>(1996) 35:12363). To quantify the productivity of this novel polyketide cellular system, culture samples were taken periodically, and the concentration of 6-dEB was measured (<cross-reference target="DRAWINGS">FIG. 9</cross-reference>). From this data it can be calculated that the specific productivity of this cellular catalyst is 0.1 mmol 6dEB/g cellular protein/day. This is significantly superior to wild-type <highlight><italic>S. erythraea </italic></highlight>and compares well to an industrially relevant strain that overproduces erythromycin (0.2 mmol erythromycin/g cellular protein/day) (Minas, W., et al., <highlight><italic>Biotechnol. Prog. </italic></highlight>(1998) 14:561) as a result of a decades-long program of directed strain improvement based on random mutagenesis. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">Construction, Expression and Purification of the A-T Loading Didomain </heading>
<paragraph id="P-0183" lvl="0"><number>&lsqb;0183&rsqb;</number> The A-T loading didomain is naturally present at the N-terminus of RifA. To investigate this didomain biochemically, it was removed from the RifA protein context. Therefore, the sequence encoding the isolated A-T didomain was subcloned into an expression vector, using an NdeI restriction site engineered at the transcriptional start site of RifA and a NotI restriction site introduced in the linker region between the C-terminal end of the consensus T domain and the N-terminal end of the consensus ketosynthase domain of module 1, as described below in more detail. Thiolation domains require covalent attachment of the 4&prime; -phosphopantetheine moiety of CoA to a conserved serine to be active (Walsh, C. T., et al., <highlight><italic>Curr. Opin. Chem. Biol. </italic></highlight>(1997) 1:309-315). The Sfp phosphopantetheinyl transferase from <highlight><italic>B. subtilis, </italic></highlight>which is capable of converting the apo forms of many heterologous recombinant proteins into the holo forms, was therefore co-expressed with the A-T didomain in the halo enzyme preparation (Lambalot, R. H., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1996) 3:923-936; Quadri, L. E. N., et al., <highlight><italic>Biochemistry </italic></highlight>(1998) 37:1585-1595). The apo and holo forms of the A-T didomain were produced in <highlight><italic>E. coli </italic></highlight>as C-terminal hexahistidine-tagged fusion proteins and were purified by nickel affinity chromatography to &gt;98% homogeneity, as describe more filly below. Purified recombinant apo and holo A-T didomain (encoded by plasmid pSA8) were overproduced in <highlight><italic>E. coli, </italic></highlight>and protein samples were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (4-15%, Bio-Rad) and stained with SimplyBlue Safestain (Invitrogen). The apo A-T didomain and the holo A-T didomain each had a molecular weight of less than the 75 kD molecular weight marker. The halo A-T didomain had a slightly higher molecular weight that the apo A-T didomain. </paragraph>
<paragraph id="P-0184" lvl="0"><number>&lsqb;0184&rsqb;</number> Materials. &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-Benzoic acid (57 mCi/mmol) and &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-3-hydroxybenzoic a (55 mCi/mmol) were obtained from American Radiolabeled Chemicals. All other substituted benzoic acids, phenylacetic acid, and 3-hydroxyphenylacetic acid were obtained from Aldrich in unlabeled form. ATP, CoA, and benzoyl-CoA were supplied by Sigma Chemical Company. AHB was synthesized according to a previously published protocol (Ghisalba, O., et al., <highlight><italic>J. Antibiot. </italic></highlight>(1981) 34:64-71). Restriction enzymes were from New England Biolabs. </paragraph>
<paragraph id="P-0185" lvl="0"><number>&lsqb;0185&rsqb;</number> Manipulation of DNA and Strains. DNA manipulations were performed in <highlight><italic>E. coli </italic></highlight>XL1 Blue (Stratagene) using standard culture conditions. Sambrook, J., et al., <highlight><italic>Molecular Cloning: A Laboratory Manual, </italic></highlight>2nd ed., (1989) Cold Spring Harbor Laboratory Press, Plainview, N.Y. Polymerase chain reactions were carried out using Pfu polymerase (Stratagene) as recommended by the manufacturer. </paragraph>
<paragraph id="P-0186" lvl="0"><number>&lsqb;0186&rsqb;</number> Construction of an Expression Vector for the A-T Didomain. An NdeI restriction site was engineered at the start codon of the rifA gene using the primers 5&prime;-GCGGCCATATGCGCACCGATCTC-3&prime; and 5&prime;-AGGGCCCGCTGGCGGGAGAAC-3&prime; (mutated bases are shown in bold, and the introduced NdeI restriction site is underlined); the amplified 2.5 kb fragment was ligated to linearized pCR-Script (Stratagene) to produce pHu29. The rifA gene with the engineered NdeI restriction site at the start codon was then reconstructed in pHu90-1, a derivative of pRM5 (McDaniel, R., et al. (1993) Science 262, 1546-1550), via pHu29, pHu35, pHu50, and pHu51. Flanking restriction sites for PacI and PstI were used to transfer the sequence encoding the loading didomain and part of module 1 from pHu90-1 into a pUC18 derivative to produce pSA2. The loading didomain and module 1 are separated by an &tilde;20 amino acid linker region, delineated by the C-terminal end of the consensus T domain of the loading didomain and the N-terminal end of the consensus ketosynthase domain of module 1 (GenBank accession no. AF040570). To isolate the loading didomain from module 1, a NotI restriction site was introduced into the linker sequence using the primers 5&prime;-ACCGAGACCTGCGGGGCGATCA-3&prime; and 5&prime;<highlight><uline>-GCGGCCGC</uline></highlight>GACGGCCTGCGTG-3&prime; (mutated bases are shown in bold, and the introduced NotI restriction site is underlined); the resulting 0.94 kb fragment encodes from within the loading didomain into the linker region. This amplified fragment was ligated to linearized pCR-Blunt (Invitrogen) to produce pSA4, which was then digested with BanHI and PstI and ligated to pSA2 digested with the same enzymes to generate pSA6. The 1.9 kb NdeI-NotI fragment derived from pSA6 was ligated to NdeI-NotI-digested pET21c (Novagen) to produce pSA8, an expression vector for the loading didomain with hexahistidine appended to its C-terminus. </paragraph>
<paragraph id="P-0187" lvl="0"><number>&lsqb;0187&rsqb;</number> Expression and Purification of the A-T Didomain. Plasmid pSA8 was introduced via transformation into <highlight><italic>E. coli </italic></highlight>BL21 (Stratagene) for expression of the apo A-T didomain. One liter cultures of BL21/pSA8 were grown at 37&deg; C. in 2 L flasks containing LB medium supplemented with 100 &mgr;g/mL carbenicillin. Expression of the A-T didomain was induced with 100 &mgr;M IPTG at an optical density at 600 nm of 0.7. After induction, incubation was continued for 6 h at 30&deg; C. The cells were then harvested by centrifugation at 2500&times;g and resuspended in disruption buffer &lsqb;200 mM sodium phosphate (pH 7.2), 200 mM sodium chloride, 2.5 mM DTT, 2.5 mM EDTA, 1.5 mM benzamidine, pepstatin (2 mg/L), leupeptin (2 mg/L), and 30% v/v glycerol&rsqb;. </paragraph>
<paragraph id="P-0188" lvl="0"><number>&lsqb;0188&rsqb;</number> All purification procedures were performed at 4&deg; C. The resuspended cells were disrupted by two passages through a French press at 13,000 psi, and the lysate was collected by centrifugation at 40,000&times;g. Nucleic acids were precipitated with polyethylenimine (0.15%) and removed via centrifugation. The supernatant was made 45% (w/v) saturated with ammonium sulfate and precipitated overnight. After centrifugation, the pellet containing protein was redissolved in 50 mM tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl) (pH 8), 300 mM sodium chloride, 10 mM imidazole, and 10% v/v glycerol. This solution was loaded onto a previously equilibrated nickel-nitrilotriacetic acid (Ni-NTA) column (2 mL, Qiagen). The column was washed with 20 mM imidazole in 50 mM Tris-HCl (pH 8), 300 mM sodium chloride, and 10% v/v glycerol, and the A-T didomain was eluted with 100 mM imidazole in the same solution. Pooled fractions containing the A-T didomain were buffer exchanged into 100 mM sodium phosphate (pH 7.2), 2.5 mM DTT, 2 mM EDTA, and 20% v/v glycerol by gel filtration (PD-10, Pharmacia) and concentrated with a Centriprep-50 concentrator (Amicon). The purified protein was flash-frozen in liquid nitrogen and stored at &minus;80 &deg; C. Protein concentration was determined using the calculated extinction coefficient at 280 nm: 49500 M<highlight><superscript>&minus;1 </superscript></highlight>cm<highlight><superscript>&minus;1 </superscript></highlight>(Gill, S. C., et al. (1989) Anal. Biochem. 182, 319-326). A typical 1 L culture produced about 30 mg of purified protein. </paragraph>
<paragraph id="P-0189" lvl="0"><number>&lsqb;0189&rsqb;</number> For expression of the holo A-T didomain, plasmid pSA8 was transformed into BL21 containing the plasmid pRSG56 (Gokhale, R. S., et al. (1999) Science 284, 482-485), which carries a kanamycin resistance gene and the sfp gene. The sfp gene expresses Sfp, a non-specific phosphopantetheinyl transferase from <highlight><italic>B. subtilis </italic></highlight>that converts the apo protein into the holo protein (Lambalot, R. H., et al. (1996) Chem. Biol. 3, 923-936; Quadri, L. E. N., et al. (1998) Biochemistry 37, 1585-1595). One liter cultures of this recombinant <highlight><italic>E. coli </italic></highlight>strain were grown at 37&deg; C. in 2 L flasks containing LB medium supplemented with 100 &mgr;g,ml carbenicillin and 50 &mgr;g/mL kanamycin. The expression and purification steps for the holo A-T didomain were performed as described above for the apo A-T didomain. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
</section>
<section>
<heading lvl="1">Radioactive Labeling of A-T Didomain to Determine Mechanism of the A-T Didomain </heading>
<paragraph id="P-0190" lvl="0"><number>&lsqb;0190&rsqb;</number> For qualitatively assessing the incorporation of B or 3-HB into the A-T didomain, reactions contained 5 &mgr;M apo or holo A-T didomain, 50 mM sodium phosphate (pH7.2), 1 mM DTT, 1 mM EDTA, 15 mM MgCl<highlight><subscript>2</subscript></highlight>, 10% glycerol, and 100 &mgr;M &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-B or &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-3-HB. In reactions where ATP was included, 5 mM was present. After incubation at 30&deg; C. for 30 min, reactions were quenched with SDS-PAGE sample buffer and electrophoresed on a 4-15% gradient gel (Bio-Rad). The gel was briefly stained with Coomassie blue, destined, dried, and autoradiographed. </paragraph>
<paragraph id="P-0191" lvl="0"><number>&lsqb;0191&rsqb;</number> As depicted in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>, both models for the mechanism of the A-T didomain involve activation of AHB as the aryl-adenylate by the A domain, followed by eventual formation of a covalent aryl thioester enzyme intermediate from attack of either aryl-CoA (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>) or the aryl-adenylate (<cross-reference target="DRAWINGS">FIG. 2B</cross-reference>) by the thiol nucleophile of the phosphopantetheine cofactor of the T domain. To investigate these possible mechanisms, we sought to covalently load the A-T didomain. Although AHB is not available in radiolabeled form, in vivo feeding experiments have demonstrated that RifA can also be primed by 3-HB (Hunziker, D., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1998) 120:1092-1093). Reactions containing &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;-3-HB or the putative substrate &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;-benzoate (B) and apo or holo A-T didomain were incubated in the presence or absence of Mg&bull;ATP and subsequently analyzed by SDS-PAGE autoradiography (<cross-reference target="DRAWINGS">FIG. 3</cross-reference>) as described in detail below. Lacking the phosphopantetheine cofactor, the apo A-T didomain could not be covalently loaded (lane 1). However, the holo A-T didomain is covalently loaded with both B and 3-HB in reactions that require Mg&bull;ATP (lanes 2-5). </paragraph>
<paragraph id="P-0192" lvl="0"><number>&lsqb;0192&rsqb;</number> CoA was not included in the labeling reactions described above, suggesting that it is not required for covalent loading of the holo A-T didomain. Since the loading didomain has been proposed to be a CoA ligase (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>) (Schupp, T., et al., <highlight><italic>FEMS Microbiol. Lett. </italic></highlight>(1998) 159:201-207; August, P. R., et al., <highlight><italic>Chem. Biol. </italic></highlight>(1998) 5:69-79; Ghisalba, O., et al., <highlight><italic>J. Antibiot. </italic></highlight>(1981) 34:64-71), we nevertheless tested the possible involvement of CoA directly. </paragraph>
<paragraph id="P-0193" lvl="0"><number>&lsqb;0193&rsqb;</number> HPLC was used to detect the possible benzoyl-CoA formation according to the following procedure. Reactions contained 10 &mgr;M apo A-T didomain, 50 mM sodium phosphate (pH 7.2), 1 mM DTT, 1 mM EDTA, 15 mM MgCl<highlight><subscript>2</subscript></highlight>, 5 mM ATP, 10% glycerol, 1 mM CoA, and 1 mM B. In reactions where benzoyl-CoA was included, 100 &mgr;M was present. After incubation at 30 &deg; C. for the indicated times, 20 &mgr;L samples were injected into an HPLC equipped with a C18 reverse phase column (VYDAC, 250&times;5 mm) with the detector monitoring at 254 nm. A linear gradient between buffer A (25 mM potassium phosphate, pH 5.4) and buffer B (100% acetonitrile) from 0% to 50% B was run over 14 min with a flow rate of 1 mL/min. The substrate and putative product peaks were identified by co-injection with authentic standards. </paragraph>
<paragraph id="P-0194" lvl="0"><number>&lsqb;0194&rsqb;</number> If the mechanism shown in <cross-reference target="DRAWINGS">FIG. 2A</cross-reference> is operative, the apo A-T didomain should be capable of producing benzoyl-CoA. However, no benzoyl-CoA formation could be detected when the apo A-T didomain was incubated with ATP, B, and CoA (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>, -benzoyl-CoA traces). To confirm that benzoyl-CoA, if formed, would persist in these reaction conditions, benzoyl-CoA was added to an otherwise identical reaction (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>, &plus;benzoyl-CoA traces). Benzoyl-CoA is degraded with an observed rate constant of &tilde;0.002 min<highlight><superscript>&minus;1</superscript></highlight>, and this degradation is enzyme-independent since the same observed rate constant is obtained for reactions in which the apo A-T didomain is omitted (data not shown); this slow nonenzymatic degradation is taken into account in the k<highlight><subscript>cat </subscript></highlight>analysis that follows. </paragraph>
<paragraph id="P-0195" lvl="0"><number>&lsqb;0195&rsqb;</number> Accumulation of 5 &mgr;M benzoyl-CoA is readily detectable using this HPLC assay. This conservative detection limit allows an upper limit for k<highlight><subscript>cat </subscript></highlight>for the formation of benzoyl-CoA by the apo A-T didomain to be calculated, as follows. Accumulation of 5 &mgr;M benzoyl-CoA would indicate that at most 10 &mgr;M benzoyl-CoA was formed during the 300 min reaction, as the half-life of benzoyl-CoA is &tilde;300 min under these conditions (t<highlight><subscript>&frac12;</subscript></highlight>&equals;In2/k<highlight><subscript>obs</subscript></highlight>; k<highlight><subscript>obs</subscript></highlight>&ap;0.002 min<highlight><superscript>&minus;1</superscript></highlight>). Therefore, the velocity of benzoyl-CoA formation is at most 0.03 &mgr;M/min (10 &mgr;M/300 min). This corresponds to k<highlight><subscript>cat</subscript></highlight>&lt;0.003 min<highlight><superscript>&minus;1</superscript></highlight>, as the concentration of the apo A-T didomain in these reactions was 10 &mgr;M (k<highlight><subscript>cat</subscript></highlight>&equals;v/&lsqb;E&rsqb;<highlight><subscript>t</subscript></highlight>). As described below, k<highlight><subscript>cat </subscript></highlight>for covalent loading of the holo A-T didomain with B is 0.14 min<highlight><superscript>&minus;1</superscript></highlight>. Therefore, benzoyl-CoA is not a competent intermediate in the arylation reaction, as the rate constant for its formation is at least 50 fold less than the rate constant for formation of E-B. These results indicate that the CoA ligase model depicted in <cross-reference target="DRAWINGS">FIG. 2A</cross-reference> is not viable for the A-T loading didomain of rifamycin synthetase. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
</section>
<section>
<heading lvl="1">Direct Measurement of Kinetic Parameters for the Holo A-T Didomain </heading>
<paragraph id="P-0196" lvl="0"><number>&lsqb;0196&rsqb;</number> Typical reactions contained 1-10 &mgr;M holo A-T didomain, 50 mM sodium phosphate (pH 7.2), 1 mM DTT, 1 mM EDTA, 5 mM ATP, 15 mM MgCl<highlight><subscript>2</subscript></highlight>, 10% glycerol, 0.5-5 &mgr;Ci/mL &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-B or &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-3-HB, and varying concentrations of unlabeled B or 3-HB . Unlabeled B and 3-HB stocks were adjusted to the reaction pH prior to addition. Reactions were incubated at 30 &deg; C., and at desired time points 20 &mgr;L aliquots were quenched in 1 mL of ice-cold 5% trichloroacetic acid and 200 &mgr;g of bovine serum albumin (Sigma) was added to this mixture to aid precipitation of the protein. The precipitate was pelleted by centrifugation, washed with 0.5 mL of 5% trichloroacetic acid and solubilized in 0.5 mL of a 100 mM phosphate (pH 8), 2% SDS solution. This solution was combined with 4.5 mL of liquid scintillation fluid (Formula 989, Packard), and the incorporated <highlight><superscript>14</superscript></highlight>C label, corresponding to E-B or E-3-HB, was quantified by liquid scintillation counting. Reaction rates were linearly dependent on enzyme concentration. Data analysis was performed using Kaleidagraph (Synergy Software), and exponential fits to the data typically gave R&gE;0.99. </paragraph>
<paragraph id="P-0197" lvl="0"><number>&lsqb;0197&rsqb;</number> B and 3-HB are substrates for the holo A-T didomain, as shown qualitatively in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. To quantitatively assess these benzoates as substrates for aryl-adenylate formation followed by arylation of the thiol of the phosphopantetheine cofactor of the T domain, we utilized the protein precipitation assay described above. As discussed above, aliquots from reactions containing holo A-T didomain, 0.5-5 &mgr;Ci/mL &lsqb;7- <highlight><superscript>14</superscript></highlight>C&rsqb;-B or &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-3-HB, and varying concentrations of unlabeled B or 3-HB were quenched with trichloroacetic acid, and the amount of radiolabeled protein in each washed protein pellet was determined by liquid scintillation counting. Initial velocities of E-B or E-3-HB formation as a function of B or 3-HB concentrations were obtained using this method and used to generate the saturation curves shown in <cross-reference target="DRAWINGS">FIG. 5</cross-reference>. Best fits of the data to a saturation model give a k<highlight><subscript>cat </subscript></highlight>of 1.9 min<highlight><superscript>&minus;1 </superscript></highlight>and K<highlight><subscript>M </subscript></highlight>of 180 &mgr;M for 3-HB, and a k<highlight><subscript>cat </subscript></highlight>of 0.14 min<highlight><superscript>&minus;1 </superscript></highlight>and K<highlight><subscript>M </subscript></highlight>of 170 &mgr;M for B. The ratio of k<highlight><subscript>cat</subscript></highlight>/K<highlight><subscript>M </subscript></highlight>values for the two substrates reveals a 12 fold preference for 3-HB over B by the A-T didomain. Addition of CoA to these reactions had no effect (data not shown), consistent with the conclusion that the A-T didomain is not a CoA ligase. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
</section>
<section>
<heading lvl="1">Chase Experiment to Screen for Substrate Specificity of the A-T Didomain </heading>
<paragraph id="P-0198" lvl="0"><number>&lsqb;0198&rsqb;</number> Reactions were carried out in 50 mM sodium phosphate (pH 7.2), 1 mM DTT, 1 mM EDTA, 5 mM ATP, 15 mM MgCl<highlight><subscript>2</subscript></highlight>, and 10% glycerol. Each reaction additionally contained 20 &mgr;M holo A-T didomain and 0.5 mM of a putative substrate, 0.5 mM unlabeled B, or no added substrate. After incubation for 30 min at 30&deg; C., 100 &mgr;L reaction aliquots were applied to individual G-25 microspin gel filtration columns (Pharmacia) that had been pre-equilibrated with the reaction buffer. The protein component of the applied sample was eluted from the microspin column in constant volume by centrifugation, according to the manufacturer&apos;s instructions. A 10 &mgr;L aliquot of each eluted protein sample was diluted with 2 &mgr;L of a &lsqb;7-<highlight><superscript>14</superscript></highlight>C&rsqb;-B solution, for a final B concentration of 200 &mgr;M. These chase reactions were incubated for 15 min at 30&deg; C. prior to analysis by SDS-PAGE autoradiography. </paragraph>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> Based on previous in vivo feeding experiments (Hunziker, D., et al., <highlight><italic>J. Am. Chem. Soc. </italic></highlight>(1998) 120:1092-1093) and the in vitro results just described, AHB, 3-HB, B, and 3,5-dihydroxybenzoate are accepted as substrates by the A-T didomain. </paragraph>
<paragraph id="P-0200" lvl="0"><number>&lsqb;0200&rsqb;</number> To screen for additional substrates that can prime the A-T didomain, the simple chase experiment was devised as described above. Holo A-T didomain was first incubated with a putative substrate under standard reaction conditions. The reaction mixture was then passed over a microspin gel filtration column to separate the protein components from the putative unreacted substrate. Radiolabeled B was finally added to the protein fraction, and the mixture was incubated briefly prior to SDS-PAGE autoradiography. Protein samples that had originally been incubated with a substrate would contain covalently loaded enzyme-substituted benzoate (E-XB), which would not react with radiolabeled B during the chase, resulting in little or no detectable enzyme-benzoate (E-B) by SDS-PAGE autoradiography. In contrast, protein samples that had originally been incubated with a poor substrate or a non-substrate would primarily contain free enzyme (E), which would readily react with radiolabeled benzoate (B) during the chase to form E-B, resulting in a radioactive band detectable by SDS-PAGE autoradiography. </paragraph>
<paragraph id="P-0201" lvl="0"><number>&lsqb;0201&rsqb;</number> The results of this screening experiment for a series of substituted benzoates are discussed below. An autoradiograph of a gel (4-15%, Bio-Rad) containing A-T didomain samples chased with radiolabeled B after incubation with no substrate; unlabeled B; 2-aminobenzoate; 3-aminobenzoate; 4-aminobenzoate; AHB; 3-amino-4-hydroxybenzoate; 4-amino-2-hydroxybenzoate; 3-bromobenzoate; 3-chlorobenzoate; 3,5-diaminobenzoate; 3,5-dibromobenzoate; 3,5-dichlorobenzoate; 3,5-difluorobenzoate; 2,3-dihydroxybenzoate; 3,5-dihydroxybenzoate; 3,5-dinitrobenzoate; 3-fluorobenzoate; 2-hydroxybenzoate; 3-HB; 4-hydroxybenzoate; 3-methoxybenzoate; 3-nitrobenzoate; 3-sulfobenzoate. </paragraph>
<paragraph id="P-0202" lvl="0"><number>&lsqb;0202&rsqb;</number> The first two lanes contain control reactions in which no substrate (lane 1) or unlabeled B (lane 2) was present in the initial incubation; as expected, radiolabeled A-T didomain was formed in the no substrate control reaction but not in the unlabeled B control reaction. Radiolabeled A-T didomain is likewise absent from reactions in which the known substrates AHB (lane 6), 3,5-dihydroxybenzoate (lane 16), and 3-HB (lane 20) were present in the initial incubation. In addition to these three substrates, ten more likely substrates were identified for further investigation based on the absence or diminution of radiolabeled A-T didomain as compared to the lane 1 control reaction. These ten substrates are 2-aminobenzoate; 3-aminobenzoate; 3-bromobenzoate; 3-chlorobenzoate; 3,5-diaminobenzoate; 3,5-dibromobenzoate; 3,5-dichlorobenzoate; 3,5-difluorobenzoate; 3-fluorobenzoate; and 3-methoxybenzoate. Although the simplest model for the absence of radiolabeled A-T didomain in a given reaction is that the substituted benzoate in question has been loaded onto the A-T didomain, blocking the enzyme from reaction with radiolabeled B during the chase, this experiment does not rule out the possibility that it is instead a tight binding competitive inhibitor. However, the observation described below that the competition between these substituted benzoates and the substrate B is time-independent renders the inhibition model unlikely. Radiolabeled A-T didomain was formed in the reactions having the following substrates: 4-aminobenzoate; 3-amino-4-hydroxybenzoate; 4-amino-2-hydroxybenzoate; 2,3-dihydroxybenzoate; 3,5-dinitrobenzoate; 2-hydroxybenzoate; 4-hydroxybenzoate; 3-nitrobenzoate; and 3-sulfobenzoate. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 10 </heading>
</section>
<section>
<heading lvl="1">Relative Specificity Determination Using Relative Rate Constants for Arylation of the A-T Didomain </heading>
<paragraph id="P-0203" lvl="0"><number>&lsqb;0203&rsqb;</number> Armed with the set of likely substrates found in the screening described in the chase experiment (Example 9), the relative specificity of the A-T didomain for aryl-adenylate formation followed by arylation of the thiol of the phosphopantetheine cofactor of the T domain was determined. Addition of a substituted benzoate to a reaction mixture containing radiolabeled benzoate (B) and the holo A-T didomain allowed partitioning between reaction with the substituted benzoate (XB) and reaction with B to be followed. Reactions were performed as described above (Example Kinetic Measurements) but in the presence of 50 &mgr;M-5 mM of a series of substituted benzoates. Substituted benzoate stocks were adjusted to the reaction pH prior to addition. The rate constant relative to an analogous reaction with benzoate (k<highlight><subscript>rel</subscript></highlight>) for reaction of a given substituted benzoate with respect to reaction of B was determined from the concentrations of B and substituted benzoate in the original reaction (&lsqb;B&rsqb;, &lsqb;XB&rsqb;) and the amount of product present as E-B and E-XB, according to the equation in Scheme 1 below. (Fersht, A. R. (1998) in Structure and Mechanism in Protein Science pp. 116-117, W.H. Freeman, New York.)  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="106.0857" wi="165.8475" file="US20020192767A1-20021219-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20020192767A1-20021219-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20020192767A1-20021219-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> The amount of E-XB product in each reaction at a given time point was determined by subtracting the amount of radiolabeled E-B in the presence of the competing substituted benzoate from that obtained at the same time point in an identical reaction lacking competitor. The ratio of E-B to E-XB was constant throughout a particular time course, indicating that no secondary reactions involving the reaction products were occurring. The constant ratios also support the view that the substituted benzoates are true substrates and not high affinity competitive inhibitors, as E-B would continue to accumulate in the presence of a competitive inhibitor, resulting in a ratio of E-B to apparent E-XB that increases as a function of time. For each substituted benzoate, the same k<highlight><subscript>rel </subscript></highlight>value, within error, was obtained for reactions performed at different substituted benzoate concentrations. The reactions were repeated for selected substituted benzoates using radiolabeled 3-HB instead of B, and the same k<highlight><subscript>rel </subscript></highlight>values (with respect to B), within error, were obtained. Each k<highlight><subscript>rel </subscript></highlight>value in Table 1 represents an average of at least 4 separate determinations. Competition with B for reaction with the A-T didomain by phenylacetate and 3-hydroxyphenylacetate could not be detected, so limits for k<highlight><subscript>rel </subscript></highlight>for these compounds are reported in Table 1. </paragraph>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> The k<highlight><subscript>rel </subscript></highlight>values in Table 1 represent the k<highlight><subscript>cat</subscript></highlight>/K<highlight><subscript>M </subscript></highlight>ratio for a given substituted benzoate and B, and as such provide a measure of the specificity of the A-T didomain for each substrate (Fersht, A. R. (1998) in Structure and Mechanism in Protein Science pp. 116-117, W. H. Freeman, New York). The validity of this approach is demonstrated by comparing the k<highlight><subscript>rel </subscript></highlight>value of 12 obtained for 3-HB with the identical k<highlight><subscript>cat</subscript></highlight>/K<highlight><subscript>M </subscript></highlight>ratio of 12 obtained from direct measurement of k<highlight><subscript>cat</subscript></highlight>/K<highlight><subscript>M </subscript></highlight>for 3-HB and B (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>). The A-T didomain exhibits a 10-1000 fold preference for AHB, its biological substrate, over all other substrates. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 11 </heading>
</section>
<section>
<heading lvl="1">Construction of Plasmid pBP165 </heading>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> To engineer a functional fusion between the A-T loading didomain from the rifamycin synthetase and the first module of DEBS, the DNA sequence immediately upstream of the KS domain in DEBS module 1 was modified to read as follows: </paragraph>
<paragraph id="P-0207" lvl="7"><number>&lsqb;0207&rsqb;</number> CCGGCGAACCGATCGCGATCGTCGCGATGG. The engineered BsaBI site (in bold) was fused to the corresponding naturally occurring BsaBI site between the A-T loading didomain and the first PKS module of the rifamycin synthetase (<cross-reference target="DRAWINGS">FIG. 6</cross-reference>). The resulting fusion was transferred into pBP144 in place of DEBS 1, giving rise to pBP 165. 
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 1</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Relative Rate Constants for Covalent Loading of</entry>
</row>
<row>
<entry>the A-T Didomain by Substituted Benzoates <highlight><superscript>a</superscript></highlight></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="28PT" align="left"/>
<colspec colname="1" colwidth="84PT" align="left"/>
<colspec colname="2" colwidth="105PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Substrate</entry>
<entry>k<highlight><subscript>rel</subscript></highlight><highlight><superscript>b</superscript></highlight></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>3-amino-5-hydroxybenzoate</entry>
<entry>120 &plusmn; 10&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>3,5-diaminobenzoate</entry>
<entry>16 &plusmn; 1&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>3-hydroxybenzoate</entry>
<entry>12 &plusmn; 2&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>3-aminobenzoate</entry>
<entry>6.6 &plusmn; 0.6</entry>
</row>
<row>
<entry></entry>
<entry>3,5-dibromobenzoate</entry>
<entry>4.1 &plusmn; 0.5</entry>
</row>
<row>
<entry></entry>
<entry>3,5-dichlorobenzoate</entry>
<entry>4.0 &plusmn; 0.5</entry>
</row>
<row>
<entry></entry>
<entry>3,5-dihydroxybenzoate</entry>
<entry>3.1 &plusmn; 0.5</entry>
</row>
<row>
<entry></entry>
<entry>3-chlorobenzoate</entry>
<entry>2.1 &plusmn; 0.2</entry>
</row>
<row>
<entry></entry>
<entry>3-bromobenzoate</entry>
<entry>1.9 &plusmn; 0.2</entry>
</row>
<row>
<entry></entry>
<entry>benzoate</entry>
<entry>(1)</entry>
</row>
<row>
<entry></entry>
<entry>2-aminobenzoate</entry>
<entry>0.62 &plusmn; 0.08</entry>
</row>
<row>
<entry></entry>
<entry>3-methoxybenzoate</entry>
<entry>0.43 &plusmn; 0.06</entry>
</row>
<row>
<entry></entry>
<entry>3-fluorobenzoate</entry>
<entry>0.42 &plusmn; 0.11</entry>
</row>
<row>
<entry></entry>
<entry>3,5-difluorobenzoate</entry>
<entry>0.13 &plusmn; 0.02</entry>
</row>
<row>
<entry></entry>
<entry>phenylacetate</entry>
<entry>&lt;0.01</entry>
</row>
<row>
<entry></entry>
<entry>3-hydroxyphenylacetate</entry>
<entry>&lt;0.01</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00001"><highlight><superscript>a </superscript></highlight>30&deg; C., 50 mM sodium phosphate, pH 7.2, 1 mM DTT, 1 mM EDTA, 15 mM MgCl<highlight><subscript>2</subscript></highlight>, 5 mM ATP, 10% glycerol. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00002"><highlight><superscript>b </superscript></highlight>Rate constant for T domain arylation, relative to T domain arylation by benzoate (Scheme 1). </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 12 </heading>
</section>
<section>
<heading lvl="1">Analytical Methods </heading>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> Optical density measurements were made at 600 nm using a Beckman DU650 spectrophotometer with necessary dilutions made with PBS. Glucose concentrations were measured using an enzymatic hexokinase detection kit (Sigma-Aldrich). Acetate and propionate concentrations were analyzed using an isocratic HPLC method with 5 mM H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4 </subscript></highlight>(Agilent 1100 HPLC series). The column used was a Bio Rad HPLC organic acid analysis column (Aminex HPX-87H) maintained at 55&deg; C. with refractive index used to detect acetate and propionate from clarified fermentation broth samples (20 &mgr;L injections). A separate HPLC assay was used to detect 6dEB as described previously (Lombo, F., et al., <highlight><italic>Biotechnol. Prog. </italic></highlight>(2001) 17(4):612-617). Protein levels were monitored after cell disruption (sonication using 2 ml samples), clarification, and detection via SDS-PAGE/SimplyBlue&trade; SafeStain (Invitrogen, Carlsbad, Calif.) staining. </paragraph>
</section>
<section>
<heading lvl="1">Preliminary Optimization </heading>
<paragraph id="P-0209" lvl="0"><number>&lsqb;0209&rsqb;</number> <highlight><italic>E. coli </italic></highlight>BAP1 was used as the host cell (F-ompT hsdS<highlight><subscript>B </subscript></highlight>(r<highlight><subscript>B</subscript></highlight>- m<highlight><subscript>B</subscript></highlight>-) gal dcm (DE3) &Dgr;prpRBCD (sfp)). 6dEB was produced by BAP1/pBP130(Carb<highlight><superscript>R</superscript></highlight>)/pBP144(Kan<highlight><superscript>R</superscript></highlight>). Pfeiffer, B. A., et al., <highlight><italic>Science </italic></highlight>(2001) 291:1790-1792, incorporated herein by reference. This strain has the necessary PKS and auxiliary genes for the synthesis of 6dEB. Two are integrated into the genome, five are on two plasmids. </paragraph>
<paragraph id="P-0210" lvl="0"><number>&lsqb;0210&rsqb;</number> Cell stocks were prepared by growing a culture of BAP1/pBP130/pBP144 in Luria Bertani medium (LB) supplemented with carbenicillin (100 mg/L) and kanamycin (50 mg/L) at 37&deg; C. and 250 rpm. After the culture reached an OD<highlight><subscript>600 </subscript></highlight>between 0.5 and 1, the cells were centrifuged and resuspended in half the initial culture volume using F1 medium with 8% glycerol. F1 medium contains: KH<highlight><subscript>2</subscript></highlight>PO<highlight><subscript>4</subscript></highlight>, 3 g/L; K<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight>, 6.62 g/L; (NH<highlight><subscript>4</subscript></highlight>)<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>, 4 g/L; MgSO<highlight><subscript>4</subscript></highlight>, 105.5 mg/L; Glucose, 5 g/L; Trace Metal Solution, 1.25 ml/L; and Vitamin Solution, 1.25 ml/L. (The trace metals solution contains: FeCl<highlight><subscript>3</subscript></highlight>.6H<highlight><subscript>2</subscript></highlight>O, 27 g/L; ZnCl<highlight><subscript>2</subscript></highlight>.4H<highlight><subscript>2</subscript></highlight>O, 2 g/L; CaCl<highlight><subscript>2</subscript></highlight>.6H<highlight><subscript>2</subscript></highlight>O, 2 g/L; Na<highlight><subscript>2</subscript></highlight>MoO<highlight><subscript>4</subscript></highlight>.2H<highlight><subscript>2</subscript></highlight>O, 2 g/L; CuSO<highlight><subscript>4</subscript></highlight>.5H<highlight><subscript>2</subscript></highlight>, 1.9 g/L; H<highlight><subscript>3</subscript></highlight>BO<highlight><subscript>3</subscript></highlight>, 0.5 g/L; conc. HCl, 100 ml/L; the vitamin solution contains: riboflavin, 0.42 g/L; pantothenic acid, 5.4 g/L; niacin, 6 g/L; pyridoxine, 1.4 g/L; biotin, 0.06 g/L; folic acid, 0.04 g/L.) Resuspended cells were aliquotted and frozen at &minus;80&deg; C. </paragraph>
<paragraph id="P-0211" lvl="0"><number>&lsqb;0211&rsqb;</number> For small-scale experiments, 25 mL F1 medium in 250 nL flasks was inoculated with 0.5 mL of a pre-frozen glycerol cell stock, and grown at 37&deg; C. and 250 rpm (with carbenicillin and kanamycin concentrations at 100 and 50 mg/L, respectively) to a suitable OD<highlight><subscript>600 </subscript></highlight>(between 0.2 to 1, as specified below). At this point the culture was cooled to 22&deg; C., induced with IPTG (isopropylthio-&bgr;-D-galactoside, GibcoBRL, Grand Island, N.Y., between 10 &mgr;M and 10 mM, as specified below), and supplemented with sodium propionate (Sigma-Aldrich, St. Louis, Mo., to a final concentration between 10 mg/L and 10 g/L, as specified below). The cultures were then incubated at 22 or 25&deg; C. at 200 rpm until no further increase in production was observed. </paragraph>
<paragraph id="P-0212" lvl="0"><number>&lsqb;0212&rsqb;</number> The effects of various growth and process parameters on the productivity and titer of 6dEB in cultures of <highlight><italic>E. coli </italic></highlight>BAP1/pBP130/pBP144 were studied under these conditions. Initially, three media that are compatible with fed-batch cultivation of <highlight><italic>E. Coli </italic></highlight>were tested (data not shown). Of these, fermentation medium F1 gave the best yields (1 mg/L over 19 hrs). The effect of IPTG and propionate concentrations, post-induction temperature, and time of induction was investigated using this medium. The optimal conditions found based on these experiments are as shown on Table 2. 
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE 2</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Variables Tested Under Shake-Flask Cultivation Conditions</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="63PT" align="left"/>
<colspec colname="3" colwidth="84PT" align="left"/>
<tbody valign="top">
<row>
<entry>Variable</entry>
<entry>Range Tested</entry>
<entry>Optimal Level</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry>OD<highlight><subscript>600 </subscript></highlight>at Induction</entry>
<entry>0.25-4.5</entry>
<entry>Between 0.25 and 1.0</entry>
</row>
<row>
<entry>IPTG</entry>
<entry>10 &mgr;M-10 mM</entry>
<entry>100 &mgr;M</entry>
</row>
<row>
<entry>Propionate</entry>
<entry>10 mg/L-10 g/L</entry>
<entry>Between 50 mg/L and 2 g/L</entry>
</row>
<row>
<entry>Post-Induction</entry>
<entry>22&deg; C. and 25&deg; C.</entry>
<entry>No effect</entry>
</row>
<row>
<entry>Temperature</entry>
</row>
<row><entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0213" lvl="7"><number>&lsqb;0213&rsqb;</number> For the best conditions, 6dEB titers were consistently found to be between 1-3 mg/L over 19 hrs. </paragraph>
</section>
<section>
<heading lvl="1">Effect of Nutrient Stream, Induction Time and Propionate Feeding </heading>
<paragraph id="P-0214" lvl="0"><number>&lsqb;0214&rsqb;</number> Fed-batch aerated fermentations were conducted using an Applikon 3L Biobundle system (Applikon Inc., Foster City, Calif.). A starter culture was grown in 1.5 mL LB medium (at 100 mg/L carbenicillin and 50 mg/L kanamycin). After reaching late exponential phase at 37&deg; C. and 250 rpm, the culture was centrifuged and resuspended in 50 mL LB (at 100 mg/L carbenicillin and 50 mg/L kanamycin). The culture grew overnight at 30&deg; C. and 200 rpm to stationary phase, was centrifuged, and resuspended in 20 mL phosphate buffered saline (PBS) for inoculation into the 3L vessel containing 2L F1 medium which contained KH<highlight><subscript>2</subscript></highlight>PO<highlight><subscript>4</subscript></highlight>, 1.5 g/L; K<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight>, 4.34 g/L; (NH<highlight><subscript>4</subscript></highlight>)<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>, 0.4 g/L; MgSO<highlight><subscript>4</subscript></highlight>, 150.5 mg/L; Glucose, 5 g/L; Trace Metal Solution, 1.25 ml/L; and Vitamin Solution, 1.25 ml/L. Growth was conducted at 37&deg; C. with pH maintained throughout the experiment at 7.1 with 1M H<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4 </subscript></highlight>and concentrated NH<highlight><subscript>4</subscript></highlight>OH. Aeration was maintained at 2.8 L/min with agitation controlled at 600-900 rpm to maintain dissolved oxygen over 50% air saturation. The fermentation apparatus including salt solution (KH<highlight><subscript>2</subscript></highlight>PO<highlight><subscript>4</subscript></highlight>, K<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight>, and (NH<highlight><subscript>4</subscript></highlight>)<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>) was autoclaved, whereas the additional feed components (MgSO<highlight><subscript>4</subscript></highlight>, glucose, trace metals, and vitamins) were filter-sterilized and added aseptically prior to inoculation along with carbenicillin at 150 mg/L and kanamycin at 75 mg/L. The feed was also filter sterilized. Once the glucose was exhausted from the starting medium (as indicated by a sudden decrease in the oxygen requirement of the culture), the temperature was reduced to 22&deg; C., and IPTG (100 &mgr;M) and sodium propionate (2 g/L) were added. At that point a peristaltic pump started to deliver 0.1 ml/mm of the Feed Medium which is: (NH<highlight><subscript>4</subscript></highlight>)<highlight><subscript>2</subscript></highlight>SO<highlight><subscript>4</subscript></highlight>, 110 g/L; MgSO<highlight><subscript>4</subscript></highlight>, 3.9 g/L; Glucose, 430 g/L; Trace Metal Solution, 10 ml/L; and Vitamin Solution, 10 ml/L, and samples were typically taken twice daily thereafter. Additional sodium propionate was added approximately every 48 hrs (to 2 g/L, assuming no propionate remained) to avoid depletion of this precursor for polyketide biosynthesis. </paragraph>
<paragraph id="P-0215" lvl="0"><number>&lsqb;0215&rsqb;</number> As shown in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>A, cell growth was extended to a final OD<highlight><subscript>600 </subscript></highlight>between 50 and 70 (24 and 33 g dry cell weight/L) by the controlled addition of a nutrient feed stream that maintained glucose and acetate concentrations below 1 g/L throughout the course of the experiment. Polyketide biosynthesis was induced at an OD<highlight><subscript>600 </subscript></highlight>between 5 and 10 by addition of 100 &mgr;M IPTG and 2 g/L propionate at 22&deg; C. Intracellular protein was analyzed periodically thereafter via SDS-PAGE, and the expressed levels of soluble PKS proteins were found to remain relatively constant throughout the length of the experiment (beginning approximately four hours after induction). This fermentation procedure yielded a final 6dEB titer of 70 mg/L over a 110 hour period. Precursor and product analysis showed that the titer reached a plateau after all the exogenous propionate had been consumed. As shown in <cross-reference target="DRAWINGS">FIG. 10</cross-reference>B, propionate supplementation in the fermentation medium reproducibly resulted in a titer increase to over 100 mg/L 6dEB. The maximum conversion of propionate into 6dEB was 6%. Fermenter and shake flask specific productivity was similar; however, the fermenter volumetric productivity was 17 fold higher than shake flask values. </paragraph>
</section>
<section>
<heading lvl="1">Effect of TEII </heading>
<paragraph id="P-0216" lvl="0"><number>&lsqb;0216&rsqb;</number> The eryH gene from the erythromycin biosynthetic gene cluster in <highlight><italic>Saccharopolyspora erythraea </italic></highlight>encodes a homolog of thioesterase genes (also designated thioesterase II or TEII) Weber, J. M., et al., <highlight><italic>J. Bacteriol. </italic></highlight>(1990) 172:2372-2383. TEII has been shown to enhance polyketide biosynthesis in actinomyces hosts by an as yet unknown mechanism (Hu, Z., unpublished result). The eryH gene was cloned under control of an IPTG-inducible T7 promoter on a chloramphenicol resistant plasmid, pGZ1 19EH (Lessl, M., et al., <highlight><italic>J. Bacteriol. </italic></highlight>(1992) 174:2493-2500). This plasmid is compatible with plasmids pBP130 and pBP144. The resulting plasmid, pBP190, was co-transformed into BAP1 along with pBP130 and pBP144, and studied using the fermentation protocol outlined above (including chloramphenicol at 34 mg/L in the starter cultures and 20 mg/L in the fermenter). </paragraph>
<paragraph id="P-0217" lvl="0"><number>&lsqb;0217&rsqb;</number> The growth characteristics of this recombinant strain mirrored those of previous experiments, but the titer of 6dEB doubled to &tilde;180 mg/L (FIG. 11). These experiments suggest that TEII co-expression enhances the polyketide productivity of <highlight><italic>E. coli </italic></highlight>analogous to its effect in Streptomyces spp. (where 6dEB production also doubled compared to cultures without TEII &lsqb;Hu, Z., unpublished result&rsqb;). </paragraph>
<paragraph id="P-0218" lvl="0"><number>&lsqb;0218&rsqb;</number> TEII coexpression described above did not significantly improve the plasmid stability properties of BAP1 and the fermentation gene expression profile showed no qualitative difference when compared to fermentations without TEII expression. Unlike the DEBS and PCC proteins, TEII was not readily visible via SDS-PAGE analysis, but when expressed in isolation using shake-flask conditions meant to mirror fermenter conditions, TEII (&tilde;30 kD) could be readily purified using an N-terminal 6&times;histidine tag. This suggests that, once expressed, TEII is present within the cellular background of <highlight><italic>E. coli</italic></highlight>. Small scale in vivo radioactive experiments Pfeiffer (2001) supra, also support the notion that titer increase was due to TEII coexpression. As noted above, <highlight><italic>E. coli</italic></highlight>, BAP1, pBP130, pBP144, and pBP190 was compared to BAP1/pBP130/pBP144/pGZ119EH. Additionally, these two strains were compared to BAP1/pBP130/pBP144. Each comparison showed an &tilde;2 fold increase in 6dEB titer with TEII coexpression. </paragraph>
<paragraph id="P-0219" lvl="0"><number>&lsqb;0219&rsqb;</number> In earlier work we have confirmed that <highlight><italic>E. coli </italic></highlight>BAP1 is unable to utilize propionate as a sole carbon source to support growth, as the only known pathway for propionate catabolism has been deleted from this recombinant strain. However, since &lt;10% of exogenous propionate is converted into 6dEB, it appears that propionate is catabolized into unknown and potentially undesirable side products. Since the ability of <highlight><italic>E. coli </italic></highlight>to activate propionate as propionyl-CoA has been retained (and intentionally amplified) in BAP1, it is possible that biosynthesis of odd chain fatty acid synthesis provides one route for the utilization of exogenous propionate. When radio labeled propionate is fed to <highlight><italic>E. coli </italic></highlight>BAP1/pBP130/pBP144, radio-labeled products which are even more lipophilic than 6dEB (as judged by radio-TLC analysis; data not shown) are observed. Another possibility is the potential utilization of propionate via non-specific transacylation mechanisms that can utilize propionyl-CoA in lieu of acetyl-CoA (the most common acyl donor in vivo). The identification of such &ldquo;dead-end&rdquo; products could lead to the genetic or metabolic attenuation or elimination of such non-productive pathways from the <highlight><italic>E. coli </italic></highlight>host, thereby further enhancing its capacity for polyketide biosynthesis. </paragraph>
<paragraph id="P-0220" lvl="0"><number>&lsqb;0220&rsqb;</number> Our results have demonstrated the utility of an accessory thioesterase present in <highlight><italic>Saccharopolyspora erythraea, </italic></highlight>the TEII, for enhancing the productivity of 6dEB in <highlight><italic>E. coli</italic></highlight>. The exact mechanism of the TEII is presently not clear, and it is believed that this enzyme plays an editing role by hydrolyzing incorrectly processed intermediates off the multifunctional PKS. Alternatively, the TEII may increase the intracellular activity of PKS enzymes by purging acyl carrier protein (ACP) domains that have been post-translationally modified with an inappropriate phosphopantetheine donor. Ordinarily ACP domains on PKSs are post-translationally modified by attachment of the phosphopantetheine arm at an active site serine. This reaction is catalyzed by a phosphopantetheinyl transferase. In BAP1, a heterologous enzyme, Sfp, from <highlight><italic>Bacillus subtilis </italic></highlight>catalyzes this reaction. The primary advantage of using Sfp is that it possesses a broad substrate specificity for virtually any acyl carrier protein domain; however, since Sfp can utilize acyl-CoA donors with comparable specificity to CoASH, it may erroneously utilize substrates such as acetyl-CoA or propionyl-CoA. If so, the acylated phosphopantetheine would effectively block polyketide intermediates from being processed past this misprimed ACP domain until the thioester bond is hydrolyzed. To the extent the TE domain can selectively hydrolyze acetyl-ACP or propionyl-ACP domains in preference to the corresponding CoA thioesters, it may act as an enhancer of newly synthesized PKS activity in vivo. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. Microbial host cells which are genetically modified for enhanced synthesis of at least one polyketide, wherein said modification comprises incorporation of at least one expression system for producing a protein that catalyzes the production of starter and/or extender units and/or disabling at least one endogenous pathway for catabolism of starter and/or extender units. </claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A method to produce a polyketide which method comprises culturing the cells of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> under conditions wherein said polyketide is produced. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A method to assess the results of a procedure effecting modification of polyketide synthase genes, resulting in a mixture of said modified genes which method comprises 
<claim-text>transfecting a culture of cells of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> with said mixture of modified genes, wherein said cells are <highlight><italic>E. coli, </italic></highlight></claim-text>
<claim-text>culturing individual colonies of said transformed <highlight><italic>E. coli, </italic></highlight>and </claim-text>
<claim-text>assessing each colony for polyketide production </claim-text>
</claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A method to determine whether a substituted benzoate can prime an adenylation-thiolation (A-T) didomain of a rifamycin synthetase comprising 
<claim-text>incubating a substituted benzoate with a holo A-T didomain under conditions suitable for priming the A-T didomain; and </claim-text>
<claim-text>measuring the amount or presence of the substituted benzoate that primed the A-T didomain. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. Procaryotic host cells which do not produce a polyketide in the absence of genetic modification and which are genetically modified for enhanced synthesis of at least one hybrid polyketide, wherein said modification comprises incorporation of at least one expression system comprising an A-T didomain, which incorporates a starter unit that primes an A-T didomain according to the method of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The procaryotic host cells defined in <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein the starter unit is selected from the group consisting of 2-aminobenzoate, 3-aminobenzoate, 4-aminobenzoate, 3-amino-5-hydroxybenzoate, 3-amino-4-hydroxybenzoate, 4-amino-2-hydroxybenzoate, 3-bromobenzoate, 3-chlorobenzoate, 3,5-diaminobenzoate, 3,5-dibromobenzoate, 3,5-dichlorobenzoate, 3,5-difluorobenzoate, 2,3-dihydroxybenzoate, 3,5-dihydroxybenzoate, 3,5-dinitrobenzoate, 3-fluorobenzoate, 2-hydroxybenzoate, 3-hydroxybenzoate, 4-hydroxybenzoate, 3-methoxybenzoate, 3-nitrobenzoate, and 3-sulfobenzoate to make a modified polyketide. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The procaryotic host cells defined in <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein the starter unit is selected from the group consisting of 2-aminobenzoate, 3-aminobenzoate, 4-aminobenzoate, 3-amino-4-hydroxybenzoate, 4-amino-2-hydroxybenzoate, 3-bromobenzoate, 3-chlorobenzoate, 3,5-diaminobenzoate, 3,5-dibromobenzoate, 3,5-dichlorobenzoate, 3,5-difluorobenzoate, 2,3-dihydroxybenzoate, 3,5-dinitrobenzoate, 3-fluorobenzoate, 2-hydroxybenzoate, 4-hydroxybenzoate, 3-methoxybenzoate, 3-nitrobenzoate, and 3-sulfobenzoate to make a modified polyketide. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A hybrid polyketide in which a starter unit is incorporated therein which starter unit primes an A-T didomain according to the method of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The hybrid polyketide defined in <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference> where the starter unit is selected from the group consisting of 2-aminobenzoate, 3-aminobenzoate, 4-aminobenzoate, 3-amino-5-hydroxybenzoate, 3-amino-4-hydroxybenzoate, 4-amino-2-hydroxybenzoate, 3-bromobenzoate, 3-chlorobenzoate, 3,5-diaminobenzoate, 3,5-dibromobenzoate, 3,5-dichlorobenzoate, 3,5-difluorobenzoate, 2,3-dihydroxybenzoate, 3,5-dihydroxybenzoate, 3,5-dinitrobenzoate, 3-fluorobenzoate, 2-hydroxybenzoate, 3-hydroxybenzoate, 4-hydroxybenzoate, 3-methoxybenzoate, 3-nitrobenzoate, and 3-sulfobenzoate. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The hybrid polyketide defined in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> where the starter unit is selected from the group consisting of 2-aminobenzoate, 3-aminobenzoate, 4-aminobenzoate, 3-amino-4-hydroxybenzoate, 4-amino-2-hydroxybenzoate, 3-bromobenzoate, 3-chlorobenzoate, 3,5-diaminobenzoate, 3,5-dibromobenzoate, 3,5-dichlorobenzoate, 3,5-difluorobenzoate, 2,3-dihydroxybenzoate, 3,5-dinitrobenzoate, 3-fluorobenzoate, 2-hydroxybenzoate, 4-hydroxybenzoate, 3-methoxybenzoate, 3-nitrobenzoate, and 3-sulfobenzoate. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A method to produce a polyketide which method comprises culturing the cells of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> under conditions wherein said polyketide is produced. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> which are of the genus Escherichia, Streptomyces, Bacillus, Pseudomonas, or Flavobacterium. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00011">claim 12</dependent-claim-reference> which are <highlight><italic>E. coli. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein said cells produce a complete polyketide derived from rifamycin, rapamycin, FK506, ansatrienin, FK520, microcystin, pimaricin, erythromycin, oleandomycin, megalomycin, picromycin, spinosad, avermectin, tylosin or epothilone. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference> which produce a modified rifamycin. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference> which produce a 6-dEB analog. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, wherein said genetic modification further comprises incorporation of at least one expression system for a polyketide synthase protein. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The cells of <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein said genetic modification comprises incorporation of at least one expression system for a phosphopantetheinyl transferase. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A method to enhance the production of at least one hybrid polyketide in a microbial host which method comprises providing said host with an expression system for producing a protein that incorporates an exogenous starter unit that primes an A-T didomain according to the method of <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A method to enhance production of a secondary metabolite in a microbial host which method comprises inducing the production of said secondary metabolite after the microbial cells have reached a high cell density in the culture. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference> wherein the secondary metabolite is a polyketide. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference> wherein said inducing is by supplying a compound which activates an inducible promoter. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A method to enhance the production of a secondary metabolite in a microbial host which method comprises maintaining the nutrient level fed to said microbe at a relatively constant level during the production of said secondary metabolite. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 23</dependent-claim-reference> wherein said secondary metabolite is a polyketide. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A method to enhance the production of a polyketide in a microbe which method comprises modifying said microbe to contain an expression system for a thioesterase II (TEII).</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020192767A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020192767A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020192767A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020192767A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020192767A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020192767A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020192767A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020192767A1-20021219-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020192767A1-20021219-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020192767A1-20021219-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020192767A1-20021219-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020192784A1-20021219-D00001.TIF SYSTEM "US20020192784A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020192784A1-20021219-D00002.TIF SYSTEM "US20020192784A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020192784A1-20021219-D00003.TIF SYSTEM "US20020192784A1-20021219-D00003.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020192784</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10113852</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020329</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C12N009/06</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C07H021/04</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12P021/02</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N005/06</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N005/04</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>435</class>
<subclass>191000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>069100</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>320100</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>800</class>
<subclass>278000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>536</class>
<subclass>023200</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>419000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Biosynthesis of S-adenosylmethionine in a recombinant yeast strain</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60280333</doc-number>
<document-date>20010330</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Dean</given-name>
<middle-name>R.</middle-name>
<family-name>Appling</family-name>
</name>
<residence>
<residence-us>
<city>Austin</city>
<state>TX</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Andrew</given-name>
<middle-name>D.</middle-name>
<family-name>Hanson</family-name>
</name>
<residence>
<residence-us>
<city>Gainesville</city>
<state>FL</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Sanja</given-name>
<family-name>Roje</family-name>
</name>
<residence>
<residence-us>
<city>Gainesville</city>
<state>FL</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Rhonda</given-name>
<middle-name>K.</middle-name>
<family-name>Raymond</family-name>
</name>
<residence>
<residence-us>
<city>Austin</city>
<state>TX</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>Sanford E. Warren</name-1>
<name-2>Gardere Wynne Sewell LLP</name-2>
<address>
<address-1>3000 Thanksgiving Tower</address-1>
<address-2>1601 Elm Street, Suite 3000</address-2>
<city>Dallas</city>
<state>TX</state>
<postalcode>75201-4767</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The present invention makes use of a chimeric gene that, when incorporated into an appropriate host, results in the overproduction of S-adenosylmethionine without the need to supply the host with a source of untransformed methionine. The need for the methionine source is eliminated because the appropriately chosen host manufactures the amino acid on its own, and when the host is modified by the inclusion of a chimeric gene of the present invention, it transforms the methionine that is produced into S-adenosylmethionine. In addition, the same chimeric gene causes accumulation of methionine and increase in folate content in the same host. One form of the present invention is a fused gene encoding for methylene tetrahydrofolate reductase (MTHFR) made up of an N-terminal domain from a yeast organism and a C-terminal domain from a plant species. An example of a suitable plant species is <highlight><italic>Arabidopsis thaliana</italic></highlight>. An example of a suitable yeast organism is <highlight><italic>Saccharomyces cerevisiae. </italic></highlight></paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims priority from Provisional Application Serial No. 60/280,333, filed on Mar. 30, 2001.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> The U.S. Government may own certain rights in this invention pursuant to the terms of the National Science Foundation grant IBN-9813999 and the National Institutes of Health grant RR09276.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The present invention relates in general to the field of recombinant DNA species, and more particularly to the production of chimeric genes. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> S-adenosylmethionine is an important metabolic agent that is formed in the body by the reaction of methionine, an essential amino acid, with adenosine triphosphate (ATP). S-adenosylmethionine is active in more than forty biological reactions in vivo. S-adenosylmethionine also operates in association with folic acid and vitamin B-12 as a methylating agent, and is essential for the formation of many sulfur-containing compounds in the body, including glutathione and various components of cartilaginous connective tissue. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> The body normally generates the required level of S-adenosylmethionine directly from the amino acid methionine; however, a deficiency of methionine, folic acid, or vitamin B-12 can result in decreased levels of S-adenosylmethionine. There is interest in the effects of supplemental dosages of S-adenosylmethionine on various conditions. The interest in supplementation stems, in part, from findings that the elderly and those suffering from osteoarthritis, various liver problems, and depression typically have lowered levels of S-adenosylmethionine. It is also known that merely increasing the dietary intake of methionine does not result in an increase in the concentration of S-adenosylmethionine in the body. S-adenosylmethionine is now widely distributed as an over-the-counter dietary supplement. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> S-adenosylmethionine is primarily used in the treatment of five conditions: depression, osteoarthritis, fibromyalgia, cirrhosis of the liver and migraine headaches. There have been numerous studies that have supported the efficacy of S-adenosylmethionine for the treatment of these conditions. It has also been recognized that S-adenosylmethionine has an excellent safety record, and is therefore appropriate for long-term use by patients. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> A major drawback to the use of S-adenosylmethionine as a medicament is the expense. Present methods of production rely on the modification of methionine. Unfortunately, the purified methionine used as a starting material is relatively expensive. There is therefore a need for a method of production of S-adenosylmethionine that eliminates the need to provide a source of methionine. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> The present invention makes use of a chimeric or &ldquo;fused&rdquo; gene that, when incorporated into an appropriate host, results in the overproduction of S-adenosylmethionine without the need to supply the host with a source of untransformed methionine. The need for the methionine source is eliminated by virtue of the fact that the appropriately chosen host manufactures the amino acid on its own, and when the host is modified by the inclusion of a chimeric gene of the present invention, it transforms the methionine that is produced into S-adenosylmethionine. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> One form of the present invention is a fused gene encoding for methylene tetrahydrofolate reductase (MTHFR) made up of an N-terminal domain from a yeast organism and a C-terminal domain from a plant species. An example of a suitable plant species is <highlight><italic>Arabidopsis thaliana</italic></highlight>. An example of a suitable yeast organism is <highlight><italic>Saccharomyces cerevisiae. </italic></highlight></paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> Other forms of the present invention includes a recombinant DNA vector that includes the fused gene referred to above and host cells, both prokaryotic and eukaryotic, that contain the recombinant DNA vector. The present invention may also take the form of a plasmid containing the fused gene referred to above. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Another form of the present invention is a nucleic acid sequence of at least 14 nucleotides from the region where the two domains are joined to form the chimeric gene. Yet another form of the present invention is a purified fusion protein encoded for by the gene referred to above. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> And yet another form of the present invention includes a recombinant DNA vector that includes the fused gene referred to above and host cells, both prokaryotic and eukaryotic, animal, yeast, or plant, that contain the recombinant DNA vector wherein the fused gene modifies methylneogenesis. The present invention may also take the form of a plasmid containing the fused gene referred to above.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> The above and further advantages of the invention may be better understood by referring to the following description in conjunction with the accompanying figures in which: </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> depicts a map of a chimeric gene in accordance with the present invention; and </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> depicts the concentration of <highlight><superscript>13</superscript></highlight>C-labeled and total S-adenosylmethionine in protein free extracts of host strains DAY4, RRY2, RRY4 and RRY5. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> depicts intracellular levels of S-adenosylmethionine (A) and free methionine (B) in yeast strains DAY4, SCY6 and SCY4.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> While the making and using of various embodiments of the present invention are discussed herein in terms of recombinant yeasts and a method of producing them, it should be appreciated that the present invention provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the invention and are not meant to limit the scope of the invention in any way. </paragraph>
<paragraph id="P-0018" lvl="7"><number>&lsqb;0018&rsqb;</number> Definitions </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> Terms used herein have meanings as commonly understood by a person of ordinary skill in the areas relevant to the present invention. Terms such as &ldquo;a,&rdquo; &ldquo;an,&rdquo; and &ldquo;the&rdquo; are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the invention, but their usage does not limit the invention, except as outlined in the claims. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> For convenience, certain terms employed in the specification, examples, and appended claims are collected here. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> As used herein, the term &ldquo;nucleic acid&rdquo; refers to polynucleotides such as deoxyribonucleic acid (DNA), and, where appropriate, ribonucleic acid (RNA). The term should also be understood to include, as equivalents, analogs of either RNA or DNA made from nucleotide analogs, and, as applicable to the embodiment being described, single (sense or antisense) and double-stranded polynucleotides. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> As used herein, the terms &ldquo;gene&rdquo;, &ldquo;recombinant gene&rdquo; and &ldquo;gene construct&rdquo; refer to a nucleic acid having an open reading frame encoding a polypeptide, such as a polypeptide, including both exon and (optionally) intron sequences. In yet another embodiment, the nucleic acid is DNA or RNA. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The term &ldquo;fused gene&rdquo; and &ldquo;chimeric gene&rdquo; are used interchangeably, and refer to a functional gene that has a regulatory domain from one organism and the catalytic domain from another, that have been spliced together using recombinant DNA techniques. The two domains may be attached directly to one another, or they may be connected using intervening nucleic acid sequences. The term &ldquo;intervening nucleic acid sequences&rdquo; means any segment of DNA used to connect the two domains that make up the &ldquo;fused gene.&rdquo;</paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> &ldquo;Domain&rdquo; refers to a discreet region of a protein that performs a specific function. &ldquo;N-terminal domain&rdquo; and &ldquo;C-terminal domain&rdquo; refer to the relative end of the protein that is ultimately produced by the expression of a gene. &ldquo;C&rdquo; and &ldquo;N&rdquo; refer to the carboxyl and amino terminal ends of the protein, respectively. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> &ldquo;Regulatory sequences&rdquo; of nucleic acids is a generic term used throughout the specification to refer to DNA sequences, such as initiation signals, enhancers, and promoters, as well as polyadenylation sites, which induce or control transcription of protein coding sequences with which they are operably linked. In some embodiments, transcription of a recombinant gene is under the control of a promoter sequence (or other transcriptional regulatory sequence) that controls the expression of the recombinant gene in a cell-type in which expression is intended. It will also be understood that the recombinant gene can be under the control of transcriptional regulatory sequences that are the same or which are different from those sequences and which control transcription of the naturally occurring form of the gene. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> When referring to proteins, &ldquo;regulatory domains&rdquo; are the portion of a protein that controls the activity of the catalytic domain of that protein. In the present invention, the regulatory domain is the sequence that controls the activity of methylene tetrahydrofolate reductase. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> &ldquo;Catalytic domain&rdquo; refers to DNA sequences that ultimately encode for amino acid sequences that form an enzymatically active protein. In the present case, that is the DNA sequence that ultimately encodes methylene tetrahydrofolate reductase. When referring to a protein, a &ldquo;catalytic domain&rdquo; is the portion of the protein that produces the enzymatic activity associated with the protein. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> &ldquo;Cells&rdquo; or &ldquo;cell cultures&rdquo; or &ldquo;recombinant host cells&rdquo; or &ldquo;host cells&rdquo; are often used interchangeably as will be clear from the context. These terms include the immediate subject cell which expresses, e.g., the methylene tetrahydrofolate reductase encoded for by the fused gene of the present invention. It is understood that not all progeny are exactly identical to the parental cell, due to chance mutations or difference in environment. Such altered progeny are included in these terms, so long as the progeny retain the characteristics relevant to those conferred on the originally transformed cell. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> As used herein, the term &ldquo;vector&rdquo; refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. The term &ldquo;expression vector&rdquo; includes DNA expression constructs, e.g., nucleic acid segments, plasmids, cosmids, phages, viruses or virus particles capable of synthesizing the subject proteins encoded by their respective recombinant genes carried by the vector. Alternatively, nucleic acid segments may also be used to create transgenic cells using non-directional or even homologous recombination. Vectors for use with the invention are those capable of autonomous replication and/or expression of nucleic acids to which they are linked. In the present specification, &ldquo;plasmid&rdquo; and &ldquo;vector&rdquo; are used interchangeably as the plasmid is the most commonly used form of a vector. Moreover, the invention is intended to include such other forms of expression vectors that serve equivalent functions and which become known in the art subsequently hereto. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> &ldquo;Homology&rdquo; and &ldquo;identity&rdquo; each refer to sequence similarity between two polypeptide sequences, with identity being a more strict comparison. Homology and identity can each be determined by comparing a position in each sequence that may be aligned for purposes of comparison. When a position in the compared sequence is occupied by the same amino acid residue, then the polypeptides can be referred to as identical at that position; when the equivalent site is occupied by the same amino acid (e.g., identical) or a similar amino acid (e.g., similar in steric and/or electronic nature), then the molecules can be referred to as homologous at that position. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> A percentage of homology or identity between sequences is a function of the number of matching or homologous positions shared by the sequences. An &ldquo;unrelated&rdquo; or &ldquo;non-homologous&rdquo; sequence shares less than 40 percent identity, though it may be less than 25 percent identity, with a reference sequence. An &ldquo;unrelated&rdquo; or &ldquo;non-homologous&rdquo; sequence can also be referred to as not being &ldquo;substantially homologous&rdquo; to the reference sequence. The terms &ldquo;homology&rdquo; and &ldquo;similarity&rdquo; are used interchangeably herein. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> By &ldquo;purified&rdquo;, it is meant, when referring to the component proteins preparations used to generate the reconstituted protein mixture, that the indicated molecule is present in the substantial absence of other biological macromolecules, such as other proteins (particularly other proteins that may substantially mask, diminish, confuse or alter the characteristics of the component proteins either as purified preparations or in their function in the subject reconstituted mixture). </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> The term &ldquo;purified&rdquo; as used herein preferably means at least 80% by dry weight, 95-99% by weight or even 99.8% by weight, of biological macromolecules of the same type present (but water, buffers, and other small molecules, especially molecules having a molecular weight of less than 5000, may be present). The term &ldquo;pure&rdquo; as used herein preferably has the same numerical limits as &ldquo;purified&rdquo; immediately above. &ldquo;Isolated&rdquo; and &ldquo;purified&rdquo; do not encompass either protein in its native state (e.g., as a part of a cell), or as part of a cell lysate, or that have been separated into components (e.g., in an acrylamide gel) but not obtained either as pure (e.g., lacking contaminating proteins) substances or solutions. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> The term &ldquo;isolated&rdquo; as used herein may also refer to a component protein that is substantially free of cellular material or culture medium when produced by recombinant DNA techniques, or chemical precursors or other chemicals when chemically synthesized. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> The term &ldquo;recombinant protein&rdquo; refers to a protein that is produced by recombinant DNA techniques, wherein generally DNA encoding the protein is inserted into a suitable expression vector that is in turn used to transform a host cell to produce the heterologous protein. Moreover, the phrase &ldquo;derived from&rdquo;, with respect to a recombinant gene, is meant to include within the meaning of &ldquo;recombinant protein&rdquo; those proteins having an amino acid sequence corresponding to a naturally occurring protein or an amino acid sequence similar thereto that is generated by mutations including substitutions and deletions. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> All technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, unless defined otherwise. Methods and materials similar or equivalent to those described herein may be used in the practice or testing of the present invention, the generally used methods and materials are now described. </paragraph>
<paragraph id="P-0037" lvl="7"><number>&lsqb;0037&rsqb;</number> Inserting Chimeric Genes into Plant Cells </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> A variety of methods may be used to insert foreign DNA, e.g., the chimeric genes of the present invention into plant cells. One such method, involves inserting a chimeric gene into Ti plasmids carried by <highlight><italic>A. tumefaciens</italic></highlight>, and co-cultivating the <highlight><italic>A. tumefaciens </italic></highlight>cells with plants. In this process, a segment of T-DNA carrying the chimeric gene is transferred into the plant genome, causing transformation. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> A variety of other methods are listed below. These methods are capable of inserting the chimeric genes of this invention into plant cells, although the reported transformation efficiencies achieved to date by such methods have been low. The chimeric genes of this invention (especially those chimeric genes such as NPTI and NPTII, which may be used as selectable markers) are likely to facilitate research on methods of inserting DNA into plants or plant cells. One alternative technique for inserting DNA into plant cells involves the use of lipid vesicles or liposomes. Liposomes are used to encapsulate one or more DNA molecules, which may be taken up by plant cells. If the inserted DNA is incorporated into the plant genome, replicated, and inherited, the plant cells are transformed. To date, efforts to use liposomes to deliver DNA into plant cells have not met with great success. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> While only relatively small DNA molecules have been transferred into plant cells by means of liposomes, and none have yet been expressed, future, liposome-delivery technology may be developed, to transfer plasmids containing the chimeric genes of this invention into plant cells by means involving liposomes. Another technique involves contacting plant cells with vector DNA that is complexed with either (a) polycationic substances, such as poly-L-ornithine, or (b) calcium phosphate. Although efficiencies of transformation achieved to date have been low, these methods may be used as selection of the transformants is possible. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> Another method involves fusing bacteria that contain desired plasmids with the plant cells. Such methods involve converting the bacteria into spheroplasts and converting the plant cells into protoplasts. Both of these methods remove the cell wall barrier from the bacterial and plant cells, using enzymatic digestion. The two cell types can then be fused together by exposure to chemical agents, such as polyethylene glycol. Although the transformation efficiencies achieved to date by this method are low, similar experiments using fusions of bacterial and animal cells have produced good results. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> Other methods that may be used to genetically transform animal cells involve (a) direct microinjection of DNA into animal cells, using very thin glass needles, and (b) electric-current-induced uptake of DNA by animal cells, or electroporation. These techniques may also be used to transform other eukaryotic cells. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> S-adenosylmethionine, herein interchangeably referred to as AdoMet, is active in more than forty biological reactions in vivo. It operates in association with folic acid and vitamin B-12 as a methylating agent, and is also essential for the formation of many sulfur-containing compounds in the body, including glutathione and various components of cartilaginous connective tissue. S-adenosylmethionine has been known to be a substance having a therapeutic effect on jecur adipsum, lipema and arteriosclerosis. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> This invention describes a DNA sequence of recombinant plant-yeast hybrid methylene tetrahydrofolate reductase (E.C. &num;1.5.1.20) that consists of the cDNA sequence encoding for the catalytic aminoterminal domain of yeast MTHFR (MET13), joined to the cDNA sequence encoding the regulatory carboxyterminal domain of MTHFR from the plant <highlight><italic>Arabidopsis thaliana </italic></highlight>(AtMTHFR-1). </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> The DNA sequences of MET13 and AtMTHFR-1 are SEQ ID NO.: 1 and SEQ ID NO.3, respectively. The protein sequences of MET13 and ATMTHFR-1 are SEQ ID NO.: 2 and SEQ ID NO.: 4, respectively. The hybrid is coded for by a fusion gene made from a DNA fragment composed of base 826 to base 1824 of SEQ ID NO.: 1 that is fused to another DNA fragment composed of base 1107 to base 1838 of SEQ ID NO.: 3. A 42-base DNA sequence that codes for the 14 amino acid sequence where the two fragments that make up the hybrid are joined is given in SEQ ID NO.: 13. The DNA sequence of SEQ ID NO.: 13 codes for seven amino acids from each fragment that makes up the hybrid. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> MET13 encodes an S-adenosylmethionine-sensitive, NADPH dependent enzyme. AtMTHFR-1 encodes an S-adenosylmethionine-insensitive, NADH-dependent enzyme. The hybrid encodes an S-adenosylmethionine-insensitive enzyme that can use both NADPH and NADH, and has novel combined catalytic and regulatory properties of both its parents. When the two yeast genomic MTHFR DNA sequences (genes MET12 and MET13) encoding S-adenosylmethionine-sensitive, NADPH-dependent proteins, are replaced with DNA encoding the hybrid MTHFR, yeast cells accumulate a high level of S-adenosylmethionine. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE </heading>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> The present invention makes use of a chimeric gene that when incorporated into an appropriate host results in the over production of S-adenosylmethionine, without the need to supply the host with a source of untransformed methionine. The hyperaccumulation of S-adenosylmethionine is accompanied by an increased accumulation of methionine and more than twice the total folate content (as compared to a host expressing a wild-type gene). The overaccumulation of methionine and S-adenosylmethionine in yeast strains engineered with ChimeraI demonstrates that allosteric inhibition of MTHFR by S-adenosylmethionine controls or modifies methylneogenesis, and hence, the commitment of Carbon-1 units to methylneogenesis. Chemicals Used &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;Formaldehyde (53 mCi mmol<highlight><superscript>&minus;1</superscript></highlight>) was purchased from NEN Life Science Products, and (6R, 6S)-&lsqb;methyl-<highlight><superscript>14</superscript></highlight>C&rsqb;CH<highlight><subscript>3</subscript></highlight>-tetrahydrofolic acid (&ldquo;CH<highlight><subscript>3</subscript></highlight>-THF&rdquo;) (56 mCI mmol<highlight><superscript>1</superscript></highlight>) from Amersham Pharmacia Biotech; specific radioactivities were adjusted to the desired values with unlabeled compound. (6R, 6S)-THF and (6R, 6S)-CH<highlight><subscript>3</subscript></highlight>-THF were obtained from Schircks Laboratories (Jona, Switzerland). The purity of THF was 86%, estimated by letting the NADH&mdash;CH<highlight><subscript>2</subscript></highlight>-THF oxidoreductase reaction go to completion. CH<highlight><subscript>3</subscript></highlight>-THF and <highlight><superscript>14</superscript></highlight>CH<highlight><subscript>3</subscript></highlight>-THF were dissolved in 8 mM sodium ascorbate and stored at &minus;80 degrees Centigrade. THF was dissolved just before use in N<highlight><subscript>2</subscript></highlight>-gassed 0.25 M triethanolamine-HCl, pH 7, containing 40 mM 2-mercaptoethanol. Glucose-6-phophate dehydrogenase (recombinant <highlight><italic>Leuconostoc mesenteroides </italic></highlight>enzyme) and all other biochemicals were from Sigma. Enzyme Isolation </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> All operations were at about 0-10 degrees Centigrade. Yeast cultures were grown to an A<highlight><subscript>600 </subscript></highlight>of at least about 1-2, washed, and broken by agitation with glass beads in 100 mM potassium phosphate buffer, pH 6.8 or 7.2, containing 1 mM EDTA, 12-25 micromolar FAD, and 10% (v/v) glycerol (Buffer A) plus 1 mM PMSF. Extracts were cleared by centrifugation (25,000&times;g, 30 minutes), desalted on PD-10 columns (Amersham Pharmacia Biotech) equilibrated in buffer A, and concentrated if necessary in Centricon-30 units (Amicon). Extracts were stored at &minus;80 degrees Centigrade after freezing in liquid N<highlight><subscript>2</subscript></highlight>; this did not affect MTHFR activity. Protein was estimated by Bradford&apos;s method using bovine serum albumin as the standard. </paragraph>
<paragraph id="P-0049" lvl="7"><number>&lsqb;0049&rsqb;</number> Assays for MTHFR Activity </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> Assays were made under conditions in which substrates were saturating and product formation was proportional to enzyme concentration and time. NAD(P)H-CH<highlight><subscript>2</subscript></highlight>-THF oxidoreductase activity was measured in reaction mixtures (final volume 20 microliters, in 2-mL screw-cap microcentrifuge tubes) containing 100 mM potassium phosphate buffer, pH 7.2, 0.3 mM EDTA, 4 mM 2-mercaptoethanol, 42 nmol (0.1 &mgr;Ci) of &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;formaldehyde, 20 nmol of THF, 0.5 nmol of FAD, 4 nmol of NAD(P)H, 20 nmol of glucose 6-phosphate, 0.06 units of glucose-6-phosphate dehydrogenase (1 unit&equals;1 micromole of NADC reduced min<highlight><superscript>&minus;1 </superscript></highlight>at pH 7.2, 24 degrees Centigrade), and enzyme preparation. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> Blank assays contained no NAD(P)H. The buffer, EDTA, &lsqb;<highlight><superscript>14</superscript></highlight>C&rsqb;formaldehyde, THF, and 2-mercaptoethanol were mixed and held for 5 minutes at 24 degrees Centigrade in hypoxic conditions (to allow <highlight><superscript>14</superscript></highlight>CH<highlight><subscript>2</subscript></highlight>-THF to form) before adding other components. Reactions were incubated at 30 degrees Centigrade for 20 minutes, and stopped by adding 1 mL of 100 mM formaldehyde. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> After standing for 20 minutes at 24 degrees Centigrade (to allow <highlight><superscript>14</superscript></highlight>C to exchange out of CH<highlight><subscript>2</subscript></highlight>-THF), 0.2 mL of a slurry of AG-50(H<highlight><superscript>&plus;</superscript></highlight>) resin (1:1 with water) was added to bind <highlight><superscript>14</superscript></highlight>CH<highlight><subscript>3</subscript></highlight>-THF. The resin was washed with 3&times;1.5 mL of 100 mM formaldehyde, mixed with 1 mL of scintillation fluid, and counted. The counting efficiency was 40%, determined using assays spiked with <highlight><superscript>14</superscript></highlight>CH<highlight><subscript>3</subscript></highlight>-THF. </paragraph>
<paragraph id="P-0053" lvl="7"><number>&lsqb;0053&rsqb;</number> Construction of Chimeric Enzyme </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> ChimeraI was constructed by a PCR-based approach. Alternative construction methods such as selective restriction fragment cloning using sticky ends, or even blunt end ligations may also be used. A map of ChimeraI is depicted in <cross-reference target="DRAWINGS">FIG. 1</cross-reference>. The DNA fragments encoding the N-terminal domain of Met13 (5&prime;-met13 fragment) and the C-terminal domain of AtMTHFR-1 (3&prime;-AtMTHFR-1 fragment) were amplified separately by PCR and joined using a short overlap sequence. The following primer pairs were used: </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> A. For the amplification of the DNA fragment encoding the N-terminal domain of Met13 (5&prime;-met13 fragment): </paragraph>
<paragraph id="P-0056" lvl="2"><number>&lsqb;0056&rsqb;</number> &gt;MET13-5PRIME (SEQ ID NO.: 5) </paragraph>
<paragraph id="P-0057" lvl="2"><number>&lsqb;0057&rsqb;</number> 5&prime;-CATGAAGATCACAGAAAAATTAGAGC-3&prime;</paragraph>
<paragraph id="P-0058" lvl="2"><number>&lsqb;0058&rsqb;</number> &gt;MET13-1-SOER (SEQ ID NO.: 6) </paragraph>
<paragraph id="P-0059" lvl="2"><number>&lsqb;0059&rsqb;</number> 5&prime;-GGTTTGCCCAGAAGATAGGTCTGACTTCC-3&prime;</paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> B. For the amplification of the DNA fragment encoding the C-terminal domain of AtMTHFR-1 (3&prime;-AtMTHFR-1 fragment): </paragraph>
<paragraph id="P-0061" lvl="2"><number>&lsqb;0061&rsqb;</number> &gt;W43486-1-SOEF (SEQ ID NO.: 7) </paragraph>
<paragraph id="P-0062" lvl="2"><number>&lsqb;0062&rsqb;</number> 5-CCTATCTTCTGGGCAAACCGTCCAAAGAGC-3&prime;</paragraph>
<paragraph id="P-0063" lvl="2"><number>&lsqb;0063&rsqb;</number> W43486-3PRIME (SEQ ID NO.: 8) </paragraph>
<paragraph id="P-0064" lvl="2"><number>&lsqb;0064&rsqb;</number> 5&prime;TGCACTGCAGTCAAGCAAAGACAGAGAAG-3&prime;</paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> Pst I </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The reaction mixtures for PCR amplification contained: </paragraph>
<paragraph id="P-0067" lvl="2"><number>&lsqb;0067&rsqb;</number> 5 &mgr;L each primer (5 &mgr;M stock) </paragraph>
<paragraph id="P-0068" lvl="2"><number>&lsqb;0068&rsqb;</number> 1 &mgr;L dNTP mixture (10 mM stock of each dATP, dGTP, dTTP, and dCTP) </paragraph>
<paragraph id="P-0069" lvl="2"><number>&lsqb;0069&rsqb;</number> 2 &mgr;L (5 units) Pfu turbo polymerase (Stratagene) </paragraph>
<paragraph id="P-0070" lvl="2"><number>&lsqb;0070&rsqb;</number> 5 &mgr;L 10&times; buffer for Pfu polymerase </paragraph>
<paragraph id="P-0071" lvl="2"><number>&lsqb;0071&rsqb;</number> 2 &mgr;L (100 ng) met 13 cDNA or AtMTHFR-1 cDNA </paragraph>
<paragraph id="P-0072" lvl="2"><number>&lsqb;0072&rsqb;</number> 30 &mgr;L water </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> The PCR products were run on 1% low-melting agarose gel, the amplified DNA bands were cut out and purified over the Wizard DNA purification minicolumn (Promega). Final volume of each sample was 50 &mgr;L. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> The two fragments (5&prime;-met13 and 3&prime;-AtMTHFR-1) were then joined by a second round of PCR as follows: </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> PCR reaction mix contained: </paragraph>
<paragraph id="P-0076" lvl="2"><number>&lsqb;0076&rsqb;</number> 5 &mgr;L MET13-5PRIME primer (5 &mgr;M stock) </paragraph>
<paragraph id="P-0077" lvl="2"><number>&lsqb;0077&rsqb;</number> 5 &mgr;L W43486-3PRIME primer (5 &mgr;M stock) </paragraph>
<paragraph id="P-0078" lvl="2"><number>&lsqb;0078&rsqb;</number> 1 &mgr;L dNTP mixture (10 mM stock of each dATP, dGTP, dTTP, and dCTP) </paragraph>
<paragraph id="P-0079" lvl="2"><number>&lsqb;0079&rsqb;</number> 2 &mgr;L (5 units) Pfu turbo polymerase (Stratagene) </paragraph>
<paragraph id="P-0080" lvl="2"><number>&lsqb;0080&rsqb;</number> 5 &mgr;L 10&times; buffer for Pfu polymerase </paragraph>
<paragraph id="P-0081" lvl="2"><number>&lsqb;0081&rsqb;</number> 2 &mgr;L (out of 50 1L) of the 5&prime;-met13 fragment amplified in the first step of PCR </paragraph>
<paragraph id="P-0082" lvl="2"><number>&lsqb;0082&rsqb;</number> 2 &mgr;L (out of 50 &mgr;L) of the 3&prime;-AtMTHFR-1 fragment amplified in the first step of PCR </paragraph>
<paragraph id="P-0083" lvl="2"><number>&lsqb;0083&rsqb;</number> 28 &mgr;L water </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> The obtained full-length PCR fragment, ChimeraI, was run on 1% low-melting agarose gel, the amplified DNA band was cut out and purified over the Wizard DNA purification minicolumn (Promega). </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> For the enzyme kinetics studies, the PCR product obtained was inserted into the yeast expression vector pVT103-U as follows: The ChimeraI PCR fragment was digested with PstI restriction enzyme. The digested fragment was run on 1% low-melting agarose gel, cut out, and purified over the Wizard DNA purification minicolumn (Promega). </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> The yeast expression vector pVT103U was prepared for ligation of the insert as follows: The vector was linearized with BamHI, ethanol precipitated, resuspended in water, and treated with T4 polymerase. Reaction was stopped by heating at 70 degrees Centigrade for 15 minutes, followed by chloroform extraction and ethanol precipitation. The fragment was then resuspended in water and digested with Pst I, run on 1% low-melting agarose gel and purified over the Wizard column as before. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> The purified vector (pVT103U) fragment and the purified ChimeraI fragment were mixed, ligated overnight, and introduced by electroporation into competent <highlight><italic>E. coli DH</italic></highlight>10B cells. The identity of the construct was verified by restriction digests and by DNA sequencing. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> The resulting construct (pChimeraI) was then introduced into RRY3 (&Dgr;met12&Dgr;met13) yeast strain for expression and enzyme kinetics studies. </paragraph>
<paragraph id="P-0089" lvl="7"><number>&lsqb;0089&rsqb;</number> Strain Construction </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> The pVT-Chimeral plasmid containing the yeast MET13 gene with its putative regulatory carboxyl terminal domain replaced by the corresponding domain of the AtMTHFR-1 gene from <highlight><italic>Arabidopsis thaliana </italic></highlight>was used as template for construction of strains RRY4 and RRY5. The Chimeral gene (CHIMERAL) was amplified with primers 5&prime;-CAACAGGTTCATGCCACTGG-3&prime; (MTR2.1, SEQ ID NO.: 9) and 5&prime;-ACAATGGAAAAGGAAGGAGCAAAATCTGGT-AAAAATTCTCGGAGATCAAGCA-3&prime;, (Chimera-R1, SEQ ID NO.: 10); sequence homologus to yeast MET13 gene in bold). </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> The 1.4 Kbp CHIMERAI fragment was gel purified using the QIAquick gel extraction kit (Qiagen) and used to transform the methionine requiring strains RRY1 (MET12 &Dgr;met13) and RRY3 (&Dgr;met12 &Dgr;met13). Transformants were selected by methionine prototrophy indicating successful integration of the CHIMERAI fragment at the disrupted met13 locus. Integration was confirmed by PCR on genomic DNA from RRY4 (MET12 CHIMERAI) and RRY5 (&Dgr;met12 CHIMERAI) using primers 5&prime;-AAGGTGATATTTCGCTCGTGG-3&prime;(M13-USF, SEQ ID NO.: 11) and 5&prime;-ATGGATCCGGGTGTTAACCAA-3&prime;(M13-DSR, SEQ ID NO.: 12). </paragraph>
<paragraph id="P-0092" lvl="7"><number>&lsqb;0092&rsqb;</number> Preparation of Extracts for NMR Analysis </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> Yeast were grown in 500 mL cultures supplemented with <highlight><superscript>13</superscript></highlight>C-labeled glycine or formate as indicated. Cells were harvested at an OD<highlight><subscript>600 </subscript></highlight>of approximately 3-5 and washed with sterile water. Extracts used for measurement of labeled choline and purines were prepared by resuspending the cell pellets in 30 mL of 0.3 N HCl and heating over a steam bath for 1.5 hours. Samples were centrifuged for 10 minutes at 10,000&times; g to pellet the cellular debris. The supernatant was evaporated in a Rotavapor-R evaporator, dissolved in 1 mL D<highlight><subscript>2</subscript></highlight>O, and submitted for NMR analysis. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> Extracts used for measurement of <highlight><superscript>13</superscript></highlight>C-labeled S-adenosylmethionine were prepared by resuspending the cell pellet in 500 mL sterile water and lysing the cells with glass beads by vortexing continuously at 4 degrees Centigrade for 20-30 minutes. Lysates were clarifed by centrifugation at 13,000&times; g for 15 minutes. Proteins were precipitated by adding 95% ethanol to a final concentration of approximately 60-70% to the crude extract. The samples were incubated on ice for 20 minutes and precipitated proteins were collected by centrifugation at 13,000&times; g for 15 minutes. The supernatant was evaporated down, dissolved in D<highlight><subscript>2</subscript></highlight>O and used to measure the <highlight><superscript>13</superscript></highlight>C labeling of S-adenosylmethionine via NMR. </paragraph>
<paragraph id="P-0095" lvl="7"><number>&lsqb;0095&rsqb;</number> NMR Analysis </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> NMR spectra were obtained on a Varian Unity-Inova Spectrometer with an <highlight><superscript>1</superscript></highlight>H frequency of 500 MHz and a <highlight><superscript>13</superscript></highlight>C frequency of 125 MHz. <highlight><superscript>13</superscript></highlight>C data were collected with an acquisition time of 1.3-sec with a 3-sec delay and 90 degree pulse angle. Two level composite pulse was used for proton decoupling with a power level of 48 dB during acquisition and 40 dB during delay. A total of 200-2000 scans of 64K data points were acquired over a sweep width of 25 kHz. Data processing included exponential line broadening of 1 Hz. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> Metabolites were identified based on the value of the chemical shifts observed from the natural abundance spectra of standard samples. The extent of the labeling of choline and purines was determined by dividing the peak integral values of the various labeled positions (C1 and C4 for choline; C2 and C8 for purines) by the peak integral value at the position derived directly from glycine (C2 for choline and C5 for purines). The ratios were normalized by dividing the sample ratio by the same ratio derived from the natural abundance spectra of a standard sample. The amount of <highlight><superscript>13</superscript></highlight>C-labeled S-adenosylmethionine was calculated by comparing the NMR peak heights to a standard sample of known concentration. <cross-reference target="DRAWINGS">FIG. 2</cross-reference> depicts a comparison of the concentration of <highlight><superscript>13</superscript></highlight>C labeled and total S-adenosylmethionine in protein free extracts of hosts strains DAY4, RRY2, RRY4 and RRY5. </paragraph>
<paragraph id="P-0098" lvl="7"><number>&lsqb;0098&rsqb;</number> HPLC Analysis </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> The method of Wise, et al. was used to measure the concentration of S-adenosylmethionine in protein-free extracts using HPLC. Twenty &mgr;l of sample was injected into a Waters HPLC attached to a Waters Spherisorb ODS2, 250&times;4.6 mm (5 &mgr;m particle size) column with a guard column. A Waters Lambda-Max Model 481 LC Spectrophotometer was used for detection at 254 nm. The mobile phase consisted of 50 mM NaH<highlight><subscript>2</subscript></highlight>PO<highlight><subscript>4</subscript></highlight>, 10 mM heptanesulfonic acid (Sigma) and 20% methanol adjusted to a pH of 4.38 with phosphoric acid. Samples were run at a rate of 0.8 mL/min. Standard samples of S-adenosylmethionine (Sigma) ranging from 2.3 to 210 &mgr;g/mL in deionized H<highlight><subscript>2</subscript></highlight>O were run before the experimental samples. </paragraph>
<paragraph id="P-0100" lvl="7"><number>&lsqb;0100&rsqb;</number> Determination of Methionine </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> To determine methionine, 200-mg samples of wet cells were suspended in 180 &mgr;L of water and heated at 100 degrees Centigrade for 5 minutes. After cooling on ice, cells were extracted essentially as above except that protein was precipitated with 5-sulfosalicylic acid (final concentration 3.5%). The deproteinized samples were submitted to Biosynthesis Inc. (Lewisville, Tex.) for amino acid analysis using a Beckman 7300 analyzer. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> Intracellular levels of S-adenosylmethionine (A) and free methionine (B) in yeast strains DAY4, SCY6 and SCY4 are shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. Cells were grown in synthetic minimal medium supplemented with glycine, formate, leucine, histidine, trytophan, and uracil and harvested at an absorbance reading of 2.6-2.9 (at 600 nm) (Roje S, et al., Metabolic Engineering in Yeast Demonstrates That S-Adenosylmethionine Controls Flux Through the Methylenetetrahydrofolate Reductase Reaction in Vivo, 2002 277:4056-61, relevant portions incorporated herein by reference). S-adenosylmethionine data are means of duplicate determinations on the same samples with standard error values less than or equal to 1% of the means. Strain SCY4 expressing the chimeric MTHFR hyperaccumulated S-adenosylmethionine compared to strain DAY4. The hyperaccumulation was observed in cultures harvested at a range of cell densitites; its magnitude varied from 75-fold to 254-fold above wild-type in four independent experiments. In addition, this strain accumulated 7-fold more methionine than DAY4. </paragraph>
<paragraph id="P-0103" lvl="7"><number>&lsqb;0103&rsqb;</number> Folate Determination </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> Yeast strains were grown, harvested, and washed as described above for S-adenosylmethionine and methionine determination. Pelleted cells were suspended in twice their wet weight of extraction buffer (50 mM HEPES, 50 mM 2-(cyclohexylamino)ethanesulfonic acid, 0.2 M 2-mercaptoethanol, and 2% (w/v) sodium ascorbate, pH 7.9). Glass beads were added at 1.5 times the wet weight of the pellet. The samples were heated at 100 degrees Centrigrade for 10 minutes and lysed by votexing for 4 minutes. After centrifugation at 20,000&times; g for 30 minutes, supernatants were decanted, their volumes were measured, and they were stored at &minus;70 degrees Centigrade until analysis. Folate species were separated by HPLC and quantitated using the <highlight><italic>Lactobacillus casei </italic></highlight>microbiologic assay. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> Yeast were grown in minimal medium supplemented with glycine, formate, leucine, histidine, tryptophan, and uracil. Folate species as determined by HPLC are shown in the TABLE where data are means of duplicates.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Folate Levels in DAY4 and SCY4 Yeast Strains</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="91PT" align="left"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="28PT" align="center"/>
<colspec colname="4" colwidth="28PT" align="center"/>
<colspec colname="5" colwidth="35PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>10-CHO-</entry>
<entry></entry>
<entry>5-CHO-</entry>
<entry>5-CH<highlight><subscript>3</subscript></highlight>-</entry>
</row>
<row>
<entry>Strain</entry>
<entry>THF</entry>
<entry>THF</entry>
<entry>THF</entry>
<entry>THF</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry>DAY4 (MET13)</entry>
<entry>&ensp;6.5</entry>
<entry>&ensp;4.3</entry>
<entry>&ensp;6.2</entry>
<entry>&ensp;49.2</entry>
</row>
<row>
<entry>SCY4 (&Dgr;met13 CHIMERA-1)</entry>
<entry>19.9</entry>
<entry>14.1</entry>
<entry>13.5</entry>
<entry>108.4</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="5" align="left"><footnote id="FOO-00001">All units in nmol/g (wet weight) </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> The TABLE illustrates that the most abundant folate in all strains was 5&mdash;CH<highlight><subscript>3</subscript></highlight>-THF, constituting at least or more than 68% of the total folate pool. The most striking difference between strains was that SCY4 expressing ChimeraI had more than twice the total folate content of the wild-type strain DAY4, although the relative amounts of the individual folates were essentially unchanged. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> Although the invention has been described in connection with specific embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Modifications and variations of the described compositions and methods of the invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Indeed, various modifications of the described compositions and modes of carrying out the invention that are obvious to those skilled in molecular biology or related arts are intended to be within the scope of the following claims. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<sequence-cwu id="SEQLST-1">
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>13 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>3082 </s211>
<s212>DNA </s212>
<s213>Saccharomyces cerevisiae </s213>
<s220>
<s221>CDS </s221>
<s222>(826)..(2625) </s222>
<s223>DNA construct </s223>
</s220>
</s200>
<s400> 1 
cgggcacgtg ttcttggcca ccttgatgtg catgtttctt ctaggtgagc tacgtgtgtt     60 
tgggcgtcgt gcactggctc acttgtacgc gcagaaatgg cagcttgtac gattggtgac    120 
ccgccttttc gacactggac cgctatggac gtggcggcgg tgtggcggcg gctcaatgac    180 
ctgtggcgcc cgtttgtggc gtgcgatagt cgagccgcct gtcacgtgcg cggccgccct    240 
gctccgtttg acgcgatgca tagcatgcga ccacccagta atcatactgc tgacgctatt    300 
ggtcacgtgg ttatggcagc tgctgttgac tgcggtggcg tcccgtttcc acaccgtacg    360 
tgagcacatg tctggattgc tagctgcgta catagtgaca ggccttgtct acgctcgcga    420 
cgcagccgcg ctacgtccag tatgactcag gaaaagttgg cgatagacca cgagcgactg    480 
aaaaaataac agcgactttt ctcccggtag cgggccgtcg tttagtcatt ctatccctcg    540 
gattatagac tgtgaatatt gcatatgcaa ctttgactca aatttttcca aaatttgata    600 
tatatatata tatatatatg tttgtatgta tatatatata tacgtatata tatcatatat    660 
acgaaaagta gaaaaaaaaa ggtgatattt cgctcgtgga aaagctaatg ccacagcttg    720 
tgtttcgtgt agtttgcctt gctccccttg attgaaatag tctccctaaa ctaaagttat    780 
cagcaaacag aaccaccaca gttactacta caaccacatc gcaat atg aag atc aca    837 
                                                  Met Lys Ile Thr 
                                                  1 
gaa aaa tta gag caa cat aga cag acc tct ggc aag ccc act tac tca      885 
Glu Lys Leu Glu Gln His Arg Gln Thr Ser Gly Lys Pro Thr Tyr Ser 
5                   10                  15                  20 
ttc gag tac ttc gtc ccg aag act aca caa ggt gta cag aac ctg tat      933 
Phe Glu Tyr Phe Val Pro Lys Thr Thr Gln Gly Val Gln Asn Leu Tyr 
                25                  30                  35 
gac cgg atg gac cgg atg tac gag gct tct ttg ccc caa ttt att gac      981 
Asp Arg Met Asp Arg Met Tyr Glu Ala Ser Leu Pro Gln Phe Ile Asp 
            40                  45                  50 
atc acc tgg aat gca ggc ggt gga cgg ttg tca cat ctg tcc acg gac     1029 
Ile Thr Trp Asn Ala Gly Gly Gly Arg Leu Ser His Leu Ser Thr Asp 
        55                  60                  65 
ttg gtt gcg aca gcg cag tct gtg ctt ggt ttg gaa acg tgc atg cac     1077 
Leu Val Ala Thr Ala Gln Ser Val Leu Gly Leu Glu Thr Cys Met His 
    70                  75                  80 
ctt acc tgc acc aat atg ccc att tcg atg att gac gac gct tta gaa     1125 
Leu Thr Cys Thr Asn Met Pro Ile Ser Met Ile Asp Asp Ala Leu Glu 
85                  90                  95                  100 
aac gct tat cac tcc ggt tgc cag aac atc cta gcg ctg aga gga gat     1173 
Asn Ala Tyr His Ser Gly Cys Gln Asn Ile Leu Ala Leu Arg Gly Asp 
                105                 110                 115 
cct cct agg gac gca gaa aac tgg act ccc gtt gaa ggt ggc ttc cag     1221 
Pro Pro Arg Asp Ala Glu Asn Trp Thr Pro Val Glu Gly Gly Phe Gln 
            120                 125                 130 
tat gcc aag gac ttg att aag tat atc aag tcc aag tac ggt gac cat     1269 
Tyr Ala Lys Asp Leu Ile Lys Tyr Ile Lys Ser Lys Tyr Gly Asp His 
        135                 140                 145 
ttc gct atc ggc gtt gcc ggc tac ccg gag tgc cat ccg gag ttg cct     1317 
Phe Ala Ile Gly Val Ala Gly Tyr Pro Glu Cys His Pro Glu Leu Pro 
    150                 155                 160 
aac aaa gac gtg aag ctt gat ctc gag tat ttg agc aga aga tcg acc     1365 
Asn Lys Asp Val Lys Leu Asp Leu Glu Tyr Leu Ser Arg Arg Ser Thr 
165                 170                 175                 180 
ggc ggc gac ttc atc atc act cag atg ttt tac gat gtt gat aat tta     1413 
Gly Gly Asp Phe Ile Ile Thr Gln Met Phe Tyr Asp Val Asp Asn Leu 
                185                 190                 195 
ctc aac tgg tgt tcc caa gtt aga gct gcg ggc atg gac gtg ccc att     1461 
Leu Asn Trp Cys Ser Gln Val Arg Ala Ala Gly Met Asp Val Pro Ile 
            200                 205                 210 
att ccc ggg atc atg ccg atc act acc tac gcg gcc ttc ttg aga agg     1509 
Ile Pro Gly Ile Met Pro Ile Thr Thr Tyr Ala Ala Phe Leu Arg Arg 
        215                 220                 225 
atc caa tgg ggc caa atc tcc atc cct caa cat ttc tcg tcc cga ttg     1557 
Ile Gln Trp Gly Gln Ile Ser Ile Pro Gln His Phe Ser Ser Arg Leu 
    230                 235                 240 
gat cct atc aag gac gat gac gag ttg gtc cgt gat atc gga act aac     1605 
Asp Pro Ile Lys Asp Asp Asp Glu Leu Val Arg Asp Ile Gly Thr Asn 
245                 250                 255                 260 
ttg atc gtg gaa atg tgt caa aaa ttg ctc gac agt ggt tac gtt tct     1653 
Leu Ile Val Glu Met Cys Gln Lys Leu Leu Asp Ser Gly Tyr Val Ser 
                265                 270                 275 
cac ttg cac atc tac acc atg aac ttg gaa aaa gcg cct ctc atg att     1701 
His Leu His Ile Tyr Thr Met Asn Leu Glu Lys Ala Pro Leu Met Ile 
            280                 285                 290 
ctg gaa aga ttg aac att cta cct acg gaa tca gag ttc aat gca cat     1749 
Leu Glu Arg Leu Asn Ile Leu Pro Thr Glu Ser Glu Phe Asn Ala His 
        295                 300                 305 
cca ttg gcc gtg ttg cca tgg aga aaa tct ttg aat cca aag cgt aaa     1797 
Pro Leu Ala Val Leu Pro Trp Arg Lys Ser Leu Asn Pro Lys Arg Lys 
    310                 315                 320 
aac gag gaa gtc aga cct atc ttc tgg aag aga aga cct tac tcc tat     1845 
Asn Glu Glu Val Arg Pro Ile Phe Trp Lys Arg Arg Pro Tyr Ser Tyr 
325                 330                 335                 340 
gtc gca aga acc tct caa tgg gcc gtg gac gaa ttc ccc aac ggt aga     1893 
Val Ala Arg Thr Ser Gln Trp Ala Val Asp Glu Phe Pro Asn Gly Arg 
                345                 350                 355 
ttc ggt gat tcg tct tct cct gcg ttc ggt gac ttg gat ctg tgt ggt     1941 
Phe Gly Asp Ser Ser Ser Pro Ala Phe Gly Asp Leu Asp Leu Cys Gly 
            360                 365                 370 
tca gac ttg atc agg caa tca gcg aac aaa tgt ctc gaa tta tgg tcc     1989 
Ser Asp Leu Ile Arg Gln Ser Ala Asn Lys Cys Leu Glu Leu Trp Ser 
        375                 380                 385 
acc cct act tcc atc aac gac gtc gcc ttc ttg gtc atc aac tac ttg     2037 
Thr Pro Thr Ser Ile Asn Asp Val Ala Phe Leu Val Ile Asn Tyr Leu 
    390                 395                 400 
aat gga aac ttg aag tgt tta cct tgg agt gat atc ccc atc aat gat     2085 
Asn Gly Asn Leu Lys Cys Leu Pro Trp Ser Asp Ile Pro Ile Asn Asp 
405                 410                 415                 420 
gaa ata aat cca atc aaa gca cac ttg att gag ctg aac cag cat tct     2133 
Glu Ile Asn Pro Ile Lys Ala His Leu Ile Glu Leu Asn Gln His Ser 
                425                 430                 435 
atc atc act ata aac tct caa cct caa gtc aac ggc att agg tcc aat     2181 
Ile Ile Thr Ile Asn Ser Gln Pro Gln Val Asn Gly Ile Arg Ser Asn 
            440                 445                 450 
gac aaa att cat ggt tgg gga ccc aag gat ggt tac gtt tac cag aag     2229 
Asp Lys Ile His Gly Trp Gly Pro Lys Asp Gly Tyr Val Tyr Gln Lys 
        455                 460                 465 
caa tat ttg gaa ttt atg ttg ccc aag act aag ttg ccc aag ttg att     2277 
Gln Tyr Leu Glu Phe Met Leu Pro Lys Thr Lys Leu Pro Lys Leu Ile 
    470                 475                 480 
gac acc ttg aaa aac aat gag ttc ttg acc tac ttc gcc atc gac tct     2325 
Asp Thr Leu Lys Asn Asn Glu Phe Leu Thr Tyr Phe Ala Ile Asp Ser 
485                 490                 495                 500 
caa ggt gac ctg cta agt aat cat cca gac aac tcc aag tcc aac gct     2373 
Gln Gly Asp Leu Leu Ser Asn His Pro Asp Asn Ser Lys Ser Asn Ala 
                505                 510                 515 
gtg act tgg ggt att ttc ccc ggc aga gaa att ctt caa cct acc att     2421 
Val Thr Trp Gly Ile Phe Pro Gly Arg Glu Ile Leu Gln Pro Thr Ile 
            520                 525                 530 
gtc gag aaa att tcg ttc tta gcg tgg aag gag gag ttc tat cat atc     2469 
Val Glu Lys Ile Ser Phe Leu Ala Trp Lys Glu Glu Phe Tyr His Ile 
        535                 540                 545 
ttg aat gaa tgg aaa cta aac atg aat aaa tac gat aaa ccg cat agt     2517 
Leu Asn Glu Trp Lys Leu Asn Met Asn Lys Tyr Asp Lys Pro His Ser 
    550                 555                 560 
gcc caa ttc att cag tcc ttg att gac gat tac tgc ttg gtc aat att     2565 
Ala Gln Phe Ile Gln Ser Leu Ile Asp Asp Tyr Cys Leu Val Asn Ile 
565                 570                 575                 580 
gtt gac aat gac tac att tct cca gat gat caa atc cat tcc atc cta     2613 
Val Asp Asn Asp Tyr Ile Ser Pro Asp Asp Gln Ile His Ser Ile Leu 
                585                 590                 595 
cta agc cta taa taacacagac aacgataaca gttctttaac agaattgtca         2665 
Leu Ser Leu 
accccccctc tttgcattac attcaacatt acattgcatt tttttttttt tattcactat   2725 
tattatggtt cttctttttt accagatttt gctccttcct tttccattgt tttaccattc   2785 
ttttttaact agcatttcaa catgtgtttg gttaacaccc cttctttttt ttcaggaaaa   2845 
tcctttcatt tcttctcata ctttcaacaa agttttttaa aggtacttta aaatagttca   2905 
acaccctctt ccttcattta tttattctct tcatattcaa catactcgaa aaggaagaac   2965 
actaaaagta cttacatttt cacatgtatg tatacctata tatatatata tatatactct   3025 
tatagatata tttacaaatt aaaggaaaaa ataataaaat aacctccctg tcacaag      3082 
</s400>
<s200>
<s210>2 </s210>
<s211>599 </s211>
<s212>PRT </s212>
<s213>Saccharomyces cerevisiae </s213>
</s200>
<s400> 2 
Met Lys Ile Thr Glu Lys Leu Glu Gln His Arg Gln Thr Ser Gly Lys 
1               5                   10                  15 
Pro Thr Tyr Ser Phe Glu Tyr Phe Val Pro Lys Thr Thr Gln Gly Val 
            20                  25                  30 
Gln Asn Leu Tyr Asp Arg Met Asp Arg Met Tyr Glu Ala Ser Leu Pro 
        35                  40                  45 
Gln Phe Ile Asp Ile Thr Trp Asn Ala Gly Gly Gly Arg Leu Ser His 
    50                  55                  60 
Leu Ser Thr Asp Leu Val Ala Thr Ala Gln Ser Val Leu Gly Leu Glu 
65                  70                  75                  80 
Thr Cys Met His Leu Thr Cys Thr Asn Met Pro Ile Ser Met Ile Asp 
                85                  90                  95 
Asp Ala Leu Glu Asn Ala Tyr His Ser Gly Cys Gln Asn Ile Leu Ala 
            100                 105                 110 
Leu Arg Gly Asp Pro Pro Arg Asp Ala Glu Asn Trp Thr Pro Val Glu 
        115                 120                 125 
Gly Gly Phe Gln Tyr Ala Lys Asp Leu Ile Lys Tyr Ile Lys Ser Lys 
    130                 135                 140 
Tyr Gly Asp His Phe Ala Ile Gly Val Ala Gly Tyr Pro Glu Cys His 
145                 150                 155                 160 
Pro Glu Leu Pro Asn Lys Asp Val Lys Leu Asp Leu Glu Tyr Leu Ser 
                165                 170                 175 
Arg Arg Ser Thr Gly Gly Asp Phe Ile Ile Thr Gln Met Phe Tyr Asp 
            180                 185                 190 
Val Asp Asn Leu Leu Asn Trp Cys Ser Gln Val Arg Ala Ala Gly Met 
        195                 200                 205 
Asp Val Pro Ile Ile Pro Gly Ile Met Pro Ile Thr Thr Tyr Ala Ala 
    210                 215                 220 
Phe Leu Arg Arg Ile Gln Trp Gly Gln Ile Ser Ile Pro Gln His Phe 
225                 230                 235                 240 
Ser Ser Arg Leu Asp Pro Ile Lys Asp Asp Asp Glu Leu Val Arg Asp 
                245                 250                 255 
Ile Gly Thr Asn Leu Ile Val Glu Met Cys Gln Lys Leu Leu Asp Ser 
            260                 265                 270 
Gly Tyr Val Ser His Leu His Ile Tyr Thr Met Asn Leu Glu Lys Ala 
        275                 280                 285 
Pro Leu Met Ile Leu Glu Arg Leu Asn Ile Leu Pro Thr Glu Ser Glu 
    290                 295                 300 
Phe Asn Ala His Pro Leu Ala Val Leu Pro Trp Arg Lys Ser Leu Asn 
305                 310                 315                 320 
Pro Lys Arg Lys Asn Glu Glu Val Arg Pro Ile Phe Trp Lys Arg Arg 
                325                 330                 335 
Pro Tyr Ser Tyr Val Ala Arg Thr Ser Gln Trp Ala Val Asp Glu Phe 
            340                 345                 350 
Pro Asn Gly Arg Phe Gly Asp Ser Ser Ser Pro Ala Phe Gly Asp Leu 
        355                 360                 365 
Asp Leu Cys Gly Ser Asp Leu Ile Arg Gln Ser Ala Asn Lys Cys Leu 
    370                 375                 380 
Glu Leu Trp Ser Thr Pro Thr Ser Ile Asn Asp Val Ala Phe Leu Val 
385                 390                 395                 400 
Ile Asn Tyr Leu Asn Gly Asn Leu Lys Cys Leu Pro Trp Ser Asp Ile 
                405                 410                 415 
Pro Ile Asn Asp Glu Ile Asn Pro Ile Lys Ala His Leu Ile Glu Leu 
            420                 425                 430 
Asn Gln His Ser Ile Ile Thr Ile Asn Ser Gln Pro Gln Val Asn Gly 
        435                 440                 445 
Ile Arg Ser Asn Asp Lys Ile His Gly Trp Gly Pro Lys Asp Gly Tyr 
    450                 455                 460 
Val Tyr Gln Lys Gln Tyr Leu Glu Phe Met Leu Pro Lys Thr Lys Leu 
465                 470                 475                 480 
Pro Lys Leu Ile Asp Thr Leu Lys Asn Asn Glu Phe Leu Thr Tyr Phe 
                485                 490                 495 
Ala Ile Asp Ser Gln Gly Asp Leu Leu Ser Asn His Pro Asp Asn Ser 
            500                 505                 510 
Lys Ser Asn Ala Val Thr Trp Gly Ile Phe Pro Gly Arg Glu Ile Leu 
        515                 520                 525 
Gln Pro Thr Ile Val Glu Lys Ile Ser Phe Leu Ala Trp Lys Glu Glu 
    530                 535                 540 
Phe Tyr His Ile Leu Asn Glu Trp Lys Leu Asn Met Asn Lys Tyr Asp 
545                 550                 555                 560 
Lys Pro His Ser Ala Gln Phe Ile Gln Ser Leu Ile Asp Asp Tyr Cys 
                565                 570                 575 
Leu Val Asn Ile Val Asp Asn Asp Tyr Ile Ser Pro Asp Asp Gln Ile 
            580                 585                 590 
His Ser Ile Leu Leu Ser Leu 
        595 
</s400>
<s200>
<s210>3 </s210>
<s211>1994 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(63)..(1841) </s222>
<s223>DNA construct </s223>
</s220>
</s200>
<s400> 3 
acttcctcta cctatctaat tccgaatctg gatttggatt tggatctcat ttcgattcaa     60 
cg atg aag gtg gtt gat aag atc aaa tcc gtg acg gag caa ggc caa       107 
   Met Lys Val Val Asp Lys Ile Lys Ser Val Thr Glu Gln Gly Gln 
   1               5                   10                  15 
aca gct ttc tcc ttc gag ttt ttc cca ccg aag aca gaa gat ggc gtc      155 
Thr Ala Phe Ser Phe Glu Phe Phe Pro Pro Lys Thr Glu Asp Gly Val 
                20                  25                  30 
gag aat ctc ttt gaa cga atg gat cga ttg gtc tct tat gga cct acc      203 
Glu Asn Leu Phe Glu Arg Met Asp Arg Leu Val Ser Tyr Gly Pro Thr 
            35                  40                  45 
ttc tgc gat atc act tgg ggt gct ggt gga tcc aca gct gat ctc act      251 
Phe Cys Asp Ile Thr Trp Gly Ala Gly Gly Ser Thr Ala Asp Leu Thr 
        50                  55                  60 
ctc gag att gct tct agg atg cag aat gtt atc tgc gtc gag act atg      299 
Leu Glu Ile Ala Ser Arg Met Gln Asn Val Ile Cys Val Glu Thr Met 
    65                  70                  75 
atg cat ctc act tgt acc aac atg ccg att gag aag att gat cac gcg      347 
Met His Leu Thr Cys Thr Asn Met Pro Ile Glu Lys Ile Asp His Ala 
80                  85                  90                  95 
ctt gag acg att aga tct aat gga att cag aat gtg ctt gct ctt aga      395 
Leu Glu Thr Ile Arg Ser Asn Gly Ile Gln Asn Val Leu Ala Leu Arg 
                100                 105                 110 
gga gat cct cct cat gga caa gat aag ttt gtt cag gtt gaa gga gga      443 
Gly Asp Pro Pro His Gly Gln Asp Lys Phe Val Gln Val Glu Gly Gly 
            115                 120                 125 
ttt gct tgt gct ttg gat ctg gtg aat cac att cgt agc aag tat ggt      491 
Phe Ala Cys Ala Leu Asp Leu Val Asn His Ile Arg Ser Lys Tyr Gly 
        130                 135                 140 
gat tac ttt gga atc act gtt gct ggt tat cct gag gct cat ccg gat      539 
Asp Tyr Phe Gly Ile Thr Val Ala Gly Tyr Pro Glu Ala His Pro Asp 
    145                 150                 155 
gtt att gaa gct gat gga ctt gct act cct gaa tct tat cag agt gat      587 
Val Ile Glu Ala Asp Gly Leu Ala Thr Pro Glu Ser Tyr Gln Ser Asp 
160                 165                 170                 175 
ctt gct tac ttg aag aaa aag gtt gat gct gga gca gat ttg att gtg      635 
Leu Ala Tyr Leu Lys Lys Lys Val Asp Ala Gly Ala Asp Leu Ile Val 
                180                 185                 190 
act cag ctt ttc tat gat act gat ata ttc ctc aag ttt gtg aat gat      683 
Thr Gln Leu Phe Tyr Asp Thr Asp Ile Phe Leu Lys Phe Val Asn Asp 
            195                 200                 205 
tgt cgg caa atc ggg att aat tgt ccc att gtt cct gga att atg cct      731 
Cys Arg Gln Ile Gly Ile Asn Cys Pro Ile Val Pro Gly Ile Met Pro 
        210                 215                 220 
att tcc aac tac aag ggg ttc ttg cgt atg gct ggt ttc tgt aag acc      779 
Ile Ser Asn Tyr Lys Gly Phe Leu Arg Met Ala Gly Phe Cys Lys Thr 
    225                 230                 235 
aag ata ccc gct gag ctc act gct gcc tta gag cct att aag gat aat      827 
Lys Ile Pro Ala Glu Leu Thr Ala Ala Leu Glu Pro Ile Lys Asp Asn 
240                 245                 250                 255 
gac gag gct gtt aaa gcc tat gga att cac ttt gca aca gaa atg tgc      875 
Asp Glu Ala Val Lys Ala Tyr Gly Ile His Phe Ala Thr Glu Met Cys 
                260                 265                 270 
aaa aag att ttg gcc cat gga atc act tcc ctt cat ctc tac aca ttg      923 
Lys Lys Ile Leu Ala His Gly Ile Thr Ser Leu His Leu Tyr Thr Leu 
            275                 280                 285 
aac gtg gac aaa tca gct att ggg ata tta atg aac ctt ggt ctg att      971 
Asn Val Asp Lys Ser Ala Ile Gly Ile Leu Met Asn Leu Gly Leu Ile 
        290                 295                 300 
gat gag tca aaa att tct cgt tct cta cct tgg aga cgc cct gca aat     1019 
Asp Glu Ser Lys Ile Ser Arg Ser Leu Pro Trp Arg Arg Pro Ala Asn 
    305                 310                 315 
gtt ttc cgt act aag gaa gat gtt cgc cca att ttc tgg gca aac cgt     1067 
Val Phe Arg Thr Lys Glu Asp Val Arg Pro Ile Phe Trp Ala Asn Arg 
320                 325                 330                 335 
cca aag agc tac ata tct aga aca aag ggc tgg aat gac ttc cca cat     1115 
Pro Lys Ser Tyr Ile Ser Arg Thr Lys Gly Trp Asn Asp Phe Pro His 
                340                 345                 350 
gga cgt tgg ggt gat tca cac agt gca gca tac agt aca ctt tcg gat     1163 
Gly Arg Trp Gly Asp Ser His Ser Ala Ala Tyr Ser Thr Leu Ser Asp 
            355                 360                 365 
tat cag ttt gcg cgc cca aaa gga cgt gac aag aag ctt cag caa gaa     1211 
Tyr Gln Phe Ala Arg Pro Lys Gly Arg Asp Lys Lys Leu Gln Gln Glu 
        370                 375                 380 
tgg gtc gtc cca ctg aaa agc att gaa gat gtt caa gag aaa ttc aaa     1259 
Trp Val Val Pro Leu Lys Ser Ile Glu Asp Val Gln Glu Lys Phe Lys 
    385                 390                 395 
gag ctc tgc att gga aac tta aaa agc agc cca tgg tct gaa tta gat     1307 
Glu Leu Cys Ile Gly Asn Leu Lys Ser Ser Pro Trp Ser Glu Leu Asp 
400                 405                 410                 415 
gga ctc cag cca gag aca aag atc ata aat gag caa ctc gga aaa atc     1355 
Gly Leu Gln Pro Glu Thr Lys Ile Ile Asn Glu Gln Leu Gly Lys Ile 
                420                 425                 430 
aac tcc aac ggt ttc ctg acc att aat agc caa cca tca gtc aat gca     1403 
Asn Ser Asn Gly Phe Leu Thr Ile Asn Ser Gln Pro Ser Val Asn Ala 
            435                 440                 445 
gcc aaa tcc gat tct cca gct att gga tgg ggt ggt cct ggt ggt tac     1451 
Ala Lys Ser Asp Ser Pro Ala Ile Gly Trp Gly Gly Pro Gly Gly Tyr 
        450                 455                 460 
gtc tac cag aaa gct tat ctg gag ttc ttc tgt tca aag gat aag tta     1499 
Val Tyr Gln Lys Ala Tyr Leu Glu Phe Phe Cys Ser Lys Asp Lys Leu 
    465                 470                 475 
gac aca ctt gtg gag aaa tcc aaa gct ttt cct tct atc acc tac atg     1547 
Asp Thr Leu Val Glu Lys Ser Lys Ala Phe Pro Ser Ile Thr Tyr Met 
480                 485                 490                 495 
gcc gtg aac aaa tca gag aat tgg gta tca aac acc ggt gag tcc gat     1595 
Ala Val Asn Lys Ser Glu Asn Trp Val Ser Asn Thr Gly Glu Ser Asp 
                500                 505                 510 
gtg aat gca gtt act tgg gga gtg ttc cca gct aag gag gtt att caa     1643 
Val Asn Ala Val Thr Trp Gly Val Phe Pro Ala Lys Glu Val Ile Gln 
            515                 520                 525 
ccg acg atc gtg gat cca gcc agt ttc aaa gtc tgg aaa gac gaa gcg     1691 
Pro Thr Ile Val Asp Pro Ala Ser Phe Lys Val Trp Lys Asp Glu Ala 
        530                 535                 540 
ttt gag att tgg tca aga agc tgg gct aac ttg tac cca gaa gat gac     1739 
Phe Glu Ile Trp Ser Arg Ser Trp Ala Asn Leu Tyr Pro Glu Asp Asp 
    545                 550                 555 
cct tct aga aag ttg ctc gag gag gtg aag aac agc tac tat ttg gta     1787 
Pro Ser Arg Lys Leu Leu Glu Glu Val Lys Asn Ser Tyr Tyr Leu Val 
560                 565                 570                 575 
agc tta gtg gac aac aat tac atc aat ggt gat atc ttc tct gtc ttt     1835 
Ser Leu Val Asp Asn Asn Tyr Ile Asn Gly Asp Ile Phe Ser Val Phe 
                580                 585                 590 
gct tga tctccgagaa aaccaccggc gaagaggaaa cattcgattt cgagatttgt      1891 
Ala 
tttgtacctt ttaaagttat ttttgattcg taataacctt actttgatga atcaacaaaa   1951 
acatcagttt gattgcaatg aaaaaaatcg ccttagcggt ttg                     1994 
</s400>
<s200>
<s210>4 </s210>
<s211>592 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
</s200>
<s400> 4 
Met Lys Val Val Asp Lys Ile Lys Ser Val Thr Glu Gln Gly Gln Thr 
1               5                   10                  15 
Ala Phe Ser Phe Glu Phe Phe Pro Pro Lys Thr Glu Asp Gly Val Glu 
            20                  25                  30 
Asn Leu Phe Glu Arg Met Asp Arg Leu Val Ser Tyr Gly Pro Thr Phe 
        35                  40                  45 
Cys Asp Ile Thr Trp Gly Ala Gly Gly Ser Thr Ala Asp Leu Thr Leu 
    50                  55                  60 
Glu Ile Ala Ser Arg Met Gln Asn Val Ile Cys Val Glu Thr Met Met 
65                  70                  75                  80 
His Leu Thr Cys Thr Asn Met Pro Ile Glu Lys Ile Asp His Ala Leu 
                85                  90                  95 
Glu Thr Ile Arg Ser Asn Gly Ile Gln Asn Val Leu Ala Leu Arg Gly 
            100                 105                 110 
Asp Pro Pro His Gly Gln Asp Lys Phe Val Gln Val Glu Gly Gly Phe 
        115                 120                 125 
Ala Cys Ala Leu Asp Leu Val Asn His Ile Arg Ser Lys Tyr Gly Asp 
    130                 135                 140 
Tyr Phe Gly Ile Thr Val Ala Gly Tyr Pro Glu Ala His Pro Asp Val 
145                 150                 155                 160 
Ile Glu Ala Asp Gly Leu Ala Thr Pro Glu Ser Tyr Gln Ser Asp Leu 
                165                 170                 175 
Ala Tyr Leu Lys Lys Lys Val Asp Ala Gly Ala Asp Leu Ile Val Thr 
            180                 185                 190 
Gln Leu Phe Tyr Asp Thr Asp Ile Phe Leu Lys Phe Val Asn Asp Cys 
        195                 200                 205 
Arg Gln Ile Gly Ile Asn Cys Pro Ile Val Pro Gly Ile Met Pro Ile 
    210                 215                 220 
Ser Asn Tyr Lys Gly Phe Leu Arg Met Ala Gly Phe Cys Lys Thr Lys 
225                 230                 235                 240 
Ile Pro Ala Glu Leu Thr Ala Ala Leu Glu Pro Ile Lys Asp Asn Asp 
                245                 250                 255 
Glu Ala Val Lys Ala Tyr Gly Ile His Phe Ala Thr Glu Met Cys Lys 
            260                 265                 270 
Lys Ile Leu Ala His Gly Ile Thr Ser Leu His Leu Tyr Thr Leu Asn 
        275                 280                 285 
Val Asp Lys Ser Ala Ile Gly Ile Leu Met Asn Leu Gly Leu Ile Asp 
    290                 295                 300 
Glu Ser Lys Ile Ser Arg Ser Leu Pro Trp Arg Arg Pro Ala Asn Val 
305                 310                 315                 320 
Phe Arg Thr Lys Glu Asp Val Arg Pro Ile Phe Trp Ala Asn Arg Pro 
                325                 330                 335 
Lys Ser Tyr Ile Ser Arg Thr Lys Gly Trp Asn Asp Phe Pro His Gly 
            340                 345                 350 
Arg Trp Gly Asp Ser His Ser Ala Ala Tyr Ser Thr Leu Ser Asp Tyr 
        355                 360                 365 
Gln Phe Ala Arg Pro Lys Gly Arg Asp Lys Lys Leu Gln Gln Glu Trp 
    370                 375                 380 
Val Val Pro Leu Lys Ser Ile Glu Asp Val Gln Glu Lys Phe Lys Glu 
385                 390                 395                 400 
Leu Cys Ile Gly Asn Leu Lys Ser Ser Pro Trp Ser Glu Leu Asp Gly 
                405                 410                 415 
Leu Gln Pro Glu Thr Lys Ile Ile Asn Glu Gln Leu Gly Lys Ile Asn 
            420                 425                 430 
Ser Asn Gly Phe Leu Thr Ile Asn Ser Gln Pro Ser Val Asn Ala Ala 
        435                 440                 445 
Lys Ser Asp Ser Pro Ala Ile Gly Trp Gly Gly Pro Gly Gly Tyr Val 
    450                 455                 460 
Tyr Gln Lys Ala Tyr Leu Glu Phe Phe Cys Ser Lys Asp Lys Leu Asp 
465                 470                 475                 480 
Thr Leu Val Glu Lys Ser Lys Ala Phe Pro Ser Ile Thr Tyr Met Ala 
                485                 490                 495 
Val Asn Lys Ser Glu Asn Trp Val Ser Asn Thr Gly Glu Ser Asp Val 
            500                 505                 510 
Asn Ala Val Thr Trp Gly Val Phe Pro Ala Lys Glu Val Ile Gln Pro 
        515                 520                 525 
Thr Ile Val Asp Pro Ala Ser Phe Lys Val Trp Lys Asp Glu Ala Phe 
    530                 535                 540 
Glu Ile Trp Ser Arg Ser Trp Ala Asn Leu Tyr Pro Glu Asp Asp Pro 
545                 550                 555                 560 
Ser Arg Lys Leu Leu Glu Glu Val Lys Asn Ser Tyr Tyr Leu Val Ser 
                565                 570                 575 
Leu Val Asp Asn Asn Tyr Ile Asn Gly Asp Ile Phe Ser Val Phe Ala 
            580                 585                 590 
</s400>
<s200>
<s210>5 </s210>
<s211>26 </s211>
<s212>DNA </s212>
<s213>Saccharomyces cerevisiae </s213>
</s200>
<s400> 5 
catgaagatc acagaaaaat tagagc                                          26 
</s400>
<s200>
<s210>6 </s210>
<s211>29 </s211>
<s212>DNA </s212>
<s213>Saccharomyces cerevisiae </s213>
</s200>
<s400> 6 
ggtttgccca gaagataggt ctgacttcc                                       29 
</s400>
<s200>
<s210>7 </s210>
<s211>30 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
</s200>
<s400> 7 
cctatcttct gggcaaaccg tccaaagagc                                      30 
</s400>
<s200>
<s210>8 </s210>
<s211>29 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
</s200>
<s400> 8 
tgcactgcag tcaagcaaag acagagaag                                       29 
</s400>
<s200>
<s210>9 </s210>
<s211>20 </s211>
<s212>DNA </s212>
<s213>CHIMERA1 </s213>
</s200>
<s400> 9 
caacaggttc atgccactgg                                                 20 
</s400>
<s200>
<s210>10 </s210>
<s211>52 </s211>
<s212>DNA </s212>
<s213>CHIMERA1 </s213>
</s200>
<s400> 10 
acaatggaaa aggaaggagc aaaatctggt aaaaattctc ggagatcaag ca             52 
</s400>
<s200>
<s210>11 </s210>
<s211>21 </s211>
<s212>DNA </s212>
<s213>CHIMERA1 </s213>
</s200>
<s400> 11 
aaggtgatat ttcgctcgtg g                                               21 
</s400>
<s200>
<s210>12 </s210>
<s211>21 </s211>
<s212>DNA </s212>
<s213>CHIMERA1 </s213>
</s200>
<s400> 12 
atggatccgg gtgttaacca a                                               21 
</s400>
<s200>
<s210>13 </s210>
<s211>42 </s211>
<s212>DNA </s212>
<s213>CHIMERA1 </s213>
</s200>
<s400> 13 
gaagtcagac ctatcttctg ggcaaaccgt ccaaagagct ac                        42
</s400>
</sequence-list-new-rules>
</sequence-cwu>
<subdoc-claims>
<heading lvl="1">What is claimed: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A fused gene encoding for methylene tetrahydrofolate reductase comprising: 
<claim-text>an N-terminal domain from a yeast; and </claim-text>
<claim-text>a C-terminal domain from a plant. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the plant comprises <highlight><italic>Arabidopsis thaliana. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the N-terminal domain is a catalytic domain. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the C-terminal domain is a regulatory domain. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the N-terminal domain comprises a nucleic acid sequence substantially homologous to the sequence from base 826 to base 1824 in SEQ ID NO.: 1. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the C-terminal domain comprises a nucleic acid sequence substantially homologous to the sequence from base 1107 to base 1838 in SEQ ID NO.: 3. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> further comprising 3&prime; and 5&prime; flanking regions. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> further comprising intervening nucleic acid sequences. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A fused gene encoding for methylene tetrahydrofolate reductase comprising: 
<claim-text>a catalytic domain from a yeast; and </claim-text>
<claim-text>a regulatory domain from a plant. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the plant comprises <highlight><italic>Arabidopsis thaliana. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the catalytic domain is a N-terminal domain. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the regulatory domain is a C-terminal domain. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the catalytic domain comprises a nucleic acid sequence substantially homologous to the sequence from base 826 to base 1824 in SEQ ID NO.: 1. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the regulatory domain comprises a nucleic acid sequence substantially homologous to the sequence from base 1107 to base 1838 in SEQ ID NO.: 3. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> further comprising 3&prime; and 5&prime; flanking regions. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> further comprising intervening nucleic acid sequences. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A recombinant DNA vector comprising the fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A recombinant host cell comprising the recombinant DNA vector recited in <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A recombinant host cell comprising a yeast chosen from the group consisting of strains DAY4, RRY2, RRY4 and RRY5. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The recombinant host cell recited in <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein the cell comprises a prokaryotic cell. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The recombinant host cell recited in <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein the cell comprises a eukaryotic cell. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The recombinant host cell recited in <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein the cell comprises a plant cell. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The recombinant host cell recited in <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein the cell comprises a yeast cell. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. A nucleic acid sequence comprising at least a 42-nucleotide sequence corresponding to or complimentary to the nucleic acid sequence in SEQ ID NO.: 13. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A fusion protein encoded for by the fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the protein comprises residues 1 to 333 of SEQ ID NO.: 2 and residues 333 to residue 592 of SEQ ID NO.: 4. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. A plasmid containing the fused gene recited in <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the gene is defined by base 826 to base 1824 of SEQ ID NO.: 1 and base 1107 to base 1838 of SEQ ID NO.: 3. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A fused gene encoding for methylene tetrahydrofolate reductase comprising: 
<claim-text>a catalytic domain from a yeast comprising a nucleic acid sequence substantially homologous to the sequence from base 826 to base 1824 in SEQ ID NO.: 1; </claim-text>
<claim-text>a regulatory domain from a plant comprising a nucleic acid sequence substantially homologous to the sequence from base 1107 to base 1838 in SEQ ID NO.: 3; </claim-text>
<claim-text>wherein the fused gene modifies methylneogenesis. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The fused gene of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein methylneogenesis is an overaccumulation of methionine. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The fused gene of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein methylneogenesis is an overaccumulation of S-adenosylmethionine. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. The fused gene of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein methylneogenesis is an overaccumulation of folate. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. The fused gene of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein the yeast comprises <highlight><italic>S. cerevisiae. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. The fused gene of <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein the plant comprises <highlight><italic>Arabidopsis thaliana. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein the fused gene is incorporated into a host cell. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the host cell comprises a prokaryotic cell, an eukaryotic cell, a plant, or a yeast cell. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. The fused gene recited in <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference>, wherein the fused gene is incorporated into a Ti vector.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020192784A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020192784A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020192784A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020193343A1-20021219-M00001.NB SYSTEM "US20020193343A1-20021219-M00001.NB" NDATA NB>
<!ENTITY US20020193343A1-20021219-M00001.TIF SYSTEM "US20020193343A1-20021219-M00001.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00001.CDX SYSTEM "US20020193343A1-20021219-C00001.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00001.MOL SYSTEM "US20020193343A1-20021219-C00001.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00001.TIF SYSTEM "US20020193343A1-20021219-C00001.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00002.CDX SYSTEM "US20020193343A1-20021219-C00002.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00002.MOL SYSTEM "US20020193343A1-20021219-C00002.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00002.TIF SYSTEM "US20020193343A1-20021219-C00002.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00003.CDX SYSTEM "US20020193343A1-20021219-C00003.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00003.MOL SYSTEM "US20020193343A1-20021219-C00003.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00003.TIF SYSTEM "US20020193343A1-20021219-C00003.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00004.CDX SYSTEM "US20020193343A1-20021219-C00004.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00004.MOL SYSTEM "US20020193343A1-20021219-C00004.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00004.TIF SYSTEM "US20020193343A1-20021219-C00004.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00005.CDX SYSTEM "US20020193343A1-20021219-C00005.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00005.MOL SYSTEM "US20020193343A1-20021219-C00005.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00005.TIF SYSTEM "US20020193343A1-20021219-C00005.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00006.CDX SYSTEM "US20020193343A1-20021219-C00006.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00006.MOL SYSTEM "US20020193343A1-20021219-C00006.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00006.TIF SYSTEM "US20020193343A1-20021219-C00006.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00007.CDX SYSTEM "US20020193343A1-20021219-C00007.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00007.MOL SYSTEM "US20020193343A1-20021219-C00007.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00007.TIF SYSTEM "US20020193343A1-20021219-C00007.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00008.CDX SYSTEM "US20020193343A1-20021219-C00008.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00008.MOL SYSTEM "US20020193343A1-20021219-C00008.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00008.TIF SYSTEM "US20020193343A1-20021219-C00008.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-C00009.CDX SYSTEM "US20020193343A1-20021219-C00009.CDX" NDATA CDX>
<!ENTITY US20020193343A1-20021219-C00009.MOL SYSTEM "US20020193343A1-20021219-C00009.MOL" NDATA MOL>
<!ENTITY US20020193343A1-20021219-C00009.TIF SYSTEM "US20020193343A1-20021219-C00009.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00001.TIF SYSTEM "US20020193343A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00002.TIF SYSTEM "US20020193343A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00003.TIF SYSTEM "US20020193343A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00004.TIF SYSTEM "US20020193343A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00005.TIF SYSTEM "US20020193343A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00006.TIF SYSTEM "US20020193343A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00007.TIF SYSTEM "US20020193343A1-20021219-D00007.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00008.TIF SYSTEM "US20020193343A1-20021219-D00008.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00009.TIF SYSTEM "US20020193343A1-20021219-D00009.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00010.TIF SYSTEM "US20020193343A1-20021219-D00010.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00011.TIF SYSTEM "US20020193343A1-20021219-D00011.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00012.TIF SYSTEM "US20020193343A1-20021219-D00012.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00013.TIF SYSTEM "US20020193343A1-20021219-D00013.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00014.TIF SYSTEM "US20020193343A1-20021219-D00014.TIF" NDATA TIF>
<!ENTITY US20020193343A1-20021219-D00015.TIF SYSTEM "US20020193343A1-20021219-D00015.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020193343</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09951099</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010911</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>A61K031/715</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>A01N043/04</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N009/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>514</class>
<subclass>054000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>183000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Controlled enzymatic degradation of guar galactomannan solutions using enzymatic inhibition</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60235762</doc-number>
<document-date>20000927</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Saad</given-name>
<middle-name>A.</middle-name>
<family-name>Khan</family-name>
</name>
<residence>
<residence-us>
<city>Cary</city>
<state>NC</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Robert</given-name>
<middle-name>M.</middle-name>
<family-name>Kelly</family-name>
</name>
<residence>
<residence-us>
<city>Cary</city>
<state>NC</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Robert</given-name>
<middle-name>K.</middle-name>
<family-name>Prud&apos;homme</family-name>
</name>
<residence>
<residence-us>
<city>Lawrenceville</city>
<state>NJ</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Matthew</given-name>
<middle-name>D.</middle-name>
<family-name>Burke</family-name>
</name>
<residence>
<residence-us>
<city>Carrboro</city>
<state>NC</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Yu</given-name>
<family-name>Cheng</family-name>
</name>
<residence>
<residence-us>
<city>Princeton</city>
<state>NJ</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Swapnil</given-name>
<family-name>Chhabra</family-name>
</name>
<residence>
<residence-us>
<city>Raleigh</city>
<state>NC</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>MYERS BIGEL SIBLEY &amp; SAJOVEC</name-1>
<name-2></name-2>
<address>
<address-1>PO BOX 37428</address-1>
<city>RALEIGH</city>
<state>NC</state>
<postalcode>27627</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">A method of controlling enzymatic degradation of guar galactomannan with &bgr;-mannanase by selectively inhibiting &bgr;-mannanase, in a pH-dependent or ionic strength-dependent manner, with an aminoglycol such as TRIS or an charged polymer agent is described. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims the benefit of provisional application Serial No. 60/235,762, filed Sep. 27, 2000, the disclosure of which is incorporated by referenced herein in its entirety.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with Government support under Grant No. BES -9707160 (North Carolina State University) and Grant No. BES 97-11781 (Princeton University) from the National Science Foundation. The Government has certain rights to this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">FIELD OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> This invention concerns controlling the activity of thermostable enzyme breakers for the hydrolysis of polysaccharides in hydraulic fracturing fluids. </paragraph>
</section>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> When the pressure of oil or gas in a reservoir declines as oil or gas is taken from that reservoir, production from a well in that reservoir declines. Hence, the economic viability of the well declines until it is no longer profitable to operate (even though it continues to produce gas or oil). Production can be increased from such wells through oil well stimulation. In addition, where forming a bore hole into a reservoir is very expensive, such as in offshore drilling, it is desirable to stimulate production from a single well. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> Oil well stimulation typically involves injecting a fracturing fluid into the well bore at extremely high pressures to create fractures in the rock formation surrounding the bore. The fractures radiate outwardly from the well bore, typically from 100 to 1000 meters, and extend the surface area from which oil or gas drains into the well. The fracturing fluid typically carries a propping agent, or &ldquo;proppant&rdquo;, such as sand, so that the fractures are propped open when the pressure on the fracturing fluid is released, and the fracture closes around the propping agent. This leaves a zone of high permeability (the propping agent trapped and compacted in the fracture in the subterranean formation. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> The fracturing fluid typically contains a water-soluble polymer, such a guar gum or a derivative thereof, which provides appropriate flow characteristics to the fluid and suspends the proppant particles therein. When pressure on the fracturing fluid is released and the fracture closes around the propping agent, water is forced therefrom and the water-soluble polymer forms a compacted cake. This compacted cake can prevent oil or gas flow if not removed. To solve this problem, &ldquo;breakers&rdquo; are included in the fracturing fluid. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Currently, breakers are either enzymatic breakers or oxidative breakers. The enzyme breakers are preferable, because (a) they are true &ldquo;catalysts&rdquo;, (b) they are relatively high in molecular weight and do not leak off into the surrounding formation, and (c) they are less susceptible to dramatic changes in activity by trace contaminants. Oxidative breakers, on the other hand, are low in molecular weight and leak off into the formation, and they are active only over a very narrow temperature range. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Effective use of enzymes to modify guar requires that the onset of enzymatic hydrolysis be controlled. Currently, the enzyme and guar solutions are mixed together before injection into the oil well. This could allow premature enzyme degradation of guar to occur thereby decreasing the guar gel&apos;s ability to fracture the subterranean formations. One approach to solving this problem is described in U.S. Pat. No. 5,869,435 to Kelly et al., which provides an enzyme breaker that is active primarily at the higher temperatures found in deep wells. Nevertheless, there remains a need for additional ways to provide selectively active enzyme breakers. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> A first aspect of the present invention is a method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: </paragraph>
<paragraph id="P-0010" lvl="2"><number>&lsqb;0010&rsqb;</number> (a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in the aqueous liquid in an amount sufficient to increase the viscosity of the aqueous liquid; (iii) an enzyme breaker which degrades the polysaccharide; and (iv) a compound according to Formula I in an amount sufficient to reduce the polysaccharide-degrading activity of the enzyme breaker;  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="77.53725" wi="156.01005" file="US20020193343A1-20021219-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20020193343A1-20021219-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20020193343A1-20021219-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0011" lvl="2"><number>&lsqb;0011&rsqb;</number> &emsp;wherein: </paragraph>
<paragraph id="P-0012" lvl="3"><number>&lsqb;0012&rsqb;</number> R<highlight><superscript>1 </superscript></highlight>is selected from the group consisting of: &mdash;F, &mdash;NR<highlight><superscript>3</superscript></highlight>R<highlight><superscript>4 </superscript></highlight>wherein R<highlight><superscript>3 </superscript></highlight>and R<highlight><superscript>4 </superscript></highlight>are each independently selected from the group consisting of H, loweralkyl,  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="20.89395" wi="88.82055" file="US20020193343A1-20021219-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20020193343A1-20021219-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20020193343A1-20021219-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0013" lvl="3"><number>&lsqb;0013&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>is selected from the group consisting of &mdash;H and &mdash;OH; and </paragraph>
<paragraph id="P-0014" lvl="3"><number>&lsqb;0014&rsqb;</number> n is 0 to 3; </paragraph>
<paragraph id="P-0015" lvl="7"><number>&lsqb;0015&rsqb;</number> then; </paragraph>
<paragraph id="P-0016" lvl="2"><number>&lsqb;0016&rsqb;</number> (b) injecting the fracturing fluid into the well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds the well bore; then </paragraph>
<paragraph id="P-0017" lvl="2"><number>&lsqb;0017&rsqb;</number> (c) reducing the pH of the fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of the enzyme; and then </paragraph>
<paragraph id="P-0018" lvl="2"><number>&lsqb;0018&rsqb;</number> (d) releasing the pressure from the fracturing fluid. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> A second aspect of the present invention is a fracturing fluid useful for fracturing a subterranean formation which surrounds a well bore, comprising: </paragraph>
<paragraph id="P-0020" lvl="2"><number>&lsqb;0020&rsqb;</number> (i) an aqueous liquid; </paragraph>
<paragraph id="P-0021" lvl="2"><number>&lsqb;0021&rsqb;</number> (ii) a polysaccharide soluble or dispersible in the aqueous liquid in an amount sufficient to increase the viscosity of the aqueous liquid; </paragraph>
<paragraph id="P-0022" lvl="2"><number>&lsqb;0022&rsqb;</number> (iii) an enzyme breaker which degrades the polysaccharide; and </paragraph>
<paragraph id="P-0023" lvl="2"><number>&lsqb;0023&rsqb;</number> (iv) a compound according to Formula I as described above in an amount sufficient to reduce the polysaccharide-degrading activity of the enzyme breaker. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> A third aspect of the present invention is a method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: </paragraph>
<paragraph id="P-0025" lvl="2"><number>&lsqb;0025&rsqb;</number> (a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in the aqueous liquid in an amount sufficient to increase the viscosity of the aqueous liquid; (iii) an enzyme breaker which degrades the polysaccharide, and (iv) a polymeric additive which has a positive charge to decrease the activity of the enzyme breaker under conditions where the enzyme has a negative charge, subject to the proviso that the polymeric additive and the polysaccharide may be different or the same; </paragraph>
<paragraph id="P-0026" lvl="2"><number>&lsqb;0026&rsqb;</number> (b) injecting the fracturing fluid into the well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds the well bore; then </paragraph>
<paragraph id="P-0027" lvl="2"><number>&lsqb;0027&rsqb;</number> (c) reducing the pH and/or increasing the ionic strength of the fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of the enzyme; and then </paragraph>
<paragraph id="P-0028" lvl="2"><number>&lsqb;0028&rsqb;</number> (d) releasing the pressure from the fracturing fluid. The polymeric additive is positively charged by virtue of carrying cationic moities such as amines, quaternary amines and sulfonium ions. Note that copolymers of cationic and nonionic monomers may be used, for example, guar with partial cationic substitution or copolymers of acrylamide and cationic monomers. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> A fourth aspect of the present invention is a method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: </paragraph>
<paragraph id="P-0030" lvl="2"><number>&lsqb;0030&rsqb;</number> (a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in the aqueous liquid in an amount sufficient to increase the viscosity of the aqueous liquid; (iii) an enzyme breaker which degrades the polysaccharide, and (iv) a polymeric additive which has a negative charge to decrease the activity of the enzyme breaker under conditions where the enzyme has a positive charge, subject to the proviso that the polymeric additive and the polysaccharide may be different or the same; </paragraph>
<paragraph id="P-0031" lvl="2"><number>&lsqb;0031&rsqb;</number> (b) injecting the fracturing fluid into the well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds the well bore; then </paragraph>
<paragraph id="P-0032" lvl="2"><number>&lsqb;0032&rsqb;</number> (c) reducing the pH and/or increasing the ionic strength of the fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of the enzyme; and then </paragraph>
<paragraph id="P-0033" lvl="2"><number>&lsqb;0033&rsqb;</number> (d) releasing the pressure from the fracturing fluid. </paragraph>
<paragraph id="P-0034" lvl="7"><number>&lsqb;0034&rsqb;</number> The polymeric additive is negatively charged by virtue of carrying anionic moities such as carboxylic, sulfate, sulfonate, phosphate and phosphonate ions. Note that copolymers of anionic and nonionic monomers may be used. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> A fifth aspect of the present invention is a fracturing fluid useful for fracturing a subterranean formation which surrounds a well bore, comprising: </paragraph>
<paragraph id="P-0036" lvl="2"><number>&lsqb;0036&rsqb;</number> (i) an aqueous liquid; </paragraph>
<paragraph id="P-0037" lvl="2"><number>&lsqb;0037&rsqb;</number> (ii) a polysaccharide soluble or dispersible in the aqueous liquid in an amount sufficient to increase the viscosity of the aqueous liquid; </paragraph>
<paragraph id="P-0038" lvl="2"><number>&lsqb;0038&rsqb;</number> (iii) an enzyme breaker which degrades the polysaccharide; </paragraph>
<paragraph id="P-0039" lvl="2"><number>&lsqb;0039&rsqb;</number> (iv) a polymeric additive which has an opposite charge to that of the enzyme to decrease the activity of the enzyme breaker, subject to the proviso that the polymeric additive and the polysaccharide may be different or the same. </paragraph>
<paragraph id="P-0040" lvl="7"><number>&lsqb;0040&rsqb;</number> The polymeric additive is charged by virtue of carrying an ionic group such as a sulfate, sulfonate, phosphate, phosphonate, carboxylate, amine, quaternary amine or sulfonium ion. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> The foregoing and other objects and aspects of the present invention are explained in greater detail in the drawings herein and the specification set forth below. </paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows the effect of pH on the enzymatic hydrolysis (by <highlight><italic>Aspergillus niger &bgr;</italic></highlight>mannanase, 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml) of 7 mg/ml guar solutions as determined by the viscosity reduction factor (&Circlesolid;, left y-axis). The pH profile of the enzyme activity (&xcirc;, right y-axis), as determined by a colorimetric technique (P. Ademark et al., <highlight><italic>Journal of Biotechnology, </italic></highlight>63 (1998) 199-210), shows a similar trend and validates viscosity reduction as an effective technique to measure enzyme activity. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> shows viscosity versus shear rate behavior of 7 mg/ml guar solutions containing various amounts of TRIS, degraded by 8.3&times;10<highlight><superscript>4 </superscript></highlight>U/ml &bgr;-mannanase for 1 hour at pH 9. The symbol (&Circlesolid;) represents the initial (undegraded) viscosity; (&xcirc;) the degraded guar solution which contained 0 mM TRIS; (&square;), 1 mM TRIS; (&square;), 5 mM TRIS; (&diams;), 10 mM TRIS; (&Dgr;), 25 mM TRIS; and (&times;), 50 mM TRIS. Due to overlap of the data for the initial viscosity, 10 mM, 25 mM and 50 mM TRIS samples, some data points are omitted for clarity. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> shows the effect of TRIS on the viscosity profile of 7 mg/ml guar solutions degraded by 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml &bgr;-mannanase, for 5 hours at pH 9. The symbol (&Circlesolid;) represents the initial viscosity; (&xcirc;) the degraded guar solution which contained 0 mM TRIS; (&squf;), 1 mM TRIS; (&square;), 5 mM TRIS; (&diams;), 10 mM TRIS; (&Dgr;), 25 mM TRIS; and (&times;), 50 mM TRIS. Due to overlap of the data for the initial viscosity, 25 mM and 50 mM TRIS samples, some data points are omitted for clarity. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4</cross-reference> shows the viscosity profile of 7 mg/ml guar solutions containing various amounts of TRIS and degraded by 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml &bgr;-mannanase for 1 hour at pH 4. The symbol (&Circlesolid;) represents the initial viscosity; (&xcirc;) the degraded guar solution which contained 0 mM TRIS; (&diams;), 10 mM TRIS; (&Dgr;), 25 mM TRIS; and (&times;), 50 mM TRIS. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5</cross-reference> shows the pH activated enzyme degradation of a 7 mg/ml guar solution by <highlight><italic>Aspergillus niger &bgr;</italic></highlight>-mannanase (8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml). The pH of the solution was maintained at 9 for the first 5 hours; subsequently, the enzyme was activated by adjusting the pH to 4. Viscosity shear rate behavior are shown for various times during the process. Zero shear viscosity is shown as a function of time in the inset. (&Circlesolid;, viscosity at 0 hr; &xcirc;, 1 hr; &squf;, 3 hr; &square;, 5 hr; &diams;, 6 hr; &Dgr;, 7 hr; &times;, 9 hr; and &nabla;, 11 hr) Due to the overlap of the data for the 0 hr, 1 hr, 3 hr and 5 hr samples, some data points were omitted for clarity. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> shows the comparison of the viscosity behavior of a 7 mg/ml guar solution (&Circlesolid;) to the viscosity profiles of guar solutions degraded with 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml &bgr;-mannanase for 1 hour at pH 9, and containing 0 mM TRIS (&xcirc;), 25 mM of TRIS (&Dgr;), 25 mM of Tris (hydroxymethyl)nitromethane (&square;)and 25 mM of N-tris (hydroxymethyl)methylglycine (&squf;). Some data points have been removed for the sake of clarity. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7</cross-reference> shows the viscosity profile of guar solutions containing varying amounts of TRIS, degraded by 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml &bgr;-mannanase for 1 hour at pH 7. The symbol (&Circlesolid;) represents the initial viscosity; (&xcirc;) the degraded guar solution which contained 0 mM TRIS; (&squf;), 1 mM TRIS; (&square;), 5 mM TRIS; (&diams;), 10 mM TRIS; and (&Dgr;), 25 mM TRIS. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 8</cross-reference> shows the pH-dependent inhibition of &bgr;-mannanase by TRIS plotted in terms of relative activity. The relative activity was obtained from viscosity data and normalized for pH, as described in the experimental section. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 9</cross-reference> shows the proposed representation of the interaction between TRIS and the acid/base catalytic and histidine residues in the active site of the enzyme. The protonation state of the structures are shown for pH 4, 7 and 9. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 10</cross-reference> shows the viscosity of 0.5 wt % guar solution as a function of shear rate plotted at different periods during enzymatic degradation. The reaction was run at ambient temperature and a pH of 7. The concentration of &bgr;-mannanase is 0.0002 units/ml polymer solution. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 11</cross-reference> shows the viscosity of 0.5 wt % cationic guar solution versus shear rate plotted at different periods during enzymatic degradation. The reaction was run at ambient temperature and a pH of 7. The concentration of &bgr;-mannanase is 0.0002 units/ml polymer solution. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 12</cross-reference> shows the viscosity of 0.5wt % cationic guar solution as a function of shear rate plotted at different periods during enzymatic degradation. The reaction was run at ambient temperature and a pH of 3.5. The concentration of ,&bgr;-mannanase is 0.0002 units/ml polymer solution. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 13</cross-reference> shows the normalized viscosity of 0.5 wt % guar solution changes with reaction time at pH&equals;7, 3.4 and cationic guar solution at pH&equals;3.5. The concentration of &bgr;-mannanase is 0.0002 units/ml polymer solution. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 14</cross-reference> shows the normalized viscosity of 0.5 wt % cationic guar solution changes with reaction time at different solution ionic strengths. All reactions were run at ambient temperature and pH of 7. The concentration of &bgr;-mannanase is 0.0002 units/ml polymer solution. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 15</cross-reference> shows the effect of salt on the enzyme activity of degrading guar: normalized viscosity of 0.5 wt % guar solution as a function of reaction time at different solution ionic strengths. All reactions were run at ambient temperature and pH of 7. The concentration of &bgr;-mannanase is 0.0002 units/ml polymer solution.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS </heading>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> Fracturing fluids used to carry out the present invention are, in general, prepared from an aqueous base fluid such as water, brine, aqueous foams or water-alcohol mixtures. Any suitable mixing apparatus may be used to provide the fracturing fluid. The fracturing fluid includes a polysaccharide as a gelling agent, as discussed below, and typically includes other ingredients such as proppant particles and crosslinking agents to crosslink the polysaccharide gelling agent, also discussed below. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> Polysaccharides soluble or dispersible in an aqueous liquid include industrial gums such as those generally classified as exudate gums, seaweed gums, seed gums, microbial polysaccharides, and hemicelluloses (cell wall polysaccharides found in land plants) other than cellulose and pectins. Examples include xylan, mannan, galactan, L-arabino-xylans, L-arabino-D-glucurono-D-xylans, D-gluco-D-mannans, D-Galacto-D-mannans, arabino-D-galactans, algins such as sodium alginate, carrageenin, fucordan, laminarin, agar, gum arabic, gum ghatti, karaya gum, tamarind gum, tragacanth gum, locust bean gum, cellulose derivative such as hydroxyethylcellulose or hydroxypropylcellulose, and the like. Particularly preferred are the hydratable polysaccharides having galactose and/or mannose monosaccharide components, examples of which include the galactomannan gums, guar gum (including derivatized guar gums such as carboxymethyl guar, hydroxypropyl guar, and carboxymethyl hydroxypropyl guar. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> When the polysaccharide is derivatized or substituted with an ionic group (e.g., ionic groups are covalently bound to the polysaccharide), any suitable ionic group may be employed. Particularly preferred are cationic groups, such as quaternary amines or sulfonium ions. Examples are given in U.S. Pat. No. 5,045,190 to Carbonell et al. at column 7, lines 16-35, the disclosure of which is incorporated herein by reference. The extensive literature on ion exchange chromatography may be referred to by those skilled in the art for numerous examples of substrates derivatized with ionic groups. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> The amount of polysaccharide included in the fracturing fluid is not particularly critical, so long as the viscosity of the fluid is sufficiently high to keep the proppant particles suspended therein during the injecting step. Thus, depending upon the application, the polysaccharide is included in the fracturing fluid in an amount of from about 10 to 150 pounds of polysaccharide per 1000 gallons of aqueous liquid, and more preferably in an amount of from about 20 to 100 pounds of polysaccharide per 1000 gallons of aqueous solution (about 2.4 to 12 kg/m<highlight><superscript>3</superscript></highlight>). </paragraph>
<paragraph id="P-0061" lvl="7"><number>&lsqb;0061&rsqb;</number> Control of Enzyme Activity </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> Enzymatic attack on the polysaccharide chain can be controlled (arrested) by addition of a complexing agent which may be (1) a low molecular weight solute (such as amino glycols or other substituted glycols), or (2) a higher molecular weight oppositely charged polymer (such as cationic guar which interacts with the anionic enzyme). By &ldquo;arrested&rdquo; or &ldquo;reduced activity&rdquo; is meant that the enzyme is inactive or essentially inactive; some minor enzyme activity is permissible as long as the viscosity of the fracturing fluid does not decrease by 10 or 20 percent or more prior to the step of reducing the pH and/or increasing the ionic strength of the fracturing fluid (e.g., a time of 1, 2, or 4 or 5 hours). </paragraph>
<paragraph id="P-0063" lvl="7"><number>&lsqb;0063&rsqb;</number> Amino Glycol Control Agents </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> Aminoglycols or other substituted glycols that may be used to carry out the invention are generally represented by Formula I:  
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="77.53725" wi="156.01005" file="US20020193343A1-20021219-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20020193343A1-20021219-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20020193343A1-20021219-C00003.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0065" lvl="7"><number>&lsqb;0065&rsqb;</number> wherein: </paragraph>
<paragraph id="P-0066" lvl="2"><number>&lsqb;0066&rsqb;</number> R<highlight><superscript>1 </superscript></highlight>is selected from the group consisting of: &mdash;F, &mdash;NR<highlight><superscript>3</superscript></highlight>R<highlight><superscript>4 </superscript></highlight>wherein R<highlight><superscript>3 </superscript></highlight>and R<highlight><superscript>4 </superscript></highlight>are each independently selected from the group consisting of H, loweralkyl,  
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="20.89395" wi="88.82055" file="US20020193343A1-20021219-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20020193343A1-20021219-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20020193343A1-20021219-C00004.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0067" lvl="2"><number>&lsqb;0067&rsqb;</number> R<highlight><superscript>2 </superscript></highlight>is selected from the group consisting of &mdash;H and &mdash;OH; and </paragraph>
<paragraph id="P-0068" lvl="2"><number>&lsqb;0068&rsqb;</number> n is 0 to 3 (preferably 1). </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> Preferably, R<highlight><superscript>1 </superscript></highlight>is &mdash;NH<highlight><subscript>2 </subscript></highlight>and preferably R<highlight><superscript>2 </superscript></highlight>is &mdash;OH. A particularly preferred compound of Formula 1 is 2-amino-2-hydroxymethyl-1,3-propanediol, or &ldquo;TRIS&rdquo;. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> &ldquo;Loweralkyl&rdquo; as used herein preferably means C1-C4 alkyl, such as methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, etc. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> Compounds as described above can be prepared in any suitable manner, such as described in U.S. Pat. No. 2,174,242, the disclosure of which is incorporated herein by reference. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> The ratio of the compound of Formula I to Enzyme in the solution is preferably 0, 1 or 5 to about 500, 600 or 1000. For example, but for a range of values for a 1 liter solution 2.0&times;10<highlight><superscript>&minus;2 </superscript></highlight>milligrams of enzyme and Tris between 0 or 1 to 12 grams may be used. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> Aminoglycols are reversible inhibitors of the enzymes. For example, at a concentration of 25mM and a pH of 9, TRIS (2-amino-2-hydroxymethyl-1,3-propanediol) inhibits enzyme degradation for an extended period of time, with an enzyme concentration of 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml of guar solution. When the pH is shifted to a pH of 4, enzyme degradation is restored and the guar molecules are degraded quickly. </paragraph>
<paragraph id="P-0074" lvl="7"><number>&lsqb;0074&rsqb;</number> Oppositely Charged Polymer Control Agents </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> The complexing can also be conducted using an oppositely charged high molecular weight (HMW) agent ( 3,000&lt;Mw&lt;10<highlight><superscript>8 </superscript></highlight>) . The HMW agent, typically a polymer, and the enzyme must be of opposite charge in the &ldquo;arrested&rdquo; state, and will initiate degradation either by shifting pH to alter the charge on either the polymer or enzyme, or by adding salts (of any anion or cation type) to free complexed enzyme to initiate degradation. The complexing can be cationically charged polymer and anionic protein, and vice versa. The opposite charged polymer may be used as the viscosifying polymer or it may be a different or separate polymer added to complex the enzyme. Examples of oppositely charged HMW agents would include sulfated, sulfonated phosphated, phosphonated, carboxylated, or amine, quaternary amine or sulfonium ion containing synthetic or natural polymers. </paragraph>
<paragraph id="P-0076" lvl="7"><number>&lsqb;0076&rsqb;</number> Other Fracturing Fluid Ingredients </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> Any crosslinking agent may be used to carry out the present invention. Examples include metal ions including aluminum, antimony, zirconium and titanium containing compounds including organotitantates (see, e.g., U.S. Pat. No. 4,514,309). Borate crosslinking agents or borate ion donating materials, are currently preferred. Examples of these include the alkali metal and alkaline earth metal borates and boric acid, such as sodium borate decahydrate. The crosslinking agent is typically included in an amount in the range of from about 0.0245 to 0.18% by weight of the aqueous fluid or more. </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> Proppant particles or propping agents are typically added to the base fluid prior to the addition of the crosslinking agent. Propping agents include, for example, quart sand grains, glass and ceramic beads, walnut shell fragments, aluminum pellets, nylon pellets, and the like. The propping agents are typically included in an amount of from 1 to 8 or even 18 pounds per gallon of fracturing fluid composition. Particle size of the proppant particles is typically in the range of about 200 to about 2 mesh on the U.S. Sieve Series scale. The base fluid may also contain other conventional fracturing fluid additives, such as buffers, surfactants, antioxidants, corrosion inhibitors, bactericides, etc. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> Enzyme breaker compositions useful for carrying out the present invention may be provided in any suitable physical form, such as concentrated or dilute aqueous solutions, lyophylized powders, etc. The compositions contain an enzyme effective for degrading the particular crosslinking polysaccharide employed as the gelling agent. Enzyme breakers are typically &bgr;-mannanases or &bgr;-glucosidases, which may be thermophilic or mesophilic and may be obtained from any suitable organism. Examples include, but are not limited to, those described in U.S. Pat. No. 5,896,435 to Kelly et al., the disclosure of which is incorporated by reference herein in its entirety. In general, the amount of enzyme will be between about 0.0005 or 0.001-0.004 or 0.01 percent by weight based on the total weight of aqueous solution Such enzymes are available from Megazyme International Ireland Ltd., Novo Nordisk of Norway, Diversa Corporation, San Diego, Calif. as well as Sigma and many other companies. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> The present invention may be carried out on subterranean formations which surround any type of well bore, including both oil and gas well bores, with the fracturing fluid being provided and injected and pressure released, etc., all in accordance with procedures well known to those skilled in the art. </paragraph>
<paragraph id="P-0081" lvl="7"><number>&lsqb;0081&rsqb;</number> Adjusting pH </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> When pH is adjusted to activate the enzyme, in general, prior to acidification, the pH range of the fracturing fluid will be about 7, 8 or 9 to 10 or more, and will be from about 2 or 3 to 6 after acidification. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> In the well bore, it would be useful to initiate the enzyme reaction at a particular time, however, adjusting the pH after the hydraulic fracturing fluid is in the well bore can be difficult to almost impossible. After injection, the fracturing fluid may be acidified by any suitable means. An acidic solution can be injected into the well bore after injection of the fracturing fluid. Pressure-sensitive capsules containing an acid can be included in the fracturing fluid, with the capsules selected to break and release their contents at the pressure encountered by the fracturing fluid upon injection. Temperature-sensitive capsules containing an acid can be included in the fracturing fluid, with the capsules selected to break and release their contents at the temperatures encountered by the fracturing fluid after injection. Water-soluble capsules containing an acid can be added to the fracturing fluid shortly before injection, or at the time of injection, so that the capsules dissolve after injection. An enzyme such as a esterase/lipases could be included in the fracturing fluid along with its appropriate substrate (esters/lipids). As the esterase/lipase reaction proceeds, the pH will be reduced. In fact, the pH change of these type of reactions are often used to quantify enzyme activity for these systems. A general schematic of the reaction is shown below.  
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="149.77305" wi="284.9175" file="US20020193343A1-20021219-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20020193343A1-20021219-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20020193343A1-20021219-C00005.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> Note that TRIS is temperature sensitive and can produce a drop of about&minus;0.028 pH units for each degree increase in the temperature. Thus, a temperature increase from 25 degrees C. to 60 degrees C. (the temperature optimum of the enzyme) will drop the pH by 0.98. While this does not shift the pH enough to activate the enzyme, it does assist in dropping the pH for well bores with temperatures higher than ambient conditions (Bates and Bower. <highlight><italic>Analyt. Chem, </italic></highlight>28, 1322 (1956)). </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> The present invention is explained in greater detail in the following non-limiting Examples, where &ldquo;U&rdquo; means unit of enzyme activity, &ldquo;ml&rdquo; means milliliter, &ldquo;mg&rdquo; means milligram, &ldquo;rpm&rdquo; means revolutions per minute, &ldquo;min&rdquo; means minute, &ldquo;mM&rdquo; means milliMolar, and temperatures are given in degrees Centigrade unless otherwise indicated, &ldquo;&mgr;&rdquo; means microliter, &ldquo;mm&rdquo; means millimeter, &ldquo;&eegr;&rdquo; means viscosity, &ldquo;&Dgr;&eegr;&rdquo; means viscosity difference, &ldquo;g&rdquo; means gram, &ldquo;ppm&rdquo; means parts per million, &ldquo;HCl&rdquo; means hydrochloric acid, &ldquo;M&rdquo; means Molar, &ldquo;M<highlight><subscript>W</subscript></highlight>&rdquo; means molecular weight, &ldquo;c&lsqb;&eegr;&rsqb;&rdquo; means specific viscosity against degree of space occupancy, &ldquo;dL&rdquo; means deciliter, &ldquo;&eegr;sp&rdquo; means specific viscosity, &ldquo;Pa&middot;s&rdquo; means pascals seconds. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1">pH-Dependent Inhibition of &bgr;-Mannanase by TRIS </heading>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> Experimental: Tris(hydroxymethyl)aminomethane, Tris(hydroxymethyl)aminomethane hydrochloride, glycine, sodium acetate, sodium phosphate, 2-(4-morphoino)-ethane sulfonic acid (MES) and sodium azide were purchased from Sigma. N-Tris(hydroxymethyl)methylglycine, Tris(hydroxymethyl)nitromethane and guar gum were purchased from Aldrich. <highlight><italic>Aspergillus niger &bgr;</italic></highlight>-mannanase (Megazyme, Ireland, Lot 50401, 41 U/mg, 297 U/ml) was used without further purification. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> Purification of Guar: Guar was sprinkled slowly into the vortex of water to a concentration of 7 mg/ml. This solution was vigorously mixed for 1 hour followed by low shear mixing for 24 hours. The solution was then centrifuged at 7000 rpm for 30 min. The supernatant was collected and 2 volumes of ethanol were added. The precipitate was collected and lyophilized for 48 hours. The purified guar was then redissolved in de-ionized water to a concentration of 7 mg/ml. Sodium azide at 0.2 mg/ml was added as a biocide. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> Enzyme Degradation Assay: Enzyme degradation was conducted with 7 mg/ml purified guar solutions containing 0.2 mg/ml sodium azide and 20 mM of the appropriate buffer. Guar solutions (19 ml) and enzyme stock solution were separately pre-incubated at 25&deg; C. for 15 minutes, followed by the addition of 78.9 &mgr;l of enzyme stock solution to 19 ml of guar solution. The final enzyme concentration was 8.3&times;10<highlight><superscript>&minus;4 </superscript></highlight>U/ml. The mixture was shaken at an agitation speed of 2 at 25&deg; C. for 1 hour in a New Brunswick gyrotory water bath shaker (Model G76). The enzyme was denatured after 1 hour by placing the enzyme/guar solution in a 90&deg; C. water bath for 10 minutes. Enzyme hydrolysis was conducted at different pH&apos;s using various buffers: sodium acetate was used for pH 4 and 5, MES was used for pH 6, sodium phosphate was used for pH 7 and pH 8 and glycine was used for pH 9. If inhibitor, inhibitor variant or NaCl was used, the appropriate amount was added to the guar solution and the pH was readjusted to the appropriate value. To check for irreversible inhibition, solutions were prepared by adding TRIS to a 0.2 U/ml enzyme solution in TRIS to enzyme molar ratio of 1:1 and 5:1. After incubating each of these solutions at 25&deg; C. for 30 minutes, 78.9 &mgr;l of this solution was added to 19 ml of guar solution and the enzymatic degradation of guar was analyzed following known techniques. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> Rheology: Steady shear experiments were conducted using a Rheometrics Dynamic Stress Rheometer (DSR II) and a couette fixture with a cup diameter of 31.9 mm, a bob diameter of 29.5 mm and a bob length of 44.25 mm. All experiments were performed at 25&deg; C. and all reported data were reproducible within 10%. Steady shear experiments were performed to determine viscosity, &eegr;, as a function of shear rate. A viscosity reduction factor was determined by dividing the zero shear (Newtonian) viscosity of the undegraded guar solution by the zero shear viscosity of the degraded guar solution, which had been treated with the enzyme for 1 hour. To analyze a portion of the data, a normalized relative activity was defined using the viscosity data. At a particular pH, the viscosity difference (&Dgr;&eegr;) between the initial zero shear viscosity and the zero shear viscosity after 1 hour of degradation was used as the reference &Dgr;&eegr;. At the same pH, the difference between the initial zero shear viscosity and zero shear viscosity after 1 hour of degradation with TRIS was then divided by the reference &Dgr;&eegr; and multiplied by 100 to calculate the normalized relative activity. In summary,  
<math-cwu id="MATH-US-00001">
<number>1</number>
<math>
<mrow>
  <mrow>
    <mi>relative</mi>
    <mo>&it;</mo>
    <mstyle>
      <mtext>&emsp;</mtext>
    </mstyle>
    <mo>&it;</mo>
    <mi>activity</mi>
  </mrow>
  <mo>=</mo>
  <mrow>
    <mfrac>
      <mrow>
        <mrow>
          <msub>
            <mi>&eta;</mi>
            <mi>o</mi>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mi>noEnzyme</mi>
              <mo>,</mo>
              <mi>noTRIS</mi>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
        <mo>-</mo>
        <mrow>
          <msub>
            <mi>&eta;</mi>
            <mi>o</mi>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mrow>
                <mi>w</mi>
                <mo>/</mo>
                <mi>Enzyme</mi>
              </mrow>
              <mo>,</mo>
              <mrow>
                <mi>w</mi>
                <mo>/</mo>
                <mi>TRIS</mi>
              </mrow>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
      </mrow>
      <mrow>
        <mrow>
          <msub>
            <mi>&eta;</mi>
            <mi>o</mi>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mi>noEnzyme</mi>
              <mo>,</mo>
              <mi>noTRIS</mi>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
        <mo>-</mo>
        <mrow>
          <msub>
            <mi>&eta;</mi>
            <mi>o</mi>
          </msub>
          <mo>&af;</mo>
          <mrow>
            <mo>(</mo>
            <mrow>
              <mrow>
                <mi>w</mi>
                <mo>/</mo>
                <mi>Enzyme</mi>
              </mrow>
              <mo>,</mo>
              <mi>noTRIS</mi>
            </mrow>
            <mo>)</mo>
          </mrow>
        </mrow>
      </mrow>
    </mfrac>
    <mo>&times;</mo>
    <mn>100</mn>
  </mrow>
</mrow>
</math>
<mathematica-file id="MATHEMATICA-00001" file="US20020193343A1-20021219-M00001.NB"/>
<image id="EMI-M00001" wi="216.027" he="18.96615" file="US20020193343A1-20021219-M00001.TIF" imf="TIFF" ti="MF"/>
</math-cwu>
</paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> Results: The effect of the solution pH on the enzymatic degradation of guar solutions is shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference> in terms of the viscosity reduction factor (ratio of undegraded solution viscosity to degraded solution viscosity). The viscosity reduction factor was determined at each pH following incubation of the guar with <highlight><italic>Aspergillus niger &bgr;-</italic></highlight>mannanase for one hour. Various buffers were used to control the pH. &bgr;-mannanase was found to be most effective at pH &tilde;4 with a viscosity reduction factor of &tilde;600. Also, shown in <cross-reference target="DRAWINGS">FIG. 1</cross-reference> is the effect of pH on the relative enzyme activity obtained using a colorimetric assay (Ademark et al., <highlight><italic>Journal of Biotechnology, </italic></highlight>63 (1998) 199-210). The similarity between the two experimental techniques indicates that the viscosity reduction factor is an effective measure of enzyme activity. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> demonstrates differences in enzyme activity, obtained at pH 8, using two different buffers: sodium phosphate and tris(hydroxymethyl)aminomethane hydrochloride (TRIS). When sodium phosphate was used as the buffer, degradation was detected by both the viscosity reduction factor and the colorimetric assay. However, when TRIS was used, a negligible reduction in viscosity was observed, suggesting that TRIS may be an inhibitor of <highlight><italic>Aspergillus niger &bgr;-mannanase thus preventing the enzymatic degradation of guar. </italic></highlight></paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> To probe the potential inhibition of &bgr;-mannanase by TRIS, viscosity profiles of guar solutions at pH 9 were examined following one hour of enzymatic degradation in the presence of TRIS. <cross-reference target="DRAWINGS">FIG. 2</cross-reference>, shows that the addition of 1 mM TRIS produced only minimal inhibition of &bgr;-mannanase. However, increasing the amount of TRIS to 5 mM inhibited the degradation considerably and samples with 10 mM and higher amounts of TRIS displayed no viscosity reduction. To test how these trends progressed with time, the viscosity of guar solutions were measured after 5 hours of &bgr;-mannanase treatment (<cross-reference target="DRAWINGS">FIG. 3</cross-reference>). It was found that even 1 mM of TRIS impeded viscosity reduction considerably. Samples with 25 mM and higher amounts of TRIS showed no viscosity reduction and samples with 10 mM showed minimal viscosity reduction. Thus, at high pH (e.g. 9), the extent of enzyme degradation could be clearly controlled by the amount of TRIS added to the guar solution. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> The effect of TRIS on enzyme degradation was examined at pH 4, the optimum pH of the enzyme (Ademark et al., <highlight><italic>Journal of Biotechnology, </italic></highlight>63 (1998) 199-210; McCleary, <highlight><italic>&bgr;-D-Mannanase</italic></highlight>, in: W. A. Wood, S. T. Kellogg, (Ed.), <highlight><italic>Methods in Enzymology</italic></highlight>, Academic Press, Inc., San Diego (1988) p. 596-611). <cross-reference target="DRAWINGS">FIG. 4</cross-reference> shows the viscosity profile after 1 hour of enzymatic hydrolysis of guar solutions containing 0-25 mM TRIS. At pH 4, all samples showed significant reduction in viscosity. No difference in viscosity was found between samples containing TRIS and those without TRIS. This indicated that the TRIS did not impede enzymatic hydrolysis by ,&bgr;-mannanase at pH 4. One possible explanation for the pH-dependent inhibition could be that the enzyme was more sensitive to ionic strength at pH 9 rather than pH 4 resulting in the pH-dependent inhibition. As TRIS-HCl was used, the additional chloride ions increased the ionic strength. To determine if ionic strength sensitivity was the cause of the inhibition, the base form of TRIS (without any salts) was purchased and tested as an inhibitor of &bgr;-mannanase. The results were exactly the same as that of TRIS in its hydrochloride form. Next, NaCl was added to the solutions at pH 4 and pH 9 in the same quantities that were present when using TRIS in its hydrochloride form. The additional salt did not alter the viscosity reduction by the enzyme (data not shown). The pH-dependent inhibition of the enzymatic degradation of TRIS allowed development of a pH-activated enzyme degradation. This type of control applicable in industrial applications where mixing of the enzyme and guar solutions is preferred, yet degradation is only needed after the solution&apos;s high viscosity has served its purpose (Cipolla et al. <highlight><italic>SPE Production and Facilities, </italic></highlight>11 (1996) 216-222; J. A. Menjivar, <highlight><italic>Use of Gelation Theory to Characterize Metal Cross-Linked Polymer Gels</italic></highlight>, in: J. E. Glass, (Ed.), <highlight><italic>Water-Soluble Polymers</italic></highlight>, American Chemical Society, Washington, D.C., 1986, p. 209-226). </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> pH Activated Enzyme Degradation: An effective pH-activated enzyme degradation is one in which no degradation takes place until the pH is changed. Without the presence of an inhibitor, a simple pH change from 9 to 4 altered the relative activity of the enzyme from 20% to 100%, based on the pH profile of the enzyme. Though there was already a pH-activated enzyme degradation process because of the large change in enzyme activity, an enzyme with 20% relative activity produces significant reduction in guar viscosity (<cross-reference target="DRAWINGS">FIG. 3</cross-reference>) even though it was not acting at its optimum level. The rapid, initial rate of viscosity reduction was due to the unique &ldquo;hyper-entanglements&rdquo; found in guar solutions that produces a stronger dependence of viscosity on molecular weight than that found in other biopolymers (Tayal et al., <highlight><italic>Enzymatic Modification of Guar Solutions: Viscosity&mdash;Molecular Weight Relationships</italic></highlight>, In: Amjad, (Ed.), <highlight><italic>Water Soluble Polymers</italic></highlight>, Plenum Press 1998, p. 41-49). Using TRIS inhibition in combination with a pH change, allowed a pH-activated enzyme degradation to be achieved. A 25 mM TRIS guar solution at pH 9 was prepared and enzyme was added. A pH of 9 was maintained for 5 hours after which the pH was adjusted to 4. <cross-reference target="DRAWINGS">FIG. 5</cross-reference> displays the viscosity profile at various time intervals of the degradation process. It shows that TRIS was able to effectively prevent enzyme degradation of the guar during the first 5 hours and the enzyme could be activated by reducing the pH to 4. After the pH was adjusted to 4, the viscosity reduction proceeded quickly during the first hour followed by a slower decrease at longer times. This shows that TRIS can effectively be used for a pH-activated enzyme degradation. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> The fact that enzymatic degradation could be triggered after 5 hours following a pH shift indicated that TRIS was a reversible inhibitor. This was further verified by mixing TRIS directly with the enzyme solution for 30 minutes prior to adding the enzyme to the guar solutions. Two different molar ratios of TRIS to enzyme were used, 1:1 and 5:1, however, neither of these solutions showed any inhibition (data not shown). If TRIS were an irreversible inhibitor, the TRIS would have been permanently bound to the enzyme and viscosity reduction would not have occurred. </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> Enzyme Degradation and the Chemical Structure of TRIS: TRIS is a simple molecule with hydroxymethyl groups forming three branches of a quaternary substituted carbon with nitrogen completing the quartet. The pH-dependent inhibition suggests that the nitrogen, whose protonation state is sensitive to pH, may play a key role. To investigate the role of nitrogen in the inhibition of enzymatic degradation, experiments were conducted using available variants of TRIS with unique nitrogen substituents. The TRIS variants used were Tris (hydroxymethyl) nitromethane and N-tris (hydroxymethyl) methylglycine. The viscosity profiles of the guar solutions containing these TRIS variants and subjected to enzyme treatment for 1 hour are shown in <cross-reference target="DRAWINGS">FIG. 6</cross-reference>. The TRIS variants displayed no inhibition with the zero shear viscosity; decreasing the same as the control with no TRIS variants or TRIS. Experiments were also conducted at various pH levels which revealed similar results (data not shown). This data showed that if access to the nitrogen was blocked using bulky substituents, the effectiveness of TRIS as an inhibitor was negated. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> Since TRIS is commonly used as a buffer, it has two forms: a protonated and an unprotonated state, with the nitrogen atom either losing or gaining the proton. The relative amounts of the two forms are dependent on the pH of the solution and can be predicted by the Henderson-Hasselbach equation. Since the pKa of TRIS is 8.1 at 25&deg; C. (Robyt and White, <highlight><italic>Biochemical Techniques</italic></highlight>. (1987) Prospect Heights, Ill.: Waveland Press, Inc. pg. 37), one possible explanation is that only the unprotonated form of TRIS inhibits the enzyme but not the protonated form. This type of inhibition behavior would be similar to other glycosyl hydrolase inhibitors based on nitrogen containing sugar analogs. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> Previous work with nitrogen-containing sugar analogues have shown that a small group of glycosyl hydrolases are inhibited by the cationic (protonated) form while most are inhibited by the basic form (unprotonated) (Legler and Finken, <highlight><italic>Carbohydrate Research, </italic></highlight>292 (1996) 103-115). An unprotonated (basic form) inhibitor was able to accept a proton from a catalytic amino acid creating a favorable electrostatic interaction between the enzyme and the inhibitor (Caron and Withers, <highlight><italic>Biochemical And Biophysical Research Communications, </italic></highlight>163 (1989) 495-499; Legler, <highlight><italic>Pure and Applied Chemistry, </italic></highlight>59 (1987) 1457-1464). A protonated (cationic) inhibitor forms an ion pair with negatively charged carboxylic acid residues in the active site of the enzyme. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> The inhibition experiments at pH 4 and 9 suggest that the basic (unprotonated) form of TRIS was inhibiting the enzyme. To verify this, the effect of TRIS on viscosity reduction was investigated at pH 7 and the results are shown in <cross-reference target="DRAWINGS">FIG. 7</cross-reference>. At pH 7, it is expected that the enzyme would not be inhibited by TRIS since it is predominately in its cationic (protonated) form. However, it was found that at low concentrations, TRIS was a better inhibitor of the enzyme than at pH 9. This suggests that both forms of TRIS can act as inhibitors but the cationic form was a more effective inhibitor. The results in <cross-reference target="DRAWINGS">FIG. 7</cross-reference> may seem to be unexpected because no inhibition of enzymatic degradation was observed at pH 4, however, the effect of pH on the enzyme itself should be considered. A pH shift from 7 to 4 can change the protonation state of the amino acids in the active site of the enzyme. Although amino acid side chain pKa values are sensitive to the microenvironment of the active site, based on standard pKa values there are only two amino acids that have functional groups with pKa values between 4 and 9, histidine (pKa&equals;6) and cysteine (pKa &equals;8.3) <highlight><italic>(Voet and Voet, Biochemistry. </italic></highlight>2nd ed. 1995, Somerset, N.J.: John Wiley &amp; Sons, Inc. 254-255). Therefore, a histidine residue is a potential amino acid, which may be responsible for the unusual pH-dependent inhibition observed at pH 4 and 7. </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> Insights into the Activity Site: The pH-dependent inhibition of &bgr;-mannanase by TRIS was quantified from pH 4 to pH 9 to further understand the pH dependency. Since the activity of the enzyme was pH dependent as well, an attempt to de-couple this effect from the effect of TRIS, by normalizing the relative activity for pH, was made. The relative activity was defined as outlined in the experimental section. <cross-reference target="DRAWINGS">FIG. 8</cross-reference> shows the relative activity as a function of pH for guar containing different amounts of TRIS. It was found that at pH 6 and below, no inhibition was observed. Above pH 6, adding 1 or 5 mM TRIS produced significant inhibition that had a minimum relative enzyme activity (or conversely maximum inhibition) at pH 7. This suggested that the most effective mechanism of inhibition was the formation of an ion pair between the negatively charged carboxylic amino acid and the positively charged TRIS, which was consistent with the majority of nitrogen based sugar analog inhibitors. Although both forms of TRIS could inhibit &bgr;-mannanase, if the cationic form were truly the better inhibitor then it raised the question as to why inhibition was not observed below pH 7. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> To explain this unusual pH dependent inhibition, the key amino acid residues located in the active site of the enzyme were examined. &bgr;-mannanases are categorized as glycosyl hydrolases and X-ray crystallography experiments have shown that a histidine or asparagine residue often stabilizes the position and protonation state of the catalytic amino acids for glycosyl hydrolases or plays a key role in transition state binding (Sulzenbacher et al., <highlight><italic>Biochemistry, </italic></highlight>36 (1997) 5902-5911; Hilge et al., <highlight><italic>Structure with Folding and Design, </italic></highlight>6 (1998) 1433-1444). In either case, mutations of this residue lead to complete loss of activity (Hilge et al., <highlight><italic>Structure with Folding and Design, </italic></highlight>6 (1998) 1433-1444). By comparing the amino acid sequence of various &bgr;-mannanases, it has been revealed that family 26 invariably has a histidine residue followed by the acid-base catalytic amino acid (Bolam et al., <highlight><italic>Biochemistry, </italic></highlight>35 (1996) 16195-16204) and family 5 invariably has an asparagine residue followed by the acid-base catalytic amino acid (Henrissat et al., <highlight><italic>Proc. Natl. Acad. Sci. USA, </italic></highlight>92 (1995) 7090-7094; Hilge et al., <highlight><italic>Structure with Folding and Design, </italic></highlight>6 (1998)1433-1444). Unfortunately, the amino acid sequence of <highlight><italic>Aspergillus niger &bgr;-mannanase has not been determined, thus preventing a priori enzyme family classification. However, based on the pH dependent inhibition, the implication is that a histidine residue precedes the acid-base catalytic amino acid due to the onset of inhibition above pH </italic></highlight>6. When the imidazole ring of the histidine was protonated, the positive charge repels the positively charged TRIS (<cross-reference target="DRAWINGS">FIG. 9</cross-reference>, pH 4 ). However, when the histidine residue became unprotonated (<cross-reference target="DRAWINGS">FIG. 9</cross-reference>, pH 7 and 9), the electrostatic repulsion was not present and the TRIS was an effective inhibitor. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> When the concentration of TRIS was increased to 10 mM (<cross-reference target="DRAWINGS">FIG. 8</cross-reference>), an inflection point continued to be observed at pH 7, which was consistent with the 1 and 5 mM TRIS data. However, at pH 9 there wais a drastic reduction in enzyme activity, much greater than the inhibition at pH 7, which was not found when using 1 or 5 mM TRIS. The concentration dependence was somewhat unclear, but previous researchers have stated that <highlight><italic>Aspergillus niger &bgr;-mannanase is only stable between pH </italic></highlight>3-8 (Ademark et al., <highlight><italic>Journal of Biotechnology, </italic></highlight>63 (1998) 199-210; McCleary, <highlight><italic>Soluble, Dye-Labeled Polysaccharides for the Assay of Endohydrolases</italic></highlight>, in: W. A. Wood, S. T. Kellogg, (Ed.), <highlight><italic>Methods in Enzymology</italic></highlight>, Academic Press, Inc., San Diego, 1988, p. 74-87). To address this issue, the enzyme was placed in a pH 9 solution for 5 hours, then its viscosity reduction ability was compared to the previously performed 5 hour degradation. By replacing the &eegr;o (w/Enzyme, w/TRIS) variable with no (w/Enzyme,w/pH 9 treatment) the relative activity definition found in the experimental section can be applied. After 5 hours in a pH 9 solution, the relative activity of the enzyme was 83%. Due to the reduced stability of the enzyme at high pH, the increased inhibition at 10 mM TRIS and pH 9 may be the result of a combined inhibition and destabilizing effect on the enzyme by the abundance of TRIS in solution. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">Triggered Enzymatic Degradation Using Cationic Modified Guar </heading>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> Experimental: A sample of cationic guar with a degree of substitution (DS) 0.14 was supplied by Rhodia Inc. (Cranbury, N.J.). The degree of substitution was defined as the average number of cationic groups substituted per sugar unit. The polymer solutions were prepared in the following manner. A mixing impeller was adjusted about 2 mm above the bottom of a 1000 ml wide mouth jar containing 150 ml deionized water. The speed of the mixing impeller was increased to 1000 rpm to form a deep vortex. Then 1 g guar powder was sprinkled slowly into the water in three minutes to produce a uniform dispersion and allowed to mix for five minutes. Another 49 ml deionized water was added to wash all residual powder into the solution. The mixing speed was then reduced to 500 rpm for an additional 60 minutes. After the speed was reduced, 100 ppm of sodium azide (FisherChemical) was added as a preservative. The solution pH was adjusted to 7.0 using HCl (EM Science). Finally, the polymer solution was transferred to a container and then placed on a low shear roller for approximately 20&tilde;24 hours. The solution was stored in a refrigerator after being taken off the roller. </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> The enzyme endo-&bgr;-mannanase from <highlight><italic>aspergillus niger </italic></highlight>(Megazyme) was supplied as an ammonium sulphate suspension in 0.02% sodium azide. To prepare solutions, 0.01 ml of this suspension was diluted 1,000 times in 10 ml 0.1 M sodium acetate (EM Science)-acetic acid (Glacial, FisherChemical) buffer solution with pH adjusted to 6. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> The enzymatic degradation reaction was run in a sealed jar at room temperature. The pH of the solution was measured and adjusted before the reaction. Into 200 ml of guar solution, 0.135 ml of enzyme buffer solution was injected using a microsyringe. The mixture was magnetically stirred during the reaction. After the reaction began, aliquots of the guar and enzyme mixture were taken out at various times. Each aliquot was immediately heated to 100&deg; C. for 20 minutes to denature the enzyme and stop the reaction. The viscosity of the solution did not change after the enzyme was denatured. Experiments were also done to show that this denaturing protocol (i.e. heat treatment) did not produce a viscosity reduction for polymer solutions in the absence of enzymes. In order to compare results from different experiments, equal endo &bgr;-mannanase concentration was used as a basis. Degradation experiments were also run at different solution ionic strengths. The ionic strength was adjusted using sodium chloride (Aldrich). </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> Steady shear rheological tests on a strain-controlled rheometer (RFS-II, Rheometrics, Piscataway, N.J.) were used to characterize the reaction samples. A Couette geometry, with inner bob and outer cup radii of 16 mm and 16.925 mm, respectively, and a bob length of 33.3 mm, was chosen. Samples without enzyme were also tested as controls to assess the initial viscosity of the solutions. All viscosity measurements were made at 25&deg; C. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> Results: <cross-reference target="DRAWINGS">FIG. 10</cross-reference> shows the viscosity versus shear rate plot for a 0.5 wt % guar solution upon exposure to &bgr;-mannanase enzyme with a concentration of 0.0002 units/ml guar solution. Under enzymatic hydrolysis, the solution viscosity decreased over two orders of magnitude after twenty hours. The samples displayed a Newtonian region at low shear rates and a shear-thinning region at higher shear rates. Therefore, &bgr;-mannanase is very active in degrading guar polymer chains at neutral pH. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> The viscosity versus shear rate plots of cationic guar solutions mixed with &bgr;-mannanase at pH 7.0 is plotted in <cross-reference target="DRAWINGS">FIG. 11</cross-reference>. The viscosity of the solution did not change over a twenty-hour period: the enzymatic degradation was prevented. When the pH was lowered to the isoelectric point of &bgr;-mannanase (pH&equals;3.5) (Megazyme International Ireland Ltd.), degradation began immediately as shown in <cross-reference target="DRAWINGS">FIG. 12</cross-reference>. Since the acetal linkages between the mannose can hydrolyze at low pH, a control curve was run to see the effect of acid-catalyzed cleavage of the polymer backbone at pH 3.5 without added enzyme (<cross-reference target="DRAWINGS">FIG. 12</cross-reference>, &diams; symbol). The viscosity of cationic guar solution decreased dramatically by two orders of magnitude over forty hours. The control solution viscosity dropped from 0.75 Pa&middot;s to 0.45 Pa&middot;s due to the acid-catalyzed cleavage of polymer molecules over the same period. This demonstrated a pH-activated trigger to control enzyme activity. At high pH, the negatively charged enzyme formed a complex with the cationic polymer, and this reversible immobilization prevented enzymatic action. As the isoelectric point of the &bgr;-mannanase is 3.5 (Megazyme International Ireland Ltd.), lowering the pH to 3.5 disrupted the Coulombic complex and initiated degradation. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> The control of degradation kinetics by pH for the &bgr;-mannanase/cationic guar pair was not due to the pH sensitivity of the enzyme activity. This is demonstrated <cross-reference target="DRAWINGS">FIG. 13</cross-reference>, which shows that there was substantial viscosity reduction for neutral guar at both pH 7 and 3.5. The enzyme showed high activity on the substrate at pH 7. However, the degradation was completely hindered for cationic guar at neutral pH. The pH optimum for &bgr;-mannanase, with neutral guar, was around 3.0 (data not shown). The degradation rate for the enzyme, with cationic guar at pH 3.5, was about at half the rate as with neutral guar. This may be due to residual Coulombic interactions or the steric inhibition of enzyme binding by the cationic graft site. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> Charge complex triggering was further evaluated at a constant pH of 7.0. <cross-reference target="DRAWINGS">FIG. 14</cross-reference> shows the effectiveness of the &bgr;-mannanase in degrading cationic guar solutions at different ionic strengths but a constant pH of 7.0. At low ionic strength, the enzymatic degradation was stopped. When the ionic strength was increased to 0.1 M, the solution viscosity decreased substantially. As the solution ionic strength increased, the electrostatic attraction between the enzyme molecule and the polymer chain was screened and the complex was disrupted. A control experiment was run on native guar to show that salt concentration has little effect on enzyme activity (<cross-reference target="DRAWINGS">FIG. 15</cross-reference>). </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> Therefore, the enzyme activity is inhibited by adding a HMW polymer agent. The HMW agent and the enzyme must be of opposite charge in the &ldquo;arrested&rdquo; state. The enzyme can be either negatively or positively charged, depending on the solution pH. The degradation can be initiated either by shifting pH to alter the charge on either the polymer or enzyme, or by adding salts (of any anion or cation type) to free complexed enzyme to initiate degradation. Examples of oppositely charged HMW agents would include sulfated, phosphated, carboxylated or amine, quaternary amine or sulfonium ion containing synthetic or natural polymers. </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> The foregoing examples are illustrative of the present invention, and are not to be construed as limiting thereof. The invention is described by the following claims, with equivalents of the claims to be included therein. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">That which is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: 
<claim-text>(a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; (iii) an enzyme breaker which degrades said polysaccharide; and (iv) a compound according to Formula I in an amount sufficient to reduce the polysaccharide-degrading activity of said enzyme breaker; </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="77.53725" wi="156.01005" file="US20020193343A1-20021219-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20020193343A1-20021219-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20020193343A1-20021219-C00006.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein: 
<claim-text>R<highlight><superscript>1 </superscript></highlight>is selected from the group consisting of: &mdash;F, &mdash;NR<highlight><superscript>3</superscript></highlight>R<highlight><superscript>4 </superscript></highlight>wherein R<highlight><superscript>3 </superscript></highlight>and R<highlight><superscript>4 </superscript></highlight>are each independently selected from the group consisting of H, loweralkyl, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00007">
<number>7</number>
<image id="EMI-C00007" he="20.89395" wi="88.82055" file="US20020193343A1-20021219-C00007.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00007" file="US20020193343A1-20021219-C00007.CDX"/>
<chemistry-mol-file id="CHEMMOL-00007" file="US20020193343A1-20021219-C00007.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>is selected from the group consisting of &mdash;H and &mdash;OH; and </claim-text>
<claim-text>n is 0 to 3; </claim-text>
<claim-text>then; </claim-text>
</claim-text>
<claim-text>(b) injecting said fracturing fluid into said well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds said well bore; then </claim-text>
<claim-text>(c) reducing the pH of said fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of said enzyme; and then </claim-text>
<claim-text>(d) releasing the pressure from said fracturing fluid. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein R<highlight><superscript>1 </superscript></highlight>is &mdash;NH<highlight><subscript>2</subscript></highlight>. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein R<highlight><superscript>2 </superscript></highlight>is &mdash;OH. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein n is 1. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said compound of Formula 1 is 2-amino-2-hydroxymethyl-1,3-propanediol. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A fracturing fluid useful for fracturing a subterranean formation which surrounds a well bore, comprising: 
<claim-text>(i) an aqueous liquid; </claim-text>
<claim-text>(ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; </claim-text>
<claim-text>(iii) an enzyme breaker which degrades said polysaccharide; and </claim-text>
<claim-text>(iv) a compound according to Formula I in an amount sufficient to reduce the polysaccharide-degrading activity of said enzyme breaker; </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00008">
<number>8</number>
<image id="EMI-C00008" he="77.53725" wi="156.01005" file="US20020193343A1-20021219-C00008.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00008" file="US20020193343A1-20021219-C00008.CDX"/>
<chemistry-mol-file id="CHEMMOL-00008" file="US20020193343A1-20021219-C00008.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein: </claim-text>
<claim-text>R<highlight><superscript>1 </superscript></highlight>is selected from the group consisting of: &mdash;F, &mdash;NR<highlight><superscript>3</superscript></highlight>R<highlight><superscript>4 </superscript></highlight>wherein R<highlight><superscript>3 </superscript></highlight>and R<highlight><superscript>4 </superscript></highlight>are each independently selected from the group consisting of H, loweralkyl, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00009">
<number>9</number>
<image id="EMI-C00009" he="20.89395" wi="88.82055" file="US20020193343A1-20021219-C00009.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00009" file="US20020193343A1-20021219-C00009.CDX"/>
<chemistry-mol-file id="CHEMMOL-00009" file="US20020193343A1-20021219-C00009.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>R<highlight><superscript>2 </superscript></highlight>is selected from the group consisting of &mdash;H and &mdash;OH; and </claim-text>
<claim-text>n is 0 to 3. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein R<highlight><superscript>1 </superscript></highlight>is &mdash;NH<highlight><subscript>2</subscript></highlight>. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein R<highlight><superscript>2 </superscript></highlight>is &mdash;OH. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein n is 1. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said compound of Formula 1 is 2-amino-2-hydroxymethyl-1,3-propanediol. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A fracturing fluid to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: 
<claim-text>(a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; (iii) an enzyme breaker which degrades said polysaccharide, and (iv) a polymeric additive which has a positive charge to decrease the activity of said enzyme breaker under conditions where the enzyme has a negative charge, subject to the proviso that said polymeric additive and said polysaccharide may be different or the same; </claim-text>
<claim-text>(b) injecting said fracturing fluid into said well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds said well bore; then </claim-text>
<claim-text>(c) reducing the pH of said fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of said enzyme; and then </claim-text>
<claim-text>(d) releasing the pressure from said fracturing fluid. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, said polymeric additive carrying cationic moities, said cationic moieties selected from the group consisting of amines, quaternary amines and sulfonium ions. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. A method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: 
<claim-text>(a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; (iii) an enzyme breaker which degrades said polysaccharide, and (iv) a polymeric additive which has a negative charge to decrease the activity of said enzyme breaker under conditions where the enzyme has a positive charge, subject to the proviso that said polymeric additive and said polysaccharide may be different or the same; </claim-text>
<claim-text>(b) injecting said fracturing fluid into said well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds said well bore; then </claim-text>
<claim-text>(c) reducing the pH of said fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of said enzyme; and then </claim-text>
<claim-text>(d) releasing the pressure from said fracturing fluid. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, said polymeric additive carrying anionic moities, wherein said anionic moieties are selected from the group consisting of carboxylic, sulfate, sulfonate, phosphate and phosphonate ions. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. A method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: 
<claim-text>(a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; (iii) an enzyme breaker which degrades said polysaccharide, and (iv) a polymeric additive which has a positive charge to decrease the activity of said enzyme breaker under conditions where the enzyme has a negative charge, subject to the proviso that said polymeric additive and said polysaccharide may be different or the same; </claim-text>
<claim-text>(b) injecting said fracturing fluid into said well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds said well bore; then </claim-text>
<claim-text>(c) increasing the ionic strength of said fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of said enzyme; and then </claim-text>
<claim-text>(d) releasing the pressure from said fracturing fluid. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, said polymeric additive carrying cationic moities, said cationic moieties selected from the group consisting of amines, quaternary amines and sulfonium ions. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide. </claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. A method of fracturing a subterranean formation which surrounds a well bore, comprising the steps of: 
<claim-text>(a) providing a fracturing fluid comprising (i) an aqueous liquid; (ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; (iii) an enzyme breaker which degrades said polysaccharide, and (iv) a polymeric additive which has a negative charge to decrease the activity of said enzyme breaker under conditions where the enzyme has a positive charge, subject to the proviso that said polymeric additive and said polysaccharide may be different or the same; </claim-text>
<claim-text>(b) injecting said fracturing fluid into said well bore at a pressure sufficient to form fractures in the subterranean formation which surrounds said well bore; then </claim-text>
<claim-text>(c) increasing the ionic strength of said fracturing fluid by an amount sufficient to increase the polysaccharide-degrading activity of said enzyme; and then </claim-text>
<claim-text>(d) releasing the pressure from said fracturing fluid. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00044">
<claim-text><highlight><bold>44</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00045">
<claim-text><highlight><bold>45</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference>, said polymeric additive carrying anionic moities, wherein said anionic moieties are selected from the group consisting of carboxylic, sulfate, sulfonate, phosphate and phosphonate ions. </claim-text>
</claim>
<claim id="CLM-00046">
<claim-text><highlight><bold>46</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00047">
<claim-text><highlight><bold>47</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00048">
<claim-text><highlight><bold>48</bold></highlight>. A method according to <dependent-claim-reference depends_on="CLM-00044">claim 42</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide. </claim-text>
</claim>
<claim id="CLM-00049">
<claim-text><highlight><bold>49</bold></highlight>. A fracturing fluid useful for fracturing a subterranean formation which surrounds a well bore, comprising: 
<claim-text>(i) an aqueous liquid; </claim-text>
<claim-text>(ii) a polysaccharide soluble or dispersible in said aqueous liquid in an amount sufficient to increase the viscosity of said aqueous liquid; </claim-text>
<claim-text>(iii) an enzyme breaker which degrades said polysaccharide; </claim-text>
<claim-text>(iv) a polymeric additive which has an opposite charge to that of the enzyme to decrease the activity of said enzyme breaker, </claim-text>
<claim-text>subject to the proviso that said polymeric additive and said polysaccharide may be different or the same. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00050">
<claim-text><highlight><bold>50</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said enzyme is a &bgr;-mannanase. </claim-text>
</claim>
<claim id="CLM-00051">
<claim-text><highlight><bold>51</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said enzyme is a &bgr;-glucosidase. </claim-text>
</claim>
<claim id="CLM-00052">
<claim-text><highlight><bold>52</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, said polymeric additive carrying an ionic group, wherein said ionic group is selected from the group consisting of sulfate, sulfonate, phosphate, phosphonate, carboxylate, amine, quaternary amine or sulfonium ions. </claim-text>
</claim>
<claim id="CLM-00053">
<claim-text><highlight><bold>53</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said polysaccharide comprises guar gum or derivatives thereof. </claim-text>
</claim>
<claim id="CLM-00054">
<claim-text><highlight><bold>54</bold></highlight>. A fracturing fluid according to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said fracturing fluid further comprises proppant particles. </claim-text>
</claim>
<claim id="CLM-00055">
<claim-text><highlight><bold>55</bold></highlight>. A fracturing fluid to <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein said fracturing fluid further comprises a crosslinking agent for crosslinking said polysaccharide.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020193343A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020193343A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020193343A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020193343A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020193343A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020193343A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020193343A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020193343A1-20021219-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020193343A1-20021219-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020193343A1-20021219-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020193343A1-20021219-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00012">
<image id="EMI-D00012" file="US20020193343A1-20021219-D00012.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00013">
<image id="EMI-D00013" file="US20020193343A1-20021219-D00013.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00014">
<image id="EMI-D00014" file="US20020193343A1-20021219-D00014.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00015">
<image id="EMI-D00015" file="US20020193343A1-20021219-D00015.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020194639A1-20021219-D00001.TIF SYSTEM "US20020194639A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00002.TIF SYSTEM "US20020194639A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00003.TIF SYSTEM "US20020194639A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00004.TIF SYSTEM "US20020194639A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00005.TIF SYSTEM "US20020194639A1-20021219-D00005.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00006.TIF SYSTEM "US20020194639A1-20021219-D00006.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00007.TIF SYSTEM "US20020194639A1-20021219-D00007.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00008.TIF SYSTEM "US20020194639A1-20021219-D00008.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00009.TIF SYSTEM "US20020194639A1-20021219-D00009.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00010.TIF SYSTEM "US20020194639A1-20021219-D00010.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00011.TIF SYSTEM "US20020194639A1-20021219-D00011.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00012.TIF SYSTEM "US20020194639A1-20021219-D00012.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00013.TIF SYSTEM "US20020194639A1-20021219-D00013.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00014.TIF SYSTEM "US20020194639A1-20021219-D00014.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00015.TIF SYSTEM "US20020194639A1-20021219-D00015.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00016.TIF SYSTEM "US20020194639A1-20021219-D00016.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00017.TIF SYSTEM "US20020194639A1-20021219-D00017.TIF" NDATA TIF>
<!ENTITY US20020194639A1-20021219-D00018.TIF SYSTEM "US20020194639A1-20021219-D00018.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020194639</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09891139</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010625</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>A01H005/00</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C07H021/04</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N009/24</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>800</class>
<subclass>278000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>419000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>200000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>320100</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>536</class>
<subclass>023200</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Bonsai, a phospholipid binding protein, is required for thermal tolerance in arabidopsis</title-of-invention>
</technical-information>
<continuity-data>
<non-provisional-of-provisional>
<document-id>
<doc-number>60213863</doc-number>
<document-date>20000623</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Jian</given-name>
<family-name>Hua</family-name>
</name>
<residence>
<residence-us>
<city>Cambridge</city>
<state>MA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Paula</given-name>
<family-name>Grisafi</family-name>
</name>
<residence>
<residence-us>
<city>Sudbury</city>
<state>MA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Gerald</given-name>
<middle-name>R.</middle-name>
<family-name>Fink</family-name>
</name>
<residence>
<residence-us>
<city>Chestnut Hill</city>
<state>MA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>HAMILTON, BROOK, SMITH &amp; REYNOLDS, P.C.</name-1>
<name-2></name-2>
<address>
<address-1>530 VIRGINIA ROAD</address-1>
<address-2>P.O. BOX 9133</address-2>
<city>CONCORD</city>
<state>MA</state>
<postalcode>01742-9133</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The invention relates to genes and proteins, namely, BON1, BON2, BON3, BAP1 and BAL, the expression of which modulate the size of a plant, and transgenic plants comprising those genes and proteins, and method of making and using same. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">RELATED APPLICATION </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application claims the benefit of U.S. Provisional Application No. 60/213,863, filed on Jun. 23, 2000, the entire teachings of the which are incorporated herein by reference.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<heading lvl="1">GOVERNMENT SUPPORT </heading>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> The invention was supported, in whole or in part, by grant MCB-9974451 from the National Science Foundation. The Government has certain rights in the invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Multicellular organisms develop and maintain a relatively constant size and shape over a wide range of different environmental conditions. This homeostasis is accomplished both by extrinsic mechanisms, e.g., movement that can reestablish a constant environment, and also by intrinsic mechanisms, e.g., mechanisms that alter cellular metabolism so that the organism can retain its morphology despite the altered environment. Animals have the ability to relocate themselves to a different location to maintain constant external conditions, whereas most plants are anchored and can only bend in response to changes in environmental factors such as light, gravity, or mechanical force. and shape in response to an environmental perturbation. Recently, a genetic pathway has been discovered in Drosophila that regulates cell, organ and body size. Mutations in genes apparently functioning in the insulin-signaling pathway result in miniature flies comprised of smaller and fewer cells under conditions where wild type flies maintain their standard size (Oldham, S., R. Bohni et al. (2000) <highlight><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci. </italic></highlight>355(1399):945-52). These mutant flies phenocopy the wild type flies under conditions of starvation or overcrowding, which reveals a link between the control of morphology and nutritional conditions that exist in the environment. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> For plants, these intrinsic genetic mechanisms must be essential in temperature homeostasis because these organisms are sessile and do not maintain constant body temperatures when the ambient temperature changes. Indeed, most plants maintain a relatively constant phenotype in varied temperatures. For example, Arabidopsis grows to similar size and morphology (less than 2-fold change) over temperatures that range from 16&deg; C. to 30&deg; C. This suggests the existence of genes whose function is to permit adaptation to temperature variation. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> Studies on the tolerance of plants to freezing have revealed the mechanisms that contribute to survival at very low temperatures. Both physiological and genetic analyses point to the membrane systems as important to this homeostasis. Extreme cold results in the disruption of membrane function and death (Steponkus, P. L. (1984) <highlight><italic>Annu. Rev. Plant Physiol. </italic></highlight>35:543-84). Plants can increase their tolerance to extreme cold by prior exposure to low, but non-freezing temperatures, a phenomenon known as cold acclimation. A prominent feature of cold acclimation is an alteration of the membrane lipid composition and the accumulation of simple sugars and some hydrophilic peptides, both of which are thought to stabilize membranes to protect against freezing injury (Thomashow, M. F. (1999) <highlight><italic>Annu. Rev. Plant Physiol. </italic></highlight>50:5,71-99). Genetic analysis has implicated the plasma membrane as important to thermotolerance. Mutants hypersensitive to freezing injury (e.g., sfr) have defects in the cryostability of the plasma membranes (Warren, G., R. McKown et al. (1996) <highlight><italic>Plant Physiol </italic></highlight>111(4):1011-9). </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> A need exists to further define the genetic control of homeostasis in plants. Plants in which size can be manipulated would be very useful commercially, in both the agricultural and ornamental plant markets. </paragraph>
</section>
<section>
<heading lvl="1">SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> Wild-type Arabidopsis plants maintain a relatively constant size over a wide range of temperatures. This homeostasis requires the BONZAI1 (BON1) gene because bon1 null mutants produce miniature fertile plants at 22&deg; C., but produce a wild-type phenotype when grown at 28&deg; C. The expression of BON1 and a BON1-associated protein (BAP1) is modulated by temperature. Thus, BON1 and BAP1 have a direct role in regulating cell expansion and cell division at lower temperatures. BON1 contains a Ca<highlight><superscript>2&plus;</superscript></highlight>-dependent phospholipid-binding domain and is associated with the plasma membrane. It belongs to the copine gene family, which is conserved from protozoa to humans. This gene family may function in the pathway of membrane trafficking in response to external conditions. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> As disclosed herein, the BONZAI1 (BON1), BON2, and BON3 genes permit wild-type Arabidopsis plants to maintain a relatively constant size over a wide range of temperatures. bon1 null mutants produce miniature fertile plants at 22&deg; C., but produce a wild-type phenotype when grown at 28&deg; C. A protein associated with BON1, &ldquo;BON1associated protein&rdquo;, or BAP1, is also modulated by temperature. Thus, BON1 and BAP1 have a direct role in regulating cell expansion and cell division at temperatures lower than those at which Arabidopsis is normally grown. BON1 contains a Ca<highlight><superscript>2&plus;</superscript></highlight> dependent phospholipid-binding domain and is associated with the plasma membrane, and belongs to the copine gene family, which is conserved from protozoa to humans. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> In one embodiment, the present invention features an isolated nucleic acid comprising SEQ ID NO:2, and degenerate variants thereof. The invention also features an isolated nucleic acid comprising 315 or more consecutive nucleotides of SEQ ID NO:2, and also an isolated nucleic acid comprising a sequence that encodes a polypeptide having an amino acid sequence which is 94% identical to SEQ ID NO:3. The invention also features an isolated polypeptide comprising the amino acid sequence of SEQ ID NO:3, and also an isolated polypeptide comprising 400 or more consecutive amino acid residues of SEQ ID NO:3, and also an isolated polypeptide comprising a sequence that has 94% sequence identity to SEQ ID NO:3. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> In another embodiment, the present invention features a vector comprising the isolated nucleic acids of SEQ ID NO:2 or degenerate variants thereof, and isolated cells (e.g., a prokaryotic cell, a eukaryotic cell) containing such a vector. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> In another embodiment, the present invention features a transgenic plant which has an altered size compared to a corresponding non-transgenic plant, comprising introducing into the plant exogenous nucleic acid which modulates BON1 in the plant. The transgenic plant can be smaller in size. In one embodiment, the invention features a transgenic plant that is smaller in size than a corresponding non-transgenic plant, comprising introducing exogenous nucleic acid which inhibits BON1 in the plant. The exogenous nucleic acid can be inserted in the twelfth exon of the BON1 gene. The exogenous nucleic acid can be a fusion of BON1 with a beta-glucuronidase gene. The exogenous nucleic acid can be inserted in the second exon of the BON1 gene. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> In another embodiment, the invention also features a transgenic tissue culture derived from the transgenic plant as described above, and a transgenic seed of such a transgenic plant, and a transgenic plant, plant part, plant cell or tissue culture, grown from such a transgenic seed. The transgenic plant, plant part, plant cell or tissue culture can be an ornamental plant or a turfgrass, or the plant part, plant cell or tissue culture can be derived from an ornamental plant or a turfgrass. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> In another embodiment, the invention features a transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which enhances BON1 in the plant. The the exogenous nucleic acid can be an exogenous BON1 gene. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> The invention also features a method of producing a transgenic plant which has an altered size compared to a corresponding non-transgenic plant, comprising introducing into the plant exogenous nucleic acid which modulates BON1 in the plant. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> The invention also features a method of producing a transgenic plant that is smaller in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which inhibits BON1 in the plant. The method can be accomplished by mutating the endogenous BON1 in the plant. The exogenous nucleic acid can be a fusion of BON1 with a beta-glucuronidase gene (BON1-GUS). The exogenous nucleic acid can result in overexpression of the C-terminus of a BON1, or overexpression of the full length BON1. The transgenic plant can be an angiosperm or a gymnosperm. The transgenic plant can be an ornamental plant or a turfgrass. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> The invention also features a method of producing a transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which enhances BON1 in the plant. The exogenous nucleic acid can be an exogenous BON1 gene. The plant can be a crop plant, or a plant grown and harvested for its biomass. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> In another embodiment, the invention also features a method of modulating homeostasis of a plant, the method comprising introducing into the plant an exogenous nucleic acid which modulates BON1 in the plant. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> The present invention relates to a method to increase the yield of a plant, comprising introducing an exogenous nucleic acid that enhances BON1 in the plant. The method can be used to produce a plant that can grow at a higher altitude or in a lower temperature region than a corresponding non-transgenic plant, where the method comprises introducing into the plant an exogenous nucleic acid that enhances BON1 in the plant. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> In another embodiment, the invention features an isolated nucleic acid comprising SEQ ID NO:5, and degenerate variants thereof. The nucleic acid can comprise 170 or more consecutive nucleotides of SEQ ID NO:5. The nucleic acid can comprise a sequence that encodes a polypeptide having an amino acid sequence which is 97% identical to SEQ ID NO:6. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> The invention also features an isolated polypeptide comprising the amino acid sequence of SEQ ID NO:6, and an isolated polypeptide comprising 550 or more consecutive amino acid residues of SEQ ID NO:6, and an isolated polypeptide comprising a sequence that has 97% sequence identity to SEQ ID NO:6. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> In another embodiment, the present invention features a vector comprising the isolated nucleic acids of SEQ ID NO:5 or degenerate variants thereof, and isolated cells (e.g., a prokaryotic cell, a eukaryotic cell) containing such a vector. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> In another embodiment, the invention features an isolated nucleic acid comprising SEQ ID NO:11, and degenerate variants thereof. The nucleic acid can comprise 390 or more consecutive nucleotides of SEQ ID NO:11. The nucleic acid can comprise a sequence having 99% sequence identity to the coding sequence of SEQ ID NO:11. The nucleic acid can comprise a sequence that encodes a polypeptide having an amino acid sequence which is 98% identical to SEQ ID NO:12. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The invention also features an isolated polypeptide comprising the amino acid sequence of SEQ ID NO:12, and an isolated polypeptide comprising 180 or more consecutive amino acid residues of SEQ ID NO:12, and an isolated polypeptide comprising a sequence that has 97% sequence identity to SEQ ID NO:12. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> In another embodiment, the present invention features a vector comprising the isolated nucleic acids of SEQ ID NO:11 or degenerate variants thereof, and isolated cells (e.g., a prokaryotic cell, a eukaryotic cell) containing such a vector. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> In another embodiment, the present invention features a method of producing a transgenic plant which has an altered size compared to a corresponding non-transgenic plant, comprising introducing into the plant exogenous nucleic acid which modulates BAP1 in the plant. In one embodiment, the method is a method of producing a transgenic plant that is smaller in size than a corresponding non-transgenic plant comprising introducing into the plant an exogenous nucleic acid sequence which inhibits BAP1. The method can be accomplished by mutating the endogenous BAP1 in the plant. The transgenic plant can be an angiosperm or a gymnosperm. The transgenic plant can be an ornamental plant or a turfgrass. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> In another embodiment, the invention also features a transgenic tissue culture derived from the transgenic plant as described above, and a transgenic seed of such a transgenic plant, and a transgenic plant, plant part, plant cell or tissue culture, grown from such a transgenic seed. The transgenic plant, plant part, plant cell or tissue culture can be an ornamental plant or a turfgrass, or the plant part, plant cell or tissue culture can be derived from an ornamental plant or a turfgrass. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> The invention also features a method of producing a transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which enhances BAP1 in the plant. The exogenous nucleic acid can be an exogenous BAP1 gene. The plant can be a crop plant, or a plant grown and harvested for its biomass. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> In another embodiment, the invention also features a method of modulating homeostasis of a plant, the method comprising introducing into the plant an exogenous nucleic acid which modulates BAP1 in the plant. The method can be used to increase the yield of a plant. The method can be used to produce a plant that can grow at a higher altitude or in a lower temperature region than a corresponding non-transgenic plant, where the method comprises introducing into the plant an isolated nucleic acid that enhances BAP1 in the plant. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> In another embodiment, the invention also features a transgenic plant produced by any of the methods described herein.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 1A, 1B</cross-reference>, <highlight><bold>1</bold></highlight>C, <highlight><bold>1</bold></highlight>D, <highlight><bold>1</bold></highlight>E and <highlight><bold>1</bold></highlight>F are a set of six photographs showing the phenotype of bon1-1 plants. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1A</cross-reference> shows wild type Arabidopsis (Col-0) and bon1-1 grown at 22&deg; C. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1B</cross-reference> shows wild type Arabidopsis (Col.-0) and bon1-1 grown at 28&deg; C. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1C</cross-reference> shows leaves of wild type Arabidopsis (Col-0) and bon1-1 grown at 22&deg; C. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1D</cross-reference> shows stems of wild type Arabidopsis (Col-0.0) and bon1-1 grown at 22&deg; C. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1E</cross-reference> shows wild type Arabidopsis (Col-0) and bon1-1 grown at 22&deg; C. for three weeks and then transferred to 28&deg; C. for ten days. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1F</cross-reference> shows wild type Arabidopsis (Col-0) and bon1-1 grown at 28&deg; C. for three weeks and then transferred to 22&deg; C. for ten days. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 2A and 2B</cross-reference> are a set of two diagrams illustrating the structure of the BON1 gene (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>) and the BON1 protein (<cross-reference target="DRAWINGS">FIG. 2B</cross-reference>). </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2A</cross-reference> shows the genomic structure of the BON1 gene. Exons are represented by boxes, and translation start and stop are indicated by &ldquo;ATG&rdquo; and &ldquo;STOP&rdquo;, respectively. The T-DNA insertion sites in bon1-1 and bon1-2 are in exons 12 and 2 as indicated. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2B</cross-reference> shows the domains of the BON1 protein, which has two C2 domains at the N-terminus and an A domain at the C-terminus. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> is a diagram showing the alignment of the amino acid sequences for <highlight><italic>Arabidopsis thaliana </italic></highlight>BON1 (SEQ ID NO:3), BON2 (SEQ ID NO:6) and BON3 (SEQ ID NO:9) proteins, aligned with the COPINE1 protein (SEQ ID NO:16) from <highlight><italic>Homo sapiens. </italic></highlight></paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 4A, 4B</cross-reference>, <highlight><bold>4</bold></highlight>C and <highlight><bold>4</bold></highlight>D show BON1 expression. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 4A, 4B</cross-reference> and <highlight><bold>4</bold></highlight>C are a set of three photographs showing the BON1-GUS expression pattern. Dark blue staining indicates GUS expression. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4A</cross-reference> shows expression in seedlings at the 4-leaf stage; expression is seen in young leaves. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4B</cross-reference> shows expression in seedlings before bolting; expression is seen in younger leaves and not in older ones. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4C</cross-reference> shows expression in the inflorescence stem; expression is seen in the apical portion of the stem. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 4D</cross-reference> is a Northern blot analysis showing that BON1 RNA expression is modulated by temperature. RNA samples were isolated from 5-week-old plants grown at 28&deg; C. (lane 1), shifted from 28&deg; C. to 22&deg; C. for 12 hours (lane 2), grown at 22&deg; C. (lane 3), shifted from 22&deg; C. to 28&deg; C. for 12 hours (lane 4). </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 5A, 5B</cross-reference>, <highlight><bold>5</bold></highlight>C and <highlight><bold>5</bold></highlight>D show the association of BON1 with membranes. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 5A, 5B</cross-reference>, <highlight><bold>5</bold></highlight>C and <highlight><bold>5</bold></highlight>D are photographs of SDS-PAGE gels stained with Coomassie Blue. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5A</cross-reference> shows that BON1 binds lipid. BON1 protein was mixed with (&plus;) or without (&minus;) phosphotidyl serine (PS) or calcium ion. The mixture was spun down and the protein in the pellet was run on SDS-PAGE and stained with Comassie Blue. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5B</cross-reference> shows that BON1 is associated with membranes in the plants. Total proteins from BON1-HA plants were extracted and incubated with buffer, buffer with 0.5 M NaCl, 2.5 M urea, 0.1 M Na<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, 1% Triton X-100, and 1% sarcosyl, respectively, for one hour. The soluble and pellet fractions were separated by ultracentrifugation. Total protein, soluble fractions, and pellet fractions were then separated by SDS-PAGE, blotted, and probed with anti-HA antibody. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5C</cross-reference> shows that calcium stimulates the association of BON1 with membranes. Total proteins from BON1-HA plants were incubated with buffer containing EGTA (25 mM) or calcium ion (25 mM) before fractionation by centrifugation. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 5D</cross-reference> shows subcellular fractionation by sucrose density centrifugation. The microsomal fraction from transgenic Arabidopsis containing BON1-HA was separated on a sucrose gradient of 25% to 50%. Proteins from each fraction were separated on a 4-20% SDS-PAGE gel and blotted to membranes. The blots were probed with anti-HA antibody, and antibodies against marker proteins from different membranes: plasma-membrane ATPase (PM-ATPase) for plasma membrane, BIP for endoplasmic reticulum, pyrophosphate (PPase) for vacoules. The activity of Golgi specific UDPase activity was assayed (Schaller, G. E. and N. D. DeWitt (1995) <highlight><italic>Methods Cell Biol. </italic></highlight>50:129-48) in each fraction and the strength of the activity was indicated from very strong (&plus;&plus;&plus;&plus;) to low (&minus;). </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 6</cross-reference> is a bar graph showing vesicle aggregation promoted by BON1 in vitro. Vesicle aggregation was monitored by the turbidity of the lipid, which was measured by the absorbance at 540 nm. Phosphotidylserine was incubated with no protein (&ldquo;A&rdquo;), control protein (&ldquo;B&rdquo;), the two C2 domains of BON1 (C2A-C2B) (&ldquo;C&rdquo;), or full-length BON1 protein (C2A-C2B-A) (&ldquo;D&rdquo;) in the presence (Ca<highlight><superscript>2&plus;</superscript></highlight>) or absence (&minus;) of calcium ion for one-half hour. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 7A and 7B</cross-reference> are a pair of Northern blots showing BAP1 expression and function. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7C</cross-reference> is a photograph showing suppression of the bon1-1 phenotype by BAP1 overexpression. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7A</cross-reference> is a Northern blot of total RNAs from different tissues (root, leaf, stem, and flower), showing tissue distribution of BAP1. BON1 and BAP1 show higher expression in leaves and stems and BAP1 also has higher expression in roots. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7B</cross-reference> shows BAP1 RNA expression in wild type and the bon1-1 mutant grown at 22&deg; C. and 28&deg; C. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 7C</cross-reference> shows suppression of the bon1-1 phenotype by BAP1 overexpression. Wild type and bon1-1 are on the left for comparison. Four independent transgenic lines of 35S::BAP1 in a bon1-1 background are on the right. The plants also show varying degrees of suppression of bon1-1 phenotype by overexpression of BAP1. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 8A, 8B</cross-reference> and <highlight><bold>8</bold></highlight>C, respectively, show the BON1 genomic (SEQ ID NO:1), BON1 cDNA (SEQ ID NO:2) and BON1 protein (SEQ ID NO:3) sequences. </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 9A and 9B</cross-reference>, respectively, show the BON2 coding (SEQ ID NO:5) and BON2 protein (SEQ ID NO:6) sequences. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 10A and 10B</cross-reference>, respectively, show the BON3 coding (SEQ ID NO:8) and BON3 protein (SEQ ID NO:9) sequences. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 11A and 11B</cross-reference>, respectively, show the BAP1 coding (SEQ ID NO: <highlight><bold>11</bold></highlight>) and BAP1 protein (SEQ ID NO:12) sequences. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 12A and 12B</cross-reference>, respectively, show the BAL coding (SEQ ID NO:14) and BAL protein (SEQ ID NO:15) sequences.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> The invention relates to nucleic acids (DNA, cDNA, RNA, mRNA) and proteins which modulate plant growth homeostasis. The nucleic acids and proteins described herein control cell expansion and cell division, resulting in changes in the size and rate at which the host plant grows when exposed to lower temperatures. In particular, the present invention relates to nucleic acids expresing the BONZAI1 protein (BON1), and its homologs BON2 and BON3, the BON1-associated protein (BAP1) and the BAL:BAP-Like protein (BAL). </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> The Arabidopsis BON1 genomic sequence is presented as SEQ ID NO:1, and the cDNA as SEQ ID NO:2. The predicted BON1 protein sequence is presented as SEQ ID NO:3. Two homologs of the BON1 protein, BON2 and BON3 are also disclosed herein. The BON2 genomic sequence is presented as SEQ ID NO:4, the BON2 coding sequence as SEQ ID NO:5, and the predicted BON2 protein sequence as SEQ 11) NO:6. The BON3 genomic sequence is presented as SEQ ID NO:7, the BON3 coding sequence as SEQ ID NO:8, and the predicted BON2 protein sequence as SEQ ID NO:9. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The Arabidopsis BAP1 genomic sequence is presented as SEQ ID NO:10, and the BAP1 coding sequence as SEQ ID NO:11. The predicted BAP1 protein sequence is presented as SEQ ID NO:12. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> A blast search revealed that BAP1 has homology to another putative Arabidopsis protein in the database which, for purposes of this study, was called BAL (&ldquo;BAP1 Like&rdquo;). The BAL genomic sequence is presented as SEQ ID NO:13, and the BAL coding sequence as SEQ ID NO:14. The predicted BAL protein sequence is presented as SEQ ID NO:15. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> One approach to identifying the genes involved in temperature homeostasis is to isolate Arabidopsis mutants that are unable to maintain size or shape over a broad temperature range. A mutant was isolated using this approach, bonzai1 (bon1), which makes miniature plants at lower temperatures. As described herein, the BON1 gene encodes one of the copines, a protein widely conserved in plants and animals. The BON1 protein is tightly associated with the plasma membrane and promotes aggregation of lipid vesicles in vitro. BON1 associates with another protein BAP1 which, when overexpressed, can suppress the bon1 phenotype. As described herein, the copine gene family may function in membrane trafficking and be transcriptionally regulated by the environmental conditions to which they are designed to respond. </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> The invention is directed to isolated nucleic acids, BON1, BON2, BON3, BAP1 and BAL, which encode proteins that are necessary for normal growth. Inhibition of one or more of these genes results in plants which are smaller in size (minaturized) when grown at lower temperature, compared to the size of the corresponding wild type plant (the same type of plant as the mutant but which does not have a defect in one or more of these genes) when grown at the same lower temperature. Enhancement of one or more of these genes results in plants which are larger in size, compared to the size of the corresponding wild type plant (the same type of plant as the mutant but which does not have a defect in one or more of these genes). </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> The present invention also relates to transgenic plants having altered size (smaller in size, larger in size) compared to the size of a corresponding wild type plant, wherein the transgenic plant comprises exogenous nucleic acid which modulates (inhibits, enhances) BON1, BON2, BON3, BAP1 and/or BAL in the transgenic plant. As used herein, &ldquo;exogenous nucleic acid&rdquo; is nucleic acid which is obtained from a source other than the recipient plant cell (i.e., the plant cell into which the exogenous nucleic acid is being introduced), and which, when encoding a peptide, is stably expressed. The exogenous nucleic acid can be present episomally or integrated into the genome of the plant cell (into genomic nucleic acid). The exogenous nucleic acid can be DNA, DNA obtained from a source in which it occurs in nature, or produced by synthetic or recombinant methods. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> In one embodiment, the present invention relates to a transgenic plant that is smaller in size than a corresponding non-transgenic plant, wherein the plant comprises exogenous nucleic acid which inhibits BON1, BON2, BON3 and/or BAP1 in the plant. The inhibition of BON1, BON2, BON3 or BAP1 can be partial or complete. Because BON1, BON2, BON3 and BAP1 are likely involved in a physiological pathway, inhibiting BON1, BON2, BON3 or BAP1 includes, for example, inhibition of the gene by knocking out the gene or mutating the gene in a way to render it non-functional (e.g., so that the gene does not encode a functional protein). Inhibition also includes interfering with the regulatory region of the gene, e.g., introducing a nucleic acid which prevents expression or the timing of the encoded product (e.g., splicing in a regulatory region, either upstream or downstream of the gene, which negatively regulates expression of the gene (interefering with, knocking out, or mutating regulatory sequences (e.g., promoter, enhancer) associated with the gene). </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> Inhibition also includes inhibition of the gene product (e.g., protein, peptide), e.g., preventing the use by the plant of the gene&apos;s expression product, by mutating the gene product so that the gene product no longer retains its biological function or its biological function is significantly diminished; mutating a molecule with which the gene product interacts; introducing a molecule (e.g., peptide, small molecule) that binds the gene product thereby inhibiting its function. Inhibition also includes inhibiting a gene or gene product upstream in the pathway in which the particular gene is involved, e.g., a gene in the BON1 pathway which, when inhibited, results in inhibition of BON1 downstream. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> One method of inhibiting expression of an endogenous gene is cosuppression. This has been shown in petunia where introduction of a recombinant chalcone synthase or dihydroflavonol4-reductase gene suppressed the homologous native genes (Napoli, C. et al., 1990<highlight><italic>, The Plant Cell </italic></highlight>2:279-289; van der Krol, A. R. et al., 1990<highlight><italic>, The Plant Cell </italic></highlight>2:291-299), and in tobacco, where transformation of a partial nopaline synthase gene into the plant suppresses the expression of the endogenous corresponding gene (Goring, D. R. et al., 1991<highlight><italic>, Proc. Natl. Acad. Sci. USA </italic></highlight>88:1770-1774). In a particular embodiment, expression of a truncated form of the relevant gene in the &ldquo;sense&rdquo; orientation can be used to suppress the endogenous expression of the native gene, thus lowering the level of the gene product. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> Another method of inhibiting expression of a gene is supression or inhibition using antisense techniques. In one embodiment, antisense RNA forms double-stranded RNA with a target gene product, thereby inhibiting action by that gene product. This is generally done by linking, in reverse orientation, the nucleic acid encoding the target gene product, downstream of its promoter, into a vector. The nucleic acid encoding the antisense product need not represent the entire gene, nor does it need to be fully homologous to the target RNA, rather, the antisense nucleic acid need only encode an RNA having enough homology to bind to the target RNA, or to be of sufficient length to bind to the target RNA in a region critical to its activity. One could use an antisense construct against the BON1, BON2 and/or BON3 proteins, for instance, to produce plants exhibiting the bon1 loss-of-function phenotype. </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> In a particular embodiment of the invention, a transgenic plant that is smaller in size than a corresponding wild type plant is produced by introducing a chimeric fusion protein, such as a BON1-GUS fusion protein (or a BON2-GUS or BON3-GUS fusion protein) into the plant (e.g., into the second exon or the twelfth exon of BON1) inhibits BON1 (or BON2 or BON3). In another embodiment, introduction of exogenous nucleic acid which overexpresses of the C-terminus of BON1, BON2 or BON3, or of an N-terminal domain of BAP1 can also be used to inhibit the genes. </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> In another embodiment, the present invention relates to a transgenic plant that is larger in size than a corresponding non-transgenic plant, wherein the transgenic plant comprises an exogenous nucleic acid which enhances BON1, BON2, BON3 and/or BAP1 in the plant. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> The enhancing of BON1, BON2, BON3 or BAP1 can be partial or complete. Because BON1, BON2, BON3 and BAP1 are likely involved in a physiological pathway, &ldquo;enhancing&rdquo; of BON1, BON2, BON3 or BAP1 can include enhancing the gene, including duplicating and/or overexpressing the gene, mutating the gene (full length) in a way that it has increased expression, etc. Enhancing also includes interfering with the regulation of the gene, e.g., enhancing its expression or the timing thereof, e.g., altering regulatory sequences associated with the gene. Enhancing also includes enhancing the gene product itself, e.g., increasing the ability of the plant to use the product or increasing the activity of the product, either by mutating the gene product so that its use by the plant is increased, or by increasing binding of the expression product to its ligand. </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> Polynucleotides encoding BON1, BON2, BON3, BAP1 or BAL can be obtained or isolated from natural sources, recombinantly produced, or chemically synthesized. In one embodiment, polynucleotides encoding BON1, BON2, BON3, BAP1 or BAL can be cloned out of isolated DNA or a cDNA library. Nucleic acids and polypeptides, referred to herein as &ldquo;isolated&rdquo; (e.g., essentially pure) are nucleic acids or polypeptides substantially free (i.e., separated away from) the material of the biological source from which they were obtained (e.g., as exists in a mixture of nucleic acids or in cells), and which may have undergone further processing. An isolated nucleic acid is not immediately contiguous with (i.e., covalently linked to) both of the nucleic acids with which it is immediately contiguous in the naturally-occurring genome of the organism from which the nucleic acid is derived. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> As used herein, &ldquo;lower temperature&rdquo; refers to a temperature at which the transgenic plant of the present invention grows smaller in size, compared to a corresponding non-transgenic plant. Such a lower temperature will vary depending upon the particular plant. For example, the normal temperature for a plant which grows in a temperate region (e.g., Arabidopsis) is from about 24&deg; C. ro about 37&deg; C. Transgenic Arabidopsis in which BON1, BON2, BON3, BAP1 and/or BAL are inhibited grows smaller in size at about 22&deg; C., compared to a corresponding non-transgenic Arabidopsis plant at 22&deg; C. Therefore, a lower temperature for plants which grow in a temperate region is from about 0&deg; C. to about 23&deg; C., from about 5&deg; C. to about 20&deg; C., and from about 10&deg; C. to about 15&deg; C. In one embodiment, a lower temperature for a plant is about 22&deg; C. Thus, a &ldquo;lower temperature&rdquo; will vary depending upon the particular plant and the region (e.g., tropical, temperate, arctic) in which the wild type plant grown and can be determined by one of ordinary skill in the art. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> Plants that are &ldquo;smaller in size&rdquo; are smaller than the corresponding wild type plant, and refers to their growth during the time of exposure to lower temperatures relative to wild type plants. For instance, as described herein, bon1 mutant plants do not grow as large, and produce smaller and fewer cells, when grown at 22&deg; C. relative to wild type plants grown at the same temperature. Ordinarily, plants grown at lower temperatures continue to grow at a slower rate, but still produce normal-sized cells. If the bon1 plants are grown at 22&deg; C. are then moved to exposure to 28&deg; C., however, the new growth of bon1 plants grow at the same rate as the wild type plants, with the bon1 plants having a portion of older tissue that is &ldquo;minaturized&rdquo;, and newer tissue that is normally proportioned. The same is true if the temperature conditions are reversed, that is, if the bon1 plants are grown at one temperature (e.g., 28&deg; C.), then switched to lower temperatures (e.g., 22&deg; C.), the bon1 plants exhibit older tissue of the same proportions as wild type, while the newer tissues are miniaturized. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> Conversely, transgenic plants of the present invention that are larger in size are larger than the corresponding wild type plant. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> The invention also encompasses alleles, degenerate variants, fragments, mutants, homologs and analogs of BON1, BON2, BON3, BAP1 and BAL nucleic acids and proteins. An &ldquo;allele&rdquo; of a protein is a polypeptide sequence containing a naturally-occurring sequence variation relative to the polypeptide sequence of the reference polypeptide. By &ldquo;allele&rdquo; of a polynucleotide encoding the polypeptide is meant a polynucleotide containing a sequence variation relative to the reference polynucleotide sequence encoding the reference polypeptide, where the allele of the polynucleotide encoding the polypeptide encodes an allelic form of the polypeptide. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> As used herein, &ldquo;degenerate variants&rdquo; of a nucleic acid are those variant nucleic acids that differ from the reference sequence due to the degeneracy of the genetic code, and encode a protein having the same amino acid sequence as that protein encoded by the reference nucleic acid. Therefore, a degenerate variant of a BON1, BON2, BON3, BAP1 or BAL nucleic acid sequence is a sequence that contains a silent or conservative substitution and therefore encodes the same protein as the reference polynucleotide sequence. </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> A &ldquo;fragment&rdquo; of the nucleic acid sequences described herein is a portion of the full length nucleic acid sequence that encodes a protein that retains the biological activity of the full-length protein. Such fragments con comprises, for example, from about 50 to about 2000 nucleotides, from about 100 to about 1500 nucleotides, from about 500 to about 1000 nucleotides. Such nucleic acids can also comprise additional sequences derived from the process of cloning, e.g., amino acid residues or amino acid sequences corresponding to full or partial linker sequences. To be encompassed by the present invention, such fragments, with or without such additional sequences, must have substantially the same biological activity as the natural or full-length version of the reference polypeptide. </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> A &ldquo;fragment&rdquo; of a protein is any amino acid sequence shorter than the full length protein, comprising at least about 25 consecutive amino acids of the full length protein. Such a fragment may alternatively comprise about 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50 consecutive amino acids of the full length protein. The fragment may comprise about 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74 or 75 consecutive amino acids of the full polypeptide. The fragments of the proteins described herein can comprise, for example, from about 100 to about 800 amino acids, from about 200 to about 700 amino acids, from about 300 to about 600 amino acids, and from about 500 to about 500 amino acids. In another embodiment, the protein fragment can be about 170 consecutive amino acids. In another embodiment, the protein fragment can be about 180 consecutive amino acids. In another embodiment, the protein fragment can be about 315 consecutive amino acids. In another embodiment, the protein fragment can be about 390 consecutive amino acids. In another embodiment, the protein fragment can be about 400 consecutive amino acids. In another embodiment, the protein fragment can be about 550 consecutive amino acids. Such molecules can comprise additional amino acids derived from the process of cloning, e.g., amino acid residues or amino acid sequences corresponding to full or partial linker sequences. To be encompassed by the present invention, such molecules, with or without such additional amino acid residues, must have substantially the same biological activity as the reference polypeptide. </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> Encompassed by the present invention are proteins that have substantially the same amino acid sequence as BON1, BON2, BON3, BAP1 or BAL, or polynucleotides that have substantially the same nucleic acid sequence as the polynucleotides encoding BON1, BON2, BON3, BAP1 or BAL. &ldquo;Substantially the same sequence&rdquo; means a nucleic acid or polypeptide that exhibits at least about 70% sequence identity, typically at least about 80% sequence identity with the reference sequence, at least about 90% sequence identity, at least about 95% identity, at least about 97%, at least about 98% sequence identity, or at least about 99% sequence identity with the BON1, BON2, BON3, BAP1 or BAL reference sequence. The length of comparison for sequences will generally be at least 75 nucleotide bases or 25 amino acids, more preferably at least 150 nucleotide bases or 50 amino acids, more preferably at least 300 nucleotides or 100 amino acids, and most preferably 600 nucleotides or 200 amino acids. In one embodiment, the length for comparisn is the full length nucleic acid or amino acid of BON1, BON2, BON3, BAP1 or BAL. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> &ldquo;Sequence identity,&rdquo; as used herein, refers to the subunit sequence similarity between two polymeric molecules, e.g., two polynucleotides or two polypeptides. When a subunit position in both of the two molecules is occupied by the same monomeric subunit, e.g., if a position in each of two peptides is occupied by serine, then they are identical at that position. The identity between two sequences is a direct function of the number of matching or identical positions, e.g., if half (e.g., 5 positions in a polymer 10 subunits in length) of the positions in two peptide or compound sequences are identical, then the two sequences are 50% identical; if 90% of the positions, e.g., 9 of 10 are matched, the two sequences share 90% sequence identity. By way of example, the amino acid sequences R<highlight><subscript>2</subscript></highlight>R<highlight><subscript>5</subscript></highlight>R<highlight><subscript>7</subscript></highlight>R<highlight><subscript>10</subscript></highlight>R<highlight><subscript>6</subscript></highlight>R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>9</subscript></highlight>R<highlight><subscript>8</subscript></highlight>R<highlight><subscript>1</subscript></highlight>R<highlight><subscript>10</subscript></highlight>R<highlight><subscript>6</subscript></highlight>R<highlight><subscript>3 </subscript></highlight>have 3 of 6 positions in common, and therefore share 50% sequence identity, while the sequences R<highlight><subscript>2</subscript></highlight>R<highlight><subscript>5</subscript></highlight>R<highlight><subscript>7</subscript></highlight>R<highlight><subscript>10</subscript></highlight>R<highlight><subscript>6</subscript></highlight>R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>8</subscript></highlight>R<highlight><subscript>1</subscript></highlight>R<highlight><subscript>10</subscript></highlight>R<highlight><subscript>6</subscript></highlight>R<highlight><subscript>3 </subscript></highlight>have 3 of 5 positions in common, and therefore share 60% sequence identity. The identity between two sequences is a direct function of the number of matching or identical positions. Thus, if a portion of the reference sequence is deleted in a particular peptide, that deleted section is not counted for purposes of calculating sequence identity, e.g., R<highlight><subscript>2</subscript></highlight>R<highlight><subscript>5</subscript></highlight>R<highlight><subscript>7</subscript></highlight>R<highlight><subscript>10</subscript></highlight>R<highlight><subscript>6</subscript></highlight>R<highlight><subscript>3 </subscript></highlight>and R<highlight><subscript>2</subscript></highlight>R<highlight><subscript>5</subscript></highlight>R<highlight><subscript>7</subscript></highlight>R<highlight><subscript>10</subscript></highlight>R<highlight><subscript>3 </subscript></highlight>have 5 out of 6 positions in common, and therefore share 83.3% sequence identity. </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> Identity is often measured using sequence analysis software e.g., BLASTN or BLASTP (available at http://www.ncbi.nlm.nih.gov/BLAST/). The default parameters for comparing two sequences (e.g., &ldquo;Blast&rdquo;-ing two sequences against each other, http://www.ncbi.nlm.nih.gov/gorf/b12.html) by BLASTN (for nucleotide sequences) are reward for match&equals;1, penalty for mismatch&equals;&minus;2, open gap&equals;5, extension gap&equals;2. When using BLASTP for protein sequences, the default parameters are reward for match&equals;0, penalty for mismatch&equals;0, open gap&equals;11, and extension gap&equals;1. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> The present invention also includes fusion proteins and chimeric proteins comprising the BON1, BON2, BON3, BAP1 or BAL proteins, their fragments, mutants, homologs, analogs, and allelic variants. A fusion or chimeric protein can be produced as a result of recombinant expression and the cloning process, e.g., the protein can be produced comprising additional amino acids or amino acid sequences corresponding to full or partial linker sequences. As used herein, the term &ldquo;fusion or chimeric protein&rdquo; is intended to encompass changes of this type to the original protein sequence. A fusion or chimeric protein can consist of a multimer of a single protein, e.g., repeats of the proteins, or the fusion and chimeric proteins can be made up of several proteins, e.g., several of the proteins. Such fusion or chimeric proteins can be linked together via post-translational modification (e.g., chemically linked), or the entire fusion protein may be made recombinantly. </paragraph>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> The invention also encompasses vectors and host cells comprising the BON1, BON2, BON3, BAP1 or BAL nucleic acid sequences. In addition, the present invention encompasses methods of producing BON1, BON2, BON3, BAP1 or BAL, and their fragments, mutants, homologs, analogs and allelic variants comprising culturing the host cells described herein under conditions appropriate to produce BON1, BON2, BON3, BAP1 and BAL. The term &ldquo;vector&rdquo; as used herein means a carrier into which pieces of nucleic acid may be inserted or cloned, which carrier functions to transfer the pieces of nucleic acid into a host cell. Such a vector may also bring about the replication and/or expression of the transferred nucleic acid pieces. Examples of vectors include nucleic acid molecules derived, e.g., from a plasmid, bacteriophage, or mammalian, plant or insect virus, or non-viral vectors such as ligand-nucleic acid conjugates, liposomes, or lipid-nucleic acid complexes. It may be desirable that the transferred nucleic molecule is operatively linked to an expression control sequence to form an expression vector capable of expressing the transferred nucleic acid. Such transfer of nucleic acids is generally called &ldquo;transformation,&rdquo; and refers to the insertion of an exogenous polynucleotide into a host cell, irrespective of the method used for the insertion. For example, direct uptake, transduction or f-mating are included. The exogenous polynucleotide may be maintained as a non-integrated vector, for example, a plasmid, or alternatively, may be integrated into the host genome. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> &ldquo;Operably linked&rdquo; refers to a situation wherein the components described are in a relationship permitting them to function in their intended manner, e.g., a control sequence &ldquo;operably linked&rdquo; to a coding sequence is ligated in such a manner that expression of the coding sequence is achieved under conditions compatible with the control sequence. A &ldquo;coding sequence&rdquo; is a polynucleotide sequence which is transcribed into mRNA and translated into a polypeptide when placed under the control of (e.g., operably linked to) appropriate regulatory sequences. The boundaries of the coding sequence are determined by a translation start codon at the 5&prime;-terminus and a translation stop codon at the 3&prime;-terminus. Such boundaries can be naturally-occurring, or can be introduced into or added the polynucleotide sequence by methods known in the art. A coding sequence can include, but is not limited to, mRNA, cDNA, and recombinant polynucleotide sequences. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> Once a polynucleotide has been cloned into a suitable vector, it can be transformed into an appropriate host cell. By &ldquo;host cell&rdquo; is meant a cell which has been or can be used as the recipient of transferred nucleic acid by means of a vector. Host cells can be prokaryotic or eukaryotic, mammalian, plant, or insect cells, and can exist as single cells, or as a collection, e.g., as a culture, or in a tissue culture, or in a tissue or an organism. Host cells can also be derived from normal or diseased tissue from a multicellular organism, e.g., a plant. Host cell, as used herein, is intended to include not only the original cell which was transformed with a nucleic acid, but also descendants of such a cell, which still contain the nucleic acid. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> In one embodiment, the isolated polynucleotide encoding one of the proteins of the present invention additionally comprises a polynucleotide linker encoding a peptide. Such linkers are known to those of skill in the art and, for example the linker can comprise at least one additional codon encoding at least one additional amino acid. Typically the linker comprises one to about twenty or thirty amino acids. The polynucleotide linker is translated, as is the polynucleotide encoding the protein, resulting in the expression of a protein with at least one additional amino acid residue at the amino or carboxyl terminus of the protein. Importantly, the additional amino acid, or amino acids, do not compromise the activity of the protein. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> The present invention also relates to an isolated nucleic acid comprising a sequence that hybridizes under highly stringent conditions to a coding sequence of the isolated nucleic acid of BON1, BON2, BON3, BAP1 or BAL. The present invention also relates to an isolated nucleic acid sequence comprising a sequence that hybridizes under highly stringent conditions to a complement (e.g., fully complementary) of the coding sequence which encodes a BON1, BON2, BON3, BAP1 or BAL protein. The polynucleotides and proteins of the present invention can be used to design probes to isolate other proteins, for example, homologs of BON, BON2, BON3, BAP1 and BAL. Appropriate hybridization methods are provided in U.S. Pat. No. 5,837,490, by Jacobs et al., the entire teachings of which are herein incorporated by reference in their entirety. The design of the oligonucleotide probe should preferably follow these parameters: (a) it should be designed to an area of the sequence which has the fewest ambiguous bases (&ldquo;N&apos;s&rdquo;), if any, and (b) it should be designed to have a T<highlight><subscript>m </subscript></highlight>of approx. 80&deg; C. (assuming 2&deg; C. for each A or T and 4&deg; C. for each G or C). </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> The oligonucleotide should preferably be labeled with &ggr;-<highlight><superscript>32</superscript></highlight>P-ATP (specific activity 6000 Ci/mmole) and T4 polynucleotide kinase using commonly employed techniques for labeling oligonucleotides. Other labeling techniques can also be used. Unincorporated label should preferably be removed by gel filtration chromatography or other established methods. The amount of radioactivity incorporated into the probe should be quantitated by measurement in a scintillation counter. Preferably, specific activity of the resulting probe should be approximately 4&times;10<highlight><superscript>6 </superscript></highlight>dpm/pmole. The bacterial culture containing the pool of full-length clones should preferably be thawed and 100 &mgr;l of the stock used to inoculate a sterile culture flask containing 25 ml of sterile L-broth containing ampicillin at 100 &mgr;g/ml. The culture should preferably be grown to saturation at 37&deg; C., and the saturated culture should preferably be diluted in fresh L-broth. Aliquots of these dilutions should preferably be plated to determine the dilution and volume which will yield approximately 5000 distinct and well-separated colonies on solid bacteriological media containing L-broth containing ampicillin at 100 &mgr;g/ml and agar at 1.5% in a 150 mm petri dish when grown overnight at 37&deg; C. Other known methods of obtaining distinct, well-separated colonies can also be employed. </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> Standard colony hybridization procedures should then be used to transfer the colonies to nitrocellulose filters, followed by lysing, denaturing and baking them. Highly stringent condition are those that are at least as stringent as, for example, 1&times; SSC at 65&deg; C., or 1&times; SSC and 50% formamide at 42&deg; C. Moderate stringency conditions are those that are at least as stringent as 4&times; SCC at 65&deg; C., or 4&times; SCC and 50% formamide at 42&deg; C. Reduced stringency conditions are those that are at least as stringent as 4&times; SCC at 50&deg; C., or 6&times; SCC and 50% formamide at 40&deg; C. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> The filter is then preferably incubated at 65&deg; C. for 1 hour with gentle agitation in 6&times; SCC (20&times; stock is 175.3 g NaCl/liter, 88.2 g Na citrate/liter, adjusted to pH 7.0 with NaOH) containing 0.5% SDS, 100 &mgr;g/ml of yeast RNA, and 10 mM EDTA (approximately 10 mL per 150 mm filter). Preferably, the probe is then added to the hybridization mix at a concentration greater than or equal to 1&times;10<highlight><superscript>6 </superscript></highlight>dpm/mL. The filter is then preferably incubated at 65&deg; C. with gentle agitation overnight. The filter is then preferably washed in 500 mL of 2&times; SCC/0.5% SDS at room temperature without agitation, preferably followed by 500 mL of 2&times; SCC/0.1% SDS at room temperature with gentle shaking for 15 minutes. A third wash with 0.1&times; SCC/0.5% SDS at 65&deg; C. for 30 minutes to 1 hour is optional. The filter is then preferably dried and subjected to autoradiography for sufficient time to visualize the positives on the X-ray film. Other known hybridization methods can also be employed. The positive colonies are then picked, grown in culture, and plasmid DNA isolated using standard procedures. The clones can then be verified by restriction analysis, hybridization analysis, or DNA sequencing. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> Stringency conditions for hybridization refers to conditions of temperature and buffer composition which permit hybridization of a first nucleic acid sequence to a second nucleic acid sequence, wherein the conditions determine the degree of identity between those sequences which hybridize to each other. Therefore, &ldquo;high stringency conditions&rdquo; are those conditions wherein only nucleic acid sequences which are very similar to each other will hybridize. The sequences may be less similar to each other if they hybridize under moderate stringency conditions. Still less similarity is needed for two sequences to hybridize under low stringency conditions. By varying the hybridization conditions from a stringency level at which no hybridization occurs, to a level at which hybridization is first observed, conditions can be determined at which a given sequence will hybridize to those sequences that are most similar to it. The precise conditions determining the stringency of a particular hybridization include not only the ionic strength, temperature, and the concentration of destabilizing agents such as formamide, but also on factors such as the length of the nucleic acid sequences, their base composition, the percent of mismatched base pairs between the two sequences, and the frequency of occurrence of subsets of the sequences (e.g., small stretches of repeats) within other non-identical sequences. Washing is the step in which conditions are set so as to determine a minimum level of similarity between the sequences hybridizing with each other. Generally, from the lowest temperature at which only homologous hybridization occurs, a 1% mismatch between two sequences results in a 1&deg; C. decrease in the melting temperature (T<highlight><subscript>m</subscript></highlight>) for any chosen SSC concentration. Generally, a doubling of the concentration of SSC results in an increase in the T<highlight><subscript>m </subscript></highlight>of about 17&deg; C. Using these guidelines, the washing temperature can be determined empirically, depending on the level of mismatch sought. Hybridization and wash conditions are explained in <highlight><italic>Current Protocols in Molecular Biology </italic></highlight>(Ausubel, F. M. et al., eds., John Wiley &amp; Sons, Inc., 1995, with supplemental updates) on pages 2.10.1 to 2.10.16, and 6.3.1 to 6.3.6. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> High stringency conditions can employ hybridization at either (1) 1&times; SSC (10&times; SSC&equals;3 M NaCl, 0.3 M Na<highlight><subscript>3</subscript></highlight>-citrate.2H<highlight><subscript>2</subscript></highlight>O (88 g/liter), pH to 7.0 with 1 M HCl), 1% SDS (sodium dodecyl sulfate), 0.1-2 mg/ml denatured salmon sperm DNA at 65&deg; C., (2) 1&times; SSC, 50% formamide, 1% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 42&deg; C., (3) 1% bovine serum albumen (fraction V), 1 mM Na<highlight><subscript>2</subscript></highlight>.EDTA, 0.5 M NaHPO<highlight><subscript>4 </subscript></highlight>(pH 7.2) (1 M NaHPO<highlight><subscript>4</subscript></highlight>&equals;134 g Na<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight>.7H<highlight><subscript>2</subscript></highlight>O, 4 ml 85% H<highlight><subscript>3</subscript></highlight>PO<highlight><subscript>4 </subscript></highlight>per liter), 7% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 65&deg; C., (4) 50% formamide, 5&times; SCC, 0.02 M Tris-HCl (pH 7.6), 1&times; Denhardt&apos;s solution (100&times;&equals;10 g Ficoll 400, 10 g polyvinylpyrrolidone, 10 g bovine serum albumin (fraction V), water to 500 ml), 10% dextran sulfate, 1% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 42&deg; C., (5) 5&times; SSC, 5&times; Denhardt&apos;s solution, 1% SDS, 100 &mgr;g/ml denatured salmon sperm DNA at 65&deg; C., or (6) 5&times; SCC, 5&times; Denhardt&apos;s solution, 50% formamide, 1% SDS, 100 &mgr;g/ml denatured salmon sperm DNA at 42&deg; C., with high stringency washes of either (1) 0.3-0.1&times; SSC, 0.1% SDS at 65&deg; C., or (2) 1 mM Na<highlight><subscript>2</subscript></highlight>EDTA, 40 mM NaHPO<highlight><subscript>4 </subscript></highlight>(pH 7.2), 1% SDS at 65&deg; C. The above conditions are intended to be used for DNA-DNA hybrids of 50 base pairs or longer. Where the hybrid is believed to be less than 18 base pairs in length, the hybridization and wash temperatures should be 5-10&deg; C. below that of the calculated T<highlight><subscript>m </subscript></highlight>of the hybrid, where T<highlight><subscript>m </subscript></highlight>in &deg; C.&equals;(2&times;the number of A and T bases)&plus;(4&times;the number of G and C bases). For hybrids believed to be about 18 to about 49 base pairs in length, the T<highlight><subscript>m </subscript></highlight>in &deg; C.&equals;(81.5&deg; C.&plus;16.6(log<highlight><subscript>10</subscript></highlight>M)&plus;0.41(% G&plus;C)&minus;0.61 (% formamide)&minus;500/L), where &ldquo;M&rdquo; is the molarity of monovalent cations (e.g., Na<highlight><superscript>&plus;</superscript></highlight>), and &ldquo;L&rdquo; is the length of the hybrid in base pairs. </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> Moderate stringency conditions can employ hybridization at either (1) 4&times; SCC, (10&times; SCC&equals;3 M NaCl, 0.3 M Na<highlight><subscript>3</subscript></highlight>-citrate.2H<highlight><subscript>2</subscript></highlight>O (88 g/liter), pH to 7.0 with 1 M HCl), 1% SDS (sodium dodecyl sulfate), 0.1-2 mg/ml denatured salmon sperm DNA at 65&deg; C., (2) 4&times; SCC, 50% formamide, 1% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 42&deg; C., (3) 1% bovine serum albumen (fraction V), 1 mM Na<highlight><subscript>2</subscript></highlight>-EDTA, 0.5 M NaHPO<highlight><subscript>4 </subscript></highlight>(pH 7.2) (1 M NaHPO<highlight><subscript>4</subscript></highlight>&equals;134 g Na<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight>.7H<highlight><subscript>2</subscript></highlight>O, 4 ml 85% H<highlight><subscript>3</subscript></highlight>PO<highlight><subscript>4 </subscript></highlight>per liter), 7% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 65&deg; C., (4) 50% formamide, 5&times; SSC, 0.02 M Tris-HCl (pH 7.6), 1&times; Denhardt&apos;s solution (100&times;&equals;10 g Ficoll 400, 10 g polyvinylpyrrolidone, 10 g bovine serum albumin (fraction V), water to 500 ml), 10% dextran sulfate, 1% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 42&deg; C., (5) 5x SSC, 5&times; Denhardt&apos;s solution, 1% SDS, 100 &mgr;g/ml denatured salmon sperm DNA at 65&deg; C., or (6) 5&times; SCC, 5&times; Denhardt&apos;s solution, 50% formamide, 1% SDS, 100 &mgr;g/ml denatured salmon sperm DNA at 42&deg; C., with moderate stringency washes of 1&times; SSC, 0.1% SDS at 65&deg; C. The above conditions are intended to be used for DNA-DNA hybrids of 50 base pairs or longer. Where the hybrid is believed to be less than 18 base pairs in length, the hybridization and wash temperatures should be 5-10&deg; C. below that of the calculated T<highlight><subscript>m </subscript></highlight>of the hybrid, where T<highlight><subscript>m </subscript></highlight>in &deg; C.&equals;(2&times;the number of A and T bases)&plus;(4&times;the number of G and C bases). For hybrids believed to be about 18 to about 49 base pairs in length, the T<highlight><subscript>m </subscript></highlight>in &deg; C.&equals;(81.5&deg; C.&plus;16.6(log<highlight><subscript>10</subscript></highlight>M)&plus;0.41(% G&plus;C)&minus;0.61 (% formamide)&minus;500/L), where &ldquo;M&rdquo; is the molarity of monovalent cations (e.g., Na<highlight><superscript>&plus;</superscript></highlight>), and &ldquo;L&rdquo; is the length of the hybrid in base pairs. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> Low stringency conditions can employ hybridization at either (1) 4&times; SCC, (10&times; SSC&equals;3 M NaCl, 0.3 M Na<highlight><subscript>3</subscript></highlight>-citrate.2H<highlight><subscript>2</subscript></highlight>O (88 g/liter), pH to 7.0 with 1 M HCl), 1% SDS (sodium dodecyl sulfate), 0.1-2 mg/ml denatured salmon sperm DNA at 50&deg; C., (2) 6&times; SCC, 50% formamide, 1% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 40&deg; C., (3) 1% bovine serum albumen (fraction V), 1 mM Na<highlight><subscript>2</subscript></highlight>.EDTA, 0.5 M NaHPO<highlight><subscript>4 </subscript></highlight>(pH 7.2) (1 M NaHPO<highlight><subscript>4</subscript></highlight>&equals;134 g Na<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight>.7H<highlight><subscript>2</subscript></highlight>O, 4 ml 85% H<highlight><subscript>3</subscript></highlight>PO<highlight><subscript>4 </subscript></highlight>per liter), 7% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 50&deg; C., (4) 50% formamide, 5&times; SCC, 0.02 M Tris-HCl (pH 7.6), 1&times; Denhardt&apos;s solution (100&times;&equals;10 g Ficoll 400, 10 g polyvinylpyrrolidone, 10 g bovine serum albumin (fraction V), water to 500 ml), 10% dextran sulfate, 1% SDS, 0.1-2 mg/ml denatured salmon sperm DNA at 40&deg; C., (5) 5&times; SSC, 5&times; Denhardt&apos;s solution, 1% SDS, 100 &mgr;g/ml denatured salmon sperm DNA at 50&deg; C., or (6) 5&times; SCC, 5&times; Denhardt&apos;s solution, 50% formamide, 1% SDS, 100 &mgr;g/ml denatured salmon sperm DNA at 40&deg; C., with low stringency washes of either 2&times; SCC, 0.1% SDS at 50&deg; C., or (2) 0.5% bovine serum albumin (fraction V), 1 mM Na<highlight><subscript>2</subscript></highlight>EDTA, 40 mM NaHPO<highlight><subscript>4 </subscript></highlight>(pH 7.2), 5% SDS. The above conditions are intended to be used for DNA-DNA hybrids of 50 base pairs or longer. Where the hybrid is believed to be less than 18 base pairs in length, the hybridization and wash temperatures should be 5-10&deg; C. below that of the calculated T<highlight><subscript>m </subscript></highlight>of the hybrid, where T<highlight><subscript>m </subscript></highlight>in &deg; C.&equals;(2&times;the number of A and T bases)&plus;(4&times; the number of G and C bases). For hybrids believed to be about 18 to about 49 base pairs in length, the T<highlight><subscript>m </subscript></highlight>in &deg; C.&equals;(81.5&deg; C.&plus;16.6(log<highlight><subscript>10</subscript></highlight>M)&plus;0.41(% G&plus;C)&minus;0.61 (% formamide)&minus;500/L), where &ldquo;M&rdquo; is the molarity of monovalent cations (e.g., Na<highlight><superscript>&plus;</superscript></highlight>), and &ldquo;L&rdquo; is the length of the hybrid in base pairs. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> The present invention also relates to a method of producing a transgenic plant, wherein the size of the plant is altered in comparison to the size of a corresponding wild type plant, comprising introducing into the plant an exogenous nucleic acid that modulates (inhibits, enhances) BON1, BON2, BON3, BAP1, and/or BAL. The invention also relates to plants produced by the methods. In one embodiment, the present invention relates to a method of producing a transgenic plant that is smaller in size than a corresponding wild type plant, comprising introducing into the plant an exogenous nucleic acid which inhibits BON1, BON2, BON3, BAP1 and/or BAL in the plant. In another embodiment, the present invention relates to a method of producing a transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an isolated nucleic acid which enhances expression of BON1, BON2, BON3, BAP1 and/or BAL protein in the plant. </paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> The nucleic acids of the present invention can be used in a variety of ways. In one embodiment, the present invention relates to methods of producing plants which are miniature in size, comprising introducing exogenous nucleic acid which inhibits BON1, BON2, BON3, BAP1, or BAL in the plant. In another embodiment, the present invention relates to methods of increasing the yield of a plant, comprising introducing into the plant an isolated nucleic acid which enhances BON1, BON2, BON3, BAP1, or BAL in the plant. In another embodiment, the present invention relates to methods of producing a transgenic plant that is able to grow at a higher altitude or in a lower temperature region than a corresponding non-transgenic plant, comprising introducing into the plant an isolated nucleic acid that enhances BON1, BON2, BON3, BAP1, or BAL in the plant. In another embodiment, the present invention relates to a method of modulating homeostasis of a plant, the method comprising introducing into the plant an exogenous nucleic acid which modulates BON1 in the plant. The present invention also relates to the plants produced by such methods, where the plants are miniature in size, are higher-yielding, grow at higher altitues or in cooler regions, or in which homeostasis regarding temperature and plant growth are modulated by the nucleic acids of the invention. </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> To produce transgenic plants of this invention, a construct comprising exogenous nucleic acid of the invention, or nucleic acid encoding a functional equivalent as described herein, and a promoter can be incorporated into a vector and introduced into the cell(s) of the plant through methods known and used by those of skill in the art. The nucleic acid to be introduced can be incorporated into a vector, to form a construct, with or without other sequences, or it may be naked nucleic acid, and associated with no such sequences. The construct can also include any other necessary regulators such as terminators or the like, operably linked to the coding sequence. It can also be beneficial to include a 5&prime; leader sequence, such as the untranslated leader from the coat protein mRNA of alfalfa mosaic virus (Jobling, S. A. and Gehrke, L. (1987) <highlight><italic>Nature </italic></highlight>325:622-625) or the maize chlorotic mottle virus (MCMV) leader (Lommel, S. A. et al. (1991) <highlight><italic>Virology </italic></highlight>81:382-385). Those of skill in the art will recognize the applicability of other leader sequences for various purposes. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> Targeting sequences are also useful and can be incorporated into the constructs of this invention. A targeting sequence is usually translated into a peptide which directs the polypeptide product of the coding nucleic acid sequence to a desired location within the cell, such as to the plastid, and becomes separated from the peptide after transit of the peptide is complete or concurrently with transit. Examples of targeting sequences useful in this invention include, but are not limited to, the yeast mitochondrial presequence (Schmitz et al. (1989) <highlight><italic>Plant Cell </italic></highlight>1:783-791), the targeting sequence from the pathogenesis-related gene (PR-1) of tobacco (Comellisen et al. (1986) <highlight><italic>EMBO J </italic></highlight>5:37-40), vacuole targeting signals (Chrispeels, M. J. and Raikhel, N. V. (1992) <highlight><italic>Cell </italic></highlight>68:613-616), secretory pathway sequences such as those of the ER or Golgi (Chrispeels, M. J. (1991) <highlight><italic>Ann. Rev. Plant Physiol. Plant Mol. Biol. </italic></highlight>42:21-53). Intraorganellar sequences may also be useful for internal sites, e.g., thylakoids in chloroplasts. Theg, S. M. and Scott, S. V. (1993) <highlight><italic>Trends in Cell Biol. </italic></highlight>3:186-190. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> In addition to 5&prime; leader sequences, terminator sequences are usually incorporated into the construct. In plant constructs, a 3&prime; untranslated region (3&prime; UTR) is generally part of the expression plasmid and contains a polyA termination sequence. The termination region which is employed will generally be one of convenience, since termination regions appear to be relatively interchangeable. The octopine synthase and nopaline synthase termination regions, derived from the Ti-plasmid of <highlight><italic>A. tumefaciens</italic></highlight>, are suitable for such use in the constructs of this invention. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> The transcriptional initiation region of the construct may provide for constitutive expression or regulated expression. In addition to the ERA1 promoter, many promoters are available which are functional in plants. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> Constitutive promoters for plant gene expression include, but are not limited to, the octopine synthase, nopaline synthase, or mannopine synthase promoters from Agrobacterium, the cauliflower mosaic virus (35S) promoter, the figwort mosaic virus (FMV) promoter, and the tobacco mosaic virus (TMV) promoter. Constitutive gene expression in plants can also be provided by the glutamine synthase promoter (Edwards et al. (1990) <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>87:3459-3463), the maize sucrose synthetase 1 promoter (Yang et al. (1990) <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>87:4144-4148), the promoter from the Rol-C gene of the TLDNA of Ri plasmid (Sagaya et al. (1989) <highlight><italic>Plant Cell Physiol. </italic></highlight>30:649-654), and the phloem-specific region of the pRVC-S-3A promoter (Aoyagi et al. (1988) <highlight><italic>Mol. Gen. Genet. </italic></highlight>213:179-185). </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> Heat-shock promoters, the ribulose-1,6-bisphosphate (RUBP) carboxylase small subunit (ssu) promoter, tissue specific promoters, and the like can be used for regulated expression of plant genes. Developmentally-regulated, stress-induced, wound-induced or pathogen-induced promoters are also useful. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> The regulatory region may be responsive to a physical stimulus, such as light, as with the RUBP carboxylase ssu promoter, differentiation signals, or metabolites. The time and level of expression of the sense or antisense orientation can have a definite effect on the phenotype produced. Therefore, the promoters chosen, coupled with the orientation of the exogenous DNA, and site of integration of a vector in the genome, will determine the effect of the introduced gene. </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> Specific examples of regulated promoters also include, but are not limited to, the low temperature Kin1 and cor6.6 promoters (Wang et al (1995) <highlight><italic>Plant Mol. Biol. </italic></highlight>28:605; Wang et al. (1995) <highlight><italic>Plant Mol. Biol. </italic></highlight>28:619-634), the ABA inducible promoter (Marcotte Jr. et al. (1989) <highlight><italic>Plant Cell </italic></highlight>1:969-976), heat shock promoters, such as the inducible hsp70 heat shock promoter of <highlight><italic>Drosphilia melanogaster </italic></highlight>(Freeling, M. et al. (1985) <highlight><italic>Ann. Rev. of Genetics </italic></highlight>19: 297-323), the cold inducible promoter from <highlight><italic>B. napus </italic></highlight>(White, T. C. et al. (1994) <highlight><italic>Plant Physiol. </italic></highlight>106:917), the alcohol dehydrogenase promoter which is induced by ethanol (Nagao, R. T. et al., Miflin, B. J., Ed. Oxford Surveys of <highlight><italic>Plant Molecular and Cell Biology</italic></highlight>, Vol. 3, p 384-438, Oxford University Press, Oxford 1986), the phloem-specific sucrose synthase ASUS1 promoter from Arabidopsis (Martin et al. (1993) <highlight><italic>Plant J. </italic></highlight>4:367-377), the ACS1 promoter (Rodrigues-Pousada et al. (1993) <highlight><italic>Plant Cell </italic></highlight>5:897-911), the 22 kDa zein protein promoter from maize (Unger et al. (1993) <highlight><italic>Plant Cell </italic></highlight>5:831-841), the ps1 lectin promoter of pea (de Pater et al. (1993) <highlight><italic>Plant Cell </italic></highlight>5:877-886), the phas promoter from <highlight><italic>Phaseolus vulgaris </italic></highlight>(Frisch et al. (1995) <highlight><italic>Plant J. </italic></highlight>7:503-512), the lea promoter (Thomas, T. L. (1993) <highlight><italic>Plant Cell </italic></highlight>5:1401-1410), the E8 gene promoter from tomato (Cordes et al. (1989) <highlight><italic>Plant Cell </italic></highlight>1:1025-1034), the PCNA promoter (Kosugi et al. (1995) <highlight><italic>Plant J. </italic></highlight>7:877-886), the NTP303 promoter (Weterings et al. (1995) <highlight><italic>Plant J. </italic></highlight>8:55-63), the OSEM promoter (Hattori et al. (1995) <highlight><italic>Plant J. </italic></highlight>7:913-925), the ADP GP promoter from potato (Muller-Rober et al. (1994) <highlight><italic>Plant Cell </italic></highlight>6:601-604), the Myb promoter from barley (Wissenbach et al. (1993) <highlight><italic>Plant J. </italic></highlight>4:411-422), and the plastocyanin promoter from Arabidopsis (Vorst et al. (1993) <highlight><italic>Plant J. </italic></highlight>4:933-945). </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> The nucleic acid can be introduced into plant cells by a method appropriate to the type of host cells (e.g., transformation, electroporation, transfection, infection). For the purposes of this disclosure, the terms &ldquo;transformed with&rdquo;, &ldquo;transformant&rdquo;, &ldquo;transformation&rdquo;, &ldquo;transfect with&rdquo;, and &ldquo;transfection&rdquo; all refer to the introduction of a nucleic acid into a cell by one of the numerous methods known to persons skilled in the art. Transformation of prokaryotic cells, for example, is commonly achieved by treating the cells with calcium chloride so as to render them &ldquo;competent&rdquo; to take up exogenous DNA, and then mixing such DNA with the competent cells. Prokaryotic cells can also be infected with a recombinant bacteriophage vector. </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> Any suitable technique can be used to introduce the nucleic acids and constructs of this invention to produce transgenic plants with an altered genome. Nucleic acids can be introduced into cells of higher organisms by viral infection, bacteria-mediated transfer (e.g., Agrobacterium T-DNA delivery system), electroporation, calcium phosphate co-precipitation, microinjection, lipofection, bombardment with nucleic-acid coated particles, mixing with silicon carbide &ldquo;whiskers&rdquo;, floral dip method or other techniques, depending on the particular cell type. &ldquo;Introduction&rdquo;, as used herein, of a nucleic acid into a plant, plant cell, plant part or tissue culture, is intended to include both those methods of transformation that are known and used with single-celled organisms (e.g., bacteria, yeast, etc.), and also those methods that are known and used for moving nucleic acid into plants, plant cells, plant parts and tissue cultures. </paragraph>
<paragraph id="P-0114" lvl="0"><number>&lsqb;0114&rsqb;</number> For grasses such as maize and sorghum, for instance, microprojectile bombardment (see for example, Sanford, J. C. et al., U.S. Pat. No. 5,100,792 (1992) can be used. In this embodiment, a nucleotide construct or a vector containing the construct is coated onto small particles which are then introduced into the targeted tissue (cells) via high velocity ballistic penetration. The vector can be any vector which permits the expression of the exogenous DNA in plant cells into which the vector is introduced. The transformed cells are then cultivated under conditions appropriate for the regeneration of plants, resulting in production of transgenic plants. </paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> Other useful protocols for the transformation of plant cells are provided in Gelvin et al., 1992. Suitable protocols for transforming and transfecting cells are also found in Sambrook et al., 1989. The nucleic acid constructs of this invention can also be incorporated into specific plant parts through the transformation and transfection techniques described herein. The constructs and methods of this invention can be adapted to any plant part, protoplast, or tissue culture wherein the tissue is derived from a photosynthetic organism. The term &ldquo;plant part&rdquo; is meant to include a portion of a plant capable of producing a regenerated plant. Preferable plant parts include cells, roots, shoots and meristematic portions thereof. Other plant parts encompassed by this invention are: leaves, stems, roots, flowers, seeds, epicotyls, hypocotyls, cotyledons, cotyledonary nodes, explants, pollen, ovules, meristematic or embryonic tissue, protoplasts, cells, explants and the like. Transgenic plants can be regenerated from any of these plant parts, including tissue culture or protoplasts, and also from explants. Methods will vary according to the species of plant. </paragraph>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> Other known methods of inserting nucleic acid constructs into plants include Agrobacterium-mediated transformation (see for example Smith, R. H. et al., U.S. Pat. No. 5,164,310 (1992)), electroporation (see for example, Calvin, N., U.S. Pat. No. 5,098,843 (1992)), introduction using laser beams (see for example, Kasuya, T. et al., U.S. Pat. No. 5,013,660 (1991)) or introduction using agents such as polyethylene glycol (see for example Golds, T. et al. (1993) <highlight><italic>Biotechnology </italic></highlight>11:95-97), and the like. In general, plant cells may be transformed with a variety of vectors, such as viral, episomal vectors, Ti plasmid vectors and the like, in accordance with well known procedures. The method of introduction of the nucleic acid into the plant cell is not critical to this invention. </paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> To aid in identification of transformed plant cells, the constructs of this invention are further manipulated to include genes coding for plant selectable markers. Useful selectable markers include enzymes which provide for resistance to an antibiotic such as gentamycin, hygromycin, kanamycin, or the like. Similarly, enzymes providing for production of a compound identifiable by color change such as GUS (&bgr;-glucuronidase), or by luminescence, such as luciferase, are useful. </paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> When cells or protoplasts containing the nucleic acids of the invention are obtained, the cells or protoplasts are regenerated into whole plants. Plant cells which have been transformed can be regenerated using known techniques. It is known that practically all plants can be regenerated from cultured cells or tissues. The transformed cells are then cultivated under conditions appropriate for the regeneration of plants, resulting in production of transgenic plants. Choice of methodology for the regeneration step is not critical, with suitable protocols being available for many varieties of plants, tissues and other photosynthetic organisms. See, e.g., Gelvin S. B. and Schilperoort R. A., eds. <highlight><italic>Plant Molecular Biology Manual, Second Edition</italic></highlight>, Suppl. 1 (1995) Kluwer Academic Publishers, Boston Mass., USA. Plant regeneration from cultured protoplasts is also described in Evans et al., <highlight><italic>Handbook of Plant Cell Cultures</italic></highlight>, Vol. 1, MacMillan Publishing Co. New York, 1983; and Vasil I. R., ed., <highlight><italic>Cell Culture and Somatic Cell Genetics of Plants</italic></highlight>, Academic Press, Orlando, Fla., USA, Vol. 1, 1984, and Vol. II, 1986). </paragraph>
<paragraph id="P-0119" lvl="0"><number>&lsqb;0119&rsqb;</number> Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing transformed explants is first provided. Callus tissue is formed and shoots may be induced from callus and subsequently rooted. Alternatively, somatic embryo formation can be induced in the callus tissue. These somatic embryos germinate as natural embryos to form plants. The culture media will generally contain various amino acids and plant hormones, such as auxin and cytokinins. It is also advantageous to add glutamic acid and proline to the medium, especially for such species as corn and alfalfa. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these three variables are controlled, then regeneration is usually reproducible and repeatable. The regenerated plants are transferred to standard soil conditions and cultivated in a conventional manner. </paragraph>
<paragraph id="P-0120" lvl="0"><number>&lsqb;0120&rsqb;</number> Because of the plasticity of culture of many plant species, the terms &ldquo;plant&rdquo;, &ldquo;plant part&rdquo;, &ldquo;plant cell&rdquo;, and &ldquo;tissue culture&rdquo; are intended to be used somewhat interchangably herein. For instance, it is possible, indeed common in the art of plant transformation and tissue culture, for one to transform either a plant, a plant part, one or more plant cells, and/or a tissue culture. Once transformed, any of these may be maintained for a time, converted to another, subcultured, and regenerated into a whole plant, from which seed may then be grown. As an example, one can use microparticle bombardment to transform cells in a single leaf on a plant. The plant may then be grown for a time (or not), and the leaf then separated from the plant, and either maintained on growth medium as a leaf, or (through changing the media components) grown as callus (undifferentiated tissue) or protoplasts (single plant cells). At such point, the callus or protoplasts may be either subcultured further as callus or protoplasts, or the callus may be converted to protoplasts, and vice versa. Either may be grown to generate individual plant parts (by manipulation of the hormone conditions in the media to preferentially produce roots and/or shoots, etc.), or to regenerate into whole plants (also by hormone manipulation). The regenerated plant may then again be cultured into plant parts, cuttings, plant cells, callus, tissue cultures, etc., or may be grown for seed. Because of this plasticity, &ldquo;transgenic plant&rdquo; is intended to encompass any subculturing, regenerant, seed, or progeny of the transgenic plant, that carries the introduced nucleic acid. It is also due to this plasticity that the term &ldquo;derived from&rdquo; is intended to encompass plants, plant parts, plant cells, tissue cultures and explants that are descended from a given plant. For instance, in the case where a descendant corn plant that has been regenerated from a callus culture which was grown from transformed protoplasts taken from a leaf of an originating maize plant, the descendant plant is said to be &ldquo;derived from&rdquo; the originating maize plant. The intervening protoplasts and callus are also said to be &ldquo;derived from&rdquo; the originating maize plant. </paragraph>
<paragraph id="P-0121" lvl="0"><number>&lsqb;0121&rsqb;</number> The methods of this invention can be used with in planta or seed transformation techniques which do not require culture or regeneration. Examples of these techniques are described in Bechtold, N. et al. (1993) <highlight><italic>C.R. Acad. Sci. Paris/Life Sciences </italic></highlight>316:118-93; Chang, S. S. et al. (1990) <highlight><italic>Abstracts of the Fourth International Conference on Arabidopsis Research</italic></highlight>, Vienna, p. 28; Feldmann, K. A. and Marks, D. M (1987) <highlight><italic>Mol. Gen. Genet. </italic></highlight>208:1-9; Ledoux, L. et al. (1985) <highlight><italic>Arabidopsis Inf. Serv. </italic></highlight>22: 1-11; Feldmann, K. A. (1992) In: <highlight><italic>Methods in Arabidopsis Research </italic></highlight>(Eds. Koncz, C., Chua, N-H, Schell, J.) pp. 274-289; Chee et al., U.S. Pat. No. 5,376,543. </paragraph>
<paragraph id="P-0122" lvl="0"><number>&lsqb;0122&rsqb;</number> After the nucleic acid to be introduced is stably incorporated into regenerated transgenic plants, it can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed. The plants are grown and harvested using conventional procedures. Such plants, if they continue to contain the introduced nucleic acid of the invention, are intended to be a &ldquo;transgenic plant&rdquo;, as the term is used herein. </paragraph>
<paragraph id="P-0123" lvl="0"><number>&lsqb;0123&rsqb;</number> Transgenic plants carrying the construct are examined for the desired phenotype using a variety of methods including, but not limited to, an appropriate phenotypic marker, such as antibiotic resistance or herbicide resistance, or visual observation, or biochemical or other methods of assaying the transgenic plant compared to a corresponding non-transgenic plant. By &ldquo;corresponding non-transgenic plant&rdquo; is meant a plant of the same species, and if applicable, same cultivar, variety, or genetic background, that was not transformed. </paragraph>
<paragraph id="P-0124" lvl="0"><number>&lsqb;0124&rsqb;</number> Any suitable plant can be used in the compositions and methods of the present invention. Such transgenic plants include, in one embodiment, transgenic plants which are angiosperms, both monocotyledons and dicotyledons. Transgenic plants include those into which DNA has been introduced and their progeny, produced from seed, vegetative propagation, cell, tissue or protoplast culture, or the like. </paragraph>
<paragraph id="P-0125" lvl="0"><number>&lsqb;0125&rsqb;</number> The constructs and methods described herein can be applied to all types of plants and other photosynthetic organisms, including, but not limited to: angiosperms (monocots and dicots), gymnosperms, spore-bearing or vegetatively-reproducing plants and the algae, including the cyanophyta (blue-green algae). Particularly preferred plants are those plants which provide commercially-valuable food crops such as the large and small grains (e.g., corn, wheat, rice, sorghum, etc.), oil plants (e.g., canola, sunflower, corn, soybean, peanut, etc.), vegetable crops (e.g., luttuce, spinach, pepper, potatoes, tomatoes, broccoli, carrots, peas, beans, etc.), fruits (e.g., apple, plum, orange, lemon, etc.), ornamental plants (e.g., rose, cut flowers, etc.), and other commercially-important plants (e.g., cotton, sugar cane, sugar beet, tobacco, grasses, etc.). </paragraph>
<paragraph id="P-0126" lvl="0"><number>&lsqb;0126&rsqb;</number> Seed can be obtained from the regenerated plant or from a cross between the regenerated plant and a suitable plant of the same species. Seed may also be obtained from plant parts, e.g., meristems grown in tissue culture. Alternatively, the plant can be vegetatively propagated by culturing plant parts under conditions suitable for the regeneration of such plant parts. </paragraph>
<paragraph id="P-0127" lvl="0"><number>&lsqb;0127&rsqb;</number> The nucleic acid and amino acid sequences of the present invention can be used in a variety of ways, e.g., the transgenic plants containing the BON1, BON2, BON3, the BAP1 and/or the BAL mutant(s) can be used to produce plants which grow slowly at lower temperatures. Such a trait would be useful in turf grasses, for instance, where it may be undesirable or labor-intensive to maintain, e.g., in low-traffic areas where the appearance of lawn is to be maintained, but the labor of mowing can be reduced. </paragraph>
<paragraph id="P-0128" lvl="0"><number>&lsqb;0128&rsqb;</number> Such miniaturized plants can be used in situations where a normal-sized plant or plant product is less desirable, e.g., miniaturized ornamental plants, such as smaller flower, vegetable or fruit plants for use by apartment residents, &ldquo;no-care&rdquo; bonsai trees, miniature water lilies, miniature fruits as novelties, etc., or low growth where extensive growth is undesirable. </paragraph>
<paragraph id="P-0129" lvl="0"><number>&lsqb;0129&rsqb;</number> Another embodiment of the invention is the production of &ldquo;baby vegetables.&rdquo; &ldquo;Baby corn,&rdquo; for instance, is very popular in Asian cuisine, and is the ear or maize which has been harvested young, before pollination has taken place, either before the silks have emerged, or just after, depending on the cultivar. Because baby corn is the immature ear of conventional maize, a great deal of land must be used to produce this vegetable, and the plants themselves are close to full height when the ears are produced. </paragraph>
<paragraph id="P-0130" lvl="0"><number>&lsqb;0130&rsqb;</number> By transforming a BON1-GUS fusion into maize protoplasts, as described below, bon1 corn plants can be made which grow as miniatures at cool temperatures. By sowing such plants in the fall in a relatively southern climate, e.g., southern Georgia or northern Florida, the plants will grow as miniatures during the cooler (but not freezing) winter. Such corn, planted for baby corn production, can be grown at a much higher density than standard-sized corn plants, and during a time of year when other crops are not grown. Other &ldquo;baby&rdquo; vegetables can also be grown in this way, such as baby turnips, eggplants, and carrots. </paragraph>
<paragraph id="P-0131" lvl="0"><number>&lsqb;0131&rsqb;</number> Another embodiment of the invention is a method of producing a transgenic plant that is able to grown at a higher altitude or in a cooler temperature region that a corresponding non-transgenic plant, comprising introducing into the plant an isolated nucleic acid that enhances BON1, BON2, BON3, BAP1 and/or BAL in the plant. The invention also encompases the plant produced by the method, where the plant are able to be grown at a higher altitude or in a cooler temperature region that a corresponding non-transgenic plant. </paragraph>
<paragraph id="P-0132" lvl="0"><number>&lsqb;0132&rsqb;</number> Another embodiment of the invention is the production of larger plants, or plants that grow at lower than normal temperatures or to modulate homeostasis at higher altitudes. Such plants can be produced by enhancing BON1, BON2, BON3 or BAP1, e.g., by overexpression as described herein. Such larger plants can be used in situations where larger fruits or vegetables are desired, or where increased biomass (total amount of vegetable matter produced by the plant per unit of land) is desired, e.g., for biomass for paper production. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES </heading>
</section>
<section>
<heading lvl="1">Example 1 </heading>
</section>
<section>
<heading lvl="1">Plant Growth Homeostasis is Controlled by the Arabidopsis BON1 and BAP1 Genes </heading>
<paragraph id="P-0133" lvl="7"><number>&lsqb;0133&rsqb;</number> Experimental Procedures </paragraph>
<paragraph id="P-0134" lvl="7"><number>&lsqb;0134&rsqb;</number> Isolation and Characterization of the bon1 Mutant </paragraph>
<paragraph id="P-0135" lvl="0"><number>&lsqb;0135&rsqb;</number> Several mutant pools from Arabidopsis Biological Resource Center were screened for leaf expansion mutants. Approximately 300 plants were grown per flat (26 cm&times;52 cm) for phenotypic screening. bon1-1 was isolated from the activation tagging lines in Col background (Weigel, D. et al. (2000) <highlight><italic>Plant Physiol. </italic></highlight>122(4):1003-13). </paragraph>
<paragraph id="P-0136" lvl="0"><number>&lsqb;0136&rsqb;</number> For scanning microscopy, plant material was fixed overnight at 4&deg; C. in 3% glutaraldehyde in 25 mM phosphate buffer (pH 7.0), dehydrated through ethanol serials, critical-point dried, gold sputter-coated, and examined by scanning electron microscope. Images were taken and the cell dimensions were analyzed using the NIH imaging program. </paragraph>
<paragraph id="P-0137" lvl="7"><number>&lsqb;0137&rsqb;</number> Cloning of the BON1 Gene </paragraph>
<paragraph id="P-0138" lvl="0"><number>&lsqb;0138&rsqb;</number> A 0.5 kb genomic fragment outside the left border of the T-DNA was rescued by using Universal Genome Walker kit (Clontech, Palo Alto, Calif., USA). The sequence of this 0.5 kb fragment revealed its location on TAC clone K22G18 from the Arabidopsis Biological Resource Center. A 6.5 kb BamHI fragment containing the gene was subcloned from this TAC clone. Using the same 0.5 kb fragment, a cDNA clone was isolated from an Arabidopsis cDNA library CD4-14 obtained from the Arabidopsis Biological Resource Center. </paragraph>
<paragraph id="P-0139" lvl="7"><number>&lsqb;0139&rsqb;</number> Constructs </paragraph>
<paragraph id="P-0140" lvl="0"><number>&lsqb;0140&rsqb;</number> For complementation, a 6.5 kb BamHI genomic fragment of BON1 was cloned into pCGN1548 (McBride, K. E. and K. R. Summerfelt (1990) <highlight><italic>Plant Mol. Biol. </italic></highlight>14:269-276) and pCGN-NOS with 3&prime;-NOS added in pCGN1548. For BON1-GFP fusion, a full-length cDNA of this gene was cloned into a GFP expression vector (Chiu, W., Y. Niwa et al. (1996) <highlight><italic>Curr. Biol. </italic></highlight>6(3): 325-30). For BON1-GUS fusion, a 5 kb BamHI/BglII fragment was cloned into PZP212 vector (Diener, A. C., H. Li et al. (2000) <highlight><italic>Plant Cell </italic></highlight>12(6):853-70). For BON1-HA fusion, a BamHI site was introduced by PCR method to the genomic BON1 gene to replace the stop codon. The 3&times;HA epitope was amplified and ligated into the BamHI site at the last codon of BON1 so that it would be in frame with BON1. The BON1-HA fusion was then inserted into pCGN-NOS. </paragraph>
<paragraph id="P-0141" lvl="7"><number>&lsqb;0141&rsqb;</number> RNA and DNA Analysis </paragraph>
<paragraph id="P-0142" lvl="0"><number>&lsqb;0142&rsqb;</number> Standard molecular techniques were used (Sambrook, J., E. F. Fritsch et al. (1989) <highlight><italic>Molecular Cloning, a Laboratory Manual</italic></highlight>, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., USA). Total RNA was prepared using Tri Reagent (Molecular Research Center, Inc., Cincinnati, Ohio, USA). </paragraph>
<paragraph id="P-0143" lvl="7"><number>&lsqb;0143&rsqb;</number> Plant Transformation </paragraph>
<paragraph id="P-0144" lvl="0"><number>&lsqb;0144&rsqb;</number> Plasmids were introduced into Agrobacterium strain ASE (Fraley, R. T., S. G. Rogers et al. (1985) <highlight><italic>Bio/Technology </italic></highlight>3:629-635) or GV3101 (Koncz, C., J. Schell (1986) <highlight><italic>Mol. Gen. Genet. </italic></highlight>204:383-396) by electroporation, and transformed into wild-type Col-0, bon1-1/&plus; or bon1-1 by the floral dip method (Clough, S. J. and A. F. Bent (1998) <highlight><italic>Plant J. </italic></highlight>16(6):735-43). </paragraph>
<paragraph id="P-0145" lvl="7"><number>&lsqb;0145&rsqb;</number> GUS Staining </paragraph>
<paragraph id="P-0146" lvl="0"><number>&lsqb;0146&rsqb;</number> Plant material was prefixed on ice in 90% acetone for 15 minutes, rinsed in staining buffer without X-Gluc (cyclohexylammonium salt), infiltrated with staining solution (50 mM NaPO<highlight><subscript>4 </subscript></highlight>pH 7.2, 0.5 mM K<highlight><subscript>3</subscript></highlight>Fe(CN)<highlight><subscript>6</subscript></highlight>, 0.5 mM K<highlight><subscript>4</subscript></highlight>Fe(CN)<highlight><subscript>6</subscript></highlight>, 2 mM XGluc) under vacuum for 15 minutes, and incubate at 37&deg; C. for overnight. Materials were then dehydrated in an ethanol series. </paragraph>
<paragraph id="P-0147" lvl="7"><number>&lsqb;0147&rsqb;</number> Protein Analysis </paragraph>
<paragraph id="P-0148" lvl="0"><number>&lsqb;0148&rsqb;</number> For total protein extraction, rosettes were homogenized in extraction buffer (12% sucrose, 100 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 mM DTT, and proteinase inhibitors (Calbiochem, La Jolla, Calif., USA) with chilled mortar and pestle. The mixture was spun at 15,000 rpm in a microcentrifuge for 5 minutes to remove insoluble debris. To assay the effects of different reagents on the association of BON1 with the membrane, supernatant was incubated for 1 hour on ice with equal volume of buffer to make the final concentration of 0.5 M NaCl, 0.1 M Na<highlight><subscript>2</subscript></highlight>CO<highlight><subscript>3</subscript></highlight>, 2.5 M urea, 1% TritonX100, and 1% sarcosyl, respectively. The soluble and pellet fractions were separated by centrifuging the supernatant at 100,000 g for 1 hour. </paragraph>
<paragraph id="P-0149" lvl="7"><number>&lsqb;0149&rsqb;</number> Western Blot </paragraph>
<paragraph id="P-0150" lvl="0"><number>&lsqb;0150&rsqb;</number> Proteins were run on 4-20% Ready-gel (Bio-Rad, Hercules, Calif., USA) and transferred to PVDF membrane (NEN Life Sciences, Inc. Products, Boston, Mass., USA). Membranes were blocked with 5% non-fat dry milk in PBT (phosphate-buffered saline with 0.1% Tween 20), incubated with primary and then secondary antibodies in 2% milk, and detected with ECL (Amersham Pharmacia Biotech, Arlington Heights, Ill., USA). HA antibody was purchased from BAbCo (Berkeley Antibody Company, Inc., Richmond, Calif., USA). </paragraph>
<paragraph id="P-0151" lvl="7"><number>&lsqb;0151&rsqb;</number> Membrane Fractionation and Analysis </paragraph>
<paragraph id="P-0152" lvl="0"><number>&lsqb;0152&rsqb;</number> The procedure was adapted from a method described previously (Schaller, G. E. and N. D. DeWitt (1995) <highlight><italic>Methods Cell Biol. </italic></highlight>50:129-48). Briefly, 3-week-old leaves grown in liquid medium of MS salt, 2% sucrose, and B5 vitamins were homogenized in extraction buffer (50 mM Tris pH 8, 2 mM EDTA, 20% glycerol, 1 mM DTT, and the proteinase inhibitor cocktail (Calbiochem, La Jolla, Calif., USA). Homogenate was filtered through Miracloth (Calbiochem, La Jolla, Calif., USA) and centrifuged at 5,000g for 5 minutes to remove organelles and debris. Supernatants were centrifuged at 100,000 g for 1 hour to pellet microsomal membranes. Membrane pellets were resuspended in buffer (25 mM Tris pH 7.5, 10% sucrose, 2 mM EDTA, 1 mM DTT, and proteinase inhibitors) at 0.625 ml/10 g starting material. Microsomes (0.5 ml) were then layered onto a 15 ml sucrose gradient of 25% to 50% and centrifuged at 100,000 g for 16 hours. Fractions of 1 ml were collected and analyzed. Fractions containing ER, vacuole, and PM were identified by Western blot using marker enzymes. Fractions containing Golgi were identified by enyzmatic analysis of Triton-stimulated UDPase. </paragraph>
<paragraph id="P-0153" lvl="7"><number>&lsqb;0153&rsqb;</number> Arabidopsis Protoplast Transient Expression and Confocal Microscopy </paragraph>
<paragraph id="P-0154" lvl="0"><number>&lsqb;0154&rsqb;</number> Leaf mesophyll protoplasts were isolated from 3-week-old Arabidopsis plants and were transfected by a modified polyethylene glycol method as described previously (Abel, S. and A. Theologis (1994) <highlight><italic>Plant J. </italic></highlight>5(3):421-7). 10,000 protoplasts were transfected with 10 &mgr;g of DNA and then incubated at 23&deg; C. for 9 hours before subcelluar localization was determined with a confocal microscope. Confocal laser scanning micrographs of transfected protoplasts were recorded using a Leica microscope (Leica Microsystems, Heidelburg, Germany) equipped with a laser scanning unit (TCS NT). </paragraph>
<paragraph id="P-0155" lvl="7"><number>&lsqb;0155&rsqb;</number> Protein Expression in <highlight><italic>E. coli </italic></highlight></paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> Full length, 2C2 domain (M1 to G308), and A domain (V319 to P578) were amplified from BON1 cDNA and cloned into a vector pKS L 1 (under T7 promoter, with 6&times; His tags at the N-terminus). The constructs were transformed into BL21plyS (Novagen, Madison, Wis., USA). Protein was induced with 1 mM IPTG at 25&deg; C. for 10 hours. Proteins were purified with Ni-NTA agarose beads (Qiagen, Valencia, Calif., USA) according to instructions. </paragraph>
<paragraph id="P-0157" lvl="7"><number>&lsqb;0157&rsqb;</number> Two Hybrid Screen </paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> DNA was prepared from the <highlight><italic>Arabidopsis thaliana </italic></highlight>MATCHMAKER cDNA library in <highlight><italic>E. coli </italic></highlight>(Clontech, Palo Alto, Calif., USA). The library complexity was 3&times;10<highlight><superscript>6</superscript></highlight>. DNA was transformed into yeast strain PJ69-4&agr; (James, P., J. Halladay et al. (1996) <highlight><italic>Genetics </italic></highlight>144(4):1425-36) and 2.5&times;10<highlight><superscript>7 </superscript></highlight>yeast transformants were pooled as the library. The bait (A domain of BON1) was cloned between EcoRI and BamHI sites of pGBD-C2 and transformed into PJ49-4a. The library a cells were mated with the bait A cells. A screening protocol (Robertson, L. S., H. C. Causton et al. (2000) <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>97(11):5984-8) was followed. Approximately 10<highlight><superscript>8 </superscript></highlight>diploid cells were plated onto SC Ade<highlight><superscript>&minus;</superscript></highlight> and His-medium supplemented with 40 mM of 3-AT. About 80 clones retested positively were chosen for plasmid rescue. </paragraph>
<paragraph id="P-0159" lvl="7"><number>&lsqb;0159&rsqb;</number> Results </paragraph>
<paragraph id="P-0160" lvl="7"><number>&lsqb;0160&rsqb;</number> BON1 is a Gene Required for Normal Plant Size at 22&deg; C. </paragraph>
<paragraph id="P-0161" lvl="0"><number>&lsqb;0161&rsqb;</number> To obtain mutants that have a restricted temperature range for normal development, a screen was conducted for Arabidopsis strains that were miniature when grown at one temperature but not at another. This screen uncovered a mutant, bon1, that exhibits a dwarf phenotype at 22&deg; C. (<cross-reference target="DRAWINGS">FIG. 1A</cross-reference>), but has a phenotype indistinguishable from that of the wild type at 28&deg; C. (<cross-reference target="DRAWINGS">FIG. 1B</cross-reference>), which is the normal growth temperature for wild type Arabidopsis. This temperature dependent phenotype is not an allele-specific phenomenon because bon1-1 is a loss-of-function mutant (see below). </paragraph>
<paragraph id="P-0162" lvl="0"><number>&lsqb;0162&rsqb;</number> At 22&deg; C., the bon1-1 leaves are greatly reduced in size and have a curved morphology (<cross-reference target="DRAWINGS">FIG. 1C</cross-reference>). The inflorescence stem is thinner and shorter than the wild type (<cross-reference target="DRAWINGS">FIG. 1D</cross-reference>). Despite the smaller size of the leaves and stems at 22&deg; C., bon1-1 plants nevertheless develop relatively normal flowers and siliques and are completely fertile. bon1-1 does not have a dramatic effect on the timing of developmental process. It bolts and sets seeds only slightly earlier than the wild type. The bon1 phenotype is genetically distinct from that of previously identified hormonal dwarf mutants such as axr1, det2, or ctr1. The bon1-1 defect cannot be rescued by the addition of hormones such as gibberellin or brassinosteroid, or by mutations in hormonal signaling. Moreover, the bon1-1 mutant is distinct from the cold-sensitive mutants deficient in the desaturation of the lipids in the membranes (Lightner, J., D. W. J. James et al. (1994) <highlight><italic>Plant J. </italic></highlight>6(3):401-412) because bon1-1 does not have an altered lipid composition or altered composition of saturated fatty acids in the lipids. These observations suggest that BON1 functions to maintain plant morphology through a novel mechanism. </paragraph>
<paragraph id="P-0163" lvl="7"><number>&lsqb;0163&rsqb;</number> BON1 is Required to Maintain Cell Size and Number at 22&deg; C. </paragraph>
<paragraph id="P-0164" lvl="0"><number>&lsqb;0164&rsqb;</number> Using scanning electron microscope (SEM), the width and length of the epidermal cells of the inflorescence stems grown at 22&deg; C. were measured. The results are shown in the Table below.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0" pgwide="1">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="273PT" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" align="center">TABLE</entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Cell size and number of the stem epidermal cells in the wild type and bon1-1.</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="42PT" align="center"/>
<colspec colname="2" colwidth="35PT" align="center"/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="35PT" align="center"/>
<colspec colname="5" colwidth="49PT" align="center"/>
<colspec colname="6" colwidth="42PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry></entry>
<entry>stem</entry>
<entry></entry>
<entry>cell number</entry>
<entry>cell number</entry>
</row>
<row>
<entry></entry>
<entry>stem length</entry>
<entry>cell length</entry>
<entry>diameter</entry>
<entry>cell width</entry>
<entry>per</entry>
<entry>per</entry>
</row>
<row>
<entry></entry>
<entry>(cm)</entry>
<entry>(mm)</entry>
<entry>(cm)</entry>
<entry>(mm)</entry>
<entry>circumference</entry>
<entry>stem file</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="6" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="7">
<colspec colname="1" colwidth="35PT" align="center"/>
<colspec colname="2" colwidth="42PT" align="char" char="."/>
<colspec colname="3" colwidth="35PT" align="center"/>
<colspec colname="4" colwidth="35PT" align="char" char="."/>
<colspec colname="5" colwidth="35PT" align="center"/>
<colspec colname="6" colwidth="49PT" align="char" char="."/>
<colspec colname="7" colwidth="42PT" align="center"/>
<tbody valign="top">
<row>
<entry>wild type</entry>
<entry>18</entry>
<entry>288 &plusmn; 55</entry>
<entry>1.0</entry>
<entry>18&plusmn; 2</entry>
<entry>&tilde;174</entry>
<entry>&tilde;625</entry>
</row>
<row>
<entry>bon1-1</entry>
<entry>2.2</entry>
<entry>&ensp;40 &plusmn; 9&ensp;</entry>
<entry>0.38</entry>
<entry>12&plusmn; 1</entry>
<entry>&tilde;99</entry>
<entry>&tilde;550</entry>
</row>
<row><entry namest="1" nameend="7" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0165" lvl="7"><number>&lsqb;0165&rsqb;</number> The length of the bon1-1 cells is approximately seven times shorter than that of the wild type, which accounts for most of the eight-fold reduction in bon1 stem length at the non-permissive temperature. A bon1-1 cell is about two-thirds as wide as the wild-type cell. There are also half as many cells per epidermal circumference in a bon1-1 mutant as there are in the wild type, although the number of cells along the length of the same was nearly the same as in the wild type. Analysis of whole stem cross sections revealed similar defects in the inner cells: there were fewer and smaller inner cells inside the stem. Reduction in the size of the pavement cells was observed by SEM on the leaf epidermis. Taken together, these data show that the small size of bon1-1 during growth at 22&deg; C. results from a reduction in both cell size and cell number. </paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> Temperature shift experiments were used to determine at what period of development BON1 function is required for growth. When bon1-1 plants were shifted from 22&deg; C. to 28&deg; C., the new stems and leaves that formed at 28&deg; C. had normal expansion and elongation in contrast with the miniature stems and leaves formed when plants were grown 22&deg; C. (<cross-reference target="DRAWINGS">FIG. 1E</cross-reference>). Conversely, after bon1-1 was shifted from 28&deg; C. to 22&deg; C., the new leaves and stems that formed at 22&deg; C. had a -miniature phenotype (<cross-reference target="DRAWINGS">FIG. 1F</cross-reference>). These data show that BON1 is required continuously for normal growth of leaves and stems at 22&deg; C. </paragraph>
<paragraph id="P-0167" lvl="7"><number>&lsqb;0167&rsqb;</number> BON1 is Expressed in Growing Tissues and the Expression is Modulated by Temperature. </paragraph>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> The BON1 gene was cloned on the basis of the T-DNA insertion that results in the bon1 phenotype. The mutation, which segregated as a single recessive trait in the F<highlight><subscript>2 </subscript></highlight>populations of a backcross to wild-type Columbia, was completely linked to the single T-DNA insertion in this mutant. A 6.5 kb wild-type genomic fragment was isolated, which flanked the T-DNA and a corresponding cDNA of this genomic fragment. Sequence alignment of the genomic fragment and the cDNA indicates that the BON1 gene is comprised of 16 exons and 15 introns (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>). The T-DNA is inserted in the twelfth exon of the gene. The bon1-1 mutant defect was complemented either with the genomic fragment or a cDNA-GFP (green fluorescent protein) fusion, confirming the identity of the gene as BON1. Northern blot analysis showed that there was no wild-type RNA transcript of this gene in the mutant, indicating that bon1-1 is a loss-of-function mutant. A second loss-of-function allele bon1-2 (<cross-reference target="DRAWINGS">FIG. 2A</cross-reference>) was subsequently isolated in the Wassilewskijas background and it exhibited a phenotype similar to that of bon1-1 when introduced into the Columbia background. </paragraph>
<paragraph id="P-0169" lvl="0"><number>&lsqb;0169&rsqb;</number> The BON1 gene is predicted to encode a protein of 578 amino acids. The N-terminal portion of the protein consists of two calcium-dependent phospholipid-binding C2 domains (C2A and C2B) and the C-terminal portion exhibits weak similarity to the A domain of integrin (<cross-reference target="DRAWINGS">FIG. 2B</cross-reference>). The BON1 protein shows extensive homology to the copine gene family. Members of this family have been found in paramecium, worm, mouse, and human and are thought to be calcium-dependent phospholipid binding proteins (Creutz, C. E., J. L. Tomsig et al. (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(3):1393-402). In each organism there is more than one member of the gene family in the genome. <highlight><italic>Arabidopsis thaliana </italic></highlight>BON1 has two paralogs that have been designated BON2 and BON3. These paralogs are between 72-81% identical and 81-91% similar to each other at the amino acid level. These plant proteins are very similar to their human counterparts. Arabidopsis BON1 has 50% identity and 67% similarity to human copine I over the entire sequence, as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0170" lvl="0"><number>&lsqb;0170&rsqb;</number> Analysis of BON1 expression by Northern blots shows that BON1 is expressed at low levels, consistent with its low representation among the population of expression sequence tags (ESTs). Tissue specific Northerns show that expression of BON1 in the leaves and stems is higher than that in roots or flowers, which could explain why leaves and stems are the most severely affected tissues in the bon1-1 mutant. </paragraph>
<paragraph id="P-0171" lvl="0"><number>&lsqb;0171&rsqb;</number> To further analyze the expression of BON1 at the tissue level, a translational fusion of BON1 with a beta-glucuronidase (GUS) reporter gene was made. GUS staining of the BON1-GUS transgenic plants shows that BON1 is more strongly expressed in growing tissues. It was expressed in younger leaves (<cross-reference target="DRAWINGS">FIG. 4A</cross-reference>) but not in older ones (<cross-reference target="DRAWINGS">FIG. 4B</cross-reference>). BON1 was also expressed in the inflorescence stems, and was especially concentrated in the apical elongation portion of the stem (<cross-reference target="DRAWINGS">FIG. 4C</cross-reference>). This expression pattern suggests a direct role of BON1 in regulating cell division and expansion. </paragraph>
<paragraph id="P-0172" lvl="0"><number>&lsqb;0172&rsqb;</number> The level of expression of BON1 RNA is regulated by temperature, especially during later development. Plants were first grown at one temperature for one month and then half of the population was moved to another temperature for 12 hours. The RNA level of BON1 increased about two-fold when plants were shifted from 28&deg; C. to 22&deg; C. (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>D, lanes 1 and 2). Conversely, there was a decrease in BON1 RNA level when plants were moved from 22&deg; C. to 28&deg; C. (<cross-reference target="DRAWINGS">FIG. 4</cross-reference>D, lanes 3 and 4). In plants less than 2 weeks old, BON1 had a relatively high expression level, as compared with older plants. In these plants there was not much difference in the level of BON1 expression between plants grown at 22&deg; C. and those grown at 28&deg; C. </paragraph>
<paragraph id="P-0173" lvl="7"><number>&lsqb;0173&rsqb;</number> BON1 is a Phospholipid Binding Protein Associated with the Plasma Membrane </paragraph>
<paragraph id="P-0174" lvl="0"><number>&lsqb;0174&rsqb;</number> The availability of the cloned BON1 gene, coupled with the mutant phenotype, provides an avenue to determine the biological function of a copine gene family member. BON1 contains two C2 domains at the amino-terminus. C2 domains are Ca<highlight><superscript>2&plus;</superscript></highlight> dependent phospholipid-binding domains that confer calcium and/or phospholipid modulation on the activity of the associated domain (Kopka, J., C. Pical et al. (1998) <highlight><italic>Plant Mol. Biol. </italic></highlight>36(5):627-37). In view of these considerations, whether BON1 protein possesses a phospholipid binding activity in vitro was examined. </paragraph>
<paragraph id="P-0175" lvl="0"><number>&lsqb;0175&rsqb;</number> The binding assay utilized a tagged (6&times; His) BON1 protein that was expressed and purified from <highlight><italic>E. coli</italic></highlight>. Purified recombinant BON1 protein was incubated with or without phospholipid and the mixture was pelleted by centrifugation. The proteins associated with the lipids in the pellets were analyzed by electrophoresis on a gel. In the presence of lipid, three times more of BON1 protein was found in the pelleted fraction (<cross-reference target="DRAWINGS">FIG. 5A</cross-reference>), indicating that BON1 was precipitated by its association with lipid. Addition of calcium to the protein lipid mixture yielded approximately six times more BON1 protein in the pellet (<cross-reference target="DRAWINGS">FIG. 5A</cross-reference>). This is likely due to an enhanced lipid binding activity of BON1 by calcium or an increased lipid aggregation by calcium which leads to more protein precipitation. </paragraph>
<paragraph id="P-0176" lvl="0"><number>&lsqb;0176&rsqb;</number> As the association of BON1 with lipids in vitro and its sequence homology suggest a membrane localization, the association of BON1 with membranes in vivo was tested by determining the localization of BON1 using transgenic plants expressing a HA tagged BON1 gene. This BON1-HA gene is functional because it was able to complement the bon1-1 mutant. Total protein was separated into a microsomal fraction and soluble fraction by ultracentrifugation. BON1-HA was found mainly in the microsomal fraction, indicating that it associates with membranes in the cell (<cross-reference target="DRAWINGS">FIG. 5B</cross-reference>). Several treatments were used to analyze this association. NaCl, urea, or carbonate (pH 111.5) did not alter the distribution of the protein significantly (<cross-reference target="DRAWINGS">FIG. 5B</cross-reference>). These treatments are capable of stripping peripheral proteins from membranes. Reagents that dissolve membranes such as Triton X-100 and sarcosyl redistributed the protein to the soluble fraction (<cross-reference target="DRAWINGS">FIG. 5B</cross-reference>). These observations suggest that BON1 is tightly bound to membranes even though the amino acid sequence of the protein does not predict any membrane spanning domains. Although the association of BON1 with membranes was stable in the presence of EGTA (<cross-reference target="DRAWINGS">FIG. 5C</cross-reference>), the addition of calcium ions partitioned all the BON1 protein to the membrane fraction (<cross-reference target="DRAWINGS">FIG. 5C</cross-reference>). This indicates that calcium enhances the association of BON1 with membranes although it is not absolutely required for it. </paragraph>
<paragraph id="P-0177" lvl="0"><number>&lsqb;0177&rsqb;</number> To identify the membrane system with which BON1 is associated, cell fractionation was carried out to separate different endomembranes and the plasma membrane. BON1-HA was not detected in protein extracts from chloroplast, nuclei or cell walls, but was present in the microsomal fraction. The microsomal fraction of BON1-HA plants was separated on a 25% to 50% (w/v) sucrose gradient. The relative position of various membranes on the gradient was determined by assaying fractions for marker proteins specific to each membrane. The BON1-HA protein exhibited a distribution similar to that of the plasma membrane ATPase (<cross-reference target="DRAWINGS">FIG. 5D</cross-reference>), and distinct from ER, vacuole, and Golgi. </paragraph>
<paragraph id="P-0178" lvl="0"><number>&lsqb;0178&rsqb;</number> The plasma membrane localization of BON1 indicated by cell fractionation was further supported by analysis in a transient expression system. A BON1-GFP fusion under a strong promoter was electroporated into Arabidopsis protoplasts and the expression of GFP was monitored eight hours later with confocal microscope. The GFP signal was mostly concentrated on the outer membrane of protoplasts, indicating a plasma membrane localization. </paragraph>
<paragraph id="P-0179" lvl="7"><number>&lsqb;0179&rsqb;</number> BON1 Enhances Vesicle Aggregation in vitro. </paragraph>
<paragraph id="P-0180" lvl="0"><number>&lsqb;0180&rsqb;</number> One mechanism by which BON1 could stimulate cell expansion and cell division would be to enhance membrane trafficking by facilitating the association and fusion of vesicles with the membrane. The ability of BON1 to enhance vesicle aggregation in vitro was tested using an assay that measures the turbidity of a lipid solution. Aggregation of the lipid vesicles is accompanied by an increase in turbidity (monitored by the absorbance at 540 nm). Constructs encoding the full-length BON1 protein, the N-terminal 2C2 domain, and the C-terminal A domain each with 6&times; His tags were expressed in <highlight><italic>E. coli </italic></highlight>and the resulting His-tagged proteins were purified. These recombinant proteins were incubated with phosphotidyl serine (PS) or phosphotidyl inositol (PI). A difference in turbidity was observed with PS but not PI. Both the full length BON1 protein and the 2C2 domain increased the absorbance of PS solution (<cross-reference target="DRAWINGS">FIG. 6</cross-reference>), indicative of an activity that promotes vesicle aggregation. By contrast, the A domain of the BON1 protein had no effect on the turbidity (<cross-reference target="DRAWINGS">FIG. 6</cross-reference>). As has been previously observed (Creutz, C. E., J. L. Tomsig et al. (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(3):1393-402), addition of calcium alone stimulates the aggregation of vesicles. Addition of calcium in the presence of either the 2C2 domain or the full-length BON1 enhanced the aggregation considerably over the background stimulation observed in the presence of calcium (<cross-reference target="DRAWINGS">FIG. 6</cross-reference>). </paragraph>
<paragraph id="P-0181" lvl="7"><number>&lsqb;0181&rsqb;</number> BAP1 is a BON1 Interacting Protein. </paragraph>
<paragraph id="P-0182" lvl="0"><number>&lsqb;0182&rsqb;</number> The data indicate that BON1 functions to promote vesicle trafficking during cell expansion and division. It is likely that BON1 does so via its interaction with other proteins, so the yeast two hybrid assay was used to look for proteins that interact with BON1. The A domain (from Val<highlight><superscript>319 </superscript></highlight>to Pro<highlight><superscript>578</superscript></highlight>) was used as bait because it is the most likely segment of BON1 to be involved in protein-protein interactions (Creutz, C. E., J. L. Tomsig et al. (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(3):1393-402). A cDNA library made from the vegetative tissues of 3-week-old plants was screened for clones that signaled an interaction with this bait. Twenty-three positive clones rescued from the screen are the same gene, which was called the BON1 Association Protein1 (BAP1). </paragraph>
<paragraph id="P-0183" lvl="0"><number>&lsqb;0183&rsqb;</number> BAP1 encodes a protein of 192 amino acids. The two-hybrid clone comprises the entire BAP1 except for the first 6 amino acids. A blast search reveals that it has homology to another putative Arabidopsis protein in the database which, for purposes of this study, was called BAL:BAP1 Like. SMART (Simple Modular Architecture Research Tool) search indicates that the amino-terminal part of BAP1 (approximately 120 amino acids) has sequence homology and structural analogy to the C2 domain. C2 domain family is very divergent (Rizo, J., T. C. Sudhof (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(26):15879-82), and the C2 domain of BAP1 is not significantly homologous to those of BON1 at the protein sequence level. The C-terminal 52 amino acids of BAP1 is 54% identical to those of BAL, but does not show significant homology to any known motifs. </paragraph>
<paragraph id="P-0184" lvl="7"><number>&lsqb;0184&rsqb;</number> BAP1 Has a Similar Function to BON1. </paragraph>
<paragraph id="P-0185" lvl="0"><number>&lsqb;0185&rsqb;</number> BAP1 is expressed ubiquitously throughout the roots, leaves, stems, and flowers with expression in leaves and stems relatively higher than in other parts of the plant, and BAP1 also has higher expression in roots (<cross-reference target="DRAWINGS">FIG. 7A</cross-reference>). The expression of BAP1, like that of BON1, is modulated by temperature. There was an increase in BAP1 RNA when plants were shifted from higher to lower temperature (<cross-reference target="DRAWINGS">FIG. 7B</cross-reference>). Conversely, higher temperature repressed BAP1 expression (<cross-reference target="DRAWINGS">FIG. 7B</cross-reference>). Moreover, BAP1 expression is affected by BON1. In the bon1-1 mutant, there was more BAP1 transcript and the modulation of its expression by temperature was more pronounced than in wild type (<cross-reference target="DRAWINGS">FIG. 7B</cross-reference>). </paragraph>
<paragraph id="P-0186" lvl="0"><number>&lsqb;0186&rsqb;</number> To identify whether BAP1 has a similar function to that of BON1, the BAP1 gene was expressed under the CaMV 35S promoter and the transgene was introduced into the bon1-1 mutant. If the two proteins are involved in the same event, then overexpression of BAP1 would likely suppress the mutant defects of the bon1 mutant. Of 18 transgenic lines analyzed, nine showed suppression to varying degrees, ranging from good (1), moderate (3), to weak (5) (<cross-reference target="DRAWINGS">FIG. 7C</cross-reference>). Those plants that were partially suppressed had more elongated stems and more expanded leaves than the bon1 mutant. Thus overexpression of BAP1 can suppress the defect in bon1, but the extent of suppression may be modified by the site of transgene integration or transgene silencing. </paragraph>
<paragraph id="P-0187" lvl="7"><number>&lsqb;0187&rsqb;</number> Discussion </paragraph>
<paragraph id="P-0188" lvl="0"><number>&lsqb;0188&rsqb;</number> Loss of BON1 function leads to miniature plants at ambient temperature, due to a reduction in both cell expansion and cell division, but has no obvious phenotype at high temperature. </paragraph>
<paragraph id="P-0189" lvl="0"><number>&lsqb;0189&rsqb;</number> Overexpression of the Arabidopsis BAP1 gene partially suppresses the bon1 phenotype, establishing a functional connection between these two genes. </paragraph>
<paragraph id="P-0190" lvl="0"><number>&lsqb;0190&rsqb;</number> The bon1 phenotype differs from that of a typical cold sensitive mutation in a vital gene. Null mutations in a vital gene would be lethal at all temperatures, whereas BON1 function and BON1 protein are required to maintain normal plant size at low temperature. Mutants with a conditional cold-sensitive phenotype similar to that of bon1 have been identified previously (Tsukaya, H., S. Naito et al. (1993) <highlight><italic>Development </italic></highlight>118:751-764; Akamatsu, T., Y. Hanzawa et al. (1999) <highlight><italic>Plant Physiol. </italic></highlight>121(3):715-22). These mutants, acaulis1, acaulis3 and acaulis4, or acl1, acl3, and acl4, respectively) grow normally at 28&deg; C. and have reduced stem elongation and leaf expansion at the lower temperature. It is possible that they could be involved in the same genetic pathway as BON1 or in a parallel pathway that maintains size at low temperature. However, such conclusions are premature because neither the identity of the genes nor the nature of the mutations responsible for these phenotypes are known. </paragraph>
<paragraph id="P-0191" lvl="0"><number>&lsqb;0191&rsqb;</number> Another Arabidopsis mutant, with increased levels of stearate, also exhibits a miniature phenotype at 22&deg; C., which can be suppressed only at the very high temperature of 36&deg; C. (Lightner, J., D. W. J. James et al. (1994) <highlight><italic>Plant J. </italic></highlight>613):401-412). </paragraph>
<paragraph id="P-0192" lvl="0"><number>&lsqb;0192&rsqb;</number> Further support for the role of BON1 and BAP1 in homeostasis at low temperature comes from analysis of the transcriptional pattern of the two genes. First, BON1 is expressed more strongly in growing tissues than in mature tissues. Second, both BON1 and BAP1 expression are under temperature control in that both have elevated expression when plants are shifted from high to lower temperature. Moreover, the enhancement of BAP1 expression in response to low temperature is more drastic in the bon1 background than in the wild type. These data indicate that BON1 and BAP1 are required for normal growth at lower temperature and that they are upregulated under the conditions where their function is required. There appears to be an additional compensatory stimulation of BAP1 expression when there is insufficient BON1. </paragraph>
<paragraph id="P-0193" lvl="0"><number>&lsqb;0193&rsqb;</number> Study of BON1 provides important insights into the function of the copine gene family, of which BON1 is a member. The copine family includes members from protozoa to humans, but despite its evolutionary conservation, little is known about the function of its members. Previous work in paramecium and mice have shown that copines have lipid binding activity and promote the aggregation of vesicles (Creutz, C. E., J. L. Tomsig et al. (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(3):1393-402). It was suggested that the paramecium copine might be involved in vesicle trafficking because of its association with secretory vesicles (Creutz, C. E., J. L. Tomsig et al. (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(3):1393-402). In mice the N-copine expressed in the hippocampus is induced by kainate stimulation. The protein is detected in neurons, both in the cell bodies and dendrites (Nakayama, T., T. Yaoi et al. (1999) <highlight><italic>J. Neurochem. </italic></highlight>72(1):373-9). Kainate has been reported to stimulate long-term potentiation and it was therefore surmised that N-copine has a role in synaptic plasticity (Nakayama, T., T. Yaoi et al. (1998) <highlight><italic>FEBS Lett. </italic></highlight>428(1-2):80-4). </paragraph>
<paragraph id="P-0194" lvl="0"><number>&lsqb;0194&rsqb;</number> The data described herein indicates that BON1 protein likely regulates membrane biogenesis and cell wall remodeling through exocytosis, which ultimately controls cell size. All copines have a similar domain structure: the C2 amino terminal domain and a carboxyl-terminal A domain. Like the paramecium and mice copines, the full length Arabidopsis BON1 protein and the truncated C2 domain bind phospholipids and the binding is stimulated by calcium. Furthermore, BON1 promotes aggregation of lipid vesicles in vitro. Therefore, all copines may have similar biochemical activities in addition to structural similarities. Previous work provided only a few hints as to the subcellular localization of copines. N-copine was localized to postsynaptic membranes where synaptic plasticity occurs (Nakayama, T., T. Yaoi et al (1999) <highlight><italic>J. Neurochem. </italic></highlight>72(l):373-9) and one of the chromaffin granule-binding proteins (chromobindin 17) is likely to be a copine (Creutz, C. E., J. L. Tomsig et al. (1998) <highlight><italic>J. Biol. Chem. </italic></highlight>273(3):1393-402). The data herein show that BON1 protein is mainly associated with the plasma membrane. </paragraph>
<paragraph id="P-0195" lvl="0"><number>&lsqb;0195&rsqb;</number> It seems likely that the copine BON1 and its interacting protein BAP1 function directly in fusion of vesicles with plasma membrane at low temperature, which is a process that contributes both to membrane growth and wall expansion. Exocytosis is required for cell growth in many organisms and in plant cells a decrease in exocytosis has been shown to decrease cell size (Carroll, A. D., C. Moyen et al. (1998) <highlight><italic>Plant Cell </italic></highlight>10(8): 1267-76). In other systems, the core machinery for vesicle docking and fusion has been identified (Jahn, R. and T. C. Sudhof (1999) <highlight><italic>Annu. Rev. Biochem. </italic></highlight>68:863-911). However it is not well understood how the basic fusion machinery is regulated. As fusion is a temperature-dependent process (Weber, T., B. V. Zemelman et al. (1998) <highlight><italic>Cell </italic></highlight>92(6):759-72), the copine/BAP1 proteins may be required to accelerate a process that occurs less rapidly at low temperature. Indeed, some of the mutations defective in membrane fusion are cold-sensitive in yeast (Lehman, K., G. Rossi et al. (1999) <highlight><italic>J. Cell Biol. </italic></highlight>146(1):125-40; Otte, S., W. J. Belden et al. (2001) <highlight><italic>J. Cell Biol. </italic></highlight>152(3):503-518). </paragraph>
<paragraph id="P-0196" lvl="0"><number>&lsqb;0196&rsqb;</number> It is likely that BON1 functions in temperature homeostasis either by acting catalytically (increasing the fusion of vesicles with the membrane) or structurally (by associating with the plasma membrane to maintain membrane function at low temperature). Recently, a protein kinase activity was attributed to the A domain of human copine m (Caudell, E. G., J. J. Caudell et al. (2000) <highlight><italic>Biochem. </italic></highlight>39(42):13034-43) suggesting that these proteins have enzymatic function. Copines in other organisms may function similarly to accelerate vesicle trafficking in response to specific environmental signals. For example, the neuronal copines could accelerate membrane trafficking at the synapse upon chemical stimulation thereby enhancing synaptic transmission. </paragraph>
<paragraph id="P-0197" lvl="0"><number>&lsqb;0197&rsqb;</number> It is clear, however, that the acl1, acl3 and al4 mutants are not identical to the BON1. In acl1 mutants (Tsukaya, H., S. Naito et al. (1993) <highlight><italic>Development </italic></highlight>118:751-764), the length of the cells is less than that of wild type, as in bon1 mutants, but unlike the bon1 mutants, the number of cells in the leaves and internodes is the same as in wild type plants. In bon1, the number, as well as the size of the cells, is decreased relative to wild type plants. In addition, the acl1 mutants exhibit cessation of development of the inflorescence meristems at 22&deg; C., whereas the meristems in bon1 mutants grow shorter than wild type, but do not cease growth. The acl3 and acl4 mutants were mapped to chromosomes 3 and 4, respectively (Akamatsu, T., Y. Hanzawa et al. (1999) <highlight><italic>Plant Physiol. </italic></highlight>121(3):715-22). BON1 shows some similarity to GenBank accession AB022212, which is located onArabidopsis chromosome 5. BAP1 shows some similarity to GenBank accession AL137898, which is located on Arabidopsis chromosome 3. </paragraph>
</section>
<section>
<heading lvl="1">Example 2 </heading>
</section>
<section>
<heading lvl="1">Transgenic Plants with BON1-GUS Fusion Gene Have bon1 Loss-of-Function Phenotype </heading>
<paragraph id="P-0198" lvl="0"><number>&lsqb;0198&rsqb;</number> The full-length BON1 gene was translationally fused with a reporter gene GUS and transformed to wild type Arabidopsis. The transformants exhibited bon1-1 phenotype in that they were miniature plants with small curly leaves and short stems, very similar to bon1-1. Furthermore, this phenotype was exhibited only at 22&deg; C., but not at 28&deg; C., as was bon1-1. Therefore, the BON1-GUS chimeric gene acts either in a dominant negative fashion or induces cosuppression in wild type plants. </paragraph>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> This finding provides a method to generate miniature plants in other species. The technique to make knockout plants through homologous recombination is not available in any higher plants. It is therefore not possible to make a bon1 mutant in other plant species via homologous recombination. However, transformation techniques are readily available in many plant species, allowing introduction of the BON1-GUS transgene, antisense constructs, or other BON1 chimeras into other species to make miniature plants. </paragraph>
</section>
<section>
<heading lvl="1">Example 3 </heading>
</section>
<section>
<heading lvl="1">Transgenic Plants with BAP1-GUS Fusion Gene Have Dwarf Phenotype </heading>
<paragraph id="P-0200" lvl="0"><number>&lsqb;0200&rsqb;</number> The N-terminal two-thirds of the BAP1 gene was translationally fused with GUS gene and was introduced into wild-type Arabidopsis. The BamHI site in the BAP1 protein, the restriction site immediately after Thr<highlight><superscript>143</superscript></highlight>, was used for the fusion. </paragraph>
<paragraph id="P-0201" lvl="0"><number>&lsqb;0201&rsqb;</number> The transgenic plants exhibited dwarf phenotype and some exhibited arrested growth, which led to death before flowering. The phenotype is reminiscent to that of the bon1-1 mutant. Interestingly, this phenotype was temperature dependent, and was present at lower temperature, but absent at higher temperature. </paragraph>
<paragraph id="P-0202" lvl="0"><number>&lsqb;0202&rsqb;</number> This finding shows that BAP1 acts closely with BON1 in plants. BON1 and BAP1 are involved in the same process of maintaining growth homeostasis at lower temperature. </paragraph>
</section>
<section>
<heading lvl="1">Example 4 </heading>
</section>
<section>
<heading lvl="1">Overexpression of BON1 </heading>
<paragraph id="P-0203" lvl="0"><number>&lsqb;0203&rsqb;</number> The BON1 gene was expressed under the control of the CaMV 35S promoter and transformed into wild type Arabidopsis, as described above. Approximately &frac15; of the transformants exhibited larger leaves and thicker stems than equivalent wild type plants, and the increase in size appeared to be due to an increase in both cell size and cell number. Overexpression of BON1 therefore appears to result in increased growth and larger plants as compared to wild type. </paragraph>
</section>
<section>
<heading lvl="1">Example 5 </heading>
</section>
<section>
<heading lvl="1">Overexpression of BAP1 </heading>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> The BAP1 gene was expressed under the control of the CaMV 35S promoter and transformed into wild type Arabidopsis. Approximately 50% of the transformants exhibited larger leaves and more extensive root growth than equivalent wild type plants. Overexpression of BAP1 therefore appears to result in increased growth and larger plants as compared to wild type. </paragraph>
</section>
<section>
<heading lvl="1">Example 6 </heading>
</section>
<section>
<heading lvl="1">Expression in Maize Protoplasts </heading>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> Maize plants were grown in the dark until the leaves were 10 cm long. The leaves were cut into 0.5 mm strips, digested in cellulase and macerozyme in a shaking flask. The protoplasts were then purified. The BON1-GFP fusion, prepared as described above, was introduced into the maize protoplasts by electroporation. The chimeric protein was expressed in plasma membrane, as it was expressed in Arabidopsis protoplasts. </paragraph>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> All patent, patent applications and references are incorporated herein in their entirety. While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. An isolated nucleic acid comprising SEQ ID NO:2, and degenerate variants thereof. </claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. An isolated nucleic acid comprising 315 or more consecutive nucleotides of SEQ ID NO:2. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. An isolated nucleic acid comprising a sequence that encodes a polypeptide having an amino acid sequence which is 94% identical to SEQ ID NO:3. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:3. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. An isolated polypeptide comprising 400 or more consecutive amino acid residues of SEQ ID NO:3. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. An isolated polypeptide comprising a sequence that has 94% sequence identity to SEQ ID NO:3. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A vector comprising the isolated nucleic acid of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. An isolated cell comprising the vector of <dependent-claim-reference depends_on="CLM-00007">claim 7</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The cell of <dependent-claim-reference depends_on="CLM-00008">claim 8</dependent-claim-reference>, wherein the cell is selected from the group consisting of: a prokaryotic cell and a eukaryotic cell. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A transgenic plant which has an altered size compared to a corresponding non-transgenic plant, comprising introducing into the plant exogenous nucleic acid which modulates BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A transgenic plant that is smaller in size than a corresponding non-transgenic plant, comprising introducing exogenous nucleic acid which inhibits BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The transgenic plant of <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein the exogenous nucleic acid is inserted in the twelfth exon of the BON1 gene. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The transgenic plant of <dependent-claim-reference depends_on="CLM-00011">claim 12</dependent-claim-reference>, wherein the exogenous nucleic acid is a fusion of BON1 with a beta-glucuronidase gene. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The transgenic plant of <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein the exogenous nucleic acid is inserted in the second exon of the BON1 gene. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A transgenic tissue culture derived from the transgenic plant of <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A transgenic seed of the transgenic plant of <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A transgenic plant, plant part, plant cell or tissue culture, grown from the transgenic seed of <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The transgenic plant, plant part, plant cell or tissue culture of <dependent-claim-reference depends_on="CLM-00011">claim 17</dependent-claim-reference>, wherein the plant is an ornamental plant or a turfgrass, or the plant part, plant cell or tissue culture is derived from an ornamental plant or a turfgrass. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which enhances BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The transgenic plant of <dependent-claim-reference depends_on="CLM-00011">claim 19</dependent-claim-reference>, wherein the exogenous nucleic acid is an exogenous BON1 gene. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A method of producing a transgenic plant which has an altered size compared to a corresponding non-transgenic plant, comprising introducing into the plant exogenous nucleic acid which modulates BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. A method of producing a transgenic plant that is smaller in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which inhibits BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A method of producing a transgenic plant that is smaller in size than a corresponding non-transgenic plant, comprising mutating the endogenous BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>, wherein the exogenous nucleic acid is a fusion of BON1 with a beta-glucuronidase gene (BON1-GUS). </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>, wherein the nucleic acid results in overexpression of the C-terminus of a BON1. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>, wherein the nucleic acid results in overexpression of the full length BON1. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>, wherein the transgenic plant is selected from the group consisting of: angiosperms and gymnosperms. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>, wherein the transgenic plant is an ornamental plant or a turfgrass. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A transgenic plant produced by the method of <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A method of producing a transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which enhances BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>, wherein the exogenous nucleic acid is an exogenous BON1 gene. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>, wherein the plant is a crop plant. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>, wherein the plant is a biomass plant. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A transgenic plant produced by the method of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. A method of modulating homeostasis of a plant, the method comprising introducing into the plant an exogenous nucleic acid which modulates BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. A method of increasing the yield of a plant, comprising introducing into the plant an exogenous nucleic acid which enhances BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. A method of producing a transgenic plant that is able to grow at a higher altitude or in a lower temperature region than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid that enhances BON1 in the plant. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. An isolated nucleic acid comprising SEQ ID NO:5, and degenerate variants thereof. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. An isolated nucleic acid comprising 170 or more consecutive nucleotides of SEQ ID NO:5. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. An isolated nucleic acid comprising a sequence that encodes a polypeptide having an amino acid sequence which is 97% identical to SEQ ID NO:6. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:6. </claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. An isolated polypeptide comprising 550 or more consecutive amino acid residues of SEQ ID NO:6. </claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. An isolated polypeptide comprising a sequence that has 97% sequence identity to SEQ ID NO:6. </claim-text>
</claim>
<claim id="CLM-00044">
<claim-text><highlight><bold>44</bold></highlight>. A vector comprising the isolated nucleic acid of <dependent-claim-reference depends_on="CLM-00033">claim 38</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00045">
<claim-text><highlight><bold>45</bold></highlight>. An isolated cell comprising the vector of <dependent-claim-reference depends_on="CLM-00044">claim 45</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00046">
<claim-text><highlight><bold>46</bold></highlight>. The cell of <dependent-claim-reference depends_on="CLM-00044">claim 45</dependent-claim-reference>, wherein the cell is selected from the group consisting of: a prokaryotic cell and a eukaryotic cell. </claim-text>
</claim>
<claim id="CLM-00047">
<claim-text><highlight><bold>47</bold></highlight>. An isolated nucleic acid comprising SEQ ID NO:11, and degenerate variants thereof. </claim-text>
</claim>
<claim id="CLM-00048">
<claim-text><highlight><bold>48</bold></highlight>. An isolated nucleic acid comprising 390 or more consecutive nucleotides of SEQ ID NO:11. </claim-text>
</claim>
<claim id="CLM-00049">
<claim-text><highlight><bold>49</bold></highlight>. An isolated nucleic acid comprising a sequence which has 99% sequence identity to the coding sequence of SEQ ID NO:11. </claim-text>
</claim>
<claim id="CLM-00050">
<claim-text><highlight><bold>50</bold></highlight>. An isolated nucleic acid comprising a sequence that encodes a polypeptide having an amino acid sequence which is 98% identical to SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00051">
<claim-text><highlight><bold>51</bold></highlight>. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00052">
<claim-text><highlight><bold>52</bold></highlight>. An isolated polypeptide comprising 180 or more consecutive amino acid residues of SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00053">
<claim-text><highlight><bold>53</bold></highlight>. A vector comprising the isolated nucleic acid of <dependent-claim-reference depends_on="CLM-00044">claim 47</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00054">
<claim-text><highlight><bold>54</bold></highlight>. An isolated cell comprising the vector of <dependent-claim-reference depends_on="CLM-00055">claim 53</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00055">
<claim-text><highlight><bold>55</bold></highlight>. The cell of <dependent-claim-reference depends_on="CLM-00055">claim 54</dependent-claim-reference>, wherein the cell is selected from the group consisting of: a prokaryotic cell and a eukaryotic cell. </claim-text>
</claim>
<claim id="CLM-00056">
<claim-text><highlight><bold>56</bold></highlight>. A method of producing a transgenic plant which has an altered size compared to a corresponding non-transgenic plant, comprising introducing into the plant exogenous nucleic acid which modulates BAP1 in the plant. </claim-text>
</claim>
<claim id="CLM-00057">
<claim-text><highlight><bold>57</bold></highlight>. A method of producing a transgenic plant that is smaller in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which inhibits BAP1 in the plant. </claim-text>
</claim>
<claim id="CLM-00058">
<claim-text><highlight><bold>58</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 57</dependent-claim-reference>, wherein the nucleic acid results in overexpression of the C-terminus of a BAP1. </claim-text>
</claim>
<claim id="CLM-00059">
<claim-text><highlight><bold>59</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 57</dependent-claim-reference>, wherein the transgenic plant is selected from the group consisting of: angiosperms and gymnosperms. </claim-text>
</claim>
<claim id="CLM-00060">
<claim-text><highlight><bold>60</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 57</dependent-claim-reference>, wherein the transgenic plant is an ornamental plant or a turfgrass. </claim-text>
</claim>
<claim id="CLM-00061">
<claim-text><highlight><bold>61</bold></highlight>. A transgenic plant produced by the method of <dependent-claim-reference depends_on="CLM-00055">claim 57</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00062">
<claim-text><highlight><bold>62</bold></highlight>. A method of producing a transgenic plant that is larger in size than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid which enhances BAP1 in the plant. </claim-text>
</claim>
<claim id="CLM-00063">
<claim-text><highlight><bold>63</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00066">claim 62</dependent-claim-reference>, wherein the exogenous nucleic acid is an exogenous BAP1 gene. </claim-text>
</claim>
<claim id="CLM-00064">
<claim-text><highlight><bold>64</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00066">claim 62</dependent-claim-reference>, wherein the plant is a crop plant. </claim-text>
</claim>
<claim id="CLM-00065">
<claim-text><highlight><bold>65</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00066">claim 64</dependent-claim-reference>, wherein the plant is a biomass plant. </claim-text>
</claim>
<claim id="CLM-00066">
<claim-text><highlight><bold>66</bold></highlight>. A transgenic plant produced by the method of <dependent-claim-reference depends_on="CLM-00066">claim 62</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00067">
<claim-text><highlight><bold>67</bold></highlight>. A method of increasing the yield of a plant, comprising introducing into the plant an exogenous nucleic acid which enhances BAP1 in the plant. </claim-text>
</claim>
<claim id="CLM-00068">
<claim-text><highlight><bold>68</bold></highlight>. A method of producing a transgenic plant that is able to grow at a higher altitude or in a lower temperature region than a corresponding non-transgenic plant, comprising introducing into the plant an exogenous nucleic acid that enhances BAP1 in the plant.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020194639A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020194639A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020194639A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020194639A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020194639A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00006">
<image id="EMI-D00006" file="US20020194639A1-20021219-D00006.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00007">
<image id="EMI-D00007" file="US20020194639A1-20021219-D00007.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00008">
<image id="EMI-D00008" file="US20020194639A1-20021219-D00008.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00009">
<image id="EMI-D00009" file="US20020194639A1-20021219-D00009.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00010">
<image id="EMI-D00010" file="US20020194639A1-20021219-D00010.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00011">
<image id="EMI-D00011" file="US20020194639A1-20021219-D00011.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00012">
<image id="EMI-D00012" file="US20020194639A1-20021219-D00012.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00013">
<image id="EMI-D00013" file="US20020194639A1-20021219-D00013.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00014">
<image id="EMI-D00014" file="US20020194639A1-20021219-D00014.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00015">
<image id="EMI-D00015" file="US20020194639A1-20021219-D00015.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00016">
<image id="EMI-D00016" file="US20020194639A1-20021219-D00016.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00017">
<image id="EMI-D00017" file="US20020194639A1-20021219-D00017.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00018">
<image id="EMI-D00018" file="US20020194639A1-20021219-D00018.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20020194642A1-20021219-D00001.TIF SYSTEM "US20020194642A1-20021219-D00001.TIF" NDATA TIF>
<!ENTITY US20020194642A1-20021219-D00002.TIF SYSTEM "US20020194642A1-20021219-D00002.TIF" NDATA TIF>
<!ENTITY US20020194642A1-20021219-D00003.TIF SYSTEM "US20020194642A1-20021219-D00003.TIF" NDATA TIF>
<!ENTITY US20020194642A1-20021219-D00004.TIF SYSTEM "US20020194642A1-20021219-D00004.TIF" NDATA TIF>
<!ENTITY US20020194642A1-20021219-D00005.TIF SYSTEM "US20020194642A1-20021219-D00005.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020194642</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10079478</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020219</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>A01H005/00</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C07H021/04</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N009/44</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12P021/02</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>C12N005/04</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>800</class>
<subclass>284000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>210000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>419000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>069100</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>435</class>
<subclass>320100</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>536</class>
<subclass>023200</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Heat stable mutants of starch biosynthesis enzymes</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>10079478</doc-number>
<kind-code>A1</kind-code>
<document-date>20020219</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09312433</doc-number>
<document-date>19990514</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>GRANTED</parent-status>
<parent-patent>
<document-id>
<doc-number>6403863</doc-number>
<country-code>US</country-code>
</document-id>
</parent-patent>
</parent-child>
</continuation-in-part-of>
</continuations>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>09312433</doc-number>
<document-date>19990514</document-date>
<country-code>US</country-code>
</document-id>
</child>
<parent>
<document-id>
<doc-number>08972545</doc-number>
<document-date>19971118</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>GRANTED</parent-status>
<parent-patent>
<document-id>
<doc-number>6069300</doc-number>
<country-code>US</country-code>
</document-id>
</parent-patent>
</parent-child>
</continuation-in-part-of>
</continuations>
<non-provisional-of-provisional>
<document-id>
<doc-number>60085460</doc-number>
<document-date>19980514</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
<non-provisional-of-provisional>
<document-id>
<doc-number>60031045</doc-number>
<document-date>19961118</document-date>
<country-code>US</country-code>
</document-id>
</non-provisional-of-provisional>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>L.</given-name>
<middle-name>Curtis</middle-name>
<family-name>Hannah</family-name>
</name>
<residence>
<residence-us>
<city>Gainesville</city>
<state>FL</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Thomas</given-name>
<middle-name>W.</middle-name>
<family-name>Greene</family-name>
</name>
<residence>
<residence-us>
<city>Zionsville</city>
<state>IN</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>SALIWANCHIK LLOYD &amp; SALIWANCHIK</name-1>
<name-2>A PROFESSIONAL ASSOCIATION</name-2>
<address>
<address-1>2421 N.W. 41ST STREET</address-1>
<address-2>SUITE A-1</address-2>
<city>GAINESVILLE</city>
<state>FL</state>
<postalcode>326066669</postalcode>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The subject invention pertains to novel mutant polynucleotide molecules that encode enzymes that have increased heat stability. These polynucleotides, when expressed in plants, result in increased yield in plants grown under conditions of heat stress. The polynucleotide molecules of the subject invention encode maize endosperm ADP glucose pyrophosphorylase (AGP) and soluble starch synthase (SSS) enzyme activities. Plants and plant tissue bred to contain, or transformed with, the mutant polynucleotides, and expressing the polypeptides encoded by the polynucleotides, are also contemplated by the present invention. The subject invention also concerns methods for isolating polynucleotides and polypeptides contemplated within the scope of the invention. Methods for increasing yield in plants grown under conditions of heat stress are also provided. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<heading lvl="1">CROSS-REFERENCE TO A RELATED APPLICATIONS </heading>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This application is a continuation-in-part of co-pending U.S. patent application Ser. No. 09/312,433, filed May 14, 1999, which is a continuation-in-part of co-pending U.S. patent application Ser. No. 08/972,545, filed Nov. 18, 1997, now U.S. Pat. No. 6,069,300. This application also claims priority from U.S. Provisional Application No. 60,085,460, filed May 14, 1998 and U.S. Provisional Application No. 60/031,045, filed Nov. 18, 1996.</paragraph>
</cross-reference-to-related-applications>
<federal-research-statement>
<paragraph-federal-research-statement id="P-0002"><number>&lsqb;0002&rsqb;</number> This invention was made with government support under National Science Foundation grant number 9316887. The government has certain rights in the invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> The sessile nature of plant life generates a constant exposure to environmental factors that exert positive and negative effects on plant growth and development. One of the major impediments facing modern agriculture is adverse environmental conditions. One important factor which causes significant crop loss is heat stress. Temperature stress greatly reduces grain yield in many cereal crops such as maize, wheat, and barley. Yield decreases due to heat stress range from 7 to 35% in the cereals of world-wide importance. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> A number of studies have identified likely physiological consequences of heat stress. Early work by Hunter et al. (Hunter, R. B., Tollenaar, M., and Breuer, C. M. &lsqb;1977<highlight><italic>&rsqb; Can. J. Plant Sci. </italic></highlight>57:1127-1133) using growth chamber conditions showed that temperature decreased the duration of grain filling in maize. Similar results in which the duration of grain filling was adversely altered by increased temperatures were identified by Tollenaar and Bruulsema (Tollenaar, M. and Bruulsema, T. W. &lsqb;1988<highlight><italic>&rsqb; Can. J. Plant Sci. </italic></highlight>68:935-940). Badu-Apraku et al. (Badu-Apraku, B., Hunter, R. B., and Tollenaar, M. &lsqb;1983<highlight><italic>&rsqb; Can. J. Plant. Sci. </italic></highlight>63:357-363) measured a marked reduction in the yield of maize plants grown under the day/night temperature regime of 35/15&deg; C. compared to growth in a 25/150&deg; C. temperature regime. Reduced yields due to increased temperatures is also supported by historical as well as climatological studies (Thompson, L. M. &lsqb;1986<highlight><italic>&rsqb; Agron. J. </italic></highlight>78:649-653; Thompson, L. M. &lsqb;1975<highlight><italic>&rsqb; Science </italic></highlight>188:535-541; Chang, J. &lsqb;1981<highlight><italic>&rsqb; Agricul. Metero. </italic></highlight>24:253-262; and Conroy, J. P., Seneweera, S., Basra, A. S., Rogers, G., and Nissen-Wooller, B. &lsqb;1994<highlight><italic>&rsqb; Aust. J. Plant Physiol. </italic></highlight>21:741-758). </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> That the physiological processes of the developing seed are adversely affected by heat stress is evident from studies using an in vitro kernel culture system (Jones, R. J., Gengenbach, B. G., and Cardwell, V. B. &lsqb;1981<highlight><italic>&rsqb; Crop Science </italic></highlight>21:761-766; Jones, R. J., Ouattar, S., and Crookston, R. K. &lsqb;1984<highlight><italic>&rsqb; Crop Science </italic></highlight>24:133-137; and Cheikh, N., and Jones, R. J. &lsqb;1995<highlight><italic>&rsqb; Physiol. Plant. </italic></highlight>95:59-66). Maize kernels cultured at the above-optimum temperature of 35&deg; C. exhibited a dramatic reduction in weight. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Work with wheat identified the loss of soluble starch synthase (SSS) activity as a hallmark of the wheat endosperm&apos;s response to heat stress (Hawker, J. S. and Jenner, C. F. &lsqb;1993<highlight><italic>&rsqb; Aust. J. Plant Physiol. </italic></highlight>20:197-209; Denyer, K., Hylton, C. M., and Smith, A. M. &lsqb;1994<highlight><italic>&rsqb; Aust. J. Plant Physiol. </italic></highlight>21:783-789; Jenner, C. F. &lsqb;1994<highlight><italic>&rsqb; Aust. J. Plant Physiol. </italic></highlight>21:791-806). Additional studies with SSS of wheat endosperm show that it is heat labile (Rijven, A. H. G. C. &lsqb;1986<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>81:448-453; Keeling, P. L., Bacon, P. J., Holt, D. C. &lsqb;1993<highlight><italic>&rsqb; Planta. </italic></highlight>191:342-348; Jenner, C. F., Denyer, K., and Guerin, J. &lsqb;1995<highlight><italic>&rsqb; Aust. J. Plant Physiol. </italic></highlight>22:703-709). </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> The roles of SSS and ADP glucose pyrophosphorylase (AGP) under heat stress conditions in maize is less clear. (AGP) catalyzes the conversion of ATP and &agr;-glucose-1-phosphate to ADP-glucose and pyrophosphate. ADP-glucose is used as a glycosyl donor in starch biosynthesis by plants and in glycogen biosynthesis by bacteria. The importance of ADP-glucose pyrophosphorylase as a key enzyme in the regulation of starch biosynthesis was noted in the study of starch deficient mutants of maize (<highlight><italic>Zea mays</italic></highlight>) endosperm (Tsai, C. Y., and Nelson, Jr., O. E. &lsqb;1966<highlight><italic>&rsqb; Science </italic></highlight>151:341-343; Dickinson, D. B., J. Preiss &lsqb;1969<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>44:1058-1062). </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Ou-Lee and Setter (Ou-Lee, T. and Setter, T. L. &lsqb;1985<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>79:852-855) examined the effects of temperature on the apical or tip regions of maize ears. With elevated temperatures, AGP activity was lower in apical kernels when compared to basal kernels during the time of intense starch deposition. In contrast, in kernels developed at normal temperatures, AGP activity was similar in apical and basal kernels during this period. However, starch synthase activity during this period was not differentially affected in apical and basal kernels. Further, heat-treated apical kernels exhibited an increase in starch synthase activity over control. This was not observed with AGP activity. Singletary et al. (Singletary, G. W., Banisadr, R., and Keeling, P. L. &lsqb;1993<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>102: 6 (suppl).; Singletary, G. W., Banisadra, R., Keeling, P. L. &lsqb;1994<highlight><italic>&rsqb; Aust. J. Plant Physiol. </italic></highlight>21:829-841) using an in vitro culture system quantified the effect of various temperatures during the grain fill period. Seed weight decreased steadily as temperature increased from 22-36&deg; C. A role for AGP in yield loss is also supported by work from Duke and Doehlert (Duke, E. R. and Doehlert, D. C. &lsqb;1996<highlight><italic>&rsqb; Environ. Exp. Botany. </italic></highlight>36:199-208). </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> Work by Keeling et al. (1994, supra) quantified SSS activity in maize and wheat using Q<highlight><subscript>10 </subscript></highlight>analysis, and showed that SSS is an important control point in the flux of carbon into starch. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> In vitro biochemical studies with AGP and SSS clearly show that both enzymes are heat labile. Maize endosperm AGP loses 96% of its activity when heated at 57&deg; C. for five minutes (Hannah, L. C., Tuschall, D. M., and Mans, R. J. &lsqb;1980<highlight><italic>&rsqb; Genetics </italic></highlight>95:961-970). This is in contrast to potato AGP which is fully stable at 70&deg; C. (Sowokinos, J. R. and Preiss, J. &lsqb;1982<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>69:1459-1466; Okita, T. W., Nakata, P. A., Anderson, J. M., Sowokinos, J., Morell, J., and Preiss, J. &lsqb;1990<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>93:785-90). Heat inactivation studies with SSS showed that it is also labile at higher temperatures, and kinetic studies determined that the Km value for amylopectin rose exponentially when temperature increased from 25-45&deg; C. (Jenner et al., 1995, supra). </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Biochemical and genetic evidence has identified AGP as a key enzyme in starch biosynthesis in higher plants and glycogen biosynthesis in <highlight><italic>E. coli </italic></highlight>(Preiss, J. and Romeo, T. &lsqb;1994<highlight><italic>&rsqb; Progress in Nuc. Acid Res. and Mol Biol. </italic></highlight>47:299-329; Preiss, J. and Sivak, M. &lsqb;1996&rsqb; &ldquo;Starch synthesis in sinks and sources,&rdquo; In <highlight><italic>Photoassimilate distribution in plants and crops: source-sink relationships</italic></highlight>. Zamski, E., ed., Marcil Dekker Inc. pp. 139-168). AGP catalyzes what is viewed as the initial step in the starch biosynthetic pathway with the product of the reaction being the activated glucosyl donor, ADPglucose. This is utilized by starch synthase for extension of the polysaccharide polymer (reviewed in Hannah, L. Curtis &lsqb;1996&rsqb; &ldquo;Starch synthesis in the maize endosperm,&rdquo; In: <highlight><italic>Advances in Cellular and Molecular Biology of Plants</italic></highlight>, Vol. 4. B. A. Larkins and I. K. Vasil (eds.). <highlight><italic>Cellular and Molecular Biology of Plant Seed Development</italic></highlight>. Kluwer Academic Publishers, Dordrecht, The Netherlands). </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> Initial studies with potato AGP showed that expression in <highlight><italic>E. coli </italic></highlight>yielded an enzyme with allosteric and kinetic properties very similar to the native tuber enzyme (Iglesias, A., Barry, G. F., Meyer, C., Bloksberg, L., Nakata, P., Greene, T., Laughlin, M. J., Okita, T. W., Kishore, G. M., and Preiss, J. &lsqb;1993<highlight><italic>&rsqb; J. Biol Chem. </italic></highlight>268:1081-86; Ballicora, M. A., Laughlin, M. J., Fu, Y., Okita, T. W., Barry, G. F., and Preiss, J. &lsqb;1995<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>109:245-251). Greene et al. (Greene, T. W., Chantler, S. E., Kahn, M. L., Barry, G. F., Preiss, J., and Okita, T. W. &lsqb;1996<highlight><italic>&rsqb; Proc. Natl. Acad. Sci. </italic></highlight>93:1509-1513; Greene, T. W., Woodbury, R. L., and Okita, T. W. &lsqb;1996<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>(1 12:1315-1320) showed the usefulness of the bacterial expression system in their structure-function studies with the potato AGP. Multiple mutations important in mapping allosteric and substrate binding sites were identified (Okita, T. W., Greene, T. W., Laughlin, M. J., Salamone, P., Woodbury, R., Choi, S., Ito, H., Kavakli, H., and Stephens, K. &lsqb;1996&rsqb; &ldquo;Engineering Plant Starches by the Generation of Modified Plant Biosynthetic Enzymes,&rdquo; In <highlight><italic>Engineering Cropsfor Industrial End Uses</italic></highlight>, Shewry, P. R., Napier, J. A., and Davis, P., eds., Portland Press Ltd., London). </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> AGP enzymes have been isolated from both bacteria and plants. Bacterial AGP consists of a homotetramer, while plant AGP from photosynthetic and non-photosynthetic tissues is a heterotetramer composed of two different subunits. The plant enzyme is encoded by two different genes, with one subunit being larger than the other. This feature has been noted in a number of plants. The AGP subunits in spinach leaf have molecular weights of 54 kDa and 51 kDa, as estimated by SDS-PAGE. Both subunits are immunoreactive with antibody raised against purified AGP from spinach leaves (Copeland, L., J. Preiss (1981) <highlight><italic>Plant Physiol. </italic></highlight>68:996-1001; Morell, M., M. Bloon, V. Knowles, J. Preiss &lsqb;1988<highlight><italic>&rsqb; J. Bio. Chem. </italic></highlight>263:633). Immunological analysis using antiserum prepared against the small and large subunits of spinach leaf showed that potato tuber AGP is also encoded by two genes (Okita et al., 1990, supra). The cDNA clones of the two subunits of potato tuber (50 and 51 kDa) have also been isolated and sequenced (Muller-Rober, B. T., J. Kossmann, L. C. Hannah, L. Willmitzer, U. Sounewald &lsqb;1990<highlight><italic>&rsqb; Mol. Gen. Genet. </italic></highlight>224:136-146; Nakata, P. A., T. W. Greene, J. M. Anderson, B. J. Smith-White, T. W. Okita, J. Preiss &lsqb;1991<highlight><italic>&rsqb; Plant Mol. Biol. </italic></highlight>17:1089-1093). The large subunit of potato tuber AGP is heat stable (Nakata et al. &lsqb;1991&rsqb;, supra). </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> As Hannah and Nelson (Hannah, L. C., O. E. Nelson (1975) <highlight><italic>Plant Physiol. </italic></highlight>55:297-302.; Hannah, L. C., and Nelson, Jr., O. E. &lsqb;1976<highlight><italic>&rsqb; Biochem. Genet. </italic></highlight>14:547-560) postulated, both Shrunken-2 (Sh2) (Bhave, M. R., S. Lawrence, C. Barton, L. C. Hannah &lsqb;1990<highlight><italic>&rsqb; Plant Cell </italic></highlight>2:581-588) and Brittle-2 (Bt2) (Bae, J. M., M. Giroux, L. C. Hannah &lsqb;1990<highlight><italic>&rsqb; Maydica </italic></highlight>35:317-322) are structural genes of maize endosperm ADP-glucose pyrophosphorylase. Sh2 and Bt2 encode the large subunit and small subunit of the enzyme, respectively. From cDNA sequencing, Sh2 and Bt2 proteins have predicted molecular weight of 57,179 Da (Shaw, J. R., L. C. Hannah &lsqb;1992<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>98:1214-1216) and 52,224 Da, respectively. The endosperm is the site of most starch deposition during kernel development in maize. Sh2 and bt2 maize endosperm mutants have greatly reduced starch levels corresponding to deficient levels of AGP activity. Mutations of either gene have been shown to reduce AGP activity by about 95% (Tsai and Nelson, 1966, supra; Dickinson and Preiss, 1969, supra). Furthermore, it has been observed that enzymatic activities increase with the dosage of functional wild type Sh2 and Bt2 alleles, whereas mutant enzymes have altered kinetic properties. AGP is the rate limiting step in starch biosynthesis in plants. Stark et al. placed a mutant form of <highlight><italic>E. coli </italic></highlight>AGP in potato tuber and obtained a 35% increase in starch content (Stark et al. &lsqb;1992<highlight><italic>&rsqb; Science </italic></highlight>258:287). </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> The cloning and characterization of the genes encoding the AGP enzyme subunits have been reported for various plants. These include Sh2 cDNA (Bhave et al., 1990, supra), Sh2 genomic DNA (Shaw and Hannah, 1992, supra), and Bt2 cDNA (Bae et al., 1990, supra) from maize; small subunit cDNA (Anderson, J. M., J. Hnilo, R. Larson, T. W. Okita, M. Morell, J. Preiss &lsqb;1989<highlight><italic>&rsqb; J. Biol. Chem. </italic></highlight>264:12238-12242) and genomic DNA (Anderson, J. M., R. Larson, D. Landencia, W. T. Kim, D. Morrow, T. W. Okita, J. Preiss &lsqb;1991<highlight><italic>&rsqb; Gene </italic></highlight>97:199-205) from rice; and small and large subunit cDNAs from spinach leaf (Morell et al., 1988, supra) and potato tuber (Muller-Rober et al., 1990, supra; Nakata, P. A., Greene, T. W., Anderson, J. W., Smith-White, B. J., Okita, T. W., and Preiss, J. &lsqb;1991<highlight><italic>&rsqb; Plant Mol. Biol. </italic></highlight>17:1089-1093). In addition, cDNA clones have been isolated from wheat endosperm and leaf tissue (Olive, M. R., R. J. Ellis, W. W. Schuch &lsqb;1989<highlight><italic>&rsqb; Plant Physiol. Mol. Biol. </italic></highlight>12:525-538) and <highlight><italic>Arabidopsis thaliana </italic></highlight>leaf (Lin, T., Caspar, T., Sommerville, C. R., and Preiss, J. &lsqb;1988<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>88:1175-1181). </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> AGP functions as an allosteric enzyme in all tissues and organisms investigated to date. The allosteric properties of AGP were first shown to be important in <highlight><italic>E. coli</italic></highlight>. A glycogen-overproducing <highlight><italic>E. coli </italic></highlight>mutant was isolated and the mutation mapped to the structural gene for AGP, designated as glyC. The mutant <highlight><italic>E. coli </italic></highlight>known as glyC-16, was shown to be more sensitive to the activator, fructose 1,6 bisphosphate, and less sensitive to the inhibitor, cAMP (Preiss, J. &lsqb;1984<highlight><italic>&rsqb; Ann. Rev. Microbiol. </italic></highlight>419-458). Although plant AGP&apos;s are also allosteric, they respond to different effector molecules than bacterial AGP&apos;s. In plants, 3-phosphoglyceric acid (3-PGA) functions as an activator while phosphate (PO<highlight><subscript>4</subscript></highlight>) serves as an inhibitor (Dickinson and Preiss, 1969, supra). </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> Using an in vivo mutagenesis system created by the Ac-mediated excision of a Ds transposable element fortuitously located close to a known activator binding site, Giroux et al. (Giroux, M. J., Shaw, J., Barry, G., Cobb, G. B., Greene, T., Okita, T. W., and Hannah, L. C. &lsqb;1996<highlight><italic>&rsqb; Proc. Natl. Acad. Sci. </italic></highlight>93:5824-5829) were able to generate site-specific mutants in a functionally important region of maize endosperm AGP. One mutant, Rev 6, contained a tyrosine-serine insert in the large subunit of AGP and conditioned a 11-18% increase in seed weight. In addition, published international application WO 01/64928 teaches that various characteristics, such as seed number, plant biomass, Harvest Index etc., can be increased in plants transformed with a polynucleotide encoding a large subunit of maize AGP containing the Rev6 mutation. </paragraph>
</section>
<section>
<heading lvl="1">BRIEF SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> The subject invention pertains to materials and methods useful for improving crop yields in plants, such as those plants that produce cereal crops. In one embodiment, the subject invention provides heat stable AGP enzymes and nucleotide sequences which encode these enzymes. In a preferred embodiment, the heat stable enzymes of the invention can be used to provide plants having greater tolerance to higher temperatures, thus enhancing the crop yields from these plants. In a particularly preferred embodiment, the improved plant is a cereal. Cereals to which this invention applies include, for example, maize, wheat, rice, and barley.</paragraph>
</section>
</summary-of-invention>
<brief-description-of-drawings>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 1</cross-reference> shows heat stable maize endosperm AGP large subunit mutants. Percentage of AGP activity remaining after five minutes of heat treatment at 60&deg; C. is shown. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 2</cross-reference> shows primary sequence alignment of the region surrounding HS 33 mutation in the AGP large subunits for maize, wheat, barley, and potato. Conserved regions are boxed. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> <cross-reference target="DRAWINGS">FIG. 3</cross-reference> shows primary sequence alignment of the region surrounding HS 40 mutation in the AGP large subunits for maize, wheat, barley, and potato. Conserved regions are boxed. Bolded aspartic acid residue corresponds to D413A allosteric mutant of potato LS (Greene, T. W., Woodbury, R. L., and Okita, T. W. &lsqb;1996<highlight><italic>&rsqb; Plant Physiol. </italic></highlight>(112:1315-1320). Spinach leaf AGP sequence is the activator site 2 peptide identified in 3-PGA analogue studies (Ball, K. and Preiss, J. &lsqb;1994<highlight><italic>&rsqb; J. Biol. Chem. </italic></highlight>269:24706-24711). The labeled lysine residue is bolded. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 4A and 4B</cross-reference> show molecular characterization of TS48 and TS60, respectively. Genetic lesion of TS48 and corresponding residues are in bold. The amino acid number is indicated above the Leu to Phe mutation of TS48. The last line is a consensus sequence. The Leu residue is highly conserved. Genetic lesions of TS60 and corresponding residues are in bold. The amino acid numbers are indicated above the Glu to Lys and Ala to Val mutations of TS60. Boxed residues correspond to the HS 33 mutation previously identified and shown to be important in heat stability of the maize endosperm AGP. The last line is a consensus sequence. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> <cross-reference target="DRAWINGS">FIGS. 5A and 5B</cross-reference> show molecular characterization of RTS 48-2 and RTS 60-1, respectively. Genetic lesion of RTS 48-2 and corresponding residues are in bold. The amino acid number is indicated above the Ala to Val mutation of RTS 48-2. The last line is a consensus sequence. Of significance, the mutation identified in RTS 48-2 maps to the identical residue found in the heat stable variant HS13. HS 13 contained an Ala to Pro mutation at position 177. Genetic lesion of RTS 60-1 and corresponding residues are in bold. The amino acid number is indicated above the Ala to Val mutation of RTS 60-1. The last line is a consensus sequence.</paragraph>
</section>
</brief-description-of-drawings>
<detailed-description>
<section>
<heading lvl="1">BRIEF DESCRIPTION OF THE SEQUENCES </heading>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> SEQ ID NO. 1 is an amino acid sequence of a region of the large subunit of AGP in maize containing the HS 33 mutation as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> SEQ ID NO. 2 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> SEQ ID NO. 3 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> SEQ ID NO. 4 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> SEQ ID NO. 5 is an amino acid sequence of a region of the large subunit of AGP in potato as shown in <cross-reference target="DRAWINGS">FIG. 2</cross-reference>. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> SEQ ID NO. 6 is an amino acid sequence of a region of the large subunit of AGP in maize containing the HS40 mutation as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> SEQ ID NO. 7 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> SEQ ID NO. 8 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> SEQ ID NO. 9 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> SEQ ID NO. 10 is an amino acid sequence of a region of the large subunit of AGP in potato as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> SEQ ID NO. 11 is an amino acid sequence of a region of the large subunit of AGP in spinach as shown in <cross-reference target="DRAWINGS">FIG. 3</cross-reference>. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> SEQ ID NO. 12 is an amino acid sequence of a region of the large subunit of AGP in maize containing the TS48 mutation as shown in <cross-reference target="DRAWINGS">FIG. 4A</cross-reference>. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> SEQ ID NO. 13 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 4A</cross-reference>. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> SEQ ID NO. 14 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 4A</cross-reference>. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> SEQ ID NO. 15 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 4A</cross-reference>. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> SEQ ID NO. 16 is an amino acid sequence of a region of the large subunit of AGP in rice as shown in <cross-reference target="DRAWINGS">FIG. 4A</cross-reference>. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> SEQ ID NO. 17 is an amino acid sequence of a region of the large subunit of AGP in maize containing the TS60 mutation as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> SEQ ID NO. 18 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> SEQ ID NO. 19 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> SEQ ID NO. 20 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> SEQ ID NO. 21 is an amino acid sequence of a region of the large subunit of AGP in rice as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> SEQ ID NO. 22 is an amino acid sequence of a region of the large subunit of AGP in maize containing the TS60 mutation as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> SEQ ID NO. 23 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> SEQ ID NO. 24 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> SEQ ID NO. 25 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> SEQ ID NO. 26 is an amino acid sequence of a region of the large subunit of AGP in rice as shown in <cross-reference target="DRAWINGS">FIG. 4B</cross-reference>. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> SEQ ID NO. 27 is an amino acid sequence of a region of the large subunit of AGP in maize containing the RTS 48-2 mutation as shown in <cross-reference target="DRAWINGS">FIG. 5A</cross-reference>. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> SEQ ID NO. 28 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 5A</cross-reference>. </paragraph>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> SEQ ID NO. 29 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 5A</cross-reference>. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> SEQ ID NO. 30 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 5A</cross-reference>. </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> SEQ ID NO. 31 is an amino acid sequence of a region of the large subunit of AGP in rice as shown in <cross-reference target="DRAWINGS">FIG. 5A</cross-reference>. </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> SEQ ID NO. 32 is an amino acid sequence of a region of the large subunit of AGP in maize containing the RTS60-1 mutation as shown in <cross-reference target="DRAWINGS">FIG. 5B</cross-reference>. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> SEQ ID NO. 33 is an amino acid sequence of a region of the large subunit of AGP in maize as shown in <cross-reference target="DRAWINGS">FIG. 5B</cross-reference>. </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> SEQ ID NO. 34 is an amino acid sequence of a region of the large subunit of AGP in wheat as shown in <cross-reference target="DRAWINGS">FIG. 5B</cross-reference>. </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> SEQ ID NO. 35 is an amino acid sequence of a region of the large subunit of AGP in barley as shown in <cross-reference target="DRAWINGS">FIG. 5B</cross-reference>. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> SEQ ID NO. 36 is an amino acid sequence of a region of the large subunit of AGP in rice as shown in <cross-reference target="DRAWINGS">FIG. 5B</cross-reference>. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DISCLOSURE OF THE INVENTION </heading>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> The subject invention concerns novel mutant polynucleotide molecules, and the polypeptides encoded thereby, that confer increased yield in plants grown under conditions of heat stress relative to plants having wild type genotype. In specific embodiments, the polynucleotide molecules of the subject invention encode maize endosperm ADP glucose pyrophosphorylase (AGP) and soluble starch synthase (SSS) enzyme activities. The mutant enzymes confer increased stability to heat stress conditions during seed and plant development in seeds and plant tissue expressing the enzymes as compared with wild type enzyme activities. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> In one embodiment, a polynucleotide of the present invention encodes a mutant large subunit of maize AGP containing a histidine-to-tyrosine amino acid substitution in the sequence of the polypeptide. This substitution occurs at amino acid residue number 333, according to the accepted number of the amino acids in this protein (Shaw and Hannah, 1992, supra). The position of this substitution can be readily identified by a person skilled in the art. A second mutation exemplified in the subject invention is a threonine-to-isoleucine substitution at position number 460 of the large subunit of the maize AGP protein. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> Also exemplified are mutants wherein the histidine at position 333 of the maize large subunit of AGP is replaced with a phenylalanine, methionine, or glycine. Additional exemplified maize AGP large subunit mutants conferring increased heat stability are shown below in Table 1.  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="28PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="126PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center">TABLE 1</entry>
</row>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Mutant</entry>
<entry>Amino Acid Change</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>HS 13</entry>
<entry>Ala to Pro at position 177</entry>
</row>
<row>
<entry></entry>
<entry>HS 14</entry>
<entry>Asp to His at position 400, and</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Val to Ile at position 454</entry>
</row>
<row>
<entry></entry>
<entry>HS 16</entry>
<entry>Arg to Thr at position 104</entry>
</row>
<row>
<entry></entry>
<entry>HS 33</entry>
<entry>His to Tyr at position 333</entry>
</row>
<row>
<entry></entry>
<entry>HS 33F</entry>
<entry>His to Phe at position 333</entry>
</row>
<row>
<entry></entry>
<entry>HS 33M</entry>
<entry>His to Met at position 333</entry>
</row>
<row>
<entry></entry>
<entry>HS 33G</entry>
<entry>His to Gly at position 333</entry>
</row>
<row>
<entry></entry>
<entry>HS 39</entry>
<entry>His to Tyr at position 333</entry>
</row>
<row>
<entry></entry>
<entry>HS 40</entry>
<entry>His to Tyr at position 333, and</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Thr to Ile at position 460</entry>
</row>
<row>
<entry></entry>
<entry>HS 47</entry>
<entry>Arg to Pro at position 216, and</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>His to Tyr at position 333</entry>
</row>
<row>
<entry></entry>
<entry>RTS 48-2</entry>
<entry>Ala to Val at position 177</entry>
</row>
<row>
<entry></entry>
<entry>RTS 60-1</entry>
<entry>Ala to Val at position 396</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> Because of the homology of AGP polypeptides between various species of plants (Smith-White and Preiss &lsqb;1992<highlight><italic>&rsqb; J. Mol. Evol. </italic></highlight>34:449-464), the ordinarily skilled artisan can readily determine the corresponding position of the mutations for maize AGP exemplified herein in AGP from plants other than maize. For example, <cross-reference target="DRAWINGS">FIGS. 2 and 3</cross-reference> show primary sequence alignment for the region around the maize HS 33 and HS 40 mutations in wheat, barley, and potato. Thus, the present invention encompasses polynucleotides that encode mutant AGP of plants other than maize, including, but not limited to, wheat, barley, and rice, that confers increased heat stability when expressed in the plant. cDNA clones for the subunits of the maize endosperm AGP (SH2 and BT2) and an <highlight><italic>E. coli </italic></highlight>strain deficient in the endogenous bacterial AGP (glg C<highlight><superscript>&minus;</superscript></highlight>) (AC70R1-504) have facilitated the establishment of a bacterial expression system to study the maize endosperm AGP. Expression of a single subunit is unable to complement the glg C<highlight><superscript>&minus;</superscript></highlight> mutant, and no glycogen is produced (Iglesias, A., Barry, G. F., Meyer, C., Bloksberg, L., Nakata, P., Greene, T., Laughlin, M. J., Okita, T. W., Kishore, G. M., and Preiss, J. &lsqb;1993<highlight><italic>&rsqb; J. Biol. Chem. </italic></highlight>268: 1081-86). However, expression of both the large and small subunits on compatible expression vectors fully complements the glg C<highlight><superscript>&minus;</superscript></highlight> mutation and restores glycogen production as evidenced by a dark, reddish-brown staining of colonies exposed to iodine. Thus, complementation is easily identified by simply exposing the colonies to iodine. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> In one embodiment, <highlight><italic>E. coli </italic></highlight>glg C<highlight><superscript>&minus;</superscript></highlight> cells expressing the structural genes for either potato or maize endosperm AGP were used. Cells containing potato AGP genes can synthesize copious levels of glycogen when grown at 37&deg; C. or at 42&deg; C. However, cells expressing maize endosperm AGP only synthesize glycogen at 37&deg; C. This result demonstrates the heat sensitivity of wild-type maize endosperm AGP. That there is a difference between potato and maize AGP&apos;s in this regard provides an efficient system for screening for mutant cells that have heat stable variants of the maize endosperm AGP. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> One aspect of the subject invention pertains to the efficient identification of AGP which is heat stable. Accordingly, a plasmid comprising a polynucleotide coding for the SH2 subunit of maize AGP was chemically mutagenized, as described below, placed into mutant <highlight><italic>E. coli </italic></highlight>cells expressing the BT2 subunit, and the cells grown at 42&deg; C. to select for mutants that could produce glycogen at that temperature. Other mutagens known in the art can also be used. Eleven heritable, iodine staining mutants, termed heat stable (HS) mutants, were isolated. Crude extracts of these mutants were prepared and the heat stability of the resulting AGP was monitored. The mutants retained between 8-59% of their activity after incubation at 60&deg; C. for five minutes (<cross-reference target="DRAWINGS">FIG. 1</cross-reference>). This compares to the 1-4% routinely observed for wild-type AGP at this temperature. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> The results show that heat stable forms of enzymes can be created according to the subject invention by mutation. Thus, one aspect of the invention pertains to processes for producing and identifying polynucleotides encoding mutant starch biosynthesis enzymes having increased heat stability compared to wild type enzymes. Unexpectedly, total activity of the maize endosperm AGP before heat treatment was elevated about two- to three-fold in the majority of these mutants. This surprising result makes these mutants particularly advantageous for use in agriculture. Mutagenesis techniques as described herein can be used according to the subject invention to identify other genes encoding heat stable starch biosynthesis enzymes. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> The genes encoding several of the heat stable mutants exemplified herein, including two of the most heat stable HS mutants, HS 33 and HS 40, were completely sequenced. HS 33, which retains 59% of its activity after heat treatment, contains a single base pair mutation that changes a histidine residue at position 333 of the amino acid sequence of the polypeptide to a tyrosine (<cross-reference target="DRAWINGS">FIG. 2</cross-reference>). Primary sequence alignments with the large subunits from wheat and barley AGPs show that a histidine is also present at the analogous residue (<cross-reference target="DRAWINGS">FIG. 3</cross-reference>) (Ainsworth, C., Hosein, F., Tarvis, M., Weir, F., Burrell, M., Devos, K. M., Gale, M. D. &lsqb;1995<highlight><italic>&rsqb; Planta </italic></highlight>197:1-10). Sequence analysis of HS 40, which retains 41% of its activity post heat treatment, also contained a histidine to tyrosine mutation at position 333. An additional point mutation was identified that generated a threonine to isoleucine substitution. The threonine residue is highly conserved in AGP large subunits, while in AGP small subunits the analogous residue is either a cysteine or serine (Ainsworth et al., 1995, supra). The threonine to isoleucine substitution is located close to the carboxyl terminus of the large subunit, and close to a known binding site for the activator 3-PGA (<cross-reference target="DRAWINGS">FIG. 3</cross-reference>). </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> Another aspect of the present invention pertains to mutant starch biosynthesis enzymes, such as AGP, and the polynucleotides that encode them, wherein these mutant enzymes are isolated by selecting for temperature sensitive (TS) mutants which are then mutagenized and screened for revertants that show enhanced stability. A further aspect of the invention concerns the methods for producing and identifying the polynucleotides and mutant enzymes encoded thereby. </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> The subject invention also concerns heat stable mutants of AGP that have mutations in the small subunit of the enzyme. Also encompassed within the scope of the invention are polynucleotides that encode the mutant small subunits of AGP. Mutations in the small subunit of AGP that confer heat stability to the enzyme can also be readily prepared and identified using the methods of the subject invention. </paragraph>
<paragraph id="P-0070" lvl="0"><number>&lsqb;0070&rsqb;</number> Plants and plant tissue bred to contain or transformed with the mutant polynucleotides of the invention, and expressing the polypeptides encoded by the polynucleotides, are also contemplated by the present invention. Plants and plant tissue expressing the mutant polynucleotides produce tissues that have, for example, lower heat-induced loss in weight or yield when subjected to heat stress during development. Plants within the scope of the present invention include monocotyledonous plants, such as rice, wheat, barley, oats, sorghum, maize, lilies, and millet, and dicotyledonous plants, such as peas, alfalfa, chickpea, chicory, clover, kale, lentil, prairie grass, soybean, tobacco, potato, sweet potato, radish, cabbage, rape, apple trees, and lettuce. In a particularly preferred embodiment, the plant is a cereal. Cereals to which this invention applies include, for example, maize, wheat, rice, barley, oats, rye, and millet. </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> Plants having mutant polynucleotides of the invention can be grown from seeds that comprise a mutant gene in their genome. In addition, techniques for transforming plants with a gene are known in the art. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> Because of the degeneracy of the genetic code, a variety of different polynucleotide sequences can encode each of the variant AGP polypeptides disclosed herein. In addition, it is well within the skill of a person trained in the art to create alternative polynucleotide sequences encoding the same, or essentially the same, polypeptides of the subject invention. These variant or alternative polynucleotide sequences are within the scope of the subject invention. As used herein, references to &ldquo;essentially the same&rdquo; sequence refers to sequences which encode amino acid substitutions, deletions, additions, or insertions which do not materially alter the functional activity of the polypeptide encoded by the AGP mutant polynucleotide described herein. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> As used herein, the terms &ldquo;nucleic acid&rdquo; and &ldquo;polynucleotide sequence&rdquo; refer to a deoxyribonucleotide or ribonucleotide polymer in either single- or double-stranded form, and unless otherwise limited, would encompass known analogs of natural nucleotides that can function in a similar manner as naturally-occurring nucleotides. The polynucleotide sequences include both the DNA strand sequence that is transcribed into RNA and the RNA sequence that is translated into protein. The polynucleotide sequences include both full-length sequences as well as shorter sequences derived from the full-length sequences. It is understood that a particular polynucleotide sequence includes the degenerate codons of the native sequence or sequences which may be introduced to provide codon preference in a specific host cell. Allelic variations of the exemplified sequences also come within the scope of the subject invention. The polynucleotide sequences falling within the scope of the subject invention further include sequences which specifically hybridize with the exemplified sequences. The polynucleotide includes both the sense and antisense strands as either individual strands or in the duplex. </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> Substitution of amino acids other than those specifically exemplified in the mutants disclosed herein are also contemplated within the scope of the present invention. Amino acids can be placed in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby a mutant AGP polypeptide having an amino acid of one class is replaced with another amino acid of the same class fall within the scope of the subject invention so long as the mutant AGP polypeptide having the substitution still retains increased heat stability relative to a wild type polypeptide. Table 2 below provides a listing of examples of amino acids belonging to each class.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="77PT" align="left"/>
<colspec colname="2" colwidth="126PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center">TABLE 2</entry>
</row>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Class of Amino Acid</entry>
<entry>Examples of Amino Acids</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Nonpolar</entry>
<entry>Ala, Val, Leu, Ile, Pro, Met, Phe, Trp</entry>
</row>
<row>
<entry></entry>
<entry>Uncharged Polar</entry>
<entry>Gly, Ser, Thr, Cys, Tyr, Asn, Gln</entry>
</row>
<row>
<entry></entry>
<entry>Acidic</entry>
<entry>Asp, Glu</entry>
</row>
<row>
<entry></entry>
<entry>Basic</entry>
<entry>Lys, Arg, His</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> For example, substitution of the tyrosine at position 333 in the HS 33, HS 39, HS 40 and HS 47 mutant maize endosperm AGP with other amino acids, such as Glycine, Serine, Threonine, Cysteine, Asparagine, and Glutamine, are encompassed within the scope of the invention. Amino acid substitutions at positions other than the site of the heat stable mutation are also contemplated within the scope of the invention so long as the polypeptide retains increased heat stability relative to wild type polypeptides. </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> The subject invention also concerns polynucleotides which encode fragments of the full length mutant polypeptide, so long as those fragments retain substantially the same functional activity as full length polypeptide. The fragments of mutant AGP polypeptide encoded by these polynucleotides are also within the scope of the present invention. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> The subject invention also contemplates those polynucleotide molecules encoding starch biosynthesis enzymes having sequences which are sufficiently homologous with the wild type sequence so as to permit hybridization with that sequence under standard high-stringency conditions. Such hybridization conditions are conventional in the art (see, e.g., Maniatis, T., E. F. Fritsch, J. Sambrook &lsqb;1989<highlight><italic>&rsqb; Molecular Cloning: A Laboratory Manual, </italic></highlight>2nd Edition, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.). </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> The polynucleotide molecules of the subject invention can be used to transform plants to express the mutant heat stable enzyme in those plants. In addition, the polynucleotides of the subject invention can be used to express the recombinant variant enzyme. They can also be used as a probe to detect related enzymes. The polynucleotides can also be used as DNA sizing standards. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> The polynucleotide molecules of the subject invention also include those polynucleotides that encode starch biosynthesis enzymes, such as AGP enzymes, that contain mutations that can confer increased seed weight, in addition to enhanced heat stability, to a plant expressing these mutants. The combination of a heat stabilizing mutation, such as for example HS 33 or HS 40, with a mutation conferring increased seed weight, e.g., Rev 6, in a polynucleotide that encodes the large subunit of maize AGP is specifically contemplated in the present invention. U.S. Pat. Nos. 5,589,618 and 5,650,557 disclose polynucleotides (e.g., Rev6) that encode mutations in the large subunit of AGP that confer increased seed weight in plants that express the mutant polypeptide. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> Mutations in the AGP subunits that confer heat stability can be combined according to the subject invention with phosphate insensitive mutants of maize, such as the Rev6 mutation, to enhance the stability of the Rev6 encoded large subunit. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> It is expected that enzymic activity of SSS will be impaired at higher temperatures as observed with AGP. Thus, mutagenized forms of SSS can be expressed under increased thermal conditions (42&deg; C.), to isolate heat stable variants in accordance with the methods described herein. These heat stable mutagenized forms of SSS, and the polynucleotides that encode them, are further aspects of the subject invention. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> The subject invention also concerns methods for increasing yield characteristics of plants under conditions of heat stress by incorporating a polynucleotide of the present invention that comprises a mutation in a starch biosynthesis enzyme that confers increased stability or resistance to heat stress conditions and a mutation that confers increased yield characteristics on the plant. Increased yield characteristics include, for example, increased seed number, increased seed weight, increased plant biomass, and increased Harvest Index. </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> The subject invention also concerns methods for producing and identifying polynucleotides and polypeptides contemplated within the scope of the invention. In one embodiment, gene mutation, followed by selection using a bacterial expression system, can be used to isolate polynucleotide molecules that encode enzymes that can alleviate heat-induced loss in starch synthesis in plants. </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> All patents, patent applications, provisional applications, and publications referred to or cited herein are hereby incorporated by reference in their entirety to the extent they are not inconsistent with the explicit teachings of this specification. </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> Following are examples which illustrate procedures for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted. </paragraph>
</section>
<section>
<heading lvl="1">Example 1 </heading>
</section>
<section>
<heading lvl="1">Use of Mutagenesis to Obtain Maize Endosperm AGP Heat Stable Variants </heading>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> The chemical mutagen hydroxylamine-HCl was initially used for the random mutagenesis of the large subunit expression plasmid. Hydroxylamine preferentially hydroxylates the amino nitrogen at the C-4 position of cytosine, and leads to a GC to AT transition (Suzuki, D. T., Griffith, A. J. F., Miller, J. H., and Lewontin, R. C. &lsqb;1989&rsqb; In <highlight><italic>Introduction to genetic analysis</italic></highlight>, Freeman, NY, 4th ed., pp. 475-499). The chemical mutagen was chosen for its high mutation frequency. Limitations of the chemical mutagen are recognized, and if a large variety of genetic variants are not isolated, PCR based random mutagenesis can be performed. PCR mutagenesis generates a broader spectrum of mutations that include similar frequencies of transitions and transversion, and provides an excellent alternative to the chemical method. The method outlined by Cadwell and Joyce (Cadwell, R. C. and Joyce, G. F. &lsqb;1992<highlight><italic>&rsqb; PCR Methods and Applications </italic></highlight>2:28-33) can be followed for the PCR based method. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> Since the complete expression plasmid is used in the random mutagenesis, it is possible that mutations will occur outside of the coding region. Although it is expected that such mutations will not have any effect on the heat stability of the maize endosperm AGP, each variant can be subcloned into an unmutated expression plasmid before any additional characterization at the enzyme level is conducted. Both the large and small subunit expression plasmids can be constructed so that a NcoI/SacI digestion will liberate the complete coding region. This can easily be cloned back into a unmutated NcoI/SacI digested expression plasmid. </paragraph>
</section>
<section>
<heading lvl="1">Example 2 </heading>
</section>
<section>
<heading lvl="1">Molecular Characterization and Analysis of Heat Stable AGP Variants </heading>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> Initially, 11 heat stable variants of the maize endosperm large subunit were obtained. Sequencing was performed using DuPont and ABI instrumentation. Sequence data can be routinely compared to the progenitor wild-type allele. This analysis reveals the extent of diversity of changes conditioning heat stability. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> Several of the sequenced HS mutants contained the identical histidine to tyrosine change at amino acid position 333 in the large subunit. PCR-derived HS mutants can be quickly screened for the histidine to tyrosine alteration by use of site-specific mutagenesis using primers that change the tyrosine back to histidine. </paragraph>
</section>
<section>
<heading lvl="1">Example 3 </heading>
</section>
<section>
<heading lvl="1">Expression Purification and Kinetic Analysis of Genetic Variants </heading>
<paragraph id="P-0090" lvl="0"><number>&lsqb;0090&rsqb;</number> Conditions for the expression of the wild-type maize endosperm AGP in <highlight><italic>E. coli </italic></highlight>have been fully characterized. Optimum growth and induction conditions vary somewhat from those previously published for potato AGP expressed in <highlight><italic>E. coli </italic></highlight>(Iglesias et al., 1993, supra; Ballicora et al., 1995, supra). Induction at room temperature for 12-14 hrs in the presence of 0.3 mM IPTG and 25 &mgr;g/ml nalidixic acid consistently gives high levels of expression and activity. Addition of 30% ammonium sulfate and 10 mM KH<highlight><subscript>2</subscript></highlight>PO<highlight><subscript>4</subscript></highlight><highlight><superscript>&minus;</superscript></highlight>/K<highlight><subscript>2</subscript></highlight>HPO<highlight><subscript>4</subscript></highlight><highlight><superscript>&minus;</superscript></highlight> to the extraction buffer stabilizes the maize AGP in the crude extract. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> Ammonium sulfate concentrated AGP is further purified by Hydrophobic Interaction Chromatography using Tentacle C3 aminopropyl media (EM Separations) packed into a Pharmacia HR 10/10 column. Protein binds to the column in a buffer containing 1 M ammonium sulfate. AGP is eluted from the column by successive step gradient washes of buffer that contains 0.75 M, 0.5 M, 0.25 M, and 0 M ammonium sulfate. Wild-type maize endosperm AGP typically elutes in the 0.25 M wash. C3 purified maize endosperm AGP is further purified by anion exchange chromatography using Macro-Prep DEAE (BioRad) anion exchange media packed into a Pharmacia HR 10/10 column. AGP is eluted by a linear gradient of 100-500 mM KCl, and typically elutes at a salt concentration around 300 mM. A Pharmacia FPLC system is used for all chromatography steps. The conditions for the individual purification steps are fully characterized. AGP activity during the purification is monitored by the pyrophosphorylysis assay, and purification steps are monitored by SDS-PAGE, Coomassie staining, and Western analysis using polyclonal antibodies specific to the maize endosperm AGP large and small subunits. </paragraph>
</section>
<section>
<heading lvl="1">Example 4 </heading>
</section>
<section>
<heading lvl="1">Enhanced Subunit Interaction </heading>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> A totally unexpected pleiotropic effect of the HS maize endosperm AGP mutants is a two- to three-fold elevation of activity before heat treatment. One possible explanation for this result is that we have, by mutational change, shifted the ratio of SH2 and BT2 monomers and polymers existing within the <highlight><italic>E. coli </italic></highlight>cell. Perhaps, in wild-type, only 10% or less of the total proteins exist in the active heterotetrameric form whereas in the mutants, this percentage is much higher. If the polymer is more heat resistant than are the monomers, then the phenotype of the mutants would be identical to what has been observed. Kinetic analysis can be used to determine changes in affinities for substrates and/or allosteric effectors. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> To test the idea that the monomer/polymer ratio may be altered in these mutants, the amounts of monomers and polymers in wild-type and in selected mutants both before and after heat treatment can be monitored. The availability of antibodies (Giroux, M. J. and Hannah, L. C. &lsqb;1994<highlight><italic>&rsqb; Mol. Gen. Genetics </italic></highlight>243:400-408) for both subunits makes this approach feasible. This can be examined both through sucrose gradient ultracentrifugation and through gel chromatography and will readily determine which method is most efficient and definitive. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> Since the higher plant AGP consists of two similar but distinct subunits that oligomerize to form the native heterotetrameric structure, mutations that enhance this interaction can provide added stability to the enzyme. A yeast two-hybrid system (CLONTECH Laboratories, Palo Alto, Calif.) can be used to evaluate subunit interactions. Specific primers for the amplification of the coding regions can be constructed. These primers add unique restriction sites to the 5&prime;- and 3&prime;- ends so that cloning facilitates the translational fusion of the individual subunit to the GAL4 DNA binding domain (pGBT9) or GAL4 activation domain (pGAD424). If the proteins cloned into the vectors interact, the DNA binding domain and the activation domain will form a functional transcription activator. This in turn activates expression of the reporter gene, lac Z, cloned behind a GAL4 promoter. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> Initially, conditions can be characterized with the wild-type subunits. The coding regions of the wild-type large and small subunits can be cloned into the pGBT9 and pGAD424 yeast expression vectors. All possible combinations can be generated and tested. pGBT9 and pGAD424 vectors containing Sh2 and Bt2 can be cotransformed into the same yeast strain, and selected for growth on media lacking tryptophan (pGBT9) and leucine (pGAD424). Subunit interaction as a function of lacZ expression can be detected two ways. Positive colonies are visually identified by a B-galactosidase filter assay. With this assay colonies are bound to the filter, lysed, and incubated with an X-gal solution. Colonies that exhibit a blue color can be analyzed. Subunit interaction can be further analyzed by an enzyme assay specific for B-galactosidase. This allows the quantification of the interaction. Mutations that enhance subunit interactions will give higher levels of B-galactosidase activity when assayed. </paragraph>
</section>
<section>
<heading lvl="1">Example 5 </heading>
</section>
<section>
<heading lvl="1">Further Enhancement of Stability </heading>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> The large subunit mutants isolated vary in their heat stability characteristics, suggesting the possibility of multiple mutations. While sequence analysis of mutants HS 33 and HS 40 reveal that the mutant sequences are not identical, both mutants contained the identical histidine to tyrosine change. Given the identification of different HS alterations within the SH2 protein, it is possible to efficiently pyramid these changes into one protein. Furthermore, any HS mutations within the small subunit can be co-expressed with HS SH2 mutants to further enhance the stability of the maize endosperm enzyme. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> Multiple HS mutants within one subunit can easily be combined. For example, different unique restriction sites that divide the coding regions of Sh2 into three distinct fragments can be used. Where appropriate, mutation combinations can be generated by subcloning the corresponding fragment containing the added mutation. If two mutations are in close proximity, then site-directed mutagenesis can be used to engineer such combinations. One method for site specific mutations involves PCR, mutagenic primer, and the use of Dpnl restriction endonuclease. Primers can be constructed to contain the mutation in the 5&prime; end, and used to PCR amplify using the proofreading polymerase Vent. Amplified DNA can then be digested with DpnI. Parental DNA isolated from <highlight><italic>E. coli </italic></highlight>is methylated and hence susceptible to DpnI. Digested DNA is size fractionated by gel electrophoresis, ligated, and cloned into the expression vectors. Mutations are confirmed by sequence analysis and transformed into the AC70R1-504 strain carrying the wild-type small subunit. Combinatorial mutants can then be analyzed. </paragraph>
</section>
<section>
<heading lvl="1">Example 6 </heading>
</section>
<section>
<heading lvl="1">Identification of Additional Mutants at Position 333 of the Large Subunit of Maize AGP </heading>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> Hydroxylamine-HCl mutagenesis gives rise only to cytosine to thymine changes, thereby limiting the types of possible substitutions. Because both strands of DNA undergo mutagenesis, thymine to cytosine changes also occur; however, taken together, only two of the 12 possible single base changes occur. Hence, not all possible amino acid substitutions would have been produced by hydroxylamine-HCl mutagenesis. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> Therefore, in order to prepare mutants where each of the 20 different amino acids were inserted, individually, at position 333 of the large subunit of maize endosperm AGP, a two step process was employed. Methodologies were derived basically from those of Stratagene. First, the codon encoding amino acid 333, plus the first base of the codon for amino acid 334, were removed via PCR-based site-specific mutagenesis (Suzuki et al., 1989, supra). Following screening for inactivity by iodine staining and subsequent sequencing to verify the deletion, the resulting plasmid was PCR mutagenized using a primer containing randomized bases at the 333 codon plus the replacement base at the first base of the codon for amino acid 334. Resulting plasmids were transformed into Bt2-containing <highlight><italic>E. coli </italic></highlight>mutant cells, screened via iodine staining for activity at 37&deg; C. and at 42&deg; C., and subsequently sequenced. Primers of lesser degeneracy were used in latter stages to more efficiently generate codons not obtained in the first round. </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> All 20 amino acid substitutions were isolated following mutagenesis and all gave rise to staining at 37&deg; C. Mutants were also scored for iodine staining at the elevated temperature of 42&deg; C. Coded strains were used for screening to remove any possible bias on the part of the investigators. Those mutants giving rise to staining equal to or greater than wildtype when grown at 42&deg; C., are listed in Table 3 below. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> As expected, the screening identified active enzymes having at position 333 of the protein the wild type amino acid, i.e., histidine, or the amino acid of the HS 33 mutant, i.e., tyrosine. Phenylalanine, which differs from tyrosine only by the absence of a polar hydroxyl group, was also identified. The screen also identified active enzymes having amino acids differing substantially from tyrosine and phenylalanine, such as, for example, glycine. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> AGP activities before and after treatment of freshly extracted enzyme preparations at 65&deg; C. for 5 minutes were also measured and results are shown in Table 3. Of the eight amino acids selected through positive staining <highlight><italic>E. coli </italic></highlight>plates grown at 42&deg; C., three mutants (HS 33, HS 33F, and HS 33M having tyrosine, phenylalanine, or methionine at position 333, respectively) proved superior activity in enzyme assays following heat treatament at 65&deg; C. While AGP activities from phenylalanine- and methionine-containing AGPs are somewhat higher than that conditioned by the tyrosine substitution, the differences in activity between these three preparations are small.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="center"/>
<colspec colname="3" colwidth="84PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center">TABLE 3</entry>
</row>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Amino Acid</entry>
<entry>Before Heat*</entry>
<entry>After Heat*</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="char" char="."/>
<colspec colname="3" colwidth="84PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>histidine (wt)</entry>
<entry>61</entry>
<entry>42</entry>
</row>
<row>
<entry></entry>
<entry>tyrosine (HS 33)</entry>
<entry>100</entry>
<entry>77</entry>
</row>
<row>
<entry></entry>
<entry>phenylalanine</entry>
<entry>138</entry>
<entry>85</entry>
</row>
<row>
<entry></entry>
<entry>methionine</entry>
<entry>160</entry>
<entry>89</entry>
</row>
<row>
<entry></entry>
<entry>cysteine</entry>
<entry>73</entry>
<entry>7</entry>
</row>
<row>
<entry></entry>
<entry>lysine</entry>
<entry>48</entry>
<entry>38</entry>
</row>
<row>
<entry></entry>
<entry>glycine</entry>
<entry>102</entry>
<entry>34</entry>
</row>
<row>
<entry></entry>
<entry>glutamine</entry>
<entry>65</entry>
<entry>21</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00001">*AGP activity in crude preps is expressed as a percentage of HS 33 activity before heat treatment. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">Example 7 </heading>
</section>
<section>
<heading lvl="1">Combination of Heat Stability Mutations with Rev6 </heading>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> According to the subject invention, the heat stable mutations can be combined with a mutation associated with increased seed weight, such as, for example, the Rev6 mutation. The goal is to maintain the desired phosphate insensitivity characteristic of Rev6 while enhancing its stability. Rev 6/HS double mutants can be constructed and confirmed as described herein. Double mutants can be transformed into AC7OR1-504 carrying the wild-type small subunit. Increased heat stability can be easily identified by a positive glycogen staining on a low glucose media. Rev6 does not stain when grown on this media. Initially all mutant combinations can be screened enzymatically for maintenance of phosphate insensitivity, and only combinations that maintain phosphate insensitivity are further analyzed. </paragraph>
</section>
<section>
<heading lvl="1">Example 8 </heading>
</section>
<section>
<heading lvl="1">Cloning of SSS I Mutants </heading>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> A glg A<highlight><superscript>&minus;</superscript></highlight><highlight><italic> E. coli </italic></highlight>strain deficient in the endogenous bacterial glycogen synthase can be obtained from the <highlight><italic>E. coli </italic></highlight>Stock Center. Bacterial expression vectors currently used for the expression of AGP can be used for expression of SSS. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> One cloning strategy, as used, for example, with Sh2 and Bt2 (Giroux et al., 1996, supra), is the following: One primer contains a unique restriction plus the 5&prime; terminus of the transcript while the other primer contains another unique restriction site and sequences 3&prime; to the translational termination codon of the gene under investigation. Subsequent cloning of these gives rise to a translational fusion within the plasmid. These gene specific primers are initially used in RT-PCR reactions using poly A&plus; RNA from developing endosperms. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> Expression of the maize endosperm SSS I will complement the lack of glycogen synthase activity in the glg A<highlight><superscript>&minus;</superscript></highlight> strain. Complementation should be easily visualized with iodine staining as it is with the expression of AGP in the glg C<highlight><superscript>&minus;</superscript></highlight> strain. Crude extracts can be incubated at various temperatures and lengths of time to determine the heat stability of SSS I. The gig A<highlight><superscript>&minus;</superscript></highlight> strain expressing the maize endosperm SSS I can be grown at various temperatures to determine if function is temperature sensitive as it is with the AGP bacterial expression system. Once a restrictive temperature is established, a random mutagenesis can be conducted with the SSS I clone. Mutant forms of SSS I can be transformed into the gig A- strain, grown at the restrictive temperature, and heat stable variants identified by their ability to produce iodine-staining glycogen at the restriction temperature. </paragraph>
</section>
<section>
<heading lvl="1">Example 9 </heading>
</section>
<section>
<heading lvl="1">Temperature Sensitive Mutants of Maize Endosperm ADP-Glucose Pyrophosphorylase </heading>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> As an alternative approach to identify additional variants with increased stability, a reverse-genetics approach was employed. Temperature sensitive (TS) mutants have been isolated. These mutants exhibit a negative iodine staining phenotype at 30&deg; C. indicating a lack of function with the maize endosperm AGP. In contrast, when the mutants are grown at 37&deg; C. they can fully complement the mutation in the bacterial AGP. This clearly shows that the mutant AGPs are functional, and that the loss of function is temperature dependent. Wild type AGP exhibits a positive glycogen staining phenotype at 30&deg; and 37&deg; C. The temperature sensitive mutants were then used to produce second site revertants that encode mutant AGP having enhanced stability. </paragraph>
<paragraph id="P-0108" lvl="7"><number>&lsqb;0108&rsqb;</number> Mutagenesis </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> pSh2 DNA was subjected to hydroxylamine mutagenesis (Greene, T. W., Chantler, S. E., Kahn, M. L., Barry, G. F., Preiss, J., and Okita, T. W. &lsqb;1996<highlight><italic>&rsqb; Proc. Natl. Acad. Sci. </italic></highlight>93:1509-1513) and transformed into AC70R1-504 <highlight><italic>E. coli </italic></highlight>cells carrying the wild type pBt2 small subunit plasmid. Cells were plated and grown at 30&deg; C. Temperature sensitive variants of AGP were identified by their negative iodine staining phenotype at 30&deg; C. Putative mutants were streaked again at 30&deg; C. and 37&deg; C. along with the wild type AGP as a control. Six mutants that consistently gave a negative iodine phenotype at 30&deg; C. and a positive iodine staining phenotype at 37&deg; C. were isolated. Expression of wild type Sh2 and Bt2 gave a positive iodine staining phenotype at both temperatures. </paragraph>
<paragraph id="P-0110" lvl="7"><number>&lsqb;0110&rsqb;</number> Characterization of TS48 and TS60</paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> Plasmid DNA from two temperature sensitive mutants, TS48 and TS60, was isolated and sequenced to identify the genetic lesion. A single point mutation that generated the replacement of leucine at amino acid position 426 with phenylalanine was identified (<cross-reference target="DRAWINGS">FIG. 4A</cross-reference>). This residue and surrounding region is highly conserved in the cereal endosperm large subunits (LS) (Smith-White and Preiss, 1992, supra). In TS60, two point mutations were identified that generated a glutamic acid to lysine change at amino acid 324 and an alanine to valine mutation at position 359 (<cross-reference target="DRAWINGS">FIG. 4B</cross-reference>). Glu-324 is highly conserved among the LS and small (SS) subunits of AGP (Smith-White and Preiss, 1992, supra). Ala-359 and the surrounding amino acids are also highly conserved among the AGP LS. Of significance, the two mutation identified in TS60 flank the HS 33 mutation described herein. The HS 33 mutation, which has the histidine to tyrosine substitution at position 333, was shown to greatly enhance heat stability of the maize endosperm AGP. That the mutations of TS60 are in close proximity to the HS 33 mutation is additional evidence that this region of the protein is important for stability. </paragraph>
<paragraph id="P-0112" lvl="7"><number>&lsqb;0112&rsqb;</number> Isolation of Second-Site Revertants </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> Isolation of the temperature sensitive mutants provides a selectable phenotype for isolating additional variants that enhance the stability of AGP. Additional hydroxylamine mutagenesis was conducted with TS48 and TS60 DNA to isolate second-site revertants that restore a positive glycogen staining phenotype at 30&deg; C. Hydroxylamine was used because the chemistry of the mutagenesis eliminates the possibility of a direct reversion of the primary mutation identified in the TS48 and TS60 mutants. This forces the selection of second-site mutations that can restore stability in these temperature sensitive mutants. </paragraph>
<paragraph id="P-0114" lvl="0"><number>&lsqb;0114&rsqb;</number> Three revertants were isolated for TS48 and the molecular characterization of one mutant, RTS 48-2, is shown (<cross-reference target="DRAWINGS">FIG. 5A</cross-reference>). RTS 48-2 contains an alanine to valine mutation at amino acid position 177 in addition to the parental mutation identified in TS48. This residue and the surrounding region are highly conserved. The RTS 48-2 mutation corresponds to the identical site of the mutation identified in the heat stable mutant, HS 13. The alanine residue was mutated to a proline at position 177 in HS 13. That these two mutations map to the same site is significant. The RTS 48-2 and HS 13 mutants were selected based on increased stability using completely different approaches, and thus these two mutations identify this site to be important in the stability of AGP. </paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> Five second-site revertants were isolated for TS60 and the sequence analysis of one, RTS 60-1, is shown (<cross-reference target="DRAWINGS">FIG. 5B</cross-reference>). An alanine to valine mutation at amino acid 396 was identified. This residue is highly conserved among the AGP LS, and it also maps close to a heat stable mutation identified in HS 14. </paragraph>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<sequence-cwu id="SEQLST-1">
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>36 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>HS33 Mutant of Zea mays </s213>
</s200>
<s400> 1 
Leu His Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Val Leu Asp Tyr 
  1               5                  10                  15 
Ser Val Gln Ala Cys Ile Phe Thr Gly Tyr Trp Glu Asp Val Gly Thr 
             20                  25                  30 
Ile 
</s400>
<s200>
<s210>2 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 2 
Leu His Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Val Leu Asp His 
  1               5                  10                  15 
Ser Val Gln Ala Cys Ile Phe Thr Gly Tyr Trp Glu Asp Val Gly Thr 
             20                  25                  30 
Ile 
</s400>
<s200>
<s210>3 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 3 
Leu His Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Leu His Asp His 
  1               5                  10                  15 
Asn Val Gln Ala Tyr Val Phe Thr Asp Tyr Trp Glu Asp Ile Gly Thr 
             20                  25                  30 
Ile 
</s400>
<s200>
<s210>4 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 4 
Leu His Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Leu His Asp His 
  1               5                  10                  15 
Asn Val Gln Ala Tyr Val Phe Thr Asp Tyr Trp Glu Asp Ile Gly Thr 
             20                  25                  30 
Ile 
</s400>
<s200>
<s210>5 </s210>
<s211>33 </s211>
<s212>PRT </s212>
<s213>Solanum tuberosum </s213>
</s200>
<s400> 5 
Ser Asn Asp Phe Gly Ser Glu Ile Leu Pro Ala Ala Ile Asp Asp Tyr 
  1               5                  10                  15 
Asn Val Gln Ala Tyr Ile Phe Lys Asp Tyr Trp Glu Asp Ile Gly Thr 
             20                  25                  30 
Ile 
</s400>
<s200>
<s210>6 </s210>
<s211>26 </s211>
<s212>PRT </s212>
<s213>HS40 Mutant of Zea mays </s213>
</s200>
<s400> 6 
Ala Gly Lys Val Pro Ile Gly Ile Gly Arg Asn Ile Lys Ile Arg Asn 
 1               5                   10                  15 
Cys Ile Ile Asp Met Asn Ala Arg Ile Gly 
            20                  25 
</s400>
<s200>
<s210>7 </s210>
<s211>26 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 7 
Ala Gly Lys Val Pro Ile Gly Ile Gly Arg Asn Thr Lys Ile Arg Asn 
 1               5                   10                  15 
Cys Ile Ile Asp Met Asn Ala Arg Ile Gly 
            20                  25 
</s400>
<s200>
<s210>8 </s210>
<s211>26 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 8 
Glu Gly Lys Val Pro Ile Gly Val Gly Glu Asn Thr Lys Ile Ser Asn 
  1               5                  10                  15 
Cys Ile Ile Asp Met Asn Ala Arg Ile Gly 
             20                  25 
</s400>
<s200>
<s210>9 </s210>
<s211>26 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 9 
Glu Gly Lys Val Pro Ile Gly Val Gly Glu Asn Thr Lys Ile Ser Asn 
  1               5                  10                  15 
Cys Ile Ile Asp Met Asn Ala Arg Ile Gly 
             20                  25 
</s400>
<s200>
<s210>10 </s210>
<s211>26 </s211>
<s212>PRT </s212>
<s213>Solanum tuberosum </s213>
</s200>
<s400> 10 
Glu Gly Lys Val Pro Ile Gly Ile Gly Glu Asn Thr Lys Ile Arg Lys 
  1               5                  10                  15 
Cys Ile Ile Asp Lys Asn Ala Lys Ile Gly 
             20                  25 
</s400>
<s200>
<s210>11 </s210>
<s211>11 </s211>
<s212>PRT </s212>
<s213>Spinicia oleracea </s213>
</s200>
<s400> 11 
Ile Lys Asp Ala Ile Ile Asp Lys Asn Ala Arg 
  1               5                  10 
</s400>
<s200>
<s210>12 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>TS48 Mutant of Zea mays </s213>
</s200>
<s400> 12 
Cys Ser Arg Val Ser Ser Gly Cys Glu Phe Lys Asp Ser Val Met Met 
  1               5                  10                  15 
Gly Ala Asp Ile 
             20 
</s400>
<s200>
<s210>13 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 13 
Cys Ser Arg Val Ser Ser Gly Cys Glu Leu Lys Asp Ser Val Met Met 
  1               5                  10                  15 
Gly Ala Asp Ile 
             20 
</s400>
<s200>
<s210>14 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 14 
Arg Ser Arg Leu Asn Ser Gly Ser Glu Leu Lys Asn Ala Met Met Met 
  1               5                  10                  15 
Gly Ala Asp Ser 
             20 
</s400>
<s200>
<s210>15 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 15 
Arg Ser Arg Leu Asn Ser Gly Ser Glu Leu Lys Asn Ala Met Met Met 
  1               5                  10                  15 
Gly Ala Asp Ser 
             20 
</s400>
<s200>
<s210>16 </s210>
<s211>12 </s211>
<s212>PRT </s212>
<s213>Oryza sativa </s213>
</s200>
<s400> 16 
Ser Ser Arg Val Ser Ser Gly Cys Glu Leu Lys Ile 
  1               5                  10 
</s400>
<s200>
<s210>17 </s210>
<s211>24 </s211>
<s212>PRT </s212>
<s213>TS60 Mutant of Zea mays </s213>
</s200>
<s400> 17 
Asp Phe Gly Ser Lys Ile Leu Pro Arg Ala Val Leu Asp His Ser Val 
  1               5                  10                  15 
Gln Ala Cys Ile Phe Thr Gly Tyr 
             20 
</s400>
<s200>
<s210>18 </s210>
<s211>24 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 18 
Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Val Leu Asp His Ser Val 
  1               5                  10                  15 
Gln Ala Cys Ile Phe Thr Gly Tyr 
             20 
</s400>
<s200>
<s210>19 </s210>
<s211>24 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 19 
Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Leu His Asp His Asn Val 
  1               5                  10                  15 
Gln Ala Tyr Val Phe Thr Asp Tyr 
             20 
</s400>
<s200>
<s210>20 </s210>
<s211>24 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 20 
Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Leu His Asp His Asn Val 
  1               5                  10                  15 
Gln Ala Tyr Val Phe Thr Asp Tyr 
             20 
</s400>
<s200>
<s210>21 </s210>
<s211>25 </s211>
<s212>PRT </s212>
<s213>Oryza sativa </s213>
</s200>
<s400> 21 
Asp Phe Gly Ser Glu Ile Leu Pro Arg Ala Leu Leu Glu His Asn Val 
  1               5                  10                  15 
Lys Val Ala Cys Val Phe Thr Glu Tyr 
             20                  25 
</s400>
<s200>
<s210>22 </s210>
<s211>25 </s211>
<s212>PRT </s212>
<s213>TS60 Mutant of Zea mays </s213>
</s200>
<s400> 22 
Glu Asp Val Gly Thr Ile Lys Ser Phe Phe Asp Ala Asn Leu Val Leu 
  1               5                  10                  15 
Thr Glu Gln Pro Ser Lys Phe Asp Phe 
             20                  25 
</s400>
<s200>
<s210>23 </s210>
<s211>25 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 23 
Glu Asp Val Gly Thr Ile Lys Ser Phe Phe Asp Ala Asn Leu Ala Leu 
  1               5                  10                  15 
Thr Glu Gln Pro Ser Lys Phe Asp Phe 
             20                  25 
</s400>
<s200>
<s210>24 </s210>
<s211>25 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 24 
Glu Asp Ile Gly Thr Ile Arg Ser Phe Phe Asp Ala Asn Met Ala Leu 
  1               5                  10                  15 
Cys Glu Gln Pro Pro Lys Phe Glu Phe 
             20                  25 
</s400>
<s200>
<s210>25 </s210>
<s211>25 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 25 
Glu Asp Ile Gly Thr Ile Arg Ser Phe Phe Asp Ala Asn Met Ala Leu 
  1               5                  10                  15 
Cys Glu Gln Pro Pro Lys Phe Glu Phe 
             20                  25 
</s400>
<s200>
<s210>26 </s210>
<s211>25 </s211>
<s212>PRT </s212>
<s213>Oryza sativa </s213>
</s200>
<s400> 26 
Glu Asp Ile Gly Thr Ile Lys Ser Phe Phe Asp Ala Asn Leu Ala Leu 
  1               5                  10                  15 
Thr Glu Gln Pro Pro Lys Phe Glu Phe 
             20                  25 
</s400>
<s200>
<s210>27 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>RTS48-2 Mutant of Zea mays </s213>
</s200>
<s400> 27 
Thr Gln Met Pro Glu Glu Pro Val Gly Trp Phe Gln Gly Thr Ala Asp 
  1               5                  10                  15 
Ser Ile Arg Lys 
             20 
</s400>
<s200>
<s210>28 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 28 
Thr Gln Met Pro Glu Glu Pro Ala Gly Trp Phe Gln Gly Thr Ala Asp 
  1               5                  10                  15 
Ser Ile Arg Lys 
             20 
</s400>
<s200>
<s210>29 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 29 
Thr Gln Met Pro Gly Glu Ala Ala Gly Trp Phe Arg Gly Thr Ala Asp 
  1               5                  10                  15 
Ala Val Arg Lys 
             20 
</s400>
<s200>
<s210>30 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 30 
Thr Gln Met Pro Gly Glu Ala Ala Gly Trp Phe Arg Gly Thr Ala Asp 
  1               5                  10                  15 
Ala Val Arg Lys 
             20 
</s400>
<s200>
<s210>31 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Oryza sativa </s213>
</s200>
<s400> 31 
Thr Gln Met Pro Asp Glu Pro Ala Gly Trp Phe Gln Gly Thr Ala Asp 
  1               5                  10                  15 
Ala Ile Arg Lys 
             20 
</s400>
<s200>
<s210>32 </s210>
<s211>18 </s211>
<s212>PRT </s212>
<s213>RTS60-1 Mutant of Zea mays </s213>
</s200>
<s400> 32 
Asp Lys Cys Lys Met Lys Tyr Val Phe Ile Ser Asp Gly Cys Leu Leu 
  1               5                  10                  15 
Arg Glu 
</s400>
<s200>
<s210>33 </s210>
<s211>18 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
</s200>
<s400> 33 
Asp Lys Cys Lys Met Lys Tyr Ala Phe Ile Ser Asp Gly Cys Leu Leu 
  1               5                  10                  15 
Arg Glu 
</s400>
<s200>
<s210>34 </s210>
<s211>18 </s211>
<s212>PRT </s212>
<s213>Triticum aestivum </s213>
</s200>
<s400> 34 
Asp Lys Cys Arg Ile Lys Glu Ala Ile Ile Ser His Gly Cys Phe Leu 
  1               5                  10                  15 
Arg Glu 
</s400>
<s200>
<s210>35 </s210>
<s211>18 </s211>
<s212>PRT </s212>
<s213>Hordeum vulgare </s213>
</s200>
<s400> 35 
Asp Lys Cys Arg Ile Lys Glu Ala Ile Ile Ser His Gly Cys Phe Leu 
  1               5                  10                  15 
Arg Glu 
</s400>
<s200>
<s210>36 </s210>
<s211>20 </s211>
<s212>PRT </s212>
<s213>Oryza sativa </s213>
</s200>
<s400> 36 
Asp Lys Cys Lys Cys Lys Ile Lys Asp Ala Ile Ile Ser Asp Gly Cys 
  1               5                  10                  15 
Ser Phe Ser Glu 
             20
</s400>
</sequence-list-new-rules>
</sequence-cwu>
<subdoc-claims>
<heading lvl="1">We claim </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A polynucleotide encoding a mutant starch biosynthesis protein, or a biologically-active fragment or variant of said mutant protein, wherein said mutant protein exhibits increased heat stability relative to the wild type protein. </claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said mutant protein encoded by said polynucleotide is a plant AGP protein. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, wherein said mutant protein encoded by said polynucleotide comprises an amino acid mutation in the large subunit of said protein. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00002">claim 2</dependent-claim-reference>, wherein said mutant protein encoded by said polynucleotide comprises an amino acid mutation in the small subunit of said protein. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00003">claim 3</dependent-claim-reference>, wherein said mutant protein encoded by said polynucleotide comprises an amino acid mutation where in a histidine residue at position 333 in the amino acid sequence of said protein is replaced by an amino acid that confers heat stability to said protein. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, wherein said amino acid substituted for histidine at position number 333 is a glycine. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, wherein said amino acid substituted for histidine at position number 333 is a phenylalanine. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference>, wherein said amino acid substituted for histidine at position number 333 is a methionine. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein said mutant protein encoded by said polynucleotide further comprises an amino acid mutation that confers increased seed weight to a plant expressing said polynucleotide. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein said polynucleotide comprises the Rev6 mutation. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein said polynucleotide encodes a maize large subunit AGP enzyme wherein at least one serine residue is inserted between amino acids 494 and 495 of the native AGP enzyme subunit. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein said polynucleotide encodes a maize large subunit AGP enzyme wherein the amino acid pair tyrosine:serine is inserted between amino acids 494 and 495 of the native AGP enzyme subunit. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The polynucleotide according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein said polynucleotide encodes a maize large subunit AGP enzyme wherein the amino acid pair serine:tyrosine is inserted between amino acids 495 and 496 of the native AGP enzyme subunit. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A method for increasing resistance of a plant to heat stress conditions, said method comprising incorporating the polynucleotide of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> into the genome of said plant and expressing the protein encoded by said polynucleotide molecule. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference>, wherein said plant is a monocotyledonous plant. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference>, wherein said monocotyledonous plant is selected from the group consisting of rice, wheat, barley, oats, sorghum, maize, lilies, and millet. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference>, wherein said plant is <highlight><italic>Zea mays. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference>, wherein said plant is a dicotyledonous plant. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The method according to <dependent-claim-reference depends_on="CLM-00011">claim 18</dependent-claim-reference>, wherein said dicotyledonous plant is selected from the group consisting of peas, alfalfa, chickpea, chicory, clover, kale, lentil, prairie grass, soybean, tobacco, potato, sweet potato, radish, cabbage, rape, apple trees, and lettuce. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A plant or plant tissue comprising the polynucleotide molecule of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The plant or plant tissue according to <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein said plant or plant tissue is monocotyledonous. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The plant or plant tissue according to <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein said monocotyledonous plant or plant tissue is selected from the group consisting of rice, wheat, barley, oats, sorghum, maize, lilies, and millet. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The plant or plant tissue according to <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein said plant is <highlight><italic>Zea mays </italic></highlight>or said plant tissue is from <highlight><italic>Zea mays. </italic></highlight></claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The plant or plant tissue according to <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein said plant or plant tissue is dicotyledonous. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The plant or plant tissue according to <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>, wherein said dicotyledonous plant or plant tissue is selected from the group consisting of peas, alfalfa, chickpea, chicory, clover, kale, lentil, prairie grass, soybean, tobacco, potato, sweet potato, radish, cabbage, rape, apple trees, and lettuce. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The plant tissue according to <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein said plant tissue is a seed. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A mutant starch biosynthesis protein encoded by the polynucleotide of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. A method for identifying a polynucleotide encoding a mutant starch biosynthesis protein wherein said mutant starch biosynthesis protein exhibits increased heat stability relative to a wild type protein, said method comprising mutating a polynucleotide encoding a starch biosynthesis protein, expressing said mutated polynucleotide in a cell to produce a mutant starch biosynthesis protein, and determining whether said mutant starch biosynthesis protein exhibits increased heat stability relative to the wild type starch biosynthesis protein. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A method for increasing a characteristic of a plant selected from the group consisting of seed number, plant biomass, Harvest Index, flag leaf weight, seed heads, and total seed weight, said method comprising incorporating the polynucleotide of <dependent-claim-reference depends_on="CLM-00011">claim 10</dependent-claim-reference> into the genome of said plant and expressing the protein encoded by said polynucleotide molecule.</claim-text>
</claim>
</subdoc-claims>
<subdoc-drawings id="DRAWINGS">
<heading lvl="0" align="CENTER">Drawings</heading>
<representative-figure>NONE</representative-figure>
<figure id="figure-D00001">
<image id="EMI-D00001" file="US20020194642A1-20021219-D00001.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00002">
<image id="EMI-D00002" file="US20020194642A1-20021219-D00002.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00003">
<image id="EMI-D00003" file="US20020194642A1-20021219-D00003.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00004">
<image id="EMI-D00004" file="US20020194642A1-20021219-D00004.TIF" imf="TIFF" ti="DR"/>
</figure>
<figure id="figure-D00005">
<image id="EMI-D00005" file="US20020194642A1-20021219-D00005.TIF" imf="TIFF" ti="DR"/>
</figure>
</subdoc-drawings>
</patent-application-publication>
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" []>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20020194645</doc-number>
<kind-code>A1</kind-code>
<document-date>20021219</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>09853450</doc-number>
</application-number>
<application-number-series-code>09</application-number-series-code>
<filing-date>20010509</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C12N015/82</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C12N015/29</ipc>
</classification-ipc-secondary>
<classification-ipc-secondary>
<ipc>A01H005/00</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>800</class>
<subclass>290000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>800</class>
<subclass>286000</subclass>
</uspc>
</classification-us-secondary>
<classification-us-secondary>
<uspc>
<class>536</class>
<subclass>023600</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Combinations of genes for producing seed plants exhibiting modulated reproductive development</title-of-invention>
</technical-information>
<inventors>
<first-named-inventor>
<name>
<given-name>Martin</given-name>
<middle-name>F.</middle-name>
<family-name>Yanofsky</family-name>
</name>
<residence>
<residence-us>
<city>San Diego</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Soraya</given-name>
<family-name>Pelaz</family-name>
</name>
<residence>
<residence-non-us>
<city>Madrid</city>
<country-code>ES</country-code>
</residence-non-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Gary</given-name>
<family-name>Ditta</family-name>
</name>
<residence>
<residence-us>
<city>Poway</city>
<state>CA</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>TOWNSEND AND TOWNSEND AND CREW, LLP</name-1>
<name-2></name-2>
<address>
<address-1>TWO EMBARCADERO CENTER</address-1>
<address-2>EIGHTH FLOOR</address-2>
<city>SAN FRANCISCO</city>
<state>CA</state>
<postalcode>94111-3834</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">The present invention provides plants that exhibit modulated reproductive development and methods of modulating the timing of reproductive development in plants. </paragraph>
</subdoc-abstract>
<subdoc-description>
<federal-research-statement>
<heading lvl="1">STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT </heading>
<paragraph-federal-research-statement id="P-0001"><number>&lsqb;0001&rsqb;</number> This work was supported by grant DCB-9018749 awarded by the National Science Foundation and by grant USDA 93-37304 awarded by the United States Department of Agriculture. The United States Government has certain rights in this invention.</paragraph-federal-research-statement>
</federal-research-statement>
<summary-of-invention>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> A flower is the reproductive structure of a flowering plant. Following fertilization, the ovary of the flower becomes a fruit and bears seeds. As a practical consequence, production of fruit and seed-derived crops such as grapes, beans, corn, wheat, rice and hops is dependent upon flowering. </paragraph>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> Early in the life cycle of a flowering plant, vegetative growth occurs, and roots, stems and leaves are formed. During the later period of reproductive growth, flowers as well as new shoots or branches develop. However, the factors responsible for the transition from vegetative to reproductive growth, and the onset of flowering, are poorly understood. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> A variety of external signals, such as length of daylight and temperature, affect the time of flowering. The time of flowering also is subject to genetic controls that prevent young plants from flowering prematurely. Thus, the pattern of genes expressed in a plant is an important determinant of the time of flowering. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> Given these external signals and genetic controls, a relatively fixed period of vegetative growth precedes flowering in a particular plant species. The length of time required for a crop to mature to flowering limits the geographic location in which it can be grown and can be an important determinant of yield. In addition, since the time of flowering determines when a plant is reproductively mature, the pace of a plant breeding program also depends upon the length of time required for a plant to flower. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Traditionally, plant breeding involves generating hybrids of existing plants, which are examined for improved yield or quality. The improvement of existing plant crops through plant breeding is central to increasing the amount of food grown in the world since the amount of land suitable for agriculture is limited. For example, the development of new strains of wheat, corn and rice through plant breeding has increased the yield of these crops grown in underdeveloped countries such as Mexico, India and Pakistan. Unfortunately, plant breeding is inherently a slow process since plants must be reproductively mature before selective breeding can proceed. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> For some plant species, the length of time needed to mature to flowering is so long that selective breeding, which requires several rounds of backcrossing progeny plants with their parents, is impractical. For example, perennial trees such as walnut, hickory, oak, maple and cherry do not flower for several years after planting. As a result, breeding of such plant species for insect or disease-resistance or to produce improved wood or fruit, for example, would require decades, even if only a few rounds of selection were performed. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> Methods of promoting early reproductive development can make breeding of long generation seed plants such as trees practical for the first time. Methods of promoting early reproductive development also would be useful for shortening growth periods, thereby broadening the geographic range in which a crop such as rice, corn or coffee can be grown. Unfortunately, methods for promoting early reproductive development in a seed plant have not yet been described. Thus, there is a need for methods that promote early reproductive development. The present invention satisfies this need and provides related advantages as well. </paragraph>
</section>
<section>
<heading lvl="1">Definitions </heading>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> As used herein, the term &ldquo;transgenic&rdquo; refers to a seed plant that contains in its genome an exogenous nucleic acid molecule, which can be derived from the same or a different plant species. The exogenous nucleic acid molecule can be a gene regulatory element such as a promoter, enhancer or other regulatory element or can contain a coding sequence, which can be linked to a heterologous gene regulatory element. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> As used herein, the term &ldquo;seed plant&rdquo; means an angiosperm or a gymnosperm. The term &ldquo;angiosperm,&rdquo; as used herein, means a seed-bearing plant whose seeds are borne in a mature ovary (fruit). An angiosperm commonly is recognized as a flowering plant. The term &ldquo;gymnosperm,&rdquo; as used herein, means a seed-bearing plant with seeds not enclosed in an ovary. </paragraph>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> Angiosperms are divided into two broad classes based on the number of cotyledons, which are seed leaves that generally store or absorb food. Thus, a monocotyledonous angiosperm is an angiosperm having a single cotyledon, and a dicotyledonous angiosperm is an angiosperm having two cotyledons. Angiosperms are well known and produce a variety of useful products including materials such as lumber, rubber, and paper; fibers such as cotton and linen; herbs and medicines such as quinine and vinblastine; ornamental flowers such as roses and orchids; and foodstuffs such as grains, oils, fruits and vegetables. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> Angiosperms encompass a variety of flowering plants, including, for example, cereal plants, leguminous plants, oilseed plants, hardwood trees, fruit-bearing plants and ornamental flowers, which general classes are not necessarily exclusive. Such angiosperms include for example, a cereal plant, which produces an edible grain cereal. Such cereal plants include, for example, corn, rice, wheat, barley, oat, rye, orchardgrass, guinea grass, sorghum and turfgrass. In addition, a leguminous plant is an angiosperm that is a member of the pea family (Fabaceae) and produces a characteristic fruit known as a legume. Examples of leguminous plants include, for example, soybean, pea, chickpea, moth bean, broad bean, kidney bean, lima bean, lentil, cowpea, dry bean, and peanut. Examples of legumes also include alfalfa, birdsfoot trefoil, clover and sainfoin. An oilseed plant also is an angiosperm with seeds that are useful as a source of oil. Examples of oilseed plants include soybean, sunflower, rapeseed and cottonseed. </paragraph>
<paragraph id="P-0013" lvl="0"><number>&lsqb;0013&rsqb;</number> An angiosperm also can be a hardwood tree, which is a perennial woody plant that generally has a single stem (trunk). Examples of such trees include alder, ash, aspen, basswood (linden), beech, birch, cherry, cottonwood, elm, eucalyptus, hickory, locust, maple, oak, persimmon, poplar, sycamore, walnut and willow. Trees are useful, for example, as a source of pulp, paper, structural material and fuel. </paragraph>
<paragraph id="P-0014" lvl="0"><number>&lsqb;0014&rsqb;</number> An angiosperm also can be a fruit-bearing plant, which produces a mature, ripened ovary (usually containing seeds) that is suitable for human or animal consumption. For example, hops are a member of the mulberry family prized for their flavoring in malt liquor. Fruit-bearing angiosperms also include grape, orange, lemon, grapefruit, avocado, date, peach, cherry, olive, plum, coconut, apple and pear trees and blackberry, blueberry, raspberry, strawberry, pineapple, tomato, cucumber and eggplant plants. An ornamental flower is an angiosperm cultivated for its decorative flower. Examples of commercially important ornamental flowers include rose, orchid, lily, tulip and chrysanthemum, snapdragon, camellia, carnation and petunia plants. The skilled artisan will recognize that the methods of the invention can be practiced using these or other angiosperms, as desired. </paragraph>
<paragraph id="P-0015" lvl="0"><number>&lsqb;0015&rsqb;</number> Gymnosperms encompass four divisions: cycads, ginkgo, conifers and gnetophytes. The conifers are the most widespread of living gymnosperms and frequently are cultivated for structural wood or for pulp or paper. Conifers include redwood trees, pines, firs, spruces, hemlocks, Douglas firs, cypresses, junipers and yews. The skilled artisan will recognize that the methods of the invention can be practiced with these and other gymnosperms. </paragraph>
<paragraph id="P-0016" lvl="0"><number>&lsqb;0016&rsqb;</number> As used herein, the term &ldquo;non-naturally occurring seed plant&rdquo; means a seed plant containing a genome that has been modified by man. A transgenic seed plant, for example, is a non-naturally occurring seed plant that contains an exogenous nucleic acid molecule and, therefore, has a genome that has been modified by man. Furthermore, a seed plant that contains, for example, a mutation in an endogenous floral meristem identity gene regulatory element as a result of calculated exposure to a mutagenic agent also contains a genome that has been modified by man. In contrast, a seed plant containing a spontaneous or naturally occurring mutation is not a &ldquo;non-naturally occurring seed plant&rdquo; and, therefore, is not encompassed within the invention. </paragraph>
<paragraph id="P-0017" lvl="0"><number>&lsqb;0017&rsqb;</number> &ldquo;Reproductive development&rdquo; refers to the production of floral organs, including but not limited to sepals, petal, stamens, carpels as well as polen, ovules and/or seed. &ldquo;Reproductive development&rdquo; initiates upon the development of the floral meristem, typically derived from a shoot meristem. </paragraph>
<paragraph id="P-0018" lvl="0"><number>&lsqb;0018&rsqb;</number> The term &ldquo;recombinant nucleic acid molecule,&rdquo; as used herein, means a non-naturally occurring nucleic acid molecule that has been manipulated in vitro such that it is genetically distinguishable from a naturally occurring nucleic acid molecule. A recombinant nucleic acid molecule of the invention comprises two nucleic acid molecules that have been manipulated in vitro such that the two nucleic acid molecules are operably linked. </paragraph>
<paragraph id="P-0019" lvl="0"><number>&lsqb;0019&rsqb;</number> As used herein, the term &ldquo;inducible regulatory element&rdquo; means a nucleic acid molecule that confers conditional expression upon an operably linked nucleic acid molecule, where expression of the operably linked nucleic acid molecule is increased in the presence of a particular inducing agent as compared to expression of the nucleic acid molecule in the absence of the inducing agent. In a method of the invention, a useful inducible regulatory element has the following characteristics: confers low level expression upon an operably linked nucleic acid molecule in the absence of an inducing agent; confers high level expression upon an operably linked nucleic acid molecule in the presence of an appropriate inducing agent; and utilizes an inducing agent that does not interfere substantially with the normal physiology of a transgenic seed plant treated with the inducing agent. It is recognized, for example, that, subsequent to introduction into a seed plant, a particularly useful inducible regulatory element is one that confers an extremely low level of expression upon an operably linked nucleic acid molecule in the absence of inducing agent. Such an inducible regulatory element is considered to be tightly regulated. </paragraph>
<paragraph id="P-0020" lvl="0"><number>&lsqb;0020&rsqb;</number> The term &ldquo;operably linked,&rdquo; as used in reference to a regulatory element, such as a promoter or inducible regulatory element, and a nucleic acid molecule encoding a floral meristem identity gene product, means that the regulatory element confers regulated expression upon the operably linked nucleic acid molecule encoding the floral meristem identity gene product. Thus, the term operably linked, as used herein in reference to an inducible regulatory element and a nucleic acid molecule encoding a floral meristem identity gene product, means that the inducible regulatory element is linked to the nucleic acid molecule encoding a floral meristem identity gene product such that the inducible regulatory element increases expression of the floral meristem identity gene product in the presence of the appropriate inducing agent. It is recognized that two nucleic acid molecules that are operably linked contain, at a minimum, all elements essential for transcription, including, for example, a TATA box. One skilled in the art knows, for example, that an inducible regulatory element that lacks minimal promoter elements can be combined with a nucleic acid molecule having minimal promoter elements and a nucleic acid molecule encoding a floral meristem identity gene product such that expression of the floral meristem identity gene product can be increased in the presence of the appropriate inducing agent. </paragraph>
<paragraph id="P-0021" lvl="0"><number>&lsqb;0021&rsqb;</number> As used herein in reference to a nucleic acid molecule of the invention, the terms &ldquo;sense&rdquo; and &ldquo;antisense&rdquo; have their commonly understood meanings. </paragraph>
<paragraph id="P-0022" lvl="0"><number>&lsqb;0022&rsqb;</number> As used herein in reference to a nucleic acid molecule of the invention, the term &ldquo;fragment&rdquo; means a portion of the nucleic acid sequence containing at least about 50 base pairs to the full-length of the nucleic acid molecule. In contrast to an active fragment, as defined herein, a fragment of a nucleic acid molecule need not encode a functional portion of a gene product. </paragraph>
<paragraph id="P-0023" lvl="0"><number>&lsqb;0023&rsqb;</number> The phrase &ldquo;nucleic acid sequence&rdquo; refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5&prime; to the 3&prime; end. It includes chromosomal DNA, self-replicating plasmids, infectious polymers of DNA or RNA and DNA or RNA that performs a primarily structural role. </paragraph>
<paragraph id="P-0024" lvl="0"><number>&lsqb;0024&rsqb;</number> A &ldquo;promoter&rdquo; is defined as an array of nucleic acid control sequences that direct transcription of an operably linked nucleic acid. As used herein, a &ldquo;plant promoter&rdquo; is a promoter that functions in plants. Promoters include necessary nucleic acid sequences near the start site of transcription, such as, in the case of a polymerase II type promoter, a TATA element. A promoter also optionally includes distal enhancer or repressor elements, which can be located as much as several thousand base pairs from the start site of transcription. A &ldquo;constitutive&rdquo; promoter is a promoter that is active under most environmental and developmental conditions. An &ldquo;inducible&rdquo; promoter is a promoter that is active under environmental or developmental regulation. The term &ldquo;operably linked&rdquo; refers to a functional linkage between a nucleic acid expression control sequence (such as a promoter, or array of transcription factor binding sites) and a second nucleic acid sequence, wherein the expression control sequence directs transcription of the nucleic acid corresponding to the second sequence. </paragraph>
<paragraph id="P-0025" lvl="0"><number>&lsqb;0025&rsqb;</number> The term &ldquo;plant&rdquo; includes whole plants, plant organs (e.g., leaves, stems, flowers, roots, etc.), seeds and plant cells and progeny of same. The class of plants which can be used in the method of the invention is generally as broad as the class of flowering plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), as well as gymnosperms. It includes plants of a variety of ploidy levels, including polyploid, diploid, haploid and hemizygous. </paragraph>
<paragraph id="P-0026" lvl="0"><number>&lsqb;0026&rsqb;</number> A polynucleotide sequence is &ldquo;heterologous to&rdquo; an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, a promoter operably linked to a heterologous coding sequence refers to a coding sequence from a species different from that from which the promoter was derived, or, if from the same species, a coding sequence which is different from any naturally occurring allelic variants. </paragraph>
<paragraph id="P-0027" lvl="0"><number>&lsqb;0027&rsqb;</number> A polynucleotide &ldquo;exogenous to&rdquo; an individual plant is a polynucleotide which is introduced into the plant, or a predecessor generation of the plant, by any means other than by a sexual cross. Examples of means by which this can be accomplished are described below, and include Agrobacterium-mediated transformation, biolistic methods, electroporation, in planta techniques, and the like. </paragraph>
<paragraph id="P-0028" lvl="0"><number>&lsqb;0028&rsqb;</number> The phrase &ldquo;host cell&rdquo; refers to a cell from any organism. Preferred host cells are derived from plants, bacteria, yeast, fungi, insects or other animals. Methods for introducing polynucleotide sequences into various types of host cells are well known in the art. </paragraph>
<paragraph id="P-0029" lvl="0"><number>&lsqb;0029&rsqb;</number> The &ldquo;biological activity of a polypeptide&rdquo; refers to any molecular activity or phenotype that is caused by the polypeptide. For example, the ability to transfer a phosphate to a substrate or the ability to bind a specific DNA sequence is a biological activity. One biological activity of of the gene products of the invention is the ability to modulate the time of development of reproductive structures in plants. </paragraph>
<paragraph id="P-0030" lvl="0"><number>&lsqb;0030&rsqb;</number> An &ldquo;expression cassette&rdquo; refers to a nucleic acid construct, which when introduced into a host cell, results in transcription and/or translation of an RNA or polypeptide, respectively. Antisense or sense constructs that are not or cannot be translated are expressly included by this definition. </paragraph>
<paragraph id="P-0031" lvl="0"><number>&lsqb;0031&rsqb;</number> In the case of both expression of transgenes and inhibition of endogenous genes (e.g., by antisense, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical, but may be only &ldquo;substantially identical&rdquo; to a sequence of the gene from which it was derived. As explained below, these substantially identical variants are specifically covered by reference to a specific nucleic acid sequence. </paragraph>
<paragraph id="P-0032" lvl="0"><number>&lsqb;0032&rsqb;</number> In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional polypeptide, one of skill will recognize that because of codon degeneracy a number of polynucleotide sequences will encode the same polypeptide. These variants are specifically covered by the terms &ldquo;nucleic acid encoding a gene product&rdquo;. In addition, the term specifically includes those sequences substantially identical (determined as described below) with an polynucleotide sequence disclosed here and that encode polypeptides that are either mutants of wild type polypeptides or retain the function of the polypeptide (e.g., resulting from conservative substitutions of amino acids in the polypeptides). In addition, variants can be those that encode dominant negative mutants as described below. </paragraph>
<paragraph id="P-0033" lvl="0"><number>&lsqb;0033&rsqb;</number> Two nucleic acid sequences or polypeptides are said to be &ldquo;identical&rdquo; if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The terms &ldquo;identical&rdquo; or percent &ldquo;identity,&rdquo; in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence over a comparison window, as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. When percentage of sequence identity is used in reference to proteins or peptides, it is recognized that residue positions that are not identical often differ by conservative amino acid substitutions, where amino acids residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. Where sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated according to, e.g., the algorithm of Meyers &amp; Miller, <highlight><italic>Computer Applic. Biol. Sci. </italic></highlight>4:11-17 (1988) e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif., USA). </paragraph>
<paragraph id="P-0034" lvl="0"><number>&lsqb;0034&rsqb;</number> The phrase &ldquo;substantially identical,&rdquo; in the context of two nucleic acids or polypeptides, refers to a sequence or subsequence that has at least 40% sequence identity with a reference sequence. Alternatively, percent identity can be any integer from 40% to 100%. More preferred embodiments include at least: 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 99%. compared to a reference sequence using the programs described herein; preferably BLAST using standard parameters, as described below. This definition also refers to the complement of a test sequence, when the test sequence has substantial identity to a reference sequence. </paragraph>
<paragraph id="P-0035" lvl="0"><number>&lsqb;0035&rsqb;</number> For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters. </paragraph>
<paragraph id="P-0036" lvl="0"><number>&lsqb;0036&rsqb;</number> A &ldquo;comparison window&rdquo;, as used herein, includes reference to a segment of any one of the number of contiguous positions selected from the group consisting of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith &amp; Waterman, <highlight><italic>Adv. Appl. Math. </italic></highlight>2:482 (1981), by the homology alignment algorithm of Needleman &amp; Wunsch, <highlight><italic>J. Mol. Biol. </italic></highlight>48:443 (1970), by the search for similarity method of Pearson &amp; Lipman, <highlight><italic>Proc. Nat&apos;l. Acad. Sci. USA </italic></highlight>85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection. </paragraph>
<paragraph id="P-0037" lvl="0"><number>&lsqb;0037&rsqb;</number> One example of a useful algorithm is PILEUP. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments to show relationship and percent sequence identity. It also plots a tree or dendogram showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng &amp; Doolittle, <highlight><italic>J. Mol. Evol. </italic></highlight>35:351-360 (1987). The method used is similar to the method described by Higgins &amp; Sharp, <highlight><italic>CABIOS </italic></highlight>5:151-153 (1989). The program can alignup to 300 sequences, each of a maximum length of 5,000 nucleotides or amino acids. The multiple alignment procedure begins with the pairwise alignment of the two most similar sequences, producing a cluster of two aligned sequences. This cluster is then aligned to the next most related sequence or cluster of aligned sequences. Two clusters of sequences are aligned by a simple extension of the pairwise alignment of two individual sequences. The final alignment is achieved by a series of progressive, pairwise alignments. The program is run by designating specific sequences and their amino acid or nucleotide coordinates for regions of sequence comparison and by designating the program parameters. For example, a reference sequence can be compared to other test sequences to determine the percent sequence identity relationship using the following parameters: default gap weight (3.00), default gap length weight (0.10), and weighted end gaps. </paragraph>
<paragraph id="P-0038" lvl="0"><number>&lsqb;0038&rsqb;</number> Another example of algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., <highlight><italic>J. Mol. Biol. </italic></highlight>215:403-410 (1990). Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul et al, supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLAST program uses as defaults a wordlength (W) of 11, the BLOSUM62 scoring matrix (see Henikoff &amp; Henikoff, <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>89:10915 (1989)) alignments (B) of 50, expectation (E) of 10, M&equals;5, N&equals;&minus;4, and a comparison of both strands. </paragraph>
<paragraph id="P-0039" lvl="0"><number>&lsqb;0039&rsqb;</number> The BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin &amp; Altschul, <highlight><italic>Proc. Nat&apos;l. Acad. Sci. USA </italic></highlight>90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.2, more preferably less than about 0.01, and most preferably less than about 0.001. </paragraph>
<paragraph id="P-0040" lvl="0"><number>&lsqb;0040&rsqb;</number> &ldquo;Conservatively modified variants&rdquo; applies to both amino acid and nucleic acid sequences. With respect to particular nucleic acid sequences, conservatively modified variants refers to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical sequences. Because of the degeneracy of the genetic code, a large number of functionally identical nucleic acids encode any given protein. For instance, the codons GCA, GCC, GCG and GCU all encode the amino acid alanine. Thus, at every position where an alanine is specified by a codon, the codon can be altered to any of the corresponding codons described without altering the encoded polypeptide. Such nucleic acid variations are &ldquo;silent variations,&rdquo; which are one species of conservatively modified variations. Every nucleic acid sequence herein which encodes a polypeptide also describes every possible silent variation of the nucleic acid. One of skill will recognize that each codon in a nucleic acid (except AUG, which is ordinarily the only codon for methionine) can be modified to yield a functionally identical molecule. Accordingly, each silent variation of a nucleic acid which encodes a polypeptide is implicit in each described sequence. </paragraph>
<paragraph id="P-0041" lvl="0"><number>&lsqb;0041&rsqb;</number> As to amino acid sequences, one of skill will recognize that individual substitutions, deletions or additions to a nucleic acid, peptide, polypeptide, or protein sequence which alters, adds or deletes a single amino acid or a small percentage of amino acids in the encoded sequence is a &ldquo;conservatively modified variant&rdquo; where the alteration results in the substitution of an amino acid with a chemically similar amino acid. Conservative substitution tables providing functionally similar amino acids are well known in the art. </paragraph>
<paragraph id="P-0042" lvl="0"><number>&lsqb;0042&rsqb;</number> The following six groups each contain amino acids that are conservative substitutions for one another:  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="1" colwidth="28PT" align="right"/>
<colspec colname="2" colwidth="189PT" align="left"/>
<thead>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry>1)</entry>
<entry>Alanine (A), Serine (S), Threonine (T);</entry>
</row>
<row>
<entry>2)</entry>
<entry>Aspartic acid (D), Glutamic acid (E);</entry>
</row>
<row>
<entry>3)</entry>
<entry>Asparagine (N), Glutamine (Q);</entry>
</row>
<row>
<entry>4)</entry>
<entry>Arginine (R), Lysine (K);</entry>
</row>
<row>
<entry>5)</entry>
<entry>Isoleucine (I), Leucine (L), Methionine (M), Valine (V); and</entry>
</row>
<row>
<entry>6)</entry>
<entry>Phenylalanine (F), Tyrosine (Y), Tryptophan (W).</entry>
</row>
<row>
<entry></entry>
<entry>(see, e.g., Creighton, Proteins (1984)).</entry>
</row>
<row><entry namest="1" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0043" lvl="0"><number>&lsqb;0043&rsqb;</number> An indication that two nucleic acid sequences or polypeptides are substantially identical is that the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the antibodies raised against the polypeptide encoded by the second nucleic acid. Thus, a polypeptide is typically substantially identical to a second polypeptide, for example, where the two peptides differ only by conservative substitutions. Another indication that two nucleic acid sequences are substantially identical is that the two molecules or their complements hybridize to each other under stringent conditions, as described below. </paragraph>
<paragraph id="P-0044" lvl="0"><number>&lsqb;0044&rsqb;</number> The phrase &ldquo;selectively (or specifically) hybridizes to&rdquo; refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent hybridization conditions when that sequence is present in a complex mixture (e.g., total cellular or library DNA or RNA). </paragraph>
<paragraph id="P-0045" lvl="0"><number>&lsqb;0045&rsqb;</number> The phrase &ldquo;stringent hybridization conditions&rdquo; refers to conditions under which a probe will hybridize to its target subsequence, typically in a complex mixture of nucleic acid, but to no other sequences. Stringent conditions are sequence-dependent and will be different in different circumstances. Longer sequences hybridize specifically at higher temperatures. An extensive guide to the hybridization of nucleic acids is found in Tijssen, <highlight><italic>Techniques in Biochemistry and Molecular Biology&mdash;Hybridization with Nucleic Probes, </italic></highlight>&ldquo;Overview of principles of hybridization and the strategy of nucleic acid assays&rdquo; (1993). Generally, highly stringent conditions are selected to be about 5-10&deg; C. lower than the thermal melting point (T<highlight><subscript>m</subscript></highlight>) for the specific sequence at a defined ionic strength pH. Low stringency conditions are generally selected to be about 15-30&deg; C. below the T<highlight><subscript>m</subscript></highlight>. The T<highlight><subscript>m </subscript></highlight>is the temperature (under defined ionic strength, pH, and nucleic concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (as the target sequences are present in excess, at T<highlight><subscript>m</subscript></highlight>, 50% of the probes are occupied at equilibrium). Stringent conditions will be those in which the salt concentration is less than about 1.0 M sodium ion, typically about 0.01 to 1.0 M sodium ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30&deg; C. for short probes (e.g., 10 to 50 nucleotides) and at least about 60&deg; C. for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. For selective or specific hybridization, a positive signal is at least two times background, preferably 10 time background hybridization. </paragraph>
<paragraph id="P-0046" lvl="0"><number>&lsqb;0046&rsqb;</number> Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides which they encode are substantially identical. This occurs, for example, when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code. In such cased, the nucleic acids typically hybridize under moderately stringent hybridization conditions. </paragraph>
<paragraph id="P-0047" lvl="0"><number>&lsqb;0047&rsqb;</number> In the present invention, genomic DNA or cDNA comprising nucleic acids of the invention can be identified in standard Southern blots under stringent conditions using the nucleic acid sequences disclosed here. For the purposes of this disclosure, suitable stringent conditions for such hybridizations are those which include a hybridization in a buffer of 40% formamide, 1 M NaCl, 1% SDS at 37&deg; C., and at least one wash in 0.2&times; SSC at a temperature of at least about 50&deg; C., usually about 55&deg; C. to about 60&deg; C., for 20 minutes, or equivalent conditions. A positive hybridization is at least twice background. Those of ordinary skill will readily recognize that alternative hybridization and wash conditions can be utilized to provide conditions of similar stringency. </paragraph>
<paragraph id="P-0048" lvl="0"><number>&lsqb;0048&rsqb;</number> A further indication that two polynucleotides are substantially identical is if the reference sequence, amplified by a pair of oligonucleotide primers, can then be used as a probe under stringent hybridization conditions to isolate the test sequence from a cDNA or genomic library, or to identify the test sequence in, e.g., a northern or Southern blot. </paragraph>
</section>
<section>
<heading lvl="1">BRIEF SUMMARY OF THE INVENTION </heading>
<paragraph id="P-0049" lvl="0"><number>&lsqb;0049&rsqb;</number> The present invention provides a non-naturally occurring seed plant, the plant comprising: (1) a first ectopically expressed polynucleotide encoding an APETALA1 gene product at least 50% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8 or a CAULIFLOWER gene product at least 50% identical to SEQ ID NO:10 or SEQ ID NO:12; and (2) a second ectopically expressed nucleic acid molecule encoding a SEP1 gene product at least 50% identical to SEQ ID NO:28, a SEP2 gene product at least 50% identical to SEQ ID NO:30, a SEP3 gene product at least 50% identical to SEQ ID NO:32 or an AGL24 gene product at least 50% identical to SEQ ID NO:38. in some embodiments, the non-naturally occurring seed plant is characterized by early reproductive development. In some embodiments, expression of the first ectopically expressed polynucleotide is increased in a tissue of a plant compared to a wild type plant. In some embodiments, expression of the second ectopically expressed polynucleotide is increased in a tissue of a plant compared to a wild type plant. In some embodiments, expression of the first ectopically expressed polynucleotide is decreased in a tissue of a plant compared to a wild type plant. In some aspects, expression of the second ectopically expressed polynucleotide is decreased in a tissue of a plant compared to a wild type plant. </paragraph>
<paragraph id="P-0050" lvl="0"><number>&lsqb;0050&rsqb;</number> The invention provides for an endogenous first ectopically expressed polynucleotide comprising a modified gene regulatory element. Alternatively, the invention provides for an endogenous second ectopically expressed polynucleotide comprising a modified gene regulatory element. For example, the non-naturally occurring seed plant is a transgenic plant comprising a first exogenous gene regulatory element operably linked to the first ectopically expressible polynucleotide and a second exogenous gene regulatory element operably linked to the second ectopically expressible polynucleotide. In some aspects, the first polynucleotide is operably linked to the first exogenous gene regulatory element in a sense orientation. In some aspects, the first polynucleotide is operably linked to the first exogenous gene regulatory element in an antisense orientation. In some aspects, the second polynucleotide is operably linked to the second exogenous gene regulatory element in a sense orientation. In some aspects, the second polynucleotide is operably linked to the second exogenous gene regulatory element in an antisense orientation. </paragraph>
<paragraph id="P-0051" lvl="0"><number>&lsqb;0051&rsqb;</number> The invention also provides methods of modulating the timing of reproductive development in a plant, the methods comprising ectopically expressing a first polynucleotide encoding an APETALA1 gene product at least 50% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8 or a CAULIFLOWER gene product at least 50% identical to SEQ ID NO:10 or SEQ ID NO:12; and ectopically expressing a second nucleic acid molecule encoding a SEP1 gene product at least 50% identical to SEQ ID NO:28, a SEP2 gene product at least 50% identical to SEQ ID NO:30, a SEP3 gene product at least 50% identical to SEQ ID NO:32 or an AGL24 gene product at least 50% identical to SEQ ID NO:38. For example, in one aspect, the invention provides for introducing a first ectopically expressed nucleic acid molecule comprising a first polynucleotide encoding an APETALA1 gene product at least 50% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8 or a CAULIFLOWER gene product at least 50% identical to SEQ ID NO:10 or SEQ ID NO:12; and introducing a second ectopically expressed nucleic acid molecule comprising a second polynucleotide encoding a SEP1 gene product at least 50% identical to SEQ ID NO:28, a SEP2 gene product at least 50% identical to SEQ ID NO:30, a SEP3 gene product at least 50% identical to SEQ ID NO:32 or an AGL24 gene product at least 50% identical to SEQ ID NO:38. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DESCRIPTION OF THE INVENTION </heading>
<paragraph id="P-0052" lvl="0"><number>&lsqb;0052&rsqb;</number> The present invention provides the surprising finding that ectopic expression of certain MADS-box-containing gene products, such as SEP1, SEP2, SEP3 or AGL24, combined with the ectopic expression of AP1, CAL or LFY gene products, result in modulated reproductive development. Thus, this invention provides plants comprising such ectopically expressible gene products as well as methods of modulating the timing of reproductive development in plants. </paragraph>
<paragraph id="P-0053" lvl="0"><number>&lsqb;0053&rsqb;</number> A flower, like a leaf or shoot, is derived from the shoot apical meristem, which is a collection of undifferentiated cells set aside during embryogenesis. The production of vegetative structures, such as leaves or shoots, and of reproductive structures, such as flowers, is temporally segregated, such that a leaf or shoot arises early in a plant life cycle, while a flower develops later. The transition from vegetative to reproductive development is the consequence of a process termed floral induction (Yanofsky, <highlight><italic>Ann. Rev. Plant Physiol. Plant Mol. Biol. </italic></highlight>46:167-188 (1995), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0054" lvl="0"><number>&lsqb;0054&rsqb;</number> Once induced, shoot apical meristem either persists and produces floral meristem, which gives rise to flowers, and lateral meristem, which gives rise to branches, or is itself converted to floral meristem. Floral meristem differentiates into a single flower having a fixed number of floral organs in a whorled arrangement. Dicots, for example, contain four whorls (concentric rings), in which sepals (first whorl) and petals (second whorl) surround stamens (third whorl) and carpels (fourth whorl). </paragraph>
<paragraph id="P-0055" lvl="0"><number>&lsqb;0055&rsqb;</number> Following the transition from vegetative to reproductive development in Arabidopsis, flower meristems arise on the flanks of the shoot apical (inflorescence) meristem and subsequently develop into flowers with four organ types (sepals, petals, stamens and carpels). Flower meristem identity is specified in part by the APETALA1 (AP1), CALIFLOWER (CAL) and LEAFY (LFY) genes. In ap1 mutants, the sepals are transformed to leaf-like organs and the petals fail to develop. In the axils of these leaf-like organs, secondary flowers arise which repeat the same pattern as the primary ones. Although cal single mutants appear wild type, ap1 cal double mutants display a massive proliferation of inflorescence-like meristems in positions that would normally be occupied by solitary flowers. The functional redundancy shared by AP1 and CAL can be explained in part by the fact that these two genes encode related members of the MADS box family of regulatory proteins (Bowman et al., <highlight><italic>Development </italic></highlight>119, 721-743 (1993); Gustafson-Brown et al., <highlight><italic>Cell </italic></highlight>76, 131-143 (1994); Kempin et al., <highlight><italic>Science </italic></highlight>267, 522-525 (1995); Mandel et al., <highlight><italic>Nature </italic></highlight>360, 273-277 (1992)). </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> Genetic studies led to the proposal of the ABC model that explains how the individual and combined activities of the ABC genes specify the four organ types of the typical eudicot flower. A alone specifies sepals, A and B specify petals, B and C specify stamens, and C alone specifies carpels. In Arabidopsis, the A-function genes are AP1 and APETALA2 (AP2), B-function genes are APETALA3 (AP3), PISTILLATA (PI), and the C-function gene is AGAMOUS (AG). In addition, recent studies have shown that a trio of closely related genes, SEPALLATA1/2/3 (SEP1/2/3), are required for petal, stamen and carpel identity, and are thus necessary for the activities of the B- and C-function genes (Pelaz et al., <highlight><italic>Nature </italic></highlight>405, 200-203 (2000)). Remarkably, with the exception of the AP2 gene, all of the other organ identity genes belong to the extended family of MADS-box genes, a family that is known to include more than 44 distinct sequences in Arabidopsis (Alvarez-Buylla et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>97, 5328-5333 (2000); Davies and Schwarz-Sommer, In <highlight><italic>Plant Promoters and Transcription Factors </italic></highlight>(<highlight><italic>Results and Problems in Cell Differentiation </italic></highlight>20), (ed. L. Nover), pp. 235-258 (1994); Purugganan et al., <highlight><italic>Genetics </italic></highlight>140, 345-356 (1995); Rounsley et al., <highlight><italic>Plant Cell </italic></highlight>7, 1259-1269 (1995)). </paragraph>
<paragraph id="P-0057" lvl="0"><number>&lsqb;0057&rsqb;</number> MADS-domain proteins, well characterized in yeast (MCM1, Ammererer, <highlight><italic>Genes Dev. </italic></highlight>4, 299-312 (1990)) and mammals (SRF, Norman et al., <highlight><italic>Cell </italic></highlight>55, 989-1003 (1988)) form dimers that bind to DNA and form ternary complexes with many unrelated proteins (Lamb and McKnight, <highlight><italic>Trends Biochem. Sci. </italic></highlight>16, 417-422 (1991); Shore and Sharrocks, <highlight><italic>Eur. J. Chem. </italic></highlight>229, 1-13 (1995)). A number of studies have shown that heterodimers and ternary complexes of plant MADS-domain proteins can occur, and given the overlapping expression pattern of numerous MADS-box genes, such interactions greatly increase the regulatory complexity of MADS-box genes (Davies et al., <highlight><italic>EMBO J. </italic></highlight>15, 4330-4343 (1996); Egea-Cortines et al., <highlight><italic>EMBO J. </italic></highlight>18, 5370-5379 (1999); Fan et al., <highlight><italic>Plant J. </italic></highlight>11, 999-1010 (1997)). The regulatory specificity of these genes is achieved through protein-protein interactions and not through different intrinsic DNA binding specificities (Krizek and Meyerowitz, <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>93, 4063-4070 (1996); Shore and Sharrocks, <highlight><italic>Eur. J. Chem. </italic></highlight>229, 1-13 (1995)). MADS box proteins are composed of four different domains, designated M, I, K and C. The MADS (M) domain, is highly conserved among these proteins, and is responsible for the binding to DNA in addition to its participation in homodimer formation of some proteins. The I region also participates in homodimer formation (Krizek and Meyerowitz, supra; Riechmann et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>93, 4793-4798 (1996)). Adjacent to the I region is the K-domain, so named, due to its similarity to the coiled-coil domain of keratin. It is absent in the non-plant proteins, and has been implicated in protein-protein interaction (Fan et al., supra; Krizek and Meyerowitz, supra; Mizukami et al., <highlight><italic>Plant Cell </italic></highlight>8, 831-845 (1996); Moon et al., <highlight><italic>Plant Physiol. </italic></highlight>120, 1193-1203 (1999); Riechmann et al., supra). The C-terminal region has been proposed to be involved in transcriptional activation (Huang et al., <highlight><italic>Plant Mol. Biol. </italic></highlight>28, 549-567 (1995)), and also to play a role in the formation of ternary complexes (Egea-Cortines et al., <highlight><italic>EMBO J. </italic></highlight>18, 5370-5379 (1999)). </paragraph>
<paragraph id="P-0058" lvl="0"><number>&lsqb;0058&rsqb;</number> Although shoot meristem and floral meristem both consist of meristemic tissue, shoot meristem is distinguishable from the more specialized floral meristem. Shoot meristem generally is indeterminate and gives rise to an unspecified number of floral and lateral meristems. In contrast, floral meristem is determinate and gives rise to the fixed number of floral organs that comprise a flower. </paragraph>
<paragraph id="P-0059" lvl="0"><number>&lsqb;0059&rsqb;</number> By convention herein, a wild-type gene sequence is represented in upper case italic letters (for example, APETALA1), and a wild-type gene product is represented in upper case non-italic letters (APETALA1). Further, a mutant gene allele is represented in lower case italic letters (ap1), and a mutant gene product is represented in lower case non-italic letters (ap1). </paragraph>
<paragraph id="P-0060" lvl="0"><number>&lsqb;0060&rsqb;</number> Genetic studies have identified a number of genes involved in regulating flower development. These genes can be classified into different groups depending on their function. Flowering time genes, for example, are involved in floral induction and regulate the transition from vegetative to reproductive growth. In comparison, the floral meristem identity genes, which are the subject matter of the present invention as disclosed herein, encode proteins that promote the conversion of shoot meristem to floral meristem in an angiosperm. In addition, floral organ identity genes encode proteins that determine whether sepals, petals, stamens or carpels are formed during floral development (Yanofsky, supra, 1995; Weigel, <highlight><italic>Ann. Rev. Genetics </italic></highlight>29:19-39 (1995), which is incorporated herein by reference). Some of the floral meristem identity gene products also have a role in specifying floral organ identity. </paragraph>
<paragraph id="P-0061" lvl="0"><number>&lsqb;0061&rsqb;</number> Floral meristem identity genes have been identified by characterizing genetic mutations that prevent or alter floral meristem formation. Among floral meristem identity gene mutations in <highlight><italic>Arabidopsis thaliana</italic></highlight>, those in the gene LEAFY (LFY) generally have the strongest effect on floral meristem identity. Mutations in LFY completely transform the basal-most flowers into secondary shoots and have variable effects on later-arising (apical) flowers. In comparison, mutations in the floral meristem identity gene APETALA1 (AP1) result in replacement of a few basal flowers by inflorescence shoots that are not subtended by leaves. An apical flower produced in an ap1 mutant has an indeterminate structure, in which a flower arises within a flower. These mutant phenotypes indicate that both AP1 and LFY contribute to establishing the identity of the floral meristem although neither gene is absolutely required. The phenotype of lfy ap1 double mutants, in which structures with flower-like characteristics are very rare, indicates that LFY and AP1 encode partially redundant activities. </paragraph>
<paragraph id="P-0062" lvl="0"><number>&lsqb;0062&rsqb;</number> In addition to the LFY and AP1 genes, a third locus that greatly enhances the ap1 mutant phenotype has been identified in Arabidopsis. This locus, designated CAULIFLOWER (CAL), derives its name from the resulting &ldquo;cauliflower&rdquo; phenotype, which is strikingly similar to the common garden variety of cauliflower (Kempin et al., <highlight><italic>Science </italic></highlight>267:522-525 (1995), which is incorporated herein by reference). In an ap1 cal double mutant, floral meristem behaves as shoot meristem in that there is a massive proliferation of meristems in the position that normally would be occupied by a single flower. However, an Arabidopsis mutant lacking only CAL, such as cal-1, has a normal phenotype, indicating that AP1 can substitute for the loss of CAL in these plants. In addition, because floral meristem that forms in an ap1 mutant behaves as shoot meristem in an ap1 cal double mutant, CAL can largely substitute for AP1 in specifying floral meristem. These genetic data indicate that CAL and AP1 encode activities that are partially redundant in converting shoot meristem to floral meristem. </paragraph>
<paragraph id="P-0063" lvl="0"><number>&lsqb;0063&rsqb;</number> Other genetic loci play at least minor roles in specifying floral meristem identity. For example, although a mutation in APETALA2 (AP2) alone does not result in altered inflorescence characteristics, ap2 ap1 double mutants have indeterminate flowers (flowers with shoot-like characteristics; Bowman et al., <highlight><italic>Development </italic></highlight>119:721-743 (1993), which is incorporated herein by reference). Also, mutations in the CLAVATA1 (CLV1) gene result in an enlarged meristem and lead to a variety of phenotypes (Clark et al., <highlight><italic>Development </italic></highlight>119:397-418 (1993)). In a cly1 ap1 double mutant, formation of flowers is initiated, but the center of each flower often develops as an indeterminate inflorescence. Thus, mutations in CLAVATA1 result in the loss of floral meristem identity in the center of wild-type flowers. Genetic evidence also indicates that the gene product of UNUSUAL FLORAL ORGANS (UFO) plays a role in determining the identity of floral meristem. Additional floral meristem identity genes associated with altered floral meristem formation remain to be isolated. </paragraph>
<paragraph id="P-0064" lvl="0"><number>&lsqb;0064&rsqb;</number> Mutations in another locus, designated TERMINAL FLOWER (TFL), produce phenotypes that generally are reversed as compared to mutations in the floral meristem identity genes. For example, tfl mutants flower early, and the indeterminate apical and lateral meristems develop as determinate floral meristems (Alvarez et al., <highlight><italic>Plant J. </italic></highlight>2:103-116 (1992)). These characteristics indicate that the TFL promotes maintenance of shoot meristem. TFL also acts directly or indirectly to negatively regulate AP1 and LFY expression in shoot meristem since these AP1 and LFY are ectopically expressed in the shoot meristem of tfl mutants (Gustafson-Brown et al., <highlight><italic>Cell </italic></highlight>76:131-143 (1994); Weigel et al., <highlight><italic>Cell </italic></highlight>69:843-859 (1992)). It is recognized that a plant having a mutation in TFL can have a phenotype similar to a non-naturally occurring seed plant of the invention. Such tfl mutants, however, which have a mutation in an endogenous TERMINAL FLOWER gene, are explicitly excluded from the scope of the present invention. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> The results of such genetic studies indicate that several floral meristem identity gene products, including AP1, CAL and LFY, act redundantly to convert shoot meristem to floral meristem in an angiosperm. As disclosed herein, ectopic expression of a single floral meristem identity gene product such as AP1, CAL or LFY is sufficient to convert shoot meristem to floral meristem in an angiosperm. Thus, the present invention provides a non-naturally occurring seed plant such as an angiosperm or gymnosperm that contains a first or second ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that such ectopic expression is not due to a mutation in an endogenous TERMINAL FLOWER gene. </paragraph>
<paragraph id="P-0066" lvl="0"><number>&lsqb;0066&rsqb;</number> As disclosed herein, an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be, for example, a transgene encoding a floral meristem identity gene product under control of a heterologous gene regulatory element. In addition, such an ectopically expressible nucleic acid molecule can be an endogenous floral meristem identity gene coding sequence that is placed under control of a heterologous gene regulatory element. The ectopically expressible nucleic acid molecule also can be, for example, an endogenous floral meristem identity gene having a modified gene regulatory element such that the endogenous floral meristem identity gene is no longer subject to negative regulation by TFL. </paragraph>
<paragraph id="P-0067" lvl="0"><number>&lsqb;0067&rsqb;</number> The term &ldquo;ectopically expressible&rdquo; is used herein to refer to a nucleic acid molecule encoding a floral meristem identity gene product that can be expressed in a tissue other than a tissue in which it normally is expressed or at a time other than the time at which it normally is expressed, provided that the floral meristem identity gene product is not expressed from its native, naturally occurring promoter. Ectopic expression of a floral meristem identity gene product is a result of the expression of the gene coding region from a heterologous promoter or from a modified variant of its own promoter, such that expression of the floral meristem identity gene product is no longer in the tissue in which it normally is expressed or at the time at which it normally is expressed. An exogenous nucleic acid molecule encoding an AP1 gene product under control of its native, wild type promoter, for example, does not constitute an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product. However, a nucleic acid molecule encoding an AP1 gene product under control of a constitutive promoter, which results in expression of AP1 in a tissue such as shoot meristem where it is not normally expressed, is an ectopically expressible nucleic acid molecule as defined herein. </paragraph>
<paragraph id="P-0068" lvl="0"><number>&lsqb;0068&rsqb;</number> Actual ectopic expression of a floral meristem identity gene is dependent on various factors and can be constitutive or inducible expression. For example, AP1, which normally is expressed in floral meristem, is ectopically expressible in the shoot meristem of an angiosperm. When a floral meristem identity gene product such as AP1, CAL or LFY is ectopically expressed in shoot meristem in an angiosperm, the shoot meristem is converted to floral meristem and early reproductive development can occur (see WO 97/46078, incorporated herein by reference). </paragraph>
<paragraph id="P-0069" lvl="0"><number>&lsqb;0069&rsqb;</number> An ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be expressed prior to the time in development at which the corresponding endogenous gene normally is expressed. For example, an Arabidopsis plant grown under continuous light conditions expresses AP1 just prior to day 18, when normal reproductive development (flowering) begins. However, AP1 can be ectopically expressed in shoot meristem prior to day 18, resulting in early conversion of shoot meristem to floral meristem and early reproductive development. See WO 97/46078. As disclosed in Example ID of WO 97/46078, a transgenic Arabidopsis plant that ectopically expresses AP1 in shoot meristem under control of a constitutive promoter can flower at day 10, which is earlier than the time of reproductive development for a non-transgenic plant grown under the same conditions (day 18). It is recognized that in some transgenic seed plants containing, for example, an exogenous nucleic acid molecule encoding AP1 under control of a constitutive promoter, neither the exogenous nor endogenous AP1 will be expressed. Such transgenic plants in which AP1 gene expression is cosuppressed, although not characterized by early reproductive development, also can be valuable as disclosed below. </paragraph>
<paragraph id="P-0070" lvl="7"><number>&lsqb;0070&rsqb;</number> I. Floral Meristem Gene Products </paragraph>
<paragraph id="P-0071" lvl="0"><number>&lsqb;0071&rsqb;</number> As used herein, the term &ldquo;floral meristem identity gene product&rdquo; means a gene product that promotes conversion of shoot meristem to floral meristem in an angiosperm. Expression of a floral meristem identity gene product such as AP1, CAL or LFY in shoot meristem can convert shoot meristem to floral meristem in an angiosperm. Furthermore, ectopic expression of a floral meristem identity gene product also can promote early reproductive development. </paragraph>
<paragraph id="P-0072" lvl="0"><number>&lsqb;0072&rsqb;</number> A floral meristem identity gene product is distinguishable from a late flowering gene product or an early flowering gene product. The use of a late flowering gene product or an early flowering gene product is not encompassed within the scope of the present invention. In addition, reference is made herein to an &ldquo;inactive&rdquo; floral meristem identity gene product, as exemplified by the product of the <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>CAL gene (BobCAL) (see below). Expression of an inactive floral meristem identity gene product in an angiosperm does not result in the conversion of shoot meristem to floral meristem in the angiosperm. An inactive floral meristem identity gene product such as BobCAL is excluded from the meaning of the term &ldquo;floral meristem identity gene product&rdquo; as defined herein. </paragraph>
<paragraph id="P-0073" lvl="0"><number>&lsqb;0073&rsqb;</number> A. AP1 </paragraph>
<paragraph id="P-0074" lvl="0"><number>&lsqb;0074&rsqb;</number> A floral meristem identity gene product can be, for example, an AP1 gene product having the amino acid sequence of SEQ ID NO: 2, which is a 256 amino acid gene product encoded by the <highlight><italic>Arabidopsis thaliana </italic></highlight>AP1 cDNA. The Arabidopsis AP1 cDNA encodes a highly conserved MADS domain, which can function as a DNA-binding domain, and a K domain, which has structural similarity to the coiled-coil domain of keratins and can be involved in protein-protein interactions. </paragraph>
<paragraph id="P-0075" lvl="0"><number>&lsqb;0075&rsqb;</number> As used herein, the term &ldquo;APETALA1,&rdquo; &ldquo;AP1&rdquo; or &ldquo;AP1 gene product&rdquo; means a floral meristem identity gene product that is characterized, in part, by having an amino acid sequence substantially identical to the amino acid sequence of SEQ ID NO: 2 in the region from amino acid 1 to amino acid 163 or with the amino acid sequence of SEQ ID NO: 8 in the region from amino acid 1 to amino acid 163. Alternatively, &ldquo;AP1 gene product&rdquo; refers to a gene product substantially identical to SEQ ID NO:2 or SEQ ID NO:8. Like other floral meristem identity gene products, AP1 promotes conversion of shoot meristem to floral meristem in an angiosperm. An AP1 gene product useful in the invention can be, for example, Arabidopsis AP1 having the amino acid sequence of SEQ ID NO: 2; <highlight><italic>Brassica oleracea </italic></highlight>AP1 having the amino acid sequence of SEQ ID NO: 4; <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 having the amino acid sequence of SEQ ID NO: 6 or <highlight><italic>Zea mays </italic></highlight>AP1 having the amino acid sequence of SEQ ID NO: 8. </paragraph>
<paragraph id="P-0076" lvl="0"><number>&lsqb;0076&rsqb;</number> In wild-type Arabidopsis, AP1 RNA is expressed in flowers but is not detectable in roots, stems or leaves (Mandel et al., <highlight><italic>Nature </italic></highlight>360:273-277 (1992), which is incorporated herein by reference). The earliest detectable expression of AP1 RNA is in young floral meristem at the time it initially forms on the flanks of shoot meristem. Expression of AP1 increases as the floral meristem increases in size; no AP1 expression is detectable in shoot meristem. In later stages of development, AP1 expression ceases in cells that will give rise to reproductive organs of a flower (stamens and carpels), but is maintained in cells that will give rise to non-reproductive organs (sepals and petals; Mandel, supra, 1992). Thus, in nature, AP1 expression is restricted to floral meristem and to certain regions of the flowers that develop from this meristemic tissue. </paragraph>
<paragraph id="P-0077" lvl="0"><number>&lsqb;0077&rsqb;</number> B. CAL </paragraph>
<paragraph id="P-0078" lvl="0"><number>&lsqb;0078&rsqb;</number> CAULIFLOWER (CAL) is another example of a floral meristem identity gene product. As used herein, the term &ldquo;CAULIFLOWER,&rdquo; &ldquo;CAL&rdquo; or &ldquo;CAL gene product&rdquo; means a floral meristem identity gene product that is characterized, in part, bysubstantial identity to an amino acid sequence of SEQ ID NO: 10 in the region from amino acid 1 to amino acid 160 or with the amino acid sequence of SEQ ID NO: 12 in the region from amino acid 1 to amino acid 160. Alternatively, &ldquo;CAL gene product&rdquo; refers to a gene product substantially identical to SEQ ID NO:10 or SEQ ID NO:12. </paragraph>
<paragraph id="P-0079" lvl="0"><number>&lsqb;0079&rsqb;</number> A CAL gene product is exemplified by the Arabidopsis CAL gene product, which has the amino acid sequence of SEQ ID NO: 10, or the <highlight><italic>Brassica oleracea </italic></highlight>CAL gene product, which has the amino acid sequence of SEQ ID NO:12. As disclosed herein, CAL, like AP1, contains a MADS domain and a K domain. The MADS domains of CAL and AP1 differ in only five of 56 amino acid residues, where four of the five differences represent conservative amino acid replacements. Over the entire sequence, the Arabidopsis CAL and Arabidopsis AP1 sequences (SEQ ID NOS: 10 and 2) are 76% identical and are 88% similar if conservative amino acid substitutions are allowed. </paragraph>
<paragraph id="P-0080" lvl="0"><number>&lsqb;0080&rsqb;</number> Similar to the expression pattern of AP1, CAL RNA is expressed in young floral meristem in Arabidopsis. However, in contrast to AP1 expression, which is high throughout sepal and petal development, CAL expression is low in these organs. Thus, in nature, CAL is expressed in floral meristem and, to a lesser extent, in the organs of developed flowers. </paragraph>
<paragraph id="P-0081" lvl="0"><number>&lsqb;0081&rsqb;</number> The skilled artisan will recognize that, due to the high sequence conservation between AP1 and CAL, a novel ortholog can be categorized as both a CAL and an AP1, as defined herein. However, if desired, an AP1 ortholog can be distinguished from a CAL ortholog by demonstrating a greater similarity to Arabidopsis AP1 than to any other MADS box gene, such as CAL, as set forth in Purugganan et al. (<highlight><italic>Genetics </italic></highlight>140:345-356 (1995), which is incorporated herein by reference). Furthermore, AP1 can be distinguished from CAL by its ability to complement, or restore a wild-type phenotype, when introduced into a strong ap1 mutant. For example, introduction of Arabidopsis AP1 (AGL7) complements the phenotype of the strong ap1-1 mutant; however, introduction of CAL (AGL10) into a cal-1 ap1-1 mutant plant yields the ap1-1 single mutant phenotype, demonstrating that CAL cannot complement the ap1-1 mutation (see, for example, Mandel et al., supra, 1992; Kempin et al., supra, 1995). Thus, AP1 can be distinguished from CAL, if desired, by the ability of a nucleic acid molecule encoding AP1 to complement a strong ap1 mutant such as ap1-1 or ap1-15. </paragraph>
<paragraph id="P-0082" lvl="0"><number>&lsqb;0082&rsqb;</number> C. LFY </paragraph>
<paragraph id="P-0083" lvl="0"><number>&lsqb;0083&rsqb;</number> LEAFY (LFY) is yet another example of a floral meristem identity gene product. As used herein, the term &ldquo;LEAFY&rdquo; or &ldquo;LFY&rdquo; or &ldquo;LFY gene product&rdquo; means a floral meristem identity gene product that is characterized, in part, by having an amino acid sequence that has substantial identity with the amino acid sequence of SEQ ID NO: 16. In nature, LFY is expressed in floral meristem as well as during vegetative development. As disclosed herein, ectopic expression in shoot meristem of a floral meristem identity gene product, which normally is expressed in floral meristem, can convert shoot meristem to floral meristem in an angiosperm. Under appropriate conditions, ectopic expression in shoot meristem of a floral meristem identity gene product such as AP1, CAL, LFY, or a combination thereof, can promote early reproductive development. </paragraph>
<paragraph id="P-0084" lvl="0"><number>&lsqb;0084&rsqb;</number> D. Floral Meristem Gene Product Orthologs </paragraph>
<paragraph id="P-0085" lvl="0"><number>&lsqb;0085&rsqb;</number> Flower development in Arabidopsis is recognized in the art as a model for flower development in angiosperms in general. Gene orthologs corresponding to the Arabidopsis genes involved in the early steps of flower formation have been identified in distantly related angiosperm species, and these gene orthologs show remarkably similar patterns of RNA expression. Mutations in gene orthologs also result in phenotypes that correspond to the phenotype produced by a similar mutation in Arabidopsis. For example, orthologs of the Arabidopsis floral meristem identity genes AP1 and LFY and the Arabidopsis organ identity genes AGAMOUS, APETALA3 and PISTILLATA have been isolated from monocots such as maize and, where characterized, reveal the anticipated RNA expression patterns and related mutant phenotypes (Schmidt et al., <highlight><italic>Plant Cell </italic></highlight>5:729-737 (1993); and Veit et al., <highlight><italic>Plant Cell </italic></highlight>5:1205-1215 (1993), each of which is incorporated herein by reference). Furthermore, a gene ortholog can be functionally interchangeable in that it can function across distantly related species boundaries (Mandel et al., <highlight><italic>Cell </italic></highlight>71:133-143 (1992), which is incorporated herein by reference). Taken together, these data suggest that the underlying mechanisms controlling the initiation and proper development of flowers are conserved across distantly related dicot and monocot boundaries. </paragraph>
<paragraph id="P-0086" lvl="0"><number>&lsqb;0086&rsqb;</number> Floral meristem identity genes in particular are conserved among distantly related angiosperm and gymnosperm species. For example, a gene ortholog of Arabidopsis AP1 has been isolated from <highlight><italic>Antirrhinum majus </italic></highlight>(snapdragon; Huijser et al., <highlight><italic>EMBO J. </italic></highlight>11:1239-1249 (1992), which is incorporated herein by reference). An ortholog of Arabidopsis AP1 also has been isolated from <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>(cauliflower, see SEQ ID NO:6), <highlight><italic>Zea Mays </italic></highlight>(maize; see SEQ ID NO:8) and rice (OsMADS14 (<highlight><italic>Plant Physiology </italic></highlight>120:1193-1203 (1999)). Furthermore, AP1 orthlogs also can be isolated from gymnosperms. Similarly, gene orthologs of Arabidopsis LFY have been isolated from angiosperms such as <highlight><italic>Antirrhinum majus</italic></highlight>, tobacco and poplar tree and from gymnosperms such as Douglas fir (Coen et al., <highlight><italic>Cell, </italic></highlight>63:1311-1322 (1990); Kelly et al., <highlight><italic>Plant Cell </italic></highlight>7:225-234 (1995); and Rottmann et al., <highlight><italic>Cell Biochem. Suppl. </italic></highlight>17B: 23 (1993); Strauss et al., <highlight><italic>Molec. Breed </italic></highlight>1:5-26 (1995), each of which is incorporated herein by reference). The conservation of floral meristem identity gene products in non-flowering plants such as coniferous trees indicates that floral meristem identity genes can promote the reproductive development of gymnosperms as well as angiosperms. </paragraph>
<paragraph id="P-0087" lvl="0"><number>&lsqb;0087&rsqb;</number> The characterization of ap1 and lfy mutants also indicates that floral meristem identity gene products such as AP1 and LFY function similarly in distantly related plant species. For example, a mutation in the Antirrhinum AP1 ortholog results in a phenotype similar to the Arabidopsis ap1 indeterminate flower within a flower phenotype (Huijser et al., supra, 1992). In addition, a mutation in the Antirrhinum LFY ortholog results in a phenotype similar to the Arabidopsis lfy mutant phenotype (Coen et al., supra, 1995) </paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> A floral meristem identity gene product also can function across species boundaries. For example, introduction of a nucleic acid molecule encoding Arabidopsis LFY into a heterologous seed plant such as tobacco or aspen results in early reproductive development (Weigel and Nilsson, <highlight><italic>Nature </italic></highlight>377:495-500 (1995), which is incorporated herein by reference). As disclosed herein, a nucleic acid molecule encoding an Arabidopsis AP1 gene product (SEQ ID NO: 1) or an Arabidopsis CAL gene product (SEQ ID NO: 9) can be introduced into a heterologous seed plant such as corn, wheat, rice or pine and, upon ectopic expression, can promote early reproductive development in the transgenic seed plant. Furthermore, as disclosed herein, the conserved nature of the AP1, CAL and LFY coding sequences among diverse seed plant species allows a nucleic acid molecule encoding a floral meristem identity gene product isolated from essentially any seed plant to be introduced into essentially any other seed plant, wherein, upon appropriate expression of the introduced nucleic acid molecule in the seed plant, the floral meristem identity gene product promotes early reproductive development in the seed plant. </paragraph>
<paragraph id="P-0089" lvl="0"><number>&lsqb;0089&rsqb;</number> If desired, a novel AP1, CAL or LFY coding sequence can be isolated from a seed plant using a nucleotide sequence as a probe and methods well known in the art of molecular biology (Sambrook et al. (eds.), <highlight><italic>Molecular Cloning: A Laboratory Manual </italic></highlight>(Second Edition), Plainview, N.Y.: Cold Spring Harbor Laboratory Press (1989), which is incorporated herein by reference). As exemplified herein and discussed in detail below (see Example VA), an AP1 ortholog from <highlight><italic>Zea Mays </italic></highlight>(maize; SEQ ID NO: 7) was isolated using the Arabidopsis AP1 cDNA (SEQ ID NO: 1) as a probe. </paragraph>
<paragraph id="P-0090" lvl="7"><number>&lsqb;0090&rsqb;</number> II. AGAMOUS-Like Gene Products </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> Modulation of expression of the gene products described below, either alone, or in combination with the ectopic expression of AP1 or CAL, results in the modulation of the development of reproductive development in plants. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> A. SEP1, SEP2 and SEP3 </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> SEP 1, SEP2 and SEP3 (previously known as AGL2, AGL4 and AGL9, respectively) are a class of floral organ identity gene products that are required for development of stamens and carpels (Pelaz, et al, <highlight><italic>Nature </italic></highlight>405:200-203 (2000)). The SEP gene products are functionally redundant. Therefore, inactivation of only one SEP gene product does not typically result in the development of a mutant floral phenotype. Ectopic or increased expression of a SEP gene product results in early development of reproductive structures. Delay of reproductive development typically requires the reduction of expression of at least two and sometimes all three SEP gene products due to the redundancy of their function. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> As used herein, the term &ldquo;SEP1&rdquo; or &ldquo;SEP1 gene product&rdquo; means a floral meristem identity gene product, or active fragment thereof, that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 28. The term &ldquo;SEP2&rdquo; or &ldquo;SEP2 gene product&rdquo; means a floral meristem identity gene product, or active fragment thereof, that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 30. SEP1 and SEP2 sequences were previously described in Ma et al., <highlight><italic>Genes </italic></highlight>&amp; <highlight><italic>Development </italic></highlight>5:484-495 (1991). An exemplary SEP1 nucleic acid sequence is displayed as SEQ ID NO:27. An exemplary SEP2 nucleic acid sequence is displayed as SEQ ID NO:29. The term &ldquo;SEP3&rdquo; or &ldquo;SEP3 gene product&rdquo; means a floral meristem identity gene product, or active fragment thereof, that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 32. SEP3 sequences were previously described in Mandel et al., <highlight><italic>Sex. Plant Reprod. </italic></highlight>11:22-28 (1998). An exemplary SEP3 nucleic acid sequence is displayed as SEQ ID NO:31. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> B. AGL20 </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> As used herein, the term &ldquo;AGL20&rdquo; or &ldquo;AGL20 gene product&rdquo; means a gene product that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 34. AGL20 is also known as &ldquo;SOC1.&rdquo; See, e.g., Samach et al. <highlight><italic>Science </italic></highlight>288:1613-1616 (2000). Reduction of endogenous expression of AGL20 results in delayed development of reproductive structures in plants. An exemplary AGL20 nucleic acid sequence is displayed as SEQ ID NO:33. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> C. AGL22 </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> As used herein, the term &ldquo;AGL22&rdquo; or &ldquo;AGL22 gene product&rdquo; means a gene product that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 36. Decreased expression of an AGL22 gene product results in early development of reproductive structures. AGL22 is also known as &ldquo;SVP.&rdquo; An exemplary AGL22 nucleic acid sequence is displayed as SEQ ID NO:35. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> D. AGL24 </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> As used herein, the term &ldquo;AGL24&rdquo; or &ldquo;AGL24 gene product&rdquo; means a gene product that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 38. An exemplary AGL24 nucleic acid sequence is displayed as SEQ ID NO:37. Ectopic or increased expression of AGL24 results in early development of reproductive structures in plants. Reduced expression of endogenous AGL24 results in delayed development of reproductive structures in plants. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> E. AGL27 </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> As used herein, the term &ldquo;AGL27&rdquo; or &ldquo;AGL27 gene product&rdquo; means a gene product that is characterized, in part, by having an amino acid sequence substantially identical to SEQ ID NO: 36. An exemplary AGL27 cDNA nucleic acid sequence is displayed as SEQ ID NO:39. An alternatively spliced AGL27 cDNA, and resulting translated product, are displayed as SEQ ID NO:48 and SEQ ID NO:49. </paragraph>
<paragraph id="P-0103" lvl="7"><number>&lsqb;0103&rsqb;</number> III. Effect of Gene Products of the Invention on Timing of Reproductive Development </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> As described in U.S. Pat. No. 6,002,069, ectopic expression of the AP1 or CAL gene products results in the early development of reproductive structures in plants. The present invention demonstrates that ectopic expression of a number of other genes in combination with the ectopic expression of AP1 or CAL, leads to significantly earlier timing of reproductive development than plants ectopically expressing AP1 or CAL alone. In one embodiment, the invention provides a non-naturally occurring seed plant that contains a first ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene, and a second ectopically expressible nucleic acid molecule encoding SEP1, SEP2, SEP3 or AGL24, wherein the plant is characterized by modulated timing of reproductive development. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> As used herein, the term &ldquo;characterized by early reproductive development,&rdquo; when used in reference to a non-naturally occurring seed plant of the invention, means a non-naturally occurring seed plant that forms reproductive structures at an earlier stage than when reproductive structures form on a corresponding naturally occurring seed plant that is grown under the same conditions and that does not ectopically express a floral meristem identity gene product. In addition, &ldquo;characterized by early reproductive development&rdquo; also refers to the formation of reproduction structures at an earlier stage than a plant identical except for the lack of ectopic expression of the nucleic acids of the invention (e.g., polynucleotides substantially similar to nucleic acid molecules encoding SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38 or SEQ ID NO:40). Note that &ldquo;stage,&rdquo; as used above, refers to either the amount of time from germination of seed or the number of leaves that a plant produces prior to initiation of reproductive structures. Similarly, &ldquo;characterized by late reproductive development&rdquo; or &ldquo;characterized by delayed reproductive development&rdquo; refers to the delayed development of reproductive structures compared to a naturally-occurring seed plant or to a plant, natural or transgenic, that does not ectopically express a nucleic acid of the invention. The reproductive structure of an angiosperm, for example, is a flower, and the reproductive structure of a coniferous plant is a cone. For a particular naturally occurring seed plant, reproductive development occurs at a well-defined time that depends, in part, on genetic factors as well as on environmental conditions, such as day length and temperature. Thus, given a defined set of environmental condition and lacking ectopic expression of a floral meristem identity gene product, a naturally occurring seed plant will undergo reproductive development at a relatively fixed time. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> It is recognized that various transgenic plants that are characterized by altered timing of reproductive development have been described previously. Such transgenic plants, as discussed herein, are distinguishable from a non-naturally occurring seed plant of the invention or are explicitly excluded from the present invention. The product of a &ldquo;late-flowering gene&rdquo; can promote early reproductive development. However, a late flowering gene product is not a floral meristem identity gene product since it does not specify the conversion of shoot meristem to floral meristem in an angiosperm. Therefore, a transgenic plant expressing a late-flowering gene product is distinguishable from a non-naturally occurring seed plant of the invention. For example, a transgenic plant expressing the late-flowering gene, CONSTANS (CO), flowers earlier than the corresponding wild type plant, but does not contain an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product (Putterill et al., <highlight><italic>Cell </italic></highlight>80:847-857 (1995)). Thus, the early-flowering transgenic plant described by Putterill et al. is not a non-naturally occurring seed plant as defined herein. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> Early reproductive development also has been observed in a transgenic tobacco plant expressing an exogenous rice MADS domain gene. Although the product of the rice MADS domain gene promotes early reproductive development, it does not specify the identity of floral meristem and, thus, cannot convert shoot meristem to floral meristem in an angiosperm (Chung et al., <highlight><italic>Plant Mol. Biol. </italic></highlight>26:657-665 (1994)). Therefore, an early-flowering transgenic plant containing this rice MADS domain gene, like an early-flowering transgenic plant containing CONSTANS, is distinguishable from an early-flowering non-naturally occurring seed plant of the invention. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> Mutations in a class of genes known as &ldquo;early-flowering genes&rdquo; also produce plants characterized by early reproductive development. Such early-flowering genes include, for example, EARLY FLOWERING 1-3 (ELF1, ELF2, ELF3); EMBRYONIC FLOWER 1,2 (EMF1, EMF2); LONG HYPOCOTYL 1,2 (HY1, HY2); PHYTOCHROME B (PHYB), SPINDLY (SPY) and TERMINAL FLOWER (TFL) (Weigel, supra, 1995). The wild type product of an early-flowering gene retards reproductive development and is distinguishable from a floral meristem identity gene product in that an early-flowering gene product does not promote conversion of shoot meristem to floral meristem in an angiosperm. A plant that flowers early due to the loss of an early-flowering gene product function is distinct from a non-naturally occurring seed plant of the invention characterized by early reproductive development since such a plant does not contain an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> An Arabidopsis plant having a mutation in the TERMINAL FLOWER (TFL) gene is characterized by early reproductive development and by the conversion of shoots to flowers (Alvarez et al., <highlight><italic>Plant J. </italic></highlight>2:103-116 (1992), which is incorporated herein by reference). However, TFL is not a floral meristem identity gene product, as defined herein. Specifically, it is the loss of TFL that promotes conversion of shoot meristem to floral meristem. Since the function of TFL is to antagonize formation of floral meristem, a tfl mutant, which lacks functional TFL, converts shoot meristem to floral meristem prematurely. Although TFL is not a floral meristem identity gene product and does not itself convert shoot meristem to floral meristem, the loss of TFL can result in a plant with an ectopically expressed floral meristem identity gene product. However, such a tfl mutant, in which a mutation in an endogenous TERMINAL FLOWER gene results in conversion of shoot meristem to floral meristem, is excluded explicitly from the present invention. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> In various embodiments, the present invention provides a non-naturally occurring seed plant containing a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. If desired, a non-naturally occurring seed plant of the invention can contain a second ectopically expressible nucleic acid molecule encoding SEP1, SE2, SEP3, AGL20, AGL22, AGL24, or AGL27, provided that the first or second nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> An ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be expressed, as desired, either constitutively or inducibly. Such an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be an endogenous floral meristem identity gene that has, for example, a mutation in a gene regulatory element. An ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product also can be an endogenous nucleic acid molecule encoding a floral meristem identity gene product that is linked to an exogenous, heterologous gene regulatory element that confers ectopic expression. In addition, an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be an exogenous nucleic acid molecule that encodes a floral meristem identity gene product under control of a heterologous gene regulatory element. </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> A non-naturally occurring seed plant of the invention can contain an endogenous floral meristem identity gene having a modified gene regulatory element. The term &ldquo;modified gene regulatory element,&rdquo; as used herein in reference to the regulatory element of a floral meristem identity gene, means a regulatory element having a mutation that results in ectopic expression of the linked endogenous floral meristem identity gene. Such a gene regulatory element can be, for example, a promoter or enhancer element and can be positioned 5&prime; or 3&prime; to the coding sequence or within an intronic sequence of the floral meristem identity gene. A modified gene regulatory element can have, for example, a nucleotide insertion, deletion or substitution that is produced, for example, by chemical mutagenesis using a mutagen such as ethylmethane sulfonate or by insertional mutagenesis using a transposable element. A modified gene regulatory element can be a functionally inactivated binding site for TFL or a functionally inactivated binding site for a gene product regulated by TFL, such that modification of the gene regulatory element results in ectopic expression of the linked floral meristem identity gene product, for example, in the shoot meristem of an angiosperm. </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> The present invention also provides a transgenic seed plant containing a first exogenous gene promoter that regulates a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product and a second exogenous gene promoter that regulates a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product. </paragraph>
<paragraph id="P-0114" lvl="0"><number>&lsqb;0114&rsqb;</number> The present invention further provides a transgenic seed plant containing a first exogenous ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product and a second exogenous gene promoter that regulates a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. </paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> The invention also provides, therefore, a plant characterized by modulated (delayed or early) reproductive development, the plant containing a sense or antisense nucleic acid molecule encoding AP, or a fragment thereof; a sense or antisense nucleic acid molecule encoding CAL, or a fragment thereof; and a sense or antisense nucleic acid molecule encoding LFY, or a fragment thereof, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant. Similarly, a sense or antisense nucleic acid molecule encoding SEP1, or a fragment thereof, a sense or antisense nucleic acid molecule encoding SEP2, or a fragment thereof, a sense or antisense nucleic acid molecule encoding SEP3, or a fragment thereof, a sense or antisense nucleic acid molecule encoding AGL20, or a fragment thereof, a sense or antisense nucleic acid molecule encoding AGL22, or a fragment thereof, a sense or antisense nucleic acid molecule encoding AGL24, or a fragment thereof, a sense or antisense nucleic acid molecule encoding AGL27, or a fragment thereof can also be used singly, in combination with each other or in combination with any of the AP1, CAL or LFY constructs discussed above. </paragraph>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> In addition, the invention provides a transgenic seed plant containing a first exogenous ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that the first second nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene, and further containing a second exogenous ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product, where the first floral meristem identity gene product is different from the second floral meristem identity gene product. </paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> As disclosed herein, ectopic expression of two different floral meristem identity gene products can be particularly useful. For example, a fraction of the progeny of a cross between a transgenic Arabidopsis line constitutively expressing AP1 under control of the cauliflower mosaic virus 35S promoter and a transgenic Arabidopsis line constitutively expressing LFY under control of the cauliflower mosaic virus 35S promoter are characterized by enhanced early reproductive development as compared to the early reproductive development of 35S-AP1 transgenic lines or 35S-LFY transgenic lines. These results indicate that ectopic expression of the combination of AP1 and LFY in a seed plant can result in enhanced early reproductive development as compared to the early reproductive development obtained by ectopic expression of AP1 or LFY alone. Similarly, the ectopic expression of the combination of at least one of AP1 and CALIFLOWER with at least one of SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 results in early reproductive development. Thus, by using a combination of two different floral meristem identity gene products, plant breeding, for example, can be accelerated further as compared to the use of a single floral meristem identity gene product. </paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> A useful combination of first and second floral meristem identity gene products can be, for example, AP1 and SEP3, CAL and SEP3, AP1 and AGL24 or CAL and AGL24. Where a transgenic seed plant of the invention contains first and second exogenous nucleic acid molecules encoding different floral meristem identity gene products, it will be recognized that the order of introducing the first and second nucleic acid molecules into the seed plant is not important for purposes of the present invention. Thus, a transgenic seed plant of the invention having, for example, AP1 as a first floral meristem identity gene product and SEP3 as a second floral meristem identity gene product is equivalent to a transgenic seed plant having SEP3 as a first floral meristem identity gene product and AP1 as a second floral meristem identity gene product. </paragraph>
<paragraph id="P-0119" lvl="7"><number>&lsqb;0119&rsqb;</number> IV. Plant Transformation </paragraph>
<paragraph id="P-0120" lvl="0"><number>&lsqb;0120&rsqb;</number> As used herein, the term &ldquo;introducing,&rdquo; when used in reference to a nucleic acid molecule and a seed plant such as an angiosperm or a gymnosperm, means transferring an exogenous nucleic acid molecule into the seed plant. For example, an exogenous nucleic acid molecule encoding a floral meristem identity gene product can be introduced into a seed plant by a variety of methods including Agrobacterium-mediated transformation or direct gene transfer methods such as electroporation or microprojectile-mediated transformation. </paragraph>
<paragraph id="P-0121" lvl="0"><number>&lsqb;0121&rsqb;</number> Transformation methods based upon the soil bacterium <highlight><italic>Agrobacteriurn tumefaciens</italic></highlight>, known as &ldquo;agro-infection,&rdquo; are useful for introducing a nucleic acid molecule into a broad range of angiosperms and gymnosperms. The wild type form of Agrobacterium contains a Ti (tumor-inducing) plasmid that directs production of tumorigenic crown gall growth on host plants. Transfer of the tumor-inducing T-DNA region of the Ti plasmid to a plant genome requires the Ti plasmid-encoded virulence genes as well as T-DNA borders, which are a set of direct DNA repeats that delineate the region to be transferred. Agrobacterium-based vector is a modified form of a Ti plasmid, in which the tumor inducing functions are replaced by nucleic acid sequence of interest to be introduced into the plant host. </paragraph>
<paragraph id="P-0122" lvl="0"><number>&lsqb;0122&rsqb;</number> Current protocols for Agrobacterium-mediated transformation employ cointegrate vectors or, preferably, binary vector systems in which the components of the Ti plasmid are divided between a helper vector, which resides permanently in the Agrobacterium host and carries the virulence genes, and a shuttle vector, which contains the gene of interest bounded by T-DNA sequences. A variety of binary vectors are well known in the art and are commercially available from, for example, Clontech (Palo Alto, Calif.). Methods of coculturing Agrobacterium with cultured plant cells or wounded tissue such as leaf tissue, root explants, hypocotyledons, stem pieces or tubers, for example, also are well known in the art (Glick and Thompson (eds.), Methods in Plant Molecular Biology and Biotechnology, Boca Raton, Fla.: CRC Press (1993), which is incorporated herein by reference). Wounded cells within the plant tissue that have been infected by Agrobacterium can develop organs de novo when cultured under the appropriate conditions; the resulting transgenic shoots eventually give rise to transgenic plants containing the exogenous nucleic acid molecule of interest, as described in Example I. </paragraph>
<paragraph id="P-0123" lvl="0"><number>&lsqb;0123&rsqb;</number> Agrobacterium-mediated transformation has been used to produce a variety of transgenic seed plants (see, for example, Wang et al. (eds), Transformation of Plants and Soil Microorganisms, Cambridge, UK: University Press (1995), which is incorporated herein by reference). For example, Agrobacterium-mediated transformation can be used to produce transgenic crudiferous plants such as Arabidopsis, mustard, rapeseed and flax; transgenic leguminous plants such as alfalfa, pea, soybean, trefoil and white clover; and transgenic solanaceous plants such as eggplant, petunia, potato, tobacco and tomato. In addition, Agrobacterium-mediated transformation can be used to introduce exogenous nucleic acids into apple, aspen, belladonna, black currant, carrot, celery, cotton, cucumber, grape, horseradish, lettuce, morning glory, muskmelon, neem, poplar, strawberry, sugar beet, sunflower, walnut and asparagus plants (see, for example, Glick and Thompson, supra, 1993). </paragraph>
<paragraph id="P-0124" lvl="0"><number>&lsqb;0124&rsqb;</number> Microprojectile-mediated transformation also is a well known method of introducing an exogenous nucleic acid molecule into a variety of seed plant species. This method, first described by Klein et al., <highlight><italic>Nature </italic></highlight>327:70-73 (1987), which is incorporated herein by reference, relies on microprojectiles such as gold or tungsten that are coated with the desired nucleic acid molecule by precipitation with calcium chloride, spermidine or PEG. The microprojectile particles are accelerated at high speed into seed plant tissue using a device such as the Biolistic&trade; PD-1000 (Biorad, Hercules, Calif.). </paragraph>
<paragraph id="P-0125" lvl="0"><number>&lsqb;0125&rsqb;</number> Microprojectile-mediated delivery or &ldquo;particle bombardment&rdquo; is especially useful to transform seed plants that are difficult to transform or regenerate using other methods. Microprojectile-mediated transformation has been used, for example, to generate a variety of transgenic seed plant species, including cotton, tobacco, corn, hybrid poplar and papaya (see, for example, Glick and Thompson, supra, 1993). The transformation of important cereal crops such as wheat, oat, barley, sorghum and rice also has been achieved using microprojectile-mediated delivery (Duan et al., <highlight><italic>Nature Biotech. </italic></highlight>14:494-498 (1996); Shimamoto, <highlight><italic>Curr. Opin. Biotech. </italic></highlight>5:158-162 (1994), each of which is incorporated herein by reference). A rapid transformation regeneration system for the production of transgenic plants, such as transgenic wheat, in two to three months also can be useful in producing a transgenic seed plant of the invention (European Patent No. EP 0 709 462 A2, Application number 95870117.9, filed Oct. 25, 1995, which is incorporated herein by reference). </paragraph>
<paragraph id="P-0126" lvl="0"><number>&lsqb;0126&rsqb;</number> Thus, a variety of methods for introducing a nucleic acid molecule into a seed plant are well known in the art. Important crop species such as rice, for example, have been transformed using microprojectile delivery, Agrobacterium-mediated transformation or protoplast transformation (Hiei et al., <highlight><italic>The Plant J. </italic></highlight>6(2):271-282 (1994); Shimamoto, <highlight><italic>Science </italic></highlight>270:1772-1773 (1995), each of which is incorporated herein by reference). Fertile transgenic maize has been obtained, for example, by microparticle bombardment (see Wang et al., supra, 1995). As discussed above, barley, wheat, oat and other small-grain cereal crops also have been transformed, for example, using microparticle bombardment (see Wang et al., supra, 1995). </paragraph>
<paragraph id="P-0127" lvl="0"><number>&lsqb;0127&rsqb;</number> Methods of transforming forest trees including both angiosperms and gymnosperms also are well known in the art. Transgenic angiosperms such as members of the genus Populus, which includes aspens and poplars, have been generated using Agrobacterium-mediated transformation, for example. In addition, transgenic Populus and sweetgum, which are of interest for biomass production for fuel, also have been produced. Transgenic gymnosperms, including conifers such as white spruce and larch, also have been obtained, for example, using microprojectile bombardment (Wang et al., supra, 1995). The skilled artisan will recognize that Agrobacterium-mediated or microprojectile-mediated transformation, as disclosed herein, or other methods known in the art can be used to introduce a nucleic acid molecule encoding a floral meristem identity gene product into a seed plant according to the methods of the invention. </paragraph>
<paragraph id="P-0128" lvl="0"><number>&lsqb;0128&rsqb;</number> The nucleic acids of the invention can be used to confer desired traits on essentially any plant. Thus, the invention has use over a broad range of plants, including species from the genera Anacardium, Arachis, Asparagus, Atropa, Avena, Brassica, Citrus, Citrullus, Capsicum, Carthamus, Cocos, Coffea, Cucumis, Cucurbita, Daucus, Elaeis, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoscyamus, Lactuca, Linum, Lolium, Lupinus, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Olea, Oryza, Panieum, Pannesetum, Persea, Phaseolus, Pistachia, Pisum, Pyrus, Prunus, Raphanus, Ricinus, Secale, Senecio, Sinapis, Solanum, Sorghum, Theobromus, Trigonella, Triticum, Vicia, Vitis, Vigna, and Zea. </paragraph>
<paragraph id="P-0129" lvl="7"><number>&lsqb;0129&rsqb;</number> V. Converting Shoot Meristem to Floral Meristem </paragraph>
<paragraph id="P-0130" lvl="0"><number>&lsqb;0130&rsqb;</number> The term &ldquo;converting shoot meristem to floral meristem,&rdquo; as used herein, means promoting the formation of flower progenitor tissue where shoot progenitor tissue otherwise would be formed in the angiosperm. As a result of the conversion of shoot meristem to floral meristem, flowers form in an angiosperm where shoots normally would form. The conversion of shoot meristem to floral meristem can be identified using well known methods, such as scanning electron microscopy, light microscopy or visual inspection (see, for example, Mandel and Yanofsky, <highlight><italic>Plant Cell </italic></highlight>7:1763-1771 (1995), which is incorporated herein by reference or Weigel and Nilsson, supra, 1995). </paragraph>
<paragraph id="P-0131" lvl="0"><number>&lsqb;0131&rsqb;</number> Provided herein are methods of converting shoot meristem to floral meristem in an angiosperm by introducing a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product and a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product into the angiosperm, where the first floral meristem identity gene product is different from the second floral meristem identity gene product. As discussed above, first and second floral meristem identity gene products useful in converting shoot meristem to floral meristem in an angiosperm can be, for example, AP1 and LFY, CAL and LFY, or AP1 and CAL. In other preferred embodiments, the ectopic expression of the combination of at least one of AP1 and CALIFLOWER with at least one of SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 results in conversion of shoot meristem to floral meristem. </paragraph>
<paragraph id="P-0132" lvl="7"><number>&lsqb;0132&rsqb;</number> VI. Methods of Modulating Reproductive Development </paragraph>
<paragraph id="P-0133" lvl="0"><number>&lsqb;0133&rsqb;</number> As discussed above, the present invention provides methods of promoting modulated timing of reproductive development in a seed plant by ectopically expressing a first nucleic acid molecule encoding a first floral meristem identity gene product in the seed plant, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. For example, the invention provides a method of promoting modulated timing of reproductive development in a seed plant by introducing an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product into the seed plant, thus producing a transgenic seed plant. A floral meristem identity gene product such as SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, AGL27, AP1, CAL or LFY, or a chimeric protein containing, in part, a floral meristem identity gene product, as disclosed below, is useful in methods of promoting early reproductive development. </paragraph>
<paragraph id="P-0134" lvl="0"><number>&lsqb;0134&rsqb;</number> The term &ldquo;promoting early reproductive development,&rdquo; as used herein in reference to a seed plant, means promoting the formation of a reproductive structure earlier than the time when a reproductive structure would form on a corresponding seed plant that is grown under the same conditions and that does not ectopically express a floral meristem identity gene product. As discussed above, the time when reproductive structures form on a particular seed plant that does not ectopically express a floral meristem identity gene product is relatively fixed and depends, in part, on genetic factors as well as environmental conditions, such as day length and temperature. Thus, given a defined set of environmental conditions, a naturally occurring angiosperm, for example, will flower at a relatively fixed time. Similarly, given a defined set of environmental conditions, a naturally occurring coniferous gymnosperm, for example, will produce cones at a relatively fixed time. </paragraph>
<paragraph id="P-0135" lvl="0"><number>&lsqb;0135&rsqb;</number> Methods for ectopically expressing polynucleotides in plants are well known in the art. For example, the expression of polynucleotides of the invention can be modulated by mutation, or introduction of at least one copy of the polynucleotides into a plant. </paragraph>
<paragraph id="P-0136" lvl="0"><number>&lsqb;0136&rsqb;</number> One of skill will recognize that a number of methods can be used to modulate gene product activity or gene expression. Gene product activity can be modulated in the plant cell at the gene, transcriptional, posttranscriptional, translational, or posttranslational, levels. Techniques for modulating gene product activity at each of these levels are generally well known to one of skill and are discussed briefly below. &ldquo;Activity&rdquo; encompasses both mechanistic activities (e.g., enzymatic, ability to induce transcription of genes under the gene products control, etc.) and phenotypic activities such as altering the time of reproductive development. </paragraph>
<paragraph id="P-0137" lvl="0"><number>&lsqb;0137&rsqb;</number> Methods for introducing genetic mutations into plant genes are well known. For instance, seeds or other plant material can be treated with a mutagenic chemical substance, according to standard techniques. Such chemical substances include, but are not limited to, the following: diethyl sulfate, ethylene imine, ethyl methanesulfonate and N-nitroso-N-ethylurea. Alternatively, ionizing radiation from sources such as, for example, X-rays or gamma rays can be used. </paragraph>
<paragraph id="P-0138" lvl="0"><number>&lsqb;0138&rsqb;</number> Alternatively, homologous recombination can be used to induce targeted gene disruptions by specifically deleting or altering the target gene in vivo (see, generally, Grewal and Klar, <highlight><italic>Genetics </italic></highlight>146: 1221-1238 (1997) and Xu et al., <highlight><italic>Genes Dev. </italic></highlight>10:2411-2422 (1996)). Homologous recombination has been demonstrated in plants (Puchta et al., <highlight><italic>Experientia </italic></highlight>50:277-284 (1994), Swoboda et al., <highlight><italic>EMBO J. </italic></highlight>13:484-489 (1994); Offringa et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>90: 7346-7350 (1993); and Kempin et al. <highlight><italic>Nature </italic></highlight>389:802-803 (1997)). </paragraph>
<paragraph id="P-0139" lvl="0"><number>&lsqb;0139&rsqb;</number> In applying homologous recombination technology to the genes of the invention, mutations in selected portions of a gene sequences (including 5&prime; upstream, 3&prime; downstream, and intragenic regions) such as those disclosed here are made in vitro and then introduced into the desired plant using standard techniques. Since the efficiency of homologous recombination is known to be dependent on the vectors used, use of dicistronic gene targeting vectors as described by Mountford et al. <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>91:4303-4307 (1994); and Vaulont et al. <highlight><italic>Transgenic Res. </italic></highlight>4:247-255 (1995) are conveniently used to increase the efficiency of selecting for altered gene expression in transgenic plants. The mutated gene will interact with the target wild-type gene in such a way that homologous recombination and targeted replacement of the wild-type gene will occur in transgenic plant cells, resulting in suppression of gene product activity. </paragraph>
<paragraph id="P-0140" lvl="0"><number>&lsqb;0140&rsqb;</number> Alternatively, oligonucleotides composed of a contiguous stretch of RNA and DNA residues in a duplex conformation with double hairpin caps on the ends can be used. The RNA/DNA sequence is designed to align with the sequence of the target gene and to contain the desired nucleotide change. Introduction of the chimeric oligonucleotide on an extrachromosomal T-DNA plasmid results in efficient and specific gene conversion directed by chimeric molecules in a small number of transformed plant cells. This method is described in Cole-Strauss et al. <highlight><italic>Science </italic></highlight>273:1386-1389 (1996) and Yoon et al. <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>93:2071-2076 (1996). </paragraph>
<paragraph id="P-0141" lvl="0"><number>&lsqb;0141&rsqb;</number> Gene expression can be inactivated using recombinant DNA techniques by transforming plant cells with constructs comprising transposons or T-DNA sequences. Mutants prepared by these methods are identified according to standard techniques. For instance, mutants can be detected by PCR or by detecting the presence or absence of mRNA, e.g., by Northern blots. Mutants can also be selected by assaying for altered timing of the development of reproductive structures. </paragraph>
<paragraph id="P-0142" lvl="0"><number>&lsqb;0142&rsqb;</number> The isolated nucleic acid sequences prepared as described herein, can also be used in a number of techniques to control endogenous gene expression at various levels. Subsequences from the sequences disclosed here can be used to control, transcription, RNA accumulation, translation, and the like. </paragraph>
<paragraph id="P-0143" lvl="0"><number>&lsqb;0143&rsqb;</number> A number of methods can be used to inhibit gene expression in plants. For instance, antisense technology can be conveniently used. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the antisense strand of RNA will be transcribed. The construct is then transformed into plants and the antisense strand of RNA is produced. In plant cells, it has been suggested that antisense suppression can act at all levels of gene regulation including suppression of RNA translation (see, Bourque <highlight><italic>Plant Sci. </italic></highlight>(Limerick) 105:125-149 (1995); Pantopoulos In Progress in Nucleic Acid Research and Molecular Biology, Vol. 48. Cohn, W. E. and K. Moldave (Ed.). Academic Press, Inc.: San Diego, Calif., USA; London, England, UK. p. 181-238; Heiser et al. <highlight><italic>Plant Sci. </italic></highlight>(Shannon) 127:61-69 (1997)) and by preventing the accumulation of mRNA which encodes the protein of interest, (see, Baulcombe <highlight><italic>Plant Mol. Bio. </italic></highlight>32:79-88 (1996); Prins and Goldbach <highlight><italic>Arch. Virol. </italic></highlight>141:2259-2276 (1996); Metzlaf fet al. <highlight><italic>Cell </italic></highlight>88:845-854 (1997), Sheehy et al., <highlight><italic>Proc. Nat. Acad. Sci. USA, </italic></highlight>85:8805-8809 (1988), and Hiatt et al., U.S. Pat. No. 4,801,340). </paragraph>
<paragraph id="P-0144" lvl="0"><number>&lsqb;0144&rsqb;</number> The nucleic acid segment to be introduced generally will be substantially identical to at least a portion of the endogenous gene or genes to be repressed. The sequence, however, need not be perfectly identical to inhibit expression. The vectors of the present invention can be designed such that the inhibitory effect applies to other genes within a family of genes exhibiting homology or substantial homology to the target gene. </paragraph>
<paragraph id="P-0145" lvl="0"><number>&lsqb;0145&rsqb;</number> For antisense suppression, the introduced sequence also need not be full length relative to either the primary transcription product or fully processed mRNA. Generally, higher homology can be used to compensate for the use of a shorter sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and homology of non-coding segments may be equally effective. Normally, a sequence of between about 30 or 40 nucleotides and about full length nucleotides should be used, though a sequence of at least about 100 nucleotides is preferred, a sequence of at least about 200 nucleotides is more preferred, and a sequence of about 500 to about 7000 nucleotides is especially preferred. </paragraph>
<paragraph id="P-0146" lvl="0"><number>&lsqb;0146&rsqb;</number> A number of gene regions can be targeted to suppress gene expression. The targets can include, for instance, the coding regions, introns, sequences from exon/intron junctions, 5&prime; or 3&prime; untranslated regions, and the like. In some embodiments, the constructs can be designed to eliminate the ability of regulatory proteins to bind to gene sequences that are required for its cell- and/or tissue-specific expression. Such transcriptional regulatory sequences can be located either 5&prime;-, 3&prime;-, or within the coding region of the gene and can be either promote (positive regulatory element) or repress (negative regulatory element) gene transcription. These sequences can be identified using standard deletion analysis, well known to those of skill in the art. Once the sequences are identified, an antisense construct targeting these sequences is introduced into plants to control gene transcription in particular tissue, for instance, in developing ovules and/or seed. In one embodiment, transgenic plants are selected for activity that is reduced but not eliminated. </paragraph>
<paragraph id="P-0147" lvl="0"><number>&lsqb;0147&rsqb;</number> Oligonucleotide-based triple-helix formation can be used to disrupt gene expression. Triplex DNA can inhibit DNA transcription and replication, generate site-specific mutations, cleave DNA, and induce homologous recombination (see, e.g., Havre and Glazer <highlight><italic>J. Virology </italic></highlight>67:7324-7331 (1993); Scanlon et al. <highlight><italic>FASEB J. </italic></highlight>9:1288-1296 (1995); Giovannangeli et al <highlight><italic>Biochemistry </italic></highlight>35:10539-10548 (1996); Chan and Glazer <highlight><italic>J. Mol. Medicine </italic></highlight>(<highlight><italic>Berlin</italic></highlight>) 75:267-282 (1997)). Triple helix DNAs can be used to target the same sequences identified for antisense regulation. </paragraph>
<paragraph id="P-0148" lvl="0"><number>&lsqb;0148&rsqb;</number> Catalytic RNA molecules or ribozymes can also be used to inhibit expression of genes. It is possible to design ribozymes that specifically pair with virtually any target RNA and cleave the phosphodiester backbone at a specific location, thereby functionally inactivating the target RNA. In carrying out this cleavage, the ribozyme is not itself altered, and is thus capable of recycling and cleaving other molecules, making it a true enzyme. The inclusion of ribozyme sequences within antisense RNAs confers RNA-cleaving activity upon them, thereby increasing the activity of the constructs. Thus, ribozymes can be used to target the same sequences identified for antisense regulation. </paragraph>
<paragraph id="P-0149" lvl="0"><number>&lsqb;0149&rsqb;</number> A number of classes of ribozymes have been identified. One class of ribozymes is derived from a number of small circular RNAs which are capable of self-cleavage and replication in plants. The RNAs replicate either alone (viroid RNAs) or with a helper virus (satellite RNAs). Examples include RNAs from avocado sunblotch viroid and the satellite RNAs from tobacco ringspot virus, lucerne transient streak virus, velvet tobacco mottle virus, solanum nodiflorum mottle virus and subterranean clover mottle virus. The design and use of target RNA-specific ribozymes is described in Zhao and Pick <highlight><italic>Nature </italic></highlight>365:448-451 (1993); Eastham and Ahlering <highlight><italic>J. Urology </italic></highlight>156:1186-1188 (1996); Sokol and Murray <highlight><italic>Transgenic Res. </italic></highlight>5:363-371 (1996); Sun et al. <highlight><italic>Mol. Biotechnology </italic></highlight>7:241-251 (1997); and Haseloff et al. <highlight><italic>Nature, </italic></highlight>334:585-591 (1988). </paragraph>
<paragraph id="P-0150" lvl="0"><number>&lsqb;0150&rsqb;</number> Another method of suppression is sense cosuppression. Introduction of nucleic acid configured in the sense orientation has been recently shown to be an effective means by which to block the transcription of target genes. For an example of the use of this method to modulate expression of endogenous genes (see, Assaad et al. <highlight><italic>Plant Mol. Bio. </italic></highlight>22:1067-1085 (1993); Flavell <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>91:3490-3496 (1994); Stam et al. <highlight><italic>Annals Bot. </italic></highlight>79:3-12 (1997); Napoli et al., <highlight><italic>The Plant Cell </italic></highlight>2:279-289 (1990); and U.S. Pat. Nos. 5,034,323, 5,231,020, and 5,283,184). </paragraph>
<paragraph id="P-0151" lvl="0"><number>&lsqb;0151&rsqb;</number> The suppressive effect may occur where the introduced sequence contains no coding sequence per se, but only intron or untranslated sequences homologous to sequences present in the primary transcript of the endogenous sequence. The introduced sequence generally will be substantially identical to the endogenous sequence intended to be repressed. This minimal identity will typically be greater than about 65%, but a higher identity might exert a more effective repression of expression of the endogenous sequences. Substantially greater identity of more than about 80% is preferred, though about 95% to absolute identity would be most preferred. As with antisense regulation, the effect should apply to any other proteins within a similar family of genes exhibiting homology or substantial homology. </paragraph>
<paragraph id="P-0152" lvl="0"><number>&lsqb;0152&rsqb;</number> For sense suppression, the introduced sequence, needing less than absolute identity, also need not be full length, relative to either the primary transcription product or fully processed mRNA. This may be preferred to avoid concurrent production of some plants that are overexpressers. A higher identity in a shorter than full length sequence compensates for a longer, less identical sequence. Furthennore, the introduced sequence need not have the same intron or exon pattern, and identity of non-coding segments will be equally effective. Normally, a sequence of the size ranges noted above for antisense regulation is used. In addition, the same gene regions noted for antisense regulation can be targeted using cosuppression technologies. </paragraph>
<paragraph id="P-0153" lvl="0"><number>&lsqb;0153&rsqb;</number> In a preferred embodiment, expression of a nucleic acid of interest can be suppressed by the simultaneous expression of both sense and antisense constructs (Waterhouse et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>95:13959-13964 (1998). See also Tabara et al. <highlight><italic>Science </italic></highlight>282:430-431 (1998). </paragraph>
<paragraph id="P-0154" lvl="0"><number>&lsqb;0154&rsqb;</number> Alternatively, gene product activity may be modulated by eliminating the proteins that are required for cell-specific gene expression. Thus, expression of regulatory proteins and/or the sequences that control gene expression can be modulated using the methods described here. </paragraph>
<paragraph id="P-0155" lvl="0"><number>&lsqb;0155&rsqb;</number> Another method is use of engineered tRNA suppression of mRNA translation. This method involves the use of suppressor tRNAs to transactivate target genes containing premature stop codons (see, Betzner et al. <highlight><italic>Plant J. </italic></highlight>11:587-595 (1997); and Choisne et al. <highlight><italic>Plant J. </italic></highlight>11:597-604 (1997). A plant line containing a constitutively expressed gene that contains an amber stop codon is first created. Multiple lines of plants, each containing tRNA suppressor gene constructs under the direction of cell-type specific promoters are also generated. The tRNA gene construct is then crossed into the desired gene product line to activate activity in a targeted manner. These tRNA suppressor lines could also be used to target the expression of any type of gene to the same cell or tissue types. </paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> Proteins may form homogeneous or heterologous complexes in vivo. Thus, production of dominant-negative forms of polypeptides that are defective in their abilities to bind to other proteins in the complex is a convenient means to inhibit endogenous gene product activity. This approach involves transformation of plants with constructs encoding mutant polypeptides that form defective complexes and thereby prevent the complex from forming properly. The mutant polypeptide may vary from the naturally occurring sequence at the primary structure level by amino acid substitutions, additions, deletions, and the like. These modifications can be used in a number of combinations to produce the final modified protein chain. Use of dominant negative mutants to inactivate target genes is described in Mizukami et al. <highlight><italic>Plant Cell </italic></highlight>8:831-845 (1996). </paragraph>
<paragraph id="P-0157" lvl="0"><number>&lsqb;0157&rsqb;</number> Another strategy to affect the ability of a protein to interact with itself or with other proteins involves the use of antibodies specific to the protein. In this method cell-specific expression of specific Abs is used inactivate functional domains through antibody:antigen recognition (see, Hupp et al. <highlight><italic>Cell </italic></highlight>83:237-245 (1995)). </paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> After plants with reduced activity are identified, a recombinant construct capable of expressing low levels of the gene product can be introduced using the methods discussed below. In this fashion, the level of activity can be regulated to produce preferred plant phenotypes. For example, a relatively weak promoter such as the ubiquitin promoter (see, e.g., Garbarino et al. <highlight><italic>Plant Physiol. </italic></highlight>109(4):1371-8 (1995); Christensen et al <highlight><italic>Transgenic Res. </italic></highlight>5(3):213-8 (1996); and Holtorf et al. <highlight><italic>Plant. Mol. Biol. </italic></highlight>29(4):637-46 (1995)) is useful to produce plants with reduced levels of activity or expression. Such plants are useful for producing, for instance, plants with altered time of developing reproductive structures. </paragraph>
<paragraph id="P-0159" lvl="0"><number>&lsqb;0159&rsqb;</number> As disclosed herein, ectopic expression of a nucleic acid molecule encoding a floral meristem identity gene product in an angiosperm converts shoot meristem to floral meristem in the angiosperm. Furthermore, ectopic expression of a nucleic acid molecule encoding a floral meristem identity gene product such as AP1, CAL or LFY in an angiosperm prior to the time when endogenous floral meristem identity gene products are expressed in the angiosperm can convert shoot meristem to floral meristem precociously, resulting in early reproductive development in the angiosperm, as indicated by early flowering. In the same manner, ectopic expression of a nucleic acid molecule encoding AP1, CAL, or LFY, for example, in a gymnosperm prior to the time when endogenous floral meristem identity gene products are expressed in the gymnosperm results in early reproductive development in the gymnosperm. </paragraph>
<paragraph id="P-0160" lvl="0"><number>&lsqb;0160&rsqb;</number> For a given seed plant species and particular set of growth conditions, constitutive expression of a floral meristem identity gene product results in a relatively invariant time of early reproductive development, which is the earliest time when all factors necessary for reproductive development are active. For example, constitutive expression of AP1 in transgenic Arabidopsis plants grown under &ldquo;long-day&rdquo; light conditions results in early reproductive development at day 10 as compared to the normal time of reproductive development, which is day 18 in non-transgenic Arabidopsis plants grown under the same conditions. Thus, under these conditions, day 10 is the relatively invariant time of early reproductive development for Arabidopsis transgenics that constitutively express a floral meristem identity gene product. Similarly, transgenic plants constitutively expressing SEP3 result in plants that develop earlier reproductive structures than wild type plants. </paragraph>
<paragraph id="P-0161" lvl="0"><number>&lsqb;0161&rsqb;</number> However, in addition to methods of constitutively expressing a floral meristem identity gene product, the present invention provides methods of selecting the time of early reproductive development. As disclosed herein, floral meristem gene product expression or activity can be regulated in response to an inducing agent or cognate ligand, for example, such that the time of reproductive development can be selected. For example, in Arabidopsis transgenics grown under the conditions described above, the time of early reproductive development need not necessarily be the relatively invariant day 10 at which early reproductive development occurs as a consequence of constitutive floral meristem identity gene product expression. If floral meristem identity gene product expression is rendered dependent upon the presence of an inducing agent, early reproductive development can be selected to occur, for example, on day 14, by contacting the seed plant with an inducing agent on or slightly before day 14. </paragraph>
<paragraph id="P-0162" lvl="0"><number>&lsqb;0162&rsqb;</number> Thus, the present invention provides recombinant nucleic acid molecules, transgenic seed plant containing such recombinant nucleic acid molecules and methods for selecting the time of early reproductive development. These methods allow a farmer or horticulturist, for example, to determine the time of early reproductive development. The methods of the invention can be useful, for example, in allowing a grower to respond to an approaching storm or impending snap-freeze by selecting the time of early reproductive development such that the crop can be harvested before being harmed by the adverse weather conditions. The methods of the invention for selecting the time of early reproductive development also can be useful to spread out the time period over which transgenic seed plants are ready to be harvested. For example, the methods of the invention can be used to increase floral meristem identity gene product expression in different crop fields at different times, resulting in a staggered time of harvest for the different fields. </paragraph>
<paragraph id="P-0163" lvl="0"><number>&lsqb;0163&rsqb;</number> Thus, the present invention provides a recombinant nucleic acid molecule containing an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product. The floral meristem identity gene product encoded within a recombinant nucleic acid molecule of the invention can be, for example, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, AGL27, AP1 or CAL. In addition, the floral meristem identity gene product encoded within a recombinant nucleic acid molecule of the invention can be LFY. As disclosed herein, a recombinant nucleic acid molecule of the invention can contain an inducible regulatory element such as a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element. </paragraph>
<paragraph id="P-0164" lvl="7"><number>&lsqb;0164&rsqb;</number> VII. Inducible Regulatory Elements </paragraph>
<paragraph id="P-0165" lvl="0"><number>&lsqb;0165&rsqb;</number> The invention also provides a transgenic seed plant containing a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product. Such a transgenic seed plant can be an angiosperm or gymnosperm and can contain, for example, a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding AP1 or CAL. Similarly, the ectopic expression of the combination of at least one of AP1 and CALIFLOWER with at least one of SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 can be used to produce seed with various desirable phenotypes. A transgenic seed plant of the invention can contain, for example, a recombinant nucleic acid molecule comprising a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element operably linked to a nucleic acid molecule encoding AP1, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27. In addition, a transgenic seed plant of the invention can contain a recombinant nucleic acid molecule comprising a copper inducible element tetracycline inducible element, ecdysone inducible element or heat shock inducible element operably linked to a nucleic acid molecule encoding CAL. A transgenic seed plant of the invention also can contain a recombinant nucleic acid molecule comprising a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element operably linked to a nucleic acid molecule encoding LFY. </paragraph>
<paragraph id="P-0166" lvl="0"><number>&lsqb;0166&rsqb;</number> A particularly useful inducible regulatory element can be, for example, a copper-inducible promoter (Mett et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>90:4567-4571 (1993), which is incorporated herein by reference); tetracycline-inducible regulatory element (Gatz et al., <highlight><italic>Plant J. </italic></highlight>2:397-404 (1992); R&ouml;der et al., <highlight><italic>Mol. Gen. Genet. </italic></highlight>243:32-38 (1994), each of which is incorporated herein by reference); ecdysone inducible element (Christopherson et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>89:6314-6318 (1992), which is incorporated herein by reference); or heat shock inducible element (Takahashi et al., <highlight><italic>Plant Physiol. </italic></highlight>99:383-390 (1992), which is incorporated herein by reference). Another useful inducible regulatory element can be a lac operon element, which is used in combination with a constitutively expressed lac repressor to confer, for example, IPTG-inducible expression, as described by Wilde et al., (<highlight><italic>EMBO J. </italic></highlight>11:1251-1259 (1992), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0167" lvl="0"><number>&lsqb;0167&rsqb;</number> An inducible regulatory element useful in a method of the invention also can be, for example, a nitrate-inducible promoter derived from the spinach nitrite reductase gene (Back et al., <highlight><italic>Plant Mol. Biol. </italic></highlight>17:9 (1991), which is incorporated herein by reference) or a light-inducible promoter, such as that associated with the small subunit of RuBP carboxylase or the LHCP gene families (Feinbaum et al., <highlight><italic>Mol. Gen. Genet. </italic></highlight>226:449 (1991); Lam and Chua, <highlight><italic>Science </italic></highlight>248:471 (1990), each of which is incorporated herein by reference). An inducible regulatory element useful in constructing a transgenic seed plant also can be a salicylic acid inducible element (Uknes et al., <highlight><italic>Plant Cell </italic></highlight>5:159-169 (1993); Bi et al., <highlight><italic>Plant J. </italic></highlight>8:235-245 (1995), each of which is incorporated herein by reference) or a plant hormone-inducible element (Yamaguchi-Shinozaki et al., <highlight><italic>Plant Mol. Biol. </italic></highlight>15:905 (1990); Kares et al., <highlight><italic>Plant Mol. Biol. </italic></highlight>15:225 (1990), each of which is incorporated herein by reference). A human glucocorticoid response element also is an inducible regulatory element that can confer hormone-dependent gene expression in seed plants (Schena et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>88:10421 (1991), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0168" lvl="0"><number>&lsqb;0168&rsqb;</number> An inducible regulatory element that is particularly useful for increasing expression of a floral meristem identity gene product in a transgenic seed plant of the invention is a copper inducible regulatory element (see, for example, Mett et al., supra, 1993). Thus, the invention provides a recombinant nucleic acid molecule comprising a copper inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product and a transgenic seed plant containing such a recombinant nucleic acid molecule. Copper, which is a natural part of the nutrient environment of a seed plant, can be used to increase expression of a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a copper inducible regulatory element. For example, an ACE1 binding site in conjunction with constitutively expressed yeast ACE1 protein confers copper inducible expression upon an operably linked nucleic acid molecule. The ACE1 protein, a metalloresponsive transcription factor, is activated by copper or silver ions, resulting in increased expression of a nucleic acid molecule operably linked to an ACE1 element. </paragraph>
<paragraph id="P-0169" lvl="0"><number>&lsqb;0169&rsqb;</number> Such a copper inducible regulatory element can be an ACE1 binding site from the metallothionein gene promoter (SEQ ID NO: 21; Furst et al., <highlight><italic>Cell </italic></highlight>55:705-717 (1988), which is incorporated herein by reference). For example, the ACE1 binding site can be combined with the 90 base-pair domain A of the cauliflower mosaic virus 35S promoter and operably linked to a nucleic acid molecule encoding AP1, CAL or LFY to produce a recombinant nucleic acid molecule of the invention. In a transgenic seed plant constitutively expressing ACE1 under control of such a modified CaMV 35S promoter, for example, copper inducible expression is conferred upon an operably linked nucleic acid molecule encoding a floral meristem identity gene product. </paragraph>
<paragraph id="P-0170" lvl="0"><number>&lsqb;0170&rsqb;</number> The expression of a nucleic acid encoding a floral meristem identity gene product operably linked to a copper inducible regulatory element, such as 5&prime;-AGCTTAGCGATGCGTCTTTTCCGCTGAACCGTTCCAGCAAAAAAGACTAG-3&prime; (SEQ ID NO: 21), can be increased in a transgenic seed plant grown under copper ion-depleted conditions, for example, and contacted with 50 &mgr;M copper sulfate in a nutrient solution or with 0.5 &mgr;M copper sulfate applied by foliar spraying of the transgenic seed plant (see, for example, Mett et al., supra, 1993). A single application of 0.5 &mgr;M copper sulfate can be sufficient to sustain increased floral meristem identity gene product expression over a period of several days. If desired, a transgenic seed plant of the invention also can be contacted with multiple applications of an inducing agent such as copper sulfate. </paragraph>
<paragraph id="P-0171" lvl="0"><number>&lsqb;0171&rsqb;</number> An inducible regulatory element also can confer tetracycline-dependent floral meristem identity gene expression in a transgenic seed plant of the invention. Thus, the present invention provides a recombinant nucleic acid molecule comprising a tetracycline inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product as well as a transgenic seed plant into which such a recombinant nucleic acid molecule has been introduced. A tetracycline inducible regulatory element is particularly useful for conferring tightly regulated gene expression as indicated by the observation that a phenotype that results from even low amounts of a gene product expression is suppressed from such an inducible system in the absence of inducing agent (see, for example, R&ouml;der et al., supra, 1994). </paragraph>
<paragraph id="P-0172" lvl="0"><number>&lsqb;0172&rsqb;</number> A transgenic seed plant constitutively expressing Tn10-encoded Tet repressor (TetR), for example, can be contacted with tetracycline to increase expression of a nucleic acid molecule encoding a floral meristem identity gene product operably linked to the cauliflower mosaic virus promoter containing several tet operator sequences (5&prime;-ACTCTATCAGTGATAGAGT-3&prime;; SEQ ID NO: 22) positioned close to the TATA box (see, for example, Gatz, <highlight><italic>Meth. Cell Biol. </italic></highlight>50:411-424 (1995), which is incorporated herein by reference; Gatz et al., supra, 1992). Such a tetracycline-inducible system can increase expression of an operably linked nucleic acid molecule as much as 200 to 500-fold in a transgenic angiosperm or gymnosperm of the invention. </paragraph>
<paragraph id="P-0173" lvl="0"><number>&lsqb;0173&rsqb;</number> A high level of Tet repressor expression (about 1&times;10<highlight><superscript>6 </superscript></highlight>molecules per cell) is critical for tight regulation. Thus, a seed plant preferably is transformed first with a plasmid encoding the Tet repressor, and screened for high level expression. For example, plasmid pBinTet (Gatz, supra, 1995) contains the Tet repressor coding region, which is expressed under control of the CaMV 35S promoter, and the neomycin phosphotransferase gene for selection of transformants. To screen transformants for a high level of Tet repressor expression, a plasmid containing a reporter gene under control of a promoter with tet operators, such as pTX-Gus-int (Gatz, supra, 1995), can be transiently introduced into a seed plant cell and assayed for activity in the presence and absence of tetracycline. High &bgr;-glucouronidase (GUS) expression that is dependent on the presence of tetracycline is indicative of high Tet repressor expression. </paragraph>
<paragraph id="P-0174" lvl="0"><number>&lsqb;0174&rsqb;</number> A particularly useful tetracycline inducible regulatory element is present in plasmid pBIN-HygTX, which has a CaMV 35S promoter, into which three tet operator sites have been inserted, and an octopine synthase polyadenylation site (Gatz, supra, 1995). A multiple cloning site between the promoter and polyadenylation signal in pBIN-HygTX allows for convenient insertion of a nucleic acid molecule encoding the desired floral meristem identity gene product, and the hygromycin phosphotransferase gene allows for selection of transformants containing the construct. In a preferred embodiment of the invention, previously selected Tet repressor positive cells are transformed with a plasmid such as pBIN-HygTX, into which a nucleic acid molecule encoding a floral meristem identity gene product has been inserted. </paragraph>
<paragraph id="P-0175" lvl="0"><number>&lsqb;0175&rsqb;</number> To increase floral meristem identity gene product expression using a tetracycline-inducible regulatory element, a transgenic seed plant of the invention can be contacted with tetracycline or, preferably, with chlor-tetracycline (SIGMA), which is a more efficient inducer than tetracycline. In addition, a useful inducing agent can be a tetracycline analog that binds the Tet repressor to function as an inducer but that does not act as an antibiotic (Gatz, supra, 1995). A transgenic seed plant of the invention can be contacted, for example, by watering with about 1 mg/liter chlor-tetracycline or tetracycline. Similarly, a plant grown in hydroponic culture can be contacted with a solution containing about 1 mg/liter chlor-tetracycline or tetracycline (Gatz, supra, 1995). If desired, a transgenic angiosperm or gymnosperm can be contacted repeatedly with chlor-tetracycline or tetracycline every other day for about 10 days (R&ouml;der et al., supra, 1994). Floral meristem identity gene product expression is increased efficiently at a tetracycline concentration that does not inhibit the growth of bacteria, indicating that the use of tetracycline as an inducing agent will not present environmental concerns. </paragraph>
<paragraph id="P-0176" lvl="0"><number>&lsqb;0176&rsqb;</number> An ecdysone inducible regulatory element also can be useful in practicing the methods of the invention. For example, an ecdysone inducible regulatory element can contain four copies of an ecdysone response element having the sequence 5&prime;-GATCCGACAAGGGTTCAATGCACTTGTCA-3&prime; (EcRE; SEQ ID NO: 23) as described in Christopherson et al., supra, 1992. In a transgenic seed plant into which a nucleic acid encoding an ecdysone receptor has been introduced, an ecdysone inducible regulatory element can confer ecdysone-dependent expression on a nucleic acid molecule encoding a floral meristem identity gene product. An appropriate inducing agent for increasing expression of a nucleic acid molecule operably linked to an ecdysone inducible regulatory element can be, for example, &forall;-ecdysone, 20-hydroxyecdysone, polypodine B, ponasterone A, muristerone A or RH-5992, which is an ecdysone agonist that mimics 20-hydroxyecdysone (see, for example, Kreutzweiser et al., <highlight><italic>Ecotoxicol. Environ. Safety </italic></highlight>28:14-24 (1994), which is incorporated herein by reference and Christopherson et al., supra, 1992). Methods for determining an appropriate inducing agent for use with an ecdysone inducible regulatory element are well known in the art. As disclosed herein, compound RH-5992 can be a particularly useful inducing agent for increasing floral meristem gene product expression in a transgenic seed plant containing an ecdysone inducible regulatory element. </paragraph>
<paragraph id="P-0177" lvl="0"><number>&lsqb;0177&rsqb;</number> An inducible regulatory element also can be derived from the promoter of a heat shock gene, such as HSP81-1 (SEQ ID NO: 24; Takahashi, supra, 1992). Thus, the invention also provides a recombinant nucleic acid molecule comprising a heat shock inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product and a transgenic seed plant containing such a recombinant nucleic acid molecule. The HSP81-1 promoter (SEQ ID NO: 24) confers low level expression upon an operably linked nucleic acid molecule in parts of roots under unstressed conditions and confers high level expression in most Arabidopsis tissues following heat shock (see, for example, Yabe et al., <highlight><italic>Plant Cell Physiol. </italic></highlight>35:1207-1219 (1994), which is incorporated herein by reference). After growth of Arabidopsis at 23EC, a single heat shock treatment at 37EC for two hours is sufficient to induce expression of a nucleic acid molecule operably linked to the HSP81-1 gene regulatory element (see Ueda et al., <highlight><italic>Mol. Gen. Genet. </italic></highlight>250:533-539 (1996), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0178" lvl="0"><number>&lsqb;0178&rsqb;</number> The use of a heat shock inducible regulatory element is particularly useful for a transgenic seed plant of the invention grown in an enclosed environment such as a green house, where temperature can be readily manipulated. The use of a heat shock inducible regulatory element especially is applicable to a transplantable or potted transgenic seed plant of the invention, which can be moved conveniently from an environment having a low temperature to an environment having a high temperature. A transgenic angiosperm or gymnosperm of the invention containing a recombinant nucleic acid molecule comprising a HSP81-1 heat shock regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product also can be induced, for example, by altering the ambient temperature, watering with heated water or submersing the transgenic seed plant in a sealed plastic bag into a heated water bath (see, for example, Ueda et al., supra, 1996). </paragraph>
<paragraph id="P-0179" lvl="0"><number>&lsqb;0179&rsqb;</number> A recombinant nucleic acid molecule of the invention comprising an inducible gene regulatory element can be expressed variably in different lines of transgenic seed plants. In some transgenic lines, for example, leaky expression of the introduced recombinant nucleic acid molecule can occur in the absence of the appropriate inducing agent due to phenomena such as position effects (see, for example, Ueda et al., supra, 1996). Thus, a transgenic seed plant containing a recombinant nucleic acid molecule comprising an inducible gene regulatory element operably linked to a nucleic acid encoding a floral meristem identity gene product can be screened, if desired, to obtain a particular transgenic seed plant in which expression of the operably linked nucleic acid molecule is desirably low in the absence of the appropriate inducing agent. </paragraph>
<paragraph id="P-0180" lvl="0"><number>&lsqb;0180&rsqb;</number> The present invention also provides a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product to produce a transgenic angiosperm, and contacting the transgenic angiosperm with an inducing agent, thereby increasing expression of the floral meristem identity gene product and converting shoot meristem to floral meristem in the transgenic angiosperm. In such a method of the invention, the inducible regulatory element can be, for example, a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element, and the floral meristem identity gene product can be, for example, AP1, CAL, LFY, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27. </paragraph>
<paragraph id="P-0181" lvl="0"><number>&lsqb;0181&rsqb;</number> In addition, the invention provides a method of promoting early reproductive development in a seed plant such as an angiosperm or gymnosperm by introducing into the seed plant a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product to produce a transgenic seed plant, and contacting the transgenic seed plant with an inducing agent, thereby increasing expression of the floral meristem identity gene product and promoting early reproductive development in the transgenic seed plant. In a method of the invention for promoting early reproductive development in a seed plant, the inducible regulatory element can be, for example, a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element, and the floral meristem identity gene product can be, for example, AP1, CAL, LFY, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27. </paragraph>
<paragraph id="P-0182" lvl="0"><number>&lsqb;0182&rsqb;</number> The term &ldquo;inducing agent,&rdquo; as used herein, means a substance or condition that effects increased expression of a nucleic acid molecule operably linked to a particular inducible regulatory element as compared to the level of expression of the nucleic acid molecule in the absence of the inducing agent. An inducing agent can be, for example, a naturally occurring or synthetic chemical or biological molecule such as a simple or complex organic molecule, a peptide, a protein or an oligonucleotide that increases expression of a nucleic acid molecule operably linked to a particular inducible regulatory element. An example of such an inducing agent is a compound such as copper sulfate, tetracycline or an ecdysone. An inducing agent also can be a condition such as heat of a certain temperature or light of a certain wavelength. When used in reference to a particular inducible regulatory element, an &ldquo;appropriate&rdquo; inducing agent means an inducing agent that results in increased expression of a nucleic acid molecule operably linked to the particular inducible regulatory element. </paragraph>
<paragraph id="P-0183" lvl="0"><number>&lsqb;0183&rsqb;</number> An inducing agent of the invention can be used alone or in solution or can be used in conjunction with an acceptable carrier that can serve to stabilize the inducing agent or to promote absorption of the inducing agent by a seed plant. If desired, a transgenic seed plant of the invention can be contacted with an inducing agent in combination with an unrelated substance such as a plant nutrient, pesticide or insecticide. </paragraph>
<paragraph id="P-0184" lvl="0"><number>&lsqb;0184&rsqb;</number> One skilled in the art can readily determine the optimum concentration of an inducing agent needed to produce increased expression of a nucleic acid molecule operably linked to an inducible regulatory element in a transgenic seed plant of the invention. For conveniently determining the optimum concentration of inducing agent from a range of useful concentrations, one skilled in the art can operably link the particular inducible regulatory element to a nucleic acid molecule encoding a reporter gene product such as &bgr;-glucouronidase (GUS) and assay for reporter gene product activity in the presence of various concentrations of inducing agent (see, for example, Jefferson et al., <highlight><italic>EMBO J. </italic></highlight>6:3901-3907 (1987), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0185" lvl="0"><number>&lsqb;0185&rsqb;</number> As used herein, the term &ldquo;contacting,&rdquo; in reference to a transgenic seed plant of the invention, means exposing the transgenic seed plant to an inducing agent, or to a cognate ligand as disclosed below, such that the agent can induce expression of a nucleic acid molecule operably linked to the particular inducible regulatory element. A transgenic seed plant such as an angiosperm or gymnosperm, which contains a recombinant nucleic acid molecule of the invention, can be contacted with an inducing agent in a variety of manners. Expression of a floral meristem identity gene product can be increased conveniently, for example, by spraying a transgenic seed plant with an aqueous solution containing an appropriate inducing agent or by adding an appropriate inducing agent to the water supply of a transgenic seed plant grown using irrigation or to the water supply of a transgenic seed plant grown hydroponically. A transgenic seed plant containing a recombinant nucleic acid molecule of the invention also can be contacted by spraying the seed plant with an inducing agent in aerosol form. In addition, a transgenic seed plant can be contacted with an appropriate inducing agent by adding the agent to the soil or other solid nutrient media in which the seed plant is grown, whereby the inducing agent is absorbed into the seed plant. Other modes of contacting a transgenic seed plant with an inducing agent, such as injecting or immersing the seed plant in a solution containing an inducing agent, are well known in the art. For an inducing agent that is temperature or light, for example, contacting can be effected by altering the temperature or light to which the transgenic seed plant is exposed, or, if desired, by moving the transgenic seed plant from an environment of one temperature or light source to an environment having the appropriate inducing temperature or light source. </paragraph>
<paragraph id="P-0186" lvl="0"><number>&lsqb;0186&rsqb;</number> If desired, a transgenic seed plant of the invention can be contacted individually with an inducing agent. Furthermore, a group of transgenic seed plants that, for example, are located together in a garden plot, hot house or field, can be contacted en masse with an inducing agent, such that floral meristem identity gene product expression is increased coordinately in all transgenic seed plants of the group. </paragraph>
<paragraph id="P-0187" lvl="0"><number>&lsqb;0187&rsqb;</number> A transgenic seed plant of the invention can be contacted with an inducing agent using one of several means. For example, a transgenic seed plant can be contacted with an inducing agent by non-automated means such as with a hand held spraying apparatus. Such manual means can be useful when the methods of the invention are applied to particularly delicate or valuable seed plant varieties or when it is desirable, for example, to promote early reproductive development in a particular transgenic seed plant without promoting early reproductive development in a neighboring transgenic seed plant. Furthermore, a transgenic seed plant of the invention can be contacted with an inducing agent by mechanical means such as with a conventional yard &ldquo;sprinkler&rdquo; for a transgenic seed plant grown, for example, in a garden; a mechanical spraying system in a green house; traditional farm machinery for spraying field crops; or &ldquo;crop dusting&rdquo; for conveniently contacting an entire field of transgenic seed plants with a particulate or gaseous inducing agent. The skilled practitioner, whether home gardener or commercial farmer, recognizes that these and other manual or mechanical means can be used to contact a transgenic seed plant with an inducing agent according to the methods of the invention. </paragraph>
<paragraph id="P-0188" lvl="0"><number>&lsqb;0188&rsqb;</number> Furthermore, it is recognized that a transgenic seed plant of the invention can be contacted with a single treatment of an inducing agent or, if desired, can be contacted with multiple applications of the inducing agent. In a preferred embodiment of the invention, a transgenic seed plant of the invention is contacted once with an inducing agent to effectively increase floral meristem identity gene product expression, thereby promoting early reproductive development in the transgenic seed plant. Similarly, a transgenic angiosperm of the invention preferably is contacted once with an inducing agent to effectively increase floral meristem identity gene product expression and convert shoot meristem to floral meristem in the transgenic angiosperm. </paragraph>
<paragraph id="P-0189" lvl="0"><number>&lsqb;0189&rsqb;</number> A single application of an inducing agent is preferable when a transient increase in floral meristem identity gene product expression from a recombinant nucleic acid molecule of the invention promotes irreversible early reproductive development in a seed plant. In many seed plant species, early reproductive development is irreversible. Transient expression of a floral meristem identity gene product from an introduced recombinant nucleic acid molecule, for example, results in sustained ectopic expression of endogenous floral meristem identity gene products, resulting in irreversible early reproductive development. For example, ectopic expression of AP1 in a transgenic plant induces endogenous LFY gene expression, and ectopic expression of LFY induces endogenous AP1 gene expression (Mandel and Yanofsky, <highlight><italic>Nature </italic></highlight>377:522-524 (1995), which is incorporated herein by reference; Weigel and Nilsson, supra, 1995). Genetic studies also indicate that CAL can act directly or indirectly to increase expression of AP1 and LFY. Thus, ectopic expression of CAL from an exogenous nucleic acid molecule, for example, can induce endogenous AP1 and LFY expression (see Bowman et al., supra, 1993). Enhanced expression of endogenous AP1, LFY or CAL following a transient increase in expression of an introduced floral meristem identity gene product induced by a single application of an inducing agent can make repeated applications of an inducing agent unnecessary. </paragraph>
<paragraph id="P-0190" lvl="0"><number>&lsqb;0190&rsqb;</number> In some seed plants, however, such as angiosperms characterized by the phenomenon of floral reversion, repeated applications of the inducing agent can be desirable. In species such as impatiens, an initiated flower can revert into a shoot such that the center of the developing flower behaves as an indeterminate shoot (see, for example, Battey and Lyndon, <highlight><italic>Ann. Bot. </italic></highlight>61:9-16 (1988), which is incorporated by reference herein). Thus, to prevent floral reversion in species such as impatiens, repeated applications of an inducing agent can be useful. Repeated applications of an inducing agent, as well as single applications, are encompassed within the scope of the present invention. </paragraph>
<paragraph id="P-0191" lvl="7"><number>&lsqb;0191&rsqb;</number> VIII. Chimeric Polypepides of the Invention </paragraph>
<paragraph id="P-0192" lvl="0"><number>&lsqb;0192&rsqb;</number> The invention further provides a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding a floral meristem identity gene product such as SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, AGL27, AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a ligand binding domain. Expression of a chimeric protein of the invention in a seed plant is useful because the ligand binding domain renders the activity of a linked gene product dependent on the presence of cognate ligand. Specifically, in a chimeric protein of the invention, floral meristem gene product activity is increased in the presence of cognate ligand, as compared to activity in the absence of cognate ligand. </paragraph>
<paragraph id="P-0193" lvl="0"><number>&lsqb;0193&rsqb;</number> A nucleic acid molecule encoding a chimeric protein of the invention comprises a nucleic acid molecule encoding a floral meristem identity gene product, such as a nucleic acid molecule having the nucleic acid sequence SEQ ID NO: 1, SEQ ID NO: 9, SEQ ID NO: 15, SEQ ID NO: 27, SEQ ID NO: 29, SEQ ID NO: 31, SEQ ID NO: 33, SEQ ID NO: 35, SEQ ID NO: 37, SEQ ID NO: 39, which encode AP1, CAL, LFY, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 and AGL27, respectively, any of which is linked in frame to a nucleic acid molecule encoding a ligand binding domain. The expression of such a nucleic acid molecule results in the production of a chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain. Thus, the invention also provides a chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain and an antibody that specifically binds such a chimeric protein. </paragraph>
<paragraph id="P-0194" lvl="0"><number>&lsqb;0194&rsqb;</number> The invention further provides a transgenic seed plant, such as angiosperm or gymnosperm, that contains a nucleic acid molecule encoding a chimeric protein of the invention. The invention provides, for example, a transgenic seed plant containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a ligand binding domain. A particularly useful transgenic seed plant contains a nucleic acid molecule encoding AP1 linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain or a glucocorticoid receptor ligand binding domain. The invention also provides a transgenic seed plant containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding CAL linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain or a glucocorticoid receptor ligand binding domain. In addition, there is provided a transgenic seed plant containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding LFY linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain or a glucocorticoid receptor ligand binding domain. </paragraph>
<paragraph id="P-0195" lvl="0"><number>&lsqb;0195&rsqb;</number> Any floral meristem identity gene product, as defined herein, is useful in a chimeric protein of the invention. Thus, a nucleic acid molecule encoding <highlight><italic>Arabidopsis thaliana </italic></highlight>AP1 (SEQ ID NO: 2), <highlight><italic>Brassica oleracea </italic></highlight>AP1 (SEQ ID NO: 4), <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>Botrytis </italic></highlight>AP1 (SEQ ID NO: 8) or <highlight><italic>Zea mays </italic></highlight>AP1 (SEQ ID NO: 10), each of which have activity in converting shoot meristem to floral meristem, can be used to construct a nucleic acid molecule encoding a chimeric protein of the invention. Similarly, a nucleic acid molecule encoding, for example, <highlight><italic>Arabidopsis thaliana </italic></highlight>CAL (SEQ ID NO: 10), <highlight><italic>Brassica oleracea </italic></highlight>CAL (SEQ ID NO: 12), or a nucleic acid molecule encoding <highlight><italic>Arabidopsis thaliana </italic></highlight>LFY (SEQ ID NO: 16) is useful when linked in frame to a nucleic acid molecule encoding a ligand binding domain to produce a nucleic acid molecule encoding a ligand-dependent chimeric protein of the invention. Similarly, nucleic acids encoding SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 can be operably linked to a nucleic acid encoding a ligand binding domain. </paragraph>
<paragraph id="P-0196" lvl="0"><number>&lsqb;0196&rsqb;</number> A ligand binding domain useful in a chimeric protein of the invention is a domain that, when fused in frame to a heterologous gene product, renders the activity of the fused gene product dependent on cognate ligand such that the activity of the fused gene product is increased in the presence of cognate ligand as compared to its activity in the absence of ligand. Such a ligand binding domain can be a steroid binding domain such as the ligand binding domain of an ecdysone receptor, glucocorticoid receptor, estrogen receptor, progesterone receptor, androgen receptor, thyroid receptor, vitamin D receptor or retinoic acid receptor. A particularly useful ligand binding domain is the ecdysone receptor ligand binding domain contained within amino acids 329 to 878 of the Drosophila ecdysone receptor (SEQ ID NO: 18); Koelle et al., <highlight><italic>Cell </italic></highlight>67:59-77 (1991); Thummel, <highlight><italic>Cell </italic></highlight>83:871-877 (1995), each of which is incorporated herein by reference) or a glucocorticoid receptor ligand binding domain, encompassed, for example, within amino acids 512 to 795 of the rat glucocorticoid receptor (SEQ ID NO: 20; Miesfeld et al., <highlight><italic>Cell </italic></highlight>46:389-399 (1986), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0197" lvl="0"><number>&lsqb;0197&rsqb;</number> A chimeric protein of the invention containing an ecdysone receptor ligand binding domain has floral meristem identity gene product activity that can be increased in the presence of ecdysone ligand. Similarly, a chimeric protein of the invention containing a glucocorticoid receptor ligand binding domain has floral meristem identity gene product activity that is increased in the presence of glucocorticoid ligand. It is well known that in a chimeric protein containing a heterologous gene product such as adenovirus E1A, c-myc, c-fos, the HIV-1 Rev transactivator, MyoD or maize regulatory factor R fused to the rat glucocorticoid receptor ligand binding domain, activity of the fused heterologous gene product can be increased by glucocorticoid ligand (Eilers et al., <highlight><italic>Nature </italic></highlight>340:66 (1989); Superti-Furga et al., <highlight><italic>Proc. Natl. Acad. Sci., U.S.A. </italic></highlight>88:5114 (1991); Hope et al., <highlight><italic>Proc. Natl. Acad. Sci., U.S.A. </italic></highlight>87:7787 (1990); Hollenberg et al., <highlight><italic>Proc. Natl. Acad. Sci., U.S.A. </italic></highlight>90:8028 (1993), each of which is incorporated herein by reference). </paragraph>
<paragraph id="P-0198" lvl="0"><number>&lsqb;0198&rsqb;</number> A nucleic acid molecule encoding a chimeric protein of the invention can be introduced into a seed plant where, under appropriate conditions, the chimeric protein is expressed. In such a transgenic seed plant, floral meristem identity gene product activity can be increased by contacting the transgenic seed plant with cognate ligand. For example, activity of a heterologous protein fused to a rat glucocorticoid receptor ligand binding domain (amino acids 512 to 795) expressed under the control of the constitutive cauliflower mosaic virus 35S promoter in Arabidopsis was low in the absence of glucocorticoid ligand; whereas, upon contacting the transformed plants with a synthetic glucocorticoid, dexamethasone, activity of the protein was increased greatly (Lloyd et al., <highlight><italic>Science </italic></highlight>266:436-439 (1994), which is incorporated herein by reference). As disclosed herein, a ligand binding domain fused to a floral meristem identity gene product renders the activity of a fused floral meristem identity gene product ligand-dependent such that, upon contacting the transgenic seed plant with cognate ligand, floral meristem identity gene product activity is increased. </paragraph>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> Methods for constructing a nucleic acid molecule encoding a chimeric protein of the invention are routine and well known in the art (Sambrook et al., supra, 1989). Methods of constructing, for example, a nucleic acid encoding an AP1-glucocorticoid receptor ligand binding domain chimeric protein are described in Example IV of WO 97/46078. For example, the skilled artisan recognizes that a stop codon encoded by the nucleic acid molecule must be removed and that the two nucleic acid molecules must be linked in frame such that the reading frame of the 3&prime; nucleic acid molecule coding sequence is preserved. Methods of transforming a seed plant such as an angiosperm or gymnosperm with a nucleic acid molecule are disclosed above and well known in the art (see Examples I, II and III of WO 97/46078; see, also, Mohoney et al., U.S. Pat. No. 5,463,174, and Barry et al., U.S. Pat. No. 5,463,175, each of which is incorporated herein by reference). </paragraph>
<paragraph id="P-0200" lvl="0"><number>&lsqb;0200&rsqb;</number> As used herein, the term &ldquo;linked in frame,&rdquo; when used in reference to two nucleic acid molecules that make up a nucleic acid molecule encoding a chimeric protein, means that the two nucleic acid molecules are linked in the correct reading frame such that, under appropriate conditions, a full-length chimeric protein is expressed. In particular, a 5&prime; nucleic acid molecule, which encodes the amino-terminal portion of the chimeric protein, must be linked to a 3&prime; nucleic acid molecule, which encodes the carboxyl-terminal portion of the chimeric protein, such that the carboxyl-terminal portion of the chimeric protein is translated in the correct reading frame. One skilled in the art would recognize that a nucleic acid molecule encoding a chimeric protein of the invention can comprise, for example, a 5&prime; nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a 3&prime; nucleic acid molecule encoding a ligand binding domain or can comprise a 5&prime; nucleic acid molecule encoding a ligand binding domain linked in frame to a 3&prime; nucleic acid molecule encoding a floral meristem identity gene product. Preferably, a nucleic acid molecule encoding a chimeric protein of the invention comprises a 5&prime; nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a 3&prime; nucleic acid molecule encoding a ligand binding domain. </paragraph>
<paragraph id="P-0201" lvl="0"><number>&lsqb;0201&rsqb;</number> In a transgenic angiosperm containing a chimeric protein of the invention, conversion of shoot meristem to floral meristem can be induced by contacting the transgenic angiosperm with a cognate ligand that is absorbed by the angiosperm and binds the chimeric protein within its ligand binding domain. Thus, the present invention provides a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a nucleic acid molecule encoding a chimeric protein to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain is expressed; and contacting the transgenic angiosperm with cognate ligand, where, upon binding of the cognate ligand to the ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm. </paragraph>
<paragraph id="P-0202" lvl="0"><number>&lsqb;0202&rsqb;</number> The present invention provides, for example, a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, AGL27, AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain, to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic angiosperm with ecdysone ligand, where, upon binding of the ecdysone ligand to the ecdysone receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm. Similarly, the invention provides, for example, a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, AGL27, AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a glucocorticoid receptor ligand binding domain, to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic angiosperm with glucocorticoid ligand, where, upon binding of the glucocorticoid ligand to the glucocorticoid receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm. </paragraph>
<paragraph id="P-0203" lvl="0"><number>&lsqb;0203&rsqb;</number> In addition, the invention provides a method of promoting early reproductive development in a seed plant by introducing into the seed plant a nucleic acid molecule encoding a chimeric protein of the invention to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain is expressed; and contacting the transgenic seed plant with cognate ligand, where, upon binding of the cognate ligand to the ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant. The methods of the invention can be practiced with numerous seed plant varieties. The seed plant can be, for example, an angiosperm such as a cereal plant, leguminous plant, hardwood tree or coffee plant, or can be a gymnosperm such as a pine, fir, spruce or redwood tree. </paragraph>
<paragraph id="P-0204" lvl="0"><number>&lsqb;0204&rsqb;</number> There is provided, for example, a method of promoting early reproductive development in a seed plant by introducing into the seed plant a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain, to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic seed plant with ecdysone ligand, where, upon binding of the ecdysone ligand to the ecdysone receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant. Similarly, the invention provides, for example, a method of promoting early reproductive development in a seed plant by introducing into the seed plant a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding AP1, CAL, LFY, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 linked in frame to a nucleic acid molecule encoding a glucocorticoid receptor ligand binding domain, to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic seed plant with glucocorticoid ligand, where, upon binding of the glucocorticoid ligand to the glucocorticoid receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant. </paragraph>
<paragraph id="P-0205" lvl="0"><number>&lsqb;0205&rsqb;</number> As used herein, the term &ldquo;ligand&rdquo; means a naturally occurring or synthetic chemical or biological molecule such as a simple or complex organic molecule, a peptide, a protein or an oligonucleotide that specifically binds a ligand binding domain. In the methods of the present invention, a ligand can be used alone or in solution or can be used in conjunction with an acceptable carrier that can serve to stabilize the ligand or promote absorption of the ligand by a seed plant. If desired, a transgenic seed plant of the invention can be contacted with a ligand for increasing floral meristem identity gene product activity in combination with an unrelated molecule such as a plant nutrient, pesticide or insecticide. When used in reference to a particular ligand binding domain, the term &ldquo;cognate ligand&rdquo; means a ligand that, under suitable conditions, specifically binds the particular ligand binding domain. </paragraph>
<paragraph id="P-0206" lvl="0"><number>&lsqb;0206&rsqb;</number> One skilled in the art readily can determine the optimum concentration of cognate ligand needed to bind a ligand binding domain and increase floral meristem identity gene product activity in a transgenic seed plant of the invention. Generally, a concentration of about 1 nM to 10 &mgr;M cognate ligand is useful for increasing floral meristem identity gene product activity in a transgenic seed plant expressing a chimeric protein of the invention. Preferably, a concentration of about 100 nM to 1 &mgr;M cognate ligand is useful for increasing floral meristem identity gene product activity in a transgenic seed plant containing a chimeric protein of the invention (see, for example, Christopherson et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>89:6314-6318 (1992), which is incorporated herein by reference; also, see Lloyd et al., supra, 1994). For example, a concentration of about 100 nM to 1 &mgr;M dexamethasone can be useful for increasing floral meristem identity gene product activity in a transgenic seed plant of the invention containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding a floral meristem identity gene product, such as AP1, CAL, LFY, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 linked in frame to a nucleic acid molecule encoding a glucocorticoid receptor ligand binding domain. </paragraph>
<paragraph id="P-0207" lvl="0"><number>&lsqb;0207&rsqb;</number> As discussed above, a transgenic seed plant of the invention, such as a transgenic seed plant expressing a chimeric protein of the invention, can be contacted in a variety of manners. A transgenic seed plant can be contacted with cognate ligand, for example, by spraying the seed plant with a gaseous ligand or with solution such as an aqueous solution containing the appropriate ligand; or by adding the cognate ligand to the water supply of a seed plant grown using irrigation or grown hydroponically; or by adding the cognate ligand to the soil or other solid nutrient medium in which a seed plant is grown, whereby the cognate ligand is absorbed into the seed plant to increase floral meristem identity gene product activity. A transgenic seed plant expressing a chimeric protein of the invention also can be contacted with a cognate ligand in aerosol form. In addition, a transgenic seed plant can be contacted with cognate ligand by injecting the seed plant or by immersing the seed plant in a solution containing the cognate ligand. </paragraph>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> A transgenic seed plant expressing a chimeric protein of the invention can be contacted individually with cognate ligand, or a group of transgenic seed plants can be contacted en masse to increase floral meristem gene product activity synchronously in all seed plants of the group. Furthermore, a variety of means can be used to contact a transgenic seed plant of the invention with cognate ligand to increase floral meristem identity gene product activity. A transgenic seed plant can be contacted with cognate ligand using, for example, a hand held spraying apparatus; conventional yard &ldquo;sprinkler&rdquo;; mechanical spraying system, such as an overhead spraying system in a green house; traditional farm machinery, or &ldquo;crop dusting.&rdquo; As discussed above in regard to the application of inducing agents, the methods of the invention can be practiced using these and other manual or mechanical means to contact a transgenic seed plant with single or multiple applications of cognate ligand. </paragraph>
<paragraph id="P-0209" lvl="7"><number>&lsqb;0209&rsqb;</number> IX. Nucleic Acid Molecules of the Invention </paragraph>
<paragraph id="P-0210" lvl="0"><number>&lsqb;0210&rsqb;</number> Generally, the nomenclature and the laboratory procedures in recombinant DNA technology described below are those well known and commonly employed in the art. Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA polymerase, restriction endonucleases and the like are performed according to the manufacturer&apos;s specifications. These techniques and various other techniques are generally performed according to Sambrook et al., <highlight><italic>Molecular Cloning&mdash;A Laboratory Manual, </italic></highlight>Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., (1989). </paragraph>
<paragraph id="P-0211" lvl="0"><number>&lsqb;0211&rsqb;</number> The isolation of nucleic acids may be accomplished by a number of techniques. For instance, oligonucleotide probes based on the sequences disclosed here can be used to identify the desired gene in a cDNA or genomic DNA library. To construct genomic libraries, large segments of genomic DNA are generated by random fragmentation, e.g. using restriction endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector. To prepare a cDNA library, mRNA is isolated from the desired organ, such as a floral organ, and a cDNA library which contains the gene transcript of interest is prepared from the mRNA. Alternatively, cDNA may be prepared from mRNA extracted from other tissues in which genes of the invention or homologs are expressed. </paragraph>
<paragraph id="P-0212" lvl="0"><number>&lsqb;0212&rsqb;</number> The cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned nucleic acid disclosed here. Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species. Alternatively, antibodies raised against an polypeptide can be used to screen an mRNA expression library. </paragraph>
<paragraph id="P-0213" lvl="0"><number>&lsqb;0213&rsqb;</number> Alternatively, the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques. For instance, polymerase chain reaction (PCR) technology can be used to amplify the sequences of the nucleic acid of the invention directly from genomic DNA, from cDNA, from genomic libraries or cDNA libraries. PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes. For a general overview of PCR see <highlight><italic>PCR Protocols: A Guide to Methods and Applications. </italic></highlight>(Innis, M, Gelfand, D., Sninsky, J. and White, T., eds.), <highlight><italic>Academic Press, </italic></highlight>San Diego (1990). Appropriate primers and probes for identifying sequences from plant tissues are generated from comparisons of the sequences provided here with other related genes. </paragraph>
<paragraph id="P-0214" lvl="0"><number>&lsqb;0214&rsqb;</number> The present invention also provides novel substantially purified nucleic acid molecules encoding gene products including AP1, CAL, LFY, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, and AGL27. For example, the invention provides a substantially purified nucleic acid molecule encoding <highlight><italic>Brassica oleracea </italic></highlight>AP1 having the amino acid sequence SEQ ID NO:4; a substantially purified nucleic acid molecule encoding <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 having the amino acid sequence SEQ ID NO:6; or a substantially purified nucleic acid molecule encoding <highlight><italic>Zea mays </italic></highlight>AP1 having the amino acid sequence SEQ ID NO: 8. In addition, the invention provides a substantially purified nucleic acid molecule that encodes a <highlight><italic>Brassica oleracea </italic></highlight>AP1, <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 or <highlight><italic>Zea mays </italic></highlight>AP1 and that contains additional 5&prime; or 3&prime; noncoding sequence. For example, a substantially purified nucleic acid molecule having a nucleotide sequence such as SEQ ID NO:3, SEQ ID NO:5 or SEQ ID NO:7 is provided. </paragraph>
<paragraph id="P-0215" lvl="0"><number>&lsqb;0215&rsqb;</number> The invention also provides a substantially purified nucleic acid molecule encoding a CALIFLOWER gene product such as <highlight><italic>Arabidopsis thaliana </italic></highlight>CAL (SEQ ID NO: 10) or <highlight><italic>Brassica oleracea </italic></highlight>CAL (SEQ ID NO: 12). The invention also provides nucleic acid molecules encoding SEP1 (SEQ ID NO:28), SEP2 (SEQ ID NO:30), SEP3 (SEQ ID NO:32), AGL20 (SEQ ID NO:34), AGL22 (SEQ ID NO:36), AGL24 (SEQ ID NO:38) or AGL27 (SEQ ID NO:40). </paragraph>
<paragraph id="P-0216" lvl="0"><number>&lsqb;0216&rsqb;</number> As used herein in reference to a particular nucleic acid molecule or gene product, the term &ldquo;substantially purified&rdquo; means that the particular nucleic acid molecule or gene product is in a form that is relatively free from contaminating lipids, unrelated gene products, unrelated nucleic acids or other cellular material normally associated with the particular nucleic acid molecule or gene product in a cell. </paragraph>
<paragraph id="P-0217" lvl="0"><number>&lsqb;0217&rsqb;</number> The present invention also provides a nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding any of the above-referenced gene products, including <highlight><italic>Brassica oleracea </italic></highlight>AP1, <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 or <highlight><italic>Zea mays </italic></highlight>AP1, provided that said nucleotide sequence is not present in a nucleic acid molecule encoding a MADS domain containing protein. For example, such a nucleotide sequence can have at least ten contiguous nucleotides of a nucleic acid molecule encoding an AP1 gene product having the amino acid sequence of SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8. A nucleotide sequence of the invention can have, for example, at least ten contiguous nucleotides of the nucleic acid sequence of SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7. </paragraph>
<paragraph id="P-0218" lvl="0"><number>&lsqb;0218&rsqb;</number> As used herein, the term &ldquo;contiguous,&rdquo; as used in reference to the nucleotides of a nucleic acid molecule means that the nucleotides of the nucleic acid molecule follow continuously in sequence. Thus, a nucleotide sequence of the invention has at least ten contiguous nucleotides of one of the recited nucleic acid molecules without any extraneous intervening nucleotides. </paragraph>
<paragraph id="P-0219" lvl="0"><number>&lsqb;0219&rsqb;</number> Explicitly excluded from a nucleotide sequence of the present invention is a nucleotide sequence having at least ten contiguous nucleotides that is present in a nucleic acid molecule encoding a MADS domain containing protein. MADS domain containing proteins are well known in the art as described in Purugganan et al., supra, 1995. </paragraph>
<paragraph id="P-0220" lvl="0"><number>&lsqb;0220&rsqb;</number> In general, a nucleotide sequence of the invention can range in size from about 10 nucleotides to the full-length of a cDNA. Such a nucleotide sequence can be chemically synthesized, using routine methods or can be purchased from a commercial source. In addition, such a nucleotide sequence can be obtained by enzymatic methods such as random priming methods, polymerase chain reaction (PCR) methods or by standard restriction endonuclease digestion, followed by denaturation (Sambrook et al., supra, 1989). </paragraph>
<paragraph id="P-0221" lvl="0"><number>&lsqb;0221&rsqb;</number> A nucleotide sequence of the invention can be useful, for example, as a primer for PCR (Innis et al. (ed.) <highlight><italic>PCR Protocols: A Guide to Methods and Applications, </italic></highlight>San Diego, Calif.: Academic Press, Inc. (1990)). Such a nucleotide sequence generally contains from about 10 to about 50 nucleotides. </paragraph>
<paragraph id="P-0222" lvl="0"><number>&lsqb;0222&rsqb;</number> A nucleotide sequence of the invention also can be useful in screening a cDNA or genomic library to obtain a related nucleotide sequence. For example, a cDNA library that is prepared from rice or wheat can be screened with a nucleotide sequence having at least ten contiguous nucleotides of the nucleic acid molecule encoding <highlight><italic>Zea mays </italic></highlight>AP1 (SEQ ID NO: 7) in order to isolate a rice or wheat ortholog of AP1. Generally, a nucleotide sequence useful for screening a cDNA or genomic library contains at least about 14 to 16 contiguous nucleotides depending, for example, on the hybridization conditions to be used. A nucleotide sequence containing at least 18 to 20 nucleotides, or containing at least 21 to 25 nucleotides, also can be useful. </paragraph>
<paragraph id="P-0223" lvl="0"><number>&lsqb;0223&rsqb;</number> A nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding <highlight><italic>Zea mays </italic></highlight>AP1 (SEQ ID NO: 7) also can be used to screen a <highlight><italic>Zea mays </italic></highlight>cDNA library to isolate a sequence that is related to but distinct from AP1. Similarly, a nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding <highlight><italic>Brassica oleracea </italic></highlight>AP1 (SEQ ID NO: 3) or a nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 (SEQ ID NO: 5) can be used to screen a <highlight><italic>Brassica oleracea </italic></highlight>or <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>cDNA library to isolate a novel sequence that is related to but distinct from AP1. Other gene orthologs, such as of SEP1, SEP2, SEP3, AGL20, AGL22, AGL24 or AGL27 can be isolated by similar methods. In addition, a nucleotide sequence of the invention can be useful in analyzing RNA levels or patterns of expression, as by northern blotting or by in situ hybridization to a tissue section. Such a nucleotide sequence also can be used in Southern blot analysis to evaluate gene structure and identify the presence of related gene sequences. </paragraph>
<paragraph id="P-0224" lvl="0"><number>&lsqb;0224&rsqb;</number> The invention also provides a vector containing a nucleic acid molecule as described above, e.g., encoding a <highlight><italic>Brassica oleracea </italic></highlight>AP1 gene product, <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 gene product or <highlight><italic>Zea mays </italic></highlight>AP1 gene product. A vector can be a cloning vector or an expression vector and provides a means to transfer an exogenous nucleic acid molecule into a host cell, which can be a prokaryotic or eukaryotic cell. Such vectors are well known and include plasmids, phage vectors and viral vectors. Various vectors and methods for introducing such vectors into a cell are described, for example, by Sambrook et al., supra, 1989, and by Glick and Thompson, supra, 1993). </paragraph>
<paragraph id="P-0225" lvl="0"><number>&lsqb;0225&rsqb;</number> The invention further provides a method of producing one of the above-described gene products by expressing a nucleic acid molecule encoding the gene product (e.g., AP1, CAL, SEP1, SEP2, SEP3, AGL20, AGL22, AGL24, or AGL27). Thus, for example, a <highlight><italic>Brassica oleracea </italic></highlight>AP1 gene product can be produced according to a method of the invention by expressing a nucleic acid molecule having the amino acid sequence of SEQ ID NO: 4 or by expressing a nucleic acid molecule having the nucleic acid sequence of SEQ ID NO: 3. Similarly, a <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 gene product can be produced according to a method of the invention by expressing a nucleic acid molecule having the amino acid sequence of SEQ ID NO: 6 or by expressing a nucleic acid molecule having the nucleic acid sequence of SEQ ID NO: 5. A <highlight><italic>Zea mays </italic></highlight>AP1 gene product can be produced by expressing a nucleic acid molecule having the amino acid sequence of SEQ ID NO: 8 or by expressing a nucleic acid molecule having the nucleic acid sequence of SEQ ID NO: 7. </paragraph>
<paragraph id="P-0226" lvl="0"><number>&lsqb;0226&rsqb;</number> The invention also provides a substantially purified AP1 gene product, such as a substantially purified gene product of th invention such as a <highlight><italic>Brassica oleracea </italic></highlight>AP1 gene product having amino acid sequence SEQ ID NO: 4; a substantially purified <highlight><italic>Brassica oleracea </italic></highlight>var. <highlight><italic>botrytis </italic></highlight>AP1 gene product having amino acid sequence SEQ ID NO: 6; or a substantially purified <highlight><italic>Zea mays </italic></highlight>AP1 gene product having amino acid sequence SEQ ID NO: 8. As used herein, the term &ldquo;gene product&rdquo; is used in its broadest sense and includes proteins, polypeptides and peptides, which are related in that each consists of a sequence of amino acids joined by peptide bonds. For convenience, the terms &ldquo;gene product,&rdquo; &ldquo;protein&rdquo; and &ldquo;polypeptide&rdquo; are used interchangeably. While no specific attempt is made to distinguish the size limitations of a protein and a peptide, one skilled in the art would understand that proteins generally consist of at least about 50 to 100 amino acids and that peptides generally consist of at least two amino acids up to a few dozen amino acids. The term gene product as used herein includes any such amino acid sequence. </paragraph>
<paragraph id="P-0227" lvl="0"><number>&lsqb;0227&rsqb;</number> An active fragment of a floral meristem identity gene product also can be useful in the methods of the invention. As used herein, the term &ldquo;active fragment,&rdquo; means a polypeptide portion of a floral meristem identity gene product that can convert shoot meristem to floral meristem in an angiosperm. An active fragment of an AP1 gene product can consist, for example, of an amino acid sequence that is derived from SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8 and has activity in converting shoot meristem to floral meristem in an angiosperm. An active fragment can be, for example, an amino terminal, carboxyl terminal or internal fragment of <highlight><italic>Zea mays </italic></highlight>AP1 (SEQ ID NO: 8) that has activity in converting shoot meristem to floral meristem in an angiosperm. The skilled artisan will recognize that an active fragment of a floral meristem identity gene product, as defined herein, can be useful in the methods of the invention for converting shoot meristem to floral meristem in an angiosperm, for producing early reproductive development in a seed plant, or for producing reproductive sterility in a seed plant. </paragraph>
<paragraph id="P-0228" lvl="0"><number>&lsqb;0228&rsqb;</number> Such an active fragment can be produced using well known recombinant DNA methods (Sambrook et al., supra, 1989). Similarly, an active fragment can be, for example, an amino terminal, carboxyl terminal or internal fragment of <highlight><italic>Arabidopsis thaliana </italic></highlight>CAL (SEQ ID NO: 10) or <highlight><italic>Brassica oleracea </italic></highlight>CAL (SEQ ID NO: 12) that has activity, for example, in converting shoot meristem to floral meristem in an angiosperm. The product of the BobCAL gene (SEQ ID NO: 24), which is truncated at amino acid 150, lacks activity in converting shoot meristem to floral meristem and, therefore, is an example of a polypeptide portion of a CAL floral meristem identity gene product that is not an &ldquo;active fragment&rdquo; of a floral meristem identity gene product. </paragraph>
<paragraph id="P-0229" lvl="0"><number>&lsqb;0229&rsqb;</number> An active fragment of a floral meristem identity gene product, which can convert shoot meristem to floral meristem in an angiosperm, can be identified using the methods described in WO 97/46078. Briefly, an angiosperm such as Arabidopsis can be transformed with a nucleic acid molecule encoding a portion of a floral meristem identity gene product in order to determine whether the portion can convert shoot meristem to floral meristem and, therefore, is an active fragment of a floral meristem identity gene product. </paragraph>
<paragraph id="P-0230" lvl="0"><number>&lsqb;0230&rsqb;</number> The invention also provides an expression vector containing a nucleic acid molecule encoding a floral meristem identity gene product such as SEP3, AGL20, AGL22, AGL24, AGL27, AP1, CAL or LFY operably linked to a heterologous regulatory element. Expression vectors are well known in the art and provide a means to transfer and express an exogenous nucleic acid molecule into a host cell. Thus, an expression vector contains, for example, transcription start and stop sites such as a TATA sequence and a poly-A signal sequence, as well as a translation start site such as a ribosome binding site and a stop codon, if not present in the coding sequence. </paragraph>
<paragraph id="P-0231" lvl="0"><number>&lsqb;0231&rsqb;</number> As used herein, the term &ldquo;heterologous regulatory element&rdquo; means a regulatory element derived from a different gene than the gene encoding the floral meristem identity gene product to which it is operably linked. A vector containing a floral meristem identity gene, however, contains a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a homolgous regulatory element. Such a vector does not contain a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a heterologous regulatory element and, thus, is not an expression vector of the invention. </paragraph>
<paragraph id="P-0232" lvl="0"><number>&lsqb;0232&rsqb;</number> The invention further provides a plant expression vector containing a floral meristem identity gene product operably linked to a heterologous regulatory element. For example, a plant expression vector containing a nucleic acid molecule encoding an AP1 gene product having at least about 70 percent amino acid identity with an amino acid sequence of <highlight><italic>Arabidopsis thaliana </italic></highlight>AP1 (SEQ ID NO: 2) in the region from amino acid 1 to amino acid 163 or with the amino acid sequence of <highlight><italic>Zea mays </italic></highlight>AP1 (SEQ ID NO: 8) in the region from amino acid 1 to amino acid 163 is provided. A plant expression vector containing a floral meristem identity gene product operably linked to a constitutive regulatory element, such as the cauliflower mosaic virus 35S promoter, is provided. In addition, a plant expression vector containing a floral meristem identity gene product operably linked to an inducible regulatory element is provided. </paragraph>
<paragraph id="P-0233" lvl="0"><number>&lsqb;0233&rsqb;</number> A useful plant expression vector can contain a constitutive regulatory element for expression of an exogenous nucleic acid molecule in all or most tissues of a seed plant. The use of a constitutive regulatory element can be particularly advantageous because expression from the element is relatively independent of developmentally regulated or tissue-specific factors. For example, the cauliflower mosaic virus 35S promoter (CaMV 35S) is a well-characterized constitutive regulatory element that produces a high level of expression in all plant tissues (Odell et al., <highlight><italic>Nature </italic></highlight>313:810-812 (1985), which is incorporated herein by reference). Furthermore, the CaMV 35S promoter can be particularly useful due to its activity in numerous different seed plant species (Benfey and Chua, <highlight><italic>Science </italic></highlight>250:959-966 (1990), which is incorporated herein by reference; Odell et al., supra, 1985). Other constitutive regulatory elements useful for expression in a seed plant include, for example, the cauliflower mosaic virus 19S promoter; the Figwort mosaic virus promoter (Singer et al., <highlight><italic>Plant Mol. Biol. </italic></highlight>14:433 (1990), which is incorporated herein by reference); and the nopaline synthase (nos) gene promoter (An, <highlight><italic>Plant Physiol. </italic></highlight>81:86 (1986), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0234" lvl="0"><number>&lsqb;0234&rsqb;</number> In addition, an expression vector of the invention can contain a regulated gene regulatory element such as a promoter or enhancer element. A particularly useful regulated promoter is a tissue-specific promoter such as the shoot meristem-specific CDC2 promoter (Hemerly et al., <highlight><italic>Plant Cell </italic></highlight>5:1711-1723 (1993), which is incorporated herein by reference), or the AGL8 promoter, which is active in the apical shoot meristem immediately after the transition to flowering (Mandel and Yanofsky, supra, 1995). The promoter of the SHOOTMERISTEMLESS gene, which is expressed exclusively in the shoot meristem beginning within an embryo and throughout the angiosperm life cycle, also can be a particularly useful tissue-specific gene regulatory element (see Long et al., <highlight><italic>Nature </italic></highlight>379:66-69 (1996), which is incorporated herein by reference). </paragraph>
<paragraph id="P-0235" lvl="0"><number>&lsqb;0235&rsqb;</number> An appropriate regulatory element such as a promoter is selected depending on the desired pattern or level of expression of a nucleic acid molecule linked thereto. For example, a constitutive promoter, which is active in all tissues, would be appropriate if expression of a gene product in all plant tissues is desired. In addition, a developmentally regulated or tissue-specific regulatory element can be useful to direct floral meristem identity gene expression to specific tissues, for example. As discussed above, inducible expression also can be particularly useful to manipulate the timing of gene expression such that, for example, a population of transgenic seed plants of the invention that contain an expression vector comprising a floral meristem identity gene linked to an inducible regulatory element can undergo early reproductive development at essentially the same time. Selecting the time of reproductive development can be useful, for example, in manipulating the time of crop harvest. </paragraph>
<paragraph id="P-0236" lvl="0"><number>&lsqb;0236&rsqb;</number> Using nucleic acid molecules encoding gene products provided herein, the skilled artisan can isolate, if desired, novel orthologs. For example, one would choose a region of AP1 that is highly conserved among known AP1 sequences such as a region that is highly conserved between Arabidopsis AP1 (SEQ ID NO: 1) and <highlight><italic>Zea mays </italic></highlight>AP1 (GenBank accession number L46400; SEQ ID NO: 7) to screen a cDNA or genomic library of interest for a novel AP1 ortholog. One can use a full-length Arabidopsis AP1 (SEQ ID NO: 1), for example, to isolate a novel ortholog of AP1 (see, e.g., Example V of WO 97/46078). If desired, the region encoding the MADS domain, which is common to a number of genes, can be excluded, from the sequence used as a probe. Similarly, the skilled artisan knows that a nucleic acid molecule encoding a full-length CAL cDNA such as Arabidopsis CAL (SEQ ID NO: 9) or <highlight><italic>Brassica oleracea </italic></highlight>CAL (SEQ ID NO: 11) can be useful in isolating a novel CAL ortholog. </paragraph>
<paragraph id="P-0237" lvl="0"><number>&lsqb;0237&rsqb;</number> For example, the Arabidopsis AP1 cDNA (SEQ ID NO: 1) can be used as a probe to identify and isolate a novel AP1 ortholog. Using a nucleotide sequence derived from a conserved region of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7, for example, a nucleic acid molecule encoding a novel AP1 ortholog can be isolated from other plant species. Using methods such as those described by Purugganan et al., supra, 1995, one can readily confirm that the newly isolated molecule is an AP1 ortholog. Thus, a nucleic acid molecule encoding an AP1 gene product, which has at least about 70 percent amino acid identity with the amino acid sequence of SEQ ID NO: 2 (Arabidopsis AP1) in the region from amino acid 1 to amino acid 163 or with the amino acid sequence of SEQ ID NO: 8 (<highlight><italic>Zea mays </italic></highlight>AP1) in the region from amino acid 1 to amino acid 163 can be isolated and identified using well known methods. </paragraph>
<paragraph id="P-0238" lvl="0"><number>&lsqb;0238&rsqb;</number> Similarly, in order to isolate an ortholog of CAL, one can choose a region of CAL that is highly conserved among known CAL cDNAs, such as a region conserved between Arabidopsis CAL (SEQ ID NO: 9) and <highlight><italic>Brassica oleracea </italic></highlight>CAL (SEQ ID NO: 11). The Arabidopsis CAL cDNA (SEQ ID NO: 9) or <highlight><italic>Brassica oleracea </italic></highlight>CAL cDNA (SEQ ID NO: 11), or a nucleotide fragment thereof, can be used to identify and isolate a novel CAL ortholog using methods such as those described in Example V of WO 97/46078. In order to identify related MADS domain genes, a nucleotide sequence derived from the MADS domain of AP1 or CAL, for example, can be useful to isolate a related gene sequence encoding this DNA-binding motif. </paragraph>
<paragraph id="P-0239" lvl="0"><number>&lsqb;0239&rsqb;</number> Hybridization conditions for isolating a gene ortholog, for example, are relatively stringent such that non-specific hybridization is minimized. Appropriate hybridization conditions can be determined empirically, or can be estimated based, for example, on the relative G&plus;C content of the probe and the number of mismatches between the probe and target sequence, if known. Hybridization conditions can be adjusted as desired by varying, for example, the temperature of hybridizing or the salt concentration (Sambrook, supra, 1989). </paragraph>
<paragraph id="P-0240" lvl="0"><number>&lsqb;0240&rsqb;</number> The invention also provides a kit for converting shoot meristem to floral meristem in an angiosperm, which contains a plant expression vector having a nucleic acid molecule encoding a floral meristem identity gene product. A kit for promoting early reproductive development in a seed plant, which contains a plant expression vector having a nucleic acid molecule encoding a floral meristem identity gene product, also is provided. If desired, such kits can contain appropriate reagents to facilitate high efficiency transformation of a seed plant with a plant expression vector of the invention. Furthermore, if desired, a control vector lacking a floral meristem identity gene can be included in the kits to determine, for example, the efficiency of transformation. </paragraph>
<paragraph id="P-0241" lvl="0"><number>&lsqb;0241&rsqb;</number> The following example is offered by way of example, not limitation.</paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">EXAMPLES </heading>
</section>
<section>
<heading lvl="1">Example 1 </heading>
<paragraph id="P-0242" lvl="0"><number>&lsqb;0242&rsqb;</number> This example shows the identification of proteins that interact with CAL. </paragraph>
<paragraph id="P-0243" lvl="7"><number>&lsqb;0243&rsqb;</number> Proteins That Interact with CAL </paragraph>
<paragraph id="P-0244" lvl="0"><number>&lsqb;0244&rsqb;</number> Yeast two-hybrid screens were performed to identify candidate genes whose products interact with AP1 and CAL. The two-hybrid library screens were performed in the YPB2 strain &lsqb;MATa ara3 his3 ade2 lys2 trp1 leu2, 112 can<highlight><superscript>r </superscript></highlight>gal4 gal80 LYS2::GAL1-HIS3, URA3::(GAL1<highlight><subscript>UAS</subscript></highlight>17mers)-lacZ&rsqb;. Yeast were transformed using a modified version of the lithium acetate method of Schiestl and Gietz, <highlight><italic>Curr. Genet. </italic></highlight>16, 339-346 (1989). </paragraph>
<paragraph id="P-0245" lvl="0"><number>&lsqb;0245&rsqb;</number> The two-hybrid cDNA expression library was constructed in the pBI771 (prey) vector using tissue of whole plants at different stages. The bait constructs were prepared by inserting the intact CAL coding region and a truncated form of AP1 into the pBI-880 vector (a variant of pPC62 described in Chevray and Nathans <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>5789-5793 (1992); Kohalmi et al, <highlight><italic>Plant. Mol. Biol. Man. </italic></highlight>M1, 1-30 (1998)) by inserting the corresponding coding region in-frame at the 3&prime; end of the GAL4 (1-147) sequence contained in the centromere LEU2 plasmid. These baits tested negative for the ability to activate transcription of both reporters, alone as well as in combination with each the prey vector and an inert control prey, the Arabidopsis cruciferin seed storage protein. </paragraph>
<paragraph id="P-0246" lvl="0"><number>&lsqb;0246&rsqb;</number> SEP3K, SOC1K, SVPK, AGL24K and SOC1KC/2 were generated by polymerase chain reaction (PCR) from the relevant cDNAs using oligos with the appropriate restriction site for posterior cloning into pBI771. The following primers were used: </paragraph>
<paragraph id="P-0247" lvl="2"><number>&lsqb;0247&rsqb;</number> SEP3-5&prime;K: 5&prime;-CCGTCGACCCATGAGCCAGCAGGAGTATCTC-3&prime;</paragraph>
<paragraph id="P-0248" lvl="2"><number>&lsqb;0248&rsqb;</number> SEP3-3&prime;Kbox: 5&prime;-CCGCGGCCGCCTTACTCTGAAGATCGTT-3&prime;</paragraph>
<paragraph id="P-0249" lvl="2"><number>&lsqb;0249&rsqb;</number> SOC1-5&prime;K: 5&prime;-CCGTCGACCCATGAAATATGAAGCAGCAAAC-3&prime;</paragraph>
<paragraph id="P-0250" lvl="2"><number>&lsqb;0250&rsqb;</number> SOC1-3&prime;Kbox: 5&prime;-CCGCGGCCGCCTCCTTTTGCTTGAGCTG-3&prime;</paragraph>
<paragraph id="P-0251" lvl="2"><number>&lsqb;0251&rsqb;</number> SOC1-C/2: 5&prime;-CCGCGGCCGCACTTTCTTGATTCTTATT-3&prime;</paragraph>
<paragraph id="P-0252" lvl="2"><number>&lsqb;0252&rsqb;</number> SVP-5&prime;K: 5&prime;-CCGTCGACCCATGAGTGATCACGCCCGAATG-3&prime;</paragraph>
<paragraph id="P-0253" lvl="2"><number>&lsqb;0253&rsqb;</number> SVP-3&prime;Kbox: 5&prime;-CCGCGGCCGCTCCCTTTTTCTGAAGTTC-3&prime;</paragraph>
<paragraph id="P-0254" lvl="2"><number>&lsqb;0254&rsqb;</number> AGL24-5&prime;K: 5&prime;-CCGTCGACCCATGCTTGAGAATTGTAACCTC-3&prime;</paragraph>
<paragraph id="P-0255" lvl="2"><number>&lsqb;0255&rsqb;</number> AGL24-3&prime;Kbox: 5&prime;-CCGCGGCCGCCTCAAGTGAGAAAATTTG-3&prime; The PCR products were subcloned directly into pCRII (invitrogen) and then digested with SalI-NotI for next subcloning into pBI-771. All constructs were confirmed by sequencing. </paragraph>
<paragraph id="P-0256" lvl="0"><number>&lsqb;0256&rsqb;</number> CAL Screen: </paragraph>
<paragraph id="P-0257" lvl="0"><number>&lsqb;0257&rsqb;</number> The frequency of clones which activated both the HIS3 and lacZ reporters from the 30&deg; C. plates was 1/(1.8&times;10<highlight><superscript>6</superscript></highlight>)&equals;5.6&times;10<highlight><superscript>&minus;7</superscript></highlight>. The frequency on the 23&deg; C. plates was 22/(1.8&times;10<highlight><superscript>6</superscript></highlight>)&equals;1.2&times;10<highlight><superscript>&minus;5. </superscript></highlight></paragraph>
<paragraph id="P-0258" lvl="0"><number>&lsqb;0258&rsqb;</number> AP1 Screen: </paragraph>
<paragraph id="P-0259" lvl="0"><number>&lsqb;0259&rsqb;</number> 9.2&times;10<highlight><superscript>4 </superscript></highlight>total transformants were screened at 23&deg; C. and the frequency of clones activating both reporter genes was 1.5&times;10<highlight><superscript>&minus;4</superscript></highlight>. </paragraph>
<paragraph id="P-0260" lvl="0"><number>&lsqb;0260&rsqb;</number> The transformants were selected on supplemented synthetic dextrose medium lacking leucine, tryptophan and histidine but containing 5 mM 3-amino-1,2,4-triazole. The colonies growing on this selective medium were assayed for &bgr;-galactosidase activity on nitrocellulose filters (Kohalmi et al., supra). Plasmid DNA from positive clones was isolated and transform into <highlight><italic>E. coli. </italic></highlight></paragraph>
<paragraph id="P-0261" lvl="0"><number>&lsqb;0261&rsqb;</number> Using a full-length CAL cDNA as bait, 23 interacting clones were identified, rescued from yeast and transformed into <highlight><italic>E. coli</italic></highlight>. Sequence analyses showed that they fell into four classes, all previously identified as AGAMOUS-like (AGL) genes. </paragraph>
<paragraph id="P-0262" lvl="0"><number>&lsqb;0262&rsqb;</number> The first class, SEP3, included four clones, all of which began within the I-region. Because the cDNA library was poly (T) primed, the clones all comprised varying lengths of the 3&prime; end of the gene. SEP3 is first expressed in the central dome of stage-two floral primordia and is maintained in the inner three whorls of the flower (Mandel and Yanofsky, <highlight><italic>Sex. Plant Reprod. </italic></highlight>11, 22-28 (1998)). SEP3 acts redundantly with SEP1 and SEP2 and is necessary for the development of petals, stamens and carpels (Pelaz et al., <highlight><italic>Current Biology </italic></highlight>11, 182-184 (2000)). </paragraph>
<paragraph id="P-0263" lvl="0"><number>&lsqb;0263&rsqb;</number> The second class identified was the SUPPRESSOR OF CO OVEREXPRESSION 1 (SOC1) gene and included seven clones. The starting point of these clones varied. One clone began with the ATG start codon, another started near the end of the MADS-box, and the remaining clones started at 5&prime; ends of the I-region. SOC1 is expressed in the inflorescence meristem, as well as in the two inner whorls of the flower beginning in late stage-two and it is involved in promoting flowering (Samach et al, <highlight><italic>Science </italic></highlight>288, 1613-1616 (2000)). </paragraph>
<paragraph id="P-0264" lvl="0"><number>&lsqb;0264&rsqb;</number> The third class was the SHORT VEGETATIVE PHASE (SVP) gene, and included four clones. Of the clones from this screen, one started in the MADS-box, and three began in the I-region. SVP was identified as an Arabidopsis expressed sequence tag with homology to the MADS-box family (Alvarez-Buylla et al., <highlight><italic>Plant J. </italic></highlight>24, 457-466 (2000)), and it was also cloned by (Hartman et al., 2000) through transposon tagging. SVP is a repressor of flowering and is expressed in young leaves and throughout the shoot apical meristem during vegetative development. After the transition to flowering, it is expressed in young flower primordia until stage 3 (Hartman et al., <highlight><italic>Plant J. </italic></highlight>21, 351-360 (2000)). </paragraph>
<paragraph id="P-0265" lvl="0"><number>&lsqb;0265&rsqb;</number> The last eight clones were identified as AGL24. One of these clones began within the MADS-box and three within the I-region. In addition, the 5&prime; ends of four clones lie in the first third of the K-box, representing the shortest clones isolated in the screen. AGL24 was first identified in a previous yeast two-hybrid screen as a clone which interacts with AG (Alvarez-Buylla et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>97, 5328-5333 (2000)). AGL24 is expressed in inflorescences and young floral primordia. </paragraph>
<paragraph id="P-0266" lvl="0"><number>&lsqb;0266&rsqb;</number> To confirm the specificity of the observed interactions, the longest and shortest clone of each class was transformed back into a yeast strain that contained either the CAL bait, the bait vector, or an inert control bait, cruciferin. The strains containing the CAL bait tested positive for both &bgr;-Gal activity and HIS prototrophy. The strains containing the bait vector or the cruciferin bait were negative in both assays, as they were not able to grow on plates lacking histidine and the yeast colonies were completely white in the &bgr;-Gal assay. </paragraph>
<paragraph id="P-0267" lvl="7"><number>&lsqb;0267&rsqb;</number> AP1 Forms Dimers in Yeast with CAL Interactors </paragraph>
<paragraph id="P-0268" lvl="0"><number>&lsqb;0268&rsqb;</number> The structural and functional similarities between CAL and AP1 suggested that they may interact with an overlapping set of proteins. In order to explore this possibility, we constructed an AP1 bait by inserting the intact AP1 coding region into the pBI-880 vector. As in the Finley and Brent system, the full-length AP1 bait activated transcription independently. To overcome this problem, a deletion construct was made encoding residues 1-196 of AP1 (AP1&Dgr;1), thus eliminating the putative trans-activating C-terminus. In contrast to the full-length AP1 clone, the deletion derivative did not activate the reporter on its own. The longest clone of each class was transformed into yeast in combination with the AP1 deletion bait. In every case, both of the reporters were strongly activated, suggesting that all four CAL-interacting proteins also interact with AP1. </paragraph>
<paragraph id="P-0269" lvl="7"><number>&lsqb;0269&rsqb;</number> Domain for Protein-Protein Interactions </paragraph>
<paragraph id="P-0270" lvl="0"><number>&lsqb;0270&rsqb;</number> Previous studies have shown that the MADS-domain and I regions may be important for homodimer formation by AG and by AP1 (Krizek and Meyerowitz, 1996; Mizukami et al, 1996; Riechmann et al, 1996) and that the I region and K-domain are needed for the formation of AP3/PI heterodimers (Krizek and Meyerowitz, <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>93, 4063-4070 (1996); Riechmann et al., <highlight><italic>Proc. Natl. Acad. Sci. USA </italic></highlight>93, 4793-4798 (1996)). In addition, the K-domain of AG is sufficient to promote interactions with SEP1, SEP2, SEP3 and AGL6 in yeast (Fan et al., <highlight><italic>Plant J. </italic></highlight>11, 999-1010 (1997)). Since many of the CAL- and AP1-interacting clones isolated as part of our study lacked the MADS-domain and I regions, we tested if the K-domain itself was sufficient to promote the observed interactions. First, we subcloned the K-box regions of SEP3, SOC1, SVP and AGL24 into the prey vector, and tested their ability to activate the reporter using either the empty bait or the cruciferin gene cloned into the bait plasmid. As expected, these K-box regions did not activate the reporter. In contrast, when these K-box prey constructs were introduced into yeast strains that contained each of the CAL or AP1 bait plasmids, reporter activity significantly above background levels was consistently observed. Furthermore, the addition of approximately half of the C-terminal domain of the SOC1 protein was sufficient to greatly strengthen the interaction, similar to what has previously been shown to occur for AG and its interactors (Fan et al., supra). Taken together, these studies suggest that the ability of CAL and AP1 to interact with SEP3, SOC1, SVP, and AGL24 is largely mediated by the K-domain. However, other protein domains appear to enhance these interactions since the level of reporter gene activation is higher when larger constructs are used. </paragraph>
</section>
<section>
<heading lvl="1">Example 2 </heading>
<paragraph id="P-0271" lvl="0"><number>&lsqb;0271&rsqb;</number> This example shows the indetifications of proteins that interact with AP1. </paragraph>
<paragraph id="P-0272" lvl="7"><number>&lsqb;0272&rsqb;</number> Proteins that Interact with AP1 </paragraph>
<paragraph id="P-0273" lvl="0"><number>&lsqb;0273&rsqb;</number> In order to find additional proteins that could interact with AP1, the library was screened with the truncated AP1 bait (1-196), and 13 clones that tested positive for &bgr;-Gal activity were characterized. As expected, we found three clones of AGL20 (also known as SOC1), five clones of AGL22 (also known as SVP), and one clone of AGL24. </paragraph>
<paragraph id="P-0274" lvl="0"><number>&lsqb;0274&rsqb;</number> In addition we found one clone of a new MADS box gene designated AGL27 (Alvarez-Buylla et al, supra), two different clones encoding a putative RNA binding protein (GI 10178188), and one clone encoding a novel protein (GI 3157943). We determined that these three newly isolated genes have overlapping expression patterns with that of AP1, consistent with the idea that they may interact with AP1 in planta. </paragraph>
<paragraph id="P-0275" lvl="0"><number>&lsqb;0275&rsqb;</number> To confirm the specificity of these interactions, the longest clone of each class was transformed back into yeast with the AP1 bait, the bait vector, and an inert control bait, cruciferin. The strains containing the AP1 bait tested positive for both &bgr;-Gal activity and HIS prototrophy. The strains containing the bait vector or the cruciferin bait were negative in both assays. We then tested if the three new AP1-interacting clones could also interact with CAL, since they had not been isolated in the CAL library screen. However, AGL27, the RNA binding protein, and the novel protein were unable to interact with CAL in yeast. </paragraph>
</section>
<section>
<heading lvl="1">Example 3 </heading>
<paragraph id="P-0276" lvl="0"><number>&lsqb;0276&rsqb;</number> This example demonstrates the characteriztion of sep3 mutants. </paragraph>
<paragraph id="P-0277" lvl="7"><number>&lsqb;0277&rsqb;</number> sep3 Mutants Resemble Intermediate Alleles of AP1 </paragraph>
<paragraph id="P-0278" lvl="0"><number>&lsqb;0278&rsqb;</number> As a start toward determining if the observed interactions in yeast reflect functional interactions in vivo, we characterized loss- and gain-of-function alleles of SEP3. If some of the activities of AP1 require an interaction with SEP3, then mutations in SEP3 might be expected to resemble mutant alleles of AP1. We recently identified two independently derived En-1 transposon insertion alleles of SEP3 and have described the phenotype of sep1 sep2 sep3 triple mutants in which the three inner whorls of organs become sepaloid (Pelaz et al., supra). </paragraph>
<paragraph id="P-0279" lvl="0"><number>&lsqb;0279&rsqb;</number> The flowers of sep3-1 and sep3-2 single mutant plants have petals that are partially transformed into sepals, and infrequently, axillary flowers develop at the base of the first-whorl sepals. When examined by scanning electronic microscopy (SEM), the abaxial cells of these transformed petals resemble cells that are a mixture of abaxial wild type sepal and abaxial wild type petal cells. The abaxial side of the wild type sepals have rectangular cells of varying size, some of which are very long, reaching 300 &mgr;m in length. These long cells can be more than ten times the length of the smallest sepal cells. Numerous stomata are visible throughout wild type sepals but are never found on wild-type petals. Cells on the abaxial side of wild type petals all have a uniformly small rounded appearance, and are typically about half of the size of the smallest sepal cells. Unlike wild type petals that have rounded cells, the abaxial side of the sep3 petals consists of rectangular cells, resembling those found on sepals. Although these mutant petal cells are larger than their wild type counterparts, they are still smaller than the wild type sepal cells. Interestingly, several stomata are interspersed on the surface of these petals, further suggesting a partial transformation of these petals into sepals. </paragraph>
<paragraph id="P-0280" lvl="0"><number>&lsqb;0280&rsqb;</number> Because the sep3 petal phenotype resembles that observed for intermediate alleles of ap1, (Bowman et al., <highlight><italic>Development </italic></highlight>119, 721-743 (1993)), we compared second whorl organs of sep3 mutants to those of intermediate alleles of ap1, including ap1-2, ap1-4 and ap1-6. The abaxial cells of these ap1 mutant petals are very similar to those of the sep3 mutants, and consist of a blend between petal and sepal cells. These ap1 mutant cells are larger and more elongated than the wild type petal cells but they do not reach the length of the longer wild type sepal cells. As was observed for sep3 mutants, petals of these intermediate alleles of ap1 develop several stomata, further indicating the sepal-like identity. The similarities of sep and ap1 mutants are consistent with the idea that some of the activities of AP1 are compromised in sep mutants, consistent with the possible loss of AP1/SEP interactions. </paragraph>
<paragraph id="P-0281" lvl="0"><number>&lsqb;0281&rsqb;</number> If the interaction between SEP and AP1 is necessary for AP1 activity, then a reduction in SEP expression would be predicted to produce some or all of the ap1-mutant phenotypes. To test this idea, we generated transgenic antisense lines in which the 5&prime; end of the SEP3 gene was expressed in the antisense orientation from the double 35S promoter. Two independent transgenic lines (SP70.1 and SP70.2) were tested for reduction in the amount of SEP3 mRNA accumulation. As expected, the amount of SEP3 mRNA in these antisense lines was reduced in comparison to the wild type. The resulting lines underexpressing SEP3 showed green petals whose cells appeared partially transformed into sepal cells. These plants also occasionally had axillary flowers arising from the base of the first-whorl sepals. These phenotypes are consistent with a reduction in AP1 activity, as intermediate alleles of ap1 produce similar phenotypes. This activity reduction does not mean less AP1 transcription, the levels of mRNA in these antisense lines are comparable to those of wild type flowers. Interestingly, the green-petal phenotype of these SEP3 antisense lines is more extreme than that observed for sep3 single mutants, based on the color change, suggesting that the SEP3 transgene may also have down regulated other closely related genes such as SEP1 and SEP2. </paragraph>
</section>
<section>
<heading lvl="1">Example 4 </heading>
<paragraph id="P-0282" lvl="0"><number>&lsqb;0282&rsqb;</number> This example demonstrates the characterization of plants overexpressing SEP3. </paragraph>
<paragraph id="P-0283" lvl="7"><number>&lsqb;0283&rsqb;</number> Constitutive Expression of SEP3 </paragraph>
<paragraph id="P-0284" lvl="0"><number>&lsqb;0284&rsqb;</number> Previous studies have demonstrated that constitutive expression of AP1 (35S:: AP1) results in plants that flower considerably earlier than wild type plants (Mandel and Yanofsky, supra). If some of the activities of AP1 require an interaction with SEP3, as the loss of function studies above would indicate, then it might be expected that constitutive SEP3 expression would further enhance the 35S::AP1 early-flowering phenotype. To test this hypothesis and to provide further evidence that SEP3 interacts with AP1 in planta, we generated 35S::SEP3 sense lines that express constitutively SEP3 throughout the plant. </paragraph>
<paragraph id="P-0285" lvl="0"><number>&lsqb;0285&rsqb;</number> Construction of the 35S::SEP3 construct was as follows: cDNA was isolated by RT-PCR using the oligos OAM37: 5&prime;-TAGAAACATCATCTTAAAAAT-3&prime; and SEP3-5&prime;: 5&prime;-CCGGATCCAAAATGGGAAGAGGGAGA-3&prime;. This cDNA was first cloned into pCRII (invitrogen) and then digested with BamHI for insertion into the BamHI site of pCGN18 (which contains 35S promoter) to produce sense lines, and confirmed by sequencing. The cDNA cloned into pCRII was digested with BamHI and BglII, the 363 bp band corresponding to the 5&prime; end of the cDNA was cloned in antisense orientation into the BamHI site of pBIN-JIT (plasmid carrying two 35S promoters in tandem). The 35S::SEP3 sense and antisense constructs were introduced into Arabidopsis, ecotype Columbia, by vacuum infiltration (Bechtold et al., <highlight><italic>C. R. Acad. Sci. </italic></highlight>316, 1194-1199 (1993)) and transgenic plants were selected on Kanamycin plates. </paragraph>
<paragraph id="P-0286" lvl="0"><number>&lsqb;0286&rsqb;</number> 35S::SEP3 transgenic plants are early flowering, and bolt after producing only four or five rosette leaves, in contrast to wild-type plants which bolt after producing approximately ten leaves under these growth conditions. In addition to the early-flowering phenotype, 35S::SEP3 plants have curled rosette leaves as well as two or three very curled cauline leaves, each of which typically subtends a solitary flower. The primary inflorescence usually produces only a few flowers before terminating. Some of the phenotypes caused by ectopic SEP3 expression are similar to those conferred by ectopic expression of several other MADS-box genes. However ectopic expression of these other genes often produces additional phenotypes, including alterations in flower organ identity and fruit development that are not seen in the 35S::SEP3 plants. </paragraph>
</section>
<section>
<heading lvl="1">Example 5 </heading>
<paragraph id="P-0287" lvl="0"><number>&lsqb;0287&rsqb;</number> This example demonstrates genetic interactions between 35S::SEP3 and 35S::AP1 transgenes. </paragraph>
<paragraph id="P-0288" lvl="0"><number>&lsqb;0288&rsqb;</number> To provide genetic evidence that SEP3 and AP1 interact, we crossed the 35S::SEP3 transgene into 35S::AP1 plants. Whereas 35S::AP1 plants flower early after producing four to five rosette leaves, 35S::AP1 35S::SEP3 doubly transgenic plants flower after producing only two rosette leaves, often developing a terminal flower directly from the rosette. Occasionally, these plants produce a very short inflorescence with two cauline leaves that subtend solitary flowers, a terminal flower at the apex, and very little internode elongation. The strong enhancement of the early-flowering phenotypes conferred by each single transgene is consistent with the suggestion that AP1 and SEP3 interact in planta. </paragraph>
<paragraph id="P-0289" lvl="0"><number>&lsqb;0289&rsqb;</number> We also used another genetic approach to investigate the interaction between SEP3 and AP1, avoiding the use of two different transgenic lines. We took advantage of the tf1l mutant, in which AP1 is ectopically activated (Bowman et al., supra; Gustafson-Brown et al., <highlight><italic>Cell </italic></highlight>76, 131-143 (1994)), producing a phenotype that closely resembles the 35S::AP1 phenotype. As expected, the tfl mutation in combination with the 35S::SEP3 transgene produces the same phenotypes as observed for plants carrying both 35S::AP1 and 35S::SEP3 transgenes. These plants flower after forming two rosette leaves and produce abbreviated shoots with very short internodes and a terminal flower. </paragraph>
</section>
<section>
<heading lvl="1">Example 6 </heading>
<paragraph id="P-0290" lvl="0"><number>&lsqb;0290&rsqb;</number> This example demonstrates the flowering time of an agl24 mutant. </paragraph>
<paragraph id="P-0291" lvl="0"><number>&lsqb;0291&rsqb;</number> The effect of AGL22 (also known as SVP) and AGL24 loss-of-function mutations was assessed. An agl24 T-DNA insertional mutant (designated W24.2) and an agl22 mutant (designated svp-E) were obtained and the time to flowering of the mutant plants was measured and compared to wildtype Columbia Arabidopsis plants. On average, the agl24 mutant produced almost twice as many leaves before flowering than wildtype plants. In addition, the agl22 mutant produced only half the number of leaves as wildtype before flowering. Results of the experiment, shown in number of leaves prior to flowering, is provided below.  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="56PT" align="center"/>
<colspec colname="2" colwidth="49PT" align="center"/>
<colspec colname="3" colwidth="49PT" align="center"/>
<colspec colname="4" colwidth="21PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Rosette</entry>
<entry>Cauline</entry>
<entry>Total</entry>
<entry>N</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="4" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="5">
<colspec colname="1" colwidth="42PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="center"/>
<colspec colname="3" colwidth="49PT" align="center"/>
<colspec colname="4" colwidth="49PT" align="center"/>
<colspec colname="5" colwidth="21PT" align="center"/>
<tbody valign="top">
<row>
<entry>Columbia</entry>
<entry>&thinsp;11 &plus;/&minus; 0.9</entry>
<entry>2.9 &plus;/&minus; 0.5</entry>
<entry>&thinsp;14 &plus;/&minus;1.1</entry>
<entry>26</entry>
</row>
<row>
<entry>svp-E</entry>
<entry>&thinsp;&ensp;6 &plus;/&minus; 0.6</entry>
<entry>2.8 &plus;/&minus; 0.4</entry>
<entry>&thinsp;&ensp;9 &plus;/&minus; 0.6</entry>
<entry>25</entry>
</row>
<row>
<entry>W24.2</entry>
<entry>&thinsp;19 &plus;/&minus; 1.5</entry>
<entry>3.1 &plus;/&minus; 0.5</entry>
<entry>&ensp;22 &plus;/&minus; 1.7</entry>
<entry>26</entry>
</row>
<row><entry namest="1" nameend="5" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0292" lvl="0"><number>&lsqb;0292&rsqb;</number> Thus, the time to flowering and the amount of vegetative growth of the agl24 mutant was increased compared to wild type plants and the time to flowering and the amount of vegetative growth of the agl22 mutant was decreased compared to wild type plants. </paragraph>
<paragraph id="P-0293" lvl="0"><number>&lsqb;0293&rsqb;</number> The above examples are provided to illustrate the invention but not to limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims. All publications, databases, Genbank sequences, patents, and patent applications cited herein are hereby incorporated by reference. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<sequence-cwu id="SEQLST-1">
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>61 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>1057 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(124)..(894) </s222>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 1 
ctttccaatt ggttcatacc aaagtctgag ctcttcttta tatctctctt gtagtttctt     60 
attgggggtc tttgttttgt ttggttcttt tagagtaaga agtttcttaa aaaaggatca    120 
aaa atg gga agg ggt agg gtt caa ttg aag agg ata gag aac aag atc      168 
    Met Gly Arg Gly Arg Val Gln Leu Lys Arg Ile Glu Asn Lys Ile 
      1               5                  10                  15 
aat aga caa gtg aca ttc tcg aaa aga aga gct ggt ctt ttg aag aaa      216 
Asn Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Leu Lys Lys 
                 20                  25                  30 
gct cat gag atc tct gtt ctc tgt gat gct gaa gtt gct ctt gtt gtc      264 
Ala His Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ala Leu Val Val 
             35                  40                  45 
ttc tcc cat aag ggg aaa ctc ttc gaa tac tcc act gat tct tgt atg      312 
Phe Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Thr Asp Ser Cys Met 
         50                  55                  60 
gag aag ata ctt gaa cgc tat gag agg tac tct tac gcc gaa aga cag      360 
Glu Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg Gln 
     65                  70                  75 
ctt att gca cct gag tcc gac gtc aat aca aac tgg tcg atg gag tat      408 
Leu Ile Ala Pro Glu Ser Asp Val Asn Thr Asn Trp Ser Met Glu Tyr 
 80                  85                  90                  95 
aac agg ctt aag gct aag att gag ctt ttg gag aga aac cag agg cat      456 
Asn Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg His 
                100                 105                 110 
tat ctt ggg gaa gac ttg caa gca atg agc cct aaa gag ctt cag aat      504 
Tyr Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Lys Glu Leu Gln Asn 
            115                 120                 125 
ctg gag cag cag ctt gac act gct ctt aag cac atc cgc act aga aaa      552 
Leu Glu Gln Gln Leu Asp Thr Ala Leu Lys His Ile Arg Thr Arg Lys 
        130                 135                 140 
aac caa ctt atg tac gag tcc atc aat gag ctc caa aaa aag gag aag      600 
Asn Gln Leu Met Tyr Glu Ser Ile Asn Glu Leu Gln Lys Lys Glu Lys 
    145                 150                 155 
gcc ata cag gag caa aac agc atg ctt tct aaa cag atc aag gag agg      648 
Ala Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gln Ile Lys Glu Arg 
160                 165                 170                 175 
gaa aaa att ctt agg gct caa cag gag cag tgg gat cag cag aac caa      696 
Glu Lys Ile Leu Arg Ala Gln Gln Glu Gln Trp Asp Gln Gln Asn Gln 
                180                 185                 190 
ggc cac aat atg cct ccc cct ctg cca ccg cag cag cac caa atc cag      744 
Gly His Asn Met Pro Pro Pro Leu Pro Pro Gln Gln His Gln Ile Gln 
            195                 200                 205 
cat cct tac atg ctc tct cat cag cca tct cct ttt ctc aac atg ggt      792 
His Pro Tyr Met Leu Ser His Gln Pro Ser Pro Phe Leu Asn Met Gly 
        210                 215                 220 
ggt ctg tat caa gaa gat gat cca atg gca atg agg agg aat gat ctc      840 
Gly Leu Tyr Gln Glu Asp Asp Pro Met Ala Met Arg Arg Asn Asp Leu 
    225                 230                 235 
gaa ctg act ctt gaa ccc gtt tac aac tgc aac ctt ggc tgc ttc gcc      888 
Glu Leu Thr Leu Glu Pro Val Tyr Asn Cys Asn Leu Gly Cys Phe Ala 
240                 245                 250                 255 
gca tga agcatttcca tatatatatt tgtaatcgtc aacaataaaa acagtttgcc       944 
Ala 
acatacatat aaatagtggc taggctcttt tcatccaatt aatatatttt ggcaaatgtt   1004 
cgatgttctt atatcatcat atataaatta gcaggctcct ttcttttttt gta          1057 
</s400>
<s200>
<s210>2 </s210>
<s211>256 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 2 
Met Gly Arg Gly Arg Val Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
His Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ala Leu Val Val Phe 
         35                  40                  45 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Thr Asp Ser Cys Met Glu 
     50                  55                  60 
Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu 
 65                  70                  75                  80 
Ile Ala Pro Glu Ser Asp Val Asn Thr Asn Trp Ser Met Glu Tyr Asn 
                 85                  90                  95 
Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg His Tyr 
            100                 105                 110 
Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Lys Glu Leu Gln Asn Leu 
        115                 120                 125 
Glu Gln Gln Leu Asp Thr Ala Leu Lys His Ile Arg Thr Arg Lys Asn 
    130                 135                 140 
Gln Leu Met Tyr Glu Ser Ile Asn Glu Leu Gln Lys Lys Glu Lys Ala 
145                 150                 155                 160 
Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gln Ile Lys Glu Arg Glu 
                165                 170                 175 
Lys Ile Leu Arg Ala Gln Gln Glu Gln Trp Asp Gln Gln Asn Gln Gly 
            180                 185                 190 
His Asn Met Pro Pro Pro Leu Pro Pro Gln Gln His Gln Ile Gln His 
        195                 200                 205 
Pro Tyr Met Leu Ser His Gln Pro Ser Pro Phe Leu Asn Met Gly Gly 
    210                 215                 220 
Leu Tyr Gln Glu Asp Asp Pro Met Ala Met Arg Arg Asn Asp Leu Glu 
225                 230                 235                 240 
Leu Thr Leu Glu Pro Val Tyr Asn Cys Asn Leu Gly Cys Phe Ala Ala 
                245                 250                 255 
</s400>
<s200>
<s210>3 </s210>
<s211>794 </s211>
<s212>DNA </s212>
<s213>Brassica oleracea </s213>
<s220>
<s221>CDS </s221>
<s222>(36)..(794) </s222>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 3 
tcttagagga aatagttcct ttaaaaggga taaaa atg gga agg ggt agg gtt        53 
                                       Met Gly Arg Gly Arg Val 
                                         1               5 
cag ttg aag agg ata gaa aac aag atc aat aga caa gtg aca ttc tcg      101 
Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn Arg Gln Val Thr Phe Ser 
             10                  15                  20 
aaa aga aga gct ggt ctt atg aag aaa gct cat gag atc tct gtt ctg      149 
Lys Arg Arg Ala Gly Leu Met Lys Lys Ala His Glu Ile Ser Val Leu 
         25                  30                  35 
tgt gat gct gaa gtt gcg ctt gtt gtc ttc tcc cat aag ggg aaa ctc      197 
Cys Asp Ala Glu Val Ala Leu Val Val Phe Ser His Lys Gly Lys Leu 
     40                  45                  50 
ttt gaa tac tcc act gat tct tgt atg gag aag ata ctt gaa cgc tat      245 
Phe Glu Tyr Ser Thr Asp Ser Cys Met Glu Lys Ile Leu Glu Arg Tyr 
 55                  60                  65                  70 
gag aga tac tct tac gcc gag aga cag ctt ata gca cct gag tcc gac      293 
Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu Ile Ala Pro Glu Ser Asp 
                 75                  80                  85 
tcc aat acg aac tgg tcg atg gag tat aat agg ctt aag gct aag att      341 
Ser Asn Thr Asn Trp Ser Met Glu Tyr Asn Arg Leu Lys Ala Lys Ile 
             90                  95                 100 
gag ctt ttg gag aga aac cag agg cac tat ctt ggg gaa gac ttg caa      389 
Glu Leu Leu Glu Arg Asn Gln Arg His Tyr Leu Gly Glu Asp Leu Gln 
        105                 110                 115 
gca atg agc cct aag gaa ctc cag aat cta gag caa cag ctt gat act      437 
Ala Met Ser Pro Lys Glu Leu Gln Asn Leu Glu Gln Gln Leu Asp Thr 
    120                 125                 130 
gct ctt aag cac atc cgc tct aga aaa aac caa ctt atg tac gac tcc      485 
Ala Leu Lys His Ile Arg Ser Arg Lys Asn Gln Leu Met Tyr Asp Ser 
135                 140                 145                 150 
atc aat gag ctc caa aga aag gag aaa gcc ata cag gaa caa aac agc      533 
Ile Asn Glu Leu Gln Arg Lys Glu Lys Ala Ile Gln Glu Gln Asn Ser 
                155                 160                 165 
atg ctt tcc aag cag att aag gag agg gaa aac gtt ctt agg gcg caa      581 
Met Leu Ser Lys Gln Ile Lys Glu Arg Glu Asn Val Leu Arg Ala Gln 
            170                 175                 180 
caa gag caa tgg gac gag cag aac cat ggc cat aat atg cct ccg cct      629 
Gln Glu Gln Trp Asp Glu Gln Asn His Gly His Asn Met Pro Pro Pro 
        185                 190                 195 
cca ccc ccg cag cag cat caa atc cag cat cct tac atg ctc tct cat      677 
Pro Pro Pro Gln Gln His Gln Ile Gln His Pro Tyr Met Leu Ser His 
    200                 205                 210 
cag cca tct cct ttt ctc aac atg ggg ggg ctg tat caa gaa gaa gat      725 
Gln Pro Ser Pro Phe Leu Asn Met Gly Gly Leu Tyr Gln Glu Glu Asp 
215                 220                 225                 230 
caa atg gca atg agg agg aac gat ctc gat ctg tct ctt gaa ccc ggt      773 
Gln Met Ala Met Arg Arg Asn Asp Leu Asp Leu Ser Leu Glu Pro Gly 
                235                 240                 245 
tat aac tgc aat ctc ggc tgc                                          794 
Tyr Asn Cys Asn Leu Gly Cys 
            250 
</s400>
<s200>
<s210>4 </s210>
<s211>253 </s211>
<s212>PRT </s212>
<s213>Brassica oleracea </s213>
<s220>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 4 
Met Gly Arg Gly Arg Val Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Met Lys Lys Ala 
             20                  25                  30 
His Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ala Leu Val Val Phe 
         35                  40                  45 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Thr Asp Ser Cys Met Glu 
     50                  55                  60 
Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu 
 65                  70                  75                  80 
Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Trp Ser Met Glu Tyr Asn 
                 85                  90                  95 
Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg His Tyr 
            100                 105                 110 
Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Lys Glu Leu Gln Asn Leu 
        115                 120                 125 
Glu Gln Gln Leu Asp Thr Ala Leu Lys His Ile Arg Ser Arg Lys Asn 
    130                 135                 140 
Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gln Arg Lys Glu Lys Ala 
145                 150                 155                 160 
Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gln Ile Lys Glu Arg Glu 
                165                 170                 175 
Asn Val Leu Arg Ala Gln Gln Glu Gln Trp Asp Glu Gln Asn His Gly 
            180                 185                 190 
His Asn Met Pro Pro Pro Pro Pro Pro Gln Gln His Gln Ile Gln His 
        195                 200                 205 
Pro Tyr Met Leu Ser His Gln Pro Ser Pro Phe Leu Asn Met Gly Gly 
    210                 215                 220 
Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Arg Arg Asn Asp Leu Asp 
225                 230                 235                 240 
Leu Ser Leu Glu Pro Gly Tyr Asn Cys Asn Leu Gly Cys 
                245                 250 
</s400>
<s200>
<s210>5 </s210>
<s211>768 </s211>
<s212>DNA </s212>
<s213>Brassica oleracea var. botrytis </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(768) </s222>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 5 
atg gga agg ggt agg gtt cag ttg aag agg ata gaa aac aag atc aat       48 
Met Gly Arg Gly Arg Val Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
aga caa gtg aca ttc tcg aaa aga aga gct ggt ctt atg aag aaa gct       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Met Lys Lys Ala 
             20                  25                  30 
cat gag atc tct gtt ctg tgt gat gct gaa gtt gcg ctt gtt gtc ttc      144 
His Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ala Leu Val Val Phe 
         35                  40                  45 
tcc cat aag ggg aaa ctc ttt gaa tac ccc act gat tct tgt atg gag      192 
Ser His Lys Gly Lys Leu Phe Glu Tyr Pro Thr Asp Ser Cys Met Glu 
     50                  55                  60 
gag ata ctt gaa cgc tat gag aga tac tct tac gcc gag aga cag ctt      240 
Glu Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu 
 65                  70                  75                  80 
ata gca cct gag tcc gac tcc aat acg aac tgg tcg atg gag tat aat      288 
Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Trp Ser Met Glu Tyr Asn 
                 85                  90                  95 
agg ctt aag gct aag att gag ctt ttg gag aga aac cag agg cac tat      336 
Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg His Tyr 
            100                 105                 110 
ctt ggg gaa gac ttg caa gca atg agc cct aag gaa ctc cag aat cta      384 
Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Lys Glu Leu Gln Asn Leu 
        115                 120                 125 
gag caa cag ctt gat act gct ctt aag cac atc cgc tct aga aaa aac      432 
Glu Gln Gln Leu Asp Thr Ala Leu Lys His Ile Arg Ser Arg Lys Asn 
    130                 135                 140 
caa ctt atg tac gac tcc atc aat gag ctc caa aga aag gag aaa gcc      480 
Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gln Arg Lys Glu Lys Ala 
145                 150                 155                 160 
ata cag gaa caa aac agc atg ctt tcc aag cag att aag gag agg gaa      528 
Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gln Ile Lys Glu Arg Glu 
                165                 170                 175 
aac gtt ctt agg gcg caa caa gag caa tgg gac gag cag aac cat ggc      576 
Asn Val Leu Arg Ala Gln Gln Glu Gln Trp Asp Glu Gln Asn His Gly 
            180                 185                 190 
cat aat atg cct ccg cct cca ccc ccg cag cag cat caa atc cag cat      624 
His Asn Met Pro Pro Pro Pro Pro Pro Gln Gln His Gln Ile Gln His 
        195                 200                 205 
cct tac atg ctc tct cat cag cca tct cct ttt ctc aac atg gga ggg      672 
Pro Tyr Met Leu Ser His Gln Pro Ser Pro Phe Leu Asn Met Gly Gly 
    210                 215                 220 
ctg tat caa gaa gaa gat caa atg gca atg agg agg aac gat ctc gat      720 
Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Arg Arg Asn Asp Leu Asp 
225                 230                 235                 240 
ctg tct ctt gaa ccc gtt tac aac tgc aac ctt ggc cgt cgc tgc tga      768 
Leu Ser Leu Glu Pro Val Tyr Asn Cys Asn Leu Gly Arg Arg Cys 
                245                 250                 255 
</s400>
<s200>
<s210>6 </s210>
<s211>255 </s211>
<s212>PRT </s212>
<s213>Brassica oleracea var. botrytis </s213>
<s220>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 6 
Met Gly Arg Gly Arg Val Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Met Lys Lys Ala 
             20                  25                  30 
His Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ala Leu Val Val Phe 
         35                  40                  45 
Ser His Lys Gly Lys Leu Phe Glu Tyr Pro Thr Asp Ser Cys Met Glu 
     50                  55                  60 
Glu Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu 
 65                  70                  75                  80 
Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Trp Ser Met Glu Tyr Asn 
                 85                  90                  95 
Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg His Tyr 
            100                 105                 110 
Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Lys Glu Leu Gln Asn Leu 
        115                 120                 125 
Glu Gln Gln Leu Asp Thr Ala Leu Lys His Ile Arg Ser Arg Lys Asn 
    130                 135                 140 
Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gln Arg Lys Glu Lys Ala 
145                 150                 155                 160 
Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gln Ile Lys Glu Arg Glu 
                165                 170                 175 
Asn Val Leu Arg Ala Gln Gln Glu Gln Trp Asp Glu Gln Asn His Gly 
            180                 185                 190 
His Asn Met Pro Pro Pro Pro Pro Pro Gln Gln His Gln Ile Gln His 
        195                 200                 205 
Pro Tyr Met Leu Ser His Gln Pro Ser Pro Phe Leu Asn Met Gly Gly 
    210                 215                 220 
Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Arg Arg Asn Asp Leu Asp 
225                 230                 235                 240 
Leu Ser Leu Glu Pro Val Tyr Asn Cys Asn Leu Gly Arg Arg Cys 
                245                 250                 255 
</s400>
<s200>
<s210>7 </s210>
<s211>1345 </s211>
<s212>DNA </s212>
<s213>Zea mays </s213>
<s220>
<s221>CDS </s221>
<s222>(149)..(970) </s222>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 7 
gcacgagtcc tcctcctcct cgcatcccac cccaccccac cttctcctta aagctacctg     60 
cctacccggc ggttgcgcgc cgcaatcgat cgaccggaag agaaagagca gctagctagc    120 
tagcagatcg gagcacggca acaaggcg atg ggg cgc ggc aag gta cag ctg       172 
                               Met Gly Arg Gly Lys Val Gln Leu 
                                 1               5 
aag cgg ata gag aac aag ata aac cgg cag gtg acc ttc tcc aag cgc      220 
Lys Arg Ile Glu Asn Lys Ile Asn Arg Gln Val Thr Phe Ser Lys Arg 
     10                  15                  20 
cgg aac ggc ctg ctc aag aag gcg cac gag atc tcc gtc ctc tgc gat      268 
Arg Asn Gly Leu Leu Lys Lys Ala His Glu Ile Ser Val Leu Cys Asp 
 25                  30                  35                  40 
gcc gag gtc gcc gtc atc gtc ttc tcc ccc aag ggc aag ctc tac gag      316 
Ala Glu Val Ala Val Ile Val Phe Ser Pro Lys Gly Lys Leu Tyr Glu 
                 45                  50                  55 
tac gcc acc gac tcc cgc atg gac aaa att ctt gaa cgc tat gag cga      364 
Tyr Ala Thr Asp Ser Arg Met Asp Lys Ile Leu Glu Arg Tyr Glu Arg 
             60                  65                  70 
tat tcc tat gct gaa aag gct ctt att tca gct gaa tct gaa agt gag      412 
Tyr Ser Tyr Ala Glu Lys Ala Leu Ile Ser Ala Glu Ser Glu Ser Glu 
         75                  80                  85 
gga aat tgg tgc cac gaa tac agg aaa ctg aag gcc aaa att gag acc      460 
Gly Asn Trp Cys His Glu Tyr Arg Lys Leu Lys Ala Lys Ile Glu Thr 
     90                  95                 100 
ata caa aaa tgc cac aag cac ctg atg gga gag gat cta gag tct ttg      508 
Ile Gln Lys Cys His Lys His Leu Met Gly Glu Asp Leu Glu Ser Leu 
105                 110                 115                 120 
aat ccc aaa gag ctc cag caa cta gag cag cag ctg gat agc tca ctg      556 
Asn Pro Lys Glu Leu Gln Gln Leu Glu Gln Gln Leu Asp Ser Ser Leu 
                125                 130                 135 
aag cac atc aga tca agg aag agc cac ctt atg gcc gag tct att tct      604 
Lys His Ile Arg Ser Arg Lys Ser His Leu Met Ala Glu Ser Ile Ser 
            140                 145                 150 
gag cta cag aag aag gag agg tca ctg cag gag gag aac aag gct ctg      652 
Glu Leu Gln Lys Lys Glu Arg Ser Leu Gln Glu Glu Asn Lys Ala Leu 
        155                 160                 165 
cag aag gaa ctt gcg gag agg cag aag gcc gtc gcg agc cgg cag cag      700 
Gln Lys Glu Leu Ala Glu Arg Gln Lys Ala Val Ala Ser Arg Gln Gln 
    170                 175                 180 
cag caa cag cag cag gtg cag tgg gac cag cag aca cat gcc cag gcc      748 
Gln Gln Gln Gln Gln Val Gln Trp Asp Gln Gln Thr His Ala Gln Ala 
185                 190                 195                 200 
cag aca agc tca tca tcg tcc tcc ttc atg atg agg cag gat cag cag      796 
Gln Thr Ser Ser Ser Ser Ser Ser Phe Met Met Arg Gln Asp Gln Gln 
                205                 210                 215 
gga ctg ccg cct cca cac aac atc tgc ttc ccg ccg ttg aca atg gga      844 
Gly Leu Pro Pro Pro His Asn Ile Cys Phe Pro Pro Leu Thr Met Gly 
            220                 225                 230 
gat aga ggt gaa gag ctg gct gcg gcg gcg gcg gcg cag cag cag cag      892 
Asp Arg Gly Glu Glu Leu Ala Ala Ala Ala Ala Ala Gln Gln Gln Gln 
        235                 240                 245 
cca ctg ccg ggg cag gcg caa ccg cag ctc cgc atc gca ggt ctg cca      940 
Pro Leu Pro Gly Gln Ala Gln Pro Gln Leu Arg Ile Ala Gly Leu Pro 
    250                 255                 260 
cca tgg atg ctg agc cac ctc aat gca taa ggagagggtc gatgaacaca        990 
Pro Trp Met Leu Ser His Leu Asn Ala 
265                 270 
tcgacctcct ctctctctct ctctcgtcat ggatcatgac gtacgcgtac catatggttg   1050 
ctgtgcctgc ccccatcgat cgcgagcaat ggcacgctca tgcaagtgat cattgctccc   1110 
cgttggttaa accctagcct atgttcatgg cgtcagcaac taagctaaac tattgttatg   1170 
tttgcaagaa agggtaaacc cgctagctgt gtaatcttgt ccagctatca gtatgcttgt   1230 
tactgcccag ttacccttga atctagcggc gcttttggtg agagggtgca gtttacttta   1290 
aacatggttc gtgacttgct gtaaatagta gtattaatcg atttgggcat ctaaa        1345 
</s400>
<s200>
<s210>8 </s210>
<s211>273 </s211>
<s212>PRT </s212>
<s213>Zea mays </s213>
<s220>
<s223>APETALA1 (AP1) </s223>
</s220>
</s200>
<s400> 8 
Met Gly Arg Gly Lys Val Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
His Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ala Val Ile Val Phe 
         35                  40                  45 
Ser Pro Lys Gly Lys Leu Tyr Glu Tyr Ala Thr Asp Ser Arg Met Asp 
     50                  55                  60 
Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Lys Ala Leu 
 65                  70                  75                  80 
Ile Ser Ala Glu Ser Glu Ser Glu Gly Asn Trp Cys His Glu Tyr Arg 
                 85                  90                  95 
Lys Leu Lys Ala Lys Ile Glu Thr Ile Gln Lys Cys His Lys His Leu 
            100                 105                 110 
Met Gly Glu Asp Leu Glu Ser Leu Asn Pro Lys Glu Leu Gln Gln Leu 
        115                 120                 125 
Glu Gln Gln Leu Asp Ser Ser Leu Lys His Ile Arg Ser Arg Lys Ser 
    130                 135                 140 
His Leu Met Ala Glu Ser Ile Ser Glu Leu Gln Lys Lys Glu Arg Ser 
145                 150                 155                 160 
Leu Gln Glu Glu Asn Lys Ala Leu Gln Lys Glu Leu Ala Glu Arg Gln 
                165                 170                 175 
Lys Ala Val Ala Ser Arg Gln Gln Gln Gln Gln Gln Gln Val Gln Trp 
            180                 185                 190 
Asp Gln Gln Thr His Ala Gln Ala Gln Thr Ser Ser Ser Ser Ser Ser 
        195                 200                 205 
Phe Met Met Arg Gln Asp Gln Gln Gly Leu Pro Pro Pro His Asn Ile 
    210                 215                 220 
Cys Phe Pro Pro Leu Thr Met Gly Asp Arg Gly Glu Glu Leu Ala Ala 
225                 230                 235                 240 
Ala Ala Ala Ala Gln Gln Gln Gln Pro Leu Pro Gly Gln Ala Gln Pro 
                245                 250                 255 
Gln Leu Arg Ile Ala Gly Leu Pro Pro Trp Met Leu Ser His Leu Asn 
            260                 265                 270 
Ala 
</s400>
<s200>
<s210>9 </s210>
<s211>779 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(10)..(777) </s222>
<s223>CAULIFLOWER (CAL) </s223>
</s220>
</s200>
<s400> 9 
ttaagagaa atg gga agg ggt agg gtt gaa ttg aag agg ata gag aac aag     51 
          Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys 
            1               5                  10 
atc aat aga caa gtg aca ttc tcg aaa aga aga act ggt ctt ttg aag       99 
Ile Asn Arg Gln Val Thr Phe Ser Lys Arg Arg Thr Gly Leu Leu Lys 
 15                  20                  25                  30 
aaa gct cag gag atc tct gtt ctt tgt gat gcc gag gtt tcc ctt att      147 
Lys Ala Gln Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ser Leu Ile 
                 35                  40                  45 
gtc ttc tcc cat aag ggc aaa ttg ttc gag tac tcc tct gaa tct tgc      195 
Val Phe Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Ser Glu Ser Cys 
             50                  55                  60 
atg gag aag gta cta gaa cgc tac gag agg tat tct tac gcc gag aga      243 
Met Glu Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg 
         65                  70                  75 
cag ctg att gca cct gac tct cac gtt aat gca cag acg aac tgg tca      291 
Gln Leu Ile Ala Pro Asp Ser His Val Asn Ala Gln Thr Asn Trp Ser 
     80                  85                  90 
atg gag tat agc agg ctt aag gcc aag att gag ctt ttg gag aga aac      339 
Met Glu Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn 
 95                 100                 105                 110 
caa agg cat tat ctg gga gaa gag ttg gaa cca atg agc ctc aag gat      387 
Gln Arg His Tyr Leu Gly Glu Glu Leu Glu Pro Met Ser Leu Lys Asp 
                115                 120                 125 
ctc caa aat ctg gag cag cag ctt gag act gct ctt aag cac att cgc      435 
Leu Gln Asn Leu Glu Gln Gln Leu Glu Thr Ala Leu Lys His Ile Arg 
            130                 135                 140 
tcc aga aaa aat caa ctc atg aat gag tcc ctc aac cac ctc caa aga      483 
Ser Arg Lys Asn Gln Leu Met Asn Glu Ser Leu Asn His Leu Gln Arg 
        145                 150                 155 
aag gag aag gag ata cag gag gaa aac agc atg ctt acc aaa cag ata      531 
Lys Glu Lys Glu Ile Gln Glu Glu Asn Ser Met Leu Thr Lys Gln Ile 
    160                 165                 170 
aag gag agg gaa aac atc cta aag aca aaa caa acc caa tgt gag cag      579 
Lys Glu Arg Glu Asn Ile Leu Lys Thr Lys Gln Thr Gln Cys Glu Gln 
175                 180                 185                 190 
ctg aac cgc agc gtc gac gat gta cca cag cca caa cca ttt caa cac      627 
Leu Asn Arg Ser Val Asp Asp Val Pro Gln Pro Gln Pro Phe Gln His 
                195                 200                 205 
ccc cat ctt tac atg atc gct cat cag act tct cct ttc cta aat atg      675 
Pro His Leu Tyr Met Ile Ala His Gln Thr Ser Pro Phe Leu Asn Met 
            210                 215                 220 
ggt ggt ttg tac caa gga gaa gac caa acg gcg atg agg agg aac aat      723 
Gly Gly Leu Tyr Gln Gly Glu Asp Gln Thr Ala Met Arg Arg Asn Asn 
        225                 230                 235 
ctg gat ctg act ctt gaa ccc att tac aat tac ctt ggc tgt tac gcc      771 
Leu Asp Leu Thr Leu Glu Pro Ile Tyr Asn Tyr Leu Gly Cys Tyr Ala 
    240                 245                 250 
gct tga nn                                                           779 
Ala 
255 
</s400>
<s200>
<s210>10 </s210>
<s211>255 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>CAULIFLOWER (CAL) </s223>
</s220>
</s200>
<s400> 10 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Thr Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
Gln Glu Ile Ser Val Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Ser Glu Ser Cys Met Glu 
     50                  55                  60 
Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu 
 65                  70                  75                  80 
Ile Ala Pro Asp Ser His Val Asn Ala Gln Thr Asn Trp Ser Met Glu 
                 85                  90                  95 
Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg 
            100                 105                 110 
His Tyr Leu Gly Glu Glu Leu Glu Pro Met Ser Leu Lys Asp Leu Gln 
        115                 120                 125 
Asn Leu Glu Gln Gln Leu Glu Thr Ala Leu Lys His Ile Arg Ser Arg 
    130                 135                 140 
Lys Asn Gln Leu Met Asn Glu Ser Leu Asn His Leu Gln Arg Lys Glu 
145                 150                 155                 160 
Lys Glu Ile Gln Glu Glu Asn Ser Met Leu Thr Lys Gln Ile Lys Glu 
                165                 170                 175 
Arg Glu Asn Ile Leu Lys Thr Lys Gln Thr Gln Cys Glu Gln Leu Asn 
            180                 185                 190 
Arg Ser Val Asp Asp Val Pro Gln Pro Gln Pro Phe Gln His Pro His 
        195                 200                 205 
Leu Tyr Met Ile Ala His Gln Thr Ser Pro Phe Leu Asn Met Gly Gly 
    210                 215                 220 
Leu Tyr Gln Gly Glu Asp Gln Thr Ala Met Arg Arg Asn Asn Leu Asp 
225                 230                 235                 240 
Leu Thr Leu Glu Pro Ile Tyr Asn Tyr Leu Gly Cys Tyr Ala Ala 
                245                 250                 255 
</s400>
<s200>
<s210>11 </s210>
<s211>756 </s211>
<s212>DNA </s212>
<s213>Brassica oleracea </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(756) </s222>
<s223>CAULIFLOWER </s223>
</s220>
</s200>
<s400> 11 
atg gga agg ggt agg gtt gaa atg aag agg ata gag aac aag atc aac       48 
Met Gly Arg Gly Arg Val Glu Met Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
cga caa gtg acg ttt tcg aaa aga aga gct ggt ctt ttg aag aaa gcc       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
cat gag atc tcg atc ctt tgt gat gct gag gtt tcc ctt att gtc ttc      144 
His Glu Ile Ser Ile Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
tcc cat aag ggg aaa ctg ttc gag tac tcg tct gaa tct tgc atg gag      192 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Ser Glu Ser Cys Met Glu 
     50                  55                  60 
aag gta cta gaa cac tac gag agg tac tct tac gcc gag aaa cag cta      240 
Lys Val Leu Glu His Tyr Glu Arg Tyr Ser Tyr Ala Glu Lys Gln Leu 
 65                  70                  75                  80 
aaa gtt cca gac tct cac gtc aat gca caa acg aac tgg tca gtg gaa      288 
Lys Val Pro Asp Ser His Val Asn Ala Gln Thr Asn Trp Ser Val Glu 
                 85                  90                  95 
tat agc agg ctt aag gct aag att gag ctt ttg gag aga aac caa agg      336 
Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg 
            100                 105                 110 
cat tat ctg ggc gaa gat tta gaa tca atc agc ata aag gag cta cag      384 
His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Ser Ile Lys Glu Leu Gln 
        115                 120                 125 
aat ctg gag cag cag ctt gac act tct ctt aaa cat att cgc tcg aga      432 
Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Lys His Ile Arg Ser Arg 
    130                 135                 140 
aaa aat caa cta atg cac gag tcc ctc aac cac ctc caa aga aag gag      480 
Lys Asn Gln Leu Met His Glu Ser Leu Asn His Leu Gln Arg Lys Glu 
145                 150                 155                 160 
aaa gaa ata ctg gag gaa aac agc atg ctt gcc aaa cag ata agg gag      528 
Lys Glu Ile Leu Glu Glu Asn Ser Met Leu Ala Lys Gln Ile Arg Glu 
                165                 170                 175 
agg gag agt atc cta agg aca cat caa aac caa tca gag cag caa aac      576 
Arg Glu Ser Ile Leu Arg Thr His Gln Asn Gln Ser Glu Gln Gln Asn 
            180                 185                 190 
cgc agc cac cat gta gct cct cag ccg caa ccg cag tta aat cct tac      624 
Arg Ser His His Val Ala Pro Gln Pro Gln Pro Gln Leu Asn Pro Tyr 
        195                 200                 205 
atg gca tca tct cct ttc cta aat atg ggt ggc atg tac caa gga gaa      672 
Met Ala Ser Ser Pro Phe Leu Asn Met Gly Gly Met Tyr Gln Gly Glu 
    210                 215                 220 
tat cca acg gcg gtg agg agg aac cgt ctc gat ctg act ctt gaa ccc      720 
Tyr Pro Thr Ala Val Arg Arg Asn Arg Leu Asp Leu Thr Leu Glu Pro 
225                 230                 235                 240 
att tac aac tgc aac ctt ggt tac ttt gcc gca tga                      756 
Ile Tyr Asn Cys Asn Leu Gly Tyr Phe Ala Ala 
                245                 250 
</s400>
<s200>
<s210>12 </s210>
<s211>251 </s211>
<s212>PRT </s212>
<s213>Brassica oleracea </s213>
<s220>
<s223>CAULIFLOWER (CAL) </s223>
</s220>
</s200>
<s400> 12 
Met Gly Arg Gly Arg Val Glu Met Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
His Glu Ile Ser Ile Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Ser Glu Ser Cys Met Glu 
     50                  55                  60 
Lys Val Leu Glu His Tyr Glu Arg Tyr Ser Tyr Ala Glu Lys Gln Leu 
 65                  70                  75                  80 
Lys Val Pro Asp Ser His Val Asn Ala Gln Thr Asn Trp Ser Val Glu 
                 85                  90                  95 
Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Arg Asn Gln Arg 
            100                 105                 110 
His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Ser Ile Lys Glu Leu Gln 
        115                 120                 125 
Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Lys His Ile Arg Ser Arg 
    130                 135                 140 
Lys Asn Gln Leu Met His Glu Ser Leu Asn His Leu Gln Arg Lys Glu 
145                 150                 155                 160 
Lys Glu Ile Leu Glu Glu Asn Ser Met Leu Ala Lys Gln Ile Arg Glu 
                165                 170                 175 
Arg Glu Ser Ile Leu Arg Thr His Gln Asn Gln Ser Glu Gln Gln Asn 
            180                 185                 190 
Arg Ser His His Val Ala Pro Gln Pro Gln Pro Gln Leu Asn Pro Tyr 
        195                 200                 205 
Met Ala Ser Ser Pro Phe Leu Asn Met Gly Gly Met Tyr Gln Gly Glu 
    210                 215                 220 
Tyr Pro Thr Ala Val Arg Arg Asn Arg Leu Asp Leu Thr Leu Glu Pro 
225                 230                 235                 240 
Ile Tyr Asn Cys Asn Leu Gly Tyr Phe Ala Ala 
                245                 250 
</s400>
<s200>
<s210>13 </s210>
<s211>756 </s211>
<s212>DNA </s212>
<s213>Brassica oleracea var. botrytis </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(453) </s222>
<s223>CAULIFLOWER </s223>
</s220>
</s200>
<s400> 13 
atg gga agg ggt agg gtt gaa atg aag agg ata gag aac aag atc aac       48 
Met Gly Arg Gly Arg Val Glu Met Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
aga caa gtg acg ttt tcg aaa aga aga gct ggt ctt ttg aag aaa gcc       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
cat gag atc tcg att ctt tgt gat gct gag gtt tcc ctt att gtc ttc      144 
His Glu Ile Ser Ile Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
tcc cat aag ggg aaa ctg ttc gag tac tcg tct gaa tct tgc atg gag      192 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Ser Glu Ser Cys Met Glu 
     50                  55                  60 
aag gta cta gaa cgc tac gag agg tac tct tac gcc gag aaa cag cta      240 
Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Lys Gln Leu 
 65                  70                  75                  80 
aaa gct cca gac tct cac gtc aat gca caa acg aac tgg tca atg gaa      288 
Lys Ala Pro Asp Ser His Val Asn Ala Gln Thr Asn Trp Ser Met Glu 
                 85                  90                  95 
tat agc agg ctt aag gct aag att gag ctt tgg gag agg aac caa agg      336 
Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Trp Glu Arg Asn Gln Arg 
            100                 105                 110 
cat tat ctg gga gaa gat tta gaa tca atc agc ata aag gag cta cag      384 
His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Ser Ile Lys Glu Leu Gln 
        115                 120                 125 
aat ctg gag cag cag ctt gac act tct ctt aaa cat att cgc tcc aga      432 
Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Lys His Ile Arg Ser Arg 
    130                 135                 140 
aaa aat caa cta atg cac tag tccctcaacc acctccaaag aaaggagaaa         483 
Lys Asn Gln Leu Met His 
145                 150 
gaaatactgg aggaaaacag catgcttgcc aaacagataa aggagaggga gagtatccta    543 
aggacacatc aaaaccaatc agagcagcaa aaccgcagcc accatgtagc tcctcagccg    603 
caaccgcagt taaatcctta catggcatca tctcctttcc taaatatggg tggcatgtac    663 
caaggagaat atccaacggc ggtgaggagg aaccgtctcg atctgactct tgaacccatt    723 
tacaactgca accttggtta ctttgccgca tga                                 756 
</s400>
<s200>
<s210>14 </s210>
<s211>150 </s211>
<s212>PRT </s212>
<s213>Brassica oleracea var. botrytis </s213>
<s220>
<s223>CAULIFLOWER (CAL) </s223>
</s220>
</s200>
<s400> 14 
Met Gly Arg Gly Arg Val Glu Met Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
His Glu Ile Ser Ile Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Ser Glu Ser Cys Met Glu 
     50                  55                  60 
Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Tyr Ala Glu Lys Gln Leu 
 65                  70                  75                  80 
Lys Ala Pro Asp Ser His Val Asn Ala Gln Thr Asn Trp Ser Met Glu 
                 85                  90                  95 
Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Trp Glu Arg Asn Gln Arg 
            100                 105                 110 
His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Ser Ile Lys Glu Leu Gln 
        115                 120                 125 
Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Lys His Ile Arg Ser Arg 
    130                 135                 140 
Lys Asn Gln Leu Met His 
145                 150 
</s400>
<s200>
<s210>15 </s210>
<s211>1500 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(72)..(1346) </s222>
<s223>LEAFY (LFY) </s223>
</s220>
</s200>
<s400> 15 
aaagcaatct gctcaaaaga gtaaagaaag agagaaaaag agagtgatag agagagagag     60 
aaaaatagat t atg gat cct gaa ggt ttc acg agt ggc tta ttc cgg tgg     110 
             Met Asp Pro Glu Gly Phe Thr Ser Gly Leu Phe Arg Trp 
               1               5                  10 
aac cca acg aga gca ttg gtt caa gca cca cct ccg gtt cca cct ccg      158 
Asn Pro Thr Arg Ala Leu Val Gln Ala Pro Pro Pro Val Pro Pro Pro 
     15                  20                  25 
ctg cag caa cag ccg gtg aca ccg cag acg gct gct ttt ggg atg cga      206 
Leu Gln Gln Gln Pro Val Thr Pro Gln Thr Ala Ala Phe Gly Met Arg 
 30                  35                  40                  45 
ctt ggt ggt tta gag gga cta ttc ggt cca tac ggt ata cgt ttc tac      254 
Leu Gly Gly Leu Glu Gly Leu Phe Gly Pro Tyr Gly Ile Arg Phe Tyr 
                 50                  55                  60 
acg gcg gcg aag ata gcg gag tta ggt ttt acg gcg agc acg ctt gtg      302 
Thr Ala Ala Lys Ile Ala Glu Leu Gly Phe Thr Ala Ser Thr Leu Val 
             65                  70                  75 
ggt atg aag gac gag gag ctt gaa gag atg atg aat agt ctc tct cat      350 
Gly Met Lys Asp Glu Glu Leu Glu Glu Met Met Asn Ser Leu Ser His 
         80                  85                  90 
atc ttt cgt tgg gag ctt ctt gtt ggt gaa cgg tac ggt atc aaa gct      398 
Ile Phe Arg Trp Glu Leu Leu Val Gly Glu Arg Tyr Gly Ile Lys Ala 
     95                 100                 105 
gcc gtt aga gct gaa cgg aga cga ttg caa gaa gag gag gaa gag gaa      446 
Ala Val Arg Ala Glu Arg Arg Arg Leu Gln Glu Glu Glu Glu Glu Glu 
110                 115                 120                 125 
tct tct aga cgc cgt cat ttg cta ctc tcc gcc gct ggt gat tcc ggt      494 
Ser Ser Arg Arg Arg His Leu Leu Leu Ser Ala Ala Gly Asp Ser Gly 
                130                 135                 140 
act cat cac gct ctt gat gct ctc tcc caa gaa gat gat tgg aca ggg      542 
Thr His His Ala Leu Asp Ala Leu Ser Gln Glu Asp Asp Trp Thr Gly 
            145                 150                 155 
tta tct gag gaa ccg gtg cag caa caa gac cag act gat gcg gcg ggg      590 
Leu Ser Glu Glu Pro Val Gln Gln Gln Asp Gln Thr Asp Ala Ala Gly 
        160                 165                 170 
aat aac ggc gga gga gga agt ggt tac tgg gac gca ggt caa gga aag      638 
Asn Asn Gly Gly Gly Gly Ser Gly Tyr Trp Asp Ala Gly Gln Gly Lys 
    175                 180                 185 
atg aag aag caa cag cag cag aga cgg aga aag aaa cca atg ctg acg      686 
Met Lys Lys Gln Gln Gln Gln Arg Arg Arg Lys Lys Pro Met Leu Thr 
190                 195                 200                 205 
tca gtg gaa acc gac gaa gac gtc aac gaa ggt gag gat gac gac ggg      734 
Ser Val Glu Thr Asp Glu Asp Val Asn Glu Gly Glu Asp Asp Asp Gly 
                210                 215                 220 
atg gat aac ggc aac gga ggt agt ggt ttg ggg aca gag aga cag agg      782 
Met Asp Asn Gly Asn Gly Gly Ser Gly Leu Gly Thr Glu Arg Gln Arg 
            225                 230                 235 
gag cat ccg ttt atc gta acg gag cct ggg gaa gtg gca cgt ggc aaa      830 
Glu His Pro Phe Ile Val Thr Glu Pro Gly Glu Val Ala Arg Gly Lys 
        240                 245                 250 
aag aac ggc tta gat tat ctg ttc cac ttg tac gaa caa tgc cgt gag      878 
Lys Asn Gly Leu Asp Tyr Leu Phe His Leu Tyr Glu Gln Cys Arg Glu 
    255                 260                 265 
ttc ctt ctt cag gtc cag aca att gct aaa gac cgt ggc gaa aaa tgc      926 
Phe Leu Leu Gln Val Gln Thr Ile Ala Lys Asp Arg Gly Glu Lys Cys 
270                 275                 280                 285 
ccc acc aag gtg acg aac caa gta ttc agg tac gcg aag aaa tca gga      974 
Pro Thr Lys Val Thr Asn Gln Val Phe Arg Tyr Ala Lys Lys Ser Gly 
                290                 295                 300 
gcg agt tac ata aac aag cct aaa atg cga cac tac gtt cac tgt tac     1022 
Ala Ser Tyr Ile Asn Lys Pro Lys Met Arg His Tyr Val His Cys Tyr 
            305                 310                 315 
gct ctc cac tgc cta gac gaa gaa gct tca aat gct ctc aga aga gcg     1070 
Ala Leu His Cys Leu Asp Glu Glu Ala Ser Asn Ala Leu Arg Arg Ala 
        320                 325                 330 
ttt aaa gaa cgc ggt gag aac gtt ggc tca tgg cgt cag gct tgt tac     1118 
Phe Lys Glu Arg Gly Glu Asn Val Gly Ser Trp Arg Gln Ala Cys Tyr 
    335                 340                 345 
aag cca ctt gtg aac atc gct tgt cgt cat ggc tgg gat ata gac gcc     1166 
Lys Pro Leu Val Asn Ile Ala Cys Arg His Gly Trp Asp Ile Asp Ala 
350                 355                 360                 365 
gtc ttt aac gct cat cct cgt ctc tct att tgg tat gtt cca aca aag     1214 
Val Phe Asn Ala His Pro Arg Leu Ser Ile Trp Tyr Val Pro Thr Lys 
                370                 375                 380 
ctg cgt cag ctt tgc cat ttg gag cgg aac aat gcg gtt gct gcg gct     1262 
Leu Arg Gln Leu Cys His Leu Glu Arg Asn Asn Ala Val Ala Ala Ala 
            385                 390                 395 
gcg gct tta gtt ggc ggt att agc tgt acc gga tcg tcg acg tct gga     1310 
Ala Ala Leu Val Gly Gly Ile Ser Cys Thr Gly Ser Ser Thr Ser Gly 
        400                 405                 410 
cgt ggt gga tgc ggc ggc gac gac ttg cgt ttc tag tttggtttgg          1356 
Arg Gly Gly Cys Gly Gly Asp Asp Leu Arg Phe 
    415                 420                 425 
gtagttgtgg tttgtttagt cgttatccta attaactatt agtctttaat ttagtcttct   1416 
tggctaattt atttttcttt ttttgtcaaa acctttaatt tgttatggct aatttgttat   1476 
acacgcagtt ttcttaatgc gtta                                          1500 
</s400>
<s200>
<s210>16 </s210>
<s211>424 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>LEAFY (LFY) </s223>
</s220>
</s200>
<s400> 16 
Met Asp Pro Glu Gly Phe Thr Ser Gly Leu Phe Arg Trp Asn Pro Thr 
  1               5                  10                  15 
Arg Ala Leu Val Gln Ala Pro Pro Pro Val Pro Pro Pro Leu Gln Gln 
             20                  25                  30 
Gln Pro Val Thr Pro Gln Thr Ala Ala Phe Gly Met Arg Leu Gly Gly 
         35                  40                  45 
Leu Glu Gly Leu Phe Gly Pro Tyr Gly Ile Arg Phe Tyr Thr Ala Ala 
     50                  55                  60 
Lys Ile Ala Glu Leu Gly Phe Thr Ala Ser Thr Leu Val Gly Met Lys 
 65                  70                  75                  80 
Asp Glu Glu Leu Glu Glu Met Met Asn Ser Leu Ser His Ile Phe Arg 
                 85                  90                  95 
Trp Glu Leu Leu Val Gly Glu Arg Tyr Gly Ile Lys Ala Ala Val Arg 
            100                 105                 110 
Ala Glu Arg Arg Arg Leu Gln Glu Glu Glu Glu Glu Glu Ser Ser Arg 
        115                 120                 125 
Arg Arg His Leu Leu Leu Ser Ala Ala Gly Asp Ser Gly Thr His His 
    130                 135                 140 
Ala Leu Asp Ala Leu Ser Gln Glu Asp Asp Trp Thr Gly Leu Ser Glu 
145                 150                 155                 160 
Glu Pro Val Gln Gln Gln Asp Gln Thr Asp Ala Ala Gly Asn Asn Gly 
                165                 170                 175 
Gly Gly Gly Ser Gly Tyr Trp Asp Ala Gly Gln Gly Lys Met Lys Lys 
            180                 185                 190 
Gln Gln Gln Gln Arg Arg Arg Lys Lys Pro Met Leu Thr Ser Val Glu 
        195                 200                 205 
Thr Asp Glu Asp Val Asn Glu Gly Glu Asp Asp Asp Gly Met Asp Asn 
    210                 215                 220 
Gly Asn Gly Gly Ser Gly Leu Gly Thr Glu Arg Gln Arg Glu His Pro 
225                 230                 235                 240 
Phe Ile Val Thr Glu Pro Gly Glu Val Ala Arg Gly Lys Lys Asn Gly 
                245                 250                 255 
Leu Asp Tyr Leu Phe His Leu Tyr Glu Gln Cys Arg Glu Phe Leu Leu 
            260                 265                 270 
Gln Val Gln Thr Ile Ala Lys Asp Arg Gly Glu Lys Cys Pro Thr Lys 
        275                 280                 285 
Val Thr Asn Gln Val Phe Arg Tyr Ala Lys Lys Ser Gly Ala Ser Tyr 
    290                 295                 300 
Ile Asn Lys Pro Lys Met Arg His Tyr Val His Cys Tyr Ala Leu His 
305                 310                 315                 320 
Cys Leu Asp Glu Glu Ala Ser Asn Ala Leu Arg Arg Ala Phe Lys Glu 
                325                 330                 335 
Arg Gly Glu Asn Val Gly Ser Trp Arg Gln Ala Cys Tyr Lys Pro Leu 
            340                 345                 350 
Val Asn Ile Ala Cys Arg His Gly Trp Asp Ile Asp Ala Val Phe Asn 
        355                 360                 365 
Ala His Pro Arg Leu Ser Ile Trp Tyr Val Pro Thr Lys Leu Arg Gln 
    370                 375                 380 
Leu Cys His Leu Glu Arg Asn Asn Ala Val Ala Ala Ala Ala Ala Leu 
385                 390                 395                 400 
Val Gly Gly Ile Ser Cys Thr Gly Ser Ser Thr Ser Gly Arg Gly Gly 
                405                 410                 415 
Cys Gly Gly Asp Asp Leu Arg Phe 
            420 
</s400>
<s200>
<s210>17 </s210>
<s211>1656 </s211>
<s212>DNA </s212>
<s213>Drosophila melanogaster </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(1653) </s222>
<s223>ecdysone receptor ligand binding domain </s223>
</s220>
</s200>
<s400> 17 
atg cgg ccg gaa tgc gtc gtc ccg gag aac caa tgt gcg atg aag cgg       48 
Met Arg Pro Glu Cys Val Val Pro Glu Asn Gln Cys Ala Met Lys Arg 
  1               5                  10                  15 
cgc gaa aag aag gcc cag aag gag aag gac aaa atg acc act tcg ccg       96 
Arg Glu Lys Lys Ala Gln Lys Glu Lys Asp Lys Met Thr Thr Ser Pro 
             20                  25                  30 
agc tct cag cat ggc ggc aat ggc agc ttg gcc tct ggt ggc ggc caa      144 
Ser Ser Gln His Gly Gly Asn Gly Ser Leu Ala Ser Gly Gly Gly Gln 
         35                  40                  45 
gac ttt gtt aag aag gag att ctt gac ctt atg aca tgc gag ccg ccc      192 
Asp Phe Val Lys Lys Glu Ile Leu Asp Leu Met Thr Cys Glu Pro Pro 
     50                  55                  60 
cag cat gcc act att ccg cta cta cct gat gaa ata ttg gcc aag tgt      240 
Gln His Ala Thr Ile Pro Leu Leu Pro Asp Glu Ile Leu Ala Lys Cys 
 65                  70                  75                  80 
caa gcg cgc aat ata cct tcc tta acg tac aat cag ttg gcc gtt ata      288 
Gln Ala Arg Asn Ile Pro Ser Leu Thr Tyr Asn Gln Leu Ala Val Ile 
                 85                  90                  95 
tac aag tta att tgg tac cag gat ggc tat gag cag cca tct gaa gag      336 
Tyr Lys Leu Ile Trp Tyr Gln Asp Gly Tyr Glu Gln Pro Ser Glu Glu 
            100                 105                 110 
gat ctc agg cgt ata atg agt caa ccc gat gag aac gag agc caa acg      384 
Asp Leu Arg Arg Ile Met Ser Gln Pro Asp Glu Asn Glu Ser Gln Thr 
        115                 120                 125 
gac gtc agc ttt cgg cat ata acc gag ata acc ata ctc acg gtc cag      432 
Asp Val Ser Phe Arg His Ile Thr Glu Ile Thr Ile Leu Thr Val Gln 
    130                 135                 140 
ttg att gtt gag ttt gct aaa ggt cta cca gcg ttt aca aag ata ccc      480 
Leu Ile Val Glu Phe Ala Lys Gly Leu Pro Ala Phe Thr Lys Ile Pro 
145                 150                 155                 160 
cag gag gac cag atc acg tta cta aag gcc tgc tcg tcg gag gtg atg      528 
Gln Glu Asp Gln Ile Thr Leu Leu Lys Ala Cys Ser Ser Glu Val Met 
                165                 170                 175 
atg ctg cgt atg gca cga cgc tat gac cac agc tcg gac tca ata ttc      576 
Met Leu Arg Met Ala Arg Arg Tyr Asp His Ser Ser Asp Ser Ile Phe 
            180                 185                 190 
ttc gcg aat aat aga tca tat acg cgg gat tct tac aaa atg gcc gga      624 
Phe Ala Asn Asn Arg Ser Tyr Thr Arg Asp Ser Tyr Lys Met Ala Gly 
        195                 200                 205 
atg gct gat aac att gaa gac ctg ctg cat ttc tgc cgc caa atg ttc      672 
Met Ala Asp Asn Ile Glu Asp Leu Leu His Phe Cys Arg Gln Met Phe 
    210                 215                 220 
tcg atg aag gtg gac aac gtc gaa tac gcg ctt ctc act gcc att gtg      720 
Ser Met Lys Val Asp Asn Val Glu Tyr Ala Leu Leu Thr Ala Ile Val 
225                 230                 235                 240 
atc ttc tcg gac cgg ccg ggc ctg gag aag gcc caa cta gtc gaa gcg      768 
Ile Phe Ser Asp Arg Pro Gly Leu Glu Lys Ala Gln Leu Val Glu Ala 
                245                 250                 255 
atc cag agc tac tac atc gac acg cta cgc att tat ata ctc aac cgc      816 
Ile Gln Ser Tyr Tyr Ile Asp Thr Leu Arg Ile Tyr Ile Leu Asn Arg 
            260                 265                 270 
cac tgc ggc gac tca atg agc ctc gtc ttc tac gca aag ctg ctc tcg      864 
His Cys Gly Asp Ser Met Ser Leu Val Phe Tyr Ala Lys Leu Leu Ser 
        275                 280                 285 
atc ctc acc gag ctg cgt acg ctg ggc aac cag aac gcc gag atg tgt      912 
Ile Leu Thr Glu Leu Arg Thr Leu Gly Asn Gln Asn Ala Glu Met Cys 
    290                 295                 300 
ttc tca cta aag ctc aaa aac cgc aaa ctg ccc aag ttc ctc gag gag      960 
Phe Ser Leu Lys Leu Lys Asn Arg Lys Leu Pro Lys Phe Leu Glu Glu 
305                 310                 315                 320 
atc tgg gac gtt cat gcc atc ccg cca tcg gtc cag tcg cac ctt cag     1008 
Ile Trp Asp Val His Ala Ile Pro Pro Ser Val Gln Ser His Leu Gln 
                325                 330                 335 
att acc cag gag gag aac gag cgt ctc gag cgg gct gag cgt atg cgg     1056 
Ile Thr Gln Glu Glu Asn Glu Arg Leu Glu Arg Ala Glu Arg Met Arg 
            340                 345                 350 
gca tcg gtt ggg ggc gcc att acc gcc ggc att gat tgc gac tct gcc     1104 
Ala Ser Val Gly Gly Ala Ile Thr Ala Gly Ile Asp Cys Asp Ser Ala 
        355                 360                 365 
tcc act tcg gcg gcg gca gcc gcg gcc cag cat cag cct cag cct cag     1152 
Ser Thr Ser Ala Ala Ala Ala Ala Ala Gln His Gln Pro Gln Pro Gln 
    370                 375                 380 
ccc cag ccc caa ccc tcc tcc ctg acc cag aac gat tcc cag cac cag     1200 
Pro Gln Pro Gln Pro Ser Ser Leu Thr Gln Asn Asp Ser Gln His Gln 
385                 390                 395                 400 
aca cag ccg cag cta caa cct cag cta cca cct cag ctg caa ggt caa     1248 
Thr Gln Pro Gln Leu Gln Pro Gln Leu Pro Pro Gln Leu Gln Gly Gln 
                405                 410                 415 
ctg caa ccc cag ctc caa cca cag ctt cag acg caa ctc cag cca cag     1296 
Leu Gln Pro Gln Leu Gln Pro Gln Leu Gln Thr Gln Leu Gln Pro Gln 
            420                 425                 430 
att caa cca cag cca cag ctc ctt ccc gtc tcc gct ccc gtg ccc gcc     1344 
Ile Gln Pro Gln Pro Gln Leu Leu Pro Val Ser Ala Pro Val Pro Ala 
        435                 440                 445 
tcc gta acc gca cct ggt tcc ttg tcc gcg gtc agt acg agc agc gaa     1392 
Ser Val Thr Ala Pro Gly Ser Leu Ser Ala Val Ser Thr Ser Ser Glu 
    450                 455                 460 
tac atg ggc gga agt gcg gcc ata gga ccc atc acg ccg gca acc acc     1440 
Tyr Met Gly Gly Ser Ala Ala Ile Gly Pro Ile Thr Pro Ala Thr Thr 
465                 470                 475                 480 
agc agt atc acg gct gcc gtt acc gct agc tcc acc aca tca gcg gta     1488 
Ser Ser Ile Thr Ala Ala Val Thr Ala Ser Ser Thr Thr Ser Ala Val 
                485                 490                 495 
ccg atg ggc aac gga gtt gga gtc ggt gtt ggg gtg ggc ggc aac gtc     1536 
Pro Met Gly Asn Gly Val Gly Val Gly Val Gly Val Gly Gly Asn Val 
            500                 505                 510 
agc atg tat gcg aac gcc cag acg gcg atg gcc ttg atg ggt gta gcc     1584 
Ser Met Tyr Ala Asn Ala Gln Thr Ala Met Ala Leu Met Gly Val Ala 
        515                 520                 525 
ctg cat tcg cac caa gag cag ctt atc ggg gga gtg gcg gtt aag tcg     1632 
Leu His Ser His Gln Glu Gln Leu Ile Gly Gly Val Ala Val Lys Ser 
    530                 535                 540 
gag cac tcg acg act gca tag cag                                     1656 
Glu His Ser Thr Thr Ala 
545                 550 
</s400>
<s200>
<s210>18 </s210>
<s211>550 </s211>
<s212>PRT </s212>
<s213>Drosophila melanogaster </s213>
<s220>
<s223>ecdysone receptor ligand binding domain </s223>
</s220>
</s200>
<s400> 18 
Met Arg Pro Glu Cys Val Val Pro Glu Asn Gln Cys Ala Met Lys Arg 
  1               5                  10                  15 
Arg Glu Lys Lys Ala Gln Lys Glu Lys Asp Lys Met Thr Thr Ser Pro 
             20                  25                  30 
Ser Ser Gln His Gly Gly Asn Gly Ser Leu Ala Ser Gly Gly Gly Gln 
         35                  40                  45 
Asp Phe Val Lys Lys Glu Ile Leu Asp Leu Met Thr Cys Glu Pro Pro 
     50                  55                  60 
Gln His Ala Thr Ile Pro Leu Leu Pro Asp Glu Ile Leu Ala Lys Cys 
 65                  70                  75                  80 
Gln Ala Arg Asn Ile Pro Ser Leu Thr Tyr Asn Gln Leu Ala Val Ile 
                 85                  90                  95 
Tyr Lys Leu Ile Trp Tyr Gln Asp Gly Tyr Glu Gln Pro Ser Glu Glu 
            100                 105                 110 
Asp Leu Arg Arg Ile Met Ser Gln Pro Asp Glu Asn Glu Ser Gln Thr 
        115                 120                 125 
Asp Val Ser Phe Arg His Ile Thr Glu Ile Thr Ile Leu Thr Val Gln 
    130                 135                 140 
Leu Ile Val Glu Phe Ala Lys Gly Leu Pro Ala Phe Thr Lys Ile Pro 
145                 150                 155                 160 
Gln Glu Asp Gln Ile Thr Leu Leu Lys Ala Cys Ser Ser Glu Val Met 
                165                 170                 175 
Met Leu Arg Met Ala Arg Arg Tyr Asp His Ser Ser Asp Ser Ile Phe 
            180                 185                 190 
Phe Ala Asn Asn Arg Ser Tyr Thr Arg Asp Ser Tyr Lys Met Ala Gly 
        195                 200                 205 
Met Ala Asp Asn Ile Glu Asp Leu Leu His Phe Cys Arg Gln Met Phe 
    210                 215                 220 
Ser Met Lys Val Asp Asn Val Glu Tyr Ala Leu Leu Thr Ala Ile Val 
225                 230                 235                 240 
Ile Phe Ser Asp Arg Pro Gly Leu Glu Lys Ala Gln Leu Val Glu Ala 
                245                 250                 255 
Ile Gln Ser Tyr Tyr Ile Asp Thr Leu Arg Ile Tyr Ile Leu Asn Arg 
            260                 265                 270 
His Cys Gly Asp Ser Met Ser Leu Val Phe Tyr Ala Lys Leu Leu Ser 
        275                 280                 285 
Ile Leu Thr Glu Leu Arg Thr Leu Gly Asn Gln Asn Ala Glu Met Cys 
    290                 295                 300 
Phe Ser Leu Lys Leu Lys Asn Arg Lys Leu Pro Lys Phe Leu Glu Glu 
305                 310                 315                 320 
Ile Trp Asp Val His Ala Ile Pro Pro Ser Val Gln Ser His Leu Gln 
                325                 330                 335 
Ile Thr Gln Glu Glu Asn Glu Arg Leu Glu Arg Ala Glu Arg Met Arg 
            340                 345                 350 
Ala Ser Val Gly Gly Ala Ile Thr Ala Gly Ile Asp Cys Asp Ser Ala 
        355                 360                 365 
Ser Thr Ser Ala Ala Ala Ala Ala Ala Gln His Gln Pro Gln Pro Gln 
    370                 375                 380 
Pro Gln Pro Gln Pro Ser Ser Leu Thr Gln Asn Asp Ser Gln His Gln 
385                 390                 395                 400 
Thr Gln Pro Gln Leu Gln Pro Gln Leu Pro Pro Gln Leu Gln Gly Gln 
                405                 410                 415 
Leu Gln Pro Gln Leu Gln Pro Gln Leu Gln Thr Gln Leu Gln Pro Gln 
            420                 425                 430 
Ile Gln Pro Gln Pro Gln Leu Leu Pro Val Ser Ala Pro Val Pro Ala 
        435                 440                 445 
Ser Val Thr Ala Pro Gly Ser Leu Ser Ala Val Ser Thr Ser Ser Glu 
    450                 455                 460 
Tyr Met Gly Gly Ser Ala Ala Ile Gly Pro Ile Thr Pro Ala Thr Thr 
465                 470                 475                 480 
Ser Ser Ile Thr Ala Ala Val Thr Ala Ser Ser Thr Thr Ser Ala Val 
                485                 490                 495 
Pro Met Gly Asn Gly Val Gly Val Gly Val Gly Val Gly Gly Asn Val 
            500                 505                 510 
Ser Met Tyr Ala Asn Ala Gln Thr Ala Met Ala Leu Met Gly Val Ala 
        515                 520                 525 
Leu His Ser His Gln Glu Gln Leu Ile Gly Gly Val Ala Val Lys Ser 
    530                 535                 540 
Glu His Ser Thr Thr Ala 
545                 550 
</s400>
<s200>
<s210>19 </s210>
<s211>855 </s211>
<s212>DNA </s212>
<s213>Rattus norvegicus </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(855) </s222>
<s223>rat glucocorticoid receptor ligand binding 
                         domain </s223>
</s220>
</s200>
<s400> 19 
aca aag aaa aaa atc aaa ggg att cag caa gcc act gca gga gtc tca       48 
Thr Lys Lys Lys Ile Lys Gly Ile Gln Gln Ala Thr Ala Gly Val Ser 
  1               5                  10                  15 
caa gac act tcg gaa aat cct aac aaa aca ata gtt cct gca gca tta       96 
Gln Asp Thr Ser Glu Asn Pro Asn Lys Thr Ile Val Pro Ala Ala Leu 
             20                  25                  30 
cca cag ctc acc cct acc ttg gtg tca ctg ctg gag gtg att gaa ccc      144 
Pro Gln Leu Thr Pro Thr Leu Val Ser Leu Leu Glu Val Ile Glu Pro 
         35                  40                  45 
gag gtg ttg tat gca gga tat gat agc tct gtt cca gat tca gca tgg      192 
Glu Val Leu Tyr Ala Gly Tyr Asp Ser Ser Val Pro Asp Ser Ala Trp 
     50                  55                  60 
aga att atg acc aca ctc aac atg tta ggt ggg cgt caa gtg att gca      240 
Arg Ile Met Thr Thr Leu Asn Met Leu Gly Gly Arg Gln Val Ile Ala 
 65                  70                  75                  80 
gca gtg aaa tgg gca aag gcg ata cta ggc ttg aga aac tta cac ctc      288 
Ala Val Lys Trp Ala Lys Ala Ile Leu Gly Leu Arg Asn Leu His Leu 
                 85                  90                  95 
gat gac caa atg acc ctg cta cag tac tca tgg atg ttt ctc atg gca      336 
Asp Asp Gln Met Thr Leu Leu Gln Tyr Ser Trp Met Phe Leu Met Ala 
            100                 105                 110 
ttt gcc ttg ggt tgg aga tca tac aga caa tca agc gga aac ctg ctc      384 
Phe Ala Leu Gly Trp Arg Ser Tyr Arg Gln Ser Ser Gly Asn Leu Leu 
        115                 120                 125 
tgc ttt gct cct gat ctg att att aat gag cag aga atg tct cta ccc      432 
Cys Phe Ala Pro Asp Leu Ile Ile Asn Glu Gln Arg Met Ser Leu Pro 
    130                 135                 140 
tgc atg tat gac caa tgt aaa cac atg ctg ttt gtc tcc tct gaa tta      480 
Cys Met Tyr Asp Gln Cys Lys His Met Leu Phe Val Ser Ser Glu Leu 
145                 150                 155                 160 
caa aga ttg cag gta tcc tat gaa gag tat ctc tgt atg aaa acc tta      528 
Gln Arg Leu Gln Val Ser Tyr Glu Glu Tyr Leu Cys Met Lys Thr Leu 
                165                 170                 175 
ctg ctt ctc tcc tca gtt gct aag gaa ggt ctg aag agc caa gag tta      576 
Leu Leu Leu Ser Ser Val Ala Lys Glu Gly Leu Lys Ser Gln Glu Leu 
            180                 185                 190 
ttt gat gag att cga atg act tat atc aaa gag cta gga aaa gcc atc      624 
Phe Asp Glu Ile Arg Met Thr Tyr Ile Lys Glu Leu Gly Lys Ala Ile 
        195                 200                 205 
gtc aaa agg gaa ggg aac tcc agt cag aac tgg caa cgg ttt tac caa      672 
Val Lys Arg Glu Gly Asn Ser Ser Gln Asn Trp Gln Arg Phe Tyr Gln 
    210                 215                 220 
ctg aca aag ctt ctg gac tcc atg cat gag gtg gtt gag aat ctc ctt      720 
Leu Thr Lys Leu Leu Asp Ser Met His Glu Val Val Glu Asn Leu Leu 
225                 230                 235                 240 
acc tac tgc ttc cag aca ttt ttg gat aag acc atg agt att gaa ttc      768 
Thr Tyr Cys Phe Gln Thr Phe Leu Asp Lys Thr Met Ser Ile Glu Phe 
                245                 250                 255 
cca gag atg tta gct gaa atc atc act aat cag ata cca aaa tat tca      816 
Pro Glu Met Leu Ala Glu Ile Ile Thr Asn Gln Ile Pro Lys Tyr Ser 
            260                 265                 270 
aat gga aat atc aaa aag ctt ctg ttt cat caa aaa tga                  855 
Asn Gly Asn Ile Lys Lys Leu Leu Phe His Gln Lys 
        275                 280                 285 
</s400>
<s200>
<s210>20 </s210>
<s211>284 </s211>
<s212>PRT </s212>
<s213>Rattus norvegicus </s213>
<s220>
<s223>rat glucocorticoid receptor ligand binding 
                         domain </s223>
</s220>
</s200>
<s400> 20 
Thr Lys Lys Lys Ile Lys Gly Ile Gln Gln Ala Thr Ala Gly Val Ser 
  1               5                  10                  15 
Gln Asp Thr Ser Glu Asn Pro Asn Lys Thr Ile Val Pro Ala Ala Leu 
             20                  25                  30 
Pro Gln Leu Thr Pro Thr Leu Val Ser Leu Leu Glu Val Ile Glu Pro 
         35                  40                  45 
Glu Val Leu Tyr Ala Gly Tyr Asp Ser Ser Val Pro Asp Ser Ala Trp 
     50                  55                  60 
Arg Ile Met Thr Thr Leu Asn Met Leu Gly Gly Arg Gln Val Ile Ala 
 65                  70                  75                  80 
Ala Val Lys Trp Ala Lys Ala Ile Leu Gly Leu Arg Asn Leu His Leu 
                 85                  90                  95 
Asp Asp Gln Met Thr Leu Leu Gln Tyr Ser Trp Met Phe Leu Met Ala 
            100                 105                 110 
Phe Ala Leu Gly Trp Arg Ser Tyr Arg Gln Ser Ser Gly Asn Leu Leu 
        115                 120                 125 
Cys Phe Ala Pro Asp Leu Ile Ile Asn Glu Gln Arg Met Ser Leu Pro 
    130                 135                 140 
Cys Met Tyr Asp Gln Cys Lys His Met Leu Phe Val Ser Ser Glu Leu 
145                 150                 155                 160 
Gln Arg Leu Gln Val Ser Tyr Glu Glu Tyr Leu Cys Met Lys Thr Leu 
                165                 170                 175 
Leu Leu Leu Ser Ser Val Ala Lys Glu Gly Leu Lys Ser Gln Glu Leu 
            180                 185                 190 
Phe Asp Glu Ile Arg Met Thr Tyr Ile Lys Glu Leu Gly Lys Ala Ile 
        195                 200                 205 
Val Lys Arg Glu Gly Asn Ser Ser Gln Asn Trp Gln Arg Phe Tyr Gln 
    210                 215                 220 
Leu Thr Lys Leu Leu Asp Ser Met His Glu Val Val Glu Asn Leu Leu 
225                 230                 235                 240 
Thr Tyr Cys Phe Gln Thr Phe Leu Asp Lys Thr Met Ser Ile Glu Phe 
                245                 250                 255 
Pro Glu Met Leu Ala Glu Ile Ile Thr Asn Gln Ile Pro Lys Tyr Ser 
            260                 265                 270 
Asn Gly Asn Ile Lys Lys Leu Leu Phe His Gln Lys 
        275                 280 
</s400>
<s200>
<s210>21 </s210>
<s211>50 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequencecopper 
      inducible regulatory element, ACE1 binding site 
      from metallothionein gene promoter </s223>
</s220>
</s200>
<s400> 21 
agcttagcga tgcgtctttt ccgctgaacc gttccagcaa aaaagactag                50 
</s400>
<s200>
<s210>22 </s210>
<s211>19 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequencetet 
                         operator sequence </s223>
</s220>
</s200>
<s400> 22 
actctatcag tgatagagt                                                  19 
</s400>
<s200>
<s210>23 </s210>
<s211>29 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequenceecdysone 
      response element (EcRE) </s223>
</s220>
</s200>
<s400> 23 
gatccgacaa gggttcaatg cacttgtca                                       29 
</s400>
<s200>
<s210>24 </s210>
<s211>371 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>inducible regulatory element from HSP81-1 heat 
      shock gene promoter </s223>
</s220>
</s200>
<s400> 24 
gtggagtctc gaaacgaaaa gaactttctg gaattcgttt gctcacaaag ctaaaaacgg     60 
ttgatttcat cgaaatacgg cgtcgttttc aaagaacaat ccagaaatca ctggttttcc    120 
tttatttcaa aagaagagac tagaacttta tttctcctct ataaaatcac tttgtttttc    180 
cctctcttct tcataaatca acaaaacaat cacaaatctc tcgaaacgct ctcgaagttc    240 
caaattttct cttagcattc tctttcgttt ctcgtttgcg ttgaatcaaa gttcgttgcg    300 
atggcggatg ttcagatggc tgatgcagag acttttgctt tccaagctga gattaaccag    360 
cttcttagct t                                                         371 
</s400>
<s200>
<s210>25 </s210>
<s211></s211>
<s212></s212>
<s213></s213>
</s200>
<s400> 25 
000 
</s400>
<s200>
<s210>26 </s210>
<s211></s211>
<s212></s212>
<s213></s213>
</s200>
<s400> 26 
000 
</s400>
<s200>
<s210>27 </s210>
<s211>747 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(747) </s222>
<s223>SEPALLATA1 (SEP1) </s223>
</s220>
</s200>
<s400> 27 
atg gga aga gga aga gta gag ctg aag agg ata gag aac aaa atc aac       48 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
aga caa gta acg ttt gca aag cgt agg aac ggt ttg ttg aag aaa gct       96 
Arg Gln Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
tat gaa ttg tct gtt ctc tgt gat gct gaa gtt gct ctc atc atc ttc      144 
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu Ile Ile Phe 
         35                  40                  45 
tcc aac cgt gga aag ctc tat gag ttt tgc agc tcc tca aac atg ctc      192 
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Ser Ser Asn Met Leu 
     50                  55                  60 
aag aca ctt gat cgg tac cag aaa tgc agc tat gga tcc att gaa gtc      240 
Lys Thr Leu Asp Arg Tyr Gln Lys Cys Ser Tyr Gly Ser Ile Glu Val 
 65                  70                  75                  80 
aac aac aaa cct gcc aaa gaa ctt gag aac agc tac aga gaa tat ctg      288 
Asn Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu 
                 85                  90                  95 
aag ctt aag ggt aga tat gag aac ctt caa cgt caa cag aga aat ctt      336 
Lys Leu Lys Gly Arg Tyr Glu Asn Leu Gln Arg Gln Gln Arg Asn Leu 
            100                 105                 110 
ctt ggg gag gat tta gga cct ttg aat tca aag gag tta gag cag ctt      384 
Leu Gly Glu Asp Leu Gly Pro Leu Asn Ser Lys Glu Leu Glu Gln Leu 
        115                 120                 125 
gag cgt caa ctg gac ggc tct ctc aag caa gtt cgg tcc atc aag aca      432 
Glu Arg Gln Leu Asp Gly Ser Leu Lys Gln Val Arg Ser Ile Lys Thr 
    130                 135                 140 
cag tac atg ctt gac cag ctc tcg gat ctt caa aat aaa gag caa atg      480 
Gln Tyr Met Leu Asp Gln Leu Ser Asp Leu Gln Asn Lys Glu Gln Met 
145                 150                 155                 160 
ttg ctt gaa acc aat aga gct ttg gca atg aag ctg gat gat atg att      528 
Leu Leu Glu Thr Asn Arg Ala Leu Ala Met Lys Leu Asp Asp Met Ile 
                165                 170                 175 
ggt gtg aga agt cat cat atg gga gga tgg gaa ggc ggt gaa cag aat      576 
Gly Val Arg Ser His His Met Gly Gly Trp Glu Gly Gly Glu Gln Asn 
            180                 185                 190 
gtt acc tac gcg cat cat caa gct cag tct cag gga cta tac cag cct      624 
Val Thr Tyr Ala His His Gln Ala Gln Ser Gln Gly Leu Tyr Gln Pro 
        195                 200                 205 
ctt gaa tgc aat cca act ctg caa atg ggg tat gat aat cca gta tgc      672 
Leu Glu Cys Asn Pro Thr Leu Gln Met Gly Tyr Asp Asn Pro Val Cys 
    210                 215                 220 
tct gag caa atc act gcg aca aca caa gct cag gcg cag ccg gga aac      720 
Ser Glu Gln Ile Thr Ala Thr Thr Gln Ala Gln Ala Gln Pro Gly Asn 
225                 230                 235                 240 
ggt tac att cca gga tgg atg ctc tga                                  747 
Gly Tyr Ile Pro Gly Trp Met Leu 
                245 
</s400>
<s200>
<s210>28 </s210>
<s211>248 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>SEPALLATA1 (SEP1) </s223>
</s220>
</s200>
<s400> 28 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu Ile Ile Phe 
         35                  40                  45 
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Ser Ser Asn Met Leu 
     50                  55                  60 
Lys Thr Leu Asp Arg Tyr Gln Lys Cys Ser Tyr Gly Ser Ile Glu Val 
 65                  70                  75                  80 
Asn Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu 
                 85                  90                  95 
Lys Leu Lys Gly Arg Tyr Glu Asn Leu Gln Arg Gln Gln Arg Asn Leu 
            100                 105                 110 
Leu Gly Glu Asp Leu Gly Pro Leu Asn Ser Lys Glu Leu Glu Gln Leu 
        115                 120                 125 
Glu Arg Gln Leu Asp Gly Ser Leu Lys Gln Val Arg Ser Ile Lys Thr 
    130                 135                 140 
Gln Tyr Met Leu Asp Gln Leu Ser Asp Leu Gln Asn Lys Glu Gln Met 
145                 150                 155                 160 
Leu Leu Glu Thr Asn Arg Ala Leu Ala Met Lys Leu Asp Asp Met Ile 
                165                 170                 175 
Gly Val Arg Ser His His Met Gly Gly Trp Glu Gly Gly Glu Gln Asn 
            180                 185                 190 
Val Thr Tyr Ala His His Gln Ala Gln Ser Gln Gly Leu Tyr Gln Pro 
        195                 200                 205 
Leu Glu Cys Asn Pro Thr Leu Gln Met Gly Tyr Asp Asn Pro Val Cys 
    210                 215                 220 
Ser Glu Gln Ile Thr Ala Thr Thr Gln Ala Gln Ala Gln Pro Gly Asn 
225                 230                 235                 240 
Gly Tyr Ile Pro Gly Trp Met Leu 
                245 
</s400>
<s200>
<s210>29 </s210>
<s211>753 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(753) </s222>
<s223>SEPALLATA2 (SEP2) </s223>
</s220>
</s200>
<s400> 29 
atg gga aga gga aga gta gag ctc aag agg ata gag aac aaa atc aac       48 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
aga caa gtg acg ttt gct aaa cgt aga aat ggt ttg ctg aaa aaa gct       96 
Arg Gln Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
tat gag ctt tct gtt ctc tgc gat gct gaa gtc tct ctc atc gtc ttc      144 
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
tcc aac cgt ggc aag ctc tac gag ttc tgc agc acc tcc aac atg ctc      192 
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Thr Ser Asn Met Leu 
     50                  55                  60 
aag aca ctg gaa agg tat cag aag tgt agc tat ggc tcc att gaa gtc      240 
Lys Thr Leu Glu Arg Tyr Gln Lys Cys Ser Tyr Gly Ser Ile Glu Val 
 65                  70                  75                  80 
aac aac aaa cct gct aaa gag ctt gag aac agc tac aga gag tac ttg      288 
Asn Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu 
                 85                  90                  95 
aag ctg aaa ggt aga tat gaa aat ctg caa cgt cag cag aga aat ctt      336 
Lys Leu Lys Gly Arg Tyr Glu Asn Leu Gln Arg Gln Gln Arg Asn Leu 
            100                 105                 110 
ctt gga gag gat ctt gga cct ctg aat tca aag gag cta gag cag ctt      384 
Leu Gly Glu Asp Leu Gly Pro Leu Asn Ser Lys Glu Leu Glu Gln Leu 
        115                 120                 125 
gag cgt caa cta gac ggc tct ctg aag caa gtt cgc tgc atc aag aca      432 
Glu Arg Gln Leu Asp Gly Ser Leu Lys Gln Val Arg Cys Ile Lys Thr 
    130                 135                 140 
cag tat atg ctt gac cag ctc tct gat ctt caa ggt aag gag cat atc      480 
Gln Tyr Met Leu Asp Gln Leu Ser Asp Leu Gln Gly Lys Glu His Ile 
145                 150                 155                 160 
ttg ctt gat gcc aac aga gct ttg tca atg aag ctg gaa gat atg atc      528 
Leu Leu Asp Ala Asn Arg Ala Leu Ser Met Lys Leu Glu Asp Met Ile 
                165                 170                 175 
ggc gtg aga cat cac cat ata gga gga gga tgg gaa ggt ggt gat caa      576 
Gly Val Arg His His His Ile Gly Gly Gly Trp Glu Gly Gly Asp Gln 
            180                 185                 190 
cag aat att gcc tat gga cat cct cag gct cat tct cag gga cta tac      624 
Gln Asn Ile Ala Tyr Gly His Pro Gln Ala His Ser Gln Gly Leu Tyr 
        195                 200                 205 
caa tct ctt gaa tgt gat ccc act ttg caa att gga tat agc cat cca      672 
Gln Ser Leu Glu Cys Asp Pro Thr Leu Gln Ile Gly Tyr Ser His Pro 
    210                 215                 220 
gtg tgc tca gag caa atg gct gtg acg gtg caa ggt cag tcc caa caa      720 
Val Cys Ser Glu Gln Met Ala Val Thr Val Gln Gly Gln Ser Gln Gln 
225                 230                 235                 240 
gga aac ggc tac atc cct ggc tgg atg ctg tga                          753 
Gly Asn Gly Tyr Ile Pro Gly Trp Met Leu 
                245                 250 
</s400>
<s200>
<s210>30 </s210>
<s211>250 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>SEPALLATA2 (SEP2) </s223>
</s220>
</s200>
<s400> 30 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ser Leu Ile Val Phe 
         35                  40                  45 
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Thr Ser Asn Met Leu 
     50                  55                  60 
Lys Thr Leu Glu Arg Tyr Gln Lys Cys Ser Tyr Gly Ser Ile Glu Val 
 65                  70                  75                  80 
Asn Asn Lys Pro Ala Lys Glu Leu Glu Asn Ser Tyr Arg Glu Tyr Leu 
                 85                  90                  95 
Lys Leu Lys Gly Arg Tyr Glu Asn Leu Gln Arg Gln Gln Arg Asn Leu 
            100                 105                 110 
Leu Gly Glu Asp Leu Gly Pro Leu Asn Ser Lys Glu Leu Glu Gln Leu 
        115                 120                 125 
Glu Arg Gln Leu Asp Gly Ser Leu Lys Gln Val Arg Cys Ile Lys Thr 
    130                 135                 140 
Gln Tyr Met Leu Asp Gln Leu Ser Asp Leu Gln Gly Lys Glu His Ile 
145                 150                 155                 160 
Leu Leu Asp Ala Asn Arg Ala Leu Ser Met Lys Leu Glu Asp Met Ile 
                165                 170                 175 
Gly Val Arg His His His Ile Gly Gly Gly Trp Glu Gly Gly Asp Gln 
            180                 185                 190 
Gln Asn Ile Ala Tyr Gly His Pro Gln Ala His Ser Gln Gly Leu Tyr 
        195                 200                 205 
Gln Ser Leu Glu Cys Asp Pro Thr Leu Gln Ile Gly Tyr Ser His Pro 
    210                 215                 220 
Val Cys Ser Glu Gln Met Ala Val Thr Val Gln Gly Gln Ser Gln Gln 
225                 230                 235                 240 
Gly Asn Gly Tyr Ile Pro Gly Trp Met Leu 
                245                 250 
</s400>
<s200>
<s210>31 </s210>
<s211>714 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(714) </s222>
<s223>SEPALLATA3 (SEP3) </s223>
</s220>
</s200>
<s400> 31 
atg gga aga ggg aga gta gaa ttg aag agg ata gag aac aag atc aat       48 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
agg caa gtg acg ttt gca aag aga agg aat ggt ctt ttg aag aaa gca       96 
Arg Gln Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
tac gag ctt tca gtt cta tgt gat gca gaa gtt gct ctc atc atc ttc      144 
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu Ile Ile Phe 
         35                  40                  45 
tca aat aga gga aag ctg tac gag ttt tgc agt agt tcg agc atg ctt      192 
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Ser Ser Ser Met Leu 
     50                  55                  60 
cgg aca ctg gag agg tac caa aag tgt aac tat gga gca cca gaa ccc      240 
Arg Thr Leu Glu Arg Tyr Gln Lys Cys Asn Tyr Gly Ala Pro Glu Pro 
 65                  70                  75                  80 
aat gtg cct tca aga gag gcc tta gca gtt gaa ctt agt agc cag cag      288 
Asn Val Pro Ser Arg Glu Ala Leu Ala Val Glu Leu Ser Ser Gln Gln 
                 85                  90                  95 
gag tat ctc aag ctt aag gag cgt tat gac gcc tta caa aga acc caa      336 
Glu Tyr Leu Lys Leu Lys Glu Arg Tyr Asp Ala Leu Gln Arg Thr Gln 
            100                 105                 110 
agg aat ctg ttg gga gaa gat ctt gga cct cta agt aca aag gag ctt      384 
Arg Asn Leu Leu Gly Glu Asp Leu Gly Pro Leu Ser Thr Lys Glu Leu 
        115                 120                 125 
gag tca ctt gag aga cag ctt gat tct tcc ttg aag cag atc aga gct      432 
Glu Ser Leu Glu Arg Gln Leu Asp Ser Ser Leu Lys Gln Ile Arg Ala 
    130                 135                 140 
ctc agg aca cag ttt atg ctt gac cag ctc aac gat ctt cag agt aag      480 
Leu Arg Thr Gln Phe Met Leu Asp Gln Leu Asn Asp Leu Gln Ser Lys 
145                 150                 155                 160 
tta gct gat ggg tat cag atg cca ctc cag ctg aac cct aac caa gaa      528 
Leu Ala Asp Gly Tyr Gln Met Pro Leu Gln Leu Asn Pro Asn Gln Glu 
                165                 170                 175 
gag gtt gat cac tac ggt cgt cat cat cat caa caa caa caa cac tcc      576 
Glu Val Asp His Tyr Gly Arg His His His Gln Gln Gln Gln His Ser 
            180                 185                 190 
caa gct ttc ttc cag cct ttg gaa tgt gaa ccc att ctt cag atc ggg      624 
Gln Ala Phe Phe Gln Pro Leu Glu Cys Glu Pro Ile Leu Gln Ile Gly 
        195                 200                 205 
tat cag ggg cag caa gat gga atg gga gca gga cca agt gtg aat aat      672 
Tyr Gln Gly Gln Gln Asp Gly Met Gly Ala Gly Pro Ser Val Asn Asn 
    210                 215                 220 
tac atg ttg ggt tgg tta cct tat gac acc aac tct att tga              714 
Tyr Met Leu Gly Trp Leu Pro Tyr Asp Thr Asn Ser Ile 
225                 230                 235 
</s400>
<s200>
<s210>32 </s210>
<s211>237 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>SEPALLATA3 (SEP3) </s223>
</s220>
</s200>
<s400> 32 
Met Gly Arg Gly Arg Val Glu Leu Lys Arg Ile Glu Asn Lys Ile Asn 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ala Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu Ile Ile Phe 
         35                  40                  45 
Ser Asn Arg Gly Lys Leu Tyr Glu Phe Cys Ser Ser Ser Ser Met Leu 
     50                  55                  60 
Arg Thr Leu Glu Arg Tyr Gln Lys Cys Asn Tyr Gly Ala Pro Glu Pro 
 65                  70                  75                  80 
Asn Val Pro Ser Arg Glu Ala Leu Ala Val Glu Leu Ser Ser Gln Gln 
                 85                  90                  95 
Glu Tyr Leu Lys Leu Lys Glu Arg Tyr Asp Ala Leu Gln Arg Thr Gln 
            100                 105                 110 
Arg Asn Leu Leu Gly Glu Asp Leu Gly Pro Leu Ser Thr Lys Glu Leu 
        115                 120                 125 
Glu Ser Leu Glu Arg Gln Leu Asp Ser Ser Leu Lys Gln Ile Arg Ala 
    130                 135                 140 
Leu Arg Thr Gln Phe Met Leu Asp Gln Leu Asn Asp Leu Gln Ser Lys 
145                 150                 155                 160 
Leu Ala Asp Gly Tyr Gln Met Pro Leu Gln Leu Asn Pro Asn Gln Glu 
                165                 170                 175 
Glu Val Asp His Tyr Gly Arg His His His Gln Gln Gln Gln His Ser 
            180                 185                 190 
Gln Ala Phe Phe Gln Pro Leu Glu Cys Glu Pro Ile Leu Gln Ile Gly 
        195                 200                 205 
Tyr Gln Gly Gln Gln Asp Gly Met Gly Ala Gly Pro Ser Val Asn Asn 
    210                 215                 220 
Tyr Met Leu Gly Trp Leu Pro Tyr Asp Thr Asn Ser Ile 
225                 230                 235 
</s400>
<s200>
<s210>33 </s210>
<s211>645 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(645) </s222>
<s223>AGL20 (SUPPRESSOR OF CONSTANS (CO) 
      OVEREXPRESSION 1 (SOC1)) </s223>
</s220>
</s200>
<s400> 33 
atg gtg agg ggc aaa act cag atg aag aga ata gag aat gca aca agc       48 
Met Val Arg Gly Lys Thr Gln Met Lys Arg Ile Glu Asn Ala Thr Ser 
  1               5                  10                  15 
aga caa gtg act ttc tcc aaa aga agg aat ggt ttg ttg aag aaa gcc       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
ttt gag ctc tca gtg ctt tgt gat gct gaa gtt tct ctt atc atc ttc      144 
Phe Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ser Leu Ile Ile Phe 
         35                  40                  45 
tct cct aaa ggc aaa ctt tat gaa ttc gcc agc tcc aat atg caa gat      192 
Ser Pro Lys Gly Lys Leu Tyr Glu Phe Ala Ser Ser Asn Met Gln Asp 
     50                  55                  60 
acc ata gat cgt tat ctg agg cat act aag gat cga gtc agc acc aaa      240 
Thr Ile Asp Arg Tyr Leu Arg His Thr Lys Asp Arg Val Ser Thr Lys 
 65                  70                  75                  80 
ccg gtt tct gaa gaa aat atg cag cat ttg aaa tat gaa gca gca aac      288 
Pro Val Ser Glu Glu Asn Met Gln His Leu Lys Tyr Glu Ala Ala Asn 
                 85                  90                  95 
atg atg aag aaa att gaa caa ctc gaa gct tct aaa cgt aaa ctc ttg      336 
Met Met Lys Lys Ile Glu Gln Leu Glu Ala Ser Lys Arg Lys Leu Leu 
            100                 105                 110 
gga gaa ggc ata gga aca tgc tca atc gag gag ctg caa cag att gag      384 
Gly Glu Gly Ile Gly Thr Cys Ser Ile Glu Glu Leu Gln Gln Ile Glu 
        115                 120                 125 
caa cag ctt gag aaa agt gtc aaa tgt att cga gca aga aag act caa      432 
Gln Gln Leu Glu Lys Ser Val Lys Cys Ile Arg Ala Arg Lys Thr Gln 
    130                 135                 140 
gtg ttt aag gaa caa att gag cag ctc aag caa aag gag aaa gct cta      480 
Val Phe Lys Glu Gln Ile Glu Gln Leu Lys Gln Lys Glu Lys Ala Leu 
145                 150                 155                 160 
gct gca gaa aac gag aag ctc tct gaa aag tgg gga tct cat gaa agc      528 
Ala Ala Glu Asn Glu Lys Leu Ser Glu Lys Trp Gly Ser His Glu Ser 
                165                 170                 175 
gaa gtt tgg tca aat aag aat caa gaa agt act gga aga ggt gat gaa      576 
Glu Val Trp Ser Asn Lys Asn Gln Glu Ser Thr Gly Arg Gly Asp Glu 
            180                 185                 190 
gag agt agc cca agt tct gaa gta gag acg caa ttg ttc att ggg tta      624 
Glu Ser Ser Pro Ser Ser Glu Val Glu Thr Gln Leu Phe Ile Gly Leu 
        195                 200                 205 
cct tgt tct tca aga aag tga                                          645 
Pro Cys Ser Ser Arg Lys 
    210                 215 
</s400>
<s200>
<s210>34 </s210>
<s211>214 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL20 (SUPPRESSOR OF CONSTANS (CO) 
      OVEREXPRESSION 1 (SOC1)) </s223>
</s220>
</s200>
<s400> 34 
Met Val Arg Gly Lys Thr Gln Met Lys Arg Ile Glu Asn Ala Thr Ser 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala 
             20                  25                  30 
Phe Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ser Leu Ile Ile Phe 
         35                  40                  45 
Ser Pro Lys Gly Lys Leu Tyr Glu Phe Ala Ser Ser Asn Met Gln Asp 
     50                  55                  60 
Thr Ile Asp Arg Tyr Leu Arg His Thr Lys Asp Arg Val Ser Thr Lys 
 65                  70                  75                  80 
Pro Val Ser Glu Glu Asn Met Gln His Leu Lys Tyr Glu Ala Ala Asn 
                 85                  90                  95 
Met Met Lys Lys Ile Glu Gln Leu Glu Ala Ser Lys Arg Lys Leu Leu 
            100                 105                 110 
Gly Glu Gly Ile Gly Thr Cys Ser Ile Glu Glu Leu Gln Gln Ile Glu 
        115                 120                 125 
Gln Gln Leu Glu Lys Ser Val Lys Cys Ile Arg Ala Arg Lys Thr Gln 
    130                 135                 140 
Val Phe Lys Glu Gln Ile Glu Gln Leu Lys Gln Lys Glu Lys Ala Leu 
145                 150                 155                 160 
Ala Ala Glu Asn Glu Lys Leu Ser Glu Lys Trp Gly Ser His Glu Ser 
                165                 170                 175 
Glu Val Trp Ser Asn Lys Asn Gln Glu Ser Thr Gly Arg Gly Asp Glu 
            180                 185                 190 
Glu Ser Ser Pro Ser Ser Glu Val Glu Thr Gln Leu Phe Ile Gly Leu 
        195                 200                 205 
Pro Cys Ser Ser Arg Lys 
    210 
</s400>
<s200>
<s210>35 </s210>
<s211>633 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(633) </s222>
<s223>AGL22 (SHORT VEGETATIVE PHASE (SVP)) </s223>
</s220>
</s200>
<s400> 35 
atg gcg aga gaa aag att cag atc agg aag atc gac aac gca acg gcg       48 
Met Ala Arg Glu Lys Ile Gln Ile Arg Lys Ile Asp Asn Ala Thr Ala 
  1               5                  10                  15 
aga caa gtg acg ttt tcg aaa cga aga aga ggg ctt ttc aag aaa gct       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Arg Gly Leu Phe Lys Lys Ala 
             20                  25                  30 
gaa gaa ctc tcc gtt ctc tgc gac gcc gat gtc gct ctc atc atc ttc      144 
Glu Glu Leu Ser Val Leu Cys Asp Ala Asp Val Ala Leu Ile Ile Phe 
         35                  40                  45 
tct tcc acc gga aaa ctg ttc gag ttc tgt agc tcc agc atg aag gaa      192 
Ser Ser Thr Gly Lys Leu Phe Glu Phe Cys Ser Ser Ser Met Lys Glu 
     50                  55                  60 
gtc cta gag agg cat aac ttn cag tca aag aac ttg gag aag ctt cat      240 
Val Leu Glu Arg His Asn Xaa Gln Ser Lys Asn Leu Glu Lys Leu His 
 65                  70                  75                  80 
cag cca tct ctt gag tta cag ctg gtt gag aac agt gat cac gcc cga      288 
Gln Pro Ser Leu Glu Leu Gln Leu Val Glu Asn Ser Asp His Ala Arg 
                 85                  90                  95 
atg agt aaa gaa att gcg gac aag agc cac cga cta agg caa atg aga      336 
Met Ser Lys Glu Ile Ala Asp Lys Ser His Arg Leu Arg Gln Met Arg 
            100                 105                 110 
gga gag gaa ctt caa gga ctt gac att gaa gag ctt cag cag cta gag      384 
Gly Glu Glu Leu Gln Gly Leu Asp Ile Glu Glu Leu Gln Gln Leu Glu 
        115                 120                 125 
aag gcc ctt gaa act ggt ttg acg cgt gtg att gaa aca aag agt gac      432 
Lys Ala Leu Glu Thr Gly Leu Thr Arg Val Ile Glu Thr Lys Ser Asp 
    130                 135                 140 
aag att atg agt gag atc agc gaa ctt cag aaa aag gga atg caa ttg      480 
Lys Ile Met Ser Glu Ile Ser Glu Leu Gln Lys Lys Gly Met Gln Leu 
145                 150                 155                 160 
atg gat gag aac aag cgg ttg agg cag caa gta tgt gtc tta ccc tct      528 
Met Asp Glu Asn Lys Arg Leu Arg Gln Gln Val Cys Val Leu Pro Ser 
                165                 170                 175 
ctg ttg ata aca aat ccc ttt ctt ttg tct acc att aac gta cac act      576 
Leu Leu Ile Thr Asn Pro Phe Leu Leu Ser Thr Ile Asn Val His Thr 
            180                 185                 190 
cct aaa ttt aat ccc cag ttg tct aca aca cat atg ttt gat cat act      624 
Pro Lys Phe Asn Pro Gln Leu Ser Thr Thr His Met Phe Asp His Thr 
        195                 200                 205 
gtg aga taa                                                          633 
Val Arg 
    210 
</s400>
<s200>
<s210>36 </s210>
<s211>210 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL22 (SHORT VEGETATIVE PHASE (SVP)) </s223>
</s220>
</s200>
<s400> 36 
Met Ala Arg Glu Lys Ile Gln Ile Arg Lys Ile Asp Asn Ala Thr Ala 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Arg Gly Leu Phe Lys Lys Ala 
             20                  25                  30 
Glu Glu Leu Ser Val Leu Cys Asp Ala Asp Val Ala Leu Ile Ile Phe 
         35                  40                  45 
Ser Ser Thr Gly Lys Leu Phe Glu Phe Cys Ser Ser Ser Met Lys Glu 
     50                  55                  60 
Val Leu Glu Arg His Asn Xaa Gln Ser Lys Asn Leu Glu Lys Leu His 
 65                  70                  75                  80 
Gln Pro Ser Leu Glu Leu Gln Leu Val Glu Asn Ser Asp His Ala Arg 
                 85                  90                  95 
Met Ser Lys Glu Ile Ala Asp Lys Ser His Arg Leu Arg Gln Met Arg 
            100                 105                 110 
Gly Glu Glu Leu Gln Gly Leu Asp Ile Glu Glu Leu Gln Gln Leu Glu 
        115                 120                 125 
Lys Ala Leu Glu Thr Gly Leu Thr Arg Val Ile Glu Thr Lys Ser Asp 
    130                 135                 140 
Lys Ile Met Ser Glu Ile Ser Glu Leu Gln Lys Lys Gly Met Gln Leu 
145                 150                 155                 160 
Met Asp Glu Asn Lys Arg Leu Arg Gln Gln Val Cys Val Leu Pro Ser 
                165                 170                 175 
Leu Leu Ile Thr Asn Pro Phe Leu Leu Ser Thr Ile Asn Val His Thr 
            180                 185                 190 
Pro Lys Phe Asn Pro Gln Leu Ser Thr Thr His Met Phe Asp His Thr 
        195                 200                 205 
Val Arg 
    210 
</s400>
<s200>
<s210>37 </s210>
<s211>663 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(663) </s222>
<s223>AGL24 </s223>
</s220>
</s200>
<s400> 37 
atg gcg aga gag aag ata agg ata aag aag att gat aac ata aca gcg       48 
Met Ala Arg Glu Lys Ile Arg Ile Lys Lys Ile Asp Asn Ile Thr Ala 
  1               5                  10                  15 
aga caa gtt act ttc tca aag aga aga aga gga atc ttc aag aaa gcc       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Arg Gly Ile Phe Lys Lys Ala 
             20                  25                  30 
gat gaa ctt tca gtt ctt tgc gat gct gat gtt gct ctc atc atc ttc      144 
Asp Glu Leu Ser Val Leu Cys Asp Ala Asp Val Ala Leu Ile Ile Phe 
         35                  40                  45 
tct gcc acc gga aag ctc ttc gag ttc tcc agc tca aga atg aga gac      192 
Ser Ala Thr Gly Lys Leu Phe Glu Phe Ser Ser Ser Arg Met Arg Asp 
     50                  55                  60 
ata ttg gga agg tat agt ctt cat gca agt aac atc aac aaa ttg atg      240 
Ile Leu Gly Arg Tyr Ser Leu His Ala Ser Asn Ile Asn Lys Leu Met 
 65                  70                  75                  80 
gat cca cct tct act cat ctc cgg ctt gag aat tgt aac ctc tcc aga      288 
Asp Pro Pro Ser Thr His Leu Arg Leu Glu Asn Cys Asn Leu Ser Arg 
                 85                  90                  95 
cta agt aag gaa gtc gaa gac aaa acc aag cag cta cgg aaa ctg aga      336 
Leu Ser Lys Glu Val Glu Asp Lys Thr Lys Gln Leu Arg Lys Leu Arg 
            100                 105                 110 
gga gag gat ctt gat gga ttg aac tta gaa gag ttg cag cgg ctg gag      384 
Gly Glu Asp Leu Asp Gly Leu Asn Leu Glu Glu Leu Gln Arg Leu Glu 
        115                 120                 125 
aaa cta ctt gaa tcc gga ctt agc cgt gtg tct gaa aag aag ggc gag      432 
Lys Leu Leu Glu Ser Gly Leu Ser Arg Val Ser Glu Lys Lys Gly Glu 
    130                 135                 140 
tgt gtg atg agc caa att ttc tca ctt gag aaa cgg gga tcg gaa ttg      480 
Cys Val Met Ser Gln Ile Phe Ser Leu Glu Lys Arg Gly Ser Glu Leu 
145                 150                 155                 160 
gtg gat gag aat aag aga ctg agg gat aaa cta gag acg ttg gaa agg      528 
Val Asp Glu Asn Lys Arg Leu Arg Asp Lys Leu Glu Thr Leu Glu Arg 
                165                 170                 175 
gca aaa ctg acg acg ctt aaa gag gct ttg gag aca gag tcg gtg acc      576 
Ala Lys Leu Thr Thr Leu Lys Glu Ala Leu Glu Thr Glu Ser Val Thr 
            180                 185                 190 
aca aat gtg tca agc tac gac agt gga act ccc ctt gag gat gac tcc      624 
Thr Asn Val Ser Ser Tyr Asp Ser Gly Thr Pro Leu Glu Asp Asp Ser 
        195                 200                 205 
gac act tcc ctg aag ctt ggg ctt cca tct tgg gaa tga                  663 
Asp Thr Ser Leu Lys Leu Gly Leu Pro Ser Trp Glu 
    210                 215                 220 
</s400>
<s200>
<s210>38 </s210>
<s211>220 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL24 </s223>
</s220>
</s200>
<s400> 38 
Met Ala Arg Glu Lys Ile Arg Ile Lys Lys Ile Asp Asn Ile Thr Ala 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Arg Gly Ile Phe Lys Lys Ala 
             20                  25                  30 
Asp Glu Leu Ser Val Leu Cys Asp Ala Asp Val Ala Leu Ile Ile Phe 
         35                  40                  45 
Ser Ala Thr Gly Lys Leu Phe Glu Phe Ser Ser Ser Arg Met Arg Asp 
     50                  55                  60 
Ile Leu Gly Arg Tyr Ser Leu His Ala Ser Asn Ile Asn Lys Leu Met 
 65                  70                  75                  80 
Asp Pro Pro Ser Thr His Leu Arg Leu Glu Asn Cys Asn Leu Ser Arg 
                 85                  90                  95 
Leu Ser Lys Glu Val Glu Asp Lys Thr Lys Gln Leu Arg Lys Leu Arg 
            100                 105                 110 
Gly Glu Asp Leu Asp Gly Leu Asn Leu Glu Glu Leu Gln Arg Leu Glu 
        115                 120                 125 
Lys Leu Leu Glu Ser Gly Leu Ser Arg Val Ser Glu Lys Lys Gly Glu 
    130                 135                 140 
Cys Val Met Ser Gln Ile Phe Ser Leu Glu Lys Arg Gly Ser Glu Leu 
145                 150                 155                 160 
Val Asp Glu Asn Lys Arg Leu Arg Asp Lys Leu Glu Thr Leu Glu Arg 
                165                 170                 175 
Ala Lys Leu Thr Thr Leu Lys Glu Ala Leu Glu Thr Glu Ser Val Thr 
            180                 185                 190 
Thr Asn Val Ser Ser Tyr Asp Ser Gly Thr Pro Leu Glu Asp Asp Ser 
        195                 200                 205 
Asp Thr Ser Leu Lys Leu Gly Leu Pro Ser Trp Glu 
    210                 215                 220 
</s400>
<s200>
<s210>39 </s210>
<s211>687 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(687) </s222>
<s223>AGL27 </s223>
</s220>
</s200>
<s400> 39 
atg gga aga aga aaa atc gag atc aag cga atc gag aac aaa agc agt       48 
Met Gly Arg Arg Lys Ile Glu Ile Lys Arg Ile Glu Asn Lys Ser Ser 
  1               5                  10                  15 
cga caa gtc act ttc tcc aaa cga cgc aat ggt ctc atc gac aaa gct       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Ile Asp Lys Ala 
             20                  25                  30 
cga caa ctt tcg att ctc tgt gaa tcc tcc gtc gct gtt gtc gtc gta      144 
Arg Gln Leu Ser Ile Leu Cys Glu Ser Ser Val Ala Val Val Val Val 
         35                  40                  45 
tct gcc tcc gga aaa ctc tat gac tct tcc tcc ggt gac gac att tcc      192 
Ser Ala Ser Gly Lys Leu Tyr Asp Ser Ser Ser Gly Asp Asp Ile Ser 
     50                  55                  60 
aag atc att gat cgt tat gaa ata caa cat gct gat gaa ctt aga gcc      240 
Lys Ile Ile Asp Arg Tyr Glu Ile Gln His Ala Asp Glu Leu Arg Ala 
 65                  70                  75                  80 
tta gat ctt gaa gaa aaa att cag aat tat ctt cca cac aag gag tta      288 
Leu Asp Leu Glu Glu Lys Ile Gln Asn Tyr Leu Pro His Lys Glu Leu 
                 85                  90                  95 
cta gaa aca gtc caa agc aag ctt gaa gaa cca aat gtc gat aat gta      336 
Leu Glu Thr Val Gln Ser Lys Leu Glu Glu Pro Asn Val Asp Asn Val 
            100                 105                 110 
agt gta gat tct cta att tct ctg gag gaa caa ctt gag act gct ctg      384 
Ser Val Asp Ser Leu Ile Ser Leu Glu Glu Gln Leu Glu Thr Ala Leu 
        115                 120                 125 
tcc gta agt aga gct agg aag gca gaa ctg atg atg gag tat atc gag      432 
Ser Val Ser Arg Ala Arg Lys Ala Glu Leu Met Met Glu Tyr Ile Glu 
    130                 135                 140 
tcc ctt aaa gaa aag gag aaa ttg ctg aga gaa gag aac cag gtt ctg      480 
Ser Leu Lys Glu Lys Glu Lys Leu Leu Arg Glu Glu Asn Gln Val Leu 
145                 150                 155                 160 
gct agc cag ctg tca gag aag aaa ggt atg tct cac cga tga aag ata      528 
Ala Ser Gln Leu Ser Glu Lys Lys Gly Met Ser His Arg     Lys Ile 
                165                 170                 175 
ctc aaa acc cga tgg gaa aga ata cgt tgc tgg caa cag atg atg aga      576 
Leu Lys Thr Arg Trp Glu Arg Ile Arg Cys Trp Gln Gln Met Met Arg 
            180                 185                 190 
gag gaa tgt ttc cgg gaa gta gct ccg gca aca aaa tac cgg aga ctc      624 
Glu Glu Cys Phe Arg Glu Val Ala Pro Ala Thr Lys Tyr Arg Arg Leu 
        195                 200                 205 
tcc cgc tgc tca att agc cac cat cat caa cgg ctg agt ttt cac ctt      672 
Ser Arg Cys Ser Ile Ser His His His Gln Arg Leu Ser Phe His Leu 
    210                 215                 220 
aaa ctc aaa gcc tga                                                  687 
Lys Leu Lys Ala 
225 
</s400>
<s200>
<s210>40 </s210>
<s211>173 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL27 </s223>
</s220>
</s200>
<s400> 40 
Met Gly Arg Arg Lys Ile Glu Ile Lys Arg Ile Glu Asn Lys Ser Ser 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Ile Asp Lys Ala 
             20                  25                  30 
Arg Gln Leu Ser Ile Leu Cys Glu Ser Ser Val Ala Val Val Val Val 
         35                  40                  45 
Ser Ala Ser Gly Lys Leu Tyr Asp Ser Ser Ser Gly Asp Asp Ile Ser 
     50                  55                  60 
Lys Ile Ile Asp Arg Tyr Glu Ile Gln His Ala Asp Glu Leu Arg Ala 
 65                  70                  75                  80 
Leu Asp Leu Glu Glu Lys Ile Gln Asn Tyr Leu Pro His Lys Glu Leu 
                 85                  90                  95 
Leu Glu Thr Val Gln Ser Lys Leu Glu Glu Pro Asn Val Asp Asn Val 
            100                 105                 110 
Ser Val Asp Ser Leu Ile Ser Leu Glu Glu Gln Leu Glu Thr Ala Leu 
        115                 120                 125 
Ser Val Ser Arg Ala Arg Lys Ala Glu Leu Met Met Glu Tyr Ile Glu 
    130                 135                 140 
Ser Leu Lys Glu Lys Glu Lys Leu Leu Arg Glu Glu Asn Gln Val Leu 
145                 150                 155                 160 
Ala Ser Gln Leu Ser Glu Lys Lys Gly Met Ser His Arg 
                165                 170 
</s400>
<s200>
<s210>41 </s210>
<s211>54 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL27 </s223>
</s220>
</s200>
<s400> 41 
Lys Ile Leu Lys Thr Arg Trp Glu Arg Ile Arg Cys Trp Gln Gln Met 
  1               5                  10                  15 
Met Arg Glu Glu Cys Phe Arg Glu Val Ala Pro Ala Thr Lys Tyr Arg 
             20                  25                  30 
Arg Leu Ser Arg Cys Ser Ile Ser His His His Gln Arg Leu Ser Phe 
         35                  40                  45 
His Leu Lys Leu Lys Ala 
     50 
</s400>
<s200>
<s210>42 </s210>
<s211>5171 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>SEP1 genomic sequence </s223>
</s220>
</s200>
<s400> 42 
cagatctctt ggcatgtgtc gaaaatgtgg agatcttaag aatgtagctt gtggccgttg     60 
caaaggaaca ggaacaatca aatcaggagg attctttggt ttcagtgact catcaaacac    120 
aagatcagtg gcttgcgata attgccaagc caaaggttgt ttcccttgcc ctgaatgctc    180 
aaaatcttga ccattttctc ggtattttat agttgtttca tcttcttgac actatgataa    240 
gtgtaatcgg tccattggta atggtaatgt taaagttgaa gaatgtcttg tttattcgag    300 
aagtctctta ttccaattct tgatctgtta ctgcaaataa ggcactttgc ttagatgtac    360 
cggatgctta tgaattactg agtaggttaa ctttaaccgg gttttatcgt cattaaaccg    420 
gagaaattca tctagtaacc aaatgctctg ctggaccttt ctttcagtga gcaactatag    480 
gtgggttttt ggcagttgat gtaccataat tggtgcaaac acacattttt cttgaatttt    540 
tgtttaactt aaataaagtt acttcgtttt cttgtttttt ttaatatgaa taaaaaaaat    600 
caaccataac tgatagtagg ttggttatct ttatcaaaac aaataaagtt aataggcaga    660 
aaaataattg tctatagaat caattatgaa aatgccattt tttgggatgg catttgtgga    720 
ttttgccctt tttttaatag tttgtgaatt ttgccatttt tcaggttacg tgaatgaata    780 
tacgttttat tcattatgtt tgggtttact cggttgtggt tgttcttagg gtttagtatt    840 
ttgtgtaaac tacgtatttt taccaaaaaa agtccgaaat ccatatattt ttaaatctta    900 
gaaaatggct tatccgtaag attttagtaa aaatggcaat ttcaaaagat ctctataaaa    960 
aatggcaaaa tcaacaataa tcccttgtct atatggtggt atttctgcta aaagtgactt   1020 
atgggtagat tttttagctt catagattct ttgtcgaaaa aaaattactt tgtacatttt   1080 
agtggagtta tttaaatttc ccaattgaac aaaaccatat attgatgaaa ttcgcaaatg   1140 
caatccaaaa ataaatatgt tccactcttt tggttagctt ttaactaaag atgcgtttta   1200 
ctttatgtaa gtggttgatc ttttggcaat gggggacaat gactatacaa tctaagagat   1260 
cattttaacg aatatcattc atatttcatc ctcttcttca aatttcagtt tcactaatta   1320 
accacgtttc aattgtagtg tatcgcgagc tgtaaatatt atctaattta tgttacataa   1380 
tcataactgt aatctttatt agacaaaaac atatatacct cactgcaaac accttcaaac   1440 
atggataact tgatttaggc atacaaatat tatttctcat ttatttgata tgacctatat   1500 
tatgtggcta ttttatcagt tttagtgttt tttatgataa ttgaaccact taaatgttta   1560 
tctcattttt caatttattt taaactgaat taaaaagtaa gaaagtatga tccaataagg   1620 
catcgacaca tggaaaccca ttttaaggta gaagatgctt ttctgcggct tctgaaaaca   1680 
actagaaaat gatatgatac gttgctttca tttattgtaa gtattattta gttttaattc   1740 
acgcgcttca tatccagctg caagactact acaacttgca attatgagac tctcgttaga   1800 
aaattaccag gtataattta aaaacaaaaa gaactagaat atattggcaa ttatttgaag   1860 
taagaaaata tgagattctt gaccgagttg ttaaactatc aaacccaaaa gttttggtta   1920 
aaaaataagc tagtactatg tacatatgtt ttatgttgaa aatatattaa actgtatgta   1980 
agagggagtg tactttcatt ttagatatac atttccagct agtacgaggt ctctatatat   2040 
aaactttctt aatatcgcta aacaaatttt actttcaagt ttgtaatgtg ataagtgaaa   2100 
gaccgtatat acatacacat gttaatcaac tgataacctt tgtgcctcgt gtgtctagtt   2160 
actagtcaac catcaaacgt gcatgatgct gtttttctta gagtactatt gttgtgttat   2220 
atataactaa acataaacaa tttgctatta tgatataaac atagaatttt caagcaatga   2280 
tatgtttaga tgttttgtat aaatattcca taaatagtag acacccatat atacacaaac   2340 
atgaattcta cctgaggaga aacacataga tgttcaaatt aaataataac cctataatga   2400 
aaactctaaa gtaagtaata cgaaataaaa atttatcctt taaataacat ataaacatat   2460 
atatacaagt ttaattggta attgtatcac aagagccaat tatttggtga ctgtatcaca   2520 
cgtgcttaaa gagagcgtgg gaatgaaagt aaagaagaat aaagaagcag agagatgggc   2580 
tagaaatgag aaaacacacc aaaccctaac ctcaccctca cacatttctt atcttttgct   2640 
ctcaatagat tccattgatt caaaacaaaa ttttcattaa gatttcacaa cctccacaca   2700 
cttccaaaca caattaaaga gaggaaaaag aatcaataac cctataaata aaaaatcaga   2760 
caaacagaag tttcctcttc ttcttcctta agctagtacc ttttgttctt gaaattaggg   2820 
ttaatttctt ttttccaaat accatcaatt ctccagacca taaaaactca aaaagatcag   2880 
atctttcctc tgaaaaagag atacccaact tatgtttttg tgtgtctgta tatagataaa   2940 
cattacatac ccatatttgt gtatagacat aaaaagtgga aattaaggta acaaaaagaa   3000 
atgggaagag gaagagtaga gctgaagagg atagagaaca aaatcaacag acaagtaacg   3060 
tttgcaaagc gtaggaacgg tttgttgaag aaagcttatg aattgtctgt tctctgtgat   3120 
gctgaagttg ctctcatcat cttctccaac cgtggaaagc tctatgagtt ttgcagctcc   3180 
tcaaagtaaa caactctctc actctttatc agtttcttga ttgagttttt gctagatctg   3240 
agcttagatc tttgtctcaa ggacttgtta tatatagatc acacgatctt gatttctacg   3300 
aagttgagtt aattagattt cttgatttca ttttctaggg tttttttcca attcttgaaa   3360 
tttaagatct ggtttttttg ttgtcaatga tttagaactg tgaattttgt aatcgaatag   3420 
attccaaatc ctgatatgca atctgaaaag ttttatataa ttaatatatg tctgtgtgat   3480 
tggaaactta aaagttgttc acagatttct atgaaaatta caagtatcca acgtagaatg   3540 
ataatatatg gttacatgca ttaaccattt gttagttcat catactttat ggtggttaaa   3600 
acttcaaacg cgtgtatatc tgtgaaggct ttgattgttt gttttttctt aaaaacaatg   3660 
tttaatagat ttttaattat atgttaaaat agttttgctt acatgcattc aagaaaatat   3720 
agcgattaat tccttttttc aaatcacaat ttgtgaatca aacgaaaacg taagatattg   3780 
cttgcaaatg ataggattga actattgata tttgtaaata taaatacgaa actttacgtt   3840 
tgaaagttga aacaatcaaa tccaaatcaa ctcgtatata atcagataaa taatggaaac   3900 
aatcttcaat tttgatggaa gaatacttta aaacttgaag agcttttttt ttatggtgat   3960 
ttataggttt agatctccaa agtcaagtat gatcttttta ataaactctt attctctctt   4020 
tttgagttat tttcagcatg ctcaagacac ttgatcggta ccagaaatgc agctatggat   4080 
ccattgaagt caacaacaaa cctgccaaag aacttgaggt gttcttaatt caaatactat   4140 
tttagattcc tatcatatca tttcaagaaa gatctttttt aaaagtttgt tttcgtgaaa   4200 
tatttcagaa cagctacaga gaatatctga agcttaaggg tagatatgag aaccttcaac   4260 
gtcaacagag gtacatatct gtctacctcc gtatatttac tcaattctgt atccatgtag   4320 
attcatattt gtaggtgtgt gtggcttttg ttggtgcaga aatcttcttg gggaggattt   4380 
aggacctttg aattcaaagg agttagagca gcttgagcgt caactggacg gctctctcaa   4440 
gcaagttcgg tccatcaagg tatctttata catggaatca atgattcaaa tgagattaat   4500 
ttgtgttgtt taattataac tactatggtg gtatgatgat tgtttgcaga cacagtacat   4560 
gcttgaccag ctctcggatc ttcaaaataa agagcaaatg ttgcttgaaa ccaatagagc   4620 
tttggcaatg aaggtataat tacagaataa atgcatttgg tgccttgcga tcaatctctt   4680 
tcacagagtt taagtttcta aacatttttg gaaacatctc tagttttctt gtttctgatt   4740 
atagtctttt ggtgaaatgt aaatgtttag ctggatgata tgattggtgt gagaagtcat   4800 
catatgggag gaggaggagg atgggaaggt ggtgaacaga atgttaccta cgcgcatcat   4860 
caagctcagt ctcagggact ataccagcct cttgaatgca atccaactct gcaaatgggg   4920 
taaatccttt gccttaaaca atcatctgca aatcagcttg tgtacttcac tactaagatt   4980 
gtacttatat aaggttcttt agttacttgg tgtaaagagg atcatcaatg tgtgtgaacc   5040 
ttttaagttg ctgttttggt gatgatgatg atgatgacag gtatgataat ccggtatgct   5100 
cagagcaaat aactgcgaca acccaagctc aggcgcagca gggaaacggt tacatcccgg   5160 
ggtggatgct c                                                        5171 
</s400>
<s200>
<s210>43 </s210>
<s211>5131 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>SEP2 genomic sequence </s223>
</s220>
</s200>
<s400> 43 
acgctctaac caactgagct aatgggccat ttgcgaatgg tagtgtctat tttacttatt     60 
cgaatctaaa tcgtcatagg taattaagaa gacatgcaaa gcttaatcaa tgatggattc    120 
tttgattcta cttctaggtg ccaccattga cgcattcata aaatcataac cggtcgttta    180 
caaaacatat tgcttgaatg attctaaaca aataatagtt ttttgttgaa attttcaaaa    240 
catatgttag gtaaggtcag gttttgccaa taagccttac tatatacagt ggcaacatgt    300 
ttcttctact ttggaggatt ttgggtgaat atgaaaccca tgtgagcatg atacatgtgt    360 
ttcttcttct attgaaattt cccccaatgg tcatttgctc tttgcgttcg tgttgcgctt    420 
tccggtatca aatcatatat atatataacc taaatgagac tagacaattt gaatcattgt    480 
aaaaggtata aagaagagat tatagtccac aattaacaaa gtaataagac ggtaaaatat    540 
caaacaaatt gaaagggtaa aaaaaaaaca agagggacaa gtcactgtta gaaaggtgac    600 
tcctcccttt gggccagccc cctaccacaa aagtcaaagc ttacttacta ttcagtcata    660 
tatcgacacg tgtacttcga accacatcac ccatcctatt acgtaatttc cactgtctag    720 
actttttttt tttttttttt ttttactttt taacgttttt tagctgtctc tctaaattac    780 
tacatacgga cttgctacgt cacctgagaa gaaagatctt tgctcgtaga ttctttgtct    840 
gaaggaaaat tatttgtatt tagttattta caattgcata attgtgtgta gtaaatccgc    900 
cagaatgata ttagagtgat actgagacga cgaatggtgt aacttgtaac atatatacta    960 
ataaacacga ttgattaaaa atttactata cagtatatcc aaaacattat gattgagagt   1020 
gtacatatac aataagtaat taaacctcaa aaccaaacag tttttttttt ttttggtcaa   1080 
caataattag aaatgagaat aaactattta acttataaat tctagaccca aaaactcata   1140 
ttttaccctt cttggtctca cctaaaaaga ctttaattcc caaaactctt gcaaacaatg   1200 
gccaaacata gaagattgga aaacaaattt aaatctactt tcacttttat aaagaataat   1260 
caacgaacca attaagttaa acctacatat attcgtatgt gatcacatat gtgttatatt   1320 
cctcacgttc tcttccattt agctaataac cttaattact tcaagaaatc atatatcaac   1380 
cgaaaactag taaaataaat atacatactg aaagcgcgca aaatttttag caatatttta   1440 
aaatacccta catcatagtc ttaactaatt aatctttctg atcaaaattt attttcataa   1500 
tattcataaa tacttatgga ttacctaaac caggatactt atccctataa atctgtcaat   1560 
catcatggat tcatggagac atggtcagat atcccacgtc cagatacaat gtaacatatt   1620 
gatatactgc ggctgattat tattttttac attagaacga gtttagatcc aaaacaaaat   1680 
tggtattctc aaacaaaaat taaaaattga atacgaaagt aatagaacaa aacttcaatg   1740 
ttgtcgaata gataggaagc aatagaaaag cgacacgtac atgtccattt taaggtagga   1800 
gaggcttttc tgcggcttgt gaagtaagaa aaagaaaatg atgatagctg ctttcgtttc   1860 
attcattgca gaagaaacca atgtttcccc aatctcacgc gcctcctcct atctaccacc   1920 
acttggacaa atcccctttt cagtattagt ttttttttcc ggacattgta cattcaaaag   1980 
cattccaagt gtctaataaa cataactaac cactccaaga tgcaaaatct agctacgaac   2040 
aaattttaaa ctatagagat gaactttaaa ttcgggcatt aattagtgga acttgagcta   2100 
ttgatgagtt ttctgacttt ttgaagctta attgagtttt atatacacta tatataggct   2160 
tgtaataata tggatcaaac aagaaatata taaactacaa attgggaatt aggttttaaa   2220 
acgttatcgt tctattttaa ttcaggcacc tttagaatat caagatccat gcatgtttca   2280 
atatttctgt tgacaaataa ataaagatgt ctcaaatatg aagtttgggc aacgtacgtg   2340 
tagacctaaa agagtcgaaa cattggtatc taagtcatat atctagatgt atatggacat   2400 
ggattatata actagacaac gtttgtttta aaaacttaat tcatttttct taattagtag   2460 
caactagcaa ctaactactc atggcaaata atggtgtctg cgtggcacgc acttgggaga   2520 
gaaggtgtga gaatgttttt tactttctgt gtaaaagatg gaagagagag aaagagtaaa   2580 
gaagtagaga gagagatatt gtatcaccaa accctaatga tctctcaccc tcacaaattt   2640 
tcttatcttt atagctttta tagattcaca aaaacttttc ttcagattca caatctcatc   2700 
acaacccttc aaaaagagaa aagatctaaa gaataaacaa gagccctaat atcaaatcac   2760 
aaccaaaaaa accaaagaaa gctaattaaa gttttctctc tagctattcc tcttcttttc   2820 
ttgttcttga aaactagggt ttacttcacc aaaagataag atctttcccc agaaaaagca   2880 
atacccaagt catgtttctg tgtgtctgta tatagataaa acattacata ccctaataag   2940 
gttacacaaa tagctataaa agagggaaaa taagataggg attttttggg gtgaggaaag   3000 
atgggaagag gaagagtaga gctcaagagg atagagaaca aaatcaacag acaagtgacg   3060 
tttgctaaac gtagaaatgg tttgctgaaa aaagcttatg agctttctgt tctctgcgat   3120 
gctgaagtct ctctcatcgt cttctccaac cgtggcaagc tctacgagtt ctgcagcacc   3180 
tccaagtact tctctttctt tatacactta ttagatctgt gtgtagatct ttcatttttc   3240 
tagtcttgtg atgagtttta tctttcttga ttgcttttta acaaaatact tgatatattt   3300 
tcagtttctt aatctgatct ctaattaggt tttgattata gaagaataat tcagtacttt   3360 
caagtgattg aatttcgaga tctgatctta atttaatcat catgtcaaat tcttagggat   3420 
ttaattgcaa tctattttta gatttatcgg agctaggaaa gtatcataat gatatactat   3480 
tattatcatg taatttcatt gtctctacac ggatatatat gtgattagaa cttggtaaag   3540 
taaactaaag attcacagtc ttcaatgaaa tttaaaagat ccaacgtaga ataattagtg   3600 
gttccatgca ttaaccagtc taattaaagc tcatgcagac atttaagcac cacatgaatt   3660 
taatatcttt ttaattaagg gatcttcttt ttataaattt tcttttgtta gtttttaaaa   3720 
ttttagtttg ttcattaaat ttatagattc ttcttctcct gatttgtgtt ttttgatctt   3780 
tcagcatgct caagacactg gaaaggtatc agaagtgtag ctatggctcc attgaagtca   3840 
acaacaaacc tgctaaagag cttgaggttt aatctccaac atctcttcga tcttaattat   3900 
ttatcctttt ttaattttat ctaaagaaaa tgtttgattt tgagacaaaa gcccttcaaa   3960 
gtttcttaca tagatattca attgtctatt atcttcgcaa ttttcagaac agctacagag   4020 
agtacttgaa gctgaaaggt agatatgaaa atctgcaacg tcagcagagg tatatacatt   4080 
aatgtggatg atgatcattt ataaacagca tatatatata tatatatata tatatatata   4140 
gtttgtattg atcatgaaag tgtgttgctg cagaaatctt cttggagagg atcttggacc   4200 
tctgaattca aaggagctag agcagcttga gcgtcaacta gacggctctc tgaagcaagt   4260 
tcgctgcatc aaggtgattt acttctgtac atacactgaa agattcacac aaatctttct   4320 
ctatatatag actgagacac atgcatgaaa tgtttttgat gcgtgaggtt atctgaaaat   4380 
gcctcttctt ttttgcagac acagtatatg cttgaccagc tctctgatct tcaaggtaag   4440 
gagcatatct tgcttgatgc caacagagct ttgtcaatga aggtatatga tgatgtttct   4500 
ctctctctcc tccagtttct atttatagat ggaaacttta aatagtccaa tttatatata   4560 
tgagtctaaa tttcacattc ttcaactgct acatgtttct tttgtattat ttctatgata   4620 
tcttcaggaa agtttgaaaa atattgtgtt ttgtttagct ggaagatatg atcggcgtga   4680 
gacatcacca tataggagga ggatgggaag gtggtgatca acagaatatt gcctatggac   4740 
atcctcaggc tcattctcag ggactatacc aatctcttga atgtgatccc actttgcaaa   4800 
ttgggtaaat caaacaactt ttcttgcctt aagacatcaa cttaggttat aaacagttag   4860 
cagtttgctt taagcccaac attgtctttg tttcatagag gctttggtta aaactcgtgt   4920 
tgtttagtct aaggattcag cactttgatg tctgaagtat ggaaaatcaa tatctcagac   4980 
ttgaaaatgt gggtttctat tgttgacttc gaaactatgt tgttgtggtg ttgcaaacag   5040 
atatagccat ccagtgtgct cagagcaaat ggctgtgacg gtgcaaggtc agtcccaaca   5100 
aggaaacggc tacatccctg gctggatgct g                                  5131 
</s400>
<s200>
<s210>44 </s210>
<s211>5070 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>SEP3 genomic sequence </s223>
</s220>
</s200>
<s400> 44 
gtccccttcc cattacgtct tgacgtggac cctgtccgtc tatttttagc agattaatcc     60 
aacggttctt attctttctt cgacccttca cgacattgcc tcaaagccgt ccgattctca    120 
tctcacgccc aatggaccac atatatcacc agtactccgc aacttagctg tcgtgtagga    180 
tttcacgtgg catttatttg ttctagtttg tagtgcaaac attgcaagtt gatatggtcc    240 
cctatcgatc accgtcgtct ctttagcttc acatcgagat tcttctttct ttcctacgtg    300 
taatagcatt tttgattttg agaatttctt tagaaccgtt ggatctctca tcgttggttg    360 
atccatccat ccaaatggga cctgtgtgtg ctccatccag ggcatatgat cccaaagcca    420 
aaagagtatt tccaagtgct ttctttcttt ctttctttct ttcttactaa cctttttttt    480 
tcttatgctt tagactaaga aatttattcg gccatatcca cttttacgaa tatacttctt    540 
acaagatcta gatttttttg agttaattcg gtgtatataa cattggcatg gactgcaatt    600 
aagtaatggt aatgtgatca tgatgcgatg tgtcgttatc agtagtataa tattgatggg    660 
ctaccctgga aaacaaaatt acgtgttata tgtacacaat ttggtagaac cgtagaaatt    720 
aaactgaata aaaccttcta taatgttcaa aattatatgg tacagattaa tacggaaaaa    780 
cattcacgct ttacgtaaca attaagtgga aagtaaaatt atcccaaaaa tatttatatc    840 
acatcattgt tatatttcta agttttttta tatctctaat ggtatatgtt ttacagattg    900 
ttttttggga aaattcttaa agagacttga agaatgtttt ttttttattt tcttgaaatg    960 
tttgacactt gaaaccgttt aaaaactcaa atatagtata tatcattgtt ggtctcatac   1020 
cttgtaattc accacatata ttatcaatgg ggaagatttg aaaatttttg ggggatcaca   1080 
aaacgaagga aagagtacaa aaagagaagg aaaagataga agatatatgt ttttaacttc   1140 
attggtatga catcaataaa taaatagttg aatgtacttt agtttctctt ttggtttaat   1200 
gcacatcatc tcgatcaatt gtcatcatct tacattgaat tatacgacca gatctgataa   1260 
caagtgaatt cgtacttgcc cttccctttc ttctcatacg tccttctaac taattttgat   1320 
tgtaacttat aattatataa ccatatttaa ttttatttta tctaaaacca attgaagcaa   1380 
attaaaatat cataaatctt gagtcccaca tgaagacaat atataaaact cgtgcaaatt   1440 
tgcttaaaat gcttctatga gaccatgacc aagtgagatt aataagcgat tcaatgtgca   1500 
aatcaaaaga gaaaagaagc taatgggttt aaatataacc aaacagaata ataatgctat   1560 
gtttagtttt tctaattgaa tcataccttt gtgtccatca cctacttacc ggtcagaata   1620 
aagcaattac gtctgcaacc aaaaagcact aagactttcg gtcagacatg atctctaaca   1680 
tcggacgaac cctaagataa ccaaaataaa ctatatctta tattcaaatc tctgtttatt   1740 
ttatccattt atgttttctt tctttcccat aatttttttt gtgtctcatc agactctctt   1800 
accaaactga atttatcaac atggtttttt ttttggccac atcaaaatgg tggtttataa   1860 
agtagactaa tacaaaagac atttctgtta atttcactaa caaaaataat cttagcagta   1920 
ctatagattg gaaaaggaaa agcaaatcta gcagtaagat ttatcaaaac tagcagtaag   1980 
agttttagat atcatgaaaa catcacaaac gagtagtgtt ttactttaca tttttaacca   2040 
atcacaaggg tagttccgta agttgggaaa atcgtacgag gcttcaccta gttaaggtta   2100 
ggtcacatga ttccctgaac tcgattttat aagtaaaaaa gaaaaattta taaaatcaaa   2160 
attttttata taaaaaaatc aggtggattt atcagaccct accatcgaga tgtcgacacg   2220 
tgtccaaact cattcattgc cctactattt tctgtttagg gttgcaatca ctcatcgcac   2280 
acgcgccatc tccaccttcc attattaatc tctcattttc aacatcacac tcttacgaat   2340 
catacgattt taatatctct gtctctctca acgtattaaa taaaaatggt tttaaatgtt   2400 
agggtttttt gtaggatttt caattattaa tctctataat tcgatgaact aagtaaaaaa   2460 
gcatcaaact ttcttggcag atcacatttt tctctaaact aaatatggac tgaaattgaa   2520 
aaattaaacc actagctaga ataaagtgtt ggtgagagtg gaactctaat ttctctcctt   2580 
tactaattat gtataaacac aaaaatgcac caaattttta ggtttgaaaa tatctaagca   2640 
tggatagggt aattaacatt ttttctttca attttgcaat atttgaataa atcctatgag   2700 
ggtctttggt acacaataat tggagggtat atagttgagt ctgagagtat attagaaaga   2760 
gaatatttca agtaatgaag ctgacatgtt tatatgtact ttgagagaag tgttgtgaga   2820 
tttgtacaaa tgtatatgta cactttaaaa agcaatataa gatagataaa aaaaatataa   2880 
agaaaaaaag aaagaaagaa agaaagaaag agagaggctc atatatatat agaattgctt   2940 
gcaaggaaag agagagagag agattgagat atcttttggg agaggagaaa gaaaaagaaa   3000 
atgggaagag ggagagtaga attgaagagg atagagaaca agatcaatag gcaagtgacg   3060 
tttgcaaaga gaaggaatgg tcttttgaag aaagcatacg agctttcagt tctatgtgat   3120 
gcagaagttg ctctcatcat cttctcaaat agaggaaagc tgtacgagtt ttgcagtagt   3180 
tcgaggtata tatctacttt tgtatatata ttacttataa cataaacatt ttatatacat   3240 
attaagtaac acaaaaatgt cttgtatgta tgggtctctc tgtgatgtgt tgttgtgtcg   3300 
tacgtacgtg ttctatcata tccttttaaa agaagcaaag aggaaaaaaa atttgggata   3360 
ccccaaatct gtatcatttt ataacaagtt tgcttttttg atgttctttt gtgtttctct   3420 
ttgatttcca tttttgtttt tgattttttt tctatttctc tttacatcta tcaaagtttt   3480 
ttttcttata ttttattgct tatttgtttg tctacttaat tcacattatc tgagagaaga   3540 
acaatctatc tgatatgaaa ttagggttaa tttctcttgt gagtactctt taattcacat   3600 
aagcttaaag tttccacctt ttgattctgg gggtcgtcca attcgatcaa atcactcaat   3660 
tttgttgtca gattgatata agttcatagg gggatattgt ttccacgaca atccatttta   3720 
gtaaccctta ggggtttcca attttgggtt ttgaattgac gctaatgtca aattcatcta   3780 
aagtccgttg gatatgtata cttggggatg ggattcatcc ttttttctgg gttctttaga   3840 
tcttctctta aaagactaac agattttgtt gtaaacccta ggaaacagtt aaaaatccca   3900 
tttttaaaaa catgttttga acttgatgag taagattaat ggaagaaatg atgtttttgt   3960 
gtggtgtgaa gcatgcttcg gacactggag aggtaccaaa agtgtaacta tggagcacca   4020 
gaacccaatg tgccttcaag agaggcctta gcagttgtac ccaattctct tctctttctt   4080 
ctaattacct taattaatta ctctcaattt ttactttgat ttttagagtc aaatgattaa   4140 
tgttataatt tgtcatatac ttcaggaact tagtagccag caggagtatc tcaagcttaa   4200 
ggagcgttat gacgccttac agagaaccca aaggtaaact aattagcttc ttcagctacc   4260 
ttcagagagt gtttgttttt ttagtagatt tttttgatgg ttttgatgtt gaaataggaa   4320 
tctgttggga gaagatcttg gacctctaag tacaaaggag cttgagtcac ttgagagaca   4380 
gcttgattct tccttgaagc agatcagagc tctcagggta ctactttgtt catcaatatc   4440 
tttatacact gatctatttc catagtaaga ttaaatttgg tgtttaattc tgcagacaca   4500 
gtttatgctt gaccagctca acgatcttca gagtaaggta aataaagaaa cactcattct   4560 
cctctctaaa ttcctcatct aaaagtaatg taaccaagaa aacacaaata tttggagcag   4620 
gaacgcatgc tgactgagac aaataaaact ctaagactaa gggtaattaa tatacattct   4680 
catatcacca aattaatgca tcactaaatt tggttataat gtgtgtgtgt atatacatat   4740 
gtgacagtta gctgatgggt atcagatgcc actccagctg aaccctaacc aagaagaggt   4800 
tgatcactac ggtcgtcatc atcatcaaca acaacaacac tcccaagctt tcttccagcc   4860 
tttggaatgt gaacccattc ttcagatcgg gtaactttag actagtataa ccaatttgat   4920 
ttgagttcta ttataagctt ttcttaagaa agtatctcaa actactaaat tttatggagc   4980 
aggtatcagg ggcaacaaga tggaatggga gcaggaccaa gtgtgaataa ttacatgttg   5040 
ggttggttac cttatgacac caactctatt                                    5070 
</s400>
<s200>
<s210>45 </s210>
<s211>5392 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL20 (SUPPRESSOR OF CONSTANS (CO) 
      OVEREXPRESSION 1 (SOC1)) genomic sequence </s223>
</s220>
</s200>
<s400> 45 
gaaaaaaaaa acacctaaag aagtgaatat aataggcata tacatatgag gaaaatgaaa     60 
acaaaaggag cgaaaaatag atttaaccta aaagaggaag taaagaggtt ataagaggta    120 
agaaaagtag gaccatataa tagctatatt gtagaatttt attatttgga gatatggcaa    180 
tttttgtgag ggtcccatga agactaaagt gtggagcacg atttatcttt gtaattaata    240 
aaataataaa tatattatta ttgtctcggg atttttcgat tgatgagaaa aagtaagagg    300 
tgcgttttcg aattatcatt ggctaacgtt tgtacgtgac tgtacggacg acgttgatgt    360 
atttctaata ttgtactctt ttttcccacc cttatttctc taattcttgt acattaaccc    420 
caaactaatt ttacaaacac attggtgttt aatcattgtg aaattttgat ttatctaaaa    480 
tacactttat atgttatgat tttgcatgag cttatgactg gtaaactcat gagatttcca    540 
tatcaccatg ttggaagtta ctaaccatac atcttttaaa tgcaaattca catcattcct    600 
agactgctag acagacatgt acttacttat acaaggtttt tctaatctaa tggcaacaaa    660 
gaaacttgtg actaaacgca tacgtatctc tcatatagtg tagactagaa ctctacgtat    720 
ctctcatata gtcatatttt taaaaaaatt atactttggg atctcgaagc gaaaattaga    780 
ttagtttata tgattatgta caaaaaaaat cggatattac taccacttaa aaataattgt    840 
agtggtcaat catatctaaa attaatcgca gtgaacaaaa acctgaagca tagcctggtt    900 
ctatcttact ttcgatgtga cacattacta acacgattgt tttaatctat aggacgaatc    960 
ctttaagtaa tgtatagttg gttcagttac gttagatact ttttgttttg gatttgtctc   1020 
aaccagttaa gaagtgatcg tatttactag tggtatacga tgatgtttct ttaaatctga   1080 
attgggtcta caaaatacat aactaaactt caaaccgggt ttatacttta tacaaacacg   1140 
aaaatataaa gatagagaca attcaccaga gaagatgtgt atttatataa aaattatcca   1200 
tacagatttt cggacctatc tgtttgatat ttaatatata taaatacgtt aacatatttc   1260 
accagagaag atgtgtattt ttcgaaataa ttagtttgtg tggtcctcct cccgatatag   1320 
ataaaagatc attagatatc gattaacaat tttatctcca aaaaaggata tttttttggt   1380 
gccactagct agacaagacg ttcgataagc tgaattatta ttggatttct aagttacgtt   1440 
ttctttagta atccgaggga ccaaaaatag caaatgcctc tttagacacg tcgctactta   1500 
acgccattgc cccattgtct ctgtactagc ctccaaatat ttggattaat ggtcacttag   1560 
gtaatgagga aattgtagta ttttgtaatg tggttttgtc caacttataa aaacttacaa   1620 
ttgcaagtaa ttaattattc acatggagat gtaagattat gtcatataac taaaaacaca   1680 
atttaagaac aacaataaga aacaatggac aaacaagcat agaaaatata caaatcaaat   1740 
gaattttatc tgttgggatg gaaagatatt ataaaaattg attaaaacca atatagttgt   1800 
attactcaca ggtaagaaaa aacgatattc ttatttttca tatcaattac aagtgggggc   1860 
atataggtac gagagagtgt ttgtgtccac attaaaaaca aaaaaagatt tttgttagaa   1920 
gaaatttaat aaaaataatt tgacaggcat ttccatccaa ctagatattt atgggaggga   1980 
aaaagatgtg tatgtaaaaa tgtccatatg tatcaaaata tgctattttt ggtctttctt   2040 
aaggcttttt tccaaaataa gtaaaggatg aggtttcaag cgtccatcat atttgcgaca   2100 
catatgactg actatttagc tcctccctct ttctttctct tattttatta tctttctcca   2160 
agaaataaaa tagaaaagaa aatatatatg gtttcacaaa caccattacc ataactacaa   2220 
cgagaagagg atctttttta aggagaaaag cagagagaga agagacgagt gtgtgaagtt   2280 
tttttgtctt ttgtttcttt tattacacac aaatagatga aacgaggaaa gctacttctt   2340 
ttgctacttc cataaaaagg ttcttccttt cgcagagaat caactttgat catcttcttc   2400 
cttctctttc tttcttcttc tccctccagt aatgcttata tagtctcctc ctatatctct   2460 
acctatacat acacaaaccc tttatcctcg aaagcttcct cctggttagg tttttatcaa   2520 
acccttttag ccaatcggta agatctcttc gtcatgatct tttctttttt cttttgcttt   2580 
gtactctgat ggatctataa acttatatgg gtttggtttc atttggttcg atttgatgtg   2640 
tttggtttct ttgtcctaaa tctcatgaaa ggaggttgca tccttcaatt aaaccgataa   2700 
caaaagtttc cattacagac ttatagatca gatactttag attgttttgc tttttgggta   2760 
cttaatcttt cgttgacttc atcagtcttc tcccacccaa acaaaaaagt catatttcga   2820 
tcatatcttc atttttttaa cctactctct ttgattcata tatgaaatgg gttgttttat   2880 
gtgtgtgact aatcttgtta ttgaggtggt tgcaccattg atctaccgtt ttcttcaatt   2940 
tttgaaaaaa taattttatt ttttttctgt gtgcaaggga aattaactaa agaagaagat   3000 
atggtgaggg gcaaaactca gatgaagaga atagagaatg caacaagcag acaagtgact   3060 
ttctccaaaa gaaggaatgg tttgttgaag aaagcctttg agctctcagt gctttgtgat   3120 
gctgaagttt ctcttatcat cttctctcct aaaggcaaac tttatgaatt cgccagctcc   3180 
aagtacgttc tttttgtctt tcttacaaat catccataga aagagagaga gagagagatc   3240 
tcattaacct ctctatttgt atcttaattt tttttggttt atatatggat ttgattggcc   3300 
ttttgtggaa tcacatctct ttgacgtttg ctttgagagg tgtgtttaaa tgagtttctt   3360 
ggtttctgca aaattagggc tattattaaa gtagtatcaa gtacatatac cctcttattt   3420 
attgtttttt tatttccgct agtatatcat cttgtttaat catctgtctc tctctttctc   3480 
aattagtttc tcaagttatg atataaataa aatgtgctct ttcgtagcca atttacactt   3540 
gttatatatt tgatcttctt agagatcatg atcacatagt attaataaaa caactttcaa   3600 
ttagtattct tttggtttga actaatcttt gtcttgttat tgctttaagc aaaacatgtt   3660 
gttctaattt ctaagtgatg attaggaagt tgtttcatca ttcctgattt attaatccct   3720 
catgcttcat ttcatgctca ttcctaattt agttcaattt gtttgaatat ttgttcctga   3780 
ttttgacata gaaactcaaa gctagctagc caaacctaaa tgttgattgt ttttgagaat   3840 
caaaagagtt ttatcttgta ctgttaggta gtagggaaac caaacttact tttgatgaat   3900 
cattacttct gtaaatgaaa atgccagctt ttgatcagat gtttcagaca tttggtccat   3960 
ttgggaaagt acttctttct ctcgaaccta ctaaatataa agataagacc tcacatgttt   4020 
ttgattttct aaaatagggg gaaaaagtac aagacttttc aagctatgtc cttgattaag   4080 
tctagtgata tcttcaataa gaaatgtttt gagaacacca ttgggatcta aatttgatct   4140 
ctgatgattt actttaatgt tccaattata tatgtttttg acagtatgca agataccata   4200 
gatcgttatc tgaggcatac taaggatcga gtcagcacca aaccggtttc tgaagaaaat   4260 
atgcaggttt attctttatg atcttcttgc ctatatatca attcttgcta attaatactt   4320 
ttactatata atatcaaaga gcggtaatga atataaccac aatatgtata taatctcaag   4380 
gtcacaggat caagtcacat atttataatt aggatatata tgtacatgca ataacatttc   4440 
tgtgatataa ccaacagcat ttgaaatatg aagcagcaaa catgatgaag aaaattgaac   4500 
aactcgaagc ttctaaacgg tttgtgatat atacatatat acaaacacat tattcatcac   4560 
ttgtatatat ctatttcatg atgcatagga gagtttgatc aattagtgtt ttgtttttgt   4620 
aatcagtaaa ctcttgggag aaggcatagg aacatgctca atcgaggagc tgcaacagat   4680 
tgagcaacag cttgagaaaa gtgtcaaatg tattcgagca agaaaggtat gtgtatatat   4740 
ttatctgtta tatctccaca ttataagtat tgttcgaatc atcttctgaa accactcata   4800 
attataactc aatttctcat ctcttttaga ctcaagtgtt taaggaacaa attgagcagc   4860 
tcaagcaaaa ggtaaagtag tttttatgag tgtatataaa cagatataag tatgtatgca   4920 
aattgtgtaa tattccaagt aagtaagcct cttgtgcttg ctttttacaa attggaatct   4980 
aaaacttttg caggagaaag ctctagctgc agaaaacgag aagctctctg aaaaggtata   5040 
atatattctt atgggtctca agttagggtt gcacattcgt ttttttattc ggtaaagata   5100 
agaaagttgg ggttcttttt gggggttatt aggttaggag agtccttact agtttttctt   5160 
ggttatcttc aatcatcaac cttctttaat ttatgtattg ttctatatat cttctaattt   5220 
gcatctatta attttgtgta ataattctat ttgaatgcag tggggatctc atgaaagcga   5280 
agtttggtca aataagaatc aagaaagtac tggaagaggt gatgaagaga gtagcccaag   5340 
ttctgaagta gagacgcaat tgttcattgg gttaccttgt tcttcaagaa ag           5392 
</s400>
<s200>
<s210>46 </s210>
<s211>5134 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL22 (SHORT VEGETATIVE PHASE (SVP)) genomic 
      sequence </s223>
</s220>
</s200>
<s400> 46 
tacaagtcat cgccgccgtc gtcattttca ggatccggcg agaaactgaa ccaaaataat     60 
acttatttta ctcgtaagga aaatttgggc ctaataaaag cccaataata ataaaaagcc    120 
cattagggac tccgctttat gataacggtg actgtagttt ccttgatgtg tcagagagag    180 
tgtgtagtgt agggactgtg tagaaagaaa gaagcctaaa atggctaaaa ggttaggtgc    240 
aatgtttcat tagagaggct tggaactgtt aagggaaagg tcacgagtcg tctactcata    300 
aaaactctga cactttgacc aatcaaaact caaagacctc accagttgtg tcacgtgcgc    360 
ctctaaacac tattcaattt caaatataaa tgattcatgc ggttccaaac gccaattgat    420 
ggatgttcta ccaaatttaa tctactttta ccaaaccatg acaaatatga ataaacatta    480 
cttgataata attttgtgag tgaacaaact tttttttttt cgaaaccaaa ccaagctgaa    540 
aaaaactcaa cgattttctt tgtttaaaat acgttagaaa ggaatatgta ttatgccgaa    600 
ataagtaata tcgatcaggc cacctctctt atagttattc tcctagcaac tttaaccact    660 
agaaggtttt gttttctagt gttttctaat atacgtcatc aaaattttca aaaaatacta    720 
catttttgtt ttaaaaactt ccataattcc attactcgta gaacacaaac gcaaaccata    780 
ttaatatttt gttgtcaaca aaaatttcaa attataattc aactatattt gcttgattac    840 
ccaattagat agaaaagagt taaagaagaa aagaaaagag tttacagtaa attaacgcaa    900 
accataatta tatttaacac cgtattaatc acatcaacca tatgactttt ttaccgtttg    960 
caacttcata attcatatag tatcataata aattcgcaat aatacaacac aagagtttcg   1020 
tcggaagagt aaataatact caaatagggg gtgagtgata cgagccacat gtattcttga   1080 
agggtagatt attgcaaact tggagtaata aagagaagaa gaatgggttt gtagtagttg   1140 
cgtggagtat ctttatttgg gtaaaacttt aatttagaaa taaaattctg tacggacaat   1200 
ggatcgtgtc ccaatcagat ttcttgtggc tgcttcgggt ctggttttgg gtccctttga   1260 
aaaattttag tggtcgacac tttttatttt actctggctc gtgcctcgag ggtccctcta   1320 
ttcactgttt cttcgtatga aggtatgctt aaacattatt ttatttttaa aaacccttta   1380 
attttatttt cttaccttta atcacggttt tgtaaattgc tttttagtct atggaatgat   1440 
gattgtggcg attgaaatca tatgtttggt tctgttgttg acgttggtga agtatatgtg   1500 
atttgtaatg ttgagcttat gtattaaaat gttaaatgat aaataacctc gtaagaaagt   1560 
gatttcattt aaattttatt ttgagttaca tattcaattg gttttataaa aaaatacttc   1620 
agtgatgatt gataccccca ttgtgtgtgt aattgttact gggattgaac aaaatttatt   1680 
tgtgcatgac aaactttcca aattagtgca tagattgtaa ttgtataatg gactacatgt   1740 
atctgagtag atatggttca ttaggttaca aacctctttt tttaaggaca caatttttcg   1800 
acaagttata tgccacatga ttgactacta aattttcaaa aattattgca ctaatgtctt   1860 
tgaaattaac aaattatttt gtcatttccg agttggattc ttacaaacca aggccgaact   1920 
cacaaactta tttctttcag taaaaacaaa acattgtcct cagaaaaatt ctgaaatgtc   1980 
atcttcccaa atgtttttac ataaataaaa ataatataca gttgatatta ttttgttctt   2040 
tctgaatttt gttatgaggt accattacca tatagtacgt agatttacaa aaatgaaaat   2100 
acgttgtagc ccttgatgtt cttcaggtct tctagttagt ttttgcagta aataccaacc   2160 
aattagttac aaggagtata agtgaacaaa gtgagacaac tcattttatg cttccctata   2220 
aaaagaaatt ccccactgac ccaaacacac acttctcttc tctctctcat ctcattggag   2280 
acttataaat cctattacct caccatatcc aataaccacc acacacagac caatatccaa   2340 
aaaaaaaact aaaactaaaa atataatata tatcgttttc tttccaaaaa taatcattta   2400 
agaaacccca tcatcttgat agtattataa aattaataaa cctctccctg aaaatatctc   2460 
atccttcacc aatcaaaacc ttctcatgtc ttcttctctc ctcgaccttt gaggtggaaa   2520 
attaaatata ttcccttagc tttttttctc ctttagtttt cttcttcttc ttgagttttt   2580 
tttcttttga tcctctctaa tttccttgtt gattcatcga ctagatctaa ttcttctcac   2640 
aaaagactga gtgtgttctt tctttcaaat ctttcaaaaa ctagggtttt tactgtcttg   2700 
aaatcatatt tattcttcta aatttagcaa aaagaacacg atttactttc catttcagtc   2760 
gtcttgtcac tctctctctc ttctttaaag tctccctttt tagcaaaaat tctctctctc   2820 
acaaaattta tttcctctgg cttcttcttc ctcctcctcc atctcttctc tttactctct   2880 
ctttaatcat ctctcattct tgaatcttga tccatcaaaa tcaatcccgt tctcgaaaga   2940 
tccattaaaa tcaaaaccta agctctctct cttgcttcta gggttttttt gttcgttgtg   3000 
atggcgagag aaaagattca gatcaggaag atcgacaacg caacggcgag acaagtgacg   3060 
ttttcgaaac gaagaagagg gcttttcaag aaagctgaag aactctccgt tctctgcgac   3120 
gccgatgtcg ctctcatcat cttctcttcc accggaaaac tgttcgagtt ctgtagctcc   3180 
aggtctttct ttctctctct aacttccctc tctatagatt tctcataact catcgaagga   3240 
atcttgtcta gatccagaca aaaaacttta aagagttttt agatgtatat ctgatacata   3300 
ggagtttact gtatcaatct ttataggacc actaactatt tatataatta aaatagttgt   3360 
tagaaacatt aatcatgacc ataaatgaca tatataaagt gtatagtaaa actctgtatt   3420 
tagataaatt aaggtatcta actacggtaa tattcaaaaa gatgtaaatc tggatatgca   3480 
tatatgtata ttattagtat ataaatacat gctctatagt aggtatttgt gtcaaccatg   3540 
tataaatcta tgtatataga tattgtggta tgatatgttt aagccgtcaa tgtcatattt   3600 
atatagaaat atgtgggtac cataacatga ggaagtatct atatgtgtgg atgtataaag   3660 
ctttcccttt gaagaagtaa tctaaaaata atatatatat atatatgtat atgtatagat   3720 
atgttggaat ctttattagt gttgggaaaa gtcatttaga gagatattat tgatattagg   3780 
gatctaaaat gacttatcgt attacagaga tacgattttg gatttttgac ccactagtta   3840 
tcagctcagt tcctatcttc ggggacatac acactttcac agataattgt gtatatatgt   3900 
aactgaaaac gatagtgtta acatgaaata atgtacatgt ttgggattaa atgtgttttg   3960 
tggatttggt ttgcatcttt tgattttaga ttttggtata ttgtcggtgt ttacatatgc   4020 
acattgttaa tatcaacagt atagttgttt ataataagtt atttattgga atgtgtttat   4080 
attatgaagc atgaaggaag tcctagagag gcataacttg cagtcaaaga acttggagaa   4140 
gcttgatcag ccatctcttg agttacaggt tagctacatt ctcgaaacga ccacacattt   4200 
tctttcccga tttctgtaac ttgcaaaatc gagtattact ccgttgaatt accaatatgt   4260 
tttagattgt tgtatttatt gaccaagaat ctcttaaaac tttgtattaa taggtacaaa   4320 
actttatatt attgcatatg attaattaga ctcgatccat gtagtagtca tgtagagtag   4380 
tcctgtgtag agagttgagc tttagatcat tatggatatg attaagagct taaatcaatg   4440 
ttttattctg ttagctggtt gagaacagtg atcacgcccg aatgagtaaa gaaattgcgg   4500 
acaagagcca ccgactaagg tacgttatat atgtatattc tatgactttt gaactaacta   4560 
tcattttcta actaattttt tttttgatca accactatca ttttctaact gtgtgtttac   4620 
atgatcatat ataggcaaat gagaggagag gaacttcaag gacttgacat tgaagagctt   4680 
cagcagctag agaaggccct tgaaactggt ttgacgcgtg tgattgaaac aaaggttgtt   4740 
aagaaaatta cttgatacca tgtataagtt tctctaagct tacgagtatg caatttacta   4800 
atacgagatg tgtttgcaga gtgacaagat tatgagtgag atcagcgaac ttcagaaaaa   4860 
ggtaataatt aaccaaaata acgtttattc tttacttgat gatttcaata ttaattttgg   4920 
cagtttcaag atccaaaatt ttcatcttct tctctttttt tttggtgttc agggaatgca   4980 
attgatggat gagaacaagc ggttgaggca gcaagtatgt gtcttaccct ctctgttgat   5040 
aacaaatccc tttcttttgt ctaccattaa cgtacacacc cctaaattta atccccagtt   5100 
gtctacaaca catatgtttg atcatactgt gaga                               5134 
</s400>
<s200>
<s210>47 </s210>
<s211>5483 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL24 genomic sequence </s223>
</s220>
</s200>
<s400> 47 
agacttacaa taacttcatc aagcaactca tacacgagca caaagttttt cctgaatgaa     60 
tcttcattca gaacaccaag ataatcctta ataacacgag caatcctttg tagaagctcc    120 
aaaacaagag agggtgacac gttaactctc gttgtcgcaa caaaatatag accaacaacc    180 
ttgacatgga agtagttcac gccatcgaca ttctataagc acaaaaaata agttagatga    240 
aatcattaca gctcacaacc aaacagaaag tataatacct acaaagatag gtggcgcctc    300 
tgcattgcca tcctccttcc agaacttgac tttacggaag aatgtctctg tacttccttt    360 
gggtacctca gcccggtctg tagcaataaa acgttacaca tcttgaaact tgtattggat    420 
ccaaccaaat cgtataatct caaaacaaat agctttcttc tactacatta catacagata    480 
ctctgcccaa actaattgaa tagttttgct atatttgtac aatctgattt ggaaattcag    540 
ctcaacataa tttgtcatcg gataagaaat gttggtagat caaacagatc aatgagctta    600 
gagaagattt caatggaaaa ttctcatgaa acagtgacat aagactcgac tctgaagaga    660 
aaaagcaaaa caggaagaag cagagaggat cagatcgaga aagagagctt acagtcacgg    720 
aagacgatgt tatctcctcg ctgagataag acgaagaatt gggagatcat catcgttcct    780 
tatagcggtg gattccgact gtttcaccgc gagtttggtt aagtctactg atcgccgatc    840 
ggtctcgtct ttttgtgtgt ctggtggtga ggtggttcac gttttaccat ttgccgtcgt    900 
tatcgtgaag cttcttcatg agacggaggg ttctgtgttt ttgtgaatta tgatttcttg    960 
ttcttatatg ggcctatttt taagacatca atatggccca aatttcgaac ttgttatgag   1020 
tttaaggaaa taagtagtaa gtactataaa tgatggttcg atctcggagg agaaaaaaaa   1080 
aaacattgtt tacgaggaag caaaatgtga gttgatataa agggtacaac acataattta   1140 
tttttggaag tcaaaacttt gaggattaag ctgacaacga aggttagtga agactttcgg   1200 
gatcgagcaa tcgggagata tacatgagcc tagagggctg acaagatgac caagcattcc   1260 
aaatgaaagg cttaagattt ttctttttct aaactcaagt aagaaacaca agatatatga   1320 
aagggtaaca agggtcaaca acaagtctaa gctttttaaa cgtgttagat gattcttctt   1380 
gaacactatt acaattactg tttagtttca catttatatg accttgggag tcttctagct   1440 
cgtcccaaat atattttcaa catattacta taagatccta aagaccaata acattgatct   1500 
acaccaaaaa ctctcacttt ctgattttgc actcgctttt tttcctccca taaacaaaac   1560 
caaaggctta caatactaaa tctgtctcac attcttagtg cttatttgtt ttagtcataa   1620 
agaacttaat cttatacaga ttgaagtctt aaagtcatct atattacttt tcacatgtat   1680 
cattatgaga tggtacgttt cccacgaatt ttatcagttt agtttaattt tcagttgtac   1740 
tttgggagaa aaaatttaca agatacttgt cggccatgat atcaccctag agttaccgga   1800 
gtccggtgat atatcatttc taattagggt taaaacttaa aagggtataa atggctgatc   1860 
aaacccaaaa ataaaagata atgatgacgg tgggagacga gtgatcttat caggtgtcgc   1920 
atctagcata tataggtgaa agactataaa aaagacatga aatatttaat agacacaact   1980 
tttgtaataa accaaaacca aaaaggtaga tgaactgatg aacagcatct tctaattacg   2040 
aataaaaaaa gtaaccaaac tttctttcca ttagaattgg tacgtagttc cttgtgtatt   2100 
gtgatttctt tcattttcca attatgtttt tttattttat catgttacat ttttgatagt   2160 
gggtaacttt tgtatcattt tatttgacct agccatatat aaatctatta acttatacgg   2220 
agtagtattt cacgtcattt atttttattt tgtttttaga tgggaagtta ttcaaaacta   2280 
gactaaaaca gtaaaactag gaaacccgct actgaataaa gttacaattc cacattattc   2340 
catgacagac taattgaatt agaaggttag gtaaattatt aaatcataac tgtagcagtc   2400 
tcttcgtctg gcagctcagt cagacaaaac acaaagtgtg tttatgtgtt atttttaatg   2460 
attatagttt gggaaaaaga cataatcaaa agggatacaa aacatatggc ccattgataa   2520 
gtatagatca ctgtttagct aaaaaaagca gactcttttt tccaatcttg aacacaaaca   2580 
cagtcaccat ctctctctct ctttctctct cactcacaca ttagggagta aacagctacc   2640 
agaaaaacct tttttatctt ctcacaaatt taataaagtg ggtgctgaga ttgaataacg   2700 
taatccaaga tcctccaact cacagaaagg taaaagctgt gaatctgtgt tctttcttct   2760 
taagcaaagt gtttgatgaa ttcatctagt cctgtccatt cttttgcttc tcatggttta   2820 
tggatctgat ctctctttct ctctctctct agccattagg gtttcctaag aatattatat   2880 
aaactctctt tagctaacac cgttccaatt ggtttctttc tttgttcttg gtctaaaatc   2940 
taaatggtgt tatgggtata ggcagattca agaacagtag tgaaggagag atctggtaaa   3000 
atggcgagag agaagataag gataaagaag attgataaca taacagcgag acaagttact   3060 
ttctcaaaga gaagaagagg aatcttcaag aaagccgatg aactttcagt tctttgcgat   3120 
gctgatgttg ctctcatcat cttctctgcc accggaaagc tcttcgagtt ctccagctca   3180 
aggtatattc tatctttttg ttagtagttg tcttattttt ttcaatccat gtttgtgttt   3240 
ttgagaatat ggttggataa atatattaag atatgtattt aaatgagatt tttattttct   3300 
cgtttactct ctaaagttaa ttatcagtag gctcggagat ctcatgtacg gcataatttg   3360 
atgacctaaa ttattatact ttaaagtata ggattgatgt tttattactt ttatgtataa   3420 
cacatcatgt atttaattcc gtttaacata atatgggttt ttaacgtgta atttttcaat   3480 
cattttcatt tagactcatg gttaagattt ctgtactggg aaataagaga gcagaatatt   3540 
atagtgtgat ttttgttaat taggaaagca tatgtatata tggatacata gtacttacca   3600 
caattagaat gaatttcttt tccctttttt catttgactt tgtgtattac aaaagtcttt   3660 
gacactgtca cttggtatga ttggggatta attcttaacc actcgtttag tttatcttgg   3720 
gaagcattac cataattggg aaacgagtca tctgtctgta tcgtgatggc tacttctgat   3780 
tacttttctt ttattataac caaaaaggct tctaatgtac ttaattaatt ttacaaatgt   3840 
aatatggacg aaggaaatgt ttataagaaa gatggattgt ttgttgaaac gtgtagaatg   3900 
agagacatat tgggaaggta tagtcttcat gcaagtaaca tcaacaaatt gatggatcca   3960 
ccttctactc atctccgggt attttcgata tcacttactc tttttttttt ttgtggattt   4020 
taaactctct gctcttttta ccaaaccctt ctctttttat caaacccttc tctctataat   4080 
attatccgat gttcactttg ttacacgtgt ttgttataat ttttagctgt aagtctaaat   4140 
atagaaacat tgagtggcat ataatcatta atcttgaagc atctaattaa ttggttttac   4200 
atattaatag cagaatcctg aaactgttga ctttgcatct agcagcttga gaattgtaac   4260 
ctctccagac taagtaagga agtcgaagac aaaaccaagc agctacggta tggctccatt   4320 
gatatgttat gcagataaac ctattttcat ataggctata gctgtaagag atcatctatt   4380 
tcatgtgtgt ggtttttttt tttatgtttt ttcaatgatg tgtgcatgct atttttaggt   4440 
tttagaatct atttcatgga aattgaagat atttcatttc acgtgtaagt tcgtcaagtt   4500 
gtggcgtgtg tcttggaaat tgatgttttg tttgtagatt ttaagagcta cttctaaaat   4560 
ttacaagagt tttgtaattt tcaattatgg cccattattc tcattaattc attaaaaaaa   4620 
ttatatacat tactatctat atctagcata ggtagttttt tttttctttt tctttggtag   4680 
acctactgaa caaatatctg atatatcact gactggataa atatctatag agatattttt   4740 
gatagaaatg agtgttaatt taacgtaaaa caggaaactg agaggagagg atcttgatgg   4800 
attgaactta gaagagttgc agcggctgga gaaactactt gaatccggac ttagccgtgt   4860 
gtctgaaaag aaggtttact actatacata aactaatagc atgcatattt tccttaacgt   4920 
ggcatataaa taataagctg tacatatata aaagtttgac tttgttgttg ttattggtaa   4980 
atagggcgag tgtgtgatga gccaaatttt ctcacttgag aaacgggtta gtagttagta   5040 
catacaattc gtataactaa tggatcataa gcctatctat agctagtgac tttcttaata   5100 
agtgaaacag ggatcggaat tggtggatga gaataagaga ctgagggata aagtacggct   5160 
ctaaaccctt atagatatca tggaataacc ttaatctatt tttttatgta taagaaaata   5220 
tgatgaggga acgtatatta tatatcggca gctagagacg ttggaaaggg caaaactgac   5280 
gacgcttaaa gaggctttgg agacagagtc ggtgaccaca aatgtgtcaa gctacgacag   5340 
tggaactccc cttgaggatg actccgacac ttccctgaag cttgggtata atttgtttaa   5400 
ctgaacatat ttcaaacttt ttgttgacat tttgtatgtg gatgtttact aactgtttgt   5460 
tggttaggct tccatcttgg gaa                                           5483 
</s400>
<s200>
<s210>48 </s210>
<s211>7200 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>AGL27 genomic sequence </s223>
</s220>
</s200>
<s400> 48 
caaccagcag caccagctgc aatcaaatcc tttacggttc tttgaatgtt tagcgcattt     60 
cctccaccgg tatcttgaaa agatcaaaag aaacctatga agagaactat aaccaagcaa    120 
atccactatt ttcaaaaagc tatgaagaga actataagca agcaagcgac tctaaccaag    180 
aaagattgat actttcaatc tttggtaaag aatcaacgac tcaatgtttt taaatgtttt    240 
ttttcctttt ttggttttag ttaagcttct tgcattcttt aatgatgtct ttattatact    300 
atcaaaattt tgcaacttta ccagcatctg caatgatggg tatattagga gctgacgcac    360 
acaccgacct tgccgtcgca gccatctccg gtggtctaaa acgacgaaag aacacaaata    420 
aaacgaaagc atacaaacaa aaaattacta aagaaagaaa aaaaaaaagg tggcgcacgt    480 
tagcaaaccg aaatcgggtt ttcccaggag agaagcggat aaggcgtaac cggatataaa    540 
accagcggag aatccggttt gctgcacaat agccgcggat aaggcatcgt agcatccagg    600 
cataagcaca atgccttgtt cttcaatcag gcgatgaaaa cgtgtttgga ttctcgctgt    660 
cggattcacc aatctcgccg cgcgtgggtt ccgtcggaat gttggtgaag ctgtaaggtt    720 
taagctgcta caacagagtg aagttgtttt gacagccatt aacatcgaca ttcttcgaag    780 
cctcgaacaa gttttttctt ctctctaatc gagttagact ctgacccaca cgcttgggat    840 
tttaatagag agcacgtggt tattatatct cggtcttatc ttatggtaac agtatctcaa    900 
agactcaaac cacaaggtat tgtgaaaatg ttagaggcaa tctaacaata aatgtataat    960 
ttggttagct taagctcatc atagaaatgg gcctttatgt caccaaacct atttcacaac   1020 
ataacacaag agcccacaaa acaacgactc ctttctccac cagaacaagc acgacaaagg   1080 
caagagagtt gcaaaagacc tataagatga taacaatcga aaagatgtaa attttgagaa   1140 
aaatcaaaat aaacaagaaa gatttcattg tttttcactt tttctccatt tctactttga   1200 
ttttacatac tctatgggcc aaccaatttc caacctaatg cttgataaaa aatgattcgg   1260 
ttttactatc tcaacaaatt gggcctacaa catccaattt catgtagtga cttgtttttg   1320 
cctttttcac atctcaacaa attgggtcgt ttgtatttaa gaaattgtta cagcttttta   1380 
gactgaattt tactttatgg ctttatgctc tctttttccg ttttgattaa gggtgaatat   1440 
gtaaactgtt gataccatct gatttttttt attttttatt tttcttgtgt gcaactatac   1500 
catctgaatt caattgacat tttagccaaa taaaaaagat tggtccactt ggatggctgt   1560 
aaaaaagttt agtggaagta tttatagggc ttgttggcaa tcttcaccaa cggctataat   1620 
gttgatcttt ttaaaattaa acttaccgtt cgactgtctt ctcaacgatt tgacaattag   1680 
ccgttagatt agtattactg atttattatt aacaaaccca tttcttttct tatttttgaa   1740 
taagctaaat caggccaata aaagggacaa gtagagatgg gctatttctt tttttctctt   1800 
tttttttttc ttatgtagta gagaaaagcc tttattctta gagctatcat ttaccaccca   1860 
ttaaccagaa gctgagaaat gaagcaagcc gaaacgaatt tgtagttttg gacggtgaaa   1920 
ttatatcggg cctttaatgg gcatgtgaat agagttgaga gtctttttgc cccaaataat   1980 
cgtttaaggg agtattggct cgttggttta atattgggcc gaaacgagat tgggaagaag   2040 
aacaatgtcg gtttaatccg gttagggtcg tgggctgatt ctggttcacc tttatagcgt   2100 
aagcgaacaa acattgaaaa tggggaagcc aaattagtta ccatccctaa ctcagttttg   2160 
agacgtagta tgaatgagcc acggcagaac ctacgaccta actcgataaa gtaatggtta   2220 
ctcttggaga cggaagaaag cacaaagatt ttgataaggc tttctagttg gtgaaatggt   2280 
caaaatcgct cggagagcca tcataggagc ggggaggtgc tatctgaata tcccaatgca   2340 
tcaagacaag atggattcag aaaacaaaga aattaaacaa acattttaaa atatgctctt   2400 
agttttagat aatataatgt tttcaatacc aattatctta cactgatagt ggtcaagtta   2460 
ctaatcactt ttaataaatt ggtgatagtc aaacgtattg aaaattatcg atttaaaaat   2520 
atttgaattc aaaaccattt tagtgaaagt ttgcattgta gttttgatta tccgatcaat   2580 
ctttaatata attacgtcaa taataactga aatccttgaa ttaaccgtta cccgattcat   2640 
aagcactact ttccgatcaa aaccaatgag ataaaataac ttttaaaccc tccaaataaa   2700 
aagagaaaac cttaaaaacc aatttctgtt cggtggggat gatgatcgga ctcggaccgg   2760 
tctaaccgac tggattaaaa agtctttaac aacgacaagc ttaaaaattt gcctcttagt   2820 
ggcttcaaaa cgcaatcgtt tcgcttaata ctattatttt ctctatctcg tttaaccaaa   2880 
aaaaaaaacg agttggagga aaaaaaaaac caagaaaaaa gaataaaaag caaaaagcat   2940 
tgagcgtctc cggagattag gattaaatta gggcataacc cttatcggag atttgaagcc   3000 
atgggaagaa gaaaaatcga gatcaagcga atcgagaaca aaagcagtcg acaagtcact   3060 
ttctccaaac gacgcaatgg tctcatcgac aaagctcgac aactttcgat tctctgtgaa   3120 
tcctccgtcg ctgttgtcgt cgtatctgcc tccggaaaac tctatgactc ttcctccggt   3180 
gacgagtaag aagatacttt ccttttctgg gtctcactcg atttttgtgc ttttttactt   3240 
tgtttaatta ctttctccat atagaagctt caaatctagg gctttttgat tccatcaaat   3300 
caactgagat tttctccttg ttttctgtat gaagatagca gatgcgtaag ctttaaccta   3360 
atttaagact aaacattttg atcgccaaga tatgttcttg atgttcgttt cgtgtttttt   3420 
ttttcgtgtt tttttttttt tcattttaaa atcattttta tctctttttt taccttcatt   3480 
tgtgacgaaa tttaatattg catgttattc aagaaacttt tctacacgtg gtgattcgtt   3540 
cttgatgttg tttaagtaat ctttgtattg ctagttccat ctgttgttca ctttgaagct   3600 
tcgttttttc atataagaaa caatatgttt agattgttca aattttgaga tttggtaatt   3660 
atattcaata ttgcaatgca cttcaagtag ttttgttgag agattatttg gggttagtgg   3720 
taacattaat cgaatatctt tggttcaaat tggttaacac attgtacttt atgttgatcc   3780 
aaaatgtatt gtagatcttt tcttttgtaa ttctctttaa ggaataaggt ttatctagtt   3840 
gattttgatg gtttattgta gtgctgggat aagtttccac attgatactc gccacacatt   3900 
cttcattact taactaattg gatatcgatt ttaacccttt taatcgtaat ttgttgtgtg   3960 
tttatgacac catacaagat acattatgtc ttactgagtg actctttgtt gctctctaag   4020 
atgttgtagt ttggatttct ttgctaaaga aactcaaact ataactgatt ttactgctac   4080 
catatatatg tcagtggcct agtaggttca ttaagtagaa atcggtcgcc aattttacta   4140 
attgggagaa accactagac tacaaccaaa tgttcaatga ctttaatagt cttctgttat   4200 
ttgtcgtgga tatttttaac cccatgaact tttgtatcta gaaaaatctc atccacttct   4260 
cttttagaat actttgaatg cgactaaaag tgagtttttt ttttctaata gacctaagat   4320 
aaaatcatca atggataagt aggaaatgga aaggtaactc ttgtcagtat gtgtatatat   4380 
acagctcctt ctcatttcct tgatgttgac tccataaatg cttgatcatg aaagcaaatt   4440 
tgttaaattt gtaaccaaca aaatgcacag actatagacg aagtattagg aaccgtatct   4500 
atctgtctcc attttacaat agtcaagctc tagttgtagc tagtttcttt atttagttct   4560 
tataccttaa caaagtggca ctatgcaaag tgtttttagt tgagattagt cgtcttatgc   4620 
gtcttactaa ttgttcattt tttcttcttt ttgtgattga tgtaaaatta ctaagtcaca   4680 
acttgagatg ttactaaaaa gataagaacg tgtaataact gaagtgaatt tgaagccagt   4740 
ctctattcat atcatagcat taatagatca tggacaacac atatatagga ttagagctgt   4800 
catgaccttc ccggaaatgc taaatcagtt tcttggttta tcctttttgg agtatcatga   4860 
tatcatttag ccaaaggttt ttggtttcag tattccgatt cgtttgacgt tatgtgtgaa   4920 
agcgtcaata actaaaactt ggattgacta gtcaaaatat aaactgattg cattgaattc   4980 
ttgaaaattt tcccttaaaa tgaacatgaa tttcatcaag attttgtctt ttggaaggat   5040 
gtgatttata atctatacaa tcatacattt tgcatgatat tagttttttg aagaaccaaa   5100 
aatagagctt ctttataaaa ctgatttagc cttgataaga aaaagaaggt agataatcga   5160 
actcatgggg atgagttaaa aatgtgtgca cttagtttct aaaacctttt gaagtcgaaa   5220 
caatgacaat attggctgcg aagttgatat ataacaggat cttaaagttg aaattgtaaa   5280 
ttcagatttt aattttagag caccagatga tcagagtttc agatttacat ttgaagtata   5340 
aaacattttg aacacatata tctaaagcag taacttcaaa aatagggtaa ctaatagtaa   5400 
cttacattgt tttttttaat gcttttatac ttactatcat ttttatatat agatgcctgg   5460 
ttaagtaaag atgattatca aaaactgttg gttagtaaca gaaattgttg caaatgtaac   5520 
atattatata agctttcttt cactttggtg cattctctct aaataatggc ctctattgat   5580 
gcagtatctg attcttagtt ttgaaatggt ttttgcataa attattgttc taatgcattt   5640 
ttgttttatc tccagcattt ccaagatcat tgatcgttat gaaatacaac atgctgatga   5700 
acttagagcc ttagtaagta attagctaag aacgtcattc taatattctt ctggatgcgg   5760 
tttttggtgt tatgaaggat agaagcgctg ttcaagccgg agaaacctca atgttttgaa   5820 
ctcgtaacac cgaacttaat tctctagagt tacagttatt gtgtctactg gaaaatacaa   5880 
gaacttcaca atctttctga ccattccttt tcttcatgtg caggatcttg aagaaaaaat   5940 
tcagaattat cttccacaca aggagttact agaaacagtc caaaggttag cagtacgaca   6000 
catttttctc ccctcttctt ctgataaaaa aaatgttttt tttcttttgt ctacttgtga   6060 
atacagcaag cttgaagaac caaatgtcga taatgtaagt gtagattctc taatttctct   6120 
ggaggaacaa cttgagactg ctctgtccgt aagtagagct aggaaggtat atgtgctgct   6180 
actaagtgat tcaaccaatt actccacaaa accttctttt tagttagtta tcctagaaca   6240 
atcttttgac ataaatctta atgtcttgtt ataggcagaa ctgatgatgg agtatatcga   6300 
gtcccttaaa gaaaaggtta gtgctttggt ttttattttc gataaaggcc atattctagg   6360 
ctatgatgat tcttgaattc tattaacctg ctgagtctac agattactat atatatatat   6420 
atatatcttt tggtcttgtc ttagttcctg atttagtatt ggcttcattc aggtgaaacc   6480 
ctaatgagaa ttaaaaaaac aagcagtttt aaactcttga tcaaatccaa cctttccctc   6540 
ataaagtgtc gaatttggat gaggatgatt tatgtttcga gaaggaaaca tgtttggaaa   6600 
tagctataga agttgttaga aactaatgac cttatgatct tttccaaaca ggagaaattg   6660 
ctgagagaag agaaccaggt tctggctagc caggtaacaa tgaccacaat atcttctgct   6720 
cttgaagcta attaatcact ttatacgtcc ccgttataga gagatacaca tatacacgta   6780 
catgaaaact aaaagttgaa ggactttgat ggatactaga caattatagt gaaaccctaa   6840 
atatgtgata agtgataaca aaatgctttt aaaatctatc tttcttgtta atttagtagc   6900 
tgtcagagaa gaaaggtatg tctcaccgat gaaagatact caaaacccgg tatttttaat   6960 
ttgtgaaatt tgcaaataaa aaaaatgctt tctacaagat agattaattt cttgcaatgt   7020 
ttagtagctg tagaaaaaaa agaaatgtaa gaaagtttct tacagatggg aaagaatacg   7080 
ttgctggcaa cagatgatga gagaggaatg tttccgggaa gtagctccgg caacaaaata   7140 
ccggagactc tcccgctgct caattagcca ccatcatcaa cggctgagtt ttcaccttaa   7200 
</s400>
<s200>
<s210>49 </s210>
<s211>579 </s211>
<s212>DNA </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s221>CDS </s221>
<s222>(1)..(579) </s222>
<s223>alternatively spliced AGL27 </s223>
</s220>
</s200>
<s400> 49 
atg gga aga aga aaa atc gag atc aag cga atc gag aac aaa agc agt       48 
Met Gly Arg Arg Lys Ile Glu Ile Lys Arg Ile Glu Asn Lys Ser Ser 
  1               5                  10                  15 
cga caa gtc act ttc tcc aaa cga cgc aat ggt ctc atc gac aaa gct       96 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Ile Asp Lys Ala 
             20                  25                  30 
cga caa ctt tcg att ctc tgt gaa tcc tcc gtc gct gtt gtc gtc gta      144 
Arg Gln Leu Ser Ile Leu Cys Glu Ser Ser Val Ala Val Val Val Val 
         35                  40                  45 
tct gcc tcc gga aaa ctc tat gac tct tcc tcc ggt gac gag ata gaa      192 
Ser Ala Ser Gly Lys Leu Tyr Asp Ser Ser Ser Gly Asp Glu Ile Glu 
     50                  55                  60 
gcg ctg ttc aag ccg gag aaa cct caa tgt ttt gaa ctc gat ctt gaa      240 
Ala Leu Phe Lys Pro Glu Lys Pro Gln Cys Phe Glu Leu Asp Leu Glu 
 65                  70                  75                  80 
gaa aaa att cag aat tat ctt cca cac aag gag tta cta gaa aca gtc      288 
Glu Lys Ile Gln Asn Tyr Leu Pro His Lys Glu Leu Leu Glu Thr Val 
                 85                  90                  95 
caa agc aag ctt gaa gaa cca aat gtc gat aat gta agt gta gat tct      336 
Gln Ser Lys Leu Glu Glu Pro Asn Val Asp Asn Val Ser Val Asp Ser 
            100                 105                 110 
cta att tct ctg gag gaa caa ctt gag act gct ctg tcc gta agt aga      384 
Leu Ile Ser Leu Glu Glu Gln Leu Glu Thr Ala Leu Ser Val Ser Arg 
        115                 120                 125 
gct agg aag gca gaa ctg atg atg gag tat atc gag tcc ctt aaa gaa      432 
Ala Arg Lys Ala Glu Leu Met Met Glu Tyr Ile Glu Ser Leu Lys Glu 
    130                 135                 140 
aag gag aaa ttg ctg aga gaa gag aac cag gtt ctg gct agc cag atg      480 
Lys Glu Lys Leu Leu Arg Glu Glu Asn Gln Val Leu Ala Ser Gln Met 
145                 150                 155                 160 
gga aag aat acg ttg ctg gca aca gat gat gag aga gga atg ttt ccg      528 
Gly Lys Asn Thr Leu Leu Ala Thr Asp Asp Glu Arg Gly Met Phe Pro 
                165                 170                 175 
gga agt agc tcc ggc aac aaa ata ccg gag act ctc ccg ctg ctc aat      576 
Gly Ser Ser Ser Gly Asn Lys Ile Pro Glu Thr Leu Pro Leu Leu Asn 
            180                 185                 190 
tag                                                                  579 
</s400>
<s200>
<s210>50 </s210>
<s211>192 </s211>
<s212>PRT </s212>
<s213>Arabidopsis thaliana </s213>
<s220>
<s223>alternatively spliced AGL27 </s223>
</s220>
</s200>
<s400> 50 
Met Gly Arg Arg Lys Ile Glu Ile Lys Arg Ile Glu Asn Lys Ser Ser 
  1               5                  10                  15 
Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gly Leu Ile Asp Lys Ala 
             20                  25                  30 
Arg Gln Leu Ser Ile Leu Cys Glu Ser Ser Val Ala Val Val Val Val 
         35                  40                  45 
Ser Ala Ser Gly Lys Leu Tyr Asp Ser Ser Ser Gly Asp Glu Ile Glu 
     50                  55                  60 
Ala Leu Phe Lys Pro Glu Lys Pro Gln Cys Phe Glu Leu Asp Leu Glu 
 65                  70                  75                  80 
Glu Lys Ile Gln Asn Tyr Leu Pro His Lys Glu Leu Leu Glu Thr Val 
                 85                  90                  95 
Gln Ser Lys Leu Glu Glu Pro Asn Val Asp Asn Val Ser Val Asp Ser 
            100                 105                 110 
Leu Ile Ser Leu Glu Glu Gln Leu Glu Thr Ala Leu Ser Val Ser Arg 
        115                 120                 125 
Ala Arg Lys Ala Glu Leu Met Met Glu Tyr Ile Glu Ser Leu Lys Glu 
    130                 135                 140 
Lys Glu Lys Leu Leu Arg Glu Glu Asn Gln Val Leu Ala Ser Gln Met 
145                 150                 155                 160 
Gly Lys Asn Thr Leu Leu Ala Thr Asp Asp Glu Arg Gly Met Phe Pro 
                165                 170                 175 
Gly Ser Ser Ser Gly Asn Lys Ile Pro Glu Thr Leu Pro Leu Leu Asn 
            180                 185                 190 
</s400>
<s200>
<s210>51 </s210>
<s211>31 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SEP3-5&prime;K </s223>
</s220>
</s200>
<s400> 51 
ccgtcgaccc atgagccagc aggagtatct c                                    31 
</s400>
<s200>
<s210>52 </s210>
<s211>28 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SEP3-3&prime;Kbox </s223>
</s220>
</s200>
<s400> 52 
ccgcggccgc cttactctga agatcgtt                                        28 
</s400>
<s200>
<s210>53 </s210>
<s211>31 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SOC1-5&prime;K </s223>
</s220>
</s200>
<s400> 53 
ccgtcgaccc atgaaatatg aagcagcaaa c                                    31 
</s400>
<s200>
<s210>54 </s210>
<s211>28 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SOC1-3&prime;Kbox </s223>
</s220>
</s200>
<s400> 54 
ccgcggccgc ctccttttgc ttgagctg                                        28 
</s400>
<s200>
<s210>55 </s210>
<s211>28 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SOC1-C/2 </s223>
</s220>
</s200>
<s400> 55 
ccgcggccgc actttcttga ttcttatt                                        28 
</s400>
<s200>
<s210>56 </s210>
<s211>31 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SVP-5&prime;K </s223>
</s220>
</s200>
<s400> 56 
ccgtcgaccc atgagtgatc acgcccgaat g                                    31 
</s400>
<s200>
<s210>57 </s210>
<s211>28 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer SVP-3&prime;Kbox </s223>
</s220>
</s200>
<s400> 57 
ccgcggccgc tccctttttc tgaagttc                                        28 
</s400>
<s200>
<s210>58 </s210>
<s211>31 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer AGL24-5&prime;K </s223>
</s220>
</s200>
<s400> 58 
ccgtcgaccc atgcttgaga attgtaacct c                                    31 
</s400>
<s200>
<s210>59 </s210>
<s211>28 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequencePCR oligo 
      primer AGL24-3&prime;Kbox </s223>
</s220>
</s200>
<s400> 59 
ccgcggccgc ctcaagtgag aaaatttg                                        28 
</s400>
<s200>
<s210>60 </s210>
<s211>21 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequenceRT-PCR oligo 
      OAM37 </s223>
</s220>
</s200>
<s400> 60 
tagaaacatc atcttaaaaa t                                               21 
</s400>
<s200>
<s210>61 </s210>
<s211>26 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial SequenceRT-PCR oligo 
      SEP3-5&prime;</s223>
</s220>
</s200>
<s400> 61 
ccggatccaa aatgggaaga gggaga                                          26
</s400>
</sequence-list-new-rules>
</sequence-cwu>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A non-naturally occurring seed plant, the plant comprising: 
<claim-text>a first ectopically expressed polynucleotide encoding an APETALA1 gene product at least 50% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8 or a CAULIFLOWER gene product at least 50% identical to SEQ ID NO:10 or SEQ ID NO:12; and </claim-text>
<claim-text>a second ectopically expressed nucleic acid molecule encoding a SEP1 gene product at least 50% identical to SEQ ID NO:28, a SEP2 gene product at least 50% identical to SEQ ID NO:30, a SEP3 gene product at least 50% identical to SEQ ID NO:32 or an AGL24 gene product at least 50% identical to SEQ ID NO:38. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, which is characterized by early reproductive development. </claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein expression of the first ectopically expressed polynucleotide is increased in a tissue of a plant compared to a wild type plant. </claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein expression of the second ectopically expressed polynucleotide is increased in a tissue of a plant compared to a wild type plant. </claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein expression of the first ectopically expressed polynucleotide is decreased in a tissue of a plant compared to a wild type plant. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein expression of the second ectopically expressed polynucleotide is decreased in a tissue of a plant compared to a wild type plant. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, comprising an endogenous first ectopically expressed polynucleotide comprising a modified gene regulatory element. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, comprising an endogenous second ectopically expressed polynucleotide comprising a modified gene regulatory element. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the non-naturally occurring seed plant is a transgenic plant comprising a first exogenous gene regulatory element operably linked to the first ectopically expressible polynucleotide and a second exogenous gene regulatory element operably linked to the second ectopically expressible polynucleotide. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the first polynucleotide is operably linked to the first exogenous gene regulatory element in a sense orientation. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the first polynucleotide is operably linked to the first exogenous gene regulatory element in an antisense orientation. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the second polynucleotide is operably linked to the second exogenous gene regulatory element in a sense orientation. </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference>, wherein the second polynucleotide is operably linked to the second exogenous gene regulatory element in an antisense orientation. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes an APETALA1 gene product at least 50% identical to a polypeptide selected from the group comprising SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8. </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes an APETALA1 gene product comprising a polypeptide selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8. </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:2. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:4. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:6. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00011">claim 15</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:8. </claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes a CAULIFLOWER gene product at least 50% identical to a polypeptide selected from the group consisting of SEQ ID NO:10 and SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide is a CAULIFLOWER gene product comprising a polypeptide selected from the group consisting of SEQ ID NO:10 and SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:10. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00022">claim 21</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide encodes an SEP1 gene product at least 50% identical to SEQ ID NO:28. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP1 gene product comprising SEQ ID NO:28. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide encodes an SEP2 gene product at least 50% identical to SEQ ID NO:30. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00022">claim 26</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP2 gene product comprising SEQ ID NO:30. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide encodes an SEP3 gene product at least 50% identical to SEQ ID NO:32. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00022">claim 28</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP3 gene product comprising SEQ ID NO:32. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an AGL24 gene product at least 50% identical to SEQ ID NO:38. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. The non-naturally occurring seed plant of <dependent-claim-reference depends_on="CLM-00033">claim 30</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an AGL24 gene product comprising SEQ ID NO:38. </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. A method of modulating the timing of reproductive development in a plant, the method comprising, 
<claim-text>ectopically expressing a first polynucleotide encoding an APETALA1 gene product at least 50% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8 or a CAULIFLOWER gene product at least 50% identical to SEQ ID NO:10 or SEQ ID NO:12; and </claim-text>
<claim-text>ectopically expressing a second nucleic acid molecule encoding a SEP1 gene product at least 50% identical to SEQ ID NO:28, a SEP2 gene product at least 50% identical to SEQ ID NO:30, a SEP3 gene product at least 50% identical to SEQ ID NO:32 or an AGL24 gene product at least 50% identical to SEQ ID NO:38. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference> comprising, 
<claim-text>introducing a first ectopically expressed nucleic acid molecule comprising a first polynucleotide encoding an APETALA1 gene product at least 50% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8 or a CAULIFLOWER gene product at least 50% identical to SEQ ID NO:10 or SEQ ID NO:12; and </claim-text>
<claim-text>introducing a second ectopically expressed nucleic acid molecule comprising a second polynucleotide encoding a SEP1 gene product at least 50% identical to SEQ ID NO:28, a SEP2 gene product at least 50% identical to SEQ ID NO:30, a SEP3 gene product at least 50% identical to SEQ ID NO:32 or an AGL24 gene product at least 50% identical to SEQ ID NO:38. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the first and second ectopically expressed nucleic acid molecules each comprise a gene regulatory element operably linked to the first and second polynucleotides. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the first polynucleotide is operably linked to the gene regulatory element in a sense orientation. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the first polynucleotide is operably linked to the gene regulatory element in an antisense orientation. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the second polynucleotide is operably linked to the gene regulatory element in a sense orientation. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the second polynucleotide is operably linked to the gene regulatory element in an antisense orientation. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein expression of the first polynucleotide is increased in a tissue of the plant compared to a wildtype plant. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein expression of the first polynucleotide is decreased in a tissue of the plant compared to a wildtype plant. </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein expression of the second polynucleotide is increased in a tissue of the plant compared to a wildtype plant. </claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein expression of the second polynucleotide is decreased in a tissue of the plant compared to a wildtype plant. </claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the gene regulatory element is constitutive. </claim-text>
</claim>
<claim id="CLM-00044">
<claim-text><highlight><bold>44</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the gene regulatory element is inducible. </claim-text>
</claim>
<claim id="CLM-00045">
<claim-text><highlight><bold>45</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference>, wherein the gene regulatory element is tissue-specific. </claim-text>
</claim>
<claim id="CLM-00046">
<claim-text><highlight><bold>46</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference>, wherein the timing of reproductive development is early compared to a wild type plant grown under the same conditions. </claim-text>
</claim>
<claim id="CLM-00047">
<claim-text><highlight><bold>47</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference>, wherein the timing of reproductive development is late compared to a wild type plant grown under the same conditions. </claim-text>
</claim>
<claim id="CLM-00048">
<claim-text><highlight><bold>48</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide is an APETALA1 gene product is at least 50% identical to a polypeptide selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 or SEQ ID NO:8. </claim-text>
</claim>
<claim id="CLM-00049">
<claim-text><highlight><bold>49</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 48</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide is an APETALA1 gene product comprises a polypeptide selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6 and SEQ ID NO:8. </claim-text>
</claim>
<claim id="CLM-00050">
<claim-text><highlight><bold>50</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 49</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:2. </claim-text>
</claim>
<claim id="CLM-00051">
<claim-text><highlight><bold>51</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 49</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:4. </claim-text>
</claim>
<claim id="CLM-00052">
<claim-text><highlight><bold>52</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 49</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:6. </claim-text>
</claim>
<claim id="CLM-00053">
<claim-text><highlight><bold>53</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00044">claim 49</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:8. </claim-text>
</claim>
<claim id="CLM-00054">
<claim-text><highlight><bold>54</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide is a CAULIFLOWER gene product is at least 50% identical to a polypeptide s elected from the group consisting of SEQ ID NO: 10 and SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00055">
<claim-text><highlight><bold>55</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 54</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide is a CAULIFLOWER gene product comprises a polypeptide selected from the group consisting of SEQ ID NO:10 and SEQ ID NO:12. </claim-text>
</claim>
<claim id="CLM-00056">
<claim-text><highlight><bold>56</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 54</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:10. </claim-text>
</claim>
<claim id="CLM-00057">
<claim-text><highlight><bold>57</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 54</dependent-claim-reference>, wherein the first ectopically expressed polynucleotide encodes SEQ ID NO:10. </claim-text>
</claim>
<claim id="CLM-00058">
<claim-text><highlight><bold>58</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP1 gene product is at least 50% identical to SEQ ID NO:28. </claim-text>
</claim>
<claim id="CLM-00059">
<claim-text><highlight><bold>59</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00055">claim 58</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP1 gene product comprising SEQ ID NO:28. </claim-text>
</claim>
<claim id="CLM-00060">
<claim-text><highlight><bold>60</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP2 gene product is at least 50% identical to SEQ ID NO:30. </claim-text>
</claim>
<claim id="CLM-00061">
<claim-text><highlight><bold>61</bold></highlight>. The method of claim <highlight><bold>60</bold></highlight>, wherein the second ectopically expressed polynucleotide is an SEP2 gene product comprises SEQ ID NO:30. </claim-text>
</claim>
<claim id="CLM-00062">
<claim-text><highlight><bold>62</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an SEP3 gene product is at least 50% identical to SEQ ID NO:32. </claim-text>
</claim>
<claim id="CLM-00063">
<claim-text><highlight><bold>63</bold></highlight>. The method of claim <highlight><bold>62</bold></highlight>, wherein the second ectopically expressed polynucleotide is an SEP3 gene product comprises SEQ ID NO:32. </claim-text>
</claim>
<claim id="CLM-00064">
<claim-text><highlight><bold>64</bold></highlight>. The method of <dependent-claim-reference depends_on="CLM-00033">claim 33</dependent-claim-reference>, wherein the second ectopically expressed polynucleotide is an AGL24 gene product is at least 50% identical to SEQ ID NO:38. </claim-text>
</claim>
<claim id="CLM-00065">
<claim-text><highlight><bold>65</bold></highlight>. The method of claim <highlight><bold>64</bold></highlight>, wherein the second ectopically expressed polynucleotide is an AGL24 gene product comprises SEQ ID NO:38. </claim-text>
</claim>
</subdoc-claims>
</patent-application-publication>
